data_2l7e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l7e _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.235 0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -129.57 119.26 47.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.153 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? -138.29 107.46 6.06 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.507 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -130.65 131.87 45.12 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.75 0.31 . . . . 0.0 110.833 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.3 t -126.37 139.86 52.95 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' CD1' HD11 ' A' ' 88' ' ' ILE . 1.5 tt -106.47 121.79 59.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.584 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.404 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 26.2 mtt180 -124.29 118.31 26.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pt -120.28 127.16 75.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.18 130.9 55.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.954 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 83.7 m -130.71 129.41 42.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.175 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 12.7 mp0 -140.48 155.12 46.77 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.092 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.74 149.1 29.36 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.384 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -139.92 119.62 13.29 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.199 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.9 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.721 0.296 . . . . 0.0 110.927 179.737 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -129.05 164.97 22.1 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.744 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.42 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 1.2 tt0 -115.2 159.29 21.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.709 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -159.73 142.33 13.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.37 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.04 133.84 25.33 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 tp -146.04 122.89 3.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.271 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.35 139.87 48.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.056 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mt -125.87 112.13 29.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.798 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.404 ' CG2' ' HB2' ' A' ' 10' ' ' ARG . 27.7 m -122.7 157.39 27.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.574 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 8' ' ' THR . 0.2 OUTLIER -171.62 172.45 4.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.558 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.6 mt -98.76 165.89 11.57 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.036 0.446 . . . . 0.0 111.235 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -166.04 -48.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.547 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -78.3 -10.36 59.64 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.091 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.61 -37.06 8.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.05 49.76 0.86 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.679 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? 62.34 117.81 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.101 0.477 . . . . 0.0 111.447 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.58 32.9 0.93 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.394 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.2 mt -127.12 131.95 24.09 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.23 158.62 48.58 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.782 2.321 . . . . 0.0 112.622 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.95 -74.35 0.62 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.331 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.3 m -108.13 -60.25 1.75 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.737 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.4 mt -119.63 -83.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.786 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.1 t80 55.69 96.83 0.02 OUTLIER 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.129 0.49 . . . . 0.0 111.383 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.48 119.76 0.79 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.286 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.9 120.88 43.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.502 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 t -120.39 115.67 47.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.416 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 2.3 mp -94.24 147.93 5.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.359 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -139.03 132.68 30.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.596 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -152.41 142.32 22.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.236 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.0 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 CA--C 1.531 0.345 0 CA-C-O 120.747 0.228 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.416 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -88.2 143.72 26.88 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.945 0.403 . . . . 0.0 111.287 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -133.02 146.61 51.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.788 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.59 116.8 12.62 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.861 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -162.57 -45.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -141.07 27.76 1.94 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.893 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.77 157.77 70.33 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.201 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.87 170.51 17.72 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.912 2.408 . . . . 0.0 112.125 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.6 158.23 51.13 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.68 2.253 . . . . 0.0 112.401 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.83 158.12 21.44 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.425 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -171.53 103.87 0.2 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.746 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.99 123.6 64.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.052 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.34 114.42 10.11 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.92 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.08 178.95 9.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.213 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.42 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.0 mt-30 -105.39 138.99 40.7 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.73 -173.17 42.96 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.887 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -112.1 109.75 19.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.607 0.241 . . . . 0.0 110.646 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.6 -117.22 0.6 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.319 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.41 91.79 1.82 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.655 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.552 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 36.4 m-85 -150.93 166.82 14.23 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 120.701 0.286 . . . . 0.0 111.267 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.34 159.52 39.4 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.151 2.568 . . . . 0.0 112.927 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.7 121.8 6.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.811 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.05 146.33 50.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.401 HD11 ' CD1' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -129.38 128.47 66.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 111.145 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.0 p -111.32 131.18 55.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 2.9 p -116.02 142.75 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.706 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -139.09 150.4 45.67 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.088 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.402 HD11 ' CG2' ' A' ' 120' ' ' ILE . 1.1 tm? -137.18 -49.02 0.61 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.26 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.55 -64.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.322 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.55 -54.19 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.079 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.97 44.24 2.48 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.989 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -105.08 -50.76 3.17 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.288 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.13 26.07 0.31 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.006 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 20.2 mt-10 -70.32 100.42 1.72 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.663 0.268 . . . . 0.0 110.772 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -142.7 156.45 45.03 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.525 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 134.69 41.74 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.328 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.46 119.69 23.21 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 121.009 0.433 . . . . 0.0 111.909 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.67 151.44 10.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.275 2.65 . . . . 0.0 112.548 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 112' ' ' TYR . 7.3 m80 -147.77 167.0 25.83 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.949 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -129.62 149.92 51.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.626 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 tp -128.68 93.88 3.73 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 111.224 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -174.85 45.39 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.236 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -141.44 127.33 19.32 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.58 119.84 6.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 69.23 66.69 0.27 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.795 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 1.2 tp10 -92.52 137.04 32.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.576 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.5 t -143.35 72.56 1.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.439 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.459 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 6.7 m-85 -121.08 119.27 31.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.335 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -144.82 147.2 32.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.366 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.0 t -122.56 148.84 26.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.913 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.08 109.02 8.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.451 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 137.51 51.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.153 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.72 150.42 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.73 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.4 mt -137.95 126.38 31.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -130.31 130.15 44.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.34 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.402 ' CG2' HD11 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -152.89 65.2 5.62 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--N 1.346 0.43 0 C-N-CA 122.533 2.155 . . . . 0.0 112.774 179.653 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.72 0.295 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -130.57 119.12 45.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.19 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -134.88 115.95 14.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.169 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 39.3 mtt180 -137.39 165.96 24.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.08 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 t -178.09 131.13 0.14 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.6 tt -104.23 118.1 50.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 121.125 0.488 . . . . 0.0 110.627 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -115.03 107.4 15.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.657 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.9 pt -114.76 131.89 65.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -124.1 135.46 53.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.113 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.54 105.75 6.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.825 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -119.34 147.58 44.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.188 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.583 ' HG2' ' HA ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -143.56 147.04 33.83 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.083 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -156.22 120.37 4.47 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.68 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.433 HG12 ' HB3' ' A' ' 30' ' ' ARG . 25.0 mt . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 120.697 0.285 . . . . 0.0 111.027 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.463 0.205 0 CA-C-O 120.584 0.23 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HB3' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -139.33 158.28 44.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.041 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 160.92 14.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 32.6 p-90 -158.4 148.16 19.66 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.034 0.445 . . . . 0.0 111.762 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -143.48 124.42 14.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.56 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tp -130.33 141.47 46.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 111.756 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.467 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.9 OUTLIER -149.44 143.78 25.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.435 ' CG2' HG12 ' A' ' 55' ' ' ILE . 4.2 mp -136.43 106.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.538 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.71 135.48 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.73 0.3 . . . . 0.0 111.281 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 tt -155.63 135.37 12.67 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 11.3 mt -70.76 164.39 25.26 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.268 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -161.23 -52.8 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.892 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.35 -13.61 61.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.584 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -103.13 -34.7 8.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.387 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.82 40.36 2.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.816 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 65.37 91.16 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.66 52.16 1.84 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.25 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.29 112.59 11.09 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.91 159.4 53.03 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.635 2.223 . . . . 0.0 112.449 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.91 -62.5 0.29 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.688 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -106.74 -68.49 0.88 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mt -113.8 -80.07 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.948 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 52.5 t80 55.39 92.76 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.874 0.368 . . . . 0.0 111.549 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 3.8 t70 -169.26 116.92 0.62 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.23 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -114.9 120.22 39.21 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.552 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.87 159.34 16.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.012 0.434 . . . . 0.0 111.524 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.435 HG12 ' CG2' ' A' ' 36' ' ' ILE . 4.2 mp -137.18 130.43 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.406 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -126.47 143.06 51.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.893 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -167.27 126.0 1.34 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 tp . . . . . 0 N--CA 1.465 0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 CA--C 1.53 0.292 0 CA-C-O 120.71 0.212 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -106.73 136.99 45.59 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.166 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.61 151.22 41.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.173 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 87.5 m -130.45 102.61 6.24 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -130.83 -48.53 1.04 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.406 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 t -140.69 -36.75 0.46 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.791 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.05 159.13 1.53 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.3 169.65 21.1 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.094 2.53 . . . . 0.0 112.851 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -57.38 152.04 49.2 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.944 2.429 . . . . 0.0 113.085 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -100.42 141.39 33.33 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.977 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HG3' ' CB ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -164.29 89.34 0.54 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.462 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.1 143.09 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.733 0.302 . . . . 0.0 111.658 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.03 143.43 46.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.72 -177.27 6.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.205 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -120.11 136.71 54.5 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -175.29 -170.0 37.73 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.92 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -127.29 110.41 12.81 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.853 0.358 . . . . 0.0 110.976 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.56 128.17 1.2 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.63 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.67 117.39 2.48 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.313 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 12.1 m-85 -157.32 166.22 17.09 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 120.579 0.228 . . . . 0.0 110.905 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.6 Cg_endo -69.49 168.33 21.5 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.029 2.486 . . . . 0.0 113.293 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 57' ' ' HIS . 0.6 OUTLIER -151.73 118.66 5.82 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.473 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.26 154.37 38.92 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.363 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.3 pt -140.91 151.46 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.47 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.412 ' CB ' ' HG2' ' A' ' 100' ' ' LYS . 79.8 p -137.06 147.66 46.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.043 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 21.6 t -126.97 139.58 51.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.301 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 30.0 m-85 -144.48 150.94 38.43 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.1 OUTLIER -142.13 -47.1 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.528 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.0 -71.5 0.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.588 0.232 . . . . 0.0 111.247 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -136.03 -68.6 0.5 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.041 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 35.99 1.32 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.107 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 120' ' ' ILE . . . -77.74 -38.18 47.61 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.43 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.424 ' HA3' HG21 ' A' ' 118' ' ' ILE . . . -168.27 37.38 0.21 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.213 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 6.9 tt0 -80.15 103.8 10.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -142.18 151.88 42.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.947 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.412 ' HG2' ' CB ' ' A' ' 89' ' ' SER . 8.2 mtpt -131.93 149.79 52.34 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.102 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.4 tp -148.71 123.9 5.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -87.56 155.13 7.73 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.217 2.611 . . . . 0.0 112.451 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.13 169.15 23.67 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.417 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -126.77 140.67 52.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.1 tp -121.9 93.32 3.96 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.996 0.426 . . . . 0.0 111.122 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.99 -168.7 1.44 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.305 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.583 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -116.07 164.01 15.09 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.08 0.466 . . . . 0.0 112.091 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 84.67 69.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.523 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 63.65 103.58 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.958 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -126.82 134.2 50.61 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.14 67.4 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.592 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -119.37 119.43 33.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.627 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.459 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 1.3 pt-20 -151.47 149.56 29.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.383 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.41 149.94 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.623 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -137.75 108.65 6.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.8 141.97 46.65 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.16 148.89 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.983 0.421 . . . . 0.0 111.927 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.424 HG21 ' HA3' ' A' ' 97' ' ' GLY . 4.3 mp -134.65 111.29 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.403 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.406 ' CG ' ' HD3' ' A' ' 121' ' ' PRO . 43.4 tt0 -125.3 114.67 19.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.605 0.24 . . . . 0.0 111.539 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.417 HD12 ' HB1' ' A' ' 96' ' ' ALA . 4.1 mp -139.91 56.21 7.65 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 111.314 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.406 ' HD3' ' CG ' ' A' ' 119' ' ' GLN . 83.4 Cg_endo . . . . . 0 C--N 1.346 0.406 0 C-N-CA 122.67 2.247 . . . . 0.0 112.454 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.662 0.268 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.04 119.23 12.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.181 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.34 106.81 6.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.383 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 163.11 24.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.363 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -170.39 129.17 0.86 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.541 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.5 tt -109.84 118.37 56.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.988 0.423 . . . . 0.0 110.882 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -123.92 117.7 25.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.705 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.8 pt -113.05 136.65 48.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.198 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 1.8 mptp? -108.38 134.94 50.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.6 m -128.02 128.27 44.69 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.889 0.376 . . . . 0.0 111.551 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -145.86 127.78 15.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.65 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -140.49 146.15 37.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.755 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -143.49 119.39 10.6 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.509 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' A' ' 30' ' ' ARG . 39.6 mt . . . . . 0 CA--C 1.531 0.217 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.102 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.717 0.294 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.444 ' HG2' HG12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -106.93 165.08 11.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.886 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.77 156.55 34.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.381 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -157.65 141.29 15.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.427 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.7 t -147.2 117.74 7.49 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 39.6 mt -135.68 136.36 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.853 0.359 . . . . 0.0 111.635 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.98 155.28 44.52 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.579 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.422 HG12 HG22 ' A' ' 55' ' ' ILE . 4.0 mp -131.38 109.0 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.26 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.61 146.26 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.376 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -163.7 170.15 17.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.313 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.42 165.29 11.62 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -168.23 -47.18 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.778 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -3.86 45.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.771 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.27 -35.38 8.01 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.514 0.197 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.34 45.92 1.25 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.461 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt 66.7 123.25 0.02 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.046 0.45 . . . . 0.0 111.525 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.66 29.06 2.12 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.429 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.9 mt -129.63 134.5 26.28 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.016 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.63 -174.23 1.94 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.672 2.248 . . . . 0.0 112.473 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.32 -51.89 0.31 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.233 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 p -126.0 -52.36 1.54 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.562 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.47 -89.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.093 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 40.3 t80 57.09 97.74 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.242 0.544 . . . . 0.0 110.861 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.65 109.96 1.27 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.53 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.481 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 1.4 mttm -112.55 137.05 51.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.354 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.5 p -139.36 149.81 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.015 0.436 . . . . 0.0 111.652 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.441 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 0.8 OUTLIER -126.72 140.66 48.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.42 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.86 130.57 38.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.704 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -132.89 113.94 13.46 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.238 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.465 0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 -179.867 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--O 1.233 0.262 0 CA-C-O 120.687 0.203 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.441 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 2.7 m120 -98.69 133.78 42.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -129.19 153.84 47.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.05 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 35.1 m -132.29 99.16 4.6 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.017 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -124.77 -49.17 1.76 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.64 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.4 t -174.49 50.81 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.155 0.502 . . . . 0.0 110.397 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.45 162.0 57.25 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.152 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.21 162.48 14.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.942 2.428 . . . . 0.0 112.625 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.39 168.68 3.65 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.11 2.54 . . . . 0.0 112.851 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.95 165.8 13.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.49 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.37 94.11 0.22 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.597 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.29 115.37 48.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -137.77 126.51 23.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.915 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -144.87 -179.13 6.4 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.426 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -130.28 177.34 7.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.176 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.09 -162.1 22.76 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.123 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -67.32 128.83 37.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.4 126.88 0.86 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.669 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.77 110.82 0.29 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.75 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -155.4 166.26 16.59 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 120.662 0.268 . . . . 0.0 111.272 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.34 177.32 0.6 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.157 2.572 . . . . 0.0 113.229 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 mp -142.84 167.01 23.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.993 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -155.15 122.9 5.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.298 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.8 pt -129.84 123.24 56.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.686 0.279 . . . . 0.0 111.144 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -119.85 142.43 48.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.78 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 4.2 t -126.71 137.41 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.806 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.476 ' CD2' ' CG ' ' A' ' 98' ' ' GLU . 48.0 m-85 -145.47 145.78 31.23 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 3.5 tp -138.49 -68.44 0.45 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.4 tp -136.64 -66.89 0.52 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.357 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.432 ' HB3' ' CE ' ' A' ' 95' ' ' LYS . 2.6 mt-10 -166.07 -54.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.432 ' CE ' ' HB3' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -115.75 45.96 1.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.165 0.507 . . . . 0.0 110.676 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -116.59 -49.53 2.65 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.217 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.4 -81.82 0.03 OUTLIER Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.396 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.6 OUTLIER 47.19 59.91 3.76 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 111.554 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.08 136.95 30.66 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.166 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 2.9 pttt -117.85 149.98 39.94 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.59 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 tt -149.45 123.5 4.63 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.961 0.41 . . . . 0.0 111.562 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.3 158.85 13.01 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.707 2.271 . . . . 0.0 112.138 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.31 172.49 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -125.59 146.52 49.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.569 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 tp -139.13 74.05 1.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.856 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -164.61 46.65 0.1 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.13 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -140.25 132.58 28.34 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.339 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.2 131.7 51.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.07 61.02 0.77 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.819 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.13 131.7 37.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.69 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.5 t -137.14 69.96 1.4 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.751 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.36 153.35 20.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.012 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.409 ' HG3' ' HA ' ' A' ' 12' ' ' LYS . 3.3 tt0 -164.66 136.61 4.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.252 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.62 143.65 33.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -139.34 108.51 6.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.719 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -113.05 119.01 36.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.477 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.45 147.67 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.631 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 20.0 mt -142.12 110.85 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.525 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -129.88 125.89 36.67 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.536 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.413 HG12 ' CD2' ' A' ' 92' ' ' LEU . 0.8 OUTLIER -152.78 54.61 1.26 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.669 179.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 C--N 1.349 0.571 0 C-N-CA 122.446 2.097 . . . . 0.0 112.506 179.674 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.566 0.222 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.409 ' HB ' HG12 ' A' ' 120' ' ' ILE . 19.5 t -126.94 119.14 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 111.338 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.25 104.91 7.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.268 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.36 169.83 9.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.409 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -165.89 123.79 1.5 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.713 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.412 ' CD1' HD12 ' A' ' 36' ' ' ILE . 8.8 tt -108.86 124.55 65.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.924 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 0.2 OUTLIER -120.11 120.33 35.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.023 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.8 pt -123.4 132.71 70.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.071 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 4.1 mtmt -120.41 146.17 46.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.22 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 116.85 13.31 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.687 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 3.8 tt0 -123.74 148.83 46.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.987 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -154.87 144.1 21.12 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.979 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -147.88 119.59 8.05 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.343 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.0 mt . . . . . 0 C--N 1.332 -0.165 0 CA-C-O 120.77 0.319 . . . . 0.0 110.633 179.253 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.765 0.317 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -138.58 164.23 30.0 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.597 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.39 151.17 22.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.55 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -155.74 132.4 10.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.419 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 14' ' ' GLN . 27.7 t -143.88 125.91 15.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 tp -135.79 129.7 48.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.78 157.06 47.79 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.412 HD12 ' CD1' ' A' ' 9' ' ' ILE . 12.5 tt -154.54 130.44 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.4 m -134.97 160.73 40.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.657 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.32 175.1 13.78 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.934 0.397 . . . . 0.0 111.531 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 mt -106.79 166.13 10.81 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.101 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.85 -56.29 0.06 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.209 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -54.98 -40.33 69.93 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.233 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -29.44 18.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.1 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.31 59.05 0.37 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.861 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.4 mttp 60.21 97.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.912 0.387 . . . . 0.0 111.618 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -24.66 62.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.507 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 mt -100.91 123.72 44.4 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-O 120.577 0.227 . . . . 0.0 110.837 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.93 169.04 2.08 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.874 2.382 . . . . 0.0 112.506 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.65 -51.48 0.51 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.621 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.0 m -110.49 -65.62 1.15 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.783 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.5 mm -138.05 -80.68 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 39.4 t80 63.08 100.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.025 0.44 . . . . 0.0 110.885 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 8.7 t70 -160.83 110.69 1.71 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.565 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -104.89 107.35 18.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.542 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.44 141.78 17.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.608 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 66' ' ' ASN . 1.7 mp -121.24 148.69 24.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.196 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -143.99 128.4 17.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.298 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 6.9 p80 -144.18 120.48 10.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.539 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 57' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.764 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 CA--C 1.533 0.449 0 CA-C-O 120.631 0.18 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.41 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 17.7 m120 -113.46 144.37 42.93 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.235 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.66 150.79 36.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.06 115.87 15.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.844 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -156.75 -47.62 0.07 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.2 t -129.4 29.08 5.14 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.006 0.431 . . . . 0.0 110.766 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -141.41 159.08 62.09 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.45 173.81 8.23 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.908 2.405 . . . . 0.0 112.469 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.9 -179.3 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.797 2.331 . . . . 0.0 112.688 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.47 157.74 44.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.793 0.33 . . . . 0.0 110.794 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.65 81.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.785 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.71 122.71 51.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.168 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.64 115.53 16.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.491 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -139.34 174.27 10.69 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.05 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.21 124.68 31.1 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.971 0.415 . . . . 0.0 110.977 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.02 -157.05 21.77 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.126 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 13.6 p-90 -82.88 116.59 22.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 111.07 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.75 -121.79 0.59 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.727 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.67 101.93 0.06 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.959 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.0 m-85 -162.96 171.04 6.77 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.63 0.252 . . . . 0.0 110.96 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 77.3 Cg_exo -52.01 166.53 0.63 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.045 2.496 . . . . 0.0 113.243 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 mp -142.92 169.74 17.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.414 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -160.43 138.82 10.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.176 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.4 tp -136.54 128.17 43.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.05 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.8 p -127.06 116.2 20.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.22 120.92 55.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.154 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 13.2 m-85 -126.1 156.02 40.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.736 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.8 OUTLIER -145.7 -166.57 2.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.56 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pp -92.06 34.47 1.02 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 111.107 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -165.66 159.07 16.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.329 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.47 47.53 1.19 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.071 0.462 . . . . 0.0 110.772 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -116.25 -37.34 3.81 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.614 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.65 30.68 5.85 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.161 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -92.57 92.77 8.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.825 0.313 . . . . 0.0 110.451 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -142.23 153.26 43.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.885 0.374 . . . . 0.0 111.817 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.75 146.37 47.57 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.786 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -141.78 122.48 8.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.64 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.06 129.26 4.56 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.866 2.377 . . . . 0.0 112.352 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.29 172.46 6.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.287 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -134.59 138.9 44.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.62 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.33 84.58 2.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.6 37.31 0.32 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.175 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -141.9 132.03 24.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.13 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.88 131.8 51.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 71.58 74.22 0.17 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.441 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.73 131.37 55.0 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.59 61.63 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.292 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -105.6 119.31 38.8 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.534 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 3.2 pt-20 -142.16 139.6 32.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.126 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.8 p -131.96 148.97 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.69 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 10' ' ' ARG . 1.2 mp0 -133.01 151.24 52.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.341 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.402 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -136.31 127.25 27.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.222 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.83 136.73 26.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.258 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.4 mt -121.49 111.22 30.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.58 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.39 117.49 20.67 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.349 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -147.38 55.75 2.51 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.744 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.349 0.573 0 C-N-CA 122.466 2.111 . . . . 0.0 112.244 179.58 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 121' ' ' PRO . 5.3 t . . . . . 0 N--CA 1.462 0.132 0 CA-C-O 120.646 0.26 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.49 119.44 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.654 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.47 117.25 13.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.35 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.496 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 75.8 mtt180 -139.8 138.73 36.06 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.514 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 t -147.46 111.18 5.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.441 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 tt -104.77 118.28 51.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.637 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.36 120.09 34.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.725 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 88' ' ' ILE . 9.2 pt -118.7 126.3 75.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 111.33 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.478 ' HD2' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -114.26 130.81 56.65 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.845 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' SER . 3.0 m -127.88 118.01 22.85 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -129.29 140.63 51.35 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.986 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.92 138.76 35.87 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.759 0.314 . . . . 0.0 111.333 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -137.92 119.73 15.25 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 6.7 mt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.773 0.32 . . . . 0.0 111.149 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 120.671 0.272 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.407 ' HB3' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -126.71 165.13 19.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.279 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.48 149.35 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -145.18 143.28 30.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.453 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 1.6 m -136.12 121.95 19.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.742 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.9 mm -130.4 117.42 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.622 0.248 . . . . 0.0 111.479 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 10.9 pt-20 -134.73 149.38 50.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.094 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 55' ' ' ILE . 14.0 tt -152.18 130.49 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.207 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.3 m -137.24 119.15 18.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.962 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.8 tp -129.7 142.46 50.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.31 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 tt -118.1 152.25 35.95 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.077 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -176.87 -30.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.318 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 7.1 p30 -53.91 -27.89 33.4 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.631 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -33.21 59.66 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.554 0.216 . . . . 0.0 110.589 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.83 -74.33 0.93 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.884 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -129.47 -48.11 1.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 41' ' ' ASP . 17.1 tt0 71.09 7.0 6.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.774 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.2 140.4 36.94 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-O 120.733 0.301 . . . . 0.0 111.413 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.63 -171.47 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.985 2.456 . . . . 0.0 112.374 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.81 -64.98 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.391 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.7 m -96.97 -56.42 2.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.172 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.6 mm -132.84 -85.28 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.839 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 44.3 t80 63.24 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.145 0.498 . . . . 0.0 111.136 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -164.19 102.17 0.86 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.571 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -97.72 102.96 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.554 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 m -103.07 143.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.478 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.456 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 2.4 mt -125.41 146.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.521 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.03 138.85 28.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.929 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 18.7 p-80 -163.77 124.36 2.21 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.573 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.79 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.763 0.235 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.456 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.7 m-80 -115.14 155.28 27.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.093 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.68 153.85 42.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 45.6 m -138.44 117.21 12.3 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.792 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -125.47 -54.63 1.56 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -89.49 -67.58 0.83 Allowed 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.379 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.461 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 0.3 OUTLIER 179.09 61.06 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.468 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' CG ' ' HA ' ' A' ' 68' ' ' THR . 94.8 Cg_endo -93.07 103.33 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.92 2.413 . . . . 0.0 113.207 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 71' ' ' ASP . 86.4 Cg_endo -84.43 178.91 4.78 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.652 2.235 . . . . 0.0 112.382 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -167.94 153.03 6.77 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.62 111.5 0.07 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.968 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.1 tp -159.62 142.01 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.853 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 14.7 pt-20 -132.27 111.6 11.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.479 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -121.39 168.3 11.82 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.338 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -109.94 176.58 5.01 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.773 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.91 -154.94 16.38 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.168 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -93.17 110.11 21.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 0.0 110.403 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.17 91.67 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.433 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -142.91 111.23 0.65 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.473 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.458 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 9.7 m-85 -160.94 168.56 11.47 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 120.613 0.244 . . . . 0.0 111.04 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.34 160.53 26.85 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.064 2.509 . . . . 0.0 112.966 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.476 ' HG ' ' HB2' ' A' ' 103' ' ' HIS . 0.8 OUTLIER -150.89 123.05 8.28 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.578 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -127.55 145.89 50.71 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.95 0.405 . . . . 0.0 111.71 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.468 HG22 HD11 ' A' ' 11' ' ' ILE . 8.9 tt -129.59 118.8 46.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.249 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.47 119.59 34.33 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.5 t -106.26 142.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.096 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -141.09 157.27 45.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.877 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -151.35 -175.74 5.3 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.733 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -20.4 61.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.15 -169.23 1.66 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.496 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 58.35 1.02 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.842 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.51 4.77 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.778 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.7 44.34 1.14 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.991 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -113.36 90.44 3.34 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.884 0.373 . . . . 0.0 111.025 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -142.66 156.59 45.07 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.532 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 pttm -112.2 140.59 46.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.479 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.1 mp -133.34 109.0 12.39 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.667 0.27 . . . . 0.0 111.506 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -88.21 147.39 6.52 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.221 2.614 . . . . 0.0 113.625 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.476 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . 8.7 m-70 -148.58 172.28 14.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.444 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -134.24 129.73 36.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.942 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.415 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 1.3 pp -113.97 100.95 8.8 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.984 0.421 . . . . 0.0 111.244 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -177.87 44.86 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.34 136.42 31.48 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.776 0.322 . . . . 0.0 111.535 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -61.73 128.95 38.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.637 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 64.45 65.3 0.66 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.26 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -105.18 131.77 52.23 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.813 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.0 p -132.79 66.71 1.55 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.869 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -104.9 119.64 39.49 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.702 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.478 ' CD ' ' HD2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -148.01 143.48 27.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.292 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.11 142.77 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.532 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -127.77 146.02 50.72 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.101 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 130.81 40.78 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.7 m -111.66 140.13 32.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.094 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.496 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 10.9 mt -139.99 111.79 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.784 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -129.9 107.55 9.46 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.265 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.9 mp -137.2 58.31 17.35 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 42.8 Cg_endo . . . . . 0 C--N 1.348 0.523 0 C-N-CA 122.47 2.113 . . . . 0.0 112.62 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.617 0.246 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.81 119.45 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 111.428 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -123.79 105.11 9.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.599 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -118.07 169.66 9.48 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.003 0.43 . . . . 0.0 111.365 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -161.56 125.37 3.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.53 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.3 tt -105.06 118.44 52.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.115 0.484 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.46 117.53 29.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.053 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.5 pt -122.83 128.75 75.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.585 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -119.23 141.89 48.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 m -137.35 111.06 8.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.151 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.5 mp0 -125.09 129.79 50.95 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.734 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -132.64 143.43 49.66 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.141 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -139.02 119.52 13.91 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.15 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.2 mt . . . . . 0 C--O 1.232 0.171 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.777 179.501 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.571 0.224 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -133.16 165.12 25.52 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.346 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.01 157.16 33.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.666 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 10.9 p-90 -155.42 142.24 18.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.449 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 p -147.93 117.93 7.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.331 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 0.9 OUTLIER -133.88 141.25 44.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.585 -179.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -131.39 134.17 46.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.641 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -124.38 106.38 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.643 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.1 t -118.04 148.44 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.696 0.284 . . . . 0.0 111.387 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.405 HD12 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -159.33 148.59 18.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.323 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 tp -102.72 160.82 14.25 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.255 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -173.76 -44.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.194 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.93 1.48 20.5 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.943 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -86.42 -36.73 18.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.578 0.228 . . . . 0.0 110.798 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.38 -72.83 0.63 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.683 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.31 116.46 9.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.779 0.323 . . . . 0.0 110.836 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.93 35.48 1.26 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.175 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.28 126.63 21.48 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.279 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.01 -174.34 1.9 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.856 2.371 . . . . 0.0 112.475 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.73 -63.69 0.13 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.622 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 m -99.07 -65.97 0.93 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.551 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.6 mt -128.58 -92.77 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.399 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.436 ' CE1' ' HE2' ' A' ' 53' ' ' LYS . 35.7 t80 62.35 97.82 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.18 0.514 . . . . 0.0 111.399 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -164.5 112.56 1.09 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.062 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.436 ' HE2' ' CE1' ' A' ' 51' ' ' PHE . 4.8 mtmt -101.89 123.74 46.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.29 116.5 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 111.136 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.474 ' CG2' ' CE1' ' A' ' 57' ' ' HIS . 3.7 mp -103.24 149.56 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.192 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 65' ' ' PRO . 20.9 m-85 -138.19 119.12 14.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.294 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.474 ' CE1' ' CG2' ' A' ' 55' ' ' ILE . 5.5 m-70 -123.39 116.44 23.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.076 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.477 ' HA ' ' CB ' ' A' ' 84' ' ' PHE . 4.2 mp . . . . . 0 N--CA 1.465 0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.918 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 23.5 Cg_exo . . . . . 0 CA--C 1.53 0.315 0 CA-C-O 120.902 0.292 . . . . 0.0 112.649 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.413 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 5.1 m120 -124.71 137.92 54.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.87 146.27 51.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.258 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.67 136.35 37.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.743 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -161.86 -50.04 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.719 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.3 t -159.03 40.36 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.166 0.508 . . . . 0.0 110.663 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.96 157.79 74.68 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.006 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 44.1 Cg_exo -56.43 170.44 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.114 2.543 . . . . 0.0 112.28 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 72' ' ' PRO . 19.0 Cg_endo -58.13 171.46 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.959 2.439 . . . . 0.0 112.903 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.36 85.9 2.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.343 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -110.21 130.57 55.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -135.19 125.83 44.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.033 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -129.83 125.25 35.25 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 8.9 mt-10 -152.76 172.98 15.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.377 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -119.17 -179.6 3.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.213 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.97 -156.06 25.06 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.362 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -69.28 130.52 42.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.66 95.2 0.1 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.71 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.06 109.03 0.39 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.908 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 30.8 m-85 -153.77 164.8 19.44 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 111.105 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 10.8 Cg_endo -54.57 168.73 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.497 2.798 . . . . 0.0 113.981 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 57' ' ' HIS . 6.7 mp -134.05 155.74 49.48 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.525 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -158.11 120.94 3.82 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.937 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.3 mp -125.22 126.36 70.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.447 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 57.4 p -127.98 115.43 18.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.997 0.427 . . . . 0.0 110.917 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 26.1 t -104.36 138.85 27.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.998 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -131.44 153.71 49.44 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.25 -165.78 2.36 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.023 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.9 mp -56.5 -62.03 2.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.371 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 179.05 50.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.013 0.435 . . . . 0.0 110.701 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.03 -154.21 0.54 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.516 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.36 -14.35 20.21 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.52 -22.65 61.75 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.811 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 4.4 pt-20 -68.08 84.84 0.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.086 0.47 . . . . 0.0 110.377 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.32 156.75 45.27 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.729 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 89' ' ' SER . 1.7 mtmm -103.07 153.22 20.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.654 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.407 HG23 ' CD2' ' A' ' 103' ' ' HIS . 25.5 mt -137.58 99.79 9.4 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.012 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.33 130.94 8.33 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.861 2.374 . . . . 0.0 112.22 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.407 ' CD2' HG23 ' A' ' 101' ' ' ILE . 4.9 m-70 -132.71 167.43 20.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.59 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -134.94 135.12 41.27 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.6 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 tp -125.75 84.72 2.31 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.675 0.274 . . . . 0.0 111.314 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -168.63 38.2 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.256 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -140.44 133.96 30.07 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.785 0.326 . . . . 0.0 111.548 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.11 130.64 47.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.829 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 67.0 61.32 0.5 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 6.3 tp10 -96.58 136.84 36.54 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.699 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.7 t -141.11 70.46 1.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.617 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.23 119.25 37.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.184 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.83 154.28 35.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.46 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 t -142.36 152.18 18.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.585 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -134.53 109.24 8.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.65 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -113.11 147.91 36.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.917 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.66 140.74 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.21 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.9 mt -124.52 117.83 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.13 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.75 116.21 19.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.017 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.7 mp -128.57 53.43 11.16 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.232 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 C--N 1.347 0.463 0 C-N-CA 122.755 2.303 . . . . 0.0 112.246 179.891 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.603 0.239 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.4 t -127.18 119.63 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.532 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -137.81 112.85 9.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.358 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 35.0 mtp180 -138.84 167.76 21.29 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.078 0.466 . . . . 0.0 111.871 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -167.6 124.97 1.18 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.675 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 17.5 tt -108.49 118.98 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.937 0.398 . . . . 0.0 110.983 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.43 ' HG2' ' HG2' ' A' ' 115' ' ' GLU . 58.1 mtp85 -122.89 111.86 17.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.801 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.8 pt -106.95 137.2 38.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.015 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.46 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -125.16 128.59 48.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.132 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.3 m -130.89 124.48 31.25 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.85 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -139.32 143.58 37.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.205 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.461 ' HG3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -137.84 144.46 41.46 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.632 0.253 . . . . 0.0 111.32 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.461 ' N ' ' HG3' ' A' ' 15' ' ' GLN . 15.3 t60 -140.36 119.42 12.75 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.066 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 6.8 mt . . . . . 0 N--CA 1.463 0.199 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.741 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.233 0.228 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 164.41 29.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.858 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -122.3 149.23 44.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.742 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -148.47 140.2 23.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.039 0.447 . . . . 0.0 111.344 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.2 t -129.94 117.69 20.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.476 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.7 mm -125.73 127.23 71.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.139 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.46 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -147.68 157.47 43.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.809 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 tt -155.13 128.42 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.962 0.41 . . . . 0.0 111.518 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 22.9 t -119.34 148.49 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.807 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.415 HD11 ' HD3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -160.41 145.47 14.67 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.698 0.285 . . . . 0.0 111.378 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 3.1 tp -103.3 164.16 11.81 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -171.74 -45.67 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.944 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.54 0.48 17.17 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -34.96 26.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.637 0.256 . . . . 0.0 110.651 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.91 -55.86 0.29 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.744 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -162.71 114.05 1.53 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 40' ' ' ASP . 18.1 tt0 -98.66 38.07 1.41 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.987 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.79 134.06 24.51 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.944 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.85 -171.24 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.834 2.356 . . . . 0.0 112.65 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -165.39 -45.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.444 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.17 -66.03 0.83 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.576 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 50' ' ' ILE . 43.3 mm -114.88 -87.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.786 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 49.3 t80 58.79 96.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.897 0.379 . . . . 0.0 111.357 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 6.7 t70 -172.52 110.64 0.23 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.878 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HD3' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -102.64 127.07 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.614 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 m -126.2 142.41 42.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.685 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mp -127.4 150.33 33.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.144 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.37 144.2 36.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.429 ' HA ' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -140.39 119.91 13.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.995 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.494 ' HA ' ' CB ' ' A' ' 84' ' ' PHE . 5.1 mp . . . . . 0 CA--C 1.532 0.253 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.309 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 CA--C 1.53 0.297 0 CA-C-O 120.598 0.166 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -108.77 151.17 26.58 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.887 0.375 . . . . 0.0 111.074 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.17 155.98 40.78 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.041 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.62 122.63 26.34 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.798 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -143.9 -57.02 0.38 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.601 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 t -148.61 34.51 0.78 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.721 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.69 160.27 45.06 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.115 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.42 171.67 10.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.934 2.422 . . . . 0.0 112.434 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HB3' HG13 ' A' ' 37' ' ' VAL . 18.7 Cg_endo -58.99 162.55 13.27 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.928 2.419 . . . . 0.0 112.822 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -108.59 156.12 19.88 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.336 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.19 121.38 0.75 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.624 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.3 tp -158.87 119.89 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.959 0.409 . . . . 0.0 111.329 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -126.86 111.52 14.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.646 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.43 161.73 25.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.81 179.74 3.99 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.957 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.91 -170.25 18.73 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.224 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -66.96 120.51 13.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.797 0.332 . . . . 0.0 111.158 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.93 128.1 0.96 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.907 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.39 107.77 0.26 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.717 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.494 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 16.0 m-85 -153.49 164.52 20.24 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.717 0.294 . . . . 0.0 111.016 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.66 163.43 13.25 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.924 2.416 . . . . 0.0 113.572 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -126.65 166.69 16.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.932 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -155.96 128.69 7.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.173 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 mp -136.1 116.45 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.654 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 6.7 t -122.82 146.22 47.74 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.214 0.531 . . . . 0.0 111.477 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 3.2 t -123.56 144.29 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.867 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.515 ' HA ' ' HG3' ' A' ' 98' ' ' GLU . 50.3 m-85 -137.24 154.43 50.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.188 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 9.2 tp -152.01 178.1 9.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.07 -30.27 62.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.738 0.304 . . . . 0.0 110.331 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -106.89 -159.19 0.69 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.161 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.405 ' N ' ' HD2' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -128.52 74.29 1.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.922 0.392 . . . . 0.0 110.683 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -115.16 -50.61 2.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.484 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.75 36.5 1.93 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.746 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.515 ' HG3' ' HA ' ' A' ' 91' ' ' PHE . 22.8 tt0 -88.5 76.36 8.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.513 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -142.72 156.74 45.06 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.689 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -110.32 149.38 30.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.063 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.9 mm -135.3 113.21 11.22 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.266 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -85.82 153.11 10.01 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.941 2.427 . . . . 0.0 112.473 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -144.4 171.39 14.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.061 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.18 143.18 49.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.034 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.442 ' HG ' ' NE2' ' A' ' 15' ' ' GLN . 9.1 tp -130.61 82.12 2.04 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.838 0.352 . . . . 0.0 111.417 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -170.73 47.25 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.286 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -141.61 132.16 25.4 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 111.725 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -64.96 115.4 5.35 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.763 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 74.86 73.0 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.433 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 40.3 tt0 -108.84 141.05 41.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.567 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.6 p -139.83 75.37 1.51 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.05 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.75 119.79 39.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.344 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.8 145.08 25.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.506 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.2 t -126.6 150.48 32.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.704 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' A' ' 10' ' ' ARG . 4.7 mt-10 -134.05 109.05 8.7 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.828 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -113.05 140.28 47.97 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.69 136.41 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.436 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 mp -126.69 111.04 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.37 132.34 45.74 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.985 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.5 tp -161.6 61.75 1.37 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 121.329 0.585 . . . . 0.0 111.377 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 C--N 1.349 0.582 0 C-N-CA 122.739 2.293 . . . . 0.0 112.772 -179.912 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.635 0.255 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.06 119.06 35.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.965 0.412 . . . . 0.0 110.977 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -137.0 116.33 12.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.192 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.8 mtt-85 -132.45 159.04 40.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.368 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -160.56 127.1 4.15 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.841 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.466 HG23 HD12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -111.77 122.84 66.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.717 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -124.72 129.03 49.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.39 127.14 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -120.82 130.26 53.9 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.185 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 33' ' ' SER . 84.8 m -133.27 108.52 8.8 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -119.5 143.93 47.29 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.143 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.432 ' HG3' ' N ' ' A' ' 16' ' ' HIS . 3.1 tp60 -139.25 142.02 37.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.186 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.432 ' N ' ' HG3' ' A' ' 15' ' ' GLN . 63.4 t-80 -144.91 119.29 9.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.925 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.401 ' HB ' ' HG ' ' A' ' 108' ' ' LEU . 17.7 mt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.974 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.721 0.296 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.45 163.48 29.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.021 0.438 . . . . 0.0 111.526 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.39 153.37 35.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.831 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -153.91 151.8 29.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.595 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 13' ' ' THR . 11.7 t -148.68 119.34 7.49 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.992 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.4 HD12 ' CD2' ' A' ' 105' ' ' LEU . 25.2 mm -126.25 137.16 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.683 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 9.3 pt-20 -157.51 119.59 3.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.702 0.287 . . . . 0.0 111.482 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.6 tt -124.98 127.71 72.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.45 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.74 158.36 42.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.478 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.09 155.61 25.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.856 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.03 168.01 13.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.764 0.316 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.11 -58.7 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.496 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.6 -23.92 67.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.151 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -90.36 -36.65 14.51 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.538 0.208 . . . . 0.0 110.93 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.92 54.55 0.55 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.39 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt 63.79 116.59 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.09 0.471 . . . . 0.0 111.646 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -88.48 31.74 0.81 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.521 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.2 mt -129.69 134.36 26.11 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.774 -0.193 . . . . 0.0 111.132 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.16 173.09 13.52 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.809 2.34 . . . . 0.0 112.36 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.48 -70.97 0.26 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.0 p -117.77 -74.69 0.6 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.63 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.9 mt -100.96 -85.74 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.534 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 3.3 t80 51.59 95.85 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.128 0.489 . . . . 0.0 111.133 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -171.3 103.78 0.21 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.717 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -99.21 114.28 26.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.037 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.07 160.76 37.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.454 ' CG2' ' HB2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -123.4 167.26 17.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.967 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -134.16 131.59 38.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.241 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.2 m170 -129.41 104.94 7.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.966 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.315 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.211 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo . . . . . 0 CA--C 1.53 0.296 0 CA-C-O 120.743 0.226 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.454 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -90.98 146.44 23.86 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.262 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.01 136.76 30.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.515 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.97 98.96 4.74 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 111.002 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -115.38 -49.58 2.76 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.865 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -146.94 35.08 0.91 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.921 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -130.52 159.73 69.45 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.29 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.26 173.08 3.57 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.063 2.509 . . . . 0.0 112.629 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.36 174.14 2.9 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.989 2.459 . . . . 0.0 112.77 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -136.38 95.08 3.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.392 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -121.19 110.33 16.04 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.002 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.6 mm -134.81 117.31 22.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -129.71 130.15 45.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.128 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -155.56 178.37 10.31 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.702 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.71 131.36 56.79 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.786 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.34 -131.07 2.14 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.03 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -120.27 110.31 16.42 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.16 0.505 . . . . 0.0 111.209 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.17 99.02 0.12 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.439 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.83 108.45 0.41 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.514 -0.851 . . . . 0.0 113.236 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -155.82 170.03 9.44 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 122.177 0.191 . . . . 0.0 110.645 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.2 168.43 4.78 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.854 2.37 . . . . 0.0 112.811 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.24 172.49 12.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.703 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -159.83 116.79 2.57 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.897 0.379 . . . . 0.0 111.085 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.1 131.57 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.4 p -128.33 119.64 25.46 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.983 0.42 . . . . 0.0 110.551 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 40.7 t -106.53 135.55 44.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.729 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -134.83 150.24 50.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.721 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 12.2 tp -142.96 -69.55 0.34 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.707 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.4 -76.73 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.541 0.21 . . . . 0.0 111.189 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -137.26 -57.48 0.7 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.289 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 27.1 0.85 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.423 ' HB1' ' CG2' ' A' ' 118' ' ' ILE . . . -78.52 -37.64 42.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.74 37.56 0.39 Allowed Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.834 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -90.1 92.39 8.94 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 110.532 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.02 144.32 33.58 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.344 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 130.13 38.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.392 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.01 132.82 21.54 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.527 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.85 143.58 16.57 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.689 2.259 . . . . 0.0 111.932 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.1 171.91 10.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.01 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -122.54 140.26 52.97 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.657 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.4 ' CD2' HD12 ' A' ' 34' ' ' ILE . 57.6 tp -140.09 70.01 1.36 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.561 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -174.62 42.8 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -141.61 137.36 31.81 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.463 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.401 ' HG ' ' HB ' ' A' ' 17' ' ' ILE . 1.6 mp -50.41 119.75 4.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 58.99 80.64 0.18 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.708 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -111.3 135.09 52.35 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.748 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.5 p -132.57 71.41 1.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.049 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -106.14 119.51 39.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.415 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.5 157.01 33.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.983 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.53 152.32 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.613 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -138.1 109.31 6.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.62 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -113.26 123.94 51.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.021 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 m -103.29 147.22 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.401 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.423 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 9.8 mt -137.87 120.65 19.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -129.46 113.49 14.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.864 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.2 pt -146.68 68.03 11.68 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.545 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 CA--C 1.532 0.412 0 C-N-CA 122.571 2.181 . . . . 0.0 112.625 179.859 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.577 0.227 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 t -130.29 119.01 45.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.779 0.323 . . . . 0.0 111.389 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -137.62 122.61 19.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.465 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -134.33 167.37 20.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.204 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 2.3 t -172.56 129.15 0.54 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.444 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.44 ' CG2' HG22 ' A' ' 90' ' ' VAL . 1.2 tt -109.26 118.3 56.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.54 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.31 114.18 16.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.942 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.403 HG13 HG21 ' A' ' 114' ' ' VAL . 1.1 pt -118.38 126.67 75.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 113.58 26.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.989 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.4 m -119.47 96.36 5.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.193 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -125.4 147.89 49.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.09 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -133.61 165.43 24.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.0 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.425 ' CD2' ' HG3' ' A' ' 109' ' ' GLN . 22.9 t-160 -163.39 119.82 1.77 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.203 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.982 0.42 . . . . 0.0 111.506 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.589 0.233 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HA ' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -93.53 155.21 17.45 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.736 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -117.42 107.0 13.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.708 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.429 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 57.5 p-90 -100.93 158.86 15.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.665 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.3 t -144.77 117.64 8.77 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.474 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.7 mm -122.88 138.79 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.618 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.16 127.84 13.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.487 HG23 HG12 ' A' ' 55' ' ' ILE . 8.6 mt -119.5 106.41 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.342 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.01 150.14 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.83 0.348 . . . . 0.0 111.627 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 8' ' ' THR . 1.1 pp -166.95 148.2 5.9 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.276 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 7.1 mt -76.95 162.84 27.25 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.329 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -166.27 -59.5 0.03 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.956 0.408 . . . . 0.0 110.393 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -58.86 -31.0 68.14 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.314 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -92.15 -29.97 16.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.72 47.75 2.29 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.709 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 mttm 57.1 94.76 0.02 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 111.156 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.28 -28.84 60.06 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.29 120.56 77.3 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.051 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.482 ' HB3' ' CD2' ' A' ' 51' ' ' PHE . 73.2 Cg_endo -75.6 -171.89 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.591 2.194 . . . . 0.0 112.545 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.84 -55.1 0.46 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.342 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -120.73 -60.49 1.66 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.631 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.9 mm -116.93 -84.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.912 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.482 ' CD2' ' HB3' ' A' ' 47' ' ' PRO . 73.8 t80 58.85 95.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.899 0.381 . . . . 0.0 111.391 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -176.68 151.79 0.94 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.71 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HD3' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -133.15 111.57 11.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.518 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.12 149.29 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.0 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.487 HG12 HG23 ' A' ' 36' ' ' ILE . 4.1 mp -135.0 154.79 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.662 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.1 150.9 38.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 111.408 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -135.49 115.33 13.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.502 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 84' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.312 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.297 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 C--O 1.233 0.262 0 CA-C-O 120.695 0.206 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -106.86 131.03 54.41 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.18 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -145.1 131.12 19.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.777 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.25 103.05 8.92 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 111.327 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -104.34 -53.87 2.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.322 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -156.25 35.65 0.33 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.82 165.44 13.97 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.85 157.65 27.72 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.77 2.314 . . . . 0.0 112.423 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.05 154.37 66.64 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.609 2.206 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.87 146.31 25.03 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -171.8 80.8 0.06 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.754 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.36 143.2 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.108 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -135.41 130.4 34.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.429 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 1.3 mt-10 -137.42 166.2 24.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.912 0.386 . . . . 0.0 111.398 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.23 126.58 46.54 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.59 -169.0 33.16 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.732 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -115.34 110.18 19.0 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.661 0.267 . . . . 0.0 110.551 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.88 128.51 1.26 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.458 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.4 95.96 0.15 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.211 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 87.6 m-85 -142.08 165.73 25.82 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-O 120.553 0.216 . . . . 0.0 111.072 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 76.2 Cg_exo -50.47 165.95 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.992 2.461 . . . . 0.0 113.367 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -146.51 165.75 28.52 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.882 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -157.38 134.94 10.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.277 0.56 . . . . 0.0 111.128 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.45 HG13 HG21 ' A' ' 55' ' ' ILE . 3.8 mp -128.94 127.19 65.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.884 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.7 p -118.05 137.48 52.88 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.005 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 3.9 t -123.8 132.72 70.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.333 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.48 158.87 37.18 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.654 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.1 OUTLIER -145.65 -49.24 0.23 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.106 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.89 -83.54 0.07 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.01 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.32 -79.49 0.59 Allowed 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 120.562 0.22 . . . . 0.0 111.224 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.75 32.71 1.04 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 111.61 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.29 -39.7 47.07 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.89 0.376 . . . . 0.0 110.361 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -148.18 24.43 1.41 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.619 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 5.0 tt0 -77.63 103.15 7.39 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.713 0.257 . . . . 0.0 110.386 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.49 155.32 45.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.057 0.456 . . . . 0.0 112.032 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.96 138.24 54.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.137 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.429 HG13 ' CG2' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -132.17 110.45 14.07 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.629 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.49 160.76 28.59 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.639 2.226 . . . . 0.0 112.326 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -144.07 170.18 16.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -134.24 95.45 3.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.423 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.8 tp -77.99 121.98 24.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.353 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.2 -179.42 5.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.084 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -107.83 166.47 10.68 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.592 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tp 77.2 60.32 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.137 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.425 ' HG3' ' CD2' ' A' ' 16' ' ' HIS . 8.9 mt-30 66.11 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.541 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -130.82 147.15 52.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.086 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -140.74 74.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.572 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -117.64 119.29 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.91 157.37 23.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.53 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.429 ' CG2' HG13 ' A' ' 101' ' ' ILE . 29.7 m -137.68 158.11 33.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.312 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -142.93 109.02 5.21 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.348 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.37 150.11 33.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.1 p -124.36 134.9 65.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.202 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.98 111.19 17.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.65 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -129.7 139.44 51.35 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.187 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 tp -169.05 72.19 0.74 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 121.369 0.604 . . . . 0.0 111.144 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 C--N 1.347 0.457 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.818 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.567 0.222 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.6 t -130.83 119.34 45.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.889 0.376 . . . . 0.0 111.018 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -133.64 110.95 10.22 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.742 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.466 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 15.1 mtt85 -126.44 161.65 27.41 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.352 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 2.3 t -170.47 116.92 0.51 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.59 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 7.8 tt -103.41 118.06 49.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 121.023 0.44 . . . . 0.0 110.93 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -118.09 112.11 19.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 pt -113.63 133.51 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.31 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -128.77 125.33 37.62 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.954 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -130.89 103.87 6.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -117.64 146.38 43.72 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.169 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.611 ' HG2' ' HA ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -146.04 148.26 32.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.887 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -162.9 120.37 1.97 Allowed 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.655 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' ARG . 24.8 mt . . . . . 0 N--CA 1.465 0.323 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.667 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 m . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.587 0.232 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 1.1 ptt-85 -131.3 160.37 35.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.069 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -100.17 160.08 14.61 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.855 0.36 . . . . 0.0 111.079 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.1 p-90 -159.4 151.58 20.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.613 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -148.36 118.11 7.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.696 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tp -124.9 137.04 58.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.926 0.393 . . . . 0.0 111.573 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.401 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -157.67 149.54 22.1 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.786 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 74' ' ' PHE . 12.5 tt -156.61 132.51 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.025 0.441 . . . . 0.0 111.331 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 35.3 m -130.39 159.04 42.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.975 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 8' ' ' THR . 0.5 OUTLIER -164.49 145.21 7.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 111.475 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -97.57 155.16 17.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.378 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.06 -46.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.973 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -78.23 2.61 17.73 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.378 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -82.24 -27.9 32.21 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.495 0.188 . . . . 0.0 110.781 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.26 -59.08 0.13 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.167 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.05 119.56 5.6 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.777 0.322 . . . . 0.0 111.453 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.19 30.41 4.17 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.957 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.43 134.44 21.21 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.177 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 36.4 Cg_endo -65.75 -44.93 7.23 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.664 2.243 . . . . 0.0 112.769 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 66.57 -76.05 0.05 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.52 0.328 . . . . 0.0 111.798 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -104.02 -69.61 0.8 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.565 0.221 . . . . 0.0 110.977 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -122.77 -81.81 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.772 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.421 ' HB3' ' HA ' ' A' ' 47' ' ' PRO . 5.5 t80 62.48 101.62 0.03 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.296 0.57 . . . . 0.0 110.953 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 35.1 t70 -166.75 111.54 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.848 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.636 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.5 OUTLIER -116.28 126.34 53.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.211 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 p -122.3 152.48 26.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.884 0.373 . . . . 0.0 111.588 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.481 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 2.1 mt -130.98 131.3 64.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.374 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.59 144.07 51.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.696 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -147.57 119.85 8.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.0 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 CA--C 1.53 0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.677 -179.822 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo . . . . . 0 CA--C 1.53 0.295 0 CA-C-O 120.603 0.168 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.481 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 3.4 m120 -128.24 145.61 50.99 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.836 0.35 . . . . 0.0 111.158 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 -141.81 153.37 44.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.636 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 4.3 m -130.71 119.07 21.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.849 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -164.13 -49.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.584 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -152.02 32.12 0.54 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.648 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.27 161.89 24.81 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.16 166.83 28.51 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.765 2.31 . . . . 0.0 112.653 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.37 138.68 36.43 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.876 2.384 . . . . 0.0 112.639 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.404 ' HB2' HG23 ' A' ' 36' ' ' ILE . 82.4 m-85 -93.37 148.57 21.94 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.146 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.69 84.1 0.08 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.72 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 mt -134.91 134.28 53.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.495 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -134.51 137.73 44.1 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.831 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.15 -177.59 6.01 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.82 125.14 48.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.595 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.95 -162.83 16.84 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.588 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -122.82 110.89 16.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.0 0.429 . . . . 0.0 110.942 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.61 124.5 0.76 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.954 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.93 107.06 0.42 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.274 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -141.59 167.47 16.9 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.67 0.271 . . . . 0.0 111.367 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.9 171.85 0.94 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.24 2.627 . . . . 0.0 113.733 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 mp -139.37 166.05 25.58 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.563 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -155.0 114.6 3.71 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.728 0.299 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.7 mp -124.19 120.45 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.623 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.05 149.37 42.29 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.853 0.359 . . . . 0.0 111.094 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 53' ' ' LYS . 3.7 t -131.08 131.38 63.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.222 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 54.2 m-85 -142.54 144.17 32.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.174 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.77 -54.01 1.15 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.396 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -179.64 -44.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.758 0.313 . . . . 0.0 110.895 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.76 -174.61 2.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.917 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.05 71.26 3.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 111.356 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.06 -50.86 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.577 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -145.65 33.14 1.56 Allowed Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.455 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -102.09 103.0 13.55 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.792 0.329 . . . . 0.0 110.786 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.34 151.18 41.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -104.52 124.92 50.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.337 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.43 114.05 29.0 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.684 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.6 151.94 15.12 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.874 2.382 . . . . 0.0 111.907 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -136.64 171.35 14.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 111.398 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -133.86 128.96 35.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.54 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 tp -108.1 106.35 16.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.777 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.99 168.11 14.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.147 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.611 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 9.3 p90 -94.9 165.61 12.37 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.419 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tp 84.45 62.59 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.341 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? 65.4 111.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.648 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.35 128.82 34.45 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.831 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.9 p -127.41 66.1 1.31 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.714 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 103' ' ' HIS . 5.0 m-85 -108.48 119.42 39.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.561 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.37 152.87 20.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.372 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.9 t -139.65 149.16 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.651 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -135.16 108.87 8.01 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.484 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.36 146.24 39.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.121 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.56 128.71 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.176 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 3.5 mp -121.5 111.21 30.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -123.03 122.78 39.35 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.1 pp -148.23 68.58 10.37 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 121.082 0.468 . . . . 0.0 111.347 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 C--N 1.346 0.436 0 C-N-CA 122.635 2.223 . . . . 0.0 112.41 179.853 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.76 119.46 51.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -138.04 117.68 13.06 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.483 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -143.08 169.2 18.03 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 9.8 t -172.39 133.58 0.65 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.427 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.406 ' CB ' HG22 ' A' ' 90' ' ' VAL . 9.5 tp -109.11 118.39 56.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.032 0.444 . . . . 0.0 111.022 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -124.89 108.21 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.79 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.58 128.95 75.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.066 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.47 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 2.6 mptp? -115.49 125.28 52.86 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.651 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.402 HG23 HD22 ' A' ' 86' ' ' LEU . 97.5 m -130.06 127.2 39.41 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -138.96 158.82 43.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.912 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.452 ' NE2' ' HG ' ' A' ' 105' ' ' LEU . 1.4 tt0 -153.11 144.28 23.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.757 0.313 . . . . 0.0 111.275 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -142.18 119.23 11.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.864 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.432 HG12 ' CB ' ' A' ' 30' ' ' ARG . 4.8 mt . . . . . 0 C--O 1.233 0.193 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.913 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 121.014 0.435 . . . . 0.0 111.968 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.432 ' CB ' HG12 ' A' ' 17' ' ' ILE . 1.1 ptt-85 -117.74 161.58 19.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.319 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.06 156.44 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.665 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -154.55 137.55 15.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.155 0.503 . . . . 0.0 111.567 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.7 t -134.83 117.21 15.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.934 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 mm -128.94 142.76 43.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.945 0.402 . . . . 0.0 111.605 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 11.4 pt-20 -151.63 143.62 23.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.633 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.44 HG23 ' CD1' ' A' ' 55' ' ' ILE . 3.8 mp -128.66 133.61 66.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.01 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.43 ' HA ' ' HB3' ' A' ' 73' ' ' PRO . 20.2 t -141.52 129.45 22.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.911 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -156.35 176.93 12.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.668 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 3.8 mm? -104.96 162.52 13.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.216 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -155.26 -59.57 0.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.42 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -77.69 -10.13 59.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.63 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -92.58 -27.8 17.13 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.77 45.6 1.2 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.444 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.98 103.76 0.07 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.006 0.431 . . . . 0.0 111.29 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 41' ' ' ASP . 1.2 tm-20 -96.83 35.57 1.52 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.258 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 mp -119.53 102.35 47.81 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.55 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.55 151.66 58.97 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.842 2.361 . . . . 0.0 112.664 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.31 -69.82 0.3 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.158 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -83.79 -58.12 2.93 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.759 0.314 . . . . 0.0 110.421 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.91 -86.39 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.634 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 46.3 t80 46.43 89.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.007 0.432 . . . . 0.0 111.703 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -175.58 134.22 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.663 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 1.4 mttt -119.86 149.73 41.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 110.675 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.3 t -141.51 116.38 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.561 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 66' ' ' ASN . 1.8 mp -103.98 138.52 28.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.22 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -132.28 139.4 48.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.842 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -154.66 117.41 4.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.172 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HB3' ' CD2' ' A' ' 105' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.504 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 C--O 1.235 0.357 0 CA-C-O 120.801 0.25 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.472 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -123.91 138.81 54.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.441 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.76 126.12 17.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.58 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 1.7 m -105.96 104.98 14.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.935 0.398 . . . . 0.0 111.373 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -134.0 -55.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.048 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -146.02 33.76 1.01 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.106 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.01 159.71 63.3 Favored Pre-proline 0 N--CA 1.466 0.365 0 CA-C-O 120.762 0.315 . . . . 0.0 111.61 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -76.57 175.78 10.92 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.227 2.618 . . . . 0.0 112.58 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . 48.0 Cg_exo -56.09 175.25 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.875 2.383 . . . . 0.0 112.739 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.43 160.79 38.11 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.21 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -176.98 104.09 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.483 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -139.65 132.7 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.045 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.67 122.95 24.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -137.28 167.56 21.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.601 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.1 173.37 6.42 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.778 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.67 -129.1 7.86 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.31 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -117.12 110.44 18.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.792 0.329 . . . . 0.0 110.627 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.2 88.71 0.09 OUTLIER Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.221 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -136.0 103.77 0.46 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.519 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.4 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -150.78 168.18 11.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 120.486 0.184 . . . . 0.0 110.766 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.91 173.34 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.973 2.449 . . . . 0.0 113.675 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 103' ' ' HIS . 3.3 mp -140.24 160.58 39.64 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.559 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -158.18 115.52 2.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.169 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 3.9 pt -113.82 105.21 18.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.242 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.4 p -112.37 136.99 51.17 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.01 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.406 HG22 ' CB ' ' A' ' 9' ' ' ILE . 5.7 t -131.62 119.27 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.344 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -125.59 155.96 39.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.947 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -149.67 -171.44 3.9 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.765 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.7 mt -77.26 136.43 38.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.832 0.348 . . . . 0.0 111.593 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 67.55 10.76 7.98 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.208 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 51.32 75.06 0.21 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.518 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.432 ' CB ' HG13 ' A' ' 120' ' ' ILE . . . -108.03 -28.14 9.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.965 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.402 ' HA3' HG21 ' A' ' 118' ' ' ILE . . . -131.31 34.54 2.59 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.722 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.85 98.96 0.3 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.643 0.258 . . . . 0.0 110.602 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -141.86 125.86 17.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.361 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 2.0 pttp -131.07 132.84 45.16 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.736 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -137.21 119.66 11.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.507 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -87.16 149.87 8.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.925 2.416 . . . . 0.0 112.607 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 58.6 m80 -139.95 172.35 12.89 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.117 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.61 144.97 49.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.818 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.452 ' HG ' ' NE2' ' A' ' 15' ' ' GLN . 2.5 tp -127.37 88.35 2.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.795 0.331 . . . . 0.0 111.461 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -167.94 39.2 0.04 OUTLIER 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.432 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -141.62 124.88 16.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.391 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -56.74 130.01 43.69 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.69 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 71.02 68.98 0.17 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.594 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -102.92 135.64 44.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.545 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.5 p -140.72 67.22 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.82 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -113.42 119.82 38.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.656 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.7 137.14 16.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.398 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.3 t -116.67 146.94 20.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.986 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -132.78 108.64 9.12 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.878 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.69 148.69 37.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.084 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.2 p -124.25 148.94 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.623 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.402 HG21 ' HA3' ' A' ' 97' ' ' GLY . 11.1 mt -133.94 110.88 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -130.3 104.5 7.31 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.401 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.432 HG13 ' CB ' ' A' ' 96' ' ' ALA . 21.2 mm -136.98 56.38 12.56 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 120.998 0.428 . . . . 0.0 111.473 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 C--N 1.348 0.508 0 C-N-CA 122.556 2.171 . . . . 0.0 112.468 179.614 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.753 0.311 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.418 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 7.2 p -140.79 127.81 21.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.275 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.03 110.36 19.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.163 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 39.0 mtp85 -109.24 157.22 19.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.269 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 t -165.94 124.95 1.61 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.469 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.4 tt -108.67 118.2 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 110.769 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -125.24 131.08 53.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.607 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.476 HD11 ' CE1' ' A' ' 103' ' ' HIS . 1.3 pt -127.35 129.84 70.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.142 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.69 112.4 25.46 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.23 113.8 20.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -135.61 154.33 51.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.738 0.304 . . . . 0.0 111.166 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.62 138.17 23.22 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.267 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -135.2 119.43 17.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.967 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 8.0 mt . . . . . 0 N--CA 1.462 0.137 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.738 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.936 0.398 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.83 162.12 18.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.425 ' CG ' ' HB3' ' A' ' 79' ' ' GLN . 2.6 mt-30 -124.2 159.83 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -158.47 160.61 36.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.262 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.1 p -146.73 121.91 10.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.523 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.4 tp -126.4 124.21 65.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.962 0.411 . . . . 0.0 110.949 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HG3' ' HB2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -127.2 135.81 51.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.632 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 74' ' ' PHE . 8.0 mt -123.91 105.89 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 73' ' ' PRO . 27.1 m -119.72 149.1 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.84 0.352 . . . . 0.0 111.6 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pp -172.04 151.89 2.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.265 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.534 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -108.05 162.51 13.98 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.514 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -174.19 -47.71 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.396 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -86.04 2.72 45.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -24.93 24.63 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 5' ' ' VAL . . . -112.35 -74.82 0.71 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.342 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -87.98 -56.55 3.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 64.95 16.77 10.73 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.239 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.6 mt -109.86 140.99 22.8 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.033 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.56 174.41 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.94 2.427 . . . . 0.0 112.633 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.29 -164.49 1.78 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.375 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -66.9 -47.8 70.7 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.431 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.43 -86.28 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.623 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 29.3 t80 53.29 92.84 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.102 0.477 . . . . 0.0 111.384 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 2.8 t70 -172.43 116.22 0.33 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.696 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.83 125.55 45.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.59 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.78 132.26 71.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.959 0.409 . . . . 0.0 111.56 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 mm -123.11 140.22 47.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.932 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -143.81 97.88 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -111.45 125.99 54.47 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.93 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.463 0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.364 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--O 1.233 0.237 0 CA-C-O 120.8 0.25 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -96.79 130.64 44.01 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -145.61 112.63 6.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.61 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.86 131.56 39.14 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -140.51 -54.05 0.51 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.603 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.95 36.48 0.4 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.741 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.19 163.35 34.32 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.01 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.85 171.66 2.72 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.865 2.377 . . . . 0.0 112.415 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 36.5 Cg_endo -64.89 169.43 11.77 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.632 2.221 . . . . 0.0 112.621 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 15.0 m-85 -117.06 64.26 0.72 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.713 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.514 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 24.4 tpt180 -82.81 90.74 6.95 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.776 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -126.84 131.82 70.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.388 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -136.65 123.24 20.97 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.536 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -133.79 177.91 7.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.579 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.425 ' HB3' ' CG ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -129.87 -179.22 5.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.066 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.49 -148.74 17.3 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.967 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.85 110.17 16.88 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.811 0.339 . . . . 0.0 110.861 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.07 -117.96 0.55 Allowed Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.118 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.11 114.79 2.32 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.679 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.0 m-85 -165.42 168.49 8.2 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 120.546 0.212 . . . . 0.0 110.976 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 37.1 Cg_endo -65.81 -177.44 0.76 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.981 2.454 . . . . 0.0 113.014 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 103' ' ' HIS . 5.4 mp -146.15 166.08 27.25 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.751 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -158.71 123.63 4.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.783 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.25 112.49 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.009 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.22 116.02 24.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.685 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 98' ' ' GLU . 1.2 p -104.7 143.32 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.314 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 27.5 m-85 -133.26 155.78 48.76 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.524 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 4.6 tp -142.2 -63.17 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.731 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.6 -68.7 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.313 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -146.62 -63.49 0.3 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.359 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 51.53 1.2 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 111.185 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -104.41 -36.98 7.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.416 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 180.0 46.04 0.08 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.535 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 91' ' ' PHE . 11.4 pt-20 -111.34 111.02 21.77 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.08 0.467 . . . . 0.0 110.745 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -142.29 151.79 42.35 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.303 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 0.2 OUTLIER -117.35 127.79 54.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.381 179.172 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.24 121.42 10.21 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 121.024 0.44 . . . . 0.0 111.921 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.56 160.5 9.4 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.916 2.41 . . . . 0.0 112.393 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.476 ' CE1' HD11 ' A' ' 11' ' ' ILE . 38.1 m80 -144.69 172.21 13.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -124.33 145.04 49.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.115 0.483 . . . . 0.0 111.053 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 tp -139.16 78.63 1.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.378 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -161.82 38.94 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.367 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -141.47 130.39 23.12 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.168 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 2.4 pp -59.86 131.51 51.1 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.467 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.32 62.97 0.36 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.658 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -103.33 134.65 46.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.649 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.1 t -134.14 71.79 1.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.16 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.73 119.17 38.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.709 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -143.08 141.93 31.4 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.205 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.9 t -127.81 145.02 35.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -140.73 108.35 5.61 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.468 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.49 138.85 49.53 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.106 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.5 m -104.5 140.9 21.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.498 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 10.0 mt -138.05 111.08 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.36 119.1 35.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.649 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.2 mp -125.07 52.13 6.01 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.748 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 C--N 1.347 0.494 0 C-N-CA 122.488 2.125 . . . . 0.0 112.637 179.764 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.872 0.367 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -129.14 119.09 48.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.808 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -137.41 104.96 5.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.586 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -125.4 165.57 18.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.956 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.5 t -172.99 139.56 0.84 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.09 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.99 118.2 56.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.47 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HD3' ' HG2' ' A' ' 115' ' ' GLU . 10.8 mtt85 -124.78 105.3 9.18 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.408 HG23 ' HA ' ' A' ' 36' ' ' ILE . 2.2 pt -112.51 134.09 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.052 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.41 141.59 48.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.27 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -138.55 109.75 6.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.081 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -120.97 136.68 54.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.502 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.433 ' OE1' HG13 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -140.06 150.43 44.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.671 0.272 . . . . 0.0 111.691 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -147.64 119.66 8.22 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.41 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.433 HG13 ' OE1' ' A' ' 15' ' ' GLN . 14.5 mt . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.972 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.5 0.191 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -109.42 163.55 13.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.311 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.05 111.02 10.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.571 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.402 ' CE2' ' HB2' ' A' ' 78' ' ' GLU . 23.3 p-90 -116.1 150.21 37.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.307 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -140.1 147.27 40.0 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.493 HG23 ' CD2' ' A' ' 57' ' ' HIS . 5.7 tp -146.48 135.32 16.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.487 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 3.7 pm0 -134.97 144.57 47.47 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.822 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.408 ' HA ' HG23 ' A' ' 11' ' ' ILE . 4.2 mp -121.32 107.07 19.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.889 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.72 138.36 34.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.245 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 8' ' ' THR . 0.6 OUTLIER -166.18 160.08 15.8 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.527 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -105.02 161.85 13.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -151.64 -63.17 0.18 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.678 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.09 -19.54 65.88 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.514 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -86.65 -32.66 20.43 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.196 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.57 48.08 0.97 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.28 106.31 0.04 OUTLIER 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.983 0.42 . . . . 0.0 111.3 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.24 16.34 6.38 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.932 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.1 mt -125.47 104.58 28.06 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-O 120.515 0.198 . . . . 0.0 111.409 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.419 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 74.2 Cg_endo -75.33 -170.5 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.799 2.333 . . . . 0.0 112.556 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.83 -45.87 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.879 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.65 -67.79 0.84 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.791 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.38 -89.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.032 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 40.3 t80 58.72 100.14 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.2 0.524 . . . . 0.0 110.864 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.8 110.36 1.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.844 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.98 102.59 13.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.364 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -103.95 139.42 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.342 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -130.69 144.84 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.433 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.08 148.15 42.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.493 ' CD2' HG23 ' A' ' 34' ' ' ILE . 26.1 p-80 -161.12 59.35 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.679 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.2 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.359 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo . . . . . 0 CA--C 1.529 0.234 0 CA-C-O 120.714 0.214 . . . . 0.0 112.618 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -109.96 128.67 55.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.701 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -144.8 139.51 27.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.997 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.04 104.65 9.01 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.095 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -102.24 -41.4 6.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.107 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 t -170.53 43.25 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.495 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.19 166.18 20.64 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.236 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.79 172.48 5.79 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.898 2.399 . . . . 0.0 112.445 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.97 -179.03 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.778 2.319 . . . . 0.0 112.61 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -140.89 159.17 42.78 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -173.92 114.18 0.2 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.075 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -142.9 151.18 17.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.245 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -133.63 141.85 47.82 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.917 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.402 ' HB2' ' CE2' ' A' ' 32' ' ' TRP . 13.6 mt-10 -133.79 152.08 51.77 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.959 0.409 . . . . 0.0 111.586 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.95 178.98 5.43 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.367 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.15 -103.72 2.81 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.67 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -121.69 112.12 18.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.085 0.469 . . . . 0.0 111.418 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.13 115.17 0.61 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.177 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -166.4 103.85 0.21 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.392 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -150.55 167.8 12.27 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.648 0.261 . . . . 0.0 111.195 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.78 173.14 2.38 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.245 2.63 . . . . 0.0 113.325 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' A' ' 105' ' ' LEU . 2.5 mp -142.62 160.11 40.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.32 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -157.6 113.4 2.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.799 0.333 . . . . 0.0 111.568 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.0 tt -116.47 121.79 68.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.533 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.6 121.94 26.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.115 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 5.8 t -99.95 154.3 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.643 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CD2' ' HG3' ' A' ' 98' ' ' GLU . 51.4 m-85 -148.52 158.23 43.99 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.3 OUTLIER -153.45 -175.13 5.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.134 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 47' ' ' PRO . 8.9 mp -60.93 -67.0 0.44 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.537 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -94.15 19.77 8.86 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.574 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm 58.35 55.36 5.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.17 -37.62 37.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 90' ' ' VAL . . . -122.49 26.39 6.32 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.606 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.0 tt0 -67.08 90.9 0.2 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.633 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -142.45 142.37 32.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.503 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -126.62 119.32 26.75 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.393 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.6 mt -128.77 120.72 20.68 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.482 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.2 154.83 8.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.004 2.47 . . . . 0.0 112.692 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 81.7 m-70 -140.12 172.1 13.23 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.396 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -128.54 124.6 36.4 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.114 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.55 ' HB2' HD12 ' A' ' 86' ' ' LEU . 1.3 tm? -113.56 95.03 5.13 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.761 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 13.6 t-20 178.8 41.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.062 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -137.4 125.27 22.61 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.663 0.268 . . . . 0.0 111.138 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.04 123.89 12.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.83 60.88 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.419 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.0 138.97 30.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.46 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.2 p -148.16 63.75 1.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.905 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -115.19 119.36 36.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.389 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -147.32 133.84 19.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.506 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 t -105.59 147.4 11.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.72 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.403 ' HG2' ' HD3' ' A' ' 10' ' ' ARG . 34.9 mt-10 -136.45 108.45 7.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.695 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -116.64 138.51 51.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.8 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.62 140.92 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.986 0.422 . . . . 0.0 111.555 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.405 HG12 ' HA3' ' A' ' 97' ' ' GLY . 2.0 mp -130.56 111.39 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.585 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -122.5 136.95 55.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.214 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.9 tt -160.24 55.85 0.75 Allowed Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 121.286 0.565 . . . . 0.0 111.21 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 C--N 1.347 0.499 0 C-N-CA 122.719 2.28 . . . . 0.0 112.531 179.904 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.738 0.304 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 44' ' ' LYS . 19.4 t -133.42 119.24 34.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.078 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -137.03 104.89 5.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.159 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.466 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -132.57 172.98 11.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.189 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t -173.22 141.36 0.93 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -109.2 118.14 55.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 110.636 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.8 mtt-85 -124.75 118.25 25.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.802 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pt -123.56 129.81 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.124 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.443 ' CG ' ' HG3' ' A' ' 113' ' ' GLU . 34.2 mtmt -108.19 133.09 52.93 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -131.33 104.2 6.89 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -115.1 137.98 51.4 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.698 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.439 ' NE2' ' HG ' ' A' ' 105' ' ' LEU . 4.8 tt0 -139.39 151.98 46.75 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.751 0.31 . . . . 0.0 111.705 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -150.0 119.18 6.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.722 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.8 mt . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.75 0.309 . . . . 0.0 110.648 179.35 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.454 ' HB ' ' HA2' ' A' ' 80' ' ' GLY . 7.3 m . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.95 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -136.08 163.43 30.34 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.213 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 3.7 mt-30 -118.54 148.94 42.12 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.075 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.452 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 15.0 p-90 -156.11 155.23 32.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.103 0.478 . . . . 0.0 112.145 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.1 t -149.29 117.74 6.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.539 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tp -122.29 143.05 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.428 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 4.0 pt-20 -144.64 118.73 9.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.833 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.499 HG22 HD11 ' A' ' 55' ' ' ILE . 4.6 mp -101.07 110.35 27.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.676 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.3 t -124.03 147.8 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.721 0.296 . . . . 0.0 111.589 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.407 HD21 ' HD3' ' A' ' 53' ' ' LYS . 2.9 pp -156.89 171.2 20.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.255 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 7' ' ' ARG . 2.5 tp -120.18 159.02 25.72 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.21 -45.62 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.287 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.3 2.58 15.29 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.43 -36.52 26.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.577 0.227 . . . . 0.0 111.007 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.4 -66.96 0.25 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.809 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HB2' HG21 ' A' ' 5' ' ' VAL . 4.2 mttt -155.07 108.92 2.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.558 0.218 . . . . 0.0 110.849 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -90.08 49.62 1.74 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.751 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.45 132.93 24.57 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.216 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.85 -177.98 4.01 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.84 2.36 . . . . 0.0 112.565 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.62 -54.53 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.25 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.8 p -125.82 -55.09 1.51 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.347 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.9 -86.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.015 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 t80 56.23 96.82 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.075 0.464 . . . . 0.0 111.213 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -174.41 127.52 0.34 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.664 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HD3' HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -114.55 133.09 56.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.806 0.336 . . . . 0.0 110.703 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.7 t -132.44 118.82 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.645 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 36' ' ' ILE . 3.6 mp -106.99 144.91 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.382 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -138.95 144.87 39.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.068 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -167.27 137.31 2.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.691 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 84' ' ' PHE . 2.6 mt . . . . . 0 N--CA 1.468 0.433 0 O-C-N 123.267 0.354 . . . . 0.0 111.044 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo . . . . . 0 CA--C 1.532 0.383 0 CA-C-O 120.671 0.196 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -108.11 139.76 42.29 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.0 0.429 . . . . 0.0 111.164 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? -137.04 147.4 46.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.749 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.77 123.83 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.061 0.458 . . . . 0.0 111.396 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -136.05 -54.46 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.311 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 t -155.65 39.34 0.38 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -123.5 155.75 65.24 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -57.25 172.72 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.08 2.52 . . . . 0.0 112.819 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.88 166.96 4.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.881 2.387 . . . . 0.0 112.939 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.8 84.46 2.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.658 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.2 ttp85 -99.85 113.91 26.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.45 115.7 18.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -122.18 144.08 49.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.3 166.64 32.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.943 0.402 . . . . 0.0 111.449 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -123.65 170.52 10.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.454 ' HA2' ' HB ' ' A' ' 29' ' ' VAL . . . 98.35 -81.8 0.62 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.472 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -113.61 116.61 29.77 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.452 ' HA3' ' CD1' ' A' ' 32' ' ' TRP . . . -170.99 88.29 0.09 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.763 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -160.26 74.64 0.2 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.666 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.527 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 22.7 m-85 -143.37 165.7 23.95 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 120.632 0.253 . . . . 0.0 111.35 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 37.3 Cg_endo -65.38 171.1 9.78 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.136 2.557 . . . . 0.0 113.729 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 103' ' ' HIS . 5.1 mp -143.29 159.59 42.06 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.964 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -155.37 112.71 3.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.663 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.52 124.46 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.685 0.279 . . . . 0.0 111.319 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.1 p -126.59 131.89 51.41 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 24.2 t -124.42 137.46 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.022 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.401 ' CD2' ' CG ' ' A' ' 98' ' ' GLU . 11.5 m-85 -131.61 154.9 48.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.349 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -141.15 -53.84 0.47 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.112 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 tt -152.48 -52.06 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.157 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -170.25 -63.63 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.563 0.22 . . . . 0.0 111.143 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.54 21.95 8.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.407 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.12 -50.86 6.34 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.802 0.334 . . . . 0.0 110.696 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -149.88 23.54 1.15 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.687 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' CG ' ' CD2' ' A' ' 91' ' ' PHE . 0.5 OUTLIER -76.66 84.76 3.31 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.731 0.301 . . . . 0.0 110.789 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -142.28 146.04 34.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.148 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -124.87 147.75 48.63 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.471 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.2 tp -148.0 111.77 3.83 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 121.008 0.433 . . . . 0.0 111.879 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -85.99 133.25 4.13 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.033 2.489 . . . . 0.0 112.342 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 1.7 m-70 -113.18 163.34 14.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.303 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.44 138.46 54.01 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.473 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 6.0 tp -123.48 92.12 3.62 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.653 0.263 . . . . 0.0 110.911 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -167.98 33.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -141.91 126.28 17.66 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.808 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 pp -58.21 131.85 51.8 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.748 0.309 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 73.09 67.16 0.11 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.63 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.45 141.28 28.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 t -144.8 64.86 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.02 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 119.27 38.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.55 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.443 ' HG3' ' CG ' ' A' ' 12' ' ' LYS . 7.5 tt0 -141.67 131.37 24.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.213 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.5 t -116.43 140.4 38.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -133.46 108.54 8.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.62 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.27 119.07 36.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.54 144.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.2 mt -134.6 111.15 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.63 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.38 106.13 8.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.174 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.1 mm -135.4 62.03 47.68 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.192 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--N 1.347 0.464 0 C-N-CA 122.352 2.035 . . . . 0.0 112.871 -179.835 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.184 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.4 119.26 48.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.128 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -129.22 106.07 8.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.545 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.46 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 46.9 mtt85 -123.46 152.71 41.39 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.996 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 6.9 t -160.96 143.95 12.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.17 125.04 73.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.2 mtt85 -132.06 108.83 9.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.552 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -117.78 132.15 68.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.069 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -118.21 139.17 51.69 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.09 102.91 4.97 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.7 tt0 -113.69 118.76 35.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.224 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 32' ' ' TRP . 13.5 tt0 -119.98 146.34 45.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 111.914 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.411 ' CD2' ' HB3' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -146.72 119.8 8.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.1 mt . . . . . 0 CA--C 1.529 0.142 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.179 -179.935 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -104.09 160.41 14.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.997 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.411 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 1.0 OUTLIER -135.84 113.57 11.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.673 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 15' ' ' GLN . 14.1 p-90 -121.8 154.63 36.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.766 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 t -136.71 118.61 15.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.529 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tp -119.18 136.95 54.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.527 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.32 138.88 43.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.346 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.507 HG23 HG12 ' A' ' 55' ' ' ILE . 2.9 mp -123.9 105.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.844 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.2 m -115.59 150.48 17.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.919 0.39 . . . . 0.0 111.499 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 8' ' ' THR . 0.5 OUTLIER -172.51 178.95 2.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.243 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 2.9 mm? -103.88 165.84 10.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.293 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -167.28 -50.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.446 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.15 -31.43 65.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.465 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.78 -36.63 25.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.045 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.19 50.07 1.11 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.824 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.9 mttm 52.85 96.62 0.01 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.89 0.376 . . . . 0.0 111.42 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -24.8 59.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.588 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mp -82.51 114.75 53.89 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.865 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.85 -175.3 1.14 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.594 2.196 . . . . 0.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.49 -51.27 0.25 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.674 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.0 m -104.77 -69.67 0.8 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.835 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -132.53 -85.07 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.838 -0.165 . . . . 0.0 111.019 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 39.0 t80 56.15 95.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.044 0.45 . . . . 0.0 111.505 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -159.16 111.86 2.22 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.498 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.21 121.68 41.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.64 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.81 128.19 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 0.0 111.109 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.507 HG12 HG23 ' A' ' 36' ' ' ILE . 3.3 mp -116.63 145.24 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.434 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -142.82 128.2 18.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -127.57 135.65 50.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.771 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.279 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.53 0.296 0 CA-C-O 120.549 0.145 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.404 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 10.0 m120 -111.74 127.39 55.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.819 0.342 . . . . 0.0 111.052 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.4 ttt-85 -143.37 122.96 13.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.71 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.63 139.32 41.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -159.86 -55.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.119 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.33 38.03 1.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.035 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.83 160.19 67.73 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.505 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -62.13 174.74 2.34 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.16 2.573 . . . . 0.0 112.649 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -74.21 148.73 39.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.74 2.293 . . . . 0.0 112.712 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -99.13 155.79 17.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.01 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.96 86.91 0.1 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.5 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -136.67 151.94 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.319 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -122.45 157.72 31.33 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.994 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.97 141.14 49.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.182 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.88 136.04 53.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.743 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 30' ' ' ARG . . . 128.19 -156.43 20.8 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.839 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -75.81 131.12 39.55 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.055 0.455 . . . . 0.0 111.312 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.9 -127.86 1.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.939 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.04 104.37 0.13 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.752 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.488 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 3.4 m-85 -155.5 170.8 8.14 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 120.707 0.289 . . . . 0.0 111.25 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 87.8 Cg_exo -49.86 170.25 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.477 2.785 . . . . 0.0 114.177 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.16 159.66 40.83 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.72 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -156.21 120.94 4.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.926 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 HG13 HG22 ' A' ' 55' ' ' ILE . 3.1 mp -135.33 124.0 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.275 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 p -123.61 122.23 37.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.95 0.405 . . . . 0.0 110.302 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 19.2 t -107.4 111.88 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.069 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -102.9 157.54 16.9 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.781 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 1.3 pt? -146.27 -159.81 1.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.612 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.4 mt -55.59 -66.85 0.35 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.409 0.147 . . . . 0.0 111.014 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -177.37 42.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.221 0.534 . . . . 0.0 110.42 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.96 -166.24 1.06 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.026 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.65 -13.44 61.36 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.817 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.12 -27.91 57.94 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.097 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -65.26 83.43 0.05 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.107 0.48 . . . . 0.0 110.624 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.46 155.45 45.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.545 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -121.54 145.89 47.5 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.615 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.59 114.47 8.77 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.468 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -88.63 155.85 6.32 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.082 2.522 . . . . 0.0 112.254 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.412 ' CE1' ' HB3' ' A' ' 112' ' ' TYR . 6.1 m170 -140.26 172.02 13.33 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.034 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.66 119.32 21.24 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.2 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.403 ' CD1' ' HB2' ' A' ' 15' ' ' GLN . 4.3 tp -112.95 86.5 2.38 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -165.36 39.83 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -142.09 139.75 32.32 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.03 127.36 31.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.368 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 64.9 79.02 0.26 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.245 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 39.3 tt0 -109.63 136.38 49.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.014 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -133.69 70.95 1.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.106 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.412 ' HB3' ' CE1' ' A' ' 103' ' ' HIS . 5.5 m-85 -110.09 119.1 38.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.059 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -154.57 132.23 11.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.415 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.0 t -109.59 145.72 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.678 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -132.16 108.65 9.41 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.079 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.29 151.71 30.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.7 149.31 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.957 0.408 . . . . 0.0 111.871 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.3 mt -143.29 110.97 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.507 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -129.79 118.33 21.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.637 0.256 . . . . 0.0 111.28 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.432 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.6 pp -138.2 48.58 2.03 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.83 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 120' ' ' ILE . 71.1 Cg_endo . . . . . 0 C--N 1.351 0.704 0 C-N-CA 122.56 2.173 . . . . 0.0 112.866 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.582 0.23 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 t -123.38 119.43 57.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.097 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.72 104.85 5.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.19 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -134.59 175.44 9.53 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.038 0.447 . . . . 0.0 111.258 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 4.9 t -160.77 146.05 14.45 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.335 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 tt -113.87 118.05 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-O 120.931 0.396 . . . . 0.0 110.784 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -130.29 111.13 12.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.505 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.444 HD11 ' CG2' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -122.06 142.27 39.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.121 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.421 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -120.59 138.4 53.91 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.755 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.2 120.12 12.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.161 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -130.33 160.14 34.84 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.77 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -152.86 142.04 21.44 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.279 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -131.96 119.67 21.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.733 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.4 mt . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.608 179.67 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.464 0.235 0 CA-C-O 120.69 0.281 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.42 162.37 26.5 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.355 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.53 162.14 19.42 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -158.87 141.47 14.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.195 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -138.38 117.65 12.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.55 139.74 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.988 0.423 . . . . 0.0 111.953 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -143.46 132.98 23.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.673 179.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.44 HG22 HG12 ' A' ' 55' ' ' ILE . 5.4 mm -113.62 111.58 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.212 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.68 133.76 64.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.707 0.289 . . . . 0.0 110.966 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 8' ' ' THR . 4.0 pp -169.37 174.95 5.76 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.582 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.94 160.92 18.98 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.413 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -167.83 -49.36 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.16 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.72 1.91 28.24 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -83.94 -34.78 24.39 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 111.052 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.9 -75.17 0.93 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.868 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.43 112.08 18.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.608 0.242 . . . . 0.0 110.79 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -104.6 30.5 5.36 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.191 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 mt -132.32 124.2 19.11 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.293 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.32 168.57 24.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.877 2.385 . . . . 0.0 112.538 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.42 -50.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.652 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 p -121.63 -68.1 0.92 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.716 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.19 -89.67 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.168 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 13.2 t80 57.47 95.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.993 0.425 . . . . 0.0 111.522 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -165.95 125.61 1.68 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.623 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.84 105.22 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.368 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.0 140.58 24.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.39 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.44 HG12 HG22 ' A' ' 36' ' ' ILE . 3.5 mp -123.86 141.5 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.963 0.411 . . . . 0.0 111.327 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -128.78 154.9 45.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.765 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 19.2 p80 -164.82 137.61 4.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.769 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.47 ' HA ' ' CB ' ' A' ' 84' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.607 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo . . . . . 0 CA--C 1.532 0.402 0 CA-C-O 120.809 0.254 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.421 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 29.1 m-20 -87.71 150.83 23.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.041 0.448 . . . . 0.0 111.559 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.62 136.67 18.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.9 m -129.41 108.08 10.0 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.069 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -141.92 -54.07 0.44 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.257 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 p -140.08 33.9 1.93 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.135 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.42 164.05 42.27 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.277 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.79 168.43 22.94 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.803 2.335 . . . . 0.0 112.696 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.79 161.54 45.54 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.721 2.281 . . . . 0.0 112.845 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -105.22 154.7 19.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.219 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.04 71.83 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.61 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 mt -130.47 141.01 47.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.414 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.57 138.77 47.56 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.526 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -140.23 167.54 21.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.002 0.43 . . . . 0.0 111.453 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.9 141.53 50.79 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.41 -131.75 2.36 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.604 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -120.2 110.33 16.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.882 0.373 . . . . 0.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.46 -126.54 0.86 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.389 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.41 94.04 1.52 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.574 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.529 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.1 m-85 -156.13 169.92 9.68 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.63 0.252 . . . . 0.0 111.088 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 58.6 Cg_endo -72.01 172.35 14.84 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.767 2.311 . . . . 0.0 113.38 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.442 ' CG ' ' HB2' ' A' ' 103' ' ' HIS . 0.4 OUTLIER -146.46 159.69 43.08 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.517 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -149.55 119.0 6.88 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.678 0.275 . . . . 0.0 111.383 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.444 ' CG2' HD11 ' A' ' 11' ' ' ILE . 5.0 tt -111.11 114.12 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -110.15 135.0 51.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 3.8 p -122.15 138.65 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.966 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -134.69 157.58 46.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.547 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 1.4 pt? -146.02 -163.47 1.74 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.5 mp -97.02 -16.78 20.4 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.35 1.77 22.06 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.24 37.42 8.29 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.01 -50.44 5.1 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.613 0.244 . . . . 0.0 111.39 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.03 16.86 56.92 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.893 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 23.4 tt0 -70.78 96.43 1.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.82 0.31 . . . . 0.0 110.559 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 156.92 45.16 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.849 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.58 139.42 51.51 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.464 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.8 mp -128.03 99.7 24.96 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-O 120.941 0.4 . . . . 0.0 111.38 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -87.89 144.32 6.24 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.032 2.488 . . . . 0.0 112.422 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.442 ' HB2' ' CG ' ' A' ' 86' ' ' LEU . 38.9 m80 -136.92 172.15 13.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 85' ' ' PRO . 9.9 p-10 -121.42 151.24 40.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.405 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 tp -139.06 85.32 2.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 0.0 110.624 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -161.41 38.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.519 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -141.68 134.04 28.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.396 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 pp -58.74 131.09 49.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.508 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 62.25 75.4 0.4 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.027 0.441 . . . . 0.0 110.599 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -105.33 135.67 46.28 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.018 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t -136.87 74.43 1.49 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.165 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -113.64 119.14 36.41 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.383 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -148.21 136.44 21.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.09 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.416 ' CG1' ' CD1' ' A' ' 11' ' ' ILE . 6.3 p -116.94 143.2 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.81 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.34 122.03 20.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.078 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.74 159.22 37.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.49 138.09 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.485 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.25 110.75 26.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.175 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -130.03 120.36 24.59 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.56 55.38 2.54 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 C--N 1.354 0.823 0 C-N-CA 122.484 2.123 . . . . 0.0 112.86 179.645 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.733 0.301 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -134.96 118.91 25.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.755 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.77 106.28 5.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.467 ' CZ ' HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -124.05 167.55 14.04 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.632 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -178.06 133.0 0.15 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.411 HG22 HG22 ' A' ' 90' ' ' VAL . 3.6 tt -106.14 118.22 53.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.059 0.457 . . . . 0.0 110.834 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -116.56 107.05 14.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.38 135.13 50.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -120.14 138.68 53.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.998 -179.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -141.07 113.99 8.42 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.2 mt-30 -127.02 147.71 50.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.677 0.275 . . . . 0.0 111.078 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -138.88 145.08 39.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -143.32 119.3 10.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.827 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 10.2 mt . . . . . 0 C--N 1.332 -0.168 0 CA-C-O 120.738 0.304 . . . . 0.0 110.792 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.888 0.375 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.35 159.4 23.48 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.107 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -116.59 158.51 23.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -157.6 145.49 18.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.334 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 p -146.04 117.56 8.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.652 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 2.3 tp -130.34 134.74 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.46 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.9 pt-20 -136.47 135.08 38.32 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.46 ' CG2' HG13 ' A' ' 55' ' ' ILE . 4.1 mp -110.06 114.83 48.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.716 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.7 t -125.2 135.69 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.277 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.422 HD12 ' HD3' ' A' ' 53' ' ' LYS . 1.4 pp -157.69 154.23 27.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.424 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -99.58 161.89 13.35 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.598 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -174.72 -46.9 0.01 OUTLIER 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.06 -19.59 65.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.363 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -98.69 -36.7 9.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.244 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.9 45.85 1.46 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.875 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt 62.01 100.98 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.08 48.47 1.37 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.198 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.1 mt -128.0 110.92 20.12 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.291 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.77 161.4 10.25 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.153 2.569 . . . . 0.0 113.036 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.64 -54.0 0.82 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.628 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 93' ' ' LEU . 32.0 m -117.06 -63.49 1.44 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.93 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.2 mt -120.82 -78.12 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.795 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.7 t80 57.75 98.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.284 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 9.9 t70 -172.53 107.45 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.898 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.422 ' HD3' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -91.34 128.92 37.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.16 116.28 28.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 121.086 0.47 . . . . 0.0 111.654 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.46 HG13 ' CG2' ' A' ' 36' ' ' ILE . 2.3 mm -106.75 155.67 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -142.24 141.13 32.46 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.408 ' CB ' HD22 ' A' ' 86' ' ' LEU . 14.5 p-80 -150.44 119.55 6.74 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.935 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' HA ' ' CB ' ' A' ' 84' ' ' PHE . 5.7 mp . . . . . 0 N--CA 1.466 0.351 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.328 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo . . . . . 0 C--O 1.233 0.266 0 CA-C-O 120.606 0.169 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.62 128.1 55.54 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.886 0.374 . . . . 0.0 111.185 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.87 105.8 3.59 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.482 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.417 ' O ' ' HD2' ' A' ' 53' ' ' LYS . 6.2 m -97.46 116.6 29.97 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.254 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -121.66 -51.23 2.05 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.96 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 p -147.33 35.36 0.89 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.77 157.94 58.37 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.302 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.82 172.48 10.59 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.093 2.528 . . . . 0.0 112.607 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.9 177.67 1.3 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.822 2.348 . . . . 0.0 112.383 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -141.74 163.47 32.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.914 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER -174.96 121.55 0.22 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -140.18 131.14 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.195 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.0 113.64 10.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.816 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -139.51 174.16 10.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.535 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.52 168.9 11.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.115 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.3 -121.67 3.77 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.324 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -118.34 110.94 18.1 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.776 0.322 . . . . 0.0 110.481 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.35 112.45 0.41 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.927 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -165.93 109.19 0.35 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.612 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.423 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 6.7 m-85 -160.85 170.65 8.13 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 120.397 0.141 . . . . 0.0 110.983 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.74 169.81 3.06 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.125 2.55 . . . . 0.0 113.253 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.408 HD22 ' CB ' ' A' ' 57' ' ' HIS . 3.6 mp -143.03 168.28 20.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.219 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -158.78 119.33 3.26 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.716 0.293 . . . . 0.0 111.651 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 1.1 pp -112.68 109.51 28.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 111.151 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.14 111.41 16.94 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.498 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 9' ' ' ILE . 19.2 t -105.29 145.65 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.607 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 11.8 m-85 -131.66 152.81 50.57 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.72 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.467 HD13 ' CZ ' ' A' ' 7' ' ' ARG . 5.4 tp -141.65 -54.46 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.089 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.408 ' O ' ' HB ' ' A' ' 49' ' ' THR . 1.2 mp -143.2 -70.46 0.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.834 0.349 . . . . 0.0 110.596 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.92 -49.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.73 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.47 29.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.563 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.03 -45.63 6.19 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.972 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -158.75 43.18 0.48 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.304 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 3.8 tt0 -100.35 99.34 9.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.539 0.209 . . . . 0.0 110.947 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -142.52 149.06 38.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.736 0.303 . . . . 0.0 111.52 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -134.33 137.3 44.09 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.145 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.4 mt -144.41 121.83 6.56 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.386 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.29 147.07 20.21 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.62 2.214 . . . . 0.0 112.363 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.27 172.58 11.67 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.164 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -131.24 138.8 49.49 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.063 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.0 tp -131.21 83.12 2.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.838 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.94 35.25 0.15 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.308 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -138.85 132.2 30.14 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -58.98 125.24 22.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.512 179.427 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 71.31 70.79 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.19 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 1.2 tp10 -107.33 138.01 44.32 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.481 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p -137.7 73.18 1.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.853 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -109.72 119.35 39.12 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.413 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -152.13 127.62 10.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.788 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -104.04 145.68 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.744 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.85 108.53 9.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.547 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.36 123.75 50.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.77 142.56 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 111.684 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.34 120.74 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.751 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -127.29 121.35 30.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.448 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.7 pt -153.92 65.13 5.07 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.607 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 C--N 1.347 0.451 0 C-N-CA 122.54 2.16 . . . . 0.0 112.884 179.802 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.784 0.326 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.64 119.02 55.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.727 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -135.77 105.82 6.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.7 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.462 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 25.8 mtt-85 -123.23 159.54 28.48 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.033 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 t -173.34 129.31 0.45 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.752 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 tt -108.38 118.26 55.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.925 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.97 110.11 16.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.663 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.3 pt -115.86 137.06 50.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 1.5 mptp? -121.55 137.98 54.5 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.044 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 m -140.65 104.62 4.77 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -121.5 154.19 36.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.938 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.454 ' HB2' ' CD2' ' A' ' 105' ' ' LEU . 3.3 tt0 -154.65 143.2 20.64 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.014 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -135.02 119.36 17.84 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.716 0.293 . . . . 0.0 111.097 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.9 mt . . . . . 0 C--O 1.233 0.226 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.783 179.746 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 t . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.715 0.293 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -126.05 152.7 45.45 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.204 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.62 154.43 21.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.187 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -152.81 137.58 17.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.053 0.454 . . . . 0.0 111.559 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.4 t -141.53 117.7 10.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.509 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 9.1 tp -128.55 144.57 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.291 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.4 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -158.4 154.83 27.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.973 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.8 tt -148.3 125.46 2.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.965 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.89 123.74 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.198 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.417 HD21 ' HD3' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -137.83 142.51 40.78 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 3.7 mm? -80.47 165.9 21.73 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.833 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.94 -65.94 0.16 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -64.4 -21.3 66.59 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.638 0.256 . . . . 0.0 111.09 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.92 -31.13 22.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.643 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.48 40.39 2.52 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.49 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 mttt 64.14 97.18 0.04 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 110.978 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -69.59 -12.44 61.64 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.662 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.56 134.96 46.93 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-O 120.525 0.203 . . . . 0.0 111.07 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.42 -172.85 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.687 2.258 . . . . 0.0 112.628 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.29 -64.1 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.6 m -116.31 -51.8 2.6 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.397 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.79 -83.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.783 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 t80 54.4 94.82 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.136 0.493 . . . . 0.0 111.13 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -171.82 143.82 1.7 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.271 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.599 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -137.61 134.47 35.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 111.238 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.92 145.82 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.531 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.487 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 2.8 mt -123.99 134.08 67.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.775 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 65' ' ' PRO . 49.6 m-85 -135.04 135.02 40.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.91 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -157.47 130.14 7.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.22 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 84' ' ' PHE . 1.8 mt . . . . . 0 C--O 1.234 0.242 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.42 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 39.1 Cg_exo . . . . . 0 N--CA 1.474 0.35 0 N-CA-C 112.788 0.265 . . . . 0.0 112.788 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.487 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.0 m-20 -101.67 151.43 22.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.471 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -144.93 156.11 43.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 87.5 m -134.71 112.82 11.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.859 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -153.18 -51.03 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.838 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.6 p -144.17 30.18 1.29 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.835 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.49 150.92 62.29 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.206 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.85 166.75 9.76 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.086 2.524 . . . . 0.0 112.466 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.18 -173.22 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.042 2.495 . . . . 0.0 112.693 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.73 161.08 39.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 111.757 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.73 94.77 0.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.661 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.66 111.19 35.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -131.92 124.57 29.72 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.027 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -153.86 168.2 27.15 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.707 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -112.8 149.36 33.15 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.982 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.93 -113.84 1.02 Allowed Glycine 0 C--N 1.334 0.448 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.262 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -126.06 109.97 13.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.574 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.27 76.88 0.16 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.673 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -129.85 106.51 0.73 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.79 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.493 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 7.1 m-85 -158.18 167.75 13.84 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.582 0.229 . . . . 0.0 110.836 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 42.0 Cg_endo -67.55 168.29 18.58 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.929 2.419 . . . . 0.0 113.662 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.437 ' HG ' ' HB2' ' A' ' 103' ' ' HIS . 0.5 OUTLIER -150.41 157.74 43.37 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.492 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -150.4 136.28 18.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.027 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.0 pt -125.92 139.14 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.886 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.2 p -130.02 146.82 51.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.858 0.361 . . . . 0.0 110.995 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 38.9 t -138.06 147.0 26.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.12 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 98' ' ' GLU . 96.6 m-85 -155.54 144.99 21.05 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.9 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.4 tp -134.4 -50.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.539 0.209 . . . . 0.0 111.455 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.67 -62.8 0.05 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.834 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -179.55 42.92 0.0 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.312 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -163.73 0.88 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.938 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.35 -26.26 38.79 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.662 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.85 -33.35 59.99 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.648 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -71.21 84.27 0.75 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.203 0.525 . . . . 0.0 110.669 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -142.4 151.81 42.2 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.34 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -121.47 143.24 49.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.79 120.72 10.3 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -90.86 150.79 4.0 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.241 2.627 . . . . 0.0 112.676 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.437 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . 59.9 m-70 -143.95 166.82 23.88 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.114 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -125.88 129.84 50.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.799 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.454 ' CD2' ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -110.28 102.21 10.89 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.785 0.326 . . . . 0.0 111.335 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.418 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 4.0 t-20 -177.26 45.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.27 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -141.55 128.61 20.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.644 0.259 . . . . 0.0 111.31 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.1 pp -60.03 132.81 55.11 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.407 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 68.98 44.66 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.171 0.51 . . . . 0.0 110.834 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.76 135.41 37.99 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.604 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -146.54 58.81 1.2 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.728 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -107.03 119.21 38.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.13 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 2.5 pt-20 -145.65 142.55 29.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.188 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.51 147.04 17.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.556 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.69 108.45 8.02 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.692 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -113.82 139.25 49.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.681 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.9 p -123.73 121.44 62.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.077 0.465 . . . . 0.0 111.223 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.74 111.24 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.377 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -126.06 148.53 49.31 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.29 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.6 tp -171.56 59.59 0.28 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 121.27 0.557 . . . . 0.0 111.554 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 C--N 1.349 0.554 0 C-N-CA 122.582 2.188 . . . . 0.0 112.521 179.582 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.716 0.293 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.481 HG23 ' HB2' ' A' ' 44' ' ' LYS . 34.0 t -137.64 119.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.032 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -129.71 105.25 7.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.606 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.3 mtt180 -123.84 163.19 21.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.092 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.9 t -158.77 143.69 16.06 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.775 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 tp -115.05 122.88 70.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.822 0.344 . . . . 0.0 110.779 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.411 ' CD ' ' HG2' ' A' ' 115' ' ' GLU . 9.3 mtt180 -134.0 106.39 7.22 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.024 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -113.12 123.44 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -114.58 124.4 51.77 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.41 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.436 ' CG2' HD12 ' A' ' 105' ' ' LEU . 5.4 m -125.0 108.75 12.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -116.22 142.33 46.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.783 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -142.14 142.18 32.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 31' ' ' GLN . 82.9 t60 -133.8 119.23 18.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.67 0.271 . . . . 0.0 111.139 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 mt . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.815 179.548 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.234 0.279 0 CA-C-O 120.622 0.248 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.68 163.99 21.59 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 111.314 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -117.08 158.17 24.64 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.844 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.436 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 67.7 p-90 -154.02 140.18 18.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.0 p -142.77 117.52 9.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.003 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.7 tp -127.61 127.2 68.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 111.422 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.551 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 1.7 pt-20 -130.37 135.35 47.95 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.668 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.452 ' CG2' HG12 ' A' ' 55' ' ' ILE . 4.3 mp -115.69 106.36 20.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.047 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -104.83 140.85 21.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.986 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 8' ' ' THR . 1.2 pp -159.26 161.52 36.0 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.187 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -120.82 159.53 25.27 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.42 -45.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.057 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.12 2.45 15.17 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.209 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -83.41 -36.24 24.42 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.65 0.262 . . . . 0.0 110.959 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.55 -70.72 0.23 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.719 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HB2' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -134.01 120.87 20.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.686 0.279 . . . . 0.0 111.32 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.83 30.01 5.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.471 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.3 mt -128.27 131.63 23.89 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.691 -0.232 . . . . 0.0 111.183 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.07 -172.72 1.43 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.828 2.352 . . . . 0.0 112.625 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.01 -49.68 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.422 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 m -110.73 -63.99 1.33 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.593 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.11 -74.41 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.838 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 47.9 t80 56.86 93.24 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.445 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -158.57 116.0 2.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.372 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -110.81 115.06 28.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.385 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 t -112.73 150.1 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 111.66 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.452 HG12 ' CG2' ' A' ' 36' ' ' ILE . 4.9 mp -131.07 133.47 62.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.639 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -127.46 121.34 30.53 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.831 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.458 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -128.67 108.98 10.93 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 57' ' ' HIS . 6.2 mp . . . . . 0 N--CA 1.467 0.391 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.531 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo . . . . . 0 C--O 1.234 0.28 0 N-CA-C 111.771 -0.126 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.433 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 1.6 m120 -119.81 139.87 51.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.158 0.504 . . . . 0.0 111.106 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.36 140.29 23.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.679 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 86.9 m -116.47 113.1 22.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.051 0.453 . . . . 0.0 111.467 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -131.95 -56.22 0.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.621 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.2 33.88 1.09 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.35 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -125.8 159.48 61.07 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.58 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.3 Cg_exo -67.07 175.01 6.08 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.346 2.697 . . . . 0.0 112.434 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 38.4 Cg_endo -65.92 -178.08 0.94 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.8 2.333 . . . . 0.0 112.502 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.82 162.43 30.58 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 111.701 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.67 80.34 0.04 OUTLIER 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.403 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.6 mm -116.6 130.76 70.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.385 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.75 128.77 29.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.579 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 3.3 mt-10 -138.26 167.34 22.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.987 0.422 . . . . 0.0 111.692 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -121.6 128.03 51.51 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.854 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.24 -121.44 1.01 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.559 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -121.21 110.1 15.77 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 110.756 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.8 106.63 0.25 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.508 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.22 101.37 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.834 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -152.94 171.33 6.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.544 0.212 . . . . 0.0 111.186 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.03 176.1 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.288 2.658 . . . . 0.0 113.308 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.78 147.14 29.54 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.07 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -145.54 124.15 12.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.854 0.359 . . . . 0.0 111.116 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.6 mm -122.96 125.74 72.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.958 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.4 p -127.81 144.84 51.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.805 0.336 . . . . 0.0 111.55 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.0 p -134.23 132.81 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 8.3 m-85 -133.44 155.76 48.94 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.562 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 1.4 pt? -144.62 -157.23 0.77 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.397 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.02 38.09 1.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.124 0.487 . . . . 0.0 110.708 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -170.54 -167.12 0.56 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.421 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 42.05 3.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.722 0.296 . . . . 0.0 111.049 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.49 -28.39 8.2 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -114.17 -10.66 13.33 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.187 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.16 107.42 0.36 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.971 0.385 . . . . 0.0 110.748 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.34 146.51 35.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.812 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 123.26 22.04 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.208 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.9 tt -129.79 124.13 21.49 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-O 120.927 0.394 . . . . 0.0 111.894 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.07 160.52 8.65 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.008 2.472 . . . . 0.0 112.312 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -148.61 172.41 14.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.966 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.63 143.75 50.96 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.696 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.436 HD12 ' CG2' ' A' ' 13' ' ' THR . 7.4 tp -130.65 88.47 2.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.011 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -172.04 42.15 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -141.51 130.03 22.61 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.163 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 pp -58.16 131.3 50.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.526 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.94 53.74 1.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.905 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 15' ' ' GLN . 1.2 tp10 -85.07 135.23 34.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.28 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.9 t -143.74 62.52 1.36 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.649 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -105.31 119.31 38.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.308 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 1.2 pt-20 -153.41 145.64 23.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.127 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.51 151.46 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.727 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.411 ' HG2' ' CD ' ' A' ' 10' ' ' ARG . 1.3 mt-10 -137.52 109.08 6.97 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.672 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 155.63 27.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.53 143.88 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.352 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.27 111.02 14.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -121.5 121.11 36.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.638 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.41 75.09 13.78 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 CA--C 1.535 0.561 0 C-N-CA 122.679 2.253 . . . . 0.0 113.55 -179.712 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.654 0.264 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 t -134.0 119.39 31.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.218 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.0 105.86 12.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.285 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.32 162.39 16.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.249 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 4.2 t -175.0 149.28 1.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.374 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tt -128.29 133.89 65.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.482 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 111.56 11.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.297 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.0 pt -114.81 130.15 69.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.37 136.89 52.83 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 m -133.66 111.51 10.67 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.77 117.27 24.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.942 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 109' ' ' GLN . 3.0 tp60 -109.97 147.12 34.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.952 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -155.03 119.93 4.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.077 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.537 HG12 ' HA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.02 0.438 . . . . 0.0 111.334 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.234 0.279 0 CA-C-O 120.948 0.404 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.537 ' HA ' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -99.69 150.51 22.22 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.772 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -105.11 163.1 12.82 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -156.57 146.96 21.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.998 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.5 p -139.9 117.45 11.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.246 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.2 mm -119.54 121.5 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.1 pm0 -131.18 116.64 17.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.666 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.44 ' CD1' HG12 ' A' ' 55' ' ' ILE . 7.9 tt -117.66 123.71 72.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.08 143.36 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.872 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 8' ' ' THR . 3.2 pp -144.32 163.02 34.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.635 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tp -106.16 157.49 17.52 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.2 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.46 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -171.45 -44.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.067 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.68 1.42 19.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.367 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -34.51 27.52 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.641 0.257 . . . . 0.0 110.751 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.8 -71.59 0.34 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.544 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -144.18 107.09 4.47 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.869 0.366 . . . . 0.0 110.799 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 40' ' ' ASP . 2.3 tt0 -96.26 45.55 1.07 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.83 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.5 118.13 21.44 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.799 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.84 161.4 6.28 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.905 2.403 . . . . 0.0 112.648 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.44 -71.43 0.62 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.568 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 p -113.06 -63.36 1.45 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.021 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.61 -80.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.07 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 31.6 t80 54.3 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.283 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.4 t0 -161.08 124.52 3.31 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -117.39 136.77 52.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.445 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.6 t -128.96 135.83 61.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.02 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.497 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 4.9 mt -112.89 140.54 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.456 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.71 129.05 18.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.478 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 6.4 p80 -140.21 123.36 16.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.977 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 75.2 mt . . . . . 0 CA--C 1.531 0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--O 1.232 0.219 0 CA-C-O 120.755 0.231 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.497 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.9 m-80 -108.02 157.64 18.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.095 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -150.77 156.22 40.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.783 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.435 ' O ' ' HD3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -134.54 126.16 28.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.91 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -165.59 -45.11 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 t -146.04 30.49 1.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -134.2 156.83 78.71 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.203 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.441 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 40.1 Cg_endo -66.76 175.61 5.18 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.014 2.476 . . . . 0.0 112.188 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 10.9 Cg_endo -54.04 168.14 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.209 2.606 . . . . 0.0 112.8 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -128.7 88.66 2.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.919 0.39 . . . . 0.0 111.965 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 3.3 ttp85 -107.69 90.8 3.41 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.222 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.07 137.28 57.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.532 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.28 142.16 50.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.827 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -159.92 168.27 26.11 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.687 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -107.06 175.02 5.64 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.881 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.76 -141.98 12.8 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.631 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -126.57 110.1 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.122 0.487 . . . . 0.0 110.934 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.4 -129.18 6.35 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.361 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.17 47.98 3.43 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.701 -0.559 . . . . 0.0 111.701 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.455 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 64.1 m-85 -142.13 159.7 57.8 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.82 0.343 . . . . 0.0 111.019 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 39.2 Cg_endo -67.32 162.63 37.82 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.941 2.427 . . . . 0.0 113.622 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -148.88 134.24 18.47 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.795 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -143.96 153.02 41.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 111.415 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.9 mp -136.99 120.5 22.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.877 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 p -105.27 145.23 30.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 6.1 p -133.29 143.28 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -145.3 155.18 43.05 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.572 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -136.22 -45.53 0.63 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.629 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.37 -75.66 0.26 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.59 0.233 . . . . 0.0 111.22 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -140.34 -55.83 0.53 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.117 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.43 61.54 0.39 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 111.261 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.78 -39.65 4.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.794 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.5 ' HA3' ' CG2' ' A' ' 118' ' ' ILE . . . -157.99 32.78 0.51 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.629 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.2 pp20? -88.93 116.76 27.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.977 0.418 . . . . 0.0 110.854 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 156.39 44.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.742 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -120.82 129.65 53.65 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.881 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.1 mt -111.37 99.84 45.4 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 120.692 0.282 . . . . 0.0 111.596 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -88.85 140.22 4.06 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.129 2.553 . . . . 0.0 112.248 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.71 172.33 17.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.314 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -114.51 150.85 34.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.647 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.41 ' HB2' HD21 ' A' ' 86' ' ' LEU . 13.2 tp -125.38 82.28 2.05 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.886 0.374 . . . . 0.0 111.102 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.7 -175.36 4.38 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.744 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.443 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 2.8 p90 -111.46 166.3 11.25 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.769 0.318 . . . . 0.0 111.856 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.49 ' HA ' HG21 ' A' ' 17' ' ' ILE . 0.5 OUTLIER 81.12 65.18 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.331 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 15' ' ' GLN . 19.3 mt-30 66.38 133.19 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.123 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -157.66 134.68 10.1 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.262 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.39 71.89 1.49 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.582 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -115.99 119.17 35.05 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.704 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -153.49 139.37 18.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.29 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.0 t -118.81 152.46 21.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.63 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.38 108.89 8.97 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -113.26 151.84 30.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.9 p -127.9 151.52 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.845 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.5 ' CG2' ' HA3' ' A' ' 97' ' ' GLY . 4.2 mp -141.32 126.5 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.079 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -127.11 117.18 21.9 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.761 0.315 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.94 61.84 60.45 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.337 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 CA--C 1.534 0.518 0 C-N-CA 122.704 2.27 . . . . 0.0 113.03 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.802 0.334 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.1 m -118.62 164.94 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.512 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.57 -178.66 4.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.332 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 t -137.88 146.48 43.42 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -129.57 119.26 47.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.153 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? -138.29 107.46 6.06 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.507 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -130.65 131.87 45.12 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.75 0.31 . . . . 0.0 110.833 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.3 t -126.37 139.86 52.95 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' CD1' HD11 ' A' ' 88' ' ' ILE . 1.5 tt -106.47 121.79 59.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.584 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.404 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 26.2 mtt180 -124.29 118.31 26.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pt -120.28 127.16 75.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.18 130.9 55.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.954 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 83.7 m -130.71 129.41 42.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.175 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 12.7 mp0 -140.48 155.12 46.77 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.092 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.74 149.1 29.36 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.384 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -139.92 119.62 13.29 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.199 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.9 mt -108.26 103.65 15.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.721 0.296 . . . . 0.0 110.927 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.7 tp -169.29 131.54 1.11 Allowed Pre-proline 0 N--CA 1.463 0.219 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.94 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.25 -50.65 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.623 2.215 . . . . 0.0 112.65 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 75.64 -56.26 0.6 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.954 0.502 . . . . 0.0 111.414 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.59 124.73 47.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.718 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -55.67 109.21 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.736 2.291 . . . . 0.0 112.371 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.85 169.27 21.62 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.7 2.267 . . . . 0.0 112.767 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 p -83.72 -34.26 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.285 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.99 -50.99 0.09 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.881 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -155.42 108.03 2.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.002 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -147.76 56.98 3.02 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.177 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.9 102.62 1.24 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.703 2.269 . . . . 0.0 112.565 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.37 141.68 18.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.276 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -129.05 164.97 22.1 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.744 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.42 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 1.2 tt0 -115.2 159.29 21.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.709 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -159.73 142.33 13.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.37 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.04 133.84 25.33 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 tp -146.04 122.89 3.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.271 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.35 139.87 48.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.056 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mt -125.87 112.13 29.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.798 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.404 ' CG2' ' HB2' ' A' ' 10' ' ' ARG . 27.7 m -122.7 157.39 27.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.574 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 8' ' ' THR . 0.2 OUTLIER -171.62 172.45 4.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.558 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.6 mt -98.76 165.89 11.57 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.036 0.446 . . . . 0.0 111.235 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -166.04 -48.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.547 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -78.3 -10.36 59.64 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.091 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.61 -37.06 8.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.05 49.76 0.86 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.679 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? 62.34 117.81 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.101 0.477 . . . . 0.0 111.447 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.58 32.9 0.93 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.394 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.2 mt -127.12 131.95 24.09 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.23 158.62 48.58 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.782 2.321 . . . . 0.0 112.622 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.95 -74.35 0.62 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.331 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.3 m -108.13 -60.25 1.75 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.737 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.4 mt -119.63 -83.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.786 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.1 t80 55.69 96.83 0.02 OUTLIER 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.129 0.49 . . . . 0.0 111.383 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.48 119.76 0.79 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.286 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.9 120.88 43.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.502 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 t -120.39 115.67 47.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.416 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 2.3 mp -94.24 147.93 5.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.359 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -139.03 132.68 30.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.596 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -152.41 142.32 22.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER 75.06 173.36 0.26 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.0 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.05 149.48 9.32 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.409 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.62 1.99 7.9 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.8 2.333 . . . . 0.0 113.888 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.0 t -74.28 8.09 2.41 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.543 0.211 . . . . 0.0 111.166 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.98 165.69 24.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.753 0.311 . . . . 0.0 110.915 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.65 -35.9 62.85 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.346 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -167.7 131.61 1.45 Allowed Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.17 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.3 -171.25 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.731 2.287 . . . . 0.0 112.479 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.416 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -88.2 143.72 26.88 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.945 0.403 . . . . 0.0 111.287 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -133.02 146.61 51.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.788 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.59 116.8 12.62 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.861 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -162.57 -45.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -141.07 27.76 1.94 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.893 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.77 157.77 70.33 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.201 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.87 170.51 17.72 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.912 2.408 . . . . 0.0 112.125 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.6 158.23 51.13 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.68 2.253 . . . . 0.0 112.401 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.83 158.12 21.44 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.425 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -171.53 103.87 0.2 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.746 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.99 123.6 64.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.052 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.34 114.42 10.11 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.92 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.08 178.95 9.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.213 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.42 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.0 mt-30 -105.39 138.99 40.7 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.73 -173.17 42.96 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.887 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -112.1 109.75 19.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.607 0.241 . . . . 0.0 110.646 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.6 -117.22 0.6 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.319 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.41 91.79 1.82 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.655 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.552 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 36.4 m-85 -150.93 166.82 14.23 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 120.701 0.286 . . . . 0.0 111.267 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.34 159.52 39.4 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.151 2.568 . . . . 0.0 112.927 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.7 121.8 6.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.811 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.05 146.33 50.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.401 HD11 ' CD1' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -129.38 128.47 66.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 111.145 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.0 p -111.32 131.18 55.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 2.9 p -116.02 142.75 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.706 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -139.09 150.4 45.67 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.088 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.402 HD11 ' CG2' ' A' ' 120' ' ' ILE . 1.1 tm? -137.18 -49.02 0.61 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.26 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.55 -64.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.322 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.55 -54.19 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.079 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.97 44.24 2.48 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.989 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -105.08 -50.76 3.17 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.288 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.13 26.07 0.31 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.006 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 20.2 mt-10 -70.32 100.42 1.72 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.663 0.268 . . . . 0.0 110.772 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -142.7 156.45 45.03 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.525 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 134.69 41.74 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.328 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.46 119.69 23.21 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 121.009 0.433 . . . . 0.0 111.909 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.67 151.44 10.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.275 2.65 . . . . 0.0 112.548 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 112' ' ' TYR . 7.3 m80 -147.77 167.0 25.83 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.949 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -129.62 149.92 51.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.626 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 tp -128.68 93.88 3.73 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 111.224 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -174.85 45.39 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.236 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -141.44 127.33 19.32 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.58 119.84 6.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 69.23 66.69 0.27 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.795 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 1.2 tp10 -92.52 137.04 32.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.576 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.5 t -143.35 72.56 1.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.439 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.459 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 6.7 m-85 -121.08 119.27 31.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.335 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -144.82 147.2 32.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.366 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.0 t -122.56 148.84 26.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.913 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.08 109.02 8.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.451 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 137.51 51.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.153 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.72 150.42 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.73 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.4 mt -137.95 126.38 31.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -130.31 130.15 44.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.34 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.402 ' CG2' HD11 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -152.89 65.2 5.62 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.27 -33.22 15.04 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.533 2.155 . . . . 0.0 112.774 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.63 -65.86 1.08 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.83 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.411 -0.804 . . . . 0.0 111.13 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.594 0.235 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p -84.24 118.26 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.857 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.77 -179.89 6.88 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.462 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -146.44 159.44 43.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.838 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -130.57 119.12 45.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.19 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -134.88 115.95 14.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.169 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 39.3 mtt180 -137.39 165.96 24.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.08 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 t -178.09 131.13 0.14 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.6 tt -104.23 118.1 50.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 121.125 0.488 . . . . 0.0 110.627 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -115.03 107.4 15.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.657 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.9 pt -114.76 131.89 65.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -124.1 135.46 53.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.113 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.54 105.75 6.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.825 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -119.34 147.58 44.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.188 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.583 ' HG2' ' HA ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -143.56 147.04 33.83 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.083 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -156.22 120.37 4.47 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.68 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.433 HG12 ' HB3' ' A' ' 30' ' ' ARG . 25.0 mt -76.91 140.84 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.697 0.285 . . . . 0.0 111.027 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.29 82.94 4.23 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.53 -50.51 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.593 2.195 . . . . 0.0 112.666 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 55.99 30.66 16.53 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.33 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.49 139.3 33.63 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.797 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.95 167.42 1.13 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.906 2.404 . . . . 0.0 112.544 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.72 -2.53 12.34 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.623 2.215 . . . . 0.0 113.195 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.19 -55.53 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 120.62 0.248 . . . . 0.0 111.37 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -123.21 159.74 28.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.205 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -90.62 165.05 13.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.258 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -168.04 87.25 0.71 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.048 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.62 95.41 0.71 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.747 2.298 . . . . 0.0 112.997 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.6 t -141.0 136.17 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HB3' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -139.33 158.28 44.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.041 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 160.92 14.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 32.6 p-90 -158.4 148.16 19.66 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.034 0.445 . . . . 0.0 111.762 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -143.48 124.42 14.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.56 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tp -130.33 141.47 46.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 111.756 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.467 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.9 OUTLIER -149.44 143.78 25.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.435 ' CG2' HG12 ' A' ' 55' ' ' ILE . 4.2 mp -136.43 106.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.538 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.71 135.48 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.73 0.3 . . . . 0.0 111.281 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 tt -155.63 135.37 12.67 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 11.3 mt -70.76 164.39 25.26 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.268 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -161.23 -52.8 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.892 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.35 -13.61 61.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.584 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -103.13 -34.7 8.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.387 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.82 40.36 2.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.816 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 65.37 91.16 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.66 52.16 1.84 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.25 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.29 112.59 11.09 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.91 159.4 53.03 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.635 2.223 . . . . 0.0 112.449 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.91 -62.5 0.29 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.688 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -106.74 -68.49 0.88 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mt -113.8 -80.07 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.948 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 52.5 t80 55.39 92.76 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.874 0.368 . . . . 0.0 111.549 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 3.8 t70 -169.26 116.92 0.62 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.23 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -114.9 120.22 39.21 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.552 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.87 159.34 16.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.012 0.434 . . . . 0.0 111.524 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.435 HG12 ' CG2' ' A' ' 36' ' ' ILE . 4.2 mp -137.18 130.43 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.406 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -126.47 143.06 51.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.893 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -167.27 126.0 1.34 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 tp 70.71 157.07 0.16 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.493 ' HB2' ' CD2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -89.32 -56.7 0.28 Allowed Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.402 ' HD2' ' HG ' ' A' ' 58' ' ' LEU . 84.1 Cg_exo -46.65 -30.65 9.21 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.009 2.473 . . . . 0.0 113.699 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.7 p -73.13 8.57 1.57 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -26.95 64.6 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.19 -41.29 68.43 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.412 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -140.21 82.72 16.49 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.062 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -61.47 172.73 3.2 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.842 2.361 . . . . 0.0 112.188 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -106.73 136.99 45.59 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.166 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.61 151.22 41.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.173 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 87.5 m -130.45 102.61 6.24 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -130.83 -48.53 1.04 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.406 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 t -140.69 -36.75 0.46 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.791 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.05 159.13 1.53 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.3 169.65 21.1 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.094 2.53 . . . . 0.0 112.851 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -57.38 152.04 49.2 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.944 2.429 . . . . 0.0 113.085 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -100.42 141.39 33.33 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.977 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HG3' ' CB ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -164.29 89.34 0.54 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.462 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.1 143.09 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.733 0.302 . . . . 0.0 111.658 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.03 143.43 46.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.72 -177.27 6.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.205 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -120.11 136.71 54.5 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -175.29 -170.0 37.73 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.92 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -127.29 110.41 12.81 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.853 0.358 . . . . 0.0 110.976 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.56 128.17 1.2 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.63 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.67 117.39 2.48 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.313 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 12.1 m-85 -157.32 166.22 17.09 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 120.579 0.228 . . . . 0.0 110.905 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.6 Cg_endo -69.49 168.33 21.5 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.029 2.486 . . . . 0.0 113.293 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 57' ' ' HIS . 0.6 OUTLIER -151.73 118.66 5.82 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.473 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.26 154.37 38.92 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.363 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.3 pt -140.91 151.46 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.47 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.412 ' CB ' ' HG2' ' A' ' 100' ' ' LYS . 79.8 p -137.06 147.66 46.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.043 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 21.6 t -126.97 139.58 51.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.301 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 30.0 m-85 -144.48 150.94 38.43 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.1 OUTLIER -142.13 -47.1 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.528 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.0 -71.5 0.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.588 0.232 . . . . 0.0 111.247 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -136.03 -68.6 0.5 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.041 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 35.99 1.32 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.107 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 120' ' ' ILE . . . -77.74 -38.18 47.61 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.43 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' HA3' HG21 ' A' ' 118' ' ' ILE . . . -168.27 37.38 0.21 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.213 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 6.9 tt0 -80.15 103.8 10.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -142.18 151.88 42.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.947 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.412 ' HG2' ' CB ' ' A' ' 89' ' ' SER . 8.2 mtpt -131.93 149.79 52.34 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.102 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.4 tp -148.71 123.9 5.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -87.56 155.13 7.73 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.217 2.611 . . . . 0.0 112.451 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.13 169.15 23.67 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.417 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -126.77 140.67 52.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.1 tp -121.9 93.32 3.96 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.996 0.426 . . . . 0.0 111.122 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.99 -168.7 1.44 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.305 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.583 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -116.07 164.01 15.09 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.08 0.466 . . . . 0.0 112.091 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 84.67 69.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.523 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 63.65 103.58 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.958 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -126.82 134.2 50.61 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.14 67.4 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.592 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -119.37 119.43 33.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.627 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.459 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 1.3 pt-20 -151.47 149.56 29.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.383 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.41 149.94 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.623 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -137.75 108.65 6.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.8 141.97 46.65 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.16 148.89 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.983 0.421 . . . . 0.0 111.927 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.424 HG21 ' HA3' ' A' ' 97' ' ' GLY . 4.3 mp -134.65 111.29 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.403 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.406 ' CG ' ' HD3' ' A' ' 121' ' ' PRO . 43.4 tt0 -125.3 114.67 19.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.605 0.24 . . . . 0.0 111.539 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.417 HD12 ' HB1' ' A' ' 96' ' ' ALA . 4.1 mp -139.91 56.21 7.65 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 111.314 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.406 ' HD3' ' CG ' ' A' ' 119' ' ' GLN . 83.4 Cg_endo -77.16 -172.6 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.67 2.247 . . . . 0.0 112.454 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 tp -100.69 89.64 3.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 110.553 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.916 -179.667 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.636 0.255 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.9 -48.9 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.393 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.14 97.75 3.57 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.802 0.334 . . . . 0.0 110.893 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.3 148.72 33.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.038 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.04 119.23 12.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.181 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.34 106.81 6.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.383 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 163.11 24.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.363 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -170.39 129.17 0.86 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.541 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.5 tt -109.84 118.37 56.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.988 0.423 . . . . 0.0 110.882 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -123.92 117.7 25.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.705 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.8 pt -113.05 136.65 48.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.198 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 1.8 mptp? -108.38 134.94 50.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.6 m -128.02 128.27 44.69 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.889 0.376 . . . . 0.0 111.551 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -145.86 127.78 15.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.65 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -140.49 146.15 37.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.755 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -143.49 119.39 10.6 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.509 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' A' ' 30' ' ' ARG . 39.6 mt -95.28 118.18 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.102 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.19 103.44 0.31 Allowed Pre-proline 0 N--CA 1.466 0.375 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.2 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HB3' ' HA ' ' A' ' 28' ' ' PRO . 41.1 Cg_endo -68.67 -41.14 6.35 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.564 2.176 . . . . 0.0 112.984 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 57.48 35.86 26.34 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 t -109.05 105.33 57.06 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.729 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.477 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 53.2 Cg_exo -53.46 -49.16 18.32 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.625 2.217 . . . . 0.0 112.73 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 93.9 Cg_endo -78.3 -8.62 16.32 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.314 2.009 . . . . 0.0 113.223 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t 63.28 94.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.827 0.346 . . . . 0.0 110.99 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -65.28 -55.44 18.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.286 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 172.06 -72.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.786 0.327 . . . . 0.0 111.288 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -93.03 148.08 35.07 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.95 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 74.5 Cg_endo -76.29 117.02 4.48 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.754 2.303 . . . . 0.0 112.395 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.15 110.63 5.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.718 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.444 ' HG2' HG12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -106.93 165.08 11.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.886 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.77 156.55 34.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.381 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -157.65 141.29 15.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.427 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.7 t -147.2 117.74 7.49 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 39.6 mt -135.68 136.36 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.853 0.359 . . . . 0.0 111.635 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.98 155.28 44.52 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.579 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.422 HG12 HG22 ' A' ' 55' ' ' ILE . 4.0 mp -131.38 109.0 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.26 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.61 146.26 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.376 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -163.7 170.15 17.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.313 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.42 165.29 11.62 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -168.23 -47.18 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.778 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -3.86 45.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.771 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.27 -35.38 8.01 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.514 0.197 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.34 45.92 1.25 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.461 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt 66.7 123.25 0.02 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.046 0.45 . . . . 0.0 111.525 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.66 29.06 2.12 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.429 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.9 mt -129.63 134.5 26.28 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.016 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.63 -174.23 1.94 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.672 2.248 . . . . 0.0 112.473 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.32 -51.89 0.31 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.233 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 p -126.0 -52.36 1.54 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.562 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.47 -89.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.093 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 40.3 t80 57.09 97.74 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.242 0.544 . . . . 0.0 110.861 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.65 109.96 1.27 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.53 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.481 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 1.4 mttm -112.55 137.05 51.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.354 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.5 p -139.36 149.81 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.015 0.436 . . . . 0.0 111.652 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.441 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 0.8 OUTLIER -126.72 140.66 48.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.42 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.86 130.57 38.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.704 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.471 ' O ' ' HB ' ' A' ' 61' ' ' THR . 3.8 p80 -132.89 113.94 13.46 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.238 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp 72.35 176.5 0.27 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.527 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 59.2 t-80 -86.84 -41.28 0.54 Allowed Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 59' ' ' HIS . 38.2 Cg_endo -72.53 2.19 5.44 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.206 1.937 . . . . 0.0 114.174 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 10.1 t -68.16 0.42 3.72 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 121.239 -0.184 . . . . 0.0 111.432 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -56.36 -33.35 65.61 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.457 0.17 . . . . 0.0 111.161 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.65 -43.9 69.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.282 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -157.25 86.54 2.74 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.958 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.04 169.37 18.15 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.702 2.268 . . . . 0.0 112.472 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.441 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 2.7 m120 -98.69 133.78 42.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -129.19 153.84 47.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.05 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 35.1 m -132.29 99.16 4.6 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.017 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -124.77 -49.17 1.76 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.64 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.4 t -174.49 50.81 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.155 0.502 . . . . 0.0 110.397 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.45 162.0 57.25 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.152 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.21 162.48 14.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.942 2.428 . . . . 0.0 112.625 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.39 168.68 3.65 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.11 2.54 . . . . 0.0 112.851 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.95 165.8 13.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.49 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.37 94.11 0.22 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.597 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.29 115.37 48.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -137.77 126.51 23.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.915 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -144.87 -179.13 6.4 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.426 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -130.28 177.34 7.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.176 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.09 -162.1 22.76 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.123 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -67.32 128.83 37.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.4 126.88 0.86 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.669 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.77 110.82 0.29 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.75 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -155.4 166.26 16.59 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 120.662 0.268 . . . . 0.0 111.272 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.34 177.32 0.6 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.157 2.572 . . . . 0.0 113.229 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 mp -142.84 167.01 23.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.993 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -155.15 122.9 5.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.298 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.8 pt -129.84 123.24 56.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.686 0.279 . . . . 0.0 111.144 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -119.85 142.43 48.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.78 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 4.2 t -126.71 137.41 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.806 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.476 ' CD2' ' CG ' ' A' ' 98' ' ' GLU . 48.0 m-85 -145.47 145.78 31.23 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 3.5 tp -138.49 -68.44 0.45 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.4 tp -136.64 -66.89 0.52 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.357 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' HB3' ' CE ' ' A' ' 95' ' ' LYS . 2.6 mt-10 -166.07 -54.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.432 ' CE ' ' HB3' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -115.75 45.96 1.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.165 0.507 . . . . 0.0 110.676 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -116.59 -49.53 2.65 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.217 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.4 -81.82 0.03 OUTLIER Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.396 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.6 OUTLIER 47.19 59.91 3.76 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 111.554 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.08 136.95 30.66 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.166 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 2.9 pttt -117.85 149.98 39.94 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.59 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 tt -149.45 123.5 4.63 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.961 0.41 . . . . 0.0 111.562 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.3 158.85 13.01 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.707 2.271 . . . . 0.0 112.138 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.31 172.49 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -125.59 146.52 49.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.569 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 tp -139.13 74.05 1.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.856 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -164.61 46.65 0.1 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.13 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -140.25 132.58 28.34 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.339 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.2 131.7 51.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.07 61.02 0.77 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.819 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.13 131.7 37.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.69 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.5 t -137.14 69.96 1.4 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.751 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.36 153.35 20.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.012 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.409 ' HG3' ' HA ' ' A' ' 12' ' ' LYS . 3.3 tt0 -164.66 136.61 4.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.252 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.62 143.65 33.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -139.34 108.51 6.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.719 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -113.05 119.01 36.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.477 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.45 147.67 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.631 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 20.0 mt -142.12 110.85 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.525 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -129.88 125.89 36.67 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.536 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.413 HG12 ' CD2' ' A' ' 92' ' ' LEU . 0.8 OUTLIER -152.78 54.61 1.26 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.669 179.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.29 -31.38 11.72 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.446 2.097 . . . . 0.0 112.506 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.85 -33.13 27.16 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.283 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.865 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 m -62.2 162.37 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.863 0.363 . . . . 0.0 111.678 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.73 93.49 8.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.316 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.29 121.14 6.55 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.49 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.409 ' HB ' HG12 ' A' ' 120' ' ' ILE . 19.5 t -126.94 119.14 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 111.338 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.25 104.91 7.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.268 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.36 169.83 9.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.409 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -165.89 123.79 1.5 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.713 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.412 ' CD1' HD12 ' A' ' 36' ' ' ILE . 8.8 tt -108.86 124.55 65.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.924 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 0.2 OUTLIER -120.11 120.33 35.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.023 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.8 pt -123.4 132.71 70.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.071 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 4.1 mtmt -120.41 146.17 46.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.22 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 116.85 13.31 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.687 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 3.8 tt0 -123.74 148.83 46.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.987 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -154.87 144.1 21.12 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.979 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -147.88 119.59 8.05 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.343 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.0 mt -89.31 100.39 10.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.77 0.319 . . . . 0.0 110.633 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.04 108.22 1.92 Allowed Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.775 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' A' ' 29' ' ' VAL . 30.5 Cg_endo -65.51 -52.94 0.88 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.662 2.241 . . . . 0.0 112.952 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 55.65 21.69 4.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.739 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.77 138.16 31.44 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.032 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.39 145.88 85.77 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.667 2.245 . . . . 0.0 112.317 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.67 96.49 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.79 2.327 . . . . 0.0 112.568 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.2 p -115.55 -38.31 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.433 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.93 -42.75 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.012 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.36 -178.3 3.94 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.409 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -174.73 -53.18 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.285 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.42 87.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.632 2.221 . . . . 0.0 112.594 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 19' ' ' PRO . 21.8 t -132.31 118.28 35.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.097 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -138.58 164.23 30.0 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.597 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.39 151.17 22.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.55 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -155.74 132.4 10.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.419 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 14' ' ' GLN . 27.7 t -143.88 125.91 15.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 tp -135.79 129.7 48.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.78 157.06 47.79 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.412 HD12 ' CD1' ' A' ' 9' ' ' ILE . 12.5 tt -154.54 130.44 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.4 m -134.97 160.73 40.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.657 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.32 175.1 13.78 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.934 0.397 . . . . 0.0 111.531 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 mt -106.79 166.13 10.81 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.101 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.85 -56.29 0.06 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.209 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -54.98 -40.33 69.93 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.233 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -29.44 18.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.1 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.31 59.05 0.37 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.861 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.4 mttp 60.21 97.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.912 0.387 . . . . 0.0 111.618 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -24.66 62.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.507 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 mt -100.91 123.72 44.4 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-O 120.577 0.227 . . . . 0.0 110.837 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.93 169.04 2.08 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.874 2.382 . . . . 0.0 112.506 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.65 -51.48 0.51 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.621 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.0 m -110.49 -65.62 1.15 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.783 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.5 mm -138.05 -80.68 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 39.4 t80 63.08 100.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.025 0.44 . . . . 0.0 110.885 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 8.7 t70 -160.83 110.69 1.71 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.565 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -104.89 107.35 18.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.542 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.44 141.78 17.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.608 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 66' ' ' ASN . 1.7 mp -121.24 148.69 24.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.196 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -143.99 128.4 17.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.298 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 6.9 p80 -144.18 120.48 10.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.539 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 57' ' ' HIS . 0.8 OUTLIER 72.75 163.12 0.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.764 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.467 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -81.79 -46.99 1.03 Allowed Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 58' ' ' LEU . 81.5 Cg_exo -46.52 -24.78 2.96 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.078 2.519 . . . . 0.0 114.194 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.6 p -77.01 6.73 5.83 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.484 0.183 . . . . 0.0 111.06 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -60.62 -33.65 73.09 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 111.021 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.95 76.56 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.298 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -151.85 94.25 3.36 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.388 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.45 -175.31 1.28 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.892 2.395 . . . . 0.0 112.362 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.41 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 17.7 m120 -113.46 144.37 42.93 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.235 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.66 150.79 36.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.06 115.87 15.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.844 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -156.75 -47.62 0.07 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.2 t -129.4 29.08 5.14 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.006 0.431 . . . . 0.0 110.766 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -141.41 159.08 62.09 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.45 173.81 8.23 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.908 2.405 . . . . 0.0 112.469 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.9 -179.3 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.797 2.331 . . . . 0.0 112.688 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.47 157.74 44.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.793 0.33 . . . . 0.0 110.794 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.65 81.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.785 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.71 122.71 51.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.168 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.64 115.53 16.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.491 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -139.34 174.27 10.69 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.05 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.21 124.68 31.1 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.971 0.415 . . . . 0.0 110.977 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.02 -157.05 21.77 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.126 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 13.6 p-90 -82.88 116.59 22.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 111.07 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.75 -121.79 0.59 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.727 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.67 101.93 0.06 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.959 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.0 m-85 -162.96 171.04 6.77 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.63 0.252 . . . . 0.0 110.96 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 77.3 Cg_exo -52.01 166.53 0.63 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.045 2.496 . . . . 0.0 113.243 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 mp -142.92 169.74 17.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.414 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -160.43 138.82 10.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.176 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.4 tp -136.54 128.17 43.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.05 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.8 p -127.06 116.2 20.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.22 120.92 55.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.154 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 13.2 m-85 -126.1 156.02 40.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.736 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.8 OUTLIER -145.7 -166.57 2.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.56 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pp -92.06 34.47 1.02 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 111.107 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -165.66 159.07 16.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.329 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.47 47.53 1.19 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.071 0.462 . . . . 0.0 110.772 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -116.25 -37.34 3.81 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.614 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.65 30.68 5.85 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.161 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -92.57 92.77 8.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.825 0.313 . . . . 0.0 110.451 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -142.23 153.26 43.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.885 0.374 . . . . 0.0 111.817 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.75 146.37 47.57 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.786 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -141.78 122.48 8.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.64 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.06 129.26 4.56 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.866 2.377 . . . . 0.0 112.352 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.29 172.46 6.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.287 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -134.59 138.9 44.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.62 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.33 84.58 2.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.6 37.31 0.32 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.175 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -141.9 132.03 24.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.13 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.88 131.8 51.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 71.58 74.22 0.17 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.441 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.73 131.37 55.0 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.59 61.63 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.292 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -105.6 119.31 38.8 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.534 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 3.2 pt-20 -142.16 139.6 32.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.126 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.8 p -131.96 148.97 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.69 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 10' ' ' ARG . 1.2 mp0 -133.01 151.24 52.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.341 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.402 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -136.31 127.25 27.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.222 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.83 136.73 26.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.258 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.4 mt -121.49 111.22 30.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.58 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.39 117.49 20.67 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.349 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -147.38 55.75 2.51 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.744 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.97 127.16 9.19 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.466 2.111 . . . . 0.0 112.244 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.04 69.78 0.74 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.748 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.7 t30 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.981 -179.757 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -74.08 -34.6 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.614 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.72 114.3 6.21 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.774 0.321 . . . . 0.0 111.282 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 121' ' ' PRO . 5.3 t -143.5 155.61 44.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.471 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.49 119.44 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.654 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.47 117.25 13.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.35 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.496 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 75.8 mtt180 -139.8 138.73 36.06 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.514 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 t -147.46 111.18 5.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.441 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 tt -104.77 118.28 51.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.637 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.36 120.09 34.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.725 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 88' ' ' ILE . 9.2 pt -118.7 126.3 75.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 111.33 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.478 ' HD2' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -114.26 130.81 56.65 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.845 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' SER . 3.0 m -127.88 118.01 22.85 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -129.29 140.63 51.35 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.986 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.92 138.76 35.87 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.759 0.314 . . . . 0.0 111.333 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -137.92 119.73 15.25 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 6.7 mt -114.55 100.32 10.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.773 0.32 . . . . 0.0 111.149 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.78 84.52 0.24 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.907 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.6 -54.24 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.512 2.141 . . . . 0.0 112.584 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -176.09 -66.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.716 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -125.15 126.09 25.21 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.644 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.93 111.13 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.59 2.193 . . . . 0.0 112.232 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 152.24 35.22 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.049 2.499 . . . . 0.0 113.233 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 p -84.55 -36.82 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.58 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -145.26 37.42 1.13 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.627 0.251 . . . . 0.0 111.613 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -143.62 154.59 43.7 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.758 0.314 . . . . 0.0 111.245 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -82.46 125.11 77.11 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.735 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.71 162.25 42.67 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.733 2.289 . . . . 0.0 112.691 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.9 146.4 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.407 ' HB3' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -126.71 165.13 19.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.279 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.48 149.35 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -145.18 143.28 30.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.453 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 1.6 m -136.12 121.95 19.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.742 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.9 mm -130.4 117.42 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.622 0.248 . . . . 0.0 111.479 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 10.9 pt-20 -134.73 149.38 50.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.094 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 55' ' ' ILE . 14.0 tt -152.18 130.49 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.207 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.3 m -137.24 119.15 18.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.962 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.8 tp -129.7 142.46 50.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.31 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 tt -118.1 152.25 35.95 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.077 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -176.87 -30.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.318 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 7.1 p30 -53.91 -27.89 33.4 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.631 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -33.21 59.66 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.554 0.216 . . . . 0.0 110.589 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.83 -74.33 0.93 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.884 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -129.47 -48.11 1.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 41' ' ' ASP . 17.1 tt0 71.09 7.0 6.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.774 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.2 140.4 36.94 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-O 120.733 0.301 . . . . 0.0 111.413 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.63 -171.47 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.985 2.456 . . . . 0.0 112.374 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.81 -64.98 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.391 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.7 m -96.97 -56.42 2.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.172 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.6 mm -132.84 -85.28 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.839 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 44.3 t80 63.24 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.145 0.498 . . . . 0.0 111.136 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -164.19 102.17 0.86 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.571 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -97.72 102.96 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.554 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 m -103.07 143.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.478 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.456 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 2.4 mt -125.41 146.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.521 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.03 138.85 28.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.929 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 18.7 p-80 -163.77 124.36 2.21 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.573 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER 67.37 168.38 0.25 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.79 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 84' ' ' PHE . 1.9 t60 -61.31 130.64 91.85 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.693 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.4 -22.32 20.68 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.916 2.41 . . . . 0.0 113.245 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 35.5 p -67.09 -3.07 6.46 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.76 -73.98 0.45 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.386 0.136 . . . . 0.0 111.056 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.35 -34.08 75.97 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.333 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 72.57 146.8 0.12 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.429 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.82 142.19 98.67 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.993 2.462 . . . . 0.0 112.479 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.456 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.7 m-80 -115.14 155.28 27.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.093 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.68 153.85 42.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 45.6 m -138.44 117.21 12.3 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.792 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -125.47 -54.63 1.56 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -89.49 -67.58 0.83 Allowed 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.379 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.461 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 0.3 OUTLIER 179.09 61.06 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.468 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' CG ' ' HA ' ' A' ' 68' ' ' THR . 94.8 Cg_endo -93.07 103.33 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.92 2.413 . . . . 0.0 113.207 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 71' ' ' ASP . 86.4 Cg_endo -84.43 178.91 4.78 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.652 2.235 . . . . 0.0 112.382 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -167.94 153.03 6.77 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.62 111.5 0.07 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.968 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.1 tp -159.62 142.01 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.853 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 14.7 pt-20 -132.27 111.6 11.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.479 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -121.39 168.3 11.82 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.338 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -109.94 176.58 5.01 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.773 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.91 -154.94 16.38 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.168 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -93.17 110.11 21.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 0.0 110.403 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.17 91.67 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.433 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -142.91 111.23 0.65 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.473 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.458 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 9.7 m-85 -160.94 168.56 11.47 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 120.613 0.244 . . . . 0.0 111.04 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.34 160.53 26.85 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.064 2.509 . . . . 0.0 112.966 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.476 ' HG ' ' HB2' ' A' ' 103' ' ' HIS . 0.8 OUTLIER -150.89 123.05 8.28 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.578 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -127.55 145.89 50.71 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.95 0.405 . . . . 0.0 111.71 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.468 HG22 HD11 ' A' ' 11' ' ' ILE . 8.9 tt -129.59 118.8 46.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.249 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.47 119.59 34.33 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.5 t -106.26 142.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.096 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -141.09 157.27 45.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.877 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -151.35 -175.74 5.3 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.733 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -20.4 61.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.15 -169.23 1.66 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.496 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 58.35 1.02 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.842 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.51 4.77 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.778 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.7 44.34 1.14 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.991 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -113.36 90.44 3.34 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.884 0.373 . . . . 0.0 111.025 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -142.66 156.59 45.07 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.532 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 pttm -112.2 140.59 46.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.479 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.1 mp -133.34 109.0 12.39 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.667 0.27 . . . . 0.0 111.506 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -88.21 147.39 6.52 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.221 2.614 . . . . 0.0 113.625 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.476 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . 8.7 m-70 -148.58 172.28 14.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.444 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -134.24 129.73 36.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.942 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.415 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 1.3 pp -113.97 100.95 8.8 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.984 0.421 . . . . 0.0 111.244 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -177.87 44.86 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.34 136.42 31.48 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.776 0.322 . . . . 0.0 111.535 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -61.73 128.95 38.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.637 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 64.45 65.3 0.66 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.26 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -105.18 131.77 52.23 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.813 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.0 p -132.79 66.71 1.55 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.869 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -104.9 119.64 39.49 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.702 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.478 ' CD ' ' HD2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -148.01 143.48 27.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.292 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.11 142.77 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.532 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -127.77 146.02 50.72 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.101 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 130.81 40.78 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.7 m -111.66 140.13 32.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.094 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.496 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 10.9 mt -139.99 111.79 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.784 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -129.9 107.55 9.46 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.265 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.9 mp -137.2 58.31 17.35 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 42.8 Cg_endo -70.26 -46.0 1.15 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.47 2.113 . . . . 0.0 112.62 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.39 40.68 0.47 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.986 0.422 . . . . 0.0 110.552 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.362 -179.9 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.682 0.277 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.81 146.71 8.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.084 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.74 59.84 5.88 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.015 0.436 . . . . 0.0 110.753 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t -132.41 151.05 52.03 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.411 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.81 119.45 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 111.428 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -123.79 105.11 9.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.599 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -118.07 169.66 9.48 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.003 0.43 . . . . 0.0 111.365 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -161.56 125.37 3.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.53 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.3 tt -105.06 118.44 52.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.115 0.484 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.46 117.53 29.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.053 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.5 pt -122.83 128.75 75.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.585 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -119.23 141.89 48.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 m -137.35 111.06 8.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.151 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.5 mp0 -125.09 129.79 50.95 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.734 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -132.64 143.43 49.66 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.141 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -139.02 119.52 13.91 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.15 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.2 mt -118.55 111.01 32.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.777 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.29 96.26 1.34 Allowed Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.217 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.37 -43.64 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.711 2.274 . . . . 0.0 112.765 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 58.69 22.94 10.49 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.611 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.4 136.11 27.81 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.99 108.74 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.827 2.352 . . . . 0.0 112.283 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.34 137.53 18.94 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.656 2.237 . . . . 0.0 112.867 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.14 -50.19 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -124.89 -61.05 1.33 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.81 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -167.87 120.33 0.88 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.667 0.27 . . . . 0.0 111.274 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -160.82 54.89 0.61 Allowed Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.193 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.93 133.71 10.27 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.721 2.281 . . . . 0.0 112.945 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.2 t -137.99 124.77 27.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.819 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -133.16 165.12 25.52 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.346 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.01 157.16 33.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.666 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 10.9 p-90 -155.42 142.24 18.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.449 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 p -147.93 117.93 7.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.331 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 0.9 OUTLIER -133.88 141.25 44.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.585 -179.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -131.39 134.17 46.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.641 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -124.38 106.38 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.643 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.1 t -118.04 148.44 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.696 0.284 . . . . 0.0 111.387 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.405 HD12 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -159.33 148.59 18.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.323 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 tp -102.72 160.82 14.25 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.255 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -173.76 -44.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.194 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.93 1.48 20.5 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.943 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -86.42 -36.73 18.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.578 0.228 . . . . 0.0 110.798 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.38 -72.83 0.63 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.683 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.31 116.46 9.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.779 0.323 . . . . 0.0 110.836 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.93 35.48 1.26 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.175 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.28 126.63 21.48 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.279 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.01 -174.34 1.9 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.856 2.371 . . . . 0.0 112.475 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.73 -63.69 0.13 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.622 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 m -99.07 -65.97 0.93 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.551 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.6 mt -128.58 -92.77 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.399 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.436 ' CE1' ' HE2' ' A' ' 53' ' ' LYS . 35.7 t80 62.35 97.82 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.18 0.514 . . . . 0.0 111.399 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -164.5 112.56 1.09 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.062 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.436 ' HE2' ' CE1' ' A' ' 51' ' ' PHE . 4.8 mtmt -101.89 123.74 46.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.29 116.5 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 111.136 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.474 ' CG2' ' CE1' ' A' ' 57' ' ' HIS . 3.7 mp -103.24 149.56 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.192 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 65' ' ' PRO . 20.9 m-85 -138.19 119.12 14.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.294 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.474 ' CE1' ' CG2' ' A' ' 55' ' ' ILE . 5.5 m-70 -123.39 116.44 23.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.076 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.477 ' HA ' ' CB ' ' A' ' 84' ' ' PHE . 4.2 mp 64.18 -178.11 0.16 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.918 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.48 109.79 2.1 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.821 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.418 ' HB3' ' HG3' ' A' ' 65' ' ' PRO . 32.3 Cg_exo -59.73 -18.49 48.72 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.805 2.336 . . . . 0.0 113.041 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 m -74.24 5.79 4.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.374 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.36 -51.23 0.58 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-O 120.528 0.204 . . . . 0.0 111.026 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 -13.68 37.59 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 30.1 t30 72.52 140.91 0.08 OUTLIER Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.803 0.335 . . . . 0.0 111.237 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 23.5 Cg_exo -63.9 171.15 7.73 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.79 2.327 . . . . 0.0 112.649 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.413 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 5.1 m120 -124.71 137.92 54.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.87 146.27 51.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.258 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.67 136.35 37.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.743 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -161.86 -50.04 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.719 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.3 t -159.03 40.36 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.166 0.508 . . . . 0.0 110.663 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.96 157.79 74.68 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.006 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 44.1 Cg_exo -56.43 170.44 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.114 2.543 . . . . 0.0 112.28 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 72' ' ' PRO . 19.0 Cg_endo -58.13 171.46 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.959 2.439 . . . . 0.0 112.903 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.36 85.9 2.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.343 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -110.21 130.57 55.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -135.19 125.83 44.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.033 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -129.83 125.25 35.25 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 8.9 mt-10 -152.76 172.98 15.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.377 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -119.17 -179.6 3.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.213 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.97 -156.06 25.06 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.362 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -69.28 130.52 42.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.66 95.2 0.1 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.71 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.06 109.03 0.39 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.908 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 30.8 m-85 -153.77 164.8 19.44 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 111.105 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 10.8 Cg_endo -54.57 168.73 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.497 2.798 . . . . 0.0 113.981 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 57' ' ' HIS . 6.7 mp -134.05 155.74 49.48 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.525 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -158.11 120.94 3.82 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.937 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.3 mp -125.22 126.36 70.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.447 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 57.4 p -127.98 115.43 18.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.997 0.427 . . . . 0.0 110.917 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 26.1 t -104.36 138.85 27.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.998 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -131.44 153.71 49.44 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.25 -165.78 2.36 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.023 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.9 mp -56.5 -62.03 2.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.371 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 179.05 50.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.013 0.435 . . . . 0.0 110.701 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.03 -154.21 0.54 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.516 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.36 -14.35 20.21 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.52 -22.65 61.75 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.811 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 4.4 pt-20 -68.08 84.84 0.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.086 0.47 . . . . 0.0 110.377 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.32 156.75 45.27 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.729 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 89' ' ' SER . 1.7 mtmm -103.07 153.22 20.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.654 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.407 HG23 ' CD2' ' A' ' 103' ' ' HIS . 25.5 mt -137.58 99.79 9.4 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.012 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.33 130.94 8.33 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.861 2.374 . . . . 0.0 112.22 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.407 ' CD2' HG23 ' A' ' 101' ' ' ILE . 4.9 m-70 -132.71 167.43 20.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.59 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -134.94 135.12 41.27 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.6 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 tp -125.75 84.72 2.31 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.675 0.274 . . . . 0.0 111.314 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -168.63 38.2 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.256 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -140.44 133.96 30.07 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.785 0.326 . . . . 0.0 111.548 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.11 130.64 47.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.829 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 67.0 61.32 0.5 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 6.3 tp10 -96.58 136.84 36.54 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.699 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.7 t -141.11 70.46 1.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.617 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.23 119.25 37.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.184 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.83 154.28 35.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.46 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 t -142.36 152.18 18.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.585 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -134.53 109.24 8.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.65 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -113.11 147.91 36.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.917 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.66 140.74 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.21 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.9 mt -124.52 117.83 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.13 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.75 116.21 19.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.017 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.7 mp -128.57 53.43 11.16 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.232 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.76 -167.81 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.755 2.303 . . . . 0.0 112.246 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 17.2 mt -91.48 51.93 1.98 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.987 0.423 . . . . 0.0 110.695 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.381 -0.819 . . . . 0.0 111.105 179.787 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mtt . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.783 0.325 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 m -142.16 75.12 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.59 -171.3 0.15 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.318 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.52 152.68 32.19 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.889 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.4 t -127.18 119.63 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.532 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -137.81 112.85 9.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.358 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 35.0 mtp180 -138.84 167.76 21.29 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.078 0.466 . . . . 0.0 111.871 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -167.6 124.97 1.18 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.675 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 17.5 tt -108.49 118.98 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.937 0.398 . . . . 0.0 110.983 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.43 ' HG2' ' HG2' ' A' ' 115' ' ' GLU . 58.1 mtp85 -122.89 111.86 17.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.801 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.8 pt -106.95 137.2 38.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.015 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.46 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -125.16 128.59 48.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.132 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.3 m -130.89 124.48 31.25 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.85 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -139.32 143.58 37.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.205 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.461 ' HG3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -137.84 144.46 41.46 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.632 0.253 . . . . 0.0 111.32 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.461 ' N ' ' HG3' ' A' ' 15' ' ' GLN . 15.3 t60 -140.36 119.42 12.75 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.066 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 6.8 mt -118.46 109.09 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.741 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.5 tp -173.14 95.66 0.35 Allowed Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.84 -55.21 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.923 2.416 . . . . 0.0 112.737 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 71.13 0.21 3.33 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.3 p -125.72 138.31 31.71 Favored Pre-proline 0 CA--C 1.531 0.212 0 O-C-N 122.435 -0.166 . . . . 0.0 110.848 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -57.27 142.4 94.73 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.686 2.257 . . . . 0.0 112.389 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.49 113.26 3.08 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.75 2.3 . . . . 0.0 112.823 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.9 m -146.93 -47.62 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.629 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -128.22 -51.29 1.3 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.35 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -83.65 -41.86 17.31 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.307 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 64.65 165.61 0.12 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.337 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.13 134.24 36.52 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.065 2.51 . . . . 0.0 113.091 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.98 176.6 3.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.976 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 164.41 29.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.858 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -122.3 149.23 44.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.742 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -148.47 140.2 23.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.039 0.447 . . . . 0.0 111.344 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.2 t -129.94 117.69 20.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.476 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.7 mm -125.73 127.23 71.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.139 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.46 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -147.68 157.47 43.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.809 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 tt -155.13 128.42 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.962 0.41 . . . . 0.0 111.518 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 22.9 t -119.34 148.49 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.807 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.415 HD11 ' HD3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -160.41 145.47 14.67 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.698 0.285 . . . . 0.0 111.378 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 3.1 tp -103.3 164.16 11.81 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -171.74 -45.67 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.944 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.54 0.48 17.17 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -34.96 26.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.637 0.256 . . . . 0.0 110.651 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.91 -55.86 0.29 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.744 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -162.71 114.05 1.53 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 40' ' ' ASP . 18.1 tt0 -98.66 38.07 1.41 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.987 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.79 134.06 24.51 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.944 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.85 -171.24 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.834 2.356 . . . . 0.0 112.65 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -165.39 -45.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.444 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.17 -66.03 0.83 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.576 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 50' ' ' ILE . 43.3 mm -114.88 -87.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.786 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 49.3 t80 58.79 96.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.897 0.379 . . . . 0.0 111.357 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 6.7 t70 -172.52 110.64 0.23 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.878 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HD3' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -102.64 127.07 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.614 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 m -126.2 142.41 42.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.685 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mp -127.4 150.33 33.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.144 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.37 144.2 36.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.429 ' HA ' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -140.39 119.91 13.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.995 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.494 ' HA ' ' CB ' ' A' ' 84' ' ' PHE . 5.1 mp 67.62 -175.35 0.19 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.309 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.87 157.55 4.03 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.86 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.05 -2.4 8.74 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.13 2.553 . . . . 0.0 113.558 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.32 -9.81 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.93 142.8 57.21 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.568 0.223 . . . . 0.0 110.799 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.59 87.0 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.391 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -154.81 129.5 4.91 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.057 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.94 -171.31 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.526 2.151 . . . . 0.0 112.15 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -108.77 151.17 26.58 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.887 0.375 . . . . 0.0 111.074 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.17 155.98 40.78 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.041 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.62 122.63 26.34 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.798 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -143.9 -57.02 0.38 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.601 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 t -148.61 34.51 0.78 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.721 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.69 160.27 45.06 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.115 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.42 171.67 10.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.934 2.422 . . . . 0.0 112.434 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HB3' HG13 ' A' ' 37' ' ' VAL . 18.7 Cg_endo -58.99 162.55 13.27 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.928 2.419 . . . . 0.0 112.822 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -108.59 156.12 19.88 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.336 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.19 121.38 0.75 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.624 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.3 tp -158.87 119.89 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.959 0.409 . . . . 0.0 111.329 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -126.86 111.52 14.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.646 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.43 161.73 25.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.81 179.74 3.99 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.957 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.91 -170.25 18.73 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.224 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -66.96 120.51 13.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.797 0.332 . . . . 0.0 111.158 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.93 128.1 0.96 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.907 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.39 107.77 0.26 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.717 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.494 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 16.0 m-85 -153.49 164.52 20.24 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.717 0.294 . . . . 0.0 111.016 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.66 163.43 13.25 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.924 2.416 . . . . 0.0 113.572 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -126.65 166.69 16.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.932 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -155.96 128.69 7.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.173 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 mp -136.1 116.45 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.654 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 6.7 t -122.82 146.22 47.74 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.214 0.531 . . . . 0.0 111.477 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 3.2 t -123.56 144.29 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.867 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.515 ' HA ' ' HG3' ' A' ' 98' ' ' GLU . 50.3 m-85 -137.24 154.43 50.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.188 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 9.2 tp -152.01 178.1 9.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.07 -30.27 62.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.738 0.304 . . . . 0.0 110.331 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -106.89 -159.19 0.69 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.161 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.405 ' N ' ' HD2' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -128.52 74.29 1.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.922 0.392 . . . . 0.0 110.683 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -115.16 -50.61 2.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.484 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.75 36.5 1.93 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.746 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.515 ' HG3' ' HA ' ' A' ' 91' ' ' PHE . 22.8 tt0 -88.5 76.36 8.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.513 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -142.72 156.74 45.06 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.689 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -110.32 149.38 30.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.063 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.9 mm -135.3 113.21 11.22 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.266 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -85.82 153.11 10.01 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.941 2.427 . . . . 0.0 112.473 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -144.4 171.39 14.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.061 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.18 143.18 49.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.034 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.442 ' HG ' ' NE2' ' A' ' 15' ' ' GLN . 9.1 tp -130.61 82.12 2.04 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.838 0.352 . . . . 0.0 111.417 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -170.73 47.25 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.286 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -141.61 132.16 25.4 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 111.725 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -64.96 115.4 5.35 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.763 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 74.86 73.0 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.433 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 40.3 tt0 -108.84 141.05 41.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.567 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.6 p -139.83 75.37 1.51 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.05 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.75 119.79 39.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.344 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.8 145.08 25.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.506 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.2 t -126.6 150.48 32.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.704 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' A' ' 10' ' ' ARG . 4.7 mt-10 -134.05 109.05 8.7 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.828 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -113.05 140.28 47.97 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.69 136.41 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.436 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 mp -126.69 111.04 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.37 132.34 45.74 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.985 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.5 tp -161.6 61.75 1.37 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 121.329 0.585 . . . . 0.0 111.377 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.66 -46.41 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.739 2.293 . . . . 0.0 112.772 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.2 tp -175.89 88.11 0.04 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.259 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.05 -179.458 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.961 0.41 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 m -106.02 -28.64 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.073 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.55 90.14 0.08 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.756 0.312 . . . . 0.0 111.377 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.48 154.78 50.66 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.875 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.06 119.06 35.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.965 0.412 . . . . 0.0 110.977 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -137.0 116.33 12.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.192 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.8 mtt-85 -132.45 159.04 40.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.368 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -160.56 127.1 4.15 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.841 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.466 HG23 HD12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -111.77 122.84 66.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.717 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -124.72 129.03 49.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.39 127.14 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -120.82 130.26 53.9 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.185 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 33' ' ' SER . 84.8 m -133.27 108.52 8.8 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -119.5 143.93 47.29 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.143 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.432 ' HG3' ' N ' ' A' ' 16' ' ' HIS . 3.1 tp60 -139.25 142.02 37.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.186 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.432 ' N ' ' HG3' ' A' ' 15' ' ' GLN . 63.4 t-80 -144.91 119.29 9.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.925 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.401 ' HB ' ' HG ' ' A' ' 108' ' ' LEU . 17.7 mt -108.57 136.94 42.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.974 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 mt -120.58 67.67 14.19 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 111.434 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.53 -23.47 7.15 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.831 2.354 . . . . 0.0 113.007 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -80.59 -63.36 1.43 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.305 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.3 t -104.26 100.05 19.97 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.16 112.92 3.66 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.5 2.133 . . . . 0.0 112.092 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.17 68.47 2.53 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.696 2.264 . . . . 0.0 112.263 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.9 t 54.16 57.72 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.052 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -142.74 164.64 29.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.356 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -108.02 134.21 51.24 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.324 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 70.17 155.36 0.15 Allowed Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.51 118.1 4.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.826 2.351 . . . . 0.0 112.754 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.4 t -112.54 152.81 14.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.369 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.45 163.48 29.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.021 0.438 . . . . 0.0 111.526 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.39 153.37 35.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.831 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -153.91 151.8 29.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.595 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 13' ' ' THR . 11.7 t -148.68 119.34 7.49 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.992 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.4 HD12 ' CD2' ' A' ' 105' ' ' LEU . 25.2 mm -126.25 137.16 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.683 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 9.3 pt-20 -157.51 119.59 3.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.702 0.287 . . . . 0.0 111.482 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.6 tt -124.98 127.71 72.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.45 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.74 158.36 42.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.478 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.09 155.61 25.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.856 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.03 168.01 13.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.764 0.316 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.11 -58.7 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.496 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.6 -23.92 67.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.151 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -90.36 -36.65 14.51 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.538 0.208 . . . . 0.0 110.93 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.92 54.55 0.55 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.39 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt 63.79 116.59 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.09 0.471 . . . . 0.0 111.646 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -88.48 31.74 0.81 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.521 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.2 mt -129.69 134.36 26.11 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.774 -0.193 . . . . 0.0 111.132 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.16 173.09 13.52 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.809 2.34 . . . . 0.0 112.36 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.48 -70.97 0.26 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.0 p -117.77 -74.69 0.6 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.63 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.9 mt -100.96 -85.74 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.534 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 3.3 t80 51.59 95.85 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.128 0.489 . . . . 0.0 111.133 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -171.3 103.78 0.21 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.717 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -99.21 114.28 26.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.037 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.07 160.76 37.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.454 ' CG2' ' HB2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -123.4 167.26 17.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.967 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -134.16 131.59 38.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.241 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.48 ' HB3' ' CE1' ' A' ' 59' ' ' HIS . 48.2 m170 -129.41 104.94 7.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.79 -34.48 73.78 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.211 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.48 ' CE1' ' HB3' ' A' ' 57' ' ' HIS . 7.4 p80 -59.09 139.48 87.69 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.127 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -57.49 -14.68 17.25 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.086 2.524 . . . . 0.0 113.87 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.42 -14.72 3.21 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.483 0.182 . . . . 0.0 111.402 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.6 110.57 9.4 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.548 0.213 . . . . 0.0 110.546 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.6 -48.45 79.34 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.398 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.75 142.32 32.8 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.78 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.26 169.69 2.02 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.872 2.381 . . . . 0.0 112.57 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.454 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -90.98 146.44 23.86 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.262 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.01 136.76 30.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.515 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.97 98.96 4.74 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 111.002 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -115.38 -49.58 2.76 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.865 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -146.94 35.08 0.91 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.921 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -130.52 159.73 69.45 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.29 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.26 173.08 3.57 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.063 2.509 . . . . 0.0 112.629 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.36 174.14 2.9 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.989 2.459 . . . . 0.0 112.77 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -136.38 95.08 3.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.392 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -121.19 110.33 16.04 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.002 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.6 mm -134.81 117.31 22.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -129.71 130.15 45.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.128 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -155.56 178.37 10.31 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.702 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.71 131.36 56.79 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.786 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.34 -131.07 2.14 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.03 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -120.27 110.31 16.42 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.16 0.505 . . . . 0.0 111.209 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.17 99.02 0.12 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.439 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.83 108.45 0.41 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.514 -0.851 . . . . 0.0 113.236 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.418 ' HB2' ' CA ' ' A' ' 59' ' ' HIS . 10.4 m-85 -155.82 170.03 9.44 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 122.177 0.191 . . . . 0.0 110.645 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.2 168.43 4.78 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.854 2.37 . . . . 0.0 112.811 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.24 172.49 12.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.703 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -159.83 116.79 2.57 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.897 0.379 . . . . 0.0 111.085 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.1 131.57 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.4 p -128.33 119.64 25.46 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.983 0.42 . . . . 0.0 110.551 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 40.7 t -106.53 135.55 44.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.729 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -134.83 150.24 50.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.721 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 12.2 tp -142.96 -69.55 0.34 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.707 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.4 -76.73 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.541 0.21 . . . . 0.0 111.189 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -137.26 -57.48 0.7 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.289 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 27.1 0.85 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.423 ' HB1' ' CG2' ' A' ' 118' ' ' ILE . . . -78.52 -37.64 42.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.74 37.56 0.39 Allowed Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.834 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -90.1 92.39 8.94 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 110.532 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.02 144.32 33.58 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.344 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 130.13 38.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.392 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.01 132.82 21.54 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.527 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.85 143.58 16.57 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.689 2.259 . . . . 0.0 111.932 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.1 171.91 10.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.01 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -122.54 140.26 52.97 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.657 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.4 ' CD2' HD12 ' A' ' 34' ' ' ILE . 57.6 tp -140.09 70.01 1.36 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.561 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -174.62 42.8 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -141.61 137.36 31.81 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.463 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.401 ' HG ' ' HB ' ' A' ' 17' ' ' ILE . 1.6 mp -50.41 119.75 4.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 58.99 80.64 0.18 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.708 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -111.3 135.09 52.35 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.748 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.5 p -132.57 71.41 1.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.049 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -106.14 119.51 39.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.415 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.5 157.01 33.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.983 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.53 152.32 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.613 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -138.1 109.31 6.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.62 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -113.26 123.94 51.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.021 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 m -103.29 147.22 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.401 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.423 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 9.8 mt -137.87 120.65 19.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -129.46 113.49 14.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.864 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.2 pt -146.68 68.03 11.68 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.545 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.69 62.33 5.56 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.571 2.181 . . . . 0.0 112.625 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -173.73 -60.98 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.08 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.097 -179.824 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.46 0.172 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 m 36.66 67.39 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.042 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.03 79.85 1.2 Allowed 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.152 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.06 135.03 20.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.452 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 t -130.29 119.01 45.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.779 0.323 . . . . 0.0 111.389 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -137.62 122.61 19.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.465 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -134.33 167.37 20.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.204 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 2.3 t -172.56 129.15 0.54 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.444 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.44 ' CG2' HG22 ' A' ' 90' ' ' VAL . 1.2 tt -109.26 118.3 56.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.54 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.31 114.18 16.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.942 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.403 HG13 HG21 ' A' ' 114' ' ' VAL . 1.1 pt -118.38 126.67 75.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 113.58 26.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.989 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.4 m -119.47 96.36 5.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.193 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -125.4 147.89 49.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.09 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -133.61 165.43 24.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.0 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.425 ' CD2' ' HG3' ' A' ' 109' ' ' GLN . 22.9 t-160 -163.39 119.82 1.77 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.203 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -94.35 128.22 45.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.982 0.42 . . . . 0.0 111.506 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.33 128.63 0.45 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.579 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.38 -51.0 2.91 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.652 2.234 . . . . 0.0 112.708 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.1 29.55 17.99 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.779 0.323 . . . . 0.0 111.059 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.459 ' CG1' ' HD2' ' A' ' 23' ' ' PRO . 10.5 t -125.41 106.8 27.22 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.21 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.477 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 48.0 Cg_exo -54.7 -47.47 26.57 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.56 2.173 . . . . 0.0 112.787 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 74.8 Cg_exo -49.92 153.3 6.32 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.688 2.259 . . . . 0.0 112.711 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.88 80.82 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.271 0.558 . . . . 0.0 111.162 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -114.68 158.11 22.23 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.102 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -123.18 -179.36 4.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 64.24 70.98 0.61 Allowed Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.057 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -57.44 145.46 88.13 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.866 2.378 . . . . 0.0 112.771 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.9 t -116.98 147.41 20.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HA ' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -93.53 155.21 17.45 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.736 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -117.42 107.0 13.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.708 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.429 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 57.5 p-90 -100.93 158.86 15.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.665 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.3 t -144.77 117.64 8.77 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.474 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.7 mm -122.88 138.79 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.618 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.16 127.84 13.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.487 HG23 HG12 ' A' ' 55' ' ' ILE . 8.6 mt -119.5 106.41 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.342 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.01 150.14 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.83 0.348 . . . . 0.0 111.627 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 8' ' ' THR . 1.1 pp -166.95 148.2 5.9 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.276 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 7.1 mt -76.95 162.84 27.25 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.329 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -166.27 -59.5 0.03 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.956 0.408 . . . . 0.0 110.393 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -58.86 -31.0 68.14 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.314 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -92.15 -29.97 16.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.72 47.75 2.29 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.709 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 mttm 57.1 94.76 0.02 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 111.156 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.28 -28.84 60.06 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.29 120.56 77.3 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.051 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.482 ' HB3' ' CD2' ' A' ' 51' ' ' PHE . 73.2 Cg_endo -75.6 -171.89 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.591 2.194 . . . . 0.0 112.545 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.84 -55.1 0.46 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.342 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -120.73 -60.49 1.66 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.631 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.9 mm -116.93 -84.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.912 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.482 ' CD2' ' HB3' ' A' ' 47' ' ' PRO . 73.8 t80 58.85 95.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.899 0.381 . . . . 0.0 111.391 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -176.68 151.79 0.94 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.71 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HD3' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -133.15 111.57 11.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.518 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.12 149.29 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.0 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.487 HG12 HG23 ' A' ' 36' ' ' ILE . 4.1 mp -135.0 154.79 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.662 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.1 150.9 38.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 111.408 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.475 ' HB3' ' NE2' ' A' ' 59' ' ' HIS . 12.6 m-70 -135.49 115.33 13.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.502 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -61.99 -39.1 91.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.297 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.475 ' NE2' ' HB3' ' A' ' 57' ' ' HIS . 20.5 p80 -56.64 134.75 77.93 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 120.764 0.316 . . . . 0.0 111.485 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.16 -15.8 30.36 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.0 2.467 . . . . 0.0 113.265 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.74 -16.47 1.71 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.44 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.63 83.95 2.21 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.858 0.361 . . . . 0.0 110.454 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.82 -36.8 82.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.397 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -99.25 122.12 53.11 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.733 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.23 164.85 3.41 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.776 2.318 . . . . 0.0 112.614 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -106.86 131.03 54.41 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.18 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -145.1 131.12 19.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.777 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.25 103.05 8.92 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 111.327 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -104.34 -53.87 2.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.322 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -156.25 35.65 0.33 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.82 165.44 13.97 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.85 157.65 27.72 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.77 2.314 . . . . 0.0 112.423 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.05 154.37 66.64 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.609 2.206 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.87 146.31 25.03 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -171.8 80.8 0.06 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.754 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.36 143.2 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.108 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -135.41 130.4 34.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 1.3 mt-10 -137.42 166.2 24.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.912 0.386 . . . . 0.0 111.398 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.23 126.58 46.54 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.59 -169.0 33.16 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.732 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -115.34 110.18 19.0 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.661 0.267 . . . . 0.0 110.551 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.88 128.51 1.26 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.458 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.4 95.96 0.15 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.211 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 87.6 m-85 -142.08 165.73 25.82 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-O 120.553 0.216 . . . . 0.0 111.072 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 76.2 Cg_exo -50.47 165.95 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.992 2.461 . . . . 0.0 113.367 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -146.51 165.75 28.52 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.882 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -157.38 134.94 10.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.277 0.56 . . . . 0.0 111.128 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.45 HG13 HG21 ' A' ' 55' ' ' ILE . 3.8 mp -128.94 127.19 65.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.884 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.7 p -118.05 137.48 52.88 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.005 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 3.9 t -123.8 132.72 70.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.333 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.48 158.87 37.18 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.654 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.1 OUTLIER -145.65 -49.24 0.23 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.106 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.89 -83.54 0.07 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.01 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.32 -79.49 0.59 Allowed 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 120.562 0.22 . . . . 0.0 111.224 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.75 32.71 1.04 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 111.61 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.29 -39.7 47.07 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.89 0.376 . . . . 0.0 110.361 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -148.18 24.43 1.41 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.619 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 5.0 tt0 -77.63 103.15 7.39 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.713 0.257 . . . . 0.0 110.386 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.49 155.32 45.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.057 0.456 . . . . 0.0 112.032 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.96 138.24 54.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.137 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.429 HG13 ' CG2' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -132.17 110.45 14.07 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.629 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.49 160.76 28.59 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.639 2.226 . . . . 0.0 112.326 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -144.07 170.18 16.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -134.24 95.45 3.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.423 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.432 ' CD2' ' CD2' ' A' ' 59' ' ' HIS . 15.8 tp -77.99 121.98 24.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.353 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.2 -179.42 5.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.084 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -107.83 166.47 10.68 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.592 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tp 77.2 60.32 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.137 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.425 ' HG3' ' CD2' ' A' ' 16' ' ' HIS . 8.9 mt-30 66.11 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.541 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -130.82 147.15 52.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.086 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -140.74 74.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.572 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -117.64 119.29 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.91 157.37 23.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.53 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.429 ' CG2' HG13 ' A' ' 101' ' ' ILE . 29.7 m -137.68 158.11 33.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.312 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -142.93 109.02 5.21 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.348 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.37 150.11 33.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.1 p -124.36 134.9 65.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.202 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.98 111.19 17.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.65 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -129.7 139.44 51.35 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.187 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 tp -169.05 72.19 0.74 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 121.369 0.604 . . . . 0.0 111.144 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.37 154.23 65.5 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.12 -43.42 21.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.827 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.868 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 44' ' ' LYS . 11.9 p -158.8 141.05 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.751 0.31 . . . . 0.0 111.701 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.93 36.61 0.4 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.682 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.52 126.27 8.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.501 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.6 t -130.83 119.34 45.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.889 0.376 . . . . 0.0 111.018 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -133.64 110.95 10.22 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.742 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.466 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 15.1 mtt85 -126.44 161.65 27.41 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.352 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 2.3 t -170.47 116.92 0.51 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.59 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 7.8 tt -103.41 118.06 49.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 121.023 0.44 . . . . 0.0 110.93 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -118.09 112.11 19.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 pt -113.63 133.51 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.31 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -128.77 125.33 37.62 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.954 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -130.89 103.87 6.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -117.64 146.38 43.72 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.169 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.611 ' HG2' ' HA ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -146.04 148.26 32.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.887 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -162.9 120.37 1.97 Allowed 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.655 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' ARG . 24.8 mt -71.91 147.27 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.667 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.42 75.43 33.21 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.928 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.62 -23.84 12.44 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.749 2.299 . . . . 0.0 112.823 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.78 -32.68 63.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.38 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.62 132.26 72.5 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.931 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.38 111.54 3.33 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.493 2.129 . . . . 0.0 112.419 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.18 -179.98 3.98 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.745 2.297 . . . . 0.0 112.517 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 m -59.39 -32.61 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.69 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.12 -67.21 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.473 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -156.13 31.33 0.34 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.032 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -118.75 79.29 16.42 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.814 0.34 . . . . 0.0 110.986 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.04 159.35 52.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.818 2.345 . . . . 0.0 112.636 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 m -122.34 176.49 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.236 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 1.1 ptt-85 -131.3 160.37 35.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.069 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -100.17 160.08 14.61 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.855 0.36 . . . . 0.0 111.079 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.1 p-90 -159.4 151.58 20.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.613 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -148.36 118.11 7.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.696 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tp -124.9 137.04 58.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.926 0.393 . . . . 0.0 111.573 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.401 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -157.67 149.54 22.1 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.786 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 74' ' ' PHE . 12.5 tt -156.61 132.51 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.025 0.441 . . . . 0.0 111.331 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 35.3 m -130.39 159.04 42.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.975 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 8' ' ' THR . 0.5 OUTLIER -164.49 145.21 7.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 111.475 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -97.57 155.16 17.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.378 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.06 -46.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.973 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -78.23 2.61 17.73 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.378 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -82.24 -27.9 32.21 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.495 0.188 . . . . 0.0 110.781 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.26 -59.08 0.13 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.167 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HB3' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -153.05 119.56 5.6 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.777 0.322 . . . . 0.0 111.453 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.19 30.41 4.17 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.957 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.43 134.44 21.21 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.177 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 36.4 Cg_endo -65.75 -44.93 7.23 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.664 2.243 . . . . 0.0 112.769 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 66.57 -76.05 0.05 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.52 0.328 . . . . 0.0 111.798 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -104.02 -69.61 0.8 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.565 0.221 . . . . 0.0 110.977 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -122.77 -81.81 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.772 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.421 ' HB3' ' HA ' ' A' ' 47' ' ' PRO . 5.5 t80 62.48 101.62 0.03 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.296 0.57 . . . . 0.0 110.953 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 35.1 t70 -166.75 111.54 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.848 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.636 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.5 OUTLIER -116.28 126.34 53.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.211 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 p -122.3 152.48 26.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.884 0.373 . . . . 0.0 111.588 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.481 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 2.1 mt -130.98 131.3 64.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.374 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.59 144.07 51.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.696 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -147.57 119.85 8.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.0 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.9 mp 67.18 -172.09 0.19 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.677 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.52 141.14 92.03 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.11 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.13 -15.1 13.27 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.844 2.363 . . . . 0.0 113.062 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.4 p -65.19 -3.54 4.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.558 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.51 161.25 2.76 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.458 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.51 -48.47 48.05 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.538 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -161.15 142.71 8.84 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 111.278 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.34 -175.83 2.41 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.88 2.387 . . . . 0.0 112.247 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.481 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 3.4 m120 -128.24 145.61 50.99 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.836 0.35 . . . . 0.0 111.158 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 -141.81 153.37 44.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.636 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 4.3 m -130.71 119.07 21.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.849 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -164.13 -49.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.584 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -152.02 32.12 0.54 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.648 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.27 161.89 24.81 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.16 166.83 28.51 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.765 2.31 . . . . 0.0 112.653 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.37 138.68 36.43 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.876 2.384 . . . . 0.0 112.639 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.404 ' HB2' HG23 ' A' ' 36' ' ' ILE . 82.4 m-85 -93.37 148.57 21.94 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.146 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.69 84.1 0.08 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.72 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 mt -134.91 134.28 53.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.495 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -134.51 137.73 44.1 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.831 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.15 -177.59 6.01 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.82 125.14 48.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.595 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.95 -162.83 16.84 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.588 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -122.82 110.89 16.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.0 0.429 . . . . 0.0 110.942 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.61 124.5 0.76 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.954 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.93 107.06 0.42 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.274 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -141.59 167.47 16.9 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.67 0.271 . . . . 0.0 111.367 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.9 171.85 0.94 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.24 2.627 . . . . 0.0 113.733 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 mp -139.37 166.05 25.58 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.563 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -155.0 114.6 3.71 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.728 0.299 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.7 mp -124.19 120.45 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.623 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.05 149.37 42.29 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.853 0.359 . . . . 0.0 111.094 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 53' ' ' LYS . 3.7 t -131.08 131.38 63.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.222 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 54.2 m-85 -142.54 144.17 32.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.174 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.77 -54.01 1.15 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.396 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -179.64 -44.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.758 0.313 . . . . 0.0 110.895 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.76 -174.61 2.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.917 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.05 71.26 3.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 111.356 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.06 -50.86 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.577 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -145.65 33.14 1.56 Allowed Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.455 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -102.09 103.0 13.55 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.792 0.329 . . . . 0.0 110.786 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.34 151.18 41.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -104.52 124.92 50.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.337 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.43 114.05 29.0 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.684 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.6 151.94 15.12 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.874 2.382 . . . . 0.0 111.907 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -136.64 171.35 14.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 111.398 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -133.86 128.96 35.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.54 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 tp -108.1 106.35 16.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.777 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.99 168.11 14.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.147 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.611 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 9.3 p90 -94.9 165.61 12.37 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.419 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tp 84.45 62.59 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.341 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? 65.4 111.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.648 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.35 128.82 34.45 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.831 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.9 p -127.41 66.1 1.31 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.714 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 103' ' ' HIS . 5.0 m-85 -108.48 119.42 39.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.561 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.37 152.87 20.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.372 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.9 t -139.65 149.16 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.651 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -135.16 108.87 8.01 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.484 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.36 146.24 39.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.121 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.56 128.71 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.176 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 3.5 mp -121.5 111.21 30.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -123.03 122.78 39.35 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.1 pp -148.23 68.58 10.37 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 121.082 0.468 . . . . 0.0 111.347 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.53 -41.11 6.73 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.635 2.223 . . . . 0.0 112.41 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.84 -47.46 2.7 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.576 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.943 179.755 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.774 0.321 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t 60.49 91.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.336 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.92 179.27 8.6 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.578 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t -140.63 147.23 39.03 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.698 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.76 119.46 51.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -138.04 117.68 13.06 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.483 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -143.08 169.2 18.03 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 9.8 t -172.39 133.58 0.65 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.427 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.406 ' CB ' HG22 ' A' ' 90' ' ' VAL . 9.5 tp -109.11 118.39 56.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.032 0.444 . . . . 0.0 111.022 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -124.89 108.21 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.79 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.58 128.95 75.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.066 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.47 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 2.6 mptp? -115.49 125.28 52.86 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.651 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.402 HG23 HD22 ' A' ' 86' ' ' LEU . 97.5 m -130.06 127.2 39.41 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -138.96 158.82 43.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.912 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.452 ' NE2' ' HG ' ' A' ' 105' ' ' LEU . 1.4 tt0 -153.11 144.28 23.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.757 0.313 . . . . 0.0 111.275 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -142.18 119.23 11.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.864 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.432 HG12 ' CB ' ' A' ' 30' ' ' ARG . 4.8 mt -114.6 101.13 11.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.913 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.6 tp 176.95 129.99 0.19 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.505 ' HG3' ' HB3' ' A' ' 28' ' ' PRO . 81.5 Cg_endo -81.88 -44.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.715 2.276 . . . . 0.0 112.494 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -179.28 -49.87 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.197 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.1 p -121.53 137.35 26.89 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.501 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.22 107.26 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.857 2.371 . . . . 0.0 112.689 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -87.03 -13.19 4.63 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.912 2.408 . . . . 0.0 113.757 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.1 t 63.45 41.87 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.985 0.421 . . . . 0.0 110.91 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.01 177.05 8.07 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.36 30.22 2.6 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.295 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.476 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -70.09 -57.81 5.77 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.443 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.505 ' HB3' ' HG3' ' A' ' 19' ' ' PRO . 17.9 Cg_endo -59.86 179.22 0.29 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.618 2.212 . . . . 0.0 113.395 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.33 174.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.968 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.432 ' CB ' HG12 ' A' ' 17' ' ' ILE . 1.1 ptt-85 -117.74 161.58 19.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.319 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.06 156.44 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.665 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -154.55 137.55 15.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.155 0.503 . . . . 0.0 111.567 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.7 t -134.83 117.21 15.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.934 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 mm -128.94 142.76 43.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.945 0.402 . . . . 0.0 111.605 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 11.4 pt-20 -151.63 143.62 23.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.633 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.44 HG23 ' CD1' ' A' ' 55' ' ' ILE . 3.8 mp -128.66 133.61 66.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.01 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.43 ' HA ' ' HB3' ' A' ' 73' ' ' PRO . 20.2 t -141.52 129.45 22.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.911 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -156.35 176.93 12.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.668 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 3.8 mm? -104.96 162.52 13.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.216 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -155.26 -59.57 0.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.42 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -77.69 -10.13 59.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.63 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -92.58 -27.8 17.13 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.77 45.6 1.2 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.444 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.98 103.76 0.07 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.006 0.431 . . . . 0.0 111.29 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 41' ' ' ASP . 1.2 tm-20 -96.83 35.57 1.52 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.258 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 mp -119.53 102.35 47.81 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.55 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.55 151.66 58.97 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.842 2.361 . . . . 0.0 112.664 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.31 -69.82 0.3 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.158 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -83.79 -58.12 2.93 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.759 0.314 . . . . 0.0 110.421 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.91 -86.39 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.634 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 46.3 t80 46.43 89.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.007 0.432 . . . . 0.0 111.703 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -175.58 134.22 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.663 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 1.4 mttt -119.86 149.73 41.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 110.675 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.3 t -141.51 116.38 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.561 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 66' ' ' ASN . 1.8 mp -103.98 138.52 28.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.22 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -132.28 139.4 48.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.842 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -154.66 117.41 4.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.172 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HB3' ' CD2' ' A' ' 105' ' ' LEU . 0.5 OUTLIER 49.32 -163.24 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.504 -179.768 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.36 118.42 68.67 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.503 0.192 . . . . 0.0 110.493 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.33 -6.08 6.23 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.83 2.353 . . . . 0.0 113.812 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 t -56.18 -16.65 5.58 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.41 -65.56 1.12 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.528 0.204 . . . . 0.0 110.957 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.92 -27.28 64.64 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.3 t30 71.92 151.95 0.14 Allowed Pre-proline 0 N--CA 1.465 0.313 0 CA-C-O 120.719 0.295 . . . . 0.0 111.387 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.72 159.25 38.07 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.512 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.472 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -123.91 138.81 54.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.441 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.76 126.12 17.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.58 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 1.7 m -105.96 104.98 14.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.935 0.398 . . . . 0.0 111.373 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -134.0 -55.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.048 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -146.02 33.76 1.01 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.106 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.01 159.71 63.3 Favored Pre-proline 0 N--CA 1.466 0.365 0 CA-C-O 120.762 0.315 . . . . 0.0 111.61 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -76.57 175.78 10.92 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.227 2.618 . . . . 0.0 112.58 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . 48.0 Cg_exo -56.09 175.25 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.875 2.383 . . . . 0.0 112.739 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.43 160.79 38.11 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.21 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -176.98 104.09 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.483 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -139.65 132.7 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.045 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.67 122.95 24.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -137.28 167.56 21.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.601 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.1 173.37 6.42 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.778 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.67 -129.1 7.86 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.31 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -117.12 110.44 18.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.792 0.329 . . . . 0.0 110.627 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.2 88.71 0.09 OUTLIER Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.221 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -136.0 103.77 0.46 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.519 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.4 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -150.78 168.18 11.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 120.486 0.184 . . . . 0.0 110.766 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.91 173.34 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.973 2.449 . . . . 0.0 113.675 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 103' ' ' HIS . 3.3 mp -140.24 160.58 39.64 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.559 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -158.18 115.52 2.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.169 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 3.9 pt -113.82 105.21 18.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.242 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.4 p -112.37 136.99 51.17 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.01 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.406 HG22 ' CB ' ' A' ' 9' ' ' ILE . 5.7 t -131.62 119.27 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.344 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -125.59 155.96 39.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.947 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -149.67 -171.44 3.9 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.765 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.7 mt -77.26 136.43 38.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.832 0.348 . . . . 0.0 111.593 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 67.55 10.76 7.98 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.208 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 51.32 75.06 0.21 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.518 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.432 ' CB ' HG13 ' A' ' 120' ' ' ILE . . . -108.03 -28.14 9.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.965 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.402 ' HA3' HG21 ' A' ' 118' ' ' ILE . . . -131.31 34.54 2.59 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.722 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.85 98.96 0.3 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.643 0.258 . . . . 0.0 110.602 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -141.86 125.86 17.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.361 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 2.0 pttp -131.07 132.84 45.16 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.736 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -137.21 119.66 11.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.507 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -87.16 149.87 8.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.925 2.416 . . . . 0.0 112.607 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 58.6 m80 -139.95 172.35 12.89 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.117 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.61 144.97 49.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.818 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.452 ' HG ' ' NE2' ' A' ' 15' ' ' GLN . 2.5 tp -127.37 88.35 2.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.795 0.331 . . . . 0.0 111.461 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -167.94 39.2 0.04 OUTLIER 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.432 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -141.62 124.88 16.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.391 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -56.74 130.01 43.69 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.69 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 71.02 68.98 0.17 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.594 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -102.92 135.64 44.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.545 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.5 p -140.72 67.22 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.82 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -113.42 119.82 38.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.656 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.7 137.14 16.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.398 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.3 t -116.67 146.94 20.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.986 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -132.78 108.64 9.12 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.878 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.69 148.69 37.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.084 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.2 p -124.25 148.94 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.623 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.402 HG21 ' HA3' ' A' ' 97' ' ' GLY . 11.1 mt -133.94 110.88 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -130.3 104.5 7.31 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.401 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.432 HG13 ' CB ' ' A' ' 96' ' ' ALA . 21.2 mm -136.98 56.38 12.56 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 120.998 0.428 . . . . 0.0 111.473 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.21 -36.17 3.46 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.556 2.171 . . . . 0.0 112.468 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.6 mt -137.58 39.0 2.44 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.745 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.356 -0.831 . . . . 0.0 111.198 179.823 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtt . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.47 177.02 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 120.672 0.273 . . . . 0.0 111.159 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.46 126.7 44.22 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.214 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 t -153.87 138.77 17.18 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.753 0.311 . . . . 0.0 110.828 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.418 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 7.2 p -140.79 127.81 21.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.275 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.03 110.36 19.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.163 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 39.0 mtp85 -109.24 157.22 19.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.269 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 t -165.94 124.95 1.61 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.469 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.4 tt -108.67 118.2 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 110.769 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -125.24 131.08 53.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.607 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.476 HD11 ' CE1' ' A' ' 103' ' ' HIS . 1.3 pt -127.35 129.84 70.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.142 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.69 112.4 25.46 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.23 113.8 20.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -135.61 154.33 51.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.738 0.304 . . . . 0.0 111.166 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.62 138.17 23.22 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.267 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -135.2 119.43 17.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.967 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 8.0 mt -118.64 121.85 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.738 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.25 117.26 1.0 Allowed Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.432 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.73 -10.51 23.44 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.739 2.293 . . . . 0.0 112.926 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.4 -44.86 35.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.261 0.224 . . . . 0.0 111.455 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.2 t -66.82 110.16 4.55 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.284 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.54 106.74 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.671 2.247 . . . . 0.0 112.402 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.19 -162.49 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.111 2.541 . . . . 0.0 111.998 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.7 t -77.63 -29.21 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.494 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -171.85 104.24 0.19 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.646 0.26 . . . . 0.0 110.393 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 11.1 p30 45.63 -161.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.636 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 26' ' ' ASN . 10.3 m-85 68.59 133.3 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-O 120.88 0.371 . . . . 0.0 111.334 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.89 -43.42 3.49 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.369 2.046 . . . . 0.0 112.578 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.1 t 67.48 128.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.223 0 O-C-N 123.442 0.463 . . . . 0.0 111.037 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.83 162.12 18.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.425 ' CG ' ' HB3' ' A' ' 79' ' ' GLN . 2.6 mt-30 -124.2 159.83 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -158.47 160.61 36.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.262 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.1 p -146.73 121.91 10.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.523 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.4 tp -126.4 124.21 65.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.962 0.411 . . . . 0.0 110.949 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HG3' ' HB2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -127.2 135.81 51.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.632 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 74' ' ' PHE . 8.0 mt -123.91 105.89 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 73' ' ' PRO . 27.1 m -119.72 149.1 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.84 0.352 . . . . 0.0 111.6 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pp -172.04 151.89 2.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.265 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.534 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -108.05 162.51 13.98 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.514 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -174.19 -47.71 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.396 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -86.04 2.72 45.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -24.93 24.63 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 5' ' ' VAL . . . -112.35 -74.82 0.71 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.342 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -87.98 -56.55 3.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 64.95 16.77 10.73 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.239 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.6 mt -109.86 140.99 22.8 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.033 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.56 174.41 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.94 2.427 . . . . 0.0 112.633 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.29 -164.49 1.78 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.375 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -66.9 -47.8 70.7 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.431 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.43 -86.28 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.623 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 29.3 t80 53.29 92.84 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.102 0.477 . . . . 0.0 111.384 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 2.8 t70 -172.43 116.22 0.33 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.696 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.83 125.55 45.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.59 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.78 132.26 71.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.959 0.409 . . . . 0.0 111.56 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 mm -123.11 140.22 47.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.932 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -143.81 97.88 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -111.45 125.99 54.47 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.93 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 mt 69.0 161.04 0.2 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.364 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.422 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -76.83 -49.84 2.53 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.609 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 59' ' ' HIS . 85.9 Cg_exo -46.39 -29.44 7.07 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.157 2.572 . . . . 0.0 113.677 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.8 m -69.9 2.64 3.25 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -60.72 -34.09 73.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.507 0.194 . . . . 0.0 110.742 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.99 89.22 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.097 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -132.41 90.68 33.13 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 121.212 0.53 . . . . 0.0 110.994 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.84 152.78 73.71 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.673 2.249 . . . . 0.0 112.179 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -96.79 130.64 44.01 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -145.61 112.63 6.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.61 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.86 131.56 39.14 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -140.51 -54.05 0.51 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.603 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.95 36.48 0.4 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.741 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.19 163.35 34.32 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.01 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.85 171.66 2.72 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.865 2.377 . . . . 0.0 112.415 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 36.5 Cg_endo -64.89 169.43 11.77 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.632 2.221 . . . . 0.0 112.621 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 15.0 m-85 -117.06 64.26 0.72 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.713 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.514 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 24.4 tpt180 -82.81 90.74 6.95 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.776 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -126.84 131.82 70.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.388 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -136.65 123.24 20.97 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.536 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -133.79 177.91 7.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.579 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.425 ' HB3' ' CG ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -129.87 -179.22 5.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.066 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.49 -148.74 17.3 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.967 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.85 110.17 16.88 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.811 0.339 . . . . 0.0 110.861 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.07 -117.96 0.55 Allowed Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.118 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.11 114.79 2.32 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.679 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.0 m-85 -165.42 168.49 8.2 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 120.546 0.212 . . . . 0.0 110.976 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 37.1 Cg_endo -65.81 -177.44 0.76 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.981 2.454 . . . . 0.0 113.014 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 103' ' ' HIS . 5.4 mp -146.15 166.08 27.25 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.751 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -158.71 123.63 4.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.783 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.25 112.49 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.009 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.22 116.02 24.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.685 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 98' ' ' GLU . 1.2 p -104.7 143.32 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.314 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 27.5 m-85 -133.26 155.78 48.76 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.524 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 4.6 tp -142.2 -63.17 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.731 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.6 -68.7 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.313 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -146.62 -63.49 0.3 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.359 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 51.53 1.2 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 111.185 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -104.41 -36.98 7.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.416 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 180.0 46.04 0.08 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.535 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 91' ' ' PHE . 11.4 pt-20 -111.34 111.02 21.77 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.08 0.467 . . . . 0.0 110.745 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -142.29 151.79 42.35 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.303 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 0.2 OUTLIER -117.35 127.79 54.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.381 179.172 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.24 121.42 10.21 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 121.024 0.44 . . . . 0.0 111.921 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.56 160.5 9.4 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.916 2.41 . . . . 0.0 112.393 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.476 ' CE1' HD11 ' A' ' 11' ' ' ILE . 38.1 m80 -144.69 172.21 13.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -124.33 145.04 49.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.115 0.483 . . . . 0.0 111.053 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 tp -139.16 78.63 1.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.378 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -161.82 38.94 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.367 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -141.47 130.39 23.12 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.168 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 2.4 pp -59.86 131.51 51.1 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.467 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.32 62.97 0.36 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.658 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -103.33 134.65 46.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.649 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.1 t -134.14 71.79 1.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.16 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.73 119.17 38.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.709 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -143.08 141.93 31.4 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.205 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.9 t -127.81 145.02 35.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -140.73 108.35 5.61 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.468 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.49 138.85 49.53 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.106 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.5 m -104.5 140.9 21.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.498 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 10.0 mt -138.05 111.08 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.36 119.1 35.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.649 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.2 mp -125.07 52.13 6.01 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.748 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.97 -44.03 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.488 2.125 . . . . 0.0 112.637 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.07 -67.52 0.23 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.277 0.361 . . . . 0.0 111.642 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.885 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.9 mtt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.511 0.196 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.62 -36.07 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.583 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.34 84.3 0.1 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.734 0.302 . . . . 0.0 111.399 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 t -149.02 155.66 41.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.872 0.367 . . . . 0.0 110.946 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -129.14 119.09 48.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.808 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -137.41 104.96 5.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.586 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -125.4 165.57 18.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.956 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.5 t -172.99 139.56 0.84 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.09 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.99 118.2 56.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.47 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HD3' ' HG2' ' A' ' 115' ' ' GLU . 10.8 mtt85 -124.78 105.3 9.18 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.408 HG23 ' HA ' ' A' ' 36' ' ' ILE . 2.2 pt -112.51 134.09 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.052 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.41 141.59 48.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.27 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -138.55 109.75 6.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.081 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -120.97 136.68 54.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.502 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.433 ' OE1' HG13 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -140.06 150.43 44.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.671 0.272 . . . . 0.0 111.691 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -147.64 119.66 8.22 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.41 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.433 HG13 ' OE1' ' A' ' 15' ' ' GLN . 14.5 mt -105.77 116.15 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.972 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.32 93.2 0.36 Allowed Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.104 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -66.22 -48.43 2.59 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.49 2.127 . . . . 0.0 112.586 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 55.67 36.11 26.59 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.998 0.428 . . . . 0.0 110.881 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.1 t -105.99 136.42 19.31 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.614 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.409 ' CB ' ' HD2' ' A' ' 23' ' ' PRO . 19.0 Cg_endo -58.29 173.98 0.85 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.797 2.331 . . . . 0.0 112.073 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 22' ' ' PRO . 12.4 Cg_endo -55.8 89.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.009 2.473 . . . . 0.0 112.36 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.8 t -135.81 -55.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.926 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -140.51 172.7 12.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.63 35.36 4.46 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.072 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.48 92.22 32.03 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.634 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.32 155.69 12.02 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.88 2.387 . . . . 0.0 112.689 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.5 t -118.95 113.52 41.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.768 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -109.42 163.55 13.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.311 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.05 111.02 10.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.571 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.402 ' CE2' ' HB2' ' A' ' 78' ' ' GLU . 23.3 p-90 -116.1 150.21 37.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.307 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -140.1 147.27 40.0 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.493 HG23 ' CD2' ' A' ' 57' ' ' HIS . 5.7 tp -146.48 135.32 16.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.487 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 3.7 pm0 -134.97 144.57 47.47 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.822 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.408 ' HA ' HG23 ' A' ' 11' ' ' ILE . 4.2 mp -121.32 107.07 19.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.889 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.72 138.36 34.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.245 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 8' ' ' THR . 0.6 OUTLIER -166.18 160.08 15.8 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.527 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -105.02 161.85 13.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -151.64 -63.17 0.18 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.678 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.09 -19.54 65.88 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.514 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -86.65 -32.66 20.43 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.196 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.57 48.08 0.97 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.28 106.31 0.04 OUTLIER 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.983 0.42 . . . . 0.0 111.3 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.24 16.34 6.38 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.932 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.1 mt -125.47 104.58 28.06 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-O 120.515 0.198 . . . . 0.0 111.409 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.419 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 74.2 Cg_endo -75.33 -170.5 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.799 2.333 . . . . 0.0 112.556 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.83 -45.87 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.879 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.65 -67.79 0.84 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.791 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.38 -89.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.032 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 40.3 t80 58.72 100.14 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.2 0.524 . . . . 0.0 110.864 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.8 110.36 1.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.844 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.98 102.59 13.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.364 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -103.95 139.42 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.342 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -130.69 144.84 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.433 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.08 148.15 42.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.493 ' CD2' HG23 ' A' ' 34' ' ' ILE . 26.1 p-80 -161.12 59.35 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.679 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -178.31 175.64 1.16 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.359 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 162.17 19.95 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.011 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.81 2.73 6.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.649 2.232 . . . . 0.0 113.713 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -4.95 8.07 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.472 ' CZ ' ' HG3' ' A' ' 65' ' ' PRO . 1.6 t80 59.94 71.29 0.58 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-O 121.001 0.429 . . . . 0.0 111.414 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.41 -28.9 12.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.872 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -168.37 85.19 0.71 Allowed Pre-proline 0 C--O 1.233 0.191 0 CA-C-O 120.761 0.315 . . . . 0.0 111.24 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HG3' ' CZ ' ' A' ' 62' ' ' PHE . 81.1 Cg_endo -77.14 140.53 19.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.623 2.215 . . . . 0.0 112.618 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -109.96 128.67 55.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.701 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -144.8 139.51 27.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.997 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.04 104.65 9.01 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.095 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -102.24 -41.4 6.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.107 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 t -170.53 43.25 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.495 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.19 166.18 20.64 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.236 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.79 172.48 5.79 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.898 2.399 . . . . 0.0 112.445 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.97 -179.03 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.778 2.319 . . . . 0.0 112.61 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -140.89 159.17 42.78 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -173.92 114.18 0.2 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.075 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -142.9 151.18 17.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.245 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -133.63 141.85 47.82 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.917 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.402 ' HB2' ' CE2' ' A' ' 32' ' ' TRP . 13.6 mt-10 -133.79 152.08 51.77 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.959 0.409 . . . . 0.0 111.586 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.95 178.98 5.43 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.367 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.15 -103.72 2.81 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.67 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -121.69 112.12 18.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.085 0.469 . . . . 0.0 111.418 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.13 115.17 0.61 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.177 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -166.4 103.85 0.21 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.392 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -150.55 167.8 12.27 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.648 0.261 . . . . 0.0 111.195 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.78 173.14 2.38 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.245 2.63 . . . . 0.0 113.325 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' A' ' 105' ' ' LEU . 2.5 mp -142.62 160.11 40.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.32 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -157.6 113.4 2.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.799 0.333 . . . . 0.0 111.568 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.0 tt -116.47 121.79 68.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.533 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.6 121.94 26.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.115 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 5.8 t -99.95 154.3 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.643 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CD2' ' HG3' ' A' ' 98' ' ' GLU . 51.4 m-85 -148.52 158.23 43.99 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.3 OUTLIER -153.45 -175.13 5.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.134 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 47' ' ' PRO . 8.9 mp -60.93 -67.0 0.44 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.537 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -94.15 19.77 8.86 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.574 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm 58.35 55.36 5.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.17 -37.62 37.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 90' ' ' VAL . . . -122.49 26.39 6.32 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.606 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.0 tt0 -67.08 90.9 0.2 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.633 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -142.45 142.37 32.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.503 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -126.62 119.32 26.75 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.393 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.6 mt -128.77 120.72 20.68 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.482 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.2 154.83 8.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.004 2.47 . . . . 0.0 112.692 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 81.7 m-70 -140.12 172.1 13.23 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.396 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -128.54 124.6 36.4 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.114 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.55 ' HB2' HD12 ' A' ' 86' ' ' LEU . 1.3 tm? -113.56 95.03 5.13 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.761 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 13.6 t-20 178.8 41.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.062 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -137.4 125.27 22.61 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.663 0.268 . . . . 0.0 111.138 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.04 123.89 12.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.83 60.88 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.419 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.0 138.97 30.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.46 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.2 p -148.16 63.75 1.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.905 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -115.19 119.36 36.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.389 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -147.32 133.84 19.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.506 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 t -105.59 147.4 11.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.72 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.403 ' HG2' ' HD3' ' A' ' 10' ' ' ARG . 34.9 mt-10 -136.45 108.45 7.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.695 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -116.64 138.51 51.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.8 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.62 140.92 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.986 0.422 . . . . 0.0 111.555 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.405 HG12 ' HA3' ' A' ' 97' ' ' GLY . 2.0 mp -130.56 111.39 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.585 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -122.5 136.95 55.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.214 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.9 tt -160.24 55.85 0.75 Allowed Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 121.286 0.565 . . . . 0.0 111.21 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.47 125.36 10.07 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.719 2.28 . . . . 0.0 112.531 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -31.49 52.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.973 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.064 -0.969 . . . . 0.0 111.151 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG2' ' N ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.424 ' N ' ' HG2' ' A' ' 1' ' ' MET . 14.4 p -82.96 -35.6 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.14 82.31 5.04 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.851 0.358 . . . . 0.0 110.955 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 t -145.91 141.76 28.1 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 44' ' ' LYS . 19.4 t -133.42 119.24 34.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.078 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -137.03 104.89 5.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.159 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.466 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -132.57 172.98 11.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.189 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t -173.22 141.36 0.93 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -109.2 118.14 55.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 110.636 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.8 mtt-85 -124.75 118.25 25.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.802 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pt -123.56 129.81 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.124 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.443 ' CG ' ' HG3' ' A' ' 113' ' ' GLU . 34.2 mtmt -108.19 133.09 52.93 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -131.33 104.2 6.89 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -115.1 137.98 51.4 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.698 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.439 ' NE2' ' HG ' ' A' ' 105' ' ' LEU . 4.8 tt0 -139.39 151.98 46.75 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.751 0.31 . . . . 0.0 111.705 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.434 ' CD2' ' HB2' ' A' ' 18' ' ' LEU . 3.7 t-160 -150.0 119.18 6.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.722 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.8 mt -97.41 101.89 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.75 0.309 . . . . 0.0 110.648 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.434 ' HB2' ' CD2' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -134.41 85.16 38.68 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.753 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.21 -57.69 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.013 2.475 . . . . 0.0 112.891 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 54.02 23.46 4.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.647 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.04 138.81 32.88 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.698 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -51.97 108.35 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.516 2.144 . . . . 0.0 112.252 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.82 103.01 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.805 2.336 . . . . 0.0 112.842 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.6 p -167.48 42.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.039 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -155.81 -50.62 0.08 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.582 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -164.13 -174.96 3.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.682 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -61.54 141.61 94.59 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-O 120.553 0.216 . . . . 0.0 110.826 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.36 169.65 2.11 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.086 2.524 . . . . 0.0 112.973 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.454 ' HB ' ' HA2' ' A' ' 80' ' ' GLY . 7.3 m -98.13 157.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.95 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -136.08 163.43 30.34 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.213 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 3.7 mt-30 -118.54 148.94 42.12 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.075 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.452 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 15.0 p-90 -156.11 155.23 32.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.103 0.478 . . . . 0.0 112.145 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.1 t -149.29 117.74 6.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.539 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tp -122.29 143.05 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.428 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 4.0 pt-20 -144.64 118.73 9.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.833 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.499 HG22 HD11 ' A' ' 55' ' ' ILE . 4.6 mp -101.07 110.35 27.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.676 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.3 t -124.03 147.8 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.721 0.296 . . . . 0.0 111.589 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.407 HD21 ' HD3' ' A' ' 53' ' ' LYS . 2.9 pp -156.89 171.2 20.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.255 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 7' ' ' ARG . 2.5 tp -120.18 159.02 25.72 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.21 -45.62 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.287 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.3 2.58 15.29 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.43 -36.52 26.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.577 0.227 . . . . 0.0 111.007 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.4 -66.96 0.25 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.809 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HB2' HG21 ' A' ' 5' ' ' VAL . 4.2 mttt -155.07 108.92 2.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.558 0.218 . . . . 0.0 110.849 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -90.08 49.62 1.74 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.751 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.45 132.93 24.57 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.216 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.85 -177.98 4.01 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.84 2.36 . . . . 0.0 112.565 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.62 -54.53 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.25 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.8 p -125.82 -55.09 1.51 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.347 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.9 -86.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.015 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 t80 56.23 96.82 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.075 0.464 . . . . 0.0 111.213 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -174.41 127.52 0.34 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.664 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HD3' HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -114.55 133.09 56.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.806 0.336 . . . . 0.0 110.703 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.7 t -132.44 118.82 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.645 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 36' ' ' ILE . 3.6 mp -106.99 144.91 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.382 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -138.95 144.87 39.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.068 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -167.27 137.31 2.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.691 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 84' ' ' PHE . 2.6 mt 74.93 147.0 0.09 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.267 0.354 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 -54.89 0.47 Allowed Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -47.64 -30.92 13.28 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.047 2.498 . . . . 0.0 114.415 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 t -81.27 9.92 6.3 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.557 0.218 . . . . 0.0 111.153 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -51.22 -30.12 16.35 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.916 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.53 6.27 18.06 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -159.09 66.88 3.06 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.641 0.258 . . . . 0.0 111.405 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.61 177.41 3.4 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.873 2.382 . . . . 0.0 112.548 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -108.11 139.76 42.29 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.0 0.429 . . . . 0.0 111.164 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? -137.04 147.4 46.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.749 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.77 123.83 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.061 0.458 . . . . 0.0 111.396 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -136.05 -54.46 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.311 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 t -155.65 39.34 0.38 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -123.5 155.75 65.24 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -57.25 172.72 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.08 2.52 . . . . 0.0 112.819 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.88 166.96 4.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.881 2.387 . . . . 0.0 112.939 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.8 84.46 2.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.658 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.2 ttp85 -99.85 113.91 26.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.45 115.7 18.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -122.18 144.08 49.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.3 166.64 32.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.943 0.402 . . . . 0.0 111.449 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -123.65 170.52 10.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.454 ' HA2' ' HB ' ' A' ' 29' ' ' VAL . . . 98.35 -81.8 0.62 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.472 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -113.61 116.61 29.77 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.452 ' HA3' ' CD1' ' A' ' 32' ' ' TRP . . . -170.99 88.29 0.09 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.763 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -160.26 74.64 0.2 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.666 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.527 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 22.7 m-85 -143.37 165.7 23.95 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 120.632 0.253 . . . . 0.0 111.35 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 37.3 Cg_endo -65.38 171.1 9.78 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.136 2.557 . . . . 0.0 113.729 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 103' ' ' HIS . 5.1 mp -143.29 159.59 42.06 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.964 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -155.37 112.71 3.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.663 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.52 124.46 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.685 0.279 . . . . 0.0 111.319 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.1 p -126.59 131.89 51.41 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 24.2 t -124.42 137.46 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.022 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.401 ' CD2' ' CG ' ' A' ' 98' ' ' GLU . 11.5 m-85 -131.61 154.9 48.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.349 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -141.15 -53.84 0.47 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.112 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 tt -152.48 -52.06 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.157 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -170.25 -63.63 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.563 0.22 . . . . 0.0 111.143 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.54 21.95 8.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.407 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.12 -50.86 6.34 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.802 0.334 . . . . 0.0 110.696 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -149.88 23.54 1.15 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.687 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' CG ' ' CD2' ' A' ' 91' ' ' PHE . 0.5 OUTLIER -76.66 84.76 3.31 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.731 0.301 . . . . 0.0 110.789 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -142.28 146.04 34.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.148 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -124.87 147.75 48.63 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.471 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.2 tp -148.0 111.77 3.83 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 121.008 0.433 . . . . 0.0 111.879 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -85.99 133.25 4.13 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.033 2.489 . . . . 0.0 112.342 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 1.7 m-70 -113.18 163.34 14.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.303 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.44 138.46 54.01 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.473 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 6.0 tp -123.48 92.12 3.62 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.653 0.263 . . . . 0.0 110.911 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -167.98 33.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -141.91 126.28 17.66 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.808 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 pp -58.21 131.85 51.8 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.748 0.309 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 73.09 67.16 0.11 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.63 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.45 141.28 28.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 t -144.8 64.86 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.02 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 119.27 38.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.55 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.443 ' HG3' ' CG ' ' A' ' 12' ' ' LYS . 7.5 tt0 -141.67 131.37 24.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.213 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.5 t -116.43 140.4 38.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -133.46 108.54 8.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.62 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.27 119.07 36.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.54 144.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.2 mt -134.6 111.15 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.63 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.38 106.13 8.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.174 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.1 mm -135.4 62.03 47.68 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.192 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.76 -43.11 1.4 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.352 2.035 . . . . 0.0 112.871 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.77 93.16 2.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.027 0.441 . . . . 0.0 110.297 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.52 -179.347 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.16 174.73 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.669 0.271 . . . . 0.0 111.233 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.81 78.71 1.58 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.985 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.56 135.41 24.91 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.4 119.26 48.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.128 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -129.22 106.07 8.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.545 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.46 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 46.9 mtt85 -123.46 152.71 41.39 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.996 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 6.9 t -160.96 143.95 12.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.17 125.04 73.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.2 mtt85 -132.06 108.83 9.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.552 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -117.78 132.15 68.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.069 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -118.21 139.17 51.69 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.09 102.91 4.97 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.7 tt0 -113.69 118.76 35.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.224 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 32' ' ' TRP . 13.5 tt0 -119.98 146.34 45.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 111.914 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.411 ' CD2' ' HB3' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -146.72 119.8 8.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.1 mt -99.46 128.5 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.179 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 mp -135.63 106.9 9.92 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.677 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.94 -56.57 0.56 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.691 2.261 . . . . 0.0 112.871 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 49.6 81.07 0.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.719 0.295 . . . . 0.0 111.443 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 36.2 t -65.12 110.11 3.82 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.301 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.97 161.51 10.31 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.741 2.294 . . . . 0.0 112.28 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.74 45.19 1.92 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.726 2.284 . . . . 0.0 112.794 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.1 t -148.18 -65.77 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.093 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -133.31 -174.52 3.52 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.873 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -132.56 116.88 17.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.601 0.239 . . . . 0.0 111.284 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -163.08 110.85 1.03 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.076 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.86 129.76 13.78 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.733 2.289 . . . . 0.0 112.465 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.08 138.31 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 111.7 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -104.09 160.41 14.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.997 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.411 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 1.0 OUTLIER -135.84 113.57 11.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.673 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 15' ' ' GLN . 14.1 p-90 -121.8 154.63 36.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.766 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 t -136.71 118.61 15.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.529 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tp -119.18 136.95 54.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.527 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.32 138.88 43.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.346 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.507 HG23 HG12 ' A' ' 55' ' ' ILE . 2.9 mp -123.9 105.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.844 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.2 m -115.59 150.48 17.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.919 0.39 . . . . 0.0 111.499 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 8' ' ' THR . 0.5 OUTLIER -172.51 178.95 2.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.243 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 2.9 mm? -103.88 165.84 10.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.293 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -167.28 -50.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.446 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.15 -31.43 65.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.465 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.78 -36.63 25.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.045 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.19 50.07 1.11 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.824 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.9 mttm 52.85 96.62 0.01 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.89 0.376 . . . . 0.0 111.42 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -24.8 59.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.588 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mp -82.51 114.75 53.89 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.865 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.85 -175.3 1.14 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.594 2.196 . . . . 0.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.49 -51.27 0.25 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.674 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.0 m -104.77 -69.67 0.8 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.835 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -132.53 -85.07 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.838 -0.165 . . . . 0.0 111.019 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 39.0 t80 56.15 95.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.044 0.45 . . . . 0.0 111.505 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -159.16 111.86 2.22 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.498 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.21 121.68 41.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.64 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.81 128.19 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 0.0 111.109 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.507 HG12 HG23 ' A' ' 36' ' ' ILE . 3.3 mp -116.63 145.24 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.434 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -142.82 128.2 18.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -127.57 135.65 50.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.771 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER 67.01 -178.93 0.21 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.279 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -52.11 154.29 4.12 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.754 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 59' ' ' HIS . 9.6 Cg_exo -71.49 2.05 4.93 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.167 2.578 . . . . 0.0 113.312 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 15.0 t -82.89 9.8 9.19 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.795 0.331 . . . . 0.0 110.817 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -61.07 162.19 7.54 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.398 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.17 -49.63 14.75 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -139.33 115.56 8.41 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.303 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 62' ' ' PHE . 56.1 Cg_endo -70.41 -179.37 3.15 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.513 2.142 . . . . 0.0 112.068 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.404 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 10.0 m120 -111.74 127.39 55.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.819 0.342 . . . . 0.0 111.052 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.4 ttt-85 -143.37 122.96 13.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.71 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.63 139.32 41.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -159.86 -55.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.119 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.33 38.03 1.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.035 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.83 160.19 67.73 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.505 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -62.13 174.74 2.34 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.16 2.573 . . . . 0.0 112.649 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -74.21 148.73 39.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.74 2.293 . . . . 0.0 112.712 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -99.13 155.79 17.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.01 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.96 86.91 0.1 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.5 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -136.67 151.94 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.319 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -122.45 157.72 31.33 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.994 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.97 141.14 49.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.182 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.88 136.04 53.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.743 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 30' ' ' ARG . . . 128.19 -156.43 20.8 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.839 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -75.81 131.12 39.55 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.055 0.455 . . . . 0.0 111.312 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.9 -127.86 1.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.939 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.04 104.37 0.13 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.752 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.488 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 3.4 m-85 -155.5 170.8 8.14 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 120.707 0.289 . . . . 0.0 111.25 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 87.8 Cg_exo -49.86 170.25 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.477 2.785 . . . . 0.0 114.177 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.16 159.66 40.83 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.72 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -156.21 120.94 4.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.926 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 HG13 HG22 ' A' ' 55' ' ' ILE . 3.1 mp -135.33 124.0 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.275 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 p -123.61 122.23 37.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.95 0.405 . . . . 0.0 110.302 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 19.2 t -107.4 111.88 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.069 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -102.9 157.54 16.9 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.781 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 1.3 pt? -146.27 -159.81 1.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.612 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.4 mt -55.59 -66.85 0.35 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.409 0.147 . . . . 0.0 111.014 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -177.37 42.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.221 0.534 . . . . 0.0 110.42 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.96 -166.24 1.06 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.026 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.65 -13.44 61.36 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.817 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.12 -27.91 57.94 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.097 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -65.26 83.43 0.05 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.107 0.48 . . . . 0.0 110.624 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.46 155.45 45.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.545 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -121.54 145.89 47.5 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.615 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.59 114.47 8.77 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.468 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -88.63 155.85 6.32 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.082 2.522 . . . . 0.0 112.254 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.412 ' CE1' ' HB3' ' A' ' 112' ' ' TYR . 6.1 m170 -140.26 172.02 13.33 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.034 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.66 119.32 21.24 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.2 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.403 ' CD1' ' HB2' ' A' ' 15' ' ' GLN . 4.3 tp -112.95 86.5 2.38 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -165.36 39.83 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -142.09 139.75 32.32 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.03 127.36 31.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.368 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 64.9 79.02 0.26 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.245 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 39.3 tt0 -109.63 136.38 49.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.014 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -133.69 70.95 1.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.106 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.412 ' HB3' ' CE1' ' A' ' 103' ' ' HIS . 5.5 m-85 -110.09 119.1 38.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.059 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -154.57 132.23 11.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.415 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.0 t -109.59 145.72 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.678 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -132.16 108.65 9.41 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.079 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.29 151.71 30.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.7 149.31 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.957 0.408 . . . . 0.0 111.871 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.3 mt -143.29 110.97 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.507 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -129.79 118.33 21.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.637 0.256 . . . . 0.0 111.28 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.432 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.6 pp -138.2 48.58 2.03 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.83 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 120' ' ' ILE . 71.1 Cg_endo -76.45 -42.41 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.56 2.173 . . . . 0.0 112.866 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 mp -103.8 -50.07 3.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.647 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.547 179.719 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmm . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.407 0.146 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 m -76.78 -32.41 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.546 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.67 83.99 2.09 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.59 128.02 9.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 t -123.38 119.43 57.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.097 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.72 104.85 5.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.19 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -134.59 175.44 9.53 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.038 0.447 . . . . 0.0 111.258 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 4.9 t -160.77 146.05 14.45 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.335 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 tt -113.87 118.05 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-O 120.931 0.396 . . . . 0.0 110.784 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -130.29 111.13 12.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.505 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.444 HD11 ' CG2' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -122.06 142.27 39.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.121 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -120.59 138.4 53.91 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.755 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.2 120.12 12.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.161 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -130.33 160.14 34.84 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.77 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -152.86 142.04 21.44 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.279 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.404 ' CD2' ' HG ' ' A' ' 18' ' ' LEU . 3.3 t-160 -131.96 119.67 21.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.733 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.4 mt -117.88 126.99 75.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.608 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HG ' ' CD2' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -120.4 75.87 24.89 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.161 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.48 -37.86 1.64 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.541 2.16 . . . . 0.0 112.716 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -80.71 -37.57 30.41 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.1 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -65.41 111.41 6.05 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.478 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.47 107.43 0.5 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.647 2.231 . . . . 0.0 112.203 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.533 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 5.8 Cg_exo -79.84 47.37 2.5 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.41 2.74 . . . . 0.0 112.937 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t 67.56 -69.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 122.798 0.439 . . . . 0.0 111.941 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -85.42 3.61 39.3 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.533 ' HA ' ' HD2' ' A' ' 23' ' ' PRO . 5.3 m-80 62.44 53.69 2.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 110.886 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -124.17 114.03 27.83 Favored Pre-proline 0 CA--C 1.529 0.135 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.032 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.92 107.97 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.94 2.426 . . . . 0.0 112.655 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.84 146.05 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.282 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.42 162.37 26.5 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.355 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.53 162.14 19.42 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -158.87 141.47 14.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.195 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -138.38 117.65 12.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.55 139.74 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.988 0.423 . . . . 0.0 111.953 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -143.46 132.98 23.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.673 179.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.44 HG22 HG12 ' A' ' 55' ' ' ILE . 5.4 mm -113.62 111.58 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.212 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.68 133.76 64.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.707 0.289 . . . . 0.0 110.966 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 8' ' ' THR . 4.0 pp -169.37 174.95 5.76 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.582 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.94 160.92 18.98 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.413 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -167.83 -49.36 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.16 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.72 1.91 28.24 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -83.94 -34.78 24.39 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 111.052 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.9 -75.17 0.93 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.868 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.43 112.08 18.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.608 0.242 . . . . 0.0 110.79 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -104.6 30.5 5.36 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.191 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 mt -132.32 124.2 19.11 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.293 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.32 168.57 24.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.877 2.385 . . . . 0.0 112.538 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.42 -50.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.652 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 p -121.63 -68.1 0.92 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.716 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.19 -89.67 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.168 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 13.2 t80 57.47 95.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.993 0.425 . . . . 0.0 111.522 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -165.95 125.61 1.68 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.623 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.84 105.22 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.368 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.0 140.58 24.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.39 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.44 HG12 HG22 ' A' ' 36' ' ' ILE . 3.5 mp -123.86 141.5 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.963 0.411 . . . . 0.0 111.327 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -128.78 154.9 45.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.765 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 19.2 p80 -164.82 137.61 4.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.769 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.47 ' HA ' ' CB ' ' A' ' 84' ' ' PHE . 0.3 OUTLIER 74.56 174.12 0.26 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.607 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.41 159.99 36.82 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.503 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.5 -9.36 10.88 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.112 2.541 . . . . 0.0 113.531 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.4 p -58.48 -13.35 5.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.379 0.133 . . . . 0.0 111.329 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.11 142.26 57.69 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 120.717 0.294 . . . . 0.0 111.092 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.66 81.13 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.212 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -153.62 115.07 2.64 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.355 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.9 -174.16 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.16 2.574 . . . . 0.0 112.517 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.421 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 29.1 m-20 -87.71 150.83 23.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.041 0.448 . . . . 0.0 111.559 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.62 136.67 18.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.9 m -129.41 108.08 10.0 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.069 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -141.92 -54.07 0.44 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.257 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 p -140.08 33.9 1.93 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.135 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.42 164.05 42.27 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.277 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.79 168.43 22.94 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.803 2.335 . . . . 0.0 112.696 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.79 161.54 45.54 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.721 2.281 . . . . 0.0 112.845 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -105.22 154.7 19.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.219 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.04 71.83 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.61 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 mt -130.47 141.01 47.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.414 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.57 138.77 47.56 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.526 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -140.23 167.54 21.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.002 0.43 . . . . 0.0 111.453 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.9 141.53 50.79 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.41 -131.75 2.36 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.604 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -120.2 110.33 16.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.882 0.373 . . . . 0.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.46 -126.54 0.86 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.389 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.41 94.04 1.52 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.574 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.529 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.1 m-85 -156.13 169.92 9.68 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.63 0.252 . . . . 0.0 111.088 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 58.6 Cg_endo -72.01 172.35 14.84 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.767 2.311 . . . . 0.0 113.38 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.442 ' CG ' ' HB2' ' A' ' 103' ' ' HIS . 0.4 OUTLIER -146.46 159.69 43.08 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.517 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -149.55 119.0 6.88 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.678 0.275 . . . . 0.0 111.383 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.444 ' CG2' HD11 ' A' ' 11' ' ' ILE . 5.0 tt -111.11 114.12 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -110.15 135.0 51.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 3.8 p -122.15 138.65 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.966 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -134.69 157.58 46.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.547 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 1.4 pt? -146.02 -163.47 1.74 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.5 mp -97.02 -16.78 20.4 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.35 1.77 22.06 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.24 37.42 8.29 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.01 -50.44 5.1 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.613 0.244 . . . . 0.0 111.39 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.03 16.86 56.92 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.893 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 23.4 tt0 -70.78 96.43 1.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.82 0.31 . . . . 0.0 110.559 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 156.92 45.16 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.849 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.58 139.42 51.51 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.464 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.8 mp -128.03 99.7 24.96 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-O 120.941 0.4 . . . . 0.0 111.38 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -87.89 144.32 6.24 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.032 2.488 . . . . 0.0 112.422 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.442 ' HB2' ' CG ' ' A' ' 86' ' ' LEU . 38.9 m80 -136.92 172.15 13.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 85' ' ' PRO . 9.9 p-10 -121.42 151.24 40.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.405 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 tp -139.06 85.32 2.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 0.0 110.624 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -161.41 38.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.519 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -141.68 134.04 28.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.396 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 pp -58.74 131.09 49.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.508 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 62.25 75.4 0.4 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.027 0.441 . . . . 0.0 110.599 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -105.33 135.67 46.28 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.018 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t -136.87 74.43 1.49 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.165 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -113.64 119.14 36.41 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.383 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -148.21 136.44 21.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.09 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.416 ' CG1' ' CD1' ' A' ' 11' ' ' ILE . 6.3 p -116.94 143.2 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.81 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.34 122.03 20.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.078 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.74 159.22 37.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.49 138.09 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.485 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.25 110.75 26.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.175 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -130.03 120.36 24.59 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.56 55.38 2.54 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.09 -44.27 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.484 2.123 . . . . 0.0 112.86 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.0 tp -106.49 -35.8 6.98 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.106 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttm . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.746 0.308 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 p -108.43 -34.85 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.657 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 58.13 77.04 0.31 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.84 0.353 . . . . 0.0 111.674 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.61 166.23 31.86 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.66 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -134.96 118.91 25.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.755 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.77 106.28 5.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.467 ' CZ ' HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -124.05 167.55 14.04 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.632 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -178.06 133.0 0.15 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.411 HG22 HG22 ' A' ' 90' ' ' VAL . 3.6 tt -106.14 118.22 53.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.059 0.457 . . . . 0.0 110.834 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -116.56 107.05 14.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.38 135.13 50.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -120.14 138.68 53.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.998 -179.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -141.07 113.99 8.42 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.2 mt-30 -127.02 147.71 50.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.677 0.275 . . . . 0.0 111.078 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -138.88 145.08 39.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -143.32 119.3 10.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.827 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 10.2 mt -114.19 141.95 28.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.738 0.304 . . . . 0.0 110.792 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.76 89.56 45.33 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.11 -1.48 11.64 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.745 2.297 . . . . 0.0 113.165 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -15.26 61.45 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.08 131.23 94.44 Favored Pre-proline 0 C--O 1.234 0.267 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.74 125.65 10.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.287 1.991 . . . . 0.0 112.855 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.13 177.55 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.994 2.463 . . . . 0.0 112.383 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 t 64.15 36.41 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.236 0.541 . . . . 0.0 110.109 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -162.67 -52.6 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.714 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -148.41 140.65 24.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.925 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.49 162.4 67.07 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.912 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.69 115.33 2.61 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.767 2.311 . . . . 0.0 112.29 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.6 128.0 45.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.02 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.35 159.4 23.48 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.107 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -116.59 158.51 23.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -157.6 145.49 18.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.334 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 p -146.04 117.56 8.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.652 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 2.3 tp -130.34 134.74 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.46 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.9 pt-20 -136.47 135.08 38.32 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.46 ' CG2' HG13 ' A' ' 55' ' ' ILE . 4.1 mp -110.06 114.83 48.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.716 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.7 t -125.2 135.69 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.277 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.422 HD12 ' HD3' ' A' ' 53' ' ' LYS . 1.4 pp -157.69 154.23 27.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.424 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -99.58 161.89 13.35 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.598 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -174.72 -46.9 0.01 OUTLIER 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.06 -19.59 65.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.363 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -98.69 -36.7 9.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.244 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.9 45.85 1.46 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.875 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt 62.01 100.98 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.08 48.47 1.37 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.198 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.1 mt -128.0 110.92 20.12 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.291 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.77 161.4 10.25 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.153 2.569 . . . . 0.0 113.036 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.64 -54.0 0.82 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.628 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 93' ' ' LEU . 32.0 m -117.06 -63.49 1.44 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.93 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.2 mt -120.82 -78.12 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.795 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.7 t80 57.75 98.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.284 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 9.9 t70 -172.53 107.45 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.898 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.422 ' HD3' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -91.34 128.92 37.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.16 116.28 28.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 121.086 0.47 . . . . 0.0 111.654 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.46 HG13 ' CG2' ' A' ' 36' ' ' ILE . 2.3 mm -106.75 155.67 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -142.24 141.13 32.46 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.408 ' CB ' HD22 ' A' ' 86' ' ' LEU . 14.5 p-80 -150.44 119.55 6.74 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.935 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' HA ' ' CB ' ' A' ' 84' ' ' PHE . 5.7 mp 67.68 162.88 0.19 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.328 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.401 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -81.78 -51.36 0.83 Allowed Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.68 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 59' ' ' HIS . 74.4 Cg_exo -49.98 -26.09 13.66 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.04 2.494 . . . . 0.0 113.872 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.41 9.25 4.07 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.605 0.24 . . . . 0.0 111.145 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -60.72 -31.5 70.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.843 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.7 -34.94 78.18 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.057 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -133.73 75.88 67.15 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 121.018 0.437 . . . . 0.0 111.402 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.26 -176.6 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.112 2.542 . . . . 0.0 112.0 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.62 128.1 55.54 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.886 0.374 . . . . 0.0 111.185 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.87 105.8 3.59 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.482 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.417 ' O ' ' HD2' ' A' ' 53' ' ' LYS . 6.2 m -97.46 116.6 29.97 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.254 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -121.66 -51.23 2.05 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.96 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 p -147.33 35.36 0.89 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.77 157.94 58.37 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.302 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.82 172.48 10.59 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.093 2.528 . . . . 0.0 112.607 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.9 177.67 1.3 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.822 2.348 . . . . 0.0 112.383 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -141.74 163.47 32.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.914 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER -174.96 121.55 0.22 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -140.18 131.14 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.195 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.0 113.64 10.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.816 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -139.51 174.16 10.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.535 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.52 168.9 11.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.115 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.3 -121.67 3.77 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.324 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -118.34 110.94 18.1 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.776 0.322 . . . . 0.0 110.481 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.35 112.45 0.41 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.927 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -165.93 109.19 0.35 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.612 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.423 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 6.7 m-85 -160.85 170.65 8.13 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 120.397 0.141 . . . . 0.0 110.983 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.74 169.81 3.06 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.125 2.55 . . . . 0.0 113.253 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.408 HD22 ' CB ' ' A' ' 57' ' ' HIS . 3.6 mp -143.03 168.28 20.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.219 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -158.78 119.33 3.26 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.716 0.293 . . . . 0.0 111.651 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 1.1 pp -112.68 109.51 28.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 111.151 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.14 111.41 16.94 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.498 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 9' ' ' ILE . 19.2 t -105.29 145.65 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.607 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 11.8 m-85 -131.66 152.81 50.57 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.72 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.467 HD13 ' CZ ' ' A' ' 7' ' ' ARG . 5.4 tp -141.65 -54.46 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.089 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.408 ' O ' ' HB ' ' A' ' 49' ' ' THR . 1.2 mp -143.2 -70.46 0.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.834 0.349 . . . . 0.0 110.596 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.92 -49.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.73 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.47 29.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.563 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.03 -45.63 6.19 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.972 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -158.75 43.18 0.48 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.304 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 3.8 tt0 -100.35 99.34 9.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.539 0.209 . . . . 0.0 110.947 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -142.52 149.06 38.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.736 0.303 . . . . 0.0 111.52 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -134.33 137.3 44.09 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.145 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.4 mt -144.41 121.83 6.56 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.386 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.29 147.07 20.21 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.62 2.214 . . . . 0.0 112.363 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.27 172.58 11.67 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.164 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -131.24 138.8 49.49 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.063 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.0 tp -131.21 83.12 2.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.838 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.94 35.25 0.15 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.308 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -138.85 132.2 30.14 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -58.98 125.24 22.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.512 179.427 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 71.31 70.79 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.19 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 1.2 tp10 -107.33 138.01 44.32 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.481 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p -137.7 73.18 1.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.853 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -109.72 119.35 39.12 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.413 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -152.13 127.62 10.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.788 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -104.04 145.68 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.744 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.85 108.53 9.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.547 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.36 123.75 50.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.77 142.56 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 111.684 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.34 120.74 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.751 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -127.29 121.35 30.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.448 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.7 pt -153.92 65.13 5.07 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.607 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.51 -31.89 40.75 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.54 2.16 . . . . 0.0 112.884 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.45 26.06 10.35 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.224 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.142 179.599 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.465 0.174 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 t -115.91 -61.84 2.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.921 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 67.79 139.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.687 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.07 147.17 26.17 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.997 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.64 119.02 55.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.727 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -135.77 105.82 6.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.7 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.462 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 25.8 mtt-85 -123.23 159.54 28.48 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.033 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 t -173.34 129.31 0.45 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.752 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 tt -108.38 118.26 55.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.925 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.97 110.11 16.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.663 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.3 pt -115.86 137.06 50.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 1.5 mptp? -121.55 137.98 54.5 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.044 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 m -140.65 104.62 4.77 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -121.5 154.19 36.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.938 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.454 ' HB2' ' CD2' ' A' ' 105' ' ' LEU . 3.3 tt0 -154.65 143.2 20.64 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.014 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -135.02 119.36 17.84 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.716 0.293 . . . . 0.0 111.097 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.9 mt -116.04 100.88 11.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.783 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.3 109.23 2.25 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.83 -48.47 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.535 2.157 . . . . 0.0 112.581 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 56.98 32.68 22.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.024 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.5 t -125.35 139.81 34.75 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.599 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.66 167.72 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.838 2.359 . . . . 0.0 112.483 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.59 79.1 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.682 2.255 . . . . 0.0 112.488 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.62 -44.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.359 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -141.72 143.16 33.39 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.006 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.93 -172.43 3.98 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.792 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 65.08 82.77 0.2 Allowed Pre-proline 0 N--CA 1.465 0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.032 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.34 160.82 44.13 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.851 2.367 . . . . 0.0 112.906 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 t -90.79 149.78 3.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.964 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -126.05 152.7 45.45 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.204 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.62 154.43 21.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.187 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -152.81 137.58 17.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.053 0.454 . . . . 0.0 111.559 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.4 t -141.53 117.7 10.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.509 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 9.1 tp -128.55 144.57 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.291 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -158.4 154.83 27.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.973 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.8 tt -148.3 125.46 2.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.965 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.89 123.74 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.198 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.417 HD21 ' HD3' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -137.83 142.51 40.78 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 3.7 mm? -80.47 165.9 21.73 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.833 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.94 -65.94 0.16 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -64.4 -21.3 66.59 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.638 0.256 . . . . 0.0 111.09 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.92 -31.13 22.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.643 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.48 40.39 2.52 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.49 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 mttt 64.14 97.18 0.04 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 110.978 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -69.59 -12.44 61.64 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.662 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.56 134.96 46.93 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-O 120.525 0.203 . . . . 0.0 111.07 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.42 -172.85 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.687 2.258 . . . . 0.0 112.628 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.29 -64.1 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.6 m -116.31 -51.8 2.6 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.397 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.79 -83.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.783 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 t80 54.4 94.82 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.136 0.493 . . . . 0.0 111.13 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -171.82 143.82 1.7 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.271 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.599 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -137.61 134.47 35.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 111.238 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.92 145.82 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.531 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.487 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 2.8 mt -123.99 134.08 67.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.775 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 65' ' ' PRO . 49.6 m-85 -135.04 135.02 40.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.91 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -157.47 130.14 7.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.22 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 84' ' ' PHE . 1.8 mt 73.75 -177.06 0.17 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -55.8 138.37 70.89 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.615 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 59' ' ' HIS . 21.7 Cg_exo -65.82 -6.24 13.71 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.987 2.458 . . . . 0.0 112.857 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -9.12 3.29 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.63 152.06 5.48 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.691 0.281 . . . . 0.0 111.11 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.68 -48.04 40.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.397 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 13.1 p30 -157.82 136.87 8.1 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.04 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.42 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 39.1 Cg_exo -57.92 170.23 2.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.943 2.429 . . . . 0.0 112.788 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.487 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.0 m-20 -101.67 151.43 22.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.471 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -144.93 156.11 43.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 87.5 m -134.71 112.82 11.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.859 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -153.18 -51.03 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.838 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.6 p -144.17 30.18 1.29 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.835 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.49 150.92 62.29 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.206 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.85 166.75 9.76 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.086 2.524 . . . . 0.0 112.466 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.18 -173.22 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.042 2.495 . . . . 0.0 112.693 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.73 161.08 39.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 111.757 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.73 94.77 0.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.661 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.66 111.19 35.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -131.92 124.57 29.72 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.027 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -153.86 168.2 27.15 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.707 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -112.8 149.36 33.15 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.982 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.93 -113.84 1.02 Allowed Glycine 0 C--N 1.334 0.448 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.262 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -126.06 109.97 13.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.574 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.27 76.88 0.16 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.673 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -129.85 106.51 0.73 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.79 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.493 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 7.1 m-85 -158.18 167.75 13.84 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.582 0.229 . . . . 0.0 110.836 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 42.0 Cg_endo -67.55 168.29 18.58 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.929 2.419 . . . . 0.0 113.662 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.437 ' HG ' ' HB2' ' A' ' 103' ' ' HIS . 0.5 OUTLIER -150.41 157.74 43.37 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.492 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -150.4 136.28 18.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.027 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.0 pt -125.92 139.14 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.886 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.2 p -130.02 146.82 51.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.858 0.361 . . . . 0.0 110.995 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 38.9 t -138.06 147.0 26.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.12 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 98' ' ' GLU . 96.6 m-85 -155.54 144.99 21.05 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.9 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.4 tp -134.4 -50.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.539 0.209 . . . . 0.0 111.455 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.67 -62.8 0.05 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.834 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -179.55 42.92 0.0 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.312 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -163.73 0.88 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.938 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.35 -26.26 38.79 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.662 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.85 -33.35 59.99 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.648 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -71.21 84.27 0.75 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.203 0.525 . . . . 0.0 110.669 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -142.4 151.81 42.2 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.34 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -121.47 143.24 49.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.79 120.72 10.3 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -90.86 150.79 4.0 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.241 2.627 . . . . 0.0 112.676 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.437 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . 59.9 m-70 -143.95 166.82 23.88 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.114 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -125.88 129.84 50.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.799 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.454 ' CD2' ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -110.28 102.21 10.89 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.785 0.326 . . . . 0.0 111.335 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.418 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 4.0 t-20 -177.26 45.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.27 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -141.55 128.61 20.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.644 0.259 . . . . 0.0 111.31 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.1 pp -60.03 132.81 55.11 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.407 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 68.98 44.66 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.171 0.51 . . . . 0.0 110.834 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.76 135.41 37.99 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.604 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -146.54 58.81 1.2 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.728 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -107.03 119.21 38.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.13 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 2.5 pt-20 -145.65 142.55 29.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.188 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.51 147.04 17.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.556 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.69 108.45 8.02 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.692 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -113.82 139.25 49.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.681 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.9 p -123.73 121.44 62.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.077 0.465 . . . . 0.0 111.223 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.74 111.24 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.377 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -126.06 148.53 49.31 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.29 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.6 tp -171.56 59.59 0.28 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 121.27 0.557 . . . . 0.0 111.554 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.04 -27.22 10.14 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.582 2.188 . . . . 0.0 112.521 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.1 mt -67.57 -43.22 81.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.003 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.6 m120 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.064 179.882 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.5 m -98.32 30.5 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.677 0.275 . . . . 0.0 111.566 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.24 150.38 21.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.708 0.29 . . . . 0.0 111.186 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.85 151.22 30.16 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.481 HG23 ' HB2' ' A' ' 44' ' ' LYS . 34.0 t -137.64 119.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.032 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -129.71 105.25 7.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.606 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.3 mtt180 -123.84 163.19 21.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.092 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.9 t -158.77 143.69 16.06 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.775 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 tp -115.05 122.88 70.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.822 0.344 . . . . 0.0 110.779 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.411 ' CD ' ' HG2' ' A' ' 115' ' ' GLU . 9.3 mtt180 -134.0 106.39 7.22 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.024 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -113.12 123.44 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -114.58 124.4 51.77 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.41 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.436 ' CG2' HD12 ' A' ' 105' ' ' LEU . 5.4 m -125.0 108.75 12.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -116.22 142.33 46.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.783 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -142.14 142.18 32.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 31' ' ' GLN . 82.9 t60 -133.8 119.23 18.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.67 0.271 . . . . 0.0 111.139 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 mt -118.73 139.23 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.815 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.8 tp -142.07 78.64 17.0 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 120.813 0.34 . . . . 0.0 111.391 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.12 -27.47 8.23 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.801 2.334 . . . . 0.0 112.941 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -65.86 -63.8 1.01 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.319 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -113.6 134.62 21.98 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.71 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -52.66 106.56 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.785 2.323 . . . . 0.0 112.442 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.77 -47.38 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.582 2.188 . . . . 0.0 112.391 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.96 -31.94 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.707 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -141.62 160.87 39.27 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.393 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -54.65 -43.34 72.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.416 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -78.35 150.17 76.57 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.806 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.56 114.05 1.59 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.969 2.446 . . . . 0.0 112.568 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.26 150.13 30.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.208 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.68 163.99 21.59 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 111.314 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -117.08 158.17 24.64 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.844 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.436 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 67.7 p-90 -154.02 140.18 18.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.0 p -142.77 117.52 9.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.003 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.7 tp -127.61 127.2 68.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 111.422 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.551 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 1.7 pt-20 -130.37 135.35 47.95 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.668 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.452 ' CG2' HG12 ' A' ' 55' ' ' ILE . 4.3 mp -115.69 106.36 20.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.047 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -104.83 140.85 21.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.986 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 8' ' ' THR . 1.2 pp -159.26 161.52 36.0 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.187 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -120.82 159.53 25.27 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.42 -45.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.057 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.12 2.45 15.17 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.209 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -83.41 -36.24 24.42 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.65 0.262 . . . . 0.0 110.959 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.55 -70.72 0.23 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.719 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HB2' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -134.01 120.87 20.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.686 0.279 . . . . 0.0 111.32 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.83 30.01 5.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.471 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.3 mt -128.27 131.63 23.89 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.691 -0.232 . . . . 0.0 111.183 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.07 -172.72 1.43 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.828 2.352 . . . . 0.0 112.625 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.01 -49.68 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.422 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 m -110.73 -63.99 1.33 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.593 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.11 -74.41 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.838 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 47.9 t80 56.86 93.24 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.445 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -158.57 116.0 2.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.372 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -110.81 115.06 28.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.385 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 t -112.73 150.1 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 111.66 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.452 HG12 ' CG2' ' A' ' 36' ' ' ILE . 4.9 mp -131.07 133.47 62.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.639 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -127.46 121.34 30.53 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.831 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.458 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -128.67 108.98 10.93 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 6.2 mp 70.39 156.23 0.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.531 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.41 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 1.7 m-70 -74.88 -50.56 4.05 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.43 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 58' ' ' LEU . 82.4 Cg_exo -47.7 -29.35 10.82 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.975 2.45 . . . . 0.0 113.496 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.5 m -73.4 9.06 1.45 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -35.49 69.68 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.702 0.287 . . . . 0.0 110.679 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.98 -31.14 71.5 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.374 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -139.85 68.17 35.82 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.206 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.57 -175.58 1.15 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.779 2.319 . . . . 0.0 111.771 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.433 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 1.6 m120 -119.81 139.87 51.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.158 0.504 . . . . 0.0 111.106 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.36 140.29 23.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.679 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 86.9 m -116.47 113.1 22.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.051 0.453 . . . . 0.0 111.467 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -131.95 -56.22 0.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.621 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.2 33.88 1.09 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.35 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -125.8 159.48 61.07 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.58 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.3 Cg_exo -67.07 175.01 6.08 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.346 2.697 . . . . 0.0 112.434 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 38.4 Cg_endo -65.92 -178.08 0.94 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.8 2.333 . . . . 0.0 112.502 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.82 162.43 30.58 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 111.701 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.67 80.34 0.04 OUTLIER 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.403 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.6 mm -116.6 130.76 70.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.385 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.75 128.77 29.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.579 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 3.3 mt-10 -138.26 167.34 22.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.987 0.422 . . . . 0.0 111.692 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -121.6 128.03 51.51 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.854 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.24 -121.44 1.01 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.559 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -121.21 110.1 15.77 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 110.756 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.8 106.63 0.25 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.508 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.22 101.37 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.834 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -152.94 171.33 6.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.544 0.212 . . . . 0.0 111.186 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.03 176.1 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.288 2.658 . . . . 0.0 113.308 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.78 147.14 29.54 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.07 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -145.54 124.15 12.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.854 0.359 . . . . 0.0 111.116 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.6 mm -122.96 125.74 72.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.958 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.4 p -127.81 144.84 51.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.805 0.336 . . . . 0.0 111.55 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.0 p -134.23 132.81 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 8.3 m-85 -133.44 155.76 48.94 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.562 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 1.4 pt? -144.62 -157.23 0.77 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.397 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.02 38.09 1.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.124 0.487 . . . . 0.0 110.708 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -170.54 -167.12 0.56 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.421 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 42.05 3.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.722 0.296 . . . . 0.0 111.049 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.49 -28.39 8.2 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -114.17 -10.66 13.33 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.187 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.16 107.42 0.36 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.971 0.385 . . . . 0.0 110.748 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.34 146.51 35.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.812 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 123.26 22.04 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.208 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.9 tt -129.79 124.13 21.49 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-O 120.927 0.394 . . . . 0.0 111.894 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.07 160.52 8.65 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.008 2.472 . . . . 0.0 112.312 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -148.61 172.41 14.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.966 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.63 143.75 50.96 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.696 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.436 HD12 ' CG2' ' A' ' 13' ' ' THR . 7.4 tp -130.65 88.47 2.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.011 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -172.04 42.15 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -141.51 130.03 22.61 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.163 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 pp -58.16 131.3 50.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.526 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.94 53.74 1.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.905 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 15' ' ' GLN . 1.2 tp10 -85.07 135.23 34.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.28 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.9 t -143.74 62.52 1.36 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.649 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -105.31 119.31 38.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.308 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 1.2 pt-20 -153.41 145.64 23.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.127 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.51 151.46 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.727 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.411 ' HG2' ' CD ' ' A' ' 10' ' ' ARG . 1.3 mt-10 -137.52 109.08 6.97 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.672 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 155.63 27.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.53 143.88 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.352 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.27 111.02 14.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -121.5 121.11 36.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.638 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.41 75.09 13.78 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.92 0.37 8.4 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.679 2.253 . . . . 0.0 113.55 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.4 tp 75.9 -62.28 0.44 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.428 0.291 . . . . 0.0 111.06 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.991 179.794 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.671 0.272 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 t -92.05 132.1 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.063 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.65 115.67 1.67 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.294 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.91 121.05 18.93 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.639 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 t -134.0 119.39 31.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.218 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.0 105.86 12.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.285 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.32 162.39 16.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.249 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 4.2 t -175.0 149.28 1.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.374 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tt -128.29 133.89 65.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.482 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 111.56 11.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.297 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.0 pt -114.81 130.15 69.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.37 136.89 52.83 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 m -133.66 111.51 10.67 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.77 117.27 24.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.942 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 109' ' ' GLN . 3.0 tp60 -109.97 147.12 34.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.952 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -155.03 119.93 4.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.077 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.537 HG12 ' HA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -112.66 129.96 67.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.02 0.438 . . . . 0.0 111.334 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.55 94.36 3.42 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.52 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.29 -55.9 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.812 2.341 . . . . 0.0 112.722 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 53.45 34.59 18.57 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.906 0.384 . . . . 0.0 111.173 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.86 139.69 34.86 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.62 167.2 2.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.78 2.32 . . . . 0.0 112.639 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.0 92.77 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.793 2.329 . . . . 0.0 112.322 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.75 -66.46 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.964 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -147.47 159.02 44.19 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.59 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -69.51 85.06 0.43 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.523 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.2 74.7 7.76 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.697 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.76 120.84 6.91 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.804 2.336 . . . . 0.0 112.572 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.61 94.38 2.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.787 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.537 ' HA ' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -99.69 150.51 22.22 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.772 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -105.11 163.1 12.82 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -156.57 146.96 21.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.998 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.5 p -139.9 117.45 11.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.246 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.2 mm -119.54 121.5 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.1 pm0 -131.18 116.64 17.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.666 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.44 ' CD1' HG12 ' A' ' 55' ' ' ILE . 7.9 tt -117.66 123.71 72.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.08 143.36 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.872 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 8' ' ' THR . 3.2 pp -144.32 163.02 34.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.635 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tp -106.16 157.49 17.52 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.2 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.46 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -171.45 -44.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.067 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.68 1.42 19.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.367 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -34.51 27.52 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.641 0.257 . . . . 0.0 110.751 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.8 -71.59 0.34 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.544 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -144.18 107.09 4.47 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.869 0.366 . . . . 0.0 110.799 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 40' ' ' ASP . 2.3 tt0 -96.26 45.55 1.07 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.83 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.5 118.13 21.44 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.799 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.84 161.4 6.28 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.905 2.403 . . . . 0.0 112.648 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.44 -71.43 0.62 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.568 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 p -113.06 -63.36 1.45 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.021 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.61 -80.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.07 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 31.6 t80 54.3 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.283 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.4 t0 -161.08 124.52 3.31 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -117.39 136.77 52.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.445 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.6 t -128.96 135.83 61.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.02 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.497 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 4.9 mt -112.89 140.54 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.456 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.71 129.05 18.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.478 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 6.4 p80 -140.21 123.36 16.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.977 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 75.2 mt 68.84 -175.79 0.2 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.86 164.63 59.77 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 120.693 0.282 . . . . 0.0 111.188 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.5 -12.66 17.93 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.006 2.47 . . . . 0.0 113.123 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.94 -13.66 2.87 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.391 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -68.05 167.86 13.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.651 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.36 -48.7 65.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.289 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -175.58 149.0 1.05 Allowed Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.115 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.36 163.43 36.47 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.621 2.214 . . . . 0.0 112.021 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.497 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.9 m-80 -108.02 157.64 18.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.095 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -150.77 156.22 40.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.783 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.435 ' O ' ' HD3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -134.54 126.16 28.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.91 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -165.59 -45.11 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 t -146.04 30.49 1.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -134.2 156.83 78.71 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.203 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.441 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 40.1 Cg_endo -66.76 175.61 5.18 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.014 2.476 . . . . 0.0 112.188 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 10.9 Cg_endo -54.04 168.14 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.209 2.606 . . . . 0.0 112.8 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -128.7 88.66 2.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.919 0.39 . . . . 0.0 111.965 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 3.3 ttp85 -107.69 90.8 3.41 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.222 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.07 137.28 57.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.532 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.28 142.16 50.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.827 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -159.92 168.27 26.11 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.687 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -107.06 175.02 5.64 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.881 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.76 -141.98 12.8 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.631 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -126.57 110.1 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.122 0.487 . . . . 0.0 110.934 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.4 -129.18 6.35 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.361 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.17 47.98 3.43 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.701 -0.559 . . . . 0.0 111.701 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.455 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 64.1 m-85 -142.13 159.7 57.8 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.82 0.343 . . . . 0.0 111.019 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 39.2 Cg_endo -67.32 162.63 37.82 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.941 2.427 . . . . 0.0 113.622 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -148.88 134.24 18.47 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.795 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -143.96 153.02 41.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 111.415 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.9 mp -136.99 120.5 22.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.877 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 p -105.27 145.23 30.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 6.1 p -133.29 143.28 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -145.3 155.18 43.05 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.572 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -136.22 -45.53 0.63 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.629 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.37 -75.66 0.26 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.59 0.233 . . . . 0.0 111.22 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -140.34 -55.83 0.53 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.117 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.43 61.54 0.39 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 111.261 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.78 -39.65 4.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.794 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.5 ' HA3' ' CG2' ' A' ' 118' ' ' ILE . . . -157.99 32.78 0.51 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.629 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.2 pp20? -88.93 116.76 27.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.977 0.418 . . . . 0.0 110.854 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 156.39 44.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.742 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -120.82 129.65 53.65 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.881 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.1 mt -111.37 99.84 45.4 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 120.692 0.282 . . . . 0.0 111.596 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -88.85 140.22 4.06 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.129 2.553 . . . . 0.0 112.248 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.71 172.33 17.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.314 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -114.51 150.85 34.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.647 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.41 ' HB2' HD21 ' A' ' 86' ' ' LEU . 13.2 tp -125.38 82.28 2.05 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.886 0.374 . . . . 0.0 111.102 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.7 -175.36 4.38 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.744 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.443 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 2.8 p90 -111.46 166.3 11.25 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.769 0.318 . . . . 0.0 111.856 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.49 ' HA ' HG21 ' A' ' 17' ' ' ILE . 0.5 OUTLIER 81.12 65.18 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.331 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 15' ' ' GLN . 19.3 mt-30 66.38 133.19 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.123 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -157.66 134.68 10.1 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.262 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.39 71.89 1.49 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.582 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -115.99 119.17 35.05 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.704 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -153.49 139.37 18.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.29 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.0 t -118.81 152.46 21.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.63 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.38 108.89 8.97 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -113.26 151.84 30.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.9 p -127.9 151.52 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.845 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.5 ' CG2' ' HA3' ' A' ' 97' ' ' GLY . 4.2 mp -141.32 126.5 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.079 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -127.11 117.18 21.9 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.761 0.315 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.94 61.84 60.45 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.337 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -87.96 26.96 0.56 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.704 2.27 . . . . 0.0 113.03 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.91 76.64 0.32 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.937 0.399 . . . . 0.0 111.095 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.169 179.759 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.235 0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 43' ' ' GLY . 25.0 t -129.57 119.26 47.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.153 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.44 ' O ' HD12 ' A' ' 39' ' ' LEU . 5.0 tmtp? -138.29 107.46 6.06 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.507 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.402 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 6.4 ptp180 -130.65 131.87 45.12 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.75 0.31 . . . . 0.0 110.833 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.3 t -126.37 139.86 52.95 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 9' ' ' ILE . 1.5 tt -106.47 121.79 59.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.584 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.413 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 26.2 mtt180 -124.29 118.31 26.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pt -120.28 127.16 75.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.415 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -112.18 130.9 55.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.954 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.593 HG21 HD11 ' A' ' 86' ' ' LEU . 83.7 m -130.71 129.41 42.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.175 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 12.7 mp0 -140.48 155.12 46.77 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.092 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.74 149.1 29.36 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.384 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 31' ' ' GLN . 11.7 t-160 -139.92 119.62 13.29 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.199 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 24.9 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.721 0.296 . . . . 0.0 110.927 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.584 HG22 ' HE1' ' A' ' 81' ' ' TRP . 21.8 t . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -129.05 164.97 22.1 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.744 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 16' ' ' HIS . 1.2 tt0 -115.2 159.29 21.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.709 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -159.73 142.33 13.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.37 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.04 133.84 25.33 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 34' ' ' ILE . 3.9 tp -146.04 122.89 3.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.271 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.415 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -132.35 139.87 48.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.056 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.715 HG21 ' CD1' ' A' ' 55' ' ' ILE . 2.9 mt -125.87 112.13 29.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.798 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 10' ' ' ARG . 27.7 m -122.7 157.39 27.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.574 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.018 HD21 HG21 ' A' ' 68' ' ' THR . 0.2 OUTLIER -171.62 172.45 4.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.558 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 6' ' ' LYS . 52.6 mt -98.76 165.89 11.57 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.036 0.446 . . . . 0.0 111.235 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -166.04 -48.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.547 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -78.3 -10.36 59.64 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.091 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.61 -37.06 8.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.741 ' O ' HG13 ' A' ' 5' ' ' VAL . . . -106.05 49.76 0.86 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.679 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? 62.34 117.81 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.101 0.477 . . . . 0.0 111.447 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.58 32.9 0.93 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.394 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.2 mt -127.12 131.95 24.09 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.23 158.62 48.58 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.782 2.321 . . . . 0.0 112.622 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HB3' HD12 ' A' ' 93' ' ' LEU . . . -120.95 -74.35 0.62 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.331 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.3 m -108.13 -60.25 1.75 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.737 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.4 mt -119.63 -83.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.786 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.1 t80 55.69 96.83 0.02 OUTLIER 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.129 0.49 . . . . 0.0 111.383 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.48 119.76 0.79 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.286 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.697 ' CE ' HD13 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -109.9 120.88 43.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.502 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.801 HG13 ' HD2' ' A' ' 67' ' ' ARG . 5.6 t -120.39 115.67 47.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.715 ' CD1' HG21 ' A' ' 36' ' ' ILE . 2.3 mp -94.24 147.93 5.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.359 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 87' ' ' ASP . 92.4 t80 -139.03 132.68 30.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.596 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -152.41 142.32 22.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.236 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.0 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 CA--C 1.531 0.345 0 CA-C-O 120.747 0.228 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -88.2 143.72 26.88 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.945 0.403 . . . . 0.0 111.287 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.801 ' HD2' HG13 ' A' ' 54' ' ' VAL . 9.2 mmm180 -133.02 146.61 51.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.788 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 1.018 HG21 HD21 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -137.59 116.8 12.62 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.861 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.681 ' CE2' HG22 ' A' ' 70' ' ' THR . 1.9 p90 -162.57 -45.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.893 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.681 HG22 ' CE2' ' A' ' 69' ' ' PHE . 15.1 t -141.07 27.76 1.94 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.893 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.77 157.77 70.33 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.201 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.87 170.51 17.72 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.912 2.408 . . . . 0.0 112.125 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.6 158.23 51.13 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.68 2.253 . . . . 0.0 112.401 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.553 ' HD2' HD11 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -113.83 158.12 21.44 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.425 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -171.53 103.87 0.2 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.746 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.553 HD11 ' HD2' ' A' ' 74' ' ' PHE . 3.8 mp -125.99 123.6 64.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.052 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.34 114.42 10.11 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.92 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.08 178.95 9.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.213 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.426 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.0 mt-30 -105.39 138.99 40.7 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.73 -173.17 42.96 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.887 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.584 ' HE1' HG22 ' A' ' 29' ' ' VAL . 11.7 m0 -112.1 109.75 19.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.607 0.241 . . . . 0.0 110.646 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.6 -117.22 0.6 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.319 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.41 91.79 1.82 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.655 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.593 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 36.4 m-85 -150.93 166.82 14.23 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 120.701 0.286 . . . . 0.0 111.267 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.34 159.52 39.4 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.151 2.568 . . . . 0.0 112.927 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.593 HD11 HG21 ' A' ' 13' ' ' THR . 0.8 OUTLIER -152.7 121.8 6.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.811 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 56' ' ' TYR . 9.2 t70 -128.05 146.33 50.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.573 HD13 ' N ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -129.38 128.47 66.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 111.145 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.573 ' N ' HD13 ' A' ' 88' ' ' ILE . 90.0 p -111.32 131.18 55.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.601 HG23 ' HG2' ' A' ' 53' ' ' LYS . 2.9 p -116.02 142.75 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.706 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -139.09 150.4 45.67 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.088 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.792 HD12 ' HB3' ' A' ' 96' ' ' ALA . 1.1 tm? -137.18 -49.02 0.61 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.26 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.632 ' HB2' HD13 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -151.55 -64.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.322 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.55 -54.19 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.079 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.97 44.24 2.48 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.989 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.792 ' HB3' HD12 ' A' ' 92' ' ' LEU . . . -105.08 -50.76 3.17 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.288 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.13 26.07 0.31 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.006 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 20.2 mt-10 -70.32 100.42 1.72 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.663 0.268 . . . . 0.0 110.772 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.465 ' H ' HG12 ' A' ' 90' ' ' VAL . 1.3 tpt180 -142.7 156.45 45.03 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.525 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 134.69 41.74 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.328 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.525 HG12 HG21 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -126.46 119.69 23.21 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 121.009 0.433 . . . . 0.0 111.909 -179.415 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.67 151.44 10.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.275 2.65 . . . . 0.0 112.548 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.472 ' CD2' ' HB3' ' A' ' 112' ' ' TYR . 7.3 m80 -147.77 167.0 25.83 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.949 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -129.62 149.92 51.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.626 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 tp -128.68 93.88 3.73 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 111.224 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -174.85 45.39 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.236 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -141.44 127.33 19.32 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -56.58 119.84 6.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.405 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 3.2 mm-40 69.23 66.69 0.27 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.795 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 1.2 tp10 -92.52 137.04 32.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.576 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.5 t -143.35 72.56 1.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.439 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.472 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 6.7 m-85 -121.08 119.27 31.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.335 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -144.82 147.2 32.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.366 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.525 HG21 HG12 ' A' ' 101' ' ' ILE . 24.0 t -122.56 148.84 26.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.913 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.08 109.02 8.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.451 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 137.51 51.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.153 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.72 150.42 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.73 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.4 mt -137.95 126.38 31.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -130.31 130.15 44.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.34 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -152.89 65.2 5.62 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--N 1.346 0.43 0 C-N-CA 122.533 2.155 . . . . 0.0 112.774 179.653 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.72 0.295 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -130.57 119.12 45.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.19 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' HD13 ' A' ' 39' ' ' LEU . 18.8 mttt -134.88 115.95 14.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.169 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.443 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 39.3 mtt180 -137.39 165.96 24.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.08 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 t -178.09 131.13 0.14 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.855 HD12 HD12 ' A' ' 38' ' ' LEU . 14.6 tt -104.23 118.1 50.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 121.125 0.488 . . . . 0.0 110.627 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -115.03 107.4 15.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.657 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.9 pt -114.76 131.89 65.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -124.1 135.46 53.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.113 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.736 HG22 HD13 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -135.54 105.75 6.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.825 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -119.34 147.58 44.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.188 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.594 ' HG2' ' HA ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -143.56 147.04 33.83 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.083 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -156.22 120.37 4.47 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.68 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.466 HG12 ' HB3' ' A' ' 30' ' ' ARG . 25.0 mt . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 120.697 0.285 . . . . 0.0 111.027 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.463 0.205 0 CA-C-O 120.584 0.23 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.466 ' HB3' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -139.33 158.28 44.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.041 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 160.92 14.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.422 ' HB3' ' NE2' ' A' ' 15' ' ' GLN . 32.6 p-90 -158.4 148.16 19.66 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.034 0.445 . . . . 0.0 111.762 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -143.48 124.42 14.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.56 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 12' ' ' LYS . 9.3 tp -130.33 141.47 46.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 111.756 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.48 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.9 OUTLIER -149.44 143.78 25.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.778 HG21 HG12 ' A' ' 55' ' ' ILE . 4.2 mp -136.43 106.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.538 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 73' ' ' PRO . 21.7 t -113.71 135.48 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.73 0.3 . . . . 0.0 111.281 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 9' ' ' ILE . 1.4 tt -155.63 135.37 12.67 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.713 HD22 ' HB2' ' A' ' 42' ' ' GLU . 11.3 mt -70.76 164.39 25.26 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.268 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -161.23 -52.8 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.892 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.35 -13.61 61.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.584 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.713 ' HB2' HD22 ' A' ' 39' ' ' LEU . 2.4 tt0 -103.13 -34.7 8.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.387 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.82 40.36 2.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.816 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 65.37 91.16 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.66 52.16 1.84 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.25 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.29 112.59 11.09 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.91 159.4 53.03 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.635 2.223 . . . . 0.0 112.449 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.723 ' HB3' HD21 ' A' ' 93' ' ' LEU . . . -146.91 -62.5 0.29 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.688 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.567 HG22 HG13 ' A' ' 50' ' ' ILE . 86.2 m -106.74 -68.49 0.88 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 49' ' ' THR . 46.1 mt -113.8 -80.07 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.948 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 52.5 t80 55.39 92.76 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.874 0.368 . . . . 0.0 111.549 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 3.8 t70 -169.26 116.92 0.62 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.23 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.701 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -114.9 120.22 39.21 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.552 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.467 HG22 ' OG ' ' A' ' 89' ' ' SER . 34.6 m -116.87 159.34 16.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.012 0.434 . . . . 0.0 111.524 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.778 HG12 HG21 ' A' ' 36' ' ' ILE . 4.2 mp -137.18 130.43 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.406 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -126.47 143.06 51.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.893 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -167.27 126.0 1.34 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 tp . . . . . 0 N--CA 1.465 0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 CA--C 1.53 0.292 0 CA-C-O 120.71 0.212 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 5.1 m120 -106.73 136.99 45.59 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.166 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.61 151.22 41.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.173 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 87.5 m -130.45 102.61 6.24 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -130.83 -48.53 1.04 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.406 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 t -140.69 -36.75 0.46 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.791 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.05 159.13 1.53 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.3 169.65 21.1 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.094 2.53 . . . . 0.0 112.851 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HB3' HG13 ' A' ' 37' ' ' VAL . 39.9 Cg_exo -57.38 152.04 49.2 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.944 2.429 . . . . 0.0 113.085 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -100.42 141.39 33.33 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.977 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.29 89.34 0.54 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.462 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.1 143.09 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.733 0.302 . . . . 0.0 111.658 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.03 143.43 46.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.72 -177.27 6.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.205 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -120.11 136.71 54.5 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -175.29 -170.0 37.73 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.92 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -127.29 110.41 12.81 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.853 0.358 . . . . 0.0 110.976 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.56 128.17 1.2 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.63 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.67 117.39 2.48 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.313 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.571 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 12.1 m-85 -157.32 166.22 17.09 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 120.579 0.228 . . . . 0.0 110.905 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.6 Cg_endo -69.49 168.33 21.5 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.029 2.486 . . . . 0.0 113.293 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.648 HD22 ' HB2' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -151.73 118.66 5.82 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.473 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.26 154.37 38.92 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.363 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.748 ' CG2' HG23 ' A' ' 55' ' ' ILE . 2.3 pt -140.91 151.46 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.47 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.467 ' OG ' HG22 ' A' ' 54' ' ' VAL . 79.8 p -137.06 147.66 46.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.043 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.701 HG13 ' HG2' ' A' ' 53' ' ' LYS . 21.6 t -126.97 139.58 51.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.301 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 30.0 m-85 -144.48 150.94 38.43 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.672 HD21 HG21 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -142.13 -47.1 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.528 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -153.0 -71.5 0.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.588 0.232 . . . . 0.0 111.247 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -136.03 -68.6 0.5 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.041 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 35.99 1.32 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.107 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.644 ' HB1' HG12 ' A' ' 120' ' ' ILE . . . -77.74 -38.18 47.61 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.43 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.525 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . -168.27 37.38 0.21 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.213 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 6.9 tt0 -80.15 103.8 10.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -142.18 151.88 42.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.947 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.427 ' HG2' ' CB ' ' A' ' 89' ' ' SER . 8.2 mtpt -131.93 149.79 52.34 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.102 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.584 HG21 HG11 ' A' ' 114' ' ' VAL . 1.4 tp -148.71 123.9 5.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -87.56 155.13 7.73 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.217 2.611 . . . . 0.0 112.451 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.13 169.15 23.67 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.417 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.415 ' C ' HD21 ' A' ' 86' ' ' LEU . 6.5 m-20 -126.77 140.67 52.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.13 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.736 HD13 HG22 ' A' ' 13' ' ' THR . 58.1 tp -121.9 93.32 3.96 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.996 0.426 . . . . 0.0 111.122 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.99 -168.7 1.44 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.305 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.594 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -116.07 164.01 15.09 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.08 0.466 . . . . 0.0 112.091 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 84.67 69.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.523 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 63.65 103.58 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.958 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -126.82 134.2 50.61 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.14 67.4 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.592 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -119.37 119.43 33.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.627 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 1.3 pt-20 -151.47 149.56 29.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.383 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 101' ' ' ILE . 4.5 t -122.41 149.94 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.623 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -137.75 108.65 6.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.403 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -113.8 141.97 46.65 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.16 148.89 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.983 0.421 . . . . 0.0 111.927 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.672 HG21 HD21 ' A' ' 92' ' ' LEU . 4.3 mp -134.65 111.29 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.403 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.427 ' CG ' ' HD3' ' A' ' 121' ' ' PRO . 43.4 tt0 -125.3 114.67 19.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.605 0.24 . . . . 0.0 111.539 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.668 ' CD1' HG22 ' A' ' 118' ' ' ILE . 4.1 mp -139.91 56.21 7.65 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 111.314 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.427 ' HD3' ' CG ' ' A' ' 119' ' ' GLN . 83.4 Cg_endo . . . . . 0 C--N 1.346 0.406 0 C-N-CA 122.67 2.247 . . . . 0.0 112.454 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.662 0.268 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 43' ' ' GLY . 21.5 t -140.04 119.23 12.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.181 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.34 106.81 6.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.383 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -127.61 163.11 24.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.363 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.485 HG22 HD23 ' A' ' 39' ' ' LEU . 5.2 t -170.39 129.17 0.86 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.541 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.5 tt -109.84 118.37 56.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.988 0.423 . . . . 0.0 110.882 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.684 ' O ' HG22 ' A' ' 37' ' ' VAL . 17.8 mtt85 -123.92 117.7 25.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.705 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.547 ' CD1' HD13 ' A' ' 88' ' ' ILE . 19.8 pt -113.05 136.65 48.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.198 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 1.8 mptp? -108.38 134.94 50.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.6 m -128.02 128.27 44.69 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.889 0.376 . . . . 0.0 111.551 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -145.86 127.78 15.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.65 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -140.49 146.15 37.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.755 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -143.49 119.39 10.6 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.509 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.753 HG23 ' HG2' ' A' ' 30' ' ' ARG . 39.6 mt . . . . . 0 CA--C 1.531 0.217 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.102 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.796 HG13 ' HA2' ' A' ' 80' ' ' GLY . 21.7 t . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.717 0.294 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.753 ' HG2' HG23 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -106.93 165.08 11.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.886 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.77 156.55 34.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.381 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -157.65 141.29 15.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.427 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.7 t -147.2 117.74 7.49 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.718 HD11 HD13 ' A' ' 105' ' ' LEU . 39.6 mt -135.68 136.36 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.853 0.359 . . . . 0.0 111.635 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.98 155.28 44.52 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.579 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.627 HG12 HG21 ' A' ' 55' ' ' ILE . 4.0 mp -131.38 109.0 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.26 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 10' ' ' ARG . 34.2 m -111.61 146.26 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.376 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD22 ' CG2' ' A' ' 68' ' ' THR . 1.2 pp -163.7 170.15 17.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.313 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.581 HD12 ' HG3' ' A' ' 42' ' ' GLU . 4.0 mm? -108.42 165.29 11.62 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -168.23 -47.18 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.778 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -3.86 45.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.771 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HG3' HD12 ' A' ' 39' ' ' LEU . 3.9 mm-40 -104.27 -35.38 8.01 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.514 0.197 . . . . 0.0 111.138 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.543 ' O ' HG13 ' A' ' 5' ' ' VAL . . . -113.34 45.92 1.25 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.461 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt 66.7 123.25 0.02 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.046 0.45 . . . . 0.0 111.525 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.66 29.06 2.12 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.429 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.9 mt -129.63 134.5 26.28 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.016 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.63 -174.23 1.94 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.672 2.248 . . . . 0.0 112.473 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.678 ' HB3' ' CD1' ' A' ' 93' ' ' LEU . . . -144.32 -51.89 0.31 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.233 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 p -126.0 -52.36 1.54 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.562 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.47 -89.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.093 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 40.3 t80 57.09 97.74 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.242 0.544 . . . . 0.0 110.861 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.65 109.96 1.27 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.53 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.82 ' HG2' HG13 ' A' ' 90' ' ' VAL . 1.4 mttm -112.55 137.05 51.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.354 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.503 ' C ' HD13 ' A' ' 55' ' ' ILE . 12.5 p -139.36 149.81 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.015 0.436 . . . . 0.0 111.652 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.878 HG23 HG22 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -126.72 140.66 48.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.42 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.86 130.57 38.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.704 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.435 ' O ' HD12 ' A' ' 58' ' ' LEU . 3.8 p80 -132.89 113.94 13.46 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.238 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 57' ' ' HIS . 1.3 mp . . . . . 0 N--CA 1.465 0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--O 1.233 0.262 0 CA-C-O 120.687 0.203 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.475 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 1.6 m-80 -98.69 133.78 42.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HG3' HG23 ' A' ' 54' ' ' VAL . 2.6 mtt180 -129.19 153.84 47.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.05 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 35.1 m -132.29 99.16 4.6 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.017 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -124.77 -49.17 1.76 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.64 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.4 t -174.49 50.81 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.155 0.502 . . . . 0.0 110.397 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.45 162.0 57.25 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.152 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.21 162.48 14.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.942 2.428 . . . . 0.0 112.625 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.39 168.68 3.65 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.11 2.54 . . . . 0.0 112.851 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.95 165.8 13.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.49 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.37 94.11 0.22 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.597 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.29 115.37 48.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -137.77 126.51 23.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.915 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -144.87 -179.13 6.4 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.426 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -130.28 177.34 7.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.176 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.796 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 96.09 -162.1 22.76 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.123 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -67.32 128.83 37.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.4 126.88 0.86 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.669 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.77 110.82 0.29 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.75 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.404 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 12.4 m-85 -155.4 166.26 16.59 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 120.662 0.268 . . . . 0.0 111.272 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.416 ' C ' HD12 ' A' ' 86' ' ' LEU . 31.6 Cg_exo -60.34 177.32 0.6 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.157 2.572 . . . . 0.0 113.229 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.653 HD11 ' HB2' ' A' ' 105' ' ' LEU . 5.3 mp -142.84 167.01 23.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.993 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -155.15 122.9 5.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.298 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.878 HG22 HG23 ' A' ' 55' ' ' ILE . 11.8 pt -129.84 123.24 56.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.686 0.279 . . . . 0.0 111.144 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -119.85 142.43 48.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.78 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.82 HG13 ' HG2' ' A' ' 53' ' ' LYS . 4.2 t -126.71 137.41 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.806 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.476 ' CD2' ' CG ' ' A' ' 98' ' ' GLU . 48.0 m-85 -145.47 145.78 31.23 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.736 HD22 ' CG2' ' A' ' 118' ' ' ILE . 3.5 tp -138.49 -68.44 0.45 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.678 ' CD1' ' HB3' ' A' ' 48' ' ' ALA . 6.4 tp -136.64 -66.89 0.52 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.357 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' HB3' ' CE ' ' A' ' 95' ' ' LYS . 2.6 mt-10 -166.07 -54.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.436 ' CE ' ' HB3' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -115.75 45.96 1.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.165 0.507 . . . . 0.0 110.676 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -116.59 -49.53 2.65 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.217 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.4 -81.82 0.03 OUTLIER Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.396 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.6 OUTLIER 47.19 59.91 3.76 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 111.554 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.08 136.95 30.66 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.166 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 2.9 pttt -117.85 149.98 39.94 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.59 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 tt -149.45 123.5 4.63 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.961 0.41 . . . . 0.0 111.562 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.3 158.85 13.01 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.707 2.271 . . . . 0.0 112.138 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.31 172.49 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -125.59 146.52 49.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.569 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.718 HD13 HD11 ' A' ' 34' ' ' ILE . 5.5 tp -139.13 74.05 1.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -164.61 46.65 0.1 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.13 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -140.25 132.58 28.34 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.339 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 3.3 pp -61.2 131.7 51.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.07 61.02 0.77 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.819 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.13 131.7 37.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.69 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.5 t -137.14 69.96 1.4 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.751 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.36 153.35 20.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.012 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 12' ' ' LYS . 3.3 tt0 -164.66 136.61 4.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.252 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.62 143.65 33.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -139.34 108.51 6.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.719 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.408 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 1.6 m-70 -113.05 119.01 36.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.477 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.45 147.67 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.631 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.736 ' CG2' HD22 ' A' ' 92' ' ' LEU . 20.0 mt -142.12 110.85 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.525 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -129.88 125.89 36.67 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.536 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.412 HG12 ' CD2' ' A' ' 92' ' ' LEU . 0.8 OUTLIER -152.78 54.61 1.26 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.669 179.258 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 C--N 1.349 0.571 0 C-N-CA 122.446 2.097 . . . . 0.0 112.506 179.674 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.566 0.222 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.666 HG22 ' HG3' ' A' ' 44' ' ' LYS . 19.5 t -126.94 119.14 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 111.338 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.25 104.91 7.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.268 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.601 ' HB3' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -118.36 169.83 9.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.409 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -165.89 123.79 1.5 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.713 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 36' ' ' ILE . 8.8 tt -108.86 124.55 65.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.924 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 0.2 OUTLIER -120.11 120.33 35.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.023 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.783 HD13 HG12 ' A' ' 88' ' ' ILE . 7.8 pt -123.4 132.71 70.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.071 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 4.1 mtmt -120.41 146.17 46.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.22 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.449 HG21 HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -136.82 116.85 13.31 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.687 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 3.8 tt0 -123.74 148.83 46.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.987 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -154.87 144.1 21.12 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.979 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -147.88 119.59 8.05 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.343 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.422 HG23 ' HG2' ' A' ' 30' ' ' ARG . 45.0 mt . . . . . 0 C--N 1.332 -0.165 0 CA-C-O 120.77 0.319 . . . . 0.0 110.633 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.765 0.317 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.422 ' HG2' HG23 ' A' ' 17' ' ' ILE . 3.7 mtt180 -138.58 164.23 30.0 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.597 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.39 151.17 22.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.55 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -155.74 132.4 10.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.419 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 14' ' ' GLN . 27.7 t -143.88 125.91 15.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.539 HG21 ' CG ' ' A' ' 57' ' ' HIS . 1.9 tp -135.79 129.7 48.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.5 OUTLIER -135.78 157.06 47.79 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 9' ' ' ILE . 12.5 tt -154.54 130.44 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.736 HG12 ' CB ' ' A' ' 73' ' ' PRO . 25.4 m -134.97 160.73 40.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.657 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.976 HD21 HG21 ' A' ' 68' ' ' THR . 0.2 OUTLIER -159.32 175.1 13.78 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.934 0.397 . . . . 0.0 111.531 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.56 HD22 ' HB2' ' A' ' 42' ' ' GLU . 3.7 mt -106.79 166.13 10.81 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.101 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.85 -56.29 0.06 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.209 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -54.98 -40.33 69.93 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.233 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.56 ' HB2' HD22 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -89.5 -29.44 18.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.1 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.428 ' C ' HG13 ' A' ' 5' ' ' VAL . . . -110.31 59.05 0.37 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.861 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.666 ' HG3' HG22 ' A' ' 5' ' ' VAL . 7.4 mttp 60.21 97.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.912 0.387 . . . . 0.0 111.618 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -24.66 62.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.507 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 1.9 mt -100.91 123.72 44.4 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-O 120.577 0.227 . . . . 0.0 110.837 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 46' ' ' ILE . 42.7 Cg_exo -56.93 169.04 2.08 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.874 2.382 . . . . 0.0 112.506 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.662 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . . . -139.65 -51.48 0.51 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.621 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.461 ' O ' HD13 ' A' ' 50' ' ' ILE . 7.0 m -110.49 -65.62 1.15 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.783 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 49' ' ' THR . 33.5 mm -138.05 -80.68 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 39.4 t80 63.08 100.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.025 0.44 . . . . 0.0 110.885 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 8.7 t70 -160.83 110.69 1.71 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.565 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.802 ' HD3' HD22 ' A' ' 38' ' ' LEU . 8.0 mttp -104.89 107.35 18.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.542 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.44 141.78 17.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.608 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 36' ' ' ILE . 1.7 mp -121.24 148.69 24.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.196 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -143.99 128.4 17.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.298 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.539 ' CG ' HG21 ' A' ' 34' ' ' ILE . 6.9 p80 -144.18 120.48 10.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.539 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 57' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.764 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 CA--C 1.533 0.449 0 CA-C-O 120.631 0.18 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 17.7 m120 -113.46 144.37 42.93 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.235 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.66 150.79 36.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.976 HG21 HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -133.06 115.87 15.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.844 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CE2' HG22 ' A' ' 70' ' ' THR . 3.2 p90 -156.75 -47.62 0.07 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.583 HG22 ' CE2' ' A' ' 69' ' ' PHE . 14.2 t -129.4 29.08 5.14 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.006 0.431 . . . . 0.0 110.766 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -141.41 159.08 62.09 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.404 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 42.8 Cg_endo -67.45 173.81 8.23 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.908 2.405 . . . . 0.0 112.469 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.736 ' CB ' HG12 ' A' ' 37' ' ' VAL . 20.3 Cg_endo -59.9 -179.3 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.797 2.331 . . . . 0.0 112.688 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.47 157.74 44.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.793 0.33 . . . . 0.0 110.794 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.65 81.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.785 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.71 122.71 51.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.168 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.64 115.53 16.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.491 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -139.34 174.27 10.69 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.05 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.21 124.68 31.1 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.971 0.415 . . . . 0.0 110.977 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.02 -157.05 21.77 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.126 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 13.6 p-90 -82.88 116.59 22.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 111.07 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.451 ' HA3' HD21 ' A' ' 58' ' ' LEU . . . -168.75 -121.79 0.59 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.727 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.754 ' HA2' HD23 ' A' ' 105' ' ' LEU . . . 71.67 101.93 0.06 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.959 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.0 m-85 -162.96 171.04 6.77 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.63 0.252 . . . . 0.0 110.96 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 77.3 Cg_exo -52.01 166.53 0.63 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.045 2.496 . . . . 0.0 113.243 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.707 HD11 ' HB2' ' A' ' 105' ' ' LEU . 4.2 mp -142.92 169.74 17.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.414 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -160.43 138.82 10.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.176 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.783 HG12 HD13 ' A' ' 11' ' ' ILE . 6.4 tp -136.54 128.17 43.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.05 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.8 p -127.06 116.2 20.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.732 HG21 HG21 ' A' ' 9' ' ' ILE . 21.6 t -104.22 120.92 55.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.154 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 13.2 m-85 -126.1 156.02 40.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.736 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.618 HD13 ' CG2' ' A' ' 118' ' ' ILE . 0.8 OUTLIER -145.7 -166.57 2.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.56 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.3 pp -92.06 34.47 1.02 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 111.107 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -165.66 159.07 16.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.329 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.47 47.53 1.19 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.071 0.462 . . . . 0.0 110.772 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -116.25 -37.34 3.81 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.614 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.591 ' H ' HD21 ' A' ' 92' ' ' LEU . . . -118.65 30.68 5.85 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.161 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 16.2 mt-10 -92.57 92.77 8.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.825 0.313 . . . . 0.0 110.451 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -142.23 153.26 43.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.885 0.374 . . . . 0.0 111.817 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' C ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -135.75 146.37 47.57 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.786 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 88' ' ' ILE . 3.7 mp -141.78 122.48 8.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.64 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.06 129.26 4.56 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.866 2.377 . . . . 0.0 112.352 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.29 172.46 6.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.287 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -134.59 138.9 44.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.62 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.754 HD23 ' HA2' ' A' ' 83' ' ' GLY . 0.9 OUTLIER -130.33 84.58 2.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -156.6 37.31 0.32 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.175 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -141.9 132.03 24.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.13 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.521 ' H ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -59.88 131.8 51.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 71.58 74.22 0.17 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.441 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.73 131.37 55.0 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.59 61.63 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.292 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -105.6 119.31 38.8 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.534 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 3.2 pt-20 -142.16 139.6 32.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.126 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.564 ' CG1' HD11 ' A' ' 11' ' ' ILE . 5.8 p -131.96 148.97 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.69 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.466 ' HG2' ' HG3' ' A' ' 10' ' ' ARG . 1.2 mp0 -133.01 151.24 52.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.341 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -136.31 127.25 27.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.222 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.83 136.73 26.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.258 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.618 ' CG2' HD13 ' A' ' 92' ' ' LEU . 27.4 mt -121.49 111.22 30.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.58 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.39 117.49 20.67 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.349 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.633 ' N ' HD13 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -147.38 55.75 2.51 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.744 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.349 0.573 0 C-N-CA 122.466 2.111 . . . . 0.0 112.244 179.58 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.462 0.132 0 CA-C-O 120.646 0.26 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.49 119.44 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.654 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HG3' ' HG2' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -137.47 117.25 13.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.35 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.517 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 75.8 mtt180 -139.8 138.73 36.06 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.514 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 t -147.46 111.18 5.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.441 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.981 HD11 HD11 ' A' ' 36' ' ' ILE . 1.3 tt -104.77 118.28 51.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.637 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HD3' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -121.36 120.09 34.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.725 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.554 HG22 ' HB ' ' A' ' 36' ' ' ILE . 9.2 pt -118.7 126.3 75.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 111.33 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.491 ' HD2' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -114.26 130.81 56.65 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.845 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.595 HG23 ' CD1' ' A' ' 34' ' ' ILE . 3.0 m -127.88 118.01 22.85 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -129.29 140.63 51.35 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.986 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.481 HE21 ' HB2' ' A' ' 30' ' ' ARG . 2.0 tp60 -139.92 138.76 35.87 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.759 0.314 . . . . 0.0 111.333 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -137.92 119.73 15.25 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.576 HG23 ' HB3' ' A' ' 30' ' ' ARG . 6.7 mt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.773 0.32 . . . . 0.0 111.149 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG13 ' HA2' ' A' ' 80' ' ' GLY . 21.5 t . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 120.671 0.272 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.576 ' HB3' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -126.71 165.13 19.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.279 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.48 149.35 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -145.18 143.28 30.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.453 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.493 ' O ' HD13 ' A' ' 34' ' ' ILE . 1.6 m -136.12 121.95 19.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.742 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 105' ' ' LEU . 19.9 mm -130.4 117.42 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.622 0.248 . . . . 0.0 111.479 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.462 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 10.9 pt-20 -134.73 149.38 50.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.094 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.981 HD11 HD11 ' A' ' 9' ' ' ILE . 14.0 tt -152.18 130.49 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.207 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.486 HG23 ' HD3' ' A' ' 10' ' ' ARG . 4.3 m -137.24 119.15 18.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.962 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' A' ' 9' ' ' ILE . 52.8 tp -129.7 142.46 50.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.31 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 42' ' ' GLU . 4.3 tt -118.1 152.25 35.95 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.077 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.593 ' N ' HD23 ' A' ' 39' ' ' LEU . 4.7 p-10 -176.87 -30.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.318 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 7.1 p30 -53.91 -27.89 33.4 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.631 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.807 ' HB2' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.02 -33.21 59.66 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.554 0.216 . . . . 0.0 110.589 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.83 -74.33 0.93 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.884 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -129.47 -48.11 1.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 41' ' ' ASP . 17.1 tt0 71.09 7.0 6.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.774 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.718 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.1 pp -126.2 140.4 36.94 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-O 120.733 0.301 . . . . 0.0 111.413 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.63 -171.47 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.985 2.456 . . . . 0.0 112.374 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.7 ' HB3' ' CB ' ' A' ' 93' ' ' LEU . . . -160.81 -64.98 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.391 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.451 ' O ' HD13 ' A' ' 50' ' ' ILE . 17.7 m -96.97 -56.42 2.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.172 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 49' ' ' THR . 48.6 mm -132.84 -85.28 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.839 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 44.3 t80 63.24 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.145 0.498 . . . . 0.0 111.136 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -164.19 102.17 0.86 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.571 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.605 ' CG ' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -97.72 102.96 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.554 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' CD ' ' A' ' 67' ' ' ARG . 8.7 m -103.07 143.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.478 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 ' OG1' ' A' ' 68' ' ' THR . 2.4 mt -125.41 146.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.521 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.03 138.85 28.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.929 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.431 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 14.8 p80 -163.77 124.36 2.21 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.573 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.79 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.763 0.235 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.485 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 1.7 m-80 -115.14 155.28 27.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.093 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.782 ' CD ' HG12 ' A' ' 54' ' ' VAL . 0.8 OUTLIER -143.68 153.85 42.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 -179.48 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.868 HG23 ' HD2' ' A' ' 72' ' ' PRO . 45.6 m -138.44 117.21 12.3 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.792 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -125.47 -54.63 1.56 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -89.49 -67.58 0.83 Allowed 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.379 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.478 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 0.3 OUTLIER 179.09 61.06 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.468 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.868 ' HD2' HG23 ' A' ' 68' ' ' THR . 94.8 Cg_endo -93.07 103.33 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.92 2.413 . . . . 0.0 113.207 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 71' ' ' ASP . 86.4 Cg_endo -84.43 178.91 4.78 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.652 2.235 . . . . 0.0 112.382 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -167.94 153.03 6.77 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.62 111.5 0.07 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.968 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 76' ' ' ILE . 6.1 tp -159.62 142.01 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.853 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 14.7 pt-20 -132.27 111.6 11.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.479 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -121.39 168.3 11.82 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.338 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -109.94 176.58 5.01 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.773 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.549 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 110.91 -154.94 16.38 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.168 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -93.17 110.11 21.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 0.0 110.403 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.17 91.67 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.433 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -142.91 111.23 0.65 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.473 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 9.7 m-85 -160.94 168.56 11.47 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 120.613 0.244 . . . . 0.0 111.04 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.34 160.53 26.85 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.064 2.509 . . . . 0.0 112.966 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.082 HD22 HD23 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -150.89 123.05 8.28 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.578 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -127.55 145.89 50.71 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.95 0.405 . . . . 0.0 111.71 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 9' ' ' ILE . 8.9 tt -129.59 118.8 46.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.249 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.435 ' OG ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -119.47 119.59 34.33 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 -179.257 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.605 HG13 ' CG ' ' A' ' 53' ' ' LYS . 4.5 t -106.26 142.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.096 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -141.09 157.27 45.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.877 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -151.35 -175.74 5.3 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.733 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.7 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -72.63 -20.4 61.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.15 -169.23 1.66 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.496 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 58.35 1.02 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.842 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.51 4.77 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.778 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.445 ' C ' HD21 ' A' ' 92' ' ' LEU . . . -137.7 44.34 1.14 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.991 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -113.36 90.44 3.34 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.884 0.373 . . . . 0.0 111.025 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -142.66 156.59 45.07 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.532 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 5.9 pttm -112.2 140.59 46.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.479 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.463 HG22 ' CE1' ' A' ' 103' ' ' HIS . 2.1 mp -133.34 109.0 12.39 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.667 0.27 . . . . 0.0 111.506 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -88.21 147.39 6.52 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.221 2.614 . . . . 0.0 113.625 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.471 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . 8.7 m-70 -148.58 172.28 14.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.444 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -134.24 129.73 36.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.942 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.082 HD23 HD22 ' A' ' 86' ' ' LEU . 1.3 pp -113.97 100.95 8.8 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.984 0.421 . . . . 0.0 111.244 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -177.87 44.86 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.34 136.42 31.48 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.776 0.322 . . . . 0.0 111.535 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.439 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -61.73 128.95 38.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.637 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 64.45 65.3 0.66 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.26 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -105.18 131.77 52.23 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.813 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.0 p -132.79 66.71 1.55 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.869 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -104.9 119.64 39.49 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.702 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.491 ' CD ' ' HD2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -148.01 143.48 27.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.292 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.552 ' CG1' HD11 ' A' ' 11' ' ' ILE . 2.8 p -141.11 142.77 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.532 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -127.77 146.02 50.72 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.101 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 130.81 40.78 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.7 m -111.66 140.13 32.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.094 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.676 HG22 ' CD1' ' A' ' 120' ' ' ILE . 10.9 mt -139.99 111.79 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.784 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.409 ' HG2' ' HG3' ' A' ' 6' ' ' LYS . 46.7 mt-30 -129.9 107.55 9.46 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.265 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.676 ' CD1' HG22 ' A' ' 118' ' ' ILE . 3.9 mp -137.2 58.31 17.35 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 C--N 1.348 0.523 0 C-N-CA 122.47 2.113 . . . . 0.0 112.62 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.617 0.246 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.508 HG13 ' H ' ' A' ' 120' ' ' ILE . 11.5 p -134.81 119.45 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 111.428 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -123.79 105.11 9.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.599 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.415 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 4.1 mtt180 -118.07 169.66 9.48 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.003 0.43 . . . . 0.0 111.365 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -161.56 125.37 3.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.53 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.3 tt -105.06 118.44 52.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.115 0.484 . . . . 0.0 110.947 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.46 117.53 29.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.053 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.613 ' CD1' HD13 ' A' ' 88' ' ' ILE . 8.5 pt -122.83 128.75 75.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.585 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -119.23 141.89 48.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.402 ' OG1' HD12 ' A' ' 34' ' ' ILE . 5.6 m -137.35 111.06 8.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.151 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.5 mp0 -125.09 129.79 50.95 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.734 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -132.64 143.43 49.66 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.141 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -139.02 119.52 13.91 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.15 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 30' ' ' ARG . 8.2 mt . . . . . 0 C--O 1.232 0.171 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.777 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.571 0.224 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.54 ' HB3' HG23 ' A' ' 17' ' ' ILE . 5.5 ptp180 -133.16 165.12 25.52 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.346 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.01 157.16 33.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.666 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 10.9 p-90 -155.42 142.24 18.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.449 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 p -147.93 117.93 7.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.331 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.437 HD13 HD21 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -133.88 141.25 44.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.585 -179.457 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -131.39 134.17 46.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.641 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 55' ' ' ILE . 19.5 mt -124.38 106.38 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.643 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 73' ' ' PRO . 18.1 t -118.04 148.44 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.696 0.284 . . . . 0.0 111.387 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.876 HD13 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -159.33 148.59 18.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.323 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 42' ' ' GLU . 1.4 tp -102.72 160.82 14.25 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.255 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -173.76 -44.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.194 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.93 1.48 20.5 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.943 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.617 ' HG3' HD21 ' A' ' 39' ' ' LEU . 15.5 mm-40 -86.42 -36.73 18.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.578 0.228 . . . . 0.0 110.798 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.38 -72.83 0.63 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.683 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HD3' HD13 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -142.31 116.46 9.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.779 0.323 . . . . 0.0 110.836 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.93 35.48 1.26 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.175 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.407 HD13 ' HD3' ' A' ' 44' ' ' LYS . 4.2 mp -131.28 126.63 21.48 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.279 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.01 -174.34 1.9 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.856 2.371 . . . . 0.0 112.475 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.586 ' HB3' ' HG ' ' A' ' 93' ' ' LEU . . . -154.73 -63.69 0.13 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.622 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.525 HG22 HG13 ' A' ' 50' ' ' ILE . 27.2 m -99.07 -65.97 0.93 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.551 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.525 HG13 HG22 ' A' ' 49' ' ' THR . 56.6 mt -128.58 -92.77 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.399 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.434 ' CE1' ' HE2' ' A' ' 53' ' ' LYS . 35.7 t80 62.35 97.82 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.18 0.514 . . . . 0.0 111.399 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -164.5 112.56 1.09 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.062 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.923 ' HG2' HG13 ' A' ' 90' ' ' VAL . 4.8 mtmt -101.89 123.74 46.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.704 HG12 ' HG3' ' A' ' 67' ' ' ARG . 11.4 m -132.29 116.5 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 111.136 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.594 HG13 HG23 ' A' ' 88' ' ' ILE . 3.7 mp -103.24 149.56 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.192 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 65' ' ' PRO . 20.9 m-85 -138.19 119.12 14.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.294 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.474 ' CE1' ' CG2' ' A' ' 55' ' ' ILE . 5.5 m-70 -123.39 116.44 23.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.076 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.519 HD11 HD22 ' A' ' 105' ' ' LEU . 4.2 mp . . . . . 0 N--CA 1.465 0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.918 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 23.5 Cg_exo . . . . . 0 CA--C 1.53 0.315 0 CA-C-O 120.902 0.292 . . . . 0.0 112.649 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.436 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 5.1 m120 -124.71 137.92 54.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.704 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -129.87 146.27 51.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.258 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.67 136.35 37.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.743 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -161.86 -50.04 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.719 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.3 t -159.03 40.36 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.166 0.508 . . . . 0.0 110.663 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.96 157.79 74.68 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.006 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 44.1 Cg_exo -56.43 170.44 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.114 2.543 . . . . 0.0 112.28 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HB3' HG22 ' A' ' 37' ' ' VAL . 19.0 Cg_endo -58.13 171.46 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.959 2.439 . . . . 0.0 112.903 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.36 85.9 2.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.343 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -110.21 130.57 55.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -135.19 125.83 44.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.033 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -129.83 125.25 35.25 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 8.9 mt-10 -152.76 172.98 15.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.377 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -119.17 -179.6 3.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.213 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.97 -156.06 25.06 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.362 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -69.28 130.52 42.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.66 95.2 0.1 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.71 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.06 109.03 0.39 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.908 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.49 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 30.8 m-85 -153.77 164.8 19.44 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 111.105 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 10.8 Cg_endo -54.57 168.73 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.497 2.798 . . . . 0.0 113.981 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.437 ' HG ' ' HA ' ' A' ' 57' ' ' HIS . 6.7 mp -134.05 155.74 49.48 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.525 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -158.11 120.94 3.82 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.937 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.613 HD13 ' CD1' ' A' ' 11' ' ' ILE . 2.3 mp -125.22 126.36 70.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.475 ' OG ' HG23 ' A' ' 54' ' ' VAL . 57.4 p -127.98 115.43 18.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.997 0.427 . . . . 0.0 110.917 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.923 HG13 ' HG2' ' A' ' 53' ' ' LYS . 26.1 t -104.36 138.85 27.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.998 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.408 ' C ' HD23 ' A' ' 92' ' ' LEU . 21.1 m-85 -131.44 153.71 49.44 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.75 HD21 ' N ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -148.25 -165.78 2.36 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.023 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.586 ' HG ' ' HB3' ' A' ' 48' ' ' ALA . 7.9 mp -56.5 -62.03 2.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 179.05 50.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.013 0.435 . . . . 0.0 110.701 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -112.03 -154.21 0.54 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.516 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.36 -14.35 20.21 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.644 ' C ' HD21 ' A' ' 92' ' ' LEU . . . -61.52 -22.65 61.75 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.811 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.75 ' N ' HD21 ' A' ' 92' ' ' LEU . 4.4 pt-20 -68.08 84.84 0.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.086 0.47 . . . . 0.0 110.377 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.32 156.75 45.27 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.729 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 89' ' ' SER . 1.7 mtmm -103.07 153.22 20.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.654 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.529 ' O ' HD12 ' A' ' 88' ' ' ILE . 25.5 mt -137.58 99.79 9.4 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.012 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.33 130.94 8.33 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.861 2.374 . . . . 0.0 112.22 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.458 ' CD2' HG22 ' A' ' 101' ' ' ILE . 4.9 m-70 -132.71 167.43 20.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.59 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -134.94 135.12 41.27 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.6 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.519 HD22 HD11 ' A' ' 58' ' ' LEU . 5.8 tp -125.75 84.72 2.31 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.675 0.274 . . . . 0.0 111.314 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -168.63 38.2 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.256 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -140.44 133.96 30.07 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.785 0.326 . . . . 0.0 111.548 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.422 ' H ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.11 130.64 47.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.829 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 67.0 61.32 0.5 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 6.3 tp10 -96.58 136.84 36.54 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.699 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.7 t -141.11 70.46 1.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.617 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.23 119.25 37.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.184 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.83 154.28 35.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.46 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 t -142.36 152.18 18.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.585 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -134.53 109.24 8.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.65 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -113.11 147.91 36.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.917 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.66 140.74 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.21 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.672 HG23 HD13 ' A' ' 92' ' ' LEU . 2.9 mt -124.52 117.83 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.13 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.75 116.21 19.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.017 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.508 ' H ' HG13 ' A' ' 5' ' ' VAL . 1.7 mp -128.57 53.43 11.16 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.232 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 C--N 1.347 0.463 0 C-N-CA 122.755 2.303 . . . . 0.0 112.246 179.891 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.668 HG22 ' CB ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.603 0.239 . . . . 0.0 110.889 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.4 t -127.18 119.63 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.532 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -137.81 112.85 9.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.358 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.57 ' NH1' HD13 ' A' ' 92' ' ' LEU . 35.0 mtp180 -138.84 167.76 21.29 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.078 0.466 . . . . 0.0 111.871 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -167.6 124.97 1.18 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.675 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.803 HD11 HD11 ' A' ' 36' ' ' ILE . 17.5 tt -108.49 118.98 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.937 0.398 . . . . 0.0 110.983 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG2' ' HG2' ' A' ' 115' ' ' GLU . 58.1 mtp85 -122.89 111.86 17.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.801 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.541 ' CD1' HD13 ' A' ' 88' ' ' ILE . 47.8 pt -106.95 137.2 38.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.015 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -125.16 128.59 48.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.132 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.586 HG23 ' CD1' ' A' ' 34' ' ' ILE . 74.3 m -130.89 124.48 31.25 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.85 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -139.32 143.58 37.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.205 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' A' ' 16' ' ' HIS . 1.8 tt0 -137.84 144.46 41.46 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.632 0.253 . . . . 0.0 111.32 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.472 ' N ' ' HG3' ' A' ' 15' ' ' GLN . 15.3 t60 -140.36 119.42 12.75 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.066 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' ' 30' ' ' ARG . 6.8 mt . . . . . 0 N--CA 1.463 0.199 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.741 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.233 0.228 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.496 ' HB3' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -138.03 164.41 29.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.858 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -122.3 149.23 44.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.742 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.452 ' HB2' HD21 ' A' ' 105' ' ' LEU . 14.9 p-90 -148.47 140.2 23.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.039 0.447 . . . . 0.0 111.344 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.2 t -129.94 117.69 20.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.476 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.586 ' CD1' HG23 ' A' ' 13' ' ' THR . 28.7 mm -125.73 127.23 71.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.139 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -147.68 157.47 43.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.809 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.803 HD11 HD11 ' A' ' 9' ' ' ILE . 11.4 tt -155.13 128.42 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.962 0.41 . . . . 0.0 111.518 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 73' ' ' PRO . 22.9 t -119.34 148.49 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.807 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.677 HD12 ' HB ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -160.41 145.47 14.67 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.698 0.285 . . . . 0.0 111.378 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.556 HD21 ' HG3' ' A' ' 42' ' ' GLU . 3.1 tp -103.3 164.16 11.81 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -171.74 -45.67 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.944 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.54 0.48 17.17 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.556 ' HG3' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -82.99 -34.96 26.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.637 0.256 . . . . 0.0 110.651 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.91 -55.86 0.29 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.744 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -162.71 114.05 1.53 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG3' ' HB3' ' A' ' 40' ' ' ASP . 18.1 tt0 -98.66 38.07 1.41 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.987 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.79 134.06 24.51 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.944 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.85 -171.24 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.834 2.356 . . . . 0.0 112.65 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.842 ' HB3' ' CB ' ' A' ' 93' ' ' LEU . . . -165.39 -45.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.444 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.17 -66.03 0.83 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.576 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.3 mm -114.88 -87.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.786 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 49.3 t80 58.79 96.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.897 0.379 . . . . 0.0 111.357 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 6.7 t70 -172.52 110.64 0.23 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.878 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.956 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -102.64 127.07 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.614 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 m -126.2 142.41 42.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.685 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.478 HG12 HD13 ' A' ' 36' ' ' ILE . 2.3 mp -127.4 150.33 33.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.37 144.2 36.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.532 ' HB2' HD12 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -140.39 119.91 13.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.995 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.532 HD12 ' HB2' ' A' ' 57' ' ' HIS . 5.1 mp . . . . . 0 CA--C 1.532 0.253 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.309 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 CA--C 1.53 0.297 0 CA-C-O 120.598 0.166 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.406 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 20.6 m-20 -108.77 151.17 26.58 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.887 0.375 . . . . 0.0 111.074 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.17 155.98 40.78 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.041 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.62 122.63 26.34 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.798 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.452 ' HA ' ' HZ2' ' A' ' 53' ' ' LYS . 16.0 t80 -143.9 -57.02 0.38 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.601 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 t -148.61 34.51 0.78 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.721 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.69 160.27 45.06 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.115 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.42 171.67 10.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.934 2.422 . . . . 0.0 112.434 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.602 ' HB3' HG13 ' A' ' 37' ' ' VAL . 18.7 Cg_endo -58.99 162.55 13.27 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.928 2.419 . . . . 0.0 112.822 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -108.59 156.12 19.88 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.336 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.19 121.38 0.75 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.624 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 76' ' ' ILE . 11.3 tp -158.87 119.89 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.959 0.409 . . . . 0.0 111.329 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -126.86 111.52 14.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.646 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.43 161.73 25.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.81 179.74 3.99 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.957 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.91 -170.25 18.73 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.224 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -66.96 120.51 13.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.797 0.332 . . . . 0.0 111.158 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.93 128.1 0.96 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.907 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.39 107.77 0.26 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.717 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.509 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 16.0 m-85 -153.49 164.52 20.24 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.717 0.294 . . . . 0.0 111.016 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.551 ' O ' HD13 ' A' ' 86' ' ' LEU . 32.3 Cg_exo -59.66 163.43 13.25 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.924 2.416 . . . . 0.0 113.572 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -126.65 166.69 16.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.932 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -155.96 128.69 7.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.173 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.541 HD13 ' CD1' ' A' ' 11' ' ' ILE . 3.4 mp -136.1 116.45 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.654 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 6.7 t -122.82 146.22 47.74 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.214 0.531 . . . . 0.0 111.477 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.956 HG13 ' HG2' ' A' ' 53' ' ' LYS . 3.2 t -123.56 144.29 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.867 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.519 ' HA ' ' HG3' ' A' ' 98' ' ' GLU . 50.3 m-85 -137.24 154.43 50.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.188 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.57 HD13 ' NH1' ' A' ' 7' ' ' ARG . 9.2 tp -152.01 178.1 9.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.842 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -74.07 -30.27 62.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.738 0.304 . . . . 0.0 110.331 179.199 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -106.89 -159.19 0.69 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.161 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -128.52 74.29 1.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.922 0.392 . . . . 0.0 110.683 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.542 ' HB3' HG23 ' A' ' 118' ' ' ILE . . . -115.16 -50.61 2.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.484 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.75 36.5 1.93 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.746 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.519 ' HG3' ' HA ' ' A' ' 91' ' ' PHE . 22.8 tt0 -88.5 76.36 8.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.513 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -142.72 156.74 45.06 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.689 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -110.32 149.38 30.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.063 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 100' ' ' LYS . 21.9 mm -135.3 113.21 11.22 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.266 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -85.82 153.11 10.01 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.941 2.427 . . . . 0.0 112.473 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.431 ' HB3' HD23 ' A' ' 86' ' ' LEU . 7.1 m170 -144.4 171.39 14.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.061 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.18 143.18 49.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.034 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.774 ' HB2' HD21 ' A' ' 86' ' ' LEU . 9.1 tp -130.61 82.12 2.04 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.838 0.352 . . . . 0.0 111.417 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -170.73 47.25 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.286 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -141.61 132.16 25.4 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 111.725 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -64.96 115.4 5.35 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.763 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.409 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 0.5 OUTLIER 74.86 73.0 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.433 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 40.3 tt0 -108.84 141.05 41.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.567 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.6 p -139.83 75.37 1.51 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.05 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.75 119.79 39.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.344 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.8 145.08 25.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.506 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.406 HG21 HG21 ' A' ' 101' ' ' ILE . 14.2 t -126.6 150.48 32.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.704 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 10' ' ' ARG . 4.7 mt-10 -134.05 109.05 8.7 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.828 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -113.05 140.28 47.97 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.69 136.41 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.436 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.542 HG23 ' HB3' ' A' ' 96' ' ' ALA . 1.8 mp -126.69 111.04 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.37 132.34 45.74 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.985 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 120' ' ' ILE . 2.5 tp -161.6 61.75 1.37 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 121.329 0.585 . . . . 0.0 111.377 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.668 ' CB ' HG22 ' A' ' 4' ' ' THR . 56.2 Cg_endo . . . . . 0 C--N 1.349 0.582 0 C-N-CA 122.739 2.293 . . . . 0.0 112.772 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.635 0.255 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.06 119.06 35.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.965 0.412 . . . . 0.0 110.977 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -137.0 116.33 12.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.192 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.541 ' HA ' HD12 ' A' ' 39' ' ' LEU . 31.8 mtt-85 -132.45 159.04 40.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.368 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -160.56 127.1 4.15 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.841 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.839 HG21 HG21 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.77 122.84 66.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.717 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.588 ' N ' HD13 ' A' ' 9' ' ' ILE . 13.3 mtt180 -124.72 129.03 49.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 88' ' ' ILE . 1.1 pt -127.39 127.14 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.969 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.493 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -120.82 130.26 53.9 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.185 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.616 HG23 ' CD1' ' A' ' 34' ' ' ILE . 84.8 m -133.27 108.52 8.8 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -119.5 143.93 47.29 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.143 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.704 ' HB2' HD12 ' A' ' 105' ' ' LEU . 3.1 tp60 -139.25 142.02 37.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.186 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.438 ' N ' ' HG3' ' A' ' 15' ' ' GLN . 63.4 t-80 -144.91 119.29 9.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.925 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 108' ' ' LEU . 17.7 mt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.974 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.721 0.296 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.45 163.48 29.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.021 0.438 . . . . 0.0 111.526 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.39 153.37 35.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.831 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -153.91 151.8 29.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.595 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 13' ' ' THR . 11.7 t -148.68 119.34 7.49 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.992 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.858 HD11 HD22 ' A' ' 105' ' ' LEU . 25.2 mm -126.25 137.16 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.683 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 9.3 pt-20 -157.51 119.59 3.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.702 0.287 . . . . 0.0 111.482 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.467 ' CD1' HD12 ' A' ' 55' ' ' ILE . 13.6 tt -124.98 127.71 72.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.45 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.76 HG12 ' CB ' ' A' ' 73' ' ' PRO . 34.6 m -129.74 158.36 42.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.478 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.64 HD13 ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -160.09 155.61 25.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.856 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 7' ' ' ARG . 81.4 mt -88.03 168.01 13.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.764 0.316 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.11 -58.7 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.496 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.6 -23.92 67.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.151 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -90.36 -36.65 14.51 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.538 0.208 . . . . 0.0 110.93 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.92 54.55 0.55 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.39 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt 63.79 116.59 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.09 0.471 . . . . 0.0 111.646 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -88.48 31.74 0.81 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.521 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.2 mt -129.69 134.36 26.11 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.774 -0.193 . . . . 0.0 111.132 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.16 173.09 13.52 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.809 2.34 . . . . 0.0 112.36 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -145.48 -70.97 0.26 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.501 ' OG1' HD13 ' A' ' 93' ' ' LEU . 19.0 p -117.77 -74.69 0.6 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.63 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.9 mt -100.96 -85.74 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.534 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 3.3 t80 51.59 95.85 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.128 0.489 . . . . 0.0 111.133 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -171.3 103.78 0.21 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.717 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.937 ' HG2' HG13 ' A' ' 90' ' ' VAL . 5.4 mttt -99.21 114.28 26.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.037 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.863 HG12 ' HA ' ' A' ' 67' ' ' ARG . 27.5 m -128.07 160.76 37.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.749 HG22 ' HB2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -123.4 167.26 17.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.967 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.511 ' N ' HG23 ' A' ' 55' ' ' ILE . 10.7 t80 -134.16 131.59 38.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.241 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.6 ' HD2' HD23 ' A' ' 86' ' ' LEU . 48.2 m170 -129.41 104.94 7.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' A' ' 85' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.315 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.211 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo . . . . . 0 CA--C 1.53 0.296 0 CA-C-O 120.743 0.226 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.749 ' HB2' HG22 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -90.98 146.44 23.86 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.262 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.863 ' HA ' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -142.01 136.76 30.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.515 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.605 ' CG2' HD11 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -130.97 98.96 4.74 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 111.002 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -115.38 -49.58 2.76 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.865 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -146.94 35.08 0.91 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.921 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -130.52 159.73 69.45 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.29 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.26 173.08 3.57 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.063 2.509 . . . . 0.0 112.629 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.76 ' CB ' HG12 ' A' ' 37' ' ' VAL . 30.0 Cg_endo -62.36 174.14 2.9 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.989 2.459 . . . . 0.0 112.77 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -136.38 95.08 3.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.392 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.542 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -121.19 110.33 16.04 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.002 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 75' ' ' ARG . 20.6 mm -134.81 117.31 22.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -129.71 130.15 45.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.128 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -155.56 178.37 10.31 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.702 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.71 131.36 56.79 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.786 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.34 -131.07 2.14 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.03 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -120.27 110.31 16.42 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.16 0.505 . . . . 0.0 111.209 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.17 99.02 0.12 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.439 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -148.83 108.45 0.41 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.514 -0.851 . . . . 0.0 113.236 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -155.82 170.03 9.44 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 122.177 0.191 . . . . 0.0 110.645 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.522 ' HB2' HD13 ' A' ' 58' ' ' LEU . 31.6 Cg_exo -59.2 168.43 4.78 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.854 2.37 . . . . 0.0 112.811 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.784 HD11 ' CB ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -144.24 172.49 12.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.703 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 21.0 t70 -159.83 116.79 2.57 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.897 0.379 . . . . 0.0 111.085 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 11' ' ' ILE . 3.7 mp -108.1 131.57 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.4 p -128.33 119.64 25.46 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.983 0.42 . . . . 0.0 110.551 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.937 HG13 ' HG2' ' A' ' 53' ' ' LYS . 40.7 t -106.53 135.55 44.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.729 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -134.83 150.24 50.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.721 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.066 HD22 HG21 ' A' ' 118' ' ' ILE . 12.2 tp -142.96 -69.55 0.34 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.707 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.501 HD13 ' OG1' ' A' ' 49' ' ' THR . 0.2 OUTLIER -129.4 -76.73 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.541 0.21 . . . . 0.0 111.189 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -137.26 -57.48 0.7 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.289 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 27.1 0.85 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -78.52 -37.64 42.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.74 37.56 0.39 Allowed Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.834 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -90.1 92.39 8.94 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 110.532 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.02 144.32 33.58 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.344 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 130.13 38.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.392 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.01 132.82 21.54 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.527 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 94.7 Cg_endo -79.85 143.58 16.57 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.689 2.259 . . . . 0.0 111.932 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.1 171.91 10.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.01 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -122.54 140.26 52.97 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.657 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.858 HD22 HD11 ' A' ' 34' ' ' ILE . 57.6 tp -140.09 70.01 1.36 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.561 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -174.62 42.8 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -141.61 137.36 31.81 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.463 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.597 HD12 HD12 ' A' ' 17' ' ' ILE . 1.6 mp -50.41 119.75 4.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 58.99 80.64 0.18 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.708 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -111.3 135.09 52.35 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.748 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.5 p -132.57 71.41 1.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.049 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -106.14 119.51 39.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.415 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.5 157.01 33.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.983 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.515 HG23 HD11 ' A' ' 11' ' ' ILE . 3.4 t -139.53 152.32 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.613 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -138.1 109.31 6.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.62 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -113.26 123.94 51.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.021 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 m -103.29 147.22 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.401 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 1.066 HG21 HD22 ' A' ' 92' ' ' LEU . 9.8 mt -137.87 120.65 19.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -129.46 113.49 14.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.864 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.2 pt -146.68 68.03 11.68 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.545 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 CA--C 1.532 0.412 0 C-N-CA 122.571 2.181 . . . . 0.0 112.625 179.859 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.577 0.227 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 t -130.29 119.01 45.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.779 0.323 . . . . 0.0 111.389 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -137.62 122.61 19.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.465 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.441 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -134.33 167.37 20.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.204 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 2.3 t -172.56 129.15 0.54 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.444 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.014 HG21 HG21 ' A' ' 90' ' ' VAL . 1.2 tt -109.26 118.3 56.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.54 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.31 114.18 16.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.942 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 36' ' ' ILE . 1.1 pt -118.38 126.67 75.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 113.58 26.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.989 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.634 HG23 ' CD1' ' A' ' 34' ' ' ILE . 85.4 m -119.47 96.36 5.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.193 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -125.4 147.89 49.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.09 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -133.61 165.43 24.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.0 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -163.39 119.82 1.77 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.203 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.508 HG12 ' HA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.982 0.42 . . . . 0.0 111.506 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.589 0.233 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HA ' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -93.53 155.21 17.45 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.736 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 1.6 mt-30 -117.42 107.0 13.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.708 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.431 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 57.5 p-90 -100.93 158.86 15.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.665 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.454 ' O ' HD13 ' A' ' 34' ' ' ILE . 15.3 t -144.77 117.64 8.77 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.634 ' CD1' HG23 ' A' ' 13' ' ' THR . 17.7 mm -122.88 138.79 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.618 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.16 127.84 13.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.658 HG21 ' CD1' ' A' ' 55' ' ' ILE . 8.6 mt -119.5 106.41 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.342 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 73' ' ' PRO . 21.6 t -118.01 150.14 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.83 0.348 . . . . 0.0 111.627 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.821 HD13 ' HD3' ' A' ' 53' ' ' LYS . 1.1 pp -166.95 148.2 5.9 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.276 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 7.1 mt -76.95 162.84 27.25 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.329 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -166.27 -59.5 0.03 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.956 0.408 . . . . 0.0 110.393 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -58.86 -31.0 68.14 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.314 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -92.15 -29.97 16.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.72 47.75 2.29 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.709 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 mttm 57.1 94.76 0.02 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 111.156 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.28 -28.84 60.06 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.29 120.56 77.3 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.051 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HB3' ' CD2' ' A' ' 51' ' ' PHE . 73.2 Cg_endo -75.6 -171.89 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.591 2.194 . . . . 0.0 112.545 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.84 -55.1 0.46 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.342 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -120.73 -60.49 1.66 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.631 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.9 mm -116.93 -84.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.912 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 47' ' ' PRO . 73.8 t80 58.85 95.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.899 0.381 . . . . 0.0 111.391 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -176.68 151.79 0.94 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.71 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.821 ' HD3' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -133.15 111.57 11.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.518 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.482 HG13 ' CG ' ' A' ' 67' ' ' ARG . 21.6 t -112.12 149.29 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.0 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.665 HG23 HG13 ' A' ' 88' ' ' ILE . 4.1 mp -135.0 154.79 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.662 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.1 150.9 38.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 111.408 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.404 ' ND1' HD21 ' A' ' 86' ' ' LEU . 12.6 m-70 -135.49 115.33 13.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.502 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 85' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.312 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.297 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 C--O 1.233 0.262 0 CA-C-O 120.695 0.206 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -106.86 131.03 54.41 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.18 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.482 ' CG ' HG13 ' A' ' 54' ' ' VAL . 3.8 mtt85 -145.1 131.12 19.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.777 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.25 103.05 8.92 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 111.327 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -104.34 -53.87 2.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.322 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -156.25 35.65 0.33 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.82 165.44 13.97 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.85 157.65 27.72 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.77 2.314 . . . . 0.0 112.423 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HB2' HG22 ' A' ' 37' ' ' VAL . 55.3 Cg_endo -70.05 154.37 66.64 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.609 2.206 . . . . 0.0 112.48 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.87 146.31 25.03 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.406 ' H ' HD12 ' A' ' 76' ' ' ILE . 2.4 tpt180 -171.8 80.8 0.06 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.754 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.406 HD12 ' H ' ' A' ' 75' ' ' ARG . 3.9 mp -141.36 143.2 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.108 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -135.41 130.4 34.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 1.3 mt-10 -137.42 166.2 24.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.912 0.386 . . . . 0.0 111.398 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -100.23 126.58 46.54 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.59 -169.0 33.16 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.732 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -115.34 110.18 19.0 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.661 0.267 . . . . 0.0 110.551 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.88 128.51 1.26 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.458 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.4 95.96 0.15 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.211 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 87.6 m-85 -142.08 165.73 25.82 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-O 120.553 0.216 . . . . 0.0 111.072 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 86' ' ' LEU . 76.2 Cg_exo -50.47 165.95 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.992 2.461 . . . . 0.0 113.367 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 85' ' ' PRO . 1.1 mp -146.51 165.75 28.52 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.882 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -157.38 134.94 10.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.277 0.56 . . . . 0.0 111.128 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.665 HG13 HG23 ' A' ' 55' ' ' ILE . 3.8 mp -128.94 127.19 65.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.884 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.7 p -118.05 137.48 52.88 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.005 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 9' ' ' ILE . 3.9 t -123.8 132.72 70.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.333 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.48 158.87 37.18 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.654 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.741 ' CD1' ' HB3' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -145.65 -49.24 0.23 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.106 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.89 -83.54 0.07 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.01 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.32 -79.49 0.59 Allowed 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 120.562 0.22 . . . . 0.0 111.224 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.75 32.71 1.04 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 111.61 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.741 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -77.29 -39.7 47.07 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.89 0.376 . . . . 0.0 110.361 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.674 ' C ' HD21 ' A' ' 92' ' ' LEU . . . -148.18 24.43 1.41 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.619 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 5.0 tt0 -77.63 103.15 7.39 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.713 0.257 . . . . 0.0 110.386 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.49 155.32 45.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.057 0.456 . . . . 0.0 112.032 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.96 138.24 54.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.137 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.975 HG13 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -132.17 110.45 14.07 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.629 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.49 160.76 28.59 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.639 2.226 . . . . 0.0 112.326 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.527 ' CE1' HG13 ' A' ' 114' ' ' VAL . 2.5 m-70 -144.07 170.18 16.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -134.24 95.45 3.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.423 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.686 HD12 ' OE1' ' A' ' 110' ' ' GLU . 15.8 tp -77.99 121.98 24.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.353 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.2 -179.42 5.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.084 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -107.83 166.47 10.68 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.592 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.48 ' HA ' HG22 ' A' ' 17' ' ' ILE . 1.9 tp 77.2 60.32 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.137 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 66.11 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.541 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.686 ' OE1' HD12 ' A' ' 105' ' ' LEU . 45.0 tt0 -130.82 147.15 52.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.086 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -140.74 74.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.572 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -117.64 119.29 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.91 157.37 23.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.53 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.975 HG21 HG13 ' A' ' 101' ' ' ILE . 29.7 m -137.68 158.11 33.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.312 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -142.93 109.02 5.21 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.348 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.37 150.11 33.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.1 p -124.36 134.9 65.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.202 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.727 ' CG2' HD13 ' A' ' 92' ' ' LEU . 3.4 mp -131.98 111.19 17.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.65 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -129.7 139.44 51.35 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.187 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.524 ' O ' HG23 ' A' ' 120' ' ' ILE . 6.5 tp -169.05 72.19 0.74 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 121.369 0.604 . . . . 0.0 111.144 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 C--N 1.347 0.457 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.818 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.567 0.222 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.856 HG22 ' HG2' ' A' ' 44' ' ' LYS . 16.6 t -130.83 119.34 45.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.889 0.376 . . . . 0.0 111.018 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -133.64 110.95 10.22 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.742 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 15.1 mtt85 -126.44 161.65 27.41 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.352 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 2.3 t -170.47 116.92 0.51 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.59 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.865 HD11 HD11 ' A' ' 36' ' ' ILE . 7.8 tt -103.41 118.06 49.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 121.023 0.44 . . . . 0.0 110.93 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -118.09 112.11 19.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.477 HG22 ' CG1' ' A' ' 36' ' ' ILE . 40.1 pt -113.63 133.51 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.31 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -128.77 125.33 37.62 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.954 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -130.89 103.87 6.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -117.64 146.38 43.72 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.169 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.634 ' HG2' ' HA ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -146.04 148.26 32.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.887 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.43 ' HA ' ' H ' ' A' ' 109' ' ' GLN . 0.6 OUTLIER -162.9 120.37 1.97 Allowed 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.655 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 107' ' ' PHE . 24.8 mt . . . . . 0 N--CA 1.465 0.323 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.667 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 m . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.587 0.232 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 1.1 ptt-85 -131.3 160.37 35.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.069 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -100.17 160.08 14.61 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.855 0.36 . . . . 0.0 111.079 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.1 p-90 -159.4 151.58 20.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.613 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -148.36 118.11 7.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.696 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tp -124.9 137.04 58.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.926 0.393 . . . . 0.0 111.573 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.413 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -157.67 149.54 22.1 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.786 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.936 HG21 HD13 ' A' ' 55' ' ' ILE . 12.5 tt -156.61 132.51 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.025 0.441 . . . . 0.0 111.331 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.81 HG12 ' CB ' ' A' ' 73' ' ' PRO . 35.3 m -130.39 159.04 42.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.975 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.58 HD12 ' HB ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER -164.49 145.21 7.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 111.475 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.769 HD21 ' HG3' ' A' ' 42' ' ' GLU . 2.7 tp -97.57 155.16 17.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.378 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.06 -46.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.973 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -78.23 2.61 17.73 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.378 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.769 ' HG3' HD21 ' A' ' 39' ' ' LEU . 8.9 mm-40 -82.24 -27.9 32.21 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.495 0.188 . . . . 0.0 110.781 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.26 -59.08 0.13 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.167 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.856 ' HG2' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -153.05 119.56 5.6 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.777 0.322 . . . . 0.0 111.453 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.19 30.41 4.17 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.957 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.43 134.44 21.21 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.177 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 36.4 Cg_endo -65.75 -44.93 7.23 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.664 2.243 . . . . 0.0 112.769 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 66.57 -76.05 0.05 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.52 0.328 . . . . 0.0 111.798 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.405 HG22 ' CD1' ' A' ' 50' ' ' ILE . 91.4 m -104.02 -69.61 0.8 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.565 0.221 . . . . 0.0 110.977 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.405 ' CD1' HG22 ' A' ' 49' ' ' THR . 2.5 mp -122.77 -81.81 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.772 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 47' ' ' PRO . 5.5 t80 62.48 101.62 0.03 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.296 0.57 . . . . 0.0 110.953 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 35.1 t70 -166.75 111.54 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.848 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.74 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -116.28 126.34 53.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.211 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.582 HG23 ' HD3' ' A' ' 67' ' ' ARG . 14.2 p -122.3 152.48 26.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.884 0.373 . . . . 0.0 111.588 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.936 HD13 HG21 ' A' ' 36' ' ' ILE . 2.1 mt -130.98 131.3 64.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.374 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.59 144.07 51.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.696 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' C ' HD12 ' A' ' 58' ' ' LEU . 5.7 p-80 -147.57 119.85 8.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.0 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.603 HD11 HD22 ' A' ' 105' ' ' LEU . 4.9 mp . . . . . 0 CA--C 1.53 0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.677 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo . . . . . 0 CA--C 1.53 0.295 0 CA-C-O 120.603 0.168 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.495 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 3.4 m120 -128.24 145.61 50.99 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.836 0.35 . . . . 0.0 111.158 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.582 ' HD3' HG23 ' A' ' 54' ' ' VAL . 3.2 mmm-85 -141.81 153.37 44.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.69 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 4.3 m -130.71 119.07 21.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.849 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.752 ' CD2' HG22 ' A' ' 70' ' ' THR . 3.1 p90 -164.13 -49.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.584 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.752 HG22 ' CD2' ' A' ' 69' ' ' PHE . 14.8 t -152.02 32.12 0.54 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.648 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.27 161.89 24.81 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.16 166.83 28.51 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.765 2.31 . . . . 0.0 112.653 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.81 ' CB ' HG12 ' A' ' 37' ' ' VAL . 55.5 Cg_endo -70.37 138.68 36.43 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.876 2.384 . . . . 0.0 112.639 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -93.37 148.57 21.94 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.146 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -171.69 84.1 0.08 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.72 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 mt -134.91 134.28 53.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.495 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -134.51 137.73 44.1 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.831 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.15 -177.59 6.01 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.82 125.14 48.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.595 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.95 -162.83 16.84 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.588 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -122.82 110.89 16.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.0 0.429 . . . . 0.0 110.942 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.61 124.5 0.76 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.954 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.662 ' HA2' HD23 ' A' ' 105' ' ' LEU . . . -144.93 107.06 0.42 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.274 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.415 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 11.0 m-85 -141.59 167.47 16.9 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.67 0.271 . . . . 0.0 111.367 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.9 171.85 0.94 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.24 2.627 . . . . 0.0 113.733 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 105' ' ' LEU . 5.1 mp -139.37 166.05 25.58 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.563 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -155.0 114.6 3.71 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.728 0.299 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.7 mp -124.19 120.45 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.623 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.05 149.37 42.29 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.853 0.359 . . . . 0.0 111.094 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.74 HG13 ' HG2' ' A' ' 53' ' ' LYS . 3.7 t -131.08 131.38 63.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.222 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 54.2 m-85 -142.54 144.17 32.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.174 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.77 -54.01 1.15 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.396 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -179.64 -44.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.758 0.313 . . . . 0.0 110.895 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.76 -174.61 2.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.917 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.05 71.26 3.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 111.356 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.06 -50.86 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.577 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -145.65 33.14 1.56 Allowed Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.455 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HB2' ' CD1' ' A' ' 91' ' ' PHE . 3.2 pt-20 -102.09 103.0 13.55 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.792 0.329 . . . . 0.0 110.786 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.34 151.18 41.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 2.0 mtmt -104.52 124.92 50.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.337 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.43 114.05 29.0 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.684 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.6 151.94 15.12 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.874 2.382 . . . . 0.0 111.907 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.467 ' HB3' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -136.64 171.35 14.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 111.398 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -133.86 128.96 35.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.54 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.693 ' HB2' HD11 ' A' ' 86' ' ' LEU . 4.4 tp -108.1 106.35 16.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.777 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.99 168.11 14.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.147 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.634 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 9.3 p90 -94.9 165.61 12.37 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.419 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tp 84.45 62.59 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.341 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.43 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 1.3 tm0? 65.4 111.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.648 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.35 128.82 34.45 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.831 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.9 p -127.41 66.1 1.31 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.714 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' A' ' 103' ' ' HIS . 5.0 m-85 -108.48 119.42 39.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.561 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.37 152.87 20.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.372 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.9 t -139.65 149.16 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.651 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -135.16 108.87 8.01 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.484 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.36 146.24 39.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.121 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.56 128.71 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.176 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 3.5 mp -121.5 111.21 30.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -123.03 122.78 39.35 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.1 pp -148.23 68.58 10.37 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 121.082 0.468 . . . . 0.0 111.347 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 C--N 1.346 0.436 0 C-N-CA 122.635 2.223 . . . . 0.0 112.41 179.853 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.76 119.46 51.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -138.04 117.68 13.06 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.502 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -143.08 169.2 18.03 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.587 HG22 HD23 ' A' ' 39' ' ' LEU . 9.8 t -172.39 133.58 0.65 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.427 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 9' ' ' ILE . 9.5 tp -109.11 118.39 56.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.032 0.444 . . . . 0.0 111.022 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -124.89 108.21 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.79 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.873 HG12 HD13 ' A' ' 88' ' ' ILE . 1.8 pp -118.58 128.95 75.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.066 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 2.6 mptp? -115.49 125.28 52.86 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.651 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.749 HG23 ' CD1' ' A' ' 34' ' ' ILE . 97.5 m -130.06 127.2 39.41 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -138.96 158.82 43.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.912 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' NE2' ' HG ' ' A' ' 105' ' ' LEU . 1.4 tt0 -153.11 144.28 23.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.757 0.313 . . . . 0.0 111.275 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.414 ' HA ' ' H ' ' A' ' 109' ' ' GLN . 14.0 m-70 -142.18 119.23 11.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.864 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 4.8 mt . . . . . 0 C--O 1.233 0.193 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.913 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 121.014 0.435 . . . . 0.0 111.968 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.439 ' CB ' HG12 ' A' ' 17' ' ' ILE . 1.1 ptt-85 -117.74 161.58 19.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.319 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.06 156.44 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.665 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -154.55 137.55 15.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.155 0.503 . . . . 0.0 111.567 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.7 t -134.83 117.21 15.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.934 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.749 ' CD1' HG23 ' A' ' 13' ' ' THR . 6.9 mm -128.94 142.76 43.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.945 0.402 . . . . 0.0 111.605 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.477 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 11.4 pt-20 -151.63 143.62 23.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.633 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.69 HG12 HG21 ' A' ' 55' ' ' ILE . 3.8 mp -128.66 133.61 66.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.01 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.495 ' C ' HD13 ' A' ' 38' ' ' LEU . 20.2 t -141.52 129.45 22.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.911 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.556 ' CD1' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -156.35 176.93 12.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.668 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.587 HD23 HG22 ' A' ' 8' ' ' THR . 3.8 mm? -104.96 162.52 13.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.216 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 1.1 m-20 -155.26 -59.57 0.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.42 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -77.69 -10.13 59.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.63 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -92.58 -27.8 17.13 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.77 45.6 1.2 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.444 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.98 103.76 0.07 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.006 0.431 . . . . 0.0 111.29 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 41' ' ' ASP . 1.2 tm-20 -96.83 35.57 1.52 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.258 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.608 ' O ' HD11 ' A' ' 93' ' ' LEU . 2.0 mp -119.53 102.35 47.81 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.55 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.55 151.66 58.97 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.842 2.361 . . . . 0.0 112.664 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.31 -69.82 0.3 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.158 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.486 ' HB ' HD12 ' A' ' 50' ' ' ILE . 8.1 p -83.79 -58.12 2.93 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.759 0.314 . . . . 0.0 110.421 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.564 HD13 ' HE3' ' A' ' 95' ' ' LYS . 4.9 mp -130.91 -86.39 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.634 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 46.3 t80 46.43 89.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.007 0.432 . . . . 0.0 111.703 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -175.58 134.22 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.663 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.593 ' HG2' HG13 ' A' ' 90' ' ' VAL . 1.4 mttt -119.86 149.73 41.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 110.675 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.663 HG13 ' HD2' ' A' ' 67' ' ' ARG . 11.3 t -141.51 116.38 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.561 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.88 HG23 HG22 ' A' ' 88' ' ' ILE . 1.8 mp -103.98 138.52 28.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.22 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -132.28 139.4 48.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.842 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.619 ' ND1' HG21 ' A' ' 34' ' ' ILE . 3.0 p-80 -154.66 117.41 4.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.172 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.594 ' HB3' HD22 ' A' ' 105' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.504 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 C--O 1.235 0.357 0 CA-C-O 120.801 0.25 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.512 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -123.91 138.81 54.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.441 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.663 ' HD2' HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -141.76 126.12 17.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.58 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 1.7 m -105.96 104.98 14.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.935 0.398 . . . . 0.0 111.373 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -134.0 -55.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.048 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -146.02 33.76 1.01 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.106 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.01 159.71 63.3 Favored Pre-proline 0 N--CA 1.466 0.365 0 CA-C-O 120.762 0.315 . . . . 0.0 111.61 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -76.57 175.78 10.92 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.227 2.618 . . . . 0.0 112.58 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.444 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . 48.0 Cg_exo -56.09 175.25 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.875 2.383 . . . . 0.0 112.739 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -137.43 160.79 38.11 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.21 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -176.98 104.09 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.483 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.479 HD11 ' CD2' ' A' ' 74' ' ' PHE . 3.7 mp -139.65 132.7 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.045 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.67 122.95 24.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -137.28 167.56 21.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.601 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.1 173.37 6.42 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.778 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.67 -129.1 7.86 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.31 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -117.12 110.44 18.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.792 0.329 . . . . 0.0 110.627 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.2 88.71 0.09 OUTLIER Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.221 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -136.0 103.77 0.46 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.519 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.424 ' CD2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -150.78 168.18 11.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 120.486 0.184 . . . . 0.0 110.766 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.424 ' HD2' ' CD2' ' A' ' 84' ' ' PHE . 53.2 Cg_exo -56.91 173.34 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.973 2.449 . . . . 0.0 113.675 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 105' ' ' LEU . 3.3 mp -140.24 160.58 39.64 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.559 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -158.18 115.52 2.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.169 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.88 HG22 HG23 ' A' ' 55' ' ' ILE . 3.9 pt -113.82 105.21 18.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.242 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.4 p -112.37 136.99 51.17 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.01 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.593 HG13 ' HG2' ' A' ' 53' ' ' LYS . 5.7 t -131.62 119.27 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.344 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.586 ' C ' HD23 ' A' ' 92' ' ' LEU . 16.5 m-85 -125.59 155.96 39.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.947 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.677 HD11 HG21 ' A' ' 118' ' ' ILE . 0.2 OUTLIER -149.67 -171.44 3.9 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.765 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.608 HD11 ' O ' ' A' ' 46' ' ' ILE . 3.7 mt -77.26 136.43 38.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.832 0.348 . . . . 0.0 111.593 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 67.55 10.76 7.98 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.208 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.564 ' HE3' HD13 ' A' ' 50' ' ' ILE . 4.8 mmpt? 51.32 75.06 0.21 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.518 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.836 ' HB1' HG13 ' A' ' 120' ' ' ILE . . . -108.03 -28.14 9.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.965 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.444 ' N ' HD11 ' A' ' 92' ' ' LEU . . . -131.31 34.54 2.59 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.722 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.85 98.96 0.3 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.643 0.258 . . . . 0.0 110.602 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -141.86 125.86 17.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.361 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 2.0 pttp -131.07 132.84 45.16 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.736 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -137.21 119.66 11.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.507 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -87.16 149.87 8.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.925 2.416 . . . . 0.0 112.607 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 58.6 m80 -139.95 172.35 12.89 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.117 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.61 144.97 49.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.818 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.704 ' HB2' HD11 ' A' ' 86' ' ' LEU . 2.5 tp -127.37 88.35 2.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.795 0.331 . . . . 0.0 111.461 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -167.94 39.2 0.04 OUTLIER 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.432 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -141.62 124.88 16.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.391 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -56.74 130.01 43.69 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.69 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.414 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER 71.02 68.98 0.17 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.594 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -102.92 135.64 44.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.545 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.5 p -140.72 67.22 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.82 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -113.42 119.82 38.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.656 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.7 137.14 16.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.398 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.3 t -116.67 146.94 20.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.986 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -132.78 108.64 9.12 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.878 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.69 148.69 37.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.084 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.2 p -124.25 148.94 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.623 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.677 HG21 HD11 ' A' ' 92' ' ' LEU . 11.1 mt -133.94 110.88 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.444 ' O ' HD13 ' A' ' 120' ' ' ILE . 29.5 tt0 -130.3 104.5 7.31 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.401 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.836 HG13 ' HB1' ' A' ' 96' ' ' ALA . 21.2 mm -136.98 56.38 12.56 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 120.998 0.428 . . . . 0.0 111.473 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 C--N 1.348 0.508 0 C-N-CA 122.556 2.171 . . . . 0.0 112.468 179.614 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.753 0.311 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 7.2 p -140.79 127.81 21.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.275 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.03 110.36 19.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.163 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.557 ' NE ' HD13 ' A' ' 92' ' ' LEU . 39.0 mtp85 -109.24 157.22 19.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.269 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 t -165.94 124.95 1.61 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.469 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.4 tt -108.67 118.2 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 110.769 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' O ' HG22 ' A' ' 37' ' ' VAL . 22.6 mtp180 -125.24 131.08 53.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.607 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.912 HG21 HD13 ' A' ' 88' ' ' ILE . 1.3 pt -127.35 129.84 70.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.142 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.69 112.4 25.46 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.23 113.8 20.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -135.61 154.33 51.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.738 0.304 . . . . 0.0 111.166 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.62 138.17 23.22 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.267 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -135.2 119.43 17.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.967 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 30' ' ' ARG . 8.0 mt . . . . . 0 N--CA 1.462 0.137 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.738 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.936 0.398 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.526 ' HB3' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -116.83 162.12 18.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.446 ' CG ' ' HB3' ' A' ' 79' ' ' GLN . 2.6 mt-30 -124.2 159.83 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -158.47 160.61 36.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.262 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.1 p -146.73 121.91 10.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.523 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.4 tp -126.4 124.21 65.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.962 0.411 . . . . 0.0 110.949 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -127.2 135.81 51.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.632 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.759 HG21 HG13 ' A' ' 55' ' ' ILE . 8.0 mt -123.91 105.89 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.917 HG12 ' HB3' ' A' ' 73' ' ' PRO . 27.1 m -119.72 149.1 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.84 0.352 . . . . 0.0 111.6 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.5 HD21 ' CB ' ' A' ' 68' ' ' THR . 2.6 pp -172.04 151.89 2.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.265 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -108.05 162.51 13.98 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.514 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -174.19 -47.71 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.396 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -86.04 2.72 45.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -24.93 24.63 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 5' ' ' VAL . . . -112.35 -74.82 0.71 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.342 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.542 ' HD3' HD12 ' A' ' 46' ' ' ILE . 7.0 mmtp -87.98 -56.55 3.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 64.95 16.77 10.73 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.239 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.542 HD12 ' HD3' ' A' ' 44' ' ' LYS . 5.6 mt -109.86 140.99 22.8 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.033 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.56 174.41 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.94 2.427 . . . . 0.0 112.633 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB1' ' HG ' ' A' ' 93' ' ' LEU . . . -155.29 -164.49 1.78 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.375 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -66.9 -47.8 70.7 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.431 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.43 -86.28 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.623 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 29.3 t80 53.29 92.84 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.102 0.477 . . . . 0.0 111.384 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 2.8 t70 -172.43 116.22 0.33 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.696 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.523 ' CG ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -99.83 125.55 45.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.59 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.747 HG12 ' HG3' ' A' ' 67' ' ' ARG . 36.0 m -122.78 132.26 71.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.959 0.409 . . . . 0.0 111.56 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.759 HG13 HG21 ' A' ' 36' ' ' ILE . 1.3 mm -123.11 140.22 47.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.932 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -143.81 97.88 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.515 ' HB3' HD23 ' A' ' 86' ' ' LEU . 22.2 p80 -111.45 125.99 54.47 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.93 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.698 HD21 HD23 ' A' ' 105' ' ' LEU . 1.1 mt . . . . . 0 N--CA 1.463 0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.364 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--O 1.233 0.237 0 CA-C-O 120.8 0.25 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.42 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 5.9 m120 -96.79 130.64 44.01 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.747 ' HG3' HG12 ' A' ' 54' ' ' VAL . 1.5 mpp_? -145.61 112.63 6.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.61 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.5 ' CB ' HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -93.86 131.56 39.14 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -140.51 -54.05 0.51 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.603 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.95 36.48 0.4 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.741 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.19 163.35 34.32 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.01 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.85 171.66 2.72 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.865 2.377 . . . . 0.0 112.415 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.917 ' HB3' HG12 ' A' ' 37' ' ' VAL . 36.5 Cg_endo -64.89 169.43 11.77 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.632 2.221 . . . . 0.0 112.621 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.522 ' HB2' HD12 ' A' ' 36' ' ' ILE . 15.0 m-85 -117.06 64.26 0.72 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.713 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.54 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 24.4 tpt180 -82.81 90.74 6.95 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.776 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 74' ' ' PHE . 1.8 mp -126.84 131.82 70.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.388 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -136.65 123.24 20.97 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.536 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -133.79 177.91 7.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.579 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.446 ' HB3' ' CG ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -129.87 -179.22 5.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.066 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.49 -148.74 17.3 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.967 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.85 110.17 16.88 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.811 0.339 . . . . 0.0 110.861 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.07 -117.96 0.55 Allowed Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.118 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.11 114.79 2.32 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.679 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.452 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.0 m-85 -165.42 168.49 8.2 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 120.546 0.212 . . . . 0.0 110.976 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.489 ' C ' HD12 ' A' ' 86' ' ' LEU . 37.1 Cg_endo -65.81 -177.44 0.76 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.981 2.454 . . . . 0.0 113.014 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 105' ' ' LEU . 5.4 mp -146.15 166.08 27.25 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.751 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -158.71 123.63 4.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.783 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.912 HD13 HG21 ' A' ' 11' ' ' ILE . 33.9 mt -129.25 112.49 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.009 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.22 116.02 24.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.685 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.523 HG23 ' CG ' ' A' ' 53' ' ' LYS . 1.2 p -104.7 143.32 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.314 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 27.5 m-85 -133.26 155.78 48.76 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.524 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.623 HD23 ' HB3' ' A' ' 96' ' ' ALA . 4.6 tp -142.2 -63.17 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.731 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.568 ' HG ' ' HB1' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -144.6 -68.7 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.313 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -146.62 -63.49 0.3 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.359 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 51.53 1.2 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 111.185 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.623 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -104.41 -36.98 7.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.416 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . 180.0 46.04 0.08 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.535 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.426 ' CB ' ' HA ' ' A' ' 91' ' ' PHE . 11.4 pt-20 -111.34 111.02 21.77 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.08 0.467 . . . . 0.0 110.745 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.454 ' H ' HG12 ' A' ' 90' ' ' VAL . 5.4 ttt180 -142.29 151.79 42.35 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.303 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 0.2 OUTLIER -117.35 127.79 54.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.381 179.172 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.424 HG23 ' CE1' ' A' ' 103' ' ' HIS . 3.7 tt -139.24 121.42 10.21 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 121.024 0.44 . . . . 0.0 111.921 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.56 160.5 9.4 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.916 2.41 . . . . 0.0 112.393 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 38.1 m80 -144.69 172.21 13.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -124.33 145.04 49.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.115 0.483 . . . . 0.0 111.053 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.698 HD23 HD21 ' A' ' 58' ' ' LEU . 6.2 tp -139.16 78.63 1.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.378 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -161.82 38.94 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.367 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -141.47 130.39 23.12 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.168 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 2.4 pp -59.86 131.51 51.1 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.467 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.32 62.97 0.36 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.658 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -103.33 134.65 46.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.649 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.1 t -134.14 71.79 1.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.16 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.73 119.17 38.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.709 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -143.08 141.93 31.4 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.205 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 31.9 t -127.81 145.02 35.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -140.73 108.35 5.61 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.468 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.49 138.85 49.53 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.106 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.5 m -104.5 140.9 21.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.498 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 10.0 mt -138.05 111.08 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.36 119.1 35.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.649 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.401 HG12 HD21 ' A' ' 92' ' ' LEU . 1.2 mp -125.07 52.13 6.01 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.748 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 C--N 1.347 0.494 0 C-N-CA 122.488 2.125 . . . . 0.0 112.637 179.764 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.872 0.367 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -129.14 119.09 48.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.808 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -137.41 104.96 5.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.586 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -125.4 165.57 18.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.956 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.5 t -172.99 139.56 0.84 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.09 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.553 HG21 HG21 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -109.99 118.2 56.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.47 179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.8 mtt85 -124.78 105.3 9.18 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.621 HG21 ' CD1' ' A' ' 88' ' ' ILE . 2.2 pt -112.51 134.09 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.052 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.623 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -118.41 141.59 48.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.27 -179.554 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -138.55 109.75 6.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.081 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -120.97 136.68 54.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.502 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.516 ' HG3' HD21 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -140.06 150.43 44.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.671 0.272 . . . . 0.0 111.691 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -147.64 119.66 8.22 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.41 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.452 HG13 ' OE1' ' A' ' 15' ' ' GLN . 14.5 mt . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.972 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.874 HG13 ' HA2' ' A' ' 80' ' ' GLY . 25.5 t . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.5 0.191 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -109.42 163.55 13.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.311 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -134.05 111.02 10.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.571 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.437 ' HB3' ' HG3' ' A' ' 15' ' ' GLN . 23.3 p-90 -116.1 150.21 37.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.307 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -140.1 147.27 40.0 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 12' ' ' LYS . 5.7 tp -146.48 135.32 16.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.487 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 3.7 pm0 -134.97 144.57 47.47 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.822 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.445 HG21 ' CD1' ' A' ' 55' ' ' ILE . 4.2 mp -121.32 107.07 19.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.889 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.72 138.36 34.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.245 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.026 HD21 HG21 ' A' ' 68' ' ' THR . 0.6 OUTLIER -166.18 160.08 15.8 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.527 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -105.02 161.85 13.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -151.64 -63.17 0.18 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.678 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.09 -19.54 65.88 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.514 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -86.65 -32.66 20.43 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.196 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.57 48.08 0.97 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.28 106.31 0.04 OUTLIER 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.983 0.42 . . . . 0.0 111.3 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.24 16.34 6.38 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.932 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.1 mt -125.47 104.58 28.06 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-O 120.515 0.198 . . . . 0.0 111.409 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HA ' HD11 ' A' ' 93' ' ' LEU . 74.2 Cg_endo -75.33 -170.5 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.799 2.333 . . . . 0.0 112.556 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.83 -45.87 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.879 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.433 ' HB ' HD12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -93.65 -67.79 0.84 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.791 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.475 HD13 ' HD3' ' A' ' 95' ' ' LYS . 4.3 mp -133.38 -89.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.032 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 40.3 t80 58.72 100.14 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.2 0.524 . . . . 0.0 110.864 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.8 110.36 1.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.844 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.724 ' HD3' HD13 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -100.98 102.59 13.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.364 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.402 HG23 ' CG ' ' A' ' 67' ' ' ARG . 9.6 p -103.95 139.42 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.342 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 55' ' ' ILE . 3.7 mp -130.69 144.84 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.433 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.08 148.15 42.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.469 ' HB3' HD23 ' A' ' 86' ' ' LEU . 19.7 p80 -161.12 59.35 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.679 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.2 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.359 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo . . . . . 0 CA--C 1.529 0.234 0 CA-C-O 120.714 0.214 . . . . 0.0 112.618 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -109.96 128.67 55.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.701 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.402 ' CG ' HG23 ' A' ' 54' ' ' VAL . 76.2 mtt180 -144.8 139.51 27.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.997 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 1.026 HG21 HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -124.04 104.65 9.01 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.095 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -102.24 -41.4 6.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.107 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 t -170.53 43.25 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.495 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.19 166.18 20.64 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.236 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.79 172.48 5.79 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.898 2.399 . . . . 0.0 112.445 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.97 -179.03 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.778 2.319 . . . . 0.0 112.61 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -140.89 159.17 42.78 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -173.92 114.18 0.2 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.075 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -142.9 151.18 17.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.245 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -133.63 141.85 47.82 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.917 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 32' ' ' TRP . 13.6 mt-10 -133.79 152.08 51.77 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.959 0.409 . . . . 0.0 111.586 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.95 178.98 5.43 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.367 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.874 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 86.15 -103.72 2.81 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.67 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -121.69 112.12 18.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.085 0.469 . . . . 0.0 111.418 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.13 115.17 0.61 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.177 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.629 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . -166.4 103.85 0.21 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.392 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.445 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -150.55 167.8 12.27 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.648 0.261 . . . . 0.0 111.195 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.78 173.14 2.38 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.245 2.63 . . . . 0.0 113.325 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 105' ' ' LEU . 2.5 mp -142.62 160.11 40.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.32 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -157.6 113.4 2.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.799 0.333 . . . . 0.0 111.568 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.621 ' CD1' HG21 ' A' ' 11' ' ' ILE . 2.0 tt -116.47 121.79 68.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.533 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.6 121.94 26.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.115 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.578 HG13 ' HG2' ' A' ' 53' ' ' LYS . 5.8 t -99.95 154.3 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.643 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.47 ' CD2' ' HG3' ' A' ' 98' ' ' GLU . 51.4 m-85 -148.52 158.23 43.99 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.885 HD13 HG21 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -153.45 -175.13 5.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.134 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 47' ' ' PRO . 8.9 mp -60.93 -67.0 0.44 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.537 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -94.15 19.77 8.86 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.574 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.475 ' HD3' HD13 ' A' ' 50' ' ' ILE . 4.4 mmmm 58.35 55.36 5.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.17 -37.62 37.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 90' ' ' VAL . . . -122.49 26.39 6.32 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.606 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.0 tt0 -67.08 90.9 0.2 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.633 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -142.45 142.37 32.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.503 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -126.62 119.32 26.75 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.393 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.6 mt -128.77 120.72 20.68 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.482 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.2 154.83 8.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.004 2.47 . . . . 0.0 112.692 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 81.7 m-70 -140.12 172.1 13.23 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.396 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -128.54 124.6 36.4 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.114 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.629 HD13 ' HA2' ' A' ' 83' ' ' GLY . 1.3 tm? -113.56 95.03 5.13 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.761 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 13.6 t-20 178.8 41.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.062 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -137.4 125.27 22.61 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.663 0.268 . . . . 0.0 111.138 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.04 123.89 12.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.83 60.88 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.419 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.0 138.97 30.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.46 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.2 p -148.16 63.75 1.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.905 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -115.19 119.36 36.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.389 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -147.32 133.84 19.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.506 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 t -105.59 147.4 11.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.72 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -136.45 108.45 7.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.695 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -116.64 138.51 51.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.8 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.62 140.92 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.986 0.422 . . . . 0.0 111.555 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.885 HG21 HD13 ' A' ' 92' ' ' LEU . 2.0 mp -130.56 111.39 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.585 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -122.5 136.95 55.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.214 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 120' ' ' ILE . 6.9 tt -160.24 55.85 0.75 Allowed Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 121.286 0.565 . . . . 0.0 111.21 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 C--N 1.347 0.499 0 C-N-CA 122.719 2.28 . . . . 0.0 112.531 179.904 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.738 0.304 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 44' ' ' LYS . 19.4 t -133.42 119.24 34.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.078 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -137.03 104.89 5.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.159 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.491 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -132.57 172.98 11.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.189 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.9 t -173.22 141.36 0.93 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.702 HG21 HG21 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -109.2 118.14 55.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 110.636 179.673 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.8 mtt-85 -124.75 118.25 25.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.802 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 36' ' ' ILE . 1.6 pt -123.56 129.81 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.661 ' O ' HD12 ' A' ' 34' ' ' ILE . 34.2 mtmt -108.19 133.09 52.93 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -131.33 104.2 6.89 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 25.3 tm0? -115.1 137.98 51.4 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.698 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 31' ' ' GLN . 21.0 tt0 -139.39 151.98 46.75 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.751 0.31 . . . . 0.0 111.705 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -150.0 119.18 6.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.722 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 40.8 mt . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.75 0.309 . . . . 0.0 110.648 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HB ' ' HA2' ' A' ' 80' ' ' GLY . 7.3 m . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.95 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.408 ' HB3' HG12 ' A' ' 17' ' ' ILE . 2.8 mtt-85 -136.08 163.43 30.34 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.213 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 3.7 mt-30 -118.54 148.94 42.12 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.075 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.464 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 15.0 p-90 -156.11 155.23 32.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.103 0.478 . . . . 0.0 112.145 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.1 t -149.29 117.74 6.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.539 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 12' ' ' LYS . 9.3 tp -122.29 143.05 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.428 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 4.0 pt-20 -144.64 118.73 9.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.833 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.744 ' HA ' HG22 ' A' ' 11' ' ' ILE . 4.6 mp -101.07 110.35 27.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.676 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 73' ' ' PRO . 24.3 t -124.03 147.8 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.721 0.296 . . . . 0.0 111.589 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.619 ' HB3' HD12 ' A' ' 9' ' ' ILE . 2.9 pp -156.89 171.2 20.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.255 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 7' ' ' ARG . 2.5 tp -120.18 159.02 25.72 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.21 -45.62 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.287 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.3 2.58 15.29 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.43 -36.52 26.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.577 0.227 . . . . 0.0 111.007 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.4 -66.96 0.25 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.809 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.829 ' HB2' HG22 ' A' ' 5' ' ' VAL . 4.2 mttt -155.07 108.92 2.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.558 0.218 . . . . 0.0 110.849 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -90.08 49.62 1.74 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.751 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.441 HD13 ' HD3' ' A' ' 44' ' ' LYS . 3.7 mp -127.45 132.93 24.57 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.216 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.85 -177.98 4.01 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.84 2.36 . . . . 0.0 112.565 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.62 -54.53 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.25 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.8 p -125.82 -55.09 1.51 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.347 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 91' ' ' PHE . 0.6 OUTLIER -118.9 -86.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.015 179.078 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 t80 56.23 96.82 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.075 0.464 . . . . 0.0 111.213 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -174.41 127.52 0.34 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.664 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.857 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -114.55 133.09 56.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.806 0.336 . . . . 0.0 110.703 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.49 HG13 ' HG3' ' A' ' 67' ' ' ARG . 6.7 t -132.44 118.82 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.645 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.512 HG21 HG12 ' A' ' 36' ' ' ILE . 3.6 mp -106.99 144.91 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.382 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -138.95 144.87 39.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.068 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.5 ' HB3' HD23 ' A' ' 86' ' ' LEU . 1.7 p80 -167.27 137.31 2.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.691 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 2.6 mt . . . . . 0 N--CA 1.468 0.433 0 O-C-N 123.267 0.354 . . . . 0.0 111.044 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo . . . . . 0 CA--C 1.532 0.383 0 CA-C-O 120.671 0.196 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.427 ' ND2' HD13 ' A' ' 36' ' ' ILE . 58.6 t30 -108.11 139.76 42.29 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.0 0.429 . . . . 0.0 111.164 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG3' HG13 ' A' ' 54' ' ' VAL . 3.6 mpp_? -137.04 147.4 46.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.749 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.44 HG21 ' CD2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -132.77 123.83 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.061 0.458 . . . . 0.0 111.396 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -136.05 -54.46 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.311 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 t -155.65 39.34 0.38 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -123.5 155.75 65.24 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -57.25 172.72 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.08 2.52 . . . . 0.0 112.819 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.847 ' HB3' HG22 ' A' ' 37' ' ' VAL . 32.6 Cg_exo -57.88 166.96 4.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.881 2.387 . . . . 0.0 112.939 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -127.8 84.46 2.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.658 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.2 ttp85 -99.85 113.91 26.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.45 115.7 18.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -122.18 144.08 49.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.3 166.64 32.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.943 0.402 . . . . 0.0 111.449 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -123.65 170.52 10.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' A' ' 29' ' ' VAL . . . 98.35 -81.8 0.62 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.472 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -113.61 116.61 29.77 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' HA3' ' CD1' ' A' ' 32' ' ' TRP . . . -170.99 88.29 0.09 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.763 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -160.26 74.64 0.2 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.666 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.552 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 22.7 m-85 -143.37 165.7 23.95 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 120.632 0.253 . . . . 0.0 111.35 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 37.3 Cg_endo -65.38 171.1 9.78 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.136 2.557 . . . . 0.0 113.729 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 103' ' ' HIS . 5.1 mp -143.29 159.59 42.06 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.964 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -155.37 112.71 3.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.663 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.479 HG23 HG13 ' A' ' 55' ' ' ILE . 3.2 mp -117.52 124.46 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.685 0.279 . . . . 0.0 111.319 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.1 p -126.59 131.89 51.41 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.857 HG13 ' HG2' ' A' ' 53' ' ' LYS . 24.2 t -124.42 137.46 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.022 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.52 ' HB3' HD12 ' A' ' 50' ' ' ILE . 11.5 m-85 -131.61 154.9 48.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.349 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' ' 96' ' ' ALA . 2.5 tm? -141.15 -53.84 0.47 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.112 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' A' ' 92' ' ' LEU . 5.5 tt -152.48 -52.06 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.157 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -170.25 -63.63 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.563 0.22 . . . . 0.0 111.143 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.54 21.95 8.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.407 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.8 ' HB3' HD12 ' A' ' 92' ' ' LEU . . . -87.12 -50.86 6.34 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.802 0.334 . . . . 0.0 110.696 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -149.88 23.54 1.15 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.687 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -76.66 84.76 3.31 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.731 0.301 . . . . 0.0 110.789 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -142.28 146.04 34.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.148 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -124.87 147.75 48.63 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.471 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 114' ' ' VAL . 8.2 tp -148.0 111.77 3.83 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 121.008 0.433 . . . . 0.0 111.879 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -85.99 133.25 4.13 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.033 2.489 . . . . 0.0 112.342 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 1.7 m-70 -113.18 163.34 14.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.303 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.44 138.46 54.01 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.484 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 6.0 tp -123.48 92.12 3.62 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.653 0.263 . . . . 0.0 110.911 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -167.98 33.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -141.91 126.28 17.66 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.808 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 2.9 pp -58.21 131.85 51.8 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.748 0.309 . . . . 0.0 110.679 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 73.09 67.16 0.11 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.63 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 32.5 tt0 -92.45 141.28 28.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 t -144.8 64.86 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.02 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 119.27 38.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.55 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 12' ' ' LYS . 7.5 tt0 -141.67 131.37 24.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.213 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.633 HG21 HG21 ' A' ' 101' ' ' ILE . 43.5 t -116.43 140.4 38.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -133.46 108.54 8.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.62 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.27 119.07 36.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.54 144.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.574 HG21 ' HG ' ' A' ' 92' ' ' LEU . 35.2 mt -134.6 111.15 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.63 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.46 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -128.38 106.13 8.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.174 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 119' ' ' GLN . 16.1 mm -135.4 62.03 47.68 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.192 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--N 1.347 0.464 0 C-N-CA 122.352 2.035 . . . . 0.0 112.871 -179.835 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.184 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.4 119.26 48.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.128 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -129.22 106.07 8.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.545 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 46.9 mtt85 -123.46 152.71 41.39 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.996 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.889 HG22 HD23 ' A' ' 39' ' ' LEU . 6.9 t -160.96 143.95 12.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 90' ' ' VAL . 1.0 OUTLIER -117.17 125.04 73.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 111.099 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.568 ' O ' HG22 ' A' ' 37' ' ' VAL . 28.2 mtt85 -132.06 108.83 9.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.552 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.436 HD13 HD13 ' A' ' 88' ' ' ILE . 1.3 pt -117.78 132.15 68.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.069 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.612 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.1 mptm? -118.21 139.17 51.69 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.445 HG22 HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -137.09 102.91 4.97 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.7 tt0 -113.69 118.76 35.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.224 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.56 ' HB2' HD11 ' A' ' 105' ' ' LEU . 13.5 tt0 -119.98 146.34 45.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 111.914 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.435 ' CD2' ' HB3' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -146.72 119.8 8.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.438 ' O ' HD23 ' A' ' 108' ' ' LEU . 26.1 mt . . . . . 0 CA--C 1.529 0.142 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.179 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -104.09 160.41 14.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.997 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.435 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 1.0 OUTLIER -135.84 113.57 11.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.673 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.695 ' CG ' HD21 ' A' ' 105' ' ' LEU . 14.1 p-90 -121.8 154.63 36.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.766 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 t -136.71 118.61 15.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.529 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 12' ' ' LYS . 6.3 tp -119.18 136.95 54.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.527 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -135.32 138.88 43.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.346 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.772 HG21 ' CD1' ' A' ' 55' ' ' ILE . 2.9 mp -123.9 105.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.844 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 73' ' ' PRO . 31.2 m -115.59 150.48 17.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.919 0.39 . . . . 0.0 111.499 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.812 HD21 HG21 ' A' ' 68' ' ' THR . 0.5 OUTLIER -172.51 178.95 2.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.243 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.889 HD23 HG22 ' A' ' 8' ' ' THR . 2.9 mm? -103.88 165.84 10.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.293 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -167.28 -50.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.446 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.15 -31.43 65.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.465 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' HB2' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -82.78 -36.63 25.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.045 -179.577 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.19 50.07 1.11 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.824 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.9 mttm 52.85 96.62 0.01 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.89 0.376 . . . . 0.0 111.42 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -24.8 59.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.588 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 46' ' ' ILE . 3.5 mp -82.51 114.75 53.89 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.865 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.85 -175.3 1.14 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.594 2.196 . . . . 0.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -145.49 -51.27 0.25 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.674 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.404 HG22 HD12 ' A' ' 50' ' ' ILE . 14.0 m -104.77 -69.67 0.8 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.835 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 49' ' ' THR . 2.7 mp -132.53 -85.07 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.838 -0.165 . . . . 0.0 111.019 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 39.0 t80 56.15 95.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.044 0.45 . . . . 0.0 111.505 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -159.16 111.86 2.22 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.498 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.926 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -99.21 121.68 41.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.64 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.411 HG12 ' OG ' ' A' ' 89' ' ' SER . 12.2 p -120.81 128.19 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 0.0 111.109 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.772 ' CD1' HG21 ' A' ' 36' ' ' ILE . 3.3 mp -116.63 145.24 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.434 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -142.82 128.2 18.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.41 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 3.6 p80 -127.57 135.65 50.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.771 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.279 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.53 0.296 0 CA-C-O 120.549 0.145 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.413 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 10.0 m120 -111.74 127.39 55.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.819 0.342 . . . . 0.0 111.052 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.4 ttt-85 -143.37 122.96 13.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.71 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.812 HG21 HD21 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -106.63 139.32 41.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -159.86 -55.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.119 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.33 38.03 1.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.035 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.83 160.19 67.73 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.505 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -62.13 174.74 2.34 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.16 2.573 . . . . 0.0 112.649 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.612 ' HB2' HG12 ' A' ' 37' ' ' VAL . 65.7 Cg_endo -74.21 148.73 39.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.74 2.293 . . . . 0.0 112.712 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -99.13 155.79 17.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.01 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.96 86.91 0.1 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.5 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -136.67 151.94 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.319 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -122.45 157.72 31.33 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.994 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.97 141.14 49.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.182 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.88 136.04 53.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.743 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 30' ' ' ARG . . . 128.19 -156.43 20.8 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.839 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -75.81 131.12 39.55 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.055 0.455 . . . . 0.0 111.312 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.9 -127.86 1.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.939 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.04 104.37 0.13 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.752 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 3.4 m-85 -155.5 170.8 8.14 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 120.707 0.289 . . . . 0.0 111.25 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 87.8 Cg_exo -49.86 170.25 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.477 2.785 . . . . 0.0 114.177 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD23 HD11 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -135.16 159.66 40.83 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.72 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -156.21 120.94 4.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.926 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.583 HG23 HG13 ' A' ' 55' ' ' ILE . 3.1 mp -135.33 124.0 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.275 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.411 ' OG ' HG12 ' A' ' 54' ' ' VAL . 1.4 p -123.61 122.23 37.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.95 0.405 . . . . 0.0 110.302 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.926 HG13 ' HG2' ' A' ' 53' ' ' LYS . 19.2 t -107.4 111.88 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.069 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -102.9 157.54 16.9 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.781 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.628 HD11 ' CB ' ' A' ' 95' ' ' LYS . 1.3 pt? -146.27 -159.81 1.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.612 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 12.4 mt -55.59 -66.85 0.35 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.409 0.147 . . . . 0.0 111.014 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -177.37 42.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.221 0.534 . . . . 0.0 110.42 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.672 ' HD2' HG21 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -110.96 -166.24 1.06 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.026 -179.512 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.65 -13.44 61.36 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.817 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.12 -27.91 57.94 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.097 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -65.26 83.43 0.05 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.107 0.48 . . . . 0.0 110.624 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.46 155.45 45.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.545 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -121.54 145.89 47.5 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.615 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.793 HG21 HG21 ' A' ' 114' ' ' VAL . 3.7 mp -138.59 114.47 8.77 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.468 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -88.63 155.85 6.32 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.082 2.522 . . . . 0.0 112.254 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -140.26 172.02 13.33 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.034 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.66 119.32 21.24 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.2 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.695 HD21 ' CG ' ' A' ' 32' ' ' TRP . 4.3 tp -112.95 86.5 2.38 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -165.36 39.83 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -142.09 139.75 32.32 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.458 HD12 ' H ' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -62.03 127.36 31.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.368 179.374 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 64.9 79.02 0.26 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.245 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 39.3 tt0 -109.63 136.38 49.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.014 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -133.69 70.95 1.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.106 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -110.09 119.1 38.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.059 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -154.57 132.23 11.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.415 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.793 HG21 HG21 ' A' ' 101' ' ' ILE . 25.0 t -109.59 145.72 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.678 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -132.16 108.65 9.41 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.079 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.424 ' HB3' HG22 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -113.29 151.71 30.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.7 149.31 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.957 0.408 . . . . 0.0 111.871 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.3 mt -143.29 110.97 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.507 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -129.79 118.33 21.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.637 0.256 . . . . 0.0 111.28 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.672 HG21 ' HD2' ' A' ' 95' ' ' LYS . 1.6 pp -138.2 48.58 2.03 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.83 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 120' ' ' ILE . 71.1 Cg_endo . . . . . 0 C--N 1.351 0.704 0 C-N-CA 122.56 2.173 . . . . 0.0 112.866 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.582 0.23 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 44' ' ' LYS . 19.0 t -123.38 119.43 57.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.097 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.72 104.85 5.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.19 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.401 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 47.3 mtt180 -134.59 175.44 9.53 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.038 0.447 . . . . 0.0 111.258 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 4.9 t -160.77 146.05 14.45 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.335 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.812 HD11 HD11 ' A' ' 88' ' ' ILE . 1.6 tt -113.87 118.05 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-O 120.931 0.396 . . . . 0.0 110.784 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -130.29 111.13 12.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.505 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.839 HD11 HG21 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -122.06 142.27 39.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.121 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.564 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -120.59 138.4 53.91 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.755 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.404 HG23 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -142.2 120.12 12.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.161 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -130.33 160.14 34.84 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.77 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -152.86 142.04 21.44 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.279 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -131.96 119.67 21.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.733 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.4 mt . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.608 179.67 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.404 HG22 ' HE1' ' A' ' 81' ' ' TRP . 40.2 t . . . . . 0 N--CA 1.464 0.235 0 CA-C-O 120.69 0.281 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.42 162.37 26.5 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.355 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.413 ' CG ' ' HB3' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -119.53 162.14 19.42 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -158.87 141.47 14.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.195 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -138.38 117.65 12.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.564 HD12 ' O ' ' A' ' 12' ' ' LYS . 8.1 tp -127.55 139.74 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.988 0.423 . . . . 0.0 111.953 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.444 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -143.46 132.98 23.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.673 179.304 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.656 HD12 HG21 ' A' ' 55' ' ' ILE . 5.4 mm -113.62 111.58 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.212 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.68 133.76 64.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.707 0.289 . . . . 0.0 110.966 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.583 HD13 ' HE2' ' A' ' 53' ' ' LYS . 4.0 pp -169.37 174.95 5.76 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.582 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.9 mm? -114.94 160.92 18.98 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.413 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -167.83 -49.36 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.16 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.72 1.91 28.24 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -83.94 -34.78 24.39 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 111.052 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.9 -75.17 0.93 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.868 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.679 ' HB2' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -119.43 112.08 18.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.608 0.242 . . . . 0.0 110.79 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -104.6 30.5 5.36 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.191 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 mt -132.32 124.2 19.11 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.293 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.32 168.57 24.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.877 2.385 . . . . 0.0 112.538 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.764 ' HB3' HD23 ' A' ' 93' ' ' LEU . . . -154.42 -50.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.652 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 p -121.63 -68.1 0.92 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.716 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.711 HD11 ' HE2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -126.19 -89.67 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.168 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 13.2 t80 57.47 95.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.993 0.425 . . . . 0.0 111.522 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -165.95 125.61 1.68 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.623 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.602 ' CG ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -110.84 105.22 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.368 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.0 140.58 24.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.39 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.656 HG21 HD12 ' A' ' 36' ' ' ILE . 3.5 mp -123.86 141.5 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.963 0.411 . . . . 0.0 111.327 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -128.78 154.9 45.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.765 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 19.2 p80 -164.82 137.61 4.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.769 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.607 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo . . . . . 0 CA--C 1.532 0.402 0 CA-C-O 120.809 0.254 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.431 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 29.1 m-20 -87.71 150.83 23.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.041 0.448 . . . . 0.0 111.559 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.62 136.67 18.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.577 HG21 HD11 ' A' ' 38' ' ' LEU . 22.9 m -129.41 108.08 10.0 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -141.92 -54.07 0.44 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.257 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 p -140.08 33.9 1.93 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.135 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.42 164.05 42.27 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.277 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.79 168.43 22.94 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.803 2.335 . . . . 0.0 112.696 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.79 161.54 45.54 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.721 2.281 . . . . 0.0 112.845 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.409 ' HB2' HG12 ' A' ' 36' ' ' ILE . 34.0 m-85 -105.22 154.7 19.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.219 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.04 71.83 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.61 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 mt -130.47 141.01 47.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.414 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.57 138.77 47.56 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.526 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -140.23 167.54 21.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.002 0.43 . . . . 0.0 111.453 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.413 ' HB3' ' CG ' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -129.9 141.53 50.79 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.847 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.41 -131.75 2.36 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.604 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.404 ' HE1' HG22 ' A' ' 29' ' ' VAL . 7.9 m0 -120.2 110.33 16.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.882 0.373 . . . . 0.0 110.848 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.46 -126.54 0.86 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.389 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.41 94.04 1.52 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.574 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.514 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.1 m-85 -156.13 169.92 9.68 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.63 0.252 . . . . 0.0 111.088 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 58.6 Cg_endo -72.01 172.35 14.84 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.767 2.311 . . . . 0.0 113.38 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.452 ' CG ' ' HB2' ' A' ' 103' ' ' HIS . 0.4 OUTLIER -146.46 159.69 43.08 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.517 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -149.55 119.0 6.88 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.678 0.275 . . . . 0.0 111.383 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.839 HG21 HD11 ' A' ' 11' ' ' ILE . 5.0 tt -111.11 114.12 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -110.15 135.0 51.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.602 HG23 ' CG ' ' A' ' 53' ' ' LYS . 3.8 p -122.15 138.65 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.966 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -134.69 157.58 46.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.547 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.529 HD11 ' H ' ' A' ' 96' ' ' ALA . 1.4 pt? -146.02 -163.47 1.74 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.764 HD23 ' HB3' ' A' ' 48' ' ' ALA . 2.5 mp -97.02 -16.78 20.4 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.469 ' HB2' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -108.35 1.77 22.06 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.711 ' HE2' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER 48.24 37.42 8.29 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.529 ' H ' HD11 ' A' ' 92' ' ' LEU . . . -95.01 -50.44 5.1 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.613 0.244 . . . . 0.0 111.39 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.03 16.86 56.92 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.893 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 23.4 tt0 -70.78 96.43 1.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.82 0.31 . . . . 0.0 110.559 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.534 ' H ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.57 156.92 45.16 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.849 -179.388 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -118.58 139.42 51.51 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.464 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.586 ' O ' HG22 ' A' ' 88' ' ' ILE . 1.8 mp -128.03 99.7 24.96 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-O 120.941 0.4 . . . . 0.0 111.38 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -87.89 144.32 6.24 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.032 2.488 . . . . 0.0 112.422 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.452 ' CE1' HG22 ' A' ' 101' ' ' ILE . 38.9 m80 -136.92 172.15 13.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -121.42 151.24 40.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.405 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 tp -139.06 85.32 2.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 0.0 110.624 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -161.41 38.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.519 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -141.68 134.04 28.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.396 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 pp -58.74 131.09 49.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.508 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 62.25 75.4 0.4 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.027 0.441 . . . . 0.0 110.599 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -105.33 135.67 46.28 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.018 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t -136.87 74.43 1.49 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.165 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -113.64 119.14 36.41 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.383 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -148.21 136.44 21.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.09 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.505 ' CG1' HD11 ' A' ' 11' ' ' ILE . 6.3 p -116.94 143.2 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.81 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.34 122.03 20.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.078 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.74 159.22 37.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.49 138.09 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.485 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.25 110.75 26.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.175 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -130.03 120.36 24.59 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.469 HD13 ' HB2' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -146.56 55.38 2.54 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 C--N 1.354 0.823 0 C-N-CA 122.484 2.123 . . . . 0.0 112.86 179.645 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 121' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.733 0.301 . . . . 0.0 110.66 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 43' ' ' GLY . 29.7 t -134.96 118.91 25.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.755 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.77 106.28 5.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.675 ' NH1' HD11 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -124.05 167.55 14.04 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.632 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -178.06 133.0 0.15 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.902 HG21 HG21 ' A' ' 90' ' ' VAL . 3.6 tt -106.14 118.22 53.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.059 0.457 . . . . 0.0 110.834 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -116.56 107.05 14.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.012 HD13 HG21 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -110.38 135.13 50.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -120.14 138.68 53.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.998 -179.543 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 105' ' ' LEU . 1.2 m -141.07 113.99 8.42 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 3.9 mt-30 -127.02 147.71 50.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.677 0.275 . . . . 0.0 111.078 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -138.88 145.08 39.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -143.32 119.3 10.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.827 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 10.2 mt . . . . . 0 C--N 1.332 -0.168 0 CA-C-O 120.738 0.304 . . . . 0.0 110.792 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.531 HG13 ' HA2' ' A' ' 80' ' ' GLY . 21.9 t . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.888 0.375 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.35 159.4 23.48 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.107 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -116.59 158.51 23.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -157.6 145.49 18.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.334 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 p -146.04 117.56 8.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.652 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 2.3 tp -130.34 134.74 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.46 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.9 pt-20 -136.47 135.08 38.32 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.471 ' CG2' HG13 ' A' ' 55' ' ' ILE . 4.1 mp -110.06 114.83 48.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.716 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.7 t -125.2 135.69 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.277 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.716 HD11 HG21 ' A' ' 68' ' ' THR . 1.4 pp -157.69 154.23 27.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.424 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 42' ' ' GLU . 2.5 mp -99.58 161.89 13.35 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.598 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -174.72 -46.9 0.01 OUTLIER 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.06 -19.59 65.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.363 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HB2' HD23 ' A' ' 39' ' ' LEU . 1.9 mt-10 -98.69 -36.7 9.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.244 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.662 ' O ' HG13 ' A' ' 5' ' ' VAL . . . -99.9 45.85 1.46 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.875 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt 62.01 100.98 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.08 48.47 1.37 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.198 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.1 mt -128.0 110.92 20.12 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.291 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.77 161.4 10.25 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.153 2.569 . . . . 0.0 113.036 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.64 -54.0 0.82 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.628 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.403 HG22 HG13 ' A' ' 50' ' ' ILE . 32.0 m -117.06 -63.49 1.44 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.93 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.403 HG13 HG22 ' A' ' 49' ' ' THR . 64.2 mt -120.82 -78.12 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.795 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.7 t80 57.75 98.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.284 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 9.9 t70 -172.53 107.45 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.898 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.507 ' CG ' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -91.34 128.92 37.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.488 HG23 ' OG ' ' A' ' 89' ' ' SER . 3.0 m -132.16 116.28 28.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 121.086 0.47 . . . . 0.0 111.654 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.991 HG23 HG22 ' A' ' 88' ' ' ILE . 2.3 mm -106.75 155.67 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -142.24 141.13 32.46 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.408 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 14.5 p-80 -150.44 119.55 6.74 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.935 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 105' ' ' LEU . 5.7 mp . . . . . 0 N--CA 1.466 0.351 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.328 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo . . . . . 0 C--O 1.233 0.266 0 CA-C-O 120.606 0.169 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -110.62 128.1 55.54 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.886 0.374 . . . . 0.0 111.185 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.87 105.8 3.59 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.482 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.716 HG21 HD11 ' A' ' 38' ' ' LEU . 6.2 m -97.46 116.6 29.97 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.254 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -121.66 -51.23 2.05 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.96 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 p -147.33 35.36 0.89 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.77 157.94 58.37 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.302 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.82 172.48 10.59 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.093 2.528 . . . . 0.0 112.607 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.9 177.67 1.3 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.822 2.348 . . . . 0.0 112.383 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -141.74 163.47 32.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.914 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER -174.96 121.55 0.22 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -140.18 131.14 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.195 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.0 113.64 10.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.816 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -139.51 174.16 10.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.535 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.52 168.9 11.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.115 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.531 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 128.3 -121.67 3.77 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.324 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -118.34 110.94 18.1 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.776 0.322 . . . . 0.0 110.481 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.35 112.45 0.41 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.927 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -165.93 109.19 0.35 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.612 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 6.7 m-85 -160.85 170.65 8.13 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 120.397 0.141 . . . . 0.0 110.983 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.74 169.81 3.06 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.125 2.55 . . . . 0.0 113.253 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 105' ' ' LEU . 3.6 mp -143.03 168.28 20.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.219 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 25.9 t0 -158.78 119.33 3.26 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.716 0.293 . . . . 0.0 111.651 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.012 HG21 HD13 ' A' ' 11' ' ' ILE . 1.1 pp -112.68 109.51 28.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 111.151 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.488 ' OG ' HG23 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -122.14 111.41 16.94 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.498 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 9' ' ' ILE . 19.2 t -105.29 145.65 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.607 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 11.8 m-85 -131.66 152.81 50.57 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.72 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.893 HD22 HG21 ' A' ' 118' ' ' ILE . 5.4 tp -141.65 -54.46 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.089 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 92' ' ' LEU . 1.2 mp -143.2 -70.46 0.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.834 0.349 . . . . 0.0 110.596 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' HB3' ' HD3' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -161.92 -49.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.73 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.436 ' HD3' ' HB3' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -140.47 29.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.563 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.689 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -98.03 -45.63 6.19 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.972 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA3' HG12 ' A' ' 118' ' ' ILE . . . -158.75 43.18 0.48 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.304 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 3.8 tt0 -100.35 99.34 9.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.539 0.209 . . . . 0.0 110.947 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -142.52 149.06 38.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.736 0.303 . . . . 0.0 111.52 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -134.33 137.3 44.09 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.145 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.4 mt -144.41 121.83 6.56 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.386 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 98.0 Cg_endo -79.29 147.07 20.21 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.62 2.214 . . . . 0.0 112.363 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.27 172.58 11.67 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.164 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -131.24 138.8 49.49 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.063 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.548 ' HB2' HD11 ' A' ' 86' ' ' LEU . 4.0 tp -131.21 83.12 2.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.838 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -160.94 35.25 0.15 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.308 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -138.85 132.2 30.14 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -58.98 125.24 22.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.512 179.427 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 71.31 70.79 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.19 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 1.2 tp10 -107.33 138.01 44.32 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.481 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p -137.7 73.18 1.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.853 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -109.72 119.35 39.12 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.413 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -152.13 127.62 10.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.788 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -104.04 145.68 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.744 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.85 108.53 9.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.547 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.36 123.75 50.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.77 142.56 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 111.684 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.893 HG21 HD22 ' A' ' 92' ' ' LEU . 3.5 mp -131.34 120.74 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.751 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -127.29 121.35 30.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.448 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.553 HD11 ' NH1' ' A' ' 7' ' ' ARG . 2.7 pt -153.92 65.13 5.07 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.607 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.636 ' HB3' HG22 ' A' ' 4' ' ' THR . 39.1 Cg_endo . . . . . 0 C--N 1.347 0.451 0 C-N-CA 122.54 2.16 . . . . 0.0 112.884 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.784 0.326 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.462 HG13 ' CA ' ' A' ' 43' ' ' GLY . 21.9 t -124.64 119.02 55.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.727 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -135.77 105.82 6.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.7 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 25.8 mtt-85 -123.23 159.54 28.48 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.033 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 t -173.34 129.31 0.45 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.752 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 36' ' ' ILE . 2.3 tt -108.38 118.26 55.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.925 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.97 110.11 16.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.663 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.3 pt -115.86 137.06 50.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.533 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.5 mptp? -121.55 137.98 54.5 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.044 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.488 HG22 ' HG ' ' A' ' 105' ' ' LEU . 3.5 m -140.65 104.62 4.77 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -121.5 154.19 36.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.938 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.52 ' HB2' HD21 ' A' ' 105' ' ' LEU . 1.4 tt0 -154.65 143.2 20.64 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.014 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -135.02 119.36 17.84 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.716 0.293 . . . . 0.0 111.097 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 14.9 mt . . . . . 0 C--O 1.233 0.226 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.783 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.495 HG13 ' HA2' ' A' ' 80' ' ' GLY . 30.2 t . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.715 0.293 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -126.05 152.7 45.45 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.204 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.62 154.43 21.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.187 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -152.81 137.58 17.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.053 0.454 . . . . 0.0 111.559 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.4 t -141.53 117.7 10.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.509 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 12' ' ' LYS . 9.1 tp -128.55 144.57 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.291 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.41 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -158.4 154.83 27.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.973 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.968 HG21 HD13 ' A' ' 55' ' ' ILE . 18.8 tt -148.3 125.46 2.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.965 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.777 HG12 ' HB3' ' A' ' 73' ' ' PRO . 27.7 m -128.89 123.74 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.198 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.588 HD22 ' CG2' ' A' ' 68' ' ' THR . 0.9 OUTLIER -137.83 142.51 40.78 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 3.7 mm? -80.47 165.9 21.73 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.833 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.94 -65.94 0.16 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -64.4 -21.3 66.59 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.638 0.256 . . . . 0.0 111.09 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.92 -31.13 22.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.643 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.462 ' CA ' HG13 ' A' ' 5' ' ' VAL . . . -106.48 40.39 2.52 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.49 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 mttt 64.14 97.18 0.04 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 110.978 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -69.59 -12.44 61.64 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.662 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.56 134.96 46.93 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-O 120.525 0.203 . . . . 0.0 111.07 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.42 -172.85 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.687 2.258 . . . . 0.0 112.628 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.688 ' CB ' HD21 ' A' ' 93' ' ' LEU . . . -162.29 -64.1 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.605 ' OG1' HD23 ' A' ' 93' ' ' LEU . 25.6 m -116.31 -51.8 2.6 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.397 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.685 HD12 ' HB3' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -133.79 -83.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.783 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.1 t80 54.4 94.82 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.136 0.493 . . . . 0.0 111.13 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -171.82 143.82 1.7 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.271 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -137.61 134.47 35.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 111.238 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.634 HG13 ' CD ' ' A' ' 67' ' ' ARG . 21.7 t -117.92 145.82 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.531 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.968 HD13 HG21 ' A' ' 36' ' ' ILE . 2.8 mt -123.99 134.08 67.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.775 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 65' ' ' PRO . 49.6 m-85 -135.04 135.02 40.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.91 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -157.47 130.14 7.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.22 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 1.8 mt . . . . . 0 C--O 1.234 0.242 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 39.1 Cg_exo . . . . . 0 N--CA 1.474 0.35 0 N-CA-C 112.788 0.265 . . . . 0.0 112.788 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.5 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.0 m-20 -101.67 151.43 22.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.471 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.634 ' CD ' HG13 ' A' ' 54' ' ' VAL . 7.6 mmm-85 -144.93 156.11 43.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.853 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.709 ' OG1' HD11 ' A' ' 55' ' ' ILE . 87.5 m -134.71 112.82 11.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.859 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.493 ' HD1' HG23 ' A' ' 70' ' ' THR . 1.7 t80 -153.18 -51.03 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.838 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.493 HG23 ' HD1' ' A' ' 69' ' ' PHE . 55.6 p -144.17 30.18 1.29 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.835 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -123.49 150.92 62.29 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.206 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 38.1 Cg_exo -60.85 166.75 9.76 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.086 2.524 . . . . 0.0 112.466 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.777 ' HB3' HG12 ' A' ' 37' ' ' VAL . 27.8 Cg_exo -62.18 -173.22 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.042 2.495 . . . . 0.0 112.693 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.73 161.08 39.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 111.757 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.73 94.77 0.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.661 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.66 111.19 35.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -131.92 124.57 29.72 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.027 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -153.86 168.2 27.15 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.707 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -112.8 149.36 33.15 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.982 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.495 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 137.93 -113.84 1.02 Allowed Glycine 0 C--N 1.334 0.448 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.262 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -126.06 109.97 13.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.574 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.27 76.88 0.16 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.673 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -129.85 106.51 0.73 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.79 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 7.1 m-85 -158.18 167.75 13.84 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.582 0.229 . . . . 0.0 110.836 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 42.0 Cg_endo -67.55 168.29 18.58 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.929 2.419 . . . . 0.0 113.662 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 103' ' ' HIS . 0.5 OUTLIER -150.41 157.74 43.37 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.492 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -150.4 136.28 18.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.027 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.0 pt -125.92 139.14 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.886 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.2 p -130.02 146.82 51.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.858 0.361 . . . . 0.0 110.995 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 38.9 t -138.06 147.0 26.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.12 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.685 ' HB3' HD12 ' A' ' 50' ' ' ILE . 96.6 m-85 -155.54 144.99 21.05 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.9 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.629 HD23 ' HD3' ' A' ' 95' ' ' LYS . 16.4 tp -134.4 -50.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.539 0.209 . . . . 0.0 111.455 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.688 HD21 ' CB ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -161.67 -62.8 0.05 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.834 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -179.55 42.92 0.0 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.312 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.629 ' HD3' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -113.85 -163.73 0.88 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.938 -179.581 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.35 -26.26 38.79 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.662 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.85 -33.35 59.99 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.648 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -71.21 84.27 0.75 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.203 0.525 . . . . 0.0 110.669 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -142.4 151.81 42.2 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.34 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -121.47 143.24 49.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.79 120.72 10.3 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -90.86 150.79 4.0 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.241 2.627 . . . . 0.0 112.676 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.434 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . 59.9 m-70 -143.95 166.82 23.88 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.114 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -125.88 129.84 50.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.799 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -110.28 102.21 10.89 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.785 0.326 . . . . 0.0 111.335 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -177.26 45.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.27 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -141.55 128.61 20.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.644 0.259 . . . . 0.0 111.31 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 109' ' ' GLN . 3.1 pp -60.03 132.81 55.11 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.407 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.482 ' HB2' HD12 ' A' ' 108' ' ' LEU . 0.1 OUTLIER 68.98 44.66 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.171 0.51 . . . . 0.0 110.834 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.76 135.41 37.99 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.604 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -146.54 58.81 1.2 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.728 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -107.03 119.21 38.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.13 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 2.5 pt-20 -145.65 142.55 29.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.188 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.51 147.04 17.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.556 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.69 108.45 8.02 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.692 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -113.82 139.25 49.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.681 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 117' ' ' VAL . 11.9 p -123.73 121.44 62.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.077 0.465 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.414 HG21 HD22 ' A' ' 92' ' ' LEU . 2.9 mp -113.74 111.24 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.377 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -126.06 148.53 49.31 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.29 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 120' ' ' ILE . 3.6 tp -171.56 59.59 0.28 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 121.27 0.557 . . . . 0.0 111.554 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 C--N 1.349 0.554 0 C-N-CA 122.582 2.188 . . . . 0.0 112.521 179.582 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.716 0.293 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 44' ' ' LYS . 34.0 t -137.64 119.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.032 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -129.71 105.25 7.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.606 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.3 mtt180 -123.84 163.19 21.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.092 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.9 t -158.77 143.69 16.06 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.775 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 tp -115.05 122.88 70.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.822 0.344 . . . . 0.0 110.779 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.432 ' CD ' ' HG2' ' A' ' 115' ' ' GLU . 9.3 mtt180 -134.0 106.39 7.22 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.024 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.84 HD13 HG13 ' A' ' 88' ' ' ILE . 1.1 pt -113.12 123.44 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.565 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -114.58 124.4 51.77 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.41 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.419 HG22 HD13 ' A' ' 105' ' ' LEU . 5.4 m -125.0 108.75 12.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 3.0 tt0 -116.22 142.33 46.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.783 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -142.14 142.18 32.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 31' ' ' GLN . 82.9 t60 -133.8 119.23 18.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.67 0.271 . . . . 0.0 111.139 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 9.9 mt . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.815 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.234 0.279 0 CA-C-O 120.622 0.248 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.68 163.99 21.59 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 111.314 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -117.08 158.17 24.64 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.844 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.455 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 67.7 p-90 -154.02 140.18 18.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.0 p -142.77 117.52 9.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.003 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.7 tp -127.61 127.2 68.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 111.422 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.565 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 1.7 pt-20 -130.37 135.35 47.95 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.668 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.77 HG12 HG21 ' A' ' 55' ' ' ILE . 4.3 mp -115.69 106.36 20.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.047 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -104.83 140.85 21.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.986 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.686 ' CD2' HG21 ' A' ' 68' ' ' THR . 1.2 pp -159.26 161.52 36.0 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.187 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 39' ' ' LEU . 1.1 mm? -120.82 159.53 25.27 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.42 -45.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.057 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.12 2.45 15.17 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.209 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -83.41 -36.24 24.42 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.65 0.262 . . . . 0.0 110.959 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.55 -70.72 0.23 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.719 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.658 ' HB2' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -134.01 120.87 20.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.686 0.279 . . . . 0.0 111.32 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.83 30.01 5.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.471 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.3 mt -128.27 131.63 23.89 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.691 -0.232 . . . . 0.0 111.183 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.544 ' HA ' HD12 ' A' ' 93' ' ' LEU . 72.5 Cg_endo -76.07 -172.72 1.43 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.828 2.352 . . . . 0.0 112.625 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.707 ' HB3' ' CB ' ' A' ' 93' ' ' LEU . . . -156.01 -49.68 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.422 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 m -110.73 -63.99 1.33 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.593 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.11 -74.41 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.838 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 47.9 t80 56.86 93.24 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.445 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -158.57 116.0 2.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.372 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.742 ' HG2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -110.81 115.06 28.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.385 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 t -112.73 150.1 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 111.66 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.829 HG23 ' CD1' ' A' ' 88' ' ' ILE . 4.9 mp -131.07 133.47 62.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.639 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -127.46 121.34 30.53 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.831 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -128.67 108.98 10.93 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.82 HD11 ' CD2' ' A' ' 105' ' ' LEU . 6.2 mp . . . . . 0 N--CA 1.467 0.391 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.531 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo . . . . . 0 C--O 1.234 0.28 0 N-CA-C 111.771 -0.126 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 1.6 m120 -119.81 139.87 51.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.158 0.504 . . . . 0.0 111.106 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.36 140.29 23.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.679 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.686 HG21 ' CD2' ' A' ' 38' ' ' LEU . 86.9 m -116.47 113.1 22.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.051 0.453 . . . . 0.0 111.467 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -131.95 -56.22 0.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.621 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.2 33.88 1.09 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.35 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -125.8 159.48 61.07 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.58 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.3 Cg_exo -67.07 175.01 6.08 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.346 2.697 . . . . 0.0 112.434 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 38.4 Cg_endo -65.92 -178.08 0.94 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.8 2.333 . . . . 0.0 112.502 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.82 162.43 30.58 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 111.701 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.67 80.34 0.04 OUTLIER 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.403 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.6 mm -116.6 130.76 70.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.385 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.75 128.77 29.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.579 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.455 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 3.3 mt-10 -138.26 167.34 22.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.987 0.422 . . . . 0.0 111.692 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -121.6 128.03 51.51 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.854 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.24 -121.44 1.01 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.559 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -121.21 110.1 15.77 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 110.756 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.8 106.63 0.25 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.508 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.22 101.37 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.834 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 10.0 m-85 -152.94 171.33 6.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.544 0.212 . . . . 0.0 111.186 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.9 Cg_exo -56.03 176.1 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.288 2.658 . . . . 0.0 113.308 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.78 147.14 29.54 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.07 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -145.54 124.15 12.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.854 0.359 . . . . 0.0 111.116 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.84 HG13 HD13 ' A' ' 11' ' ' ILE . 14.6 mm -122.96 125.74 72.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.958 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.4 p -127.81 144.84 51.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.805 0.336 . . . . 0.0 111.55 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.742 HG23 ' HG2' ' A' ' 53' ' ' LYS . 4.0 p -134.23 132.81 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 8.3 m-85 -133.44 155.76 48.94 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.562 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.452 HD23 ' N ' ' A' ' 92' ' ' LEU . 1.4 pt? -144.62 -157.23 0.77 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.397 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.707 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -98.02 38.09 1.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.124 0.487 . . . . 0.0 110.708 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -170.54 -167.12 0.56 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.421 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 42.05 3.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.722 0.296 . . . . 0.0 111.049 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.49 -28.39 8.2 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -114.17 -10.66 13.33 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.187 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -56.16 107.42 0.36 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.971 0.385 . . . . 0.0 110.748 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.466 ' H ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.34 146.51 35.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.812 -179.641 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 123.26 22.04 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.208 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.952 HD13 HG11 ' A' ' 114' ' ' VAL . 19.9 tt -129.79 124.13 21.49 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-O 120.927 0.394 . . . . 0.0 111.894 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.07 160.52 8.65 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.008 2.472 . . . . 0.0 112.312 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -148.61 172.41 14.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.966 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.63 143.75 50.96 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.696 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.82 ' CD2' HD11 ' A' ' 58' ' ' LEU . 7.4 tp -130.65 88.47 2.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.011 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -172.04 42.15 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -141.51 130.03 22.61 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.163 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 3.4 pp -58.16 131.3 50.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.526 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.94 53.74 1.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.905 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 15' ' ' GLN . 1.2 tp10 -85.07 135.23 34.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.28 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.9 t -143.74 62.52 1.36 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.649 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -105.31 119.31 38.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.308 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 1.2 pt-20 -153.41 145.64 23.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.127 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.952 HG11 HD13 ' A' ' 101' ' ' ILE . 27.0 m -125.51 151.46 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.727 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.432 ' HG2' ' CD ' ' A' ' 10' ' ' ARG . 1.3 mt-10 -137.52 109.08 6.97 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.672 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 155.63 27.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.53 143.88 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.352 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.27 111.02 14.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -121.5 121.11 36.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.638 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.65 HD13 HD21 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -145.41 75.09 13.78 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 CA--C 1.535 0.561 0 C-N-CA 122.679 2.253 . . . . 0.0 113.55 -179.712 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.654 0.264 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 44' ' ' LYS . 17.5 t -134.0 119.39 31.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.218 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.0 105.86 12.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.285 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.32 162.39 16.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.249 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 4.2 t -175.0 149.28 1.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.374 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.744 HD11 HD11 ' A' ' 36' ' ' ILE . 2.5 tt -128.29 133.89 65.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.482 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 111.56 11.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.297 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.93 HD13 HD13 ' A' ' 88' ' ' ILE . 8.0 pt -114.81 130.15 69.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.37 136.89 52.83 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.8 HG23 ' CD1' ' A' ' 34' ' ' ILE . 5.6 m -133.66 111.51 10.67 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.77 117.27 24.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.942 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 109' ' ' GLN . 3.0 tp60 -109.97 147.12 34.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.952 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -155.03 119.93 4.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.077 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.862 HG22 ' HA ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.02 0.438 . . . . 0.0 111.334 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.234 0.279 0 CA-C-O 120.948 0.404 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.569 ' HA ' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -99.69 150.51 22.22 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.772 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -105.11 163.1 12.82 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -156.57 146.96 21.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.998 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.5 p -139.9 117.45 11.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.246 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.8 ' CD1' HG23 ' A' ' 13' ' ' THR . 27.2 mm -119.54 121.5 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.1 pm0 -131.18 116.64 17.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.666 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.744 HD11 HD11 ' A' ' 9' ' ' ILE . 7.9 tt -117.66 123.71 72.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.754 HG12 ' HB3' ' A' ' 73' ' ' PRO . 35.5 m -128.08 143.36 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.872 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.609 HD22 ' HE2' ' A' ' 53' ' ' LYS . 3.2 pp -144.32 163.02 34.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.635 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tp -106.16 157.49 17.52 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.2 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.48 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -171.45 -44.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.067 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.68 1.42 19.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.367 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -34.51 27.52 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.641 0.257 . . . . 0.0 110.751 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.8 -71.59 0.34 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.544 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.8 ' HB2' HG22 ' A' ' 5' ' ' VAL . 1.3 mtmt -144.18 107.09 4.47 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.869 0.366 . . . . 0.0 110.799 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.48 ' HG3' ' HB3' ' A' ' 40' ' ' ASP . 2.3 tt0 -96.26 45.55 1.07 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.83 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.5 118.13 21.44 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.799 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.84 161.4 6.28 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.905 2.403 . . . . 0.0 112.648 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB3' ' HG ' ' A' ' 93' ' ' LEU . . . -129.44 -71.43 0.62 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.568 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 p -113.06 -63.36 1.45 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.021 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.61 -80.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.07 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 31.6 t80 54.3 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.283 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.4 t0 -161.08 124.52 3.31 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.805 ' HG2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -117.39 136.77 52.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.445 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.751 HG13 ' HG3' ' A' ' 67' ' ' ARG . 6.6 t -128.96 135.83 61.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.02 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.507 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 4.9 mt -112.89 140.54 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.456 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.71 129.05 18.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.478 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.445 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 6.4 p80 -140.21 123.36 16.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.977 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.604 HD21 HD23 ' A' ' 105' ' ' LEU . 75.2 mt . . . . . 0 CA--C 1.531 0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--O 1.232 0.219 0 CA-C-O 120.755 0.231 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.507 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.9 m-80 -108.02 157.64 18.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.095 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.751 ' HG3' HG13 ' A' ' 54' ' ' VAL . 4.0 mtt180 -150.77 156.22 40.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.783 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.546 HG21 HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -134.54 126.16 28.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.91 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.749 ' CE2' HG22 ' A' ' 70' ' ' THR . 10.2 p90 -165.59 -45.11 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.887 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.749 HG22 ' CE2' ' A' ' 69' ' ' PHE . 13.6 t -146.04 30.49 1.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -134.2 156.83 78.71 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.203 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 40.1 Cg_endo -66.76 175.61 5.18 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.014 2.476 . . . . 0.0 112.188 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.754 ' HB3' HG12 ' A' ' 37' ' ' VAL . 10.9 Cg_endo -54.04 168.14 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.209 2.606 . . . . 0.0 112.8 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -128.7 88.66 2.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.919 0.39 . . . . 0.0 111.965 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 3.3 ttp85 -107.69 90.8 3.41 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.222 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.07 137.28 57.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.532 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.28 142.16 50.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.827 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -159.92 168.27 26.11 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.687 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -107.06 175.02 5.64 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.881 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.76 -141.98 12.8 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.631 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -126.57 110.1 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.122 0.487 . . . . 0.0 110.934 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.4 -129.18 6.35 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.361 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.17 47.98 3.43 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.701 -0.559 . . . . 0.0 111.701 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.497 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 64.1 m-85 -142.13 159.7 57.8 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.82 0.343 . . . . 0.0 111.019 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 39.2 Cg_endo -67.32 162.63 37.82 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.941 2.427 . . . . 0.0 113.622 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -148.88 134.24 18.47 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.795 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -143.96 153.02 41.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 111.415 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.93 HD13 HD13 ' A' ' 11' ' ' ILE . 3.9 mp -136.99 120.5 22.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 p -105.27 145.23 30.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.805 HG23 ' HG2' ' A' ' 53' ' ' LYS . 6.1 p -133.29 143.28 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -145.3 155.18 43.05 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.572 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.928 HD11 ' HB3' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -136.22 -45.53 0.63 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.629 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -143.37 -75.66 0.26 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.59 0.233 . . . . 0.0 111.22 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -140.34 -55.83 0.53 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.117 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.43 61.54 0.39 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 111.261 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.928 ' HB3' HD11 ' A' ' 92' ' ' LEU . . . -111.78 -39.65 4.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.794 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.624 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . -157.99 32.78 0.51 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.629 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.2 pp20? -88.93 116.76 27.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.977 0.418 . . . . 0.0 110.854 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.51 ' H ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -143.61 156.39 44.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.742 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -120.82 129.65 53.65 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.881 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.658 ' CG2' HG21 ' A' ' 114' ' ' VAL . 3.1 mt -111.37 99.84 45.4 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 120.692 0.282 . . . . 0.0 111.596 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -88.85 140.22 4.06 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.129 2.553 . . . . 0.0 112.248 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.71 172.33 17.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.314 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -114.51 150.85 34.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.647 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.776 ' HB2' HD22 ' A' ' 86' ' ' LEU . 13.2 tp -125.38 82.28 2.05 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.886 0.374 . . . . 0.0 111.102 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.7 -175.36 4.38 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.744 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.477 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 2.8 p90 -111.46 166.3 11.25 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.769 0.318 . . . . 0.0 111.856 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.862 ' HA ' HG22 ' A' ' 17' ' ' ILE . 0.5 OUTLIER 81.12 65.18 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.331 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 15' ' ' GLN . 19.3 mt-30 66.38 133.19 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.123 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.419 ' CB ' ' HB3' ' A' ' 15' ' ' GLN . 35.4 tt0 -157.66 134.68 10.1 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.262 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.39 71.89 1.49 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.582 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -115.99 119.17 35.05 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.704 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -153.49 139.37 18.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.29 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.658 HG21 ' CG2' ' A' ' 101' ' ' ILE . 13.0 t -118.81 152.46 21.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.63 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.38 108.89 8.97 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -113.26 151.84 30.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.431 ' C ' HD12 ' A' ' 118' ' ' ILE . 13.9 p -127.9 151.52 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.845 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.624 HG23 ' HA3' ' A' ' 97' ' ' GLY . 4.2 mp -141.32 126.5 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.079 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -127.11 117.18 21.9 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.761 0.315 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -129.94 61.84 60.45 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.337 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 CA--C 1.534 0.518 0 C-N-CA 122.704 2.27 . . . . 0.0 113.03 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.802 0.334 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.1 m -118.62 164.94 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.512 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.57 -178.66 4.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.332 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 t -137.88 146.48 43.42 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 43' ' ' GLY . 25.0 t -129.57 119.26 47.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.153 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.44 ' O ' HD12 ' A' ' 39' ' ' LEU . 5.0 tmtp? -138.29 107.46 6.06 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.507 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.402 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 6.4 ptp180 -130.65 131.87 45.12 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.75 0.31 . . . . 0.0 110.833 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.3 t -126.37 139.86 52.95 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 9' ' ' ILE . 1.5 tt -106.47 121.79 59.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.584 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.413 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 26.2 mtt180 -124.29 118.31 26.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pt -120.28 127.16 75.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.415 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -112.18 130.9 55.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.954 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.593 HG21 HD11 ' A' ' 86' ' ' LEU . 83.7 m -130.71 129.41 42.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.175 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 12.7 mp0 -140.48 155.12 46.77 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.092 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.74 149.1 29.36 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.384 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 31' ' ' GLN . 11.7 t-160 -139.92 119.62 13.29 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.199 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 24.9 mt -108.26 103.65 15.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.721 0.296 . . . . 0.0 110.927 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.7 tp -169.29 131.54 1.11 Allowed Pre-proline 0 N--CA 1.463 0.219 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.94 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.25 -50.65 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.623 2.215 . . . . 0.0 112.65 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 75.64 -56.26 0.6 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.954 0.502 . . . . 0.0 111.414 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.59 124.73 47.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.718 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -55.67 109.21 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.736 2.291 . . . . 0.0 112.371 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.85 169.27 21.62 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.7 2.267 . . . . 0.0 112.767 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 p -83.72 -34.26 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.285 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.99 -50.99 0.09 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.881 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -155.42 108.03 2.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.002 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -147.76 56.98 3.02 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.177 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.9 102.62 1.24 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.703 2.269 . . . . 0.0 112.565 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.584 HG22 ' HE1' ' A' ' 81' ' ' TRP . 21.8 t -102.37 141.68 18.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.276 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -129.05 164.97 22.1 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.744 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 16' ' ' HIS . 1.2 tt0 -115.2 159.29 21.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.709 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -159.73 142.33 13.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.37 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.04 133.84 25.33 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 34' ' ' ILE . 3.9 tp -146.04 122.89 3.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.271 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.415 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -132.35 139.87 48.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.056 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.715 HG21 ' CD1' ' A' ' 55' ' ' ILE . 2.9 mt -125.87 112.13 29.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.798 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 10' ' ' ARG . 27.7 m -122.7 157.39 27.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.574 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.018 HD21 HG21 ' A' ' 68' ' ' THR . 0.2 OUTLIER -171.62 172.45 4.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.558 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 6' ' ' LYS . 52.6 mt -98.76 165.89 11.57 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.036 0.446 . . . . 0.0 111.235 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -166.04 -48.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.547 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -78.3 -10.36 59.64 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.091 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.61 -37.06 8.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.741 ' O ' HG13 ' A' ' 5' ' ' VAL . . . -106.05 49.76 0.86 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.679 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? 62.34 117.81 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.101 0.477 . . . . 0.0 111.447 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.58 32.9 0.93 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.394 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.2 mt -127.12 131.95 24.09 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.23 158.62 48.58 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.782 2.321 . . . . 0.0 112.622 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HB3' HD12 ' A' ' 93' ' ' LEU . . . -120.95 -74.35 0.62 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.331 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.3 m -108.13 -60.25 1.75 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.737 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.4 mt -119.63 -83.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.786 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.1 t80 55.69 96.83 0.02 OUTLIER 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.129 0.49 . . . . 0.0 111.383 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.48 119.76 0.79 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.286 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.697 ' CE ' HD13 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -109.9 120.88 43.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.502 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.801 HG13 ' HD2' ' A' ' 67' ' ' ARG . 5.6 t -120.39 115.67 47.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.715 ' CD1' HG21 ' A' ' 36' ' ' ILE . 2.3 mp -94.24 147.93 5.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.359 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 87' ' ' ASP . 92.4 t80 -139.03 132.68 30.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.596 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -152.41 142.32 22.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER 75.06 173.36 0.26 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.0 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.585 ' CG ' HG22 ' A' ' 61' ' ' THR . 0.3 OUTLIER -52.05 149.48 9.32 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.409 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.62 1.99 7.9 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.8 2.333 . . . . 0.0 113.888 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.585 HG22 ' CG ' ' A' ' 59' ' ' HIS . 8.0 t -74.28 8.09 2.41 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.543 0.211 . . . . 0.0 111.166 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.98 165.69 24.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.753 0.311 . . . . 0.0 110.915 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.65 -35.9 62.85 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.346 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -167.7 131.61 1.45 Allowed Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.17 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.3 -171.25 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.731 2.287 . . . . 0.0 112.479 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -88.2 143.72 26.88 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.945 0.403 . . . . 0.0 111.287 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.801 ' HD2' HG13 ' A' ' 54' ' ' VAL . 9.2 mmm180 -133.02 146.61 51.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.788 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 1.018 HG21 HD21 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -137.59 116.8 12.62 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.861 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.681 ' CE2' HG22 ' A' ' 70' ' ' THR . 1.9 p90 -162.57 -45.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.893 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.681 HG22 ' CE2' ' A' ' 69' ' ' PHE . 15.1 t -141.07 27.76 1.94 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.893 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.77 157.77 70.33 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.201 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.87 170.51 17.72 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.912 2.408 . . . . 0.0 112.125 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.6 158.23 51.13 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.68 2.253 . . . . 0.0 112.401 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.553 ' HD2' HD11 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -113.83 158.12 21.44 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.425 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -171.53 103.87 0.2 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.746 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.553 HD11 ' HD2' ' A' ' 74' ' ' PHE . 3.8 mp -125.99 123.6 64.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.052 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.34 114.42 10.11 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.92 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.08 178.95 9.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.213 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.426 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.0 mt-30 -105.39 138.99 40.7 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.73 -173.17 42.96 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.887 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.584 ' HE1' HG22 ' A' ' 29' ' ' VAL . 11.7 m0 -112.1 109.75 19.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.607 0.241 . . . . 0.0 110.646 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.6 -117.22 0.6 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.319 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.41 91.79 1.82 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.655 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.593 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 36.4 m-85 -150.93 166.82 14.23 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 120.701 0.286 . . . . 0.0 111.267 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.34 159.52 39.4 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.151 2.568 . . . . 0.0 112.927 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.593 HD11 HG21 ' A' ' 13' ' ' THR . 0.8 OUTLIER -152.7 121.8 6.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.811 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 56' ' ' TYR . 9.2 t70 -128.05 146.33 50.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.573 HD13 ' N ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -129.38 128.47 66.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 111.145 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.573 ' N ' HD13 ' A' ' 88' ' ' ILE . 90.0 p -111.32 131.18 55.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.601 HG23 ' HG2' ' A' ' 53' ' ' LYS . 2.9 p -116.02 142.75 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.706 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -139.09 150.4 45.67 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.088 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.792 HD12 ' HB3' ' A' ' 96' ' ' ALA . 1.1 tm? -137.18 -49.02 0.61 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.26 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.632 ' HB2' HD13 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -151.55 -64.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.322 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.55 -54.19 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.079 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.97 44.24 2.48 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.989 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.792 ' HB3' HD12 ' A' ' 92' ' ' LEU . . . -105.08 -50.76 3.17 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.288 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.13 26.07 0.31 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.006 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 20.2 mt-10 -70.32 100.42 1.72 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.663 0.268 . . . . 0.0 110.772 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.465 ' H ' HG12 ' A' ' 90' ' ' VAL . 1.3 tpt180 -142.7 156.45 45.03 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.525 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 134.69 41.74 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.328 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.525 HG12 HG21 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -126.46 119.69 23.21 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 121.009 0.433 . . . . 0.0 111.909 -179.415 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.67 151.44 10.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.275 2.65 . . . . 0.0 112.548 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.472 ' CD2' ' HB3' ' A' ' 112' ' ' TYR . 7.3 m80 -147.77 167.0 25.83 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.949 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -129.62 149.92 51.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.626 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 tp -128.68 93.88 3.73 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 111.224 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -174.85 45.39 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.236 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -141.44 127.33 19.32 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -56.58 119.84 6.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.405 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 3.2 mm-40 69.23 66.69 0.27 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.795 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 1.2 tp10 -92.52 137.04 32.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.576 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.5 t -143.35 72.56 1.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.439 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.472 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 6.7 m-85 -121.08 119.27 31.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.335 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -144.82 147.2 32.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.366 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.525 HG21 HG12 ' A' ' 101' ' ' ILE . 24.0 t -122.56 148.84 26.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.913 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.08 109.02 8.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.451 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 137.51 51.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.153 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.72 150.42 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.73 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.4 mt -137.95 126.38 31.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -130.31 130.15 44.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.34 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -152.89 65.2 5.62 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.27 -33.22 15.04 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.533 2.155 . . . . 0.0 112.774 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.63 -65.86 1.08 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.83 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.411 -0.804 . . . . 0.0 111.13 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.594 0.235 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 2' ' ' VAL . 11.6 p -84.24 118.26 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.857 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.77 -179.89 6.88 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.462 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -146.44 159.44 43.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.838 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -130.57 119.12 45.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.19 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' HD13 ' A' ' 39' ' ' LEU . 18.8 mttt -134.88 115.95 14.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.169 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.443 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 39.3 mtt180 -137.39 165.96 24.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.08 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 t -178.09 131.13 0.14 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.855 HD12 HD12 ' A' ' 38' ' ' LEU . 14.6 tt -104.23 118.1 50.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 121.125 0.488 . . . . 0.0 110.627 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -115.03 107.4 15.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.657 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.9 pt -114.76 131.89 65.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -124.1 135.46 53.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.113 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.736 HG22 HD13 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -135.54 105.75 6.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.825 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -119.34 147.58 44.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.188 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.594 ' HG2' ' HA ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -143.56 147.04 33.83 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.083 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -156.22 120.37 4.47 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.68 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.466 HG12 ' HB3' ' A' ' 30' ' ' ARG . 25.0 mt -76.91 140.84 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.697 0.285 . . . . 0.0 111.027 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.29 82.94 4.23 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.642 ' O ' HG23 ' A' ' 21' ' ' VAL . 35.7 Cg_endo -67.53 -50.51 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.593 2.195 . . . . 0.0 112.666 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 55.99 30.66 16.53 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.33 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 19' ' ' PRO . 22.1 t -125.49 139.3 33.63 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.797 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.95 167.42 1.13 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.906 2.404 . . . . 0.0 112.544 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.72 -2.53 12.34 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.623 2.215 . . . . 0.0 113.195 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.19 -55.53 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 120.62 0.248 . . . . 0.0 111.37 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -123.21 159.74 28.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.205 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -90.62 165.05 13.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.258 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -168.04 87.25 0.71 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.048 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.62 95.41 0.71 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.747 2.298 . . . . 0.0 112.997 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.6 t -141.0 136.17 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.466 ' HB3' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -139.33 158.28 44.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.041 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 160.92 14.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.422 ' HB3' ' NE2' ' A' ' 15' ' ' GLN . 32.6 p-90 -158.4 148.16 19.66 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.034 0.445 . . . . 0.0 111.762 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -143.48 124.42 14.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.56 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 12' ' ' LYS . 9.3 tp -130.33 141.47 46.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 111.756 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.48 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.9 OUTLIER -149.44 143.78 25.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.778 HG21 HG12 ' A' ' 55' ' ' ILE . 4.2 mp -136.43 106.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.538 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 73' ' ' PRO . 21.7 t -113.71 135.48 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.73 0.3 . . . . 0.0 111.281 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 9' ' ' ILE . 1.4 tt -155.63 135.37 12.67 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.713 HD22 ' HB2' ' A' ' 42' ' ' GLU . 11.3 mt -70.76 164.39 25.26 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.268 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -161.23 -52.8 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.892 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.35 -13.61 61.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.584 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.713 ' HB2' HD22 ' A' ' 39' ' ' LEU . 2.4 tt0 -103.13 -34.7 8.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.387 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.82 40.36 2.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.816 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 65.37 91.16 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.66 52.16 1.84 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.25 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.29 112.59 11.09 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.91 159.4 53.03 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.635 2.223 . . . . 0.0 112.449 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.723 ' HB3' HD21 ' A' ' 93' ' ' LEU . . . -146.91 -62.5 0.29 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.688 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.567 HG22 HG13 ' A' ' 50' ' ' ILE . 86.2 m -106.74 -68.49 0.88 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 49' ' ' THR . 46.1 mt -113.8 -80.07 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.948 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 52.5 t80 55.39 92.76 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.874 0.368 . . . . 0.0 111.549 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 3.8 t70 -169.26 116.92 0.62 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.23 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.701 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -114.9 120.22 39.21 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.552 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.467 HG22 ' OG ' ' A' ' 89' ' ' SER . 34.6 m -116.87 159.34 16.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.012 0.434 . . . . 0.0 111.524 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.778 HG12 HG21 ' A' ' 36' ' ' ILE . 4.2 mp -137.18 130.43 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.406 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -126.47 143.06 51.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.893 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -167.27 126.0 1.34 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 tp 70.71 157.07 0.16 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.503 ' HB2' ' CD2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -89.32 -56.7 0.28 Allowed Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.419 ' HD2' ' HG ' ' A' ' 58' ' ' LEU . 84.1 Cg_exo -46.65 -30.65 9.21 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.009 2.473 . . . . 0.0 113.699 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.7 p -73.13 8.57 1.57 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -26.95 64.6 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.19 -41.29 68.43 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.412 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -140.21 82.72 16.49 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.062 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -61.47 172.73 3.2 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.842 2.361 . . . . 0.0 112.188 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 5.1 m120 -106.73 136.99 45.59 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.166 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.61 151.22 41.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.173 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 87.5 m -130.45 102.61 6.24 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -130.83 -48.53 1.04 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.406 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 t -140.69 -36.75 0.46 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.791 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.05 159.13 1.53 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.3 169.65 21.1 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.094 2.53 . . . . 0.0 112.851 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HB3' HG13 ' A' ' 37' ' ' VAL . 39.9 Cg_exo -57.38 152.04 49.2 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.944 2.429 . . . . 0.0 113.085 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -100.42 141.39 33.33 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.977 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.29 89.34 0.54 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.462 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.1 143.09 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.733 0.302 . . . . 0.0 111.658 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.03 143.43 46.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.72 -177.27 6.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.205 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -120.11 136.71 54.5 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -175.29 -170.0 37.73 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.92 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -127.29 110.41 12.81 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.853 0.358 . . . . 0.0 110.976 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.56 128.17 1.2 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.63 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.67 117.39 2.48 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.313 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.571 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 12.1 m-85 -157.32 166.22 17.09 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 120.579 0.228 . . . . 0.0 110.905 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.6 Cg_endo -69.49 168.33 21.5 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.029 2.486 . . . . 0.0 113.293 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.648 HD22 ' HB2' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -151.73 118.66 5.82 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.473 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.26 154.37 38.92 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.363 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.748 ' CG2' HG23 ' A' ' 55' ' ' ILE . 2.3 pt -140.91 151.46 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.47 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.467 ' OG ' HG22 ' A' ' 54' ' ' VAL . 79.8 p -137.06 147.66 46.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.043 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.701 HG13 ' HG2' ' A' ' 53' ' ' LYS . 21.6 t -126.97 139.58 51.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.301 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 30.0 m-85 -144.48 150.94 38.43 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.672 HD21 HG21 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -142.13 -47.1 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.528 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -153.0 -71.5 0.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.588 0.232 . . . . 0.0 111.247 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -136.03 -68.6 0.5 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.041 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 35.99 1.32 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.107 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.644 ' HB1' HG12 ' A' ' 120' ' ' ILE . . . -77.74 -38.18 47.61 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.43 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.525 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . -168.27 37.38 0.21 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.213 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 6.9 tt0 -80.15 103.8 10.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -142.18 151.88 42.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.947 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.427 ' HG2' ' CB ' ' A' ' 89' ' ' SER . 8.2 mtpt -131.93 149.79 52.34 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.102 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.584 HG21 HG11 ' A' ' 114' ' ' VAL . 1.4 tp -148.71 123.9 5.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -87.56 155.13 7.73 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.217 2.611 . . . . 0.0 112.451 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.13 169.15 23.67 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.417 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.415 ' C ' HD21 ' A' ' 86' ' ' LEU . 6.5 m-20 -126.77 140.67 52.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.13 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.736 HD13 HG22 ' A' ' 13' ' ' THR . 58.1 tp -121.9 93.32 3.96 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.996 0.426 . . . . 0.0 111.122 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.99 -168.7 1.44 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.305 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.594 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -116.07 164.01 15.09 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.08 0.466 . . . . 0.0 112.091 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 84.67 69.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.523 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 63.65 103.58 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.958 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -126.82 134.2 50.61 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.14 67.4 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.592 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -119.37 119.43 33.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.627 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 1.3 pt-20 -151.47 149.56 29.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.383 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 101' ' ' ILE . 4.5 t -122.41 149.94 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.623 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -137.75 108.65 6.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.403 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -113.8 141.97 46.65 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.16 148.89 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.983 0.421 . . . . 0.0 111.927 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.672 HG21 HD21 ' A' ' 92' ' ' LEU . 4.3 mp -134.65 111.29 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.403 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.427 ' CG ' ' HD3' ' A' ' 121' ' ' PRO . 43.4 tt0 -125.3 114.67 19.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.605 0.24 . . . . 0.0 111.539 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.668 ' CD1' HG22 ' A' ' 118' ' ' ILE . 4.1 mp -139.91 56.21 7.65 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 111.314 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.427 ' HD3' ' CG ' ' A' ' 119' ' ' GLN . 83.4 Cg_endo -77.16 -172.6 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.67 2.247 . . . . 0.0 112.454 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 tp -100.69 89.64 3.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 110.553 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.916 -179.667 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.636 0.255 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.9 -48.9 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.393 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.14 97.75 3.57 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.802 0.334 . . . . 0.0 110.893 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.3 148.72 33.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.038 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 43' ' ' GLY . 21.5 t -140.04 119.23 12.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.181 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.34 106.81 6.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.383 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -127.61 163.11 24.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.363 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.485 HG22 HD23 ' A' ' 39' ' ' LEU . 5.2 t -170.39 129.17 0.86 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.541 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.5 tt -109.84 118.37 56.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.988 0.423 . . . . 0.0 110.882 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.684 ' O ' HG22 ' A' ' 37' ' ' VAL . 17.8 mtt85 -123.92 117.7 25.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.705 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.547 ' CD1' HD13 ' A' ' 88' ' ' ILE . 19.8 pt -113.05 136.65 48.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.198 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 1.8 mptp? -108.38 134.94 50.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.6 m -128.02 128.27 44.69 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.889 0.376 . . . . 0.0 111.551 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -145.86 127.78 15.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.65 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -140.49 146.15 37.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.755 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -143.49 119.39 10.6 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.509 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.753 HG23 ' HG2' ' A' ' 30' ' ' ARG . 39.6 mt -95.28 118.18 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.102 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -173.19 103.44 0.31 Allowed Pre-proline 0 N--CA 1.466 0.375 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.2 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 28' ' ' PRO . 41.1 Cg_endo -68.67 -41.14 6.35 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.564 2.176 . . . . 0.0 112.984 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 57.48 35.86 26.34 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.522 HG12 ' HD2' ' A' ' 23' ' ' PRO . 8.9 t -109.05 105.33 57.06 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.729 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.471 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 53.2 Cg_exo -53.46 -49.16 18.32 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.625 2.217 . . . . 0.0 112.73 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HD2' HG12 ' A' ' 21' ' ' VAL . 93.9 Cg_endo -78.3 -8.62 16.32 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.314 2.009 . . . . 0.0 113.223 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t 63.28 94.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.827 0.346 . . . . 0.0 110.99 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.514 ' OE2' HG21 ' A' ' 21' ' ' VAL . 7.6 pt-20 -65.28 -55.44 18.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.286 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 172.06 -72.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.786 0.327 . . . . 0.0 111.288 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -93.03 148.08 35.07 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.95 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 74.5 Cg_endo -76.29 117.02 4.48 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.754 2.303 . . . . 0.0 112.395 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.796 HG13 ' HA2' ' A' ' 80' ' ' GLY . 21.7 t -72.15 110.63 5.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.718 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.753 ' HG2' HG23 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -106.93 165.08 11.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.886 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.77 156.55 34.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.381 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -157.65 141.29 15.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.427 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.7 t -147.2 117.74 7.49 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.718 HD11 HD13 ' A' ' 105' ' ' LEU . 39.6 mt -135.68 136.36 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.853 0.359 . . . . 0.0 111.635 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.98 155.28 44.52 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.579 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.627 HG12 HG21 ' A' ' 55' ' ' ILE . 4.0 mp -131.38 109.0 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.26 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 10' ' ' ARG . 34.2 m -111.61 146.26 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.376 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD22 ' CG2' ' A' ' 68' ' ' THR . 1.2 pp -163.7 170.15 17.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.313 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.581 HD12 ' HG3' ' A' ' 42' ' ' GLU . 4.0 mm? -108.42 165.29 11.62 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -168.23 -47.18 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.778 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -3.86 45.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.771 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HG3' HD12 ' A' ' 39' ' ' LEU . 3.9 mm-40 -104.27 -35.38 8.01 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.514 0.197 . . . . 0.0 111.138 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.543 ' O ' HG13 ' A' ' 5' ' ' VAL . . . -113.34 45.92 1.25 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.461 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt 66.7 123.25 0.02 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.046 0.45 . . . . 0.0 111.525 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.66 29.06 2.12 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.429 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.9 mt -129.63 134.5 26.28 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.016 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.63 -174.23 1.94 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.672 2.248 . . . . 0.0 112.473 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.678 ' HB3' ' CD1' ' A' ' 93' ' ' LEU . . . -144.32 -51.89 0.31 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.233 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 p -126.0 -52.36 1.54 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.562 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.47 -89.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.093 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 40.3 t80 57.09 97.74 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.242 0.544 . . . . 0.0 110.861 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.65 109.96 1.27 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.53 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.82 ' HG2' HG13 ' A' ' 90' ' ' VAL . 1.4 mttm -112.55 137.05 51.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.354 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.503 ' C ' HD13 ' A' ' 55' ' ' ILE . 12.5 p -139.36 149.81 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.015 0.436 . . . . 0.0 111.652 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.878 HG23 HG22 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -126.72 140.66 48.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.42 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.86 130.57 38.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.704 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.447 ' O ' ' HB ' ' A' ' 61' ' ' THR . 3.8 p80 -132.89 113.94 13.46 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.238 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 57' ' ' HIS . 1.3 mp 72.35 176.5 0.27 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.55 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 59.2 t-80 -86.84 -41.28 0.54 Allowed Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 59' ' ' HIS . 38.2 Cg_endo -72.53 2.19 5.44 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.206 1.937 . . . . 0.0 114.174 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 10.1 t -68.16 0.42 3.72 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 121.239 -0.184 . . . . 0.0 111.432 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -56.36 -33.35 65.61 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.457 0.17 . . . . 0.0 111.161 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.65 -43.9 69.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.282 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -157.25 86.54 2.74 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.958 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.04 169.37 18.15 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.702 2.268 . . . . 0.0 112.472 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.475 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 1.6 m-80 -98.69 133.78 42.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HG3' HG23 ' A' ' 54' ' ' VAL . 2.6 mtt180 -129.19 153.84 47.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.05 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 35.1 m -132.29 99.16 4.6 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.017 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -124.77 -49.17 1.76 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.64 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.4 t -174.49 50.81 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.155 0.502 . . . . 0.0 110.397 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.45 162.0 57.25 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.152 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.21 162.48 14.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.942 2.428 . . . . 0.0 112.625 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.39 168.68 3.65 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.11 2.54 . . . . 0.0 112.851 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.95 165.8 13.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.49 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.37 94.11 0.22 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.597 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.29 115.37 48.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -137.77 126.51 23.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.915 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -144.87 -179.13 6.4 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.426 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -130.28 177.34 7.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.176 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.796 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 96.09 -162.1 22.76 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.123 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -67.32 128.83 37.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.4 126.88 0.86 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.669 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.77 110.82 0.29 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.75 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.404 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 12.4 m-85 -155.4 166.26 16.59 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 120.662 0.268 . . . . 0.0 111.272 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.416 ' C ' HD12 ' A' ' 86' ' ' LEU . 31.6 Cg_exo -60.34 177.32 0.6 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.157 2.572 . . . . 0.0 113.229 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.653 HD11 ' HB2' ' A' ' 105' ' ' LEU . 5.3 mp -142.84 167.01 23.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.993 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -155.15 122.9 5.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.298 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.878 HG22 HG23 ' A' ' 55' ' ' ILE . 11.8 pt -129.84 123.24 56.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.686 0.279 . . . . 0.0 111.144 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -119.85 142.43 48.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.78 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.82 HG13 ' HG2' ' A' ' 53' ' ' LYS . 4.2 t -126.71 137.41 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.806 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.476 ' CD2' ' CG ' ' A' ' 98' ' ' GLU . 48.0 m-85 -145.47 145.78 31.23 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.736 HD22 ' CG2' ' A' ' 118' ' ' ILE . 3.5 tp -138.49 -68.44 0.45 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.678 ' CD1' ' HB3' ' A' ' 48' ' ' ALA . 6.4 tp -136.64 -66.89 0.52 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.357 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' HB3' ' CE ' ' A' ' 95' ' ' LYS . 2.6 mt-10 -166.07 -54.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.436 ' CE ' ' HB3' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -115.75 45.96 1.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.165 0.507 . . . . 0.0 110.676 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -116.59 -49.53 2.65 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.217 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.4 -81.82 0.03 OUTLIER Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.396 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.6 OUTLIER 47.19 59.91 3.76 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 111.554 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.08 136.95 30.66 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.166 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 2.9 pttt -117.85 149.98 39.94 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.59 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 tt -149.45 123.5 4.63 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.961 0.41 . . . . 0.0 111.562 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.3 158.85 13.01 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.707 2.271 . . . . 0.0 112.138 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.31 172.49 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -125.59 146.52 49.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.569 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.718 HD13 HD11 ' A' ' 34' ' ' ILE . 5.5 tp -139.13 74.05 1.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -164.61 46.65 0.1 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.13 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -140.25 132.58 28.34 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.339 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 3.3 pp -61.2 131.7 51.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.07 61.02 0.77 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.819 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.13 131.7 37.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.69 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.5 t -137.14 69.96 1.4 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.751 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.36 153.35 20.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.012 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 12' ' ' LYS . 3.3 tt0 -164.66 136.61 4.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.252 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.62 143.65 33.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -139.34 108.51 6.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.719 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.408 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 1.6 m-70 -113.05 119.01 36.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.477 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.45 147.67 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.631 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.736 ' CG2' HD22 ' A' ' 92' ' ' LEU . 20.0 mt -142.12 110.85 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.525 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -129.88 125.89 36.67 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.536 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.412 HG12 ' CD2' ' A' ' 92' ' ' LEU . 0.8 OUTLIER -152.78 54.61 1.26 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.669 179.258 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.29 -31.38 11.72 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.446 2.097 . . . . 0.0 112.506 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.85 -33.13 27.16 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.283 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.865 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 m -62.2 162.37 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.863 0.363 . . . . 0.0 111.678 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 122' ' ' LEU . . . -85.73 93.49 8.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.316 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.29 121.14 6.55 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.49 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.666 HG22 ' HG3' ' A' ' 44' ' ' LYS . 19.5 t -126.94 119.14 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 111.338 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.25 104.91 7.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.268 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.601 ' HB3' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -118.36 169.83 9.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.409 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -165.89 123.79 1.5 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.713 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 36' ' ' ILE . 8.8 tt -108.86 124.55 65.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.924 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 0.2 OUTLIER -120.11 120.33 35.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.023 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.783 HD13 HG12 ' A' ' 88' ' ' ILE . 7.8 pt -123.4 132.71 70.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.071 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 4.1 mtmt -120.41 146.17 46.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.22 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.449 HG21 HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -136.82 116.85 13.31 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.687 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 3.8 tt0 -123.74 148.83 46.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.987 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -154.87 144.1 21.12 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.979 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -147.88 119.59 8.05 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.343 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.422 HG23 ' HG2' ' A' ' 30' ' ' ARG . 45.0 mt -89.31 100.39 10.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.77 0.319 . . . . 0.0 110.633 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.04 108.22 1.92 Allowed Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.775 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.51 -52.94 0.88 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.662 2.241 . . . . 0.0 112.952 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 55.65 21.69 4.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.739 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.471 HG23 ' HD2' ' A' ' 22' ' ' PRO . 8.4 p -125.77 138.16 31.44 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.032 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.471 ' HD2' HG23 ' A' ' 21' ' ' VAL . 15.6 Cg_endo -57.39 145.88 85.77 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.667 2.245 . . . . 0.0 112.317 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.67 96.49 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.79 2.327 . . . . 0.0 112.568 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.591 HG13 ' HG3' ' A' ' 25' ' ' GLU . 13.2 p -115.55 -38.31 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.433 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.591 ' HG3' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -173.93 -42.75 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.012 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.36 -178.3 3.94 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.409 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -174.73 -53.18 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.285 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.42 87.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.632 2.221 . . . . 0.0 112.594 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.31 118.28 35.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.097 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.422 ' HG2' HG23 ' A' ' 17' ' ' ILE . 3.7 mtt180 -138.58 164.23 30.0 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.597 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.39 151.17 22.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.55 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -155.74 132.4 10.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.419 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 14' ' ' GLN . 27.7 t -143.88 125.91 15.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.539 HG21 ' CG ' ' A' ' 57' ' ' HIS . 1.9 tp -135.79 129.7 48.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.5 OUTLIER -135.78 157.06 47.79 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 9' ' ' ILE . 12.5 tt -154.54 130.44 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.736 HG12 ' CB ' ' A' ' 73' ' ' PRO . 25.4 m -134.97 160.73 40.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.657 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.976 HD21 HG21 ' A' ' 68' ' ' THR . 0.2 OUTLIER -159.32 175.1 13.78 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.934 0.397 . . . . 0.0 111.531 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.56 HD22 ' HB2' ' A' ' 42' ' ' GLU . 3.7 mt -106.79 166.13 10.81 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.101 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.85 -56.29 0.06 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.209 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -54.98 -40.33 69.93 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.233 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.56 ' HB2' HD22 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -89.5 -29.44 18.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.1 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.428 ' C ' HG13 ' A' ' 5' ' ' VAL . . . -110.31 59.05 0.37 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.861 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.666 ' HG3' HG22 ' A' ' 5' ' ' VAL . 7.4 mttp 60.21 97.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.912 0.387 . . . . 0.0 111.618 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -24.66 62.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.507 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 1.9 mt -100.91 123.72 44.4 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-O 120.577 0.227 . . . . 0.0 110.837 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 46' ' ' ILE . 42.7 Cg_exo -56.93 169.04 2.08 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.874 2.382 . . . . 0.0 112.506 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.662 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . . . -139.65 -51.48 0.51 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.621 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.461 ' O ' HD13 ' A' ' 50' ' ' ILE . 7.0 m -110.49 -65.62 1.15 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.783 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 49' ' ' THR . 33.5 mm -138.05 -80.68 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 39.4 t80 63.08 100.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.025 0.44 . . . . 0.0 110.885 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 8.7 t70 -160.83 110.69 1.71 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.565 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.802 ' HD3' HD22 ' A' ' 38' ' ' LEU . 8.0 mttp -104.89 107.35 18.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.542 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.44 141.78 17.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.608 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 36' ' ' ILE . 1.7 mp -121.24 148.69 24.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.196 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -143.99 128.4 17.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.298 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.539 ' CG ' HG21 ' A' ' 34' ' ' ILE . 6.9 p80 -144.18 120.48 10.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.539 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 57' ' ' HIS . 0.8 OUTLIER 72.75 163.12 0.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.764 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.467 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -81.79 -46.99 1.03 Allowed Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 58' ' ' LEU . 81.5 Cg_exo -46.52 -24.78 2.96 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.078 2.519 . . . . 0.0 114.194 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.6 p -77.01 6.73 5.83 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.484 0.183 . . . . 0.0 111.06 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -60.62 -33.65 73.09 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 111.021 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.95 76.56 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.298 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -151.85 94.25 3.36 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.388 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.45 -175.31 1.28 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.892 2.395 . . . . 0.0 112.362 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 17.7 m120 -113.46 144.37 42.93 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.235 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.66 150.79 36.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.976 HG21 HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -133.06 115.87 15.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.844 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CE2' HG22 ' A' ' 70' ' ' THR . 3.2 p90 -156.75 -47.62 0.07 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.583 HG22 ' CE2' ' A' ' 69' ' ' PHE . 14.2 t -129.4 29.08 5.14 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.006 0.431 . . . . 0.0 110.766 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -141.41 159.08 62.09 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.404 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 42.8 Cg_endo -67.45 173.81 8.23 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.908 2.405 . . . . 0.0 112.469 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.736 ' CB ' HG12 ' A' ' 37' ' ' VAL . 20.3 Cg_endo -59.9 -179.3 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.797 2.331 . . . . 0.0 112.688 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.47 157.74 44.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.793 0.33 . . . . 0.0 110.794 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.65 81.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.785 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.71 122.71 51.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.168 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.64 115.53 16.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.491 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -139.34 174.27 10.69 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.05 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.21 124.68 31.1 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.971 0.415 . . . . 0.0 110.977 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.02 -157.05 21.77 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.126 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 13.6 p-90 -82.88 116.59 22.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 111.07 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.451 ' HA3' HD21 ' A' ' 58' ' ' LEU . . . -168.75 -121.79 0.59 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.727 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.754 ' HA2' HD23 ' A' ' 105' ' ' LEU . . . 71.67 101.93 0.06 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.959 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.0 m-85 -162.96 171.04 6.77 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.63 0.252 . . . . 0.0 110.96 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 77.3 Cg_exo -52.01 166.53 0.63 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.045 2.496 . . . . 0.0 113.243 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.707 HD11 ' HB2' ' A' ' 105' ' ' LEU . 4.2 mp -142.92 169.74 17.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.414 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -160.43 138.82 10.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.176 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.783 HG12 HD13 ' A' ' 11' ' ' ILE . 6.4 tp -136.54 128.17 43.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.05 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.8 p -127.06 116.2 20.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.732 HG21 HG21 ' A' ' 9' ' ' ILE . 21.6 t -104.22 120.92 55.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.154 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 13.2 m-85 -126.1 156.02 40.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.736 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.618 HD13 ' CG2' ' A' ' 118' ' ' ILE . 0.8 OUTLIER -145.7 -166.57 2.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.56 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.3 pp -92.06 34.47 1.02 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 111.107 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -165.66 159.07 16.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.329 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.47 47.53 1.19 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.071 0.462 . . . . 0.0 110.772 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -116.25 -37.34 3.81 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.614 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.591 ' H ' HD21 ' A' ' 92' ' ' LEU . . . -118.65 30.68 5.85 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.161 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 16.2 mt-10 -92.57 92.77 8.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.825 0.313 . . . . 0.0 110.451 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -142.23 153.26 43.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.885 0.374 . . . . 0.0 111.817 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' C ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -135.75 146.37 47.57 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.786 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 88' ' ' ILE . 3.7 mp -141.78 122.48 8.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.64 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.06 129.26 4.56 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.866 2.377 . . . . 0.0 112.352 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.29 172.46 6.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.287 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -134.59 138.9 44.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.62 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.754 HD23 ' HA2' ' A' ' 83' ' ' GLY . 0.9 OUTLIER -130.33 84.58 2.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -156.6 37.31 0.32 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.175 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -141.9 132.03 24.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.13 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.521 ' H ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -59.88 131.8 51.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 71.58 74.22 0.17 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.441 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.73 131.37 55.0 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.59 61.63 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.292 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -105.6 119.31 38.8 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.534 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 3.2 pt-20 -142.16 139.6 32.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.126 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.564 ' CG1' HD11 ' A' ' 11' ' ' ILE . 5.8 p -131.96 148.97 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.69 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.466 ' HG2' ' HG3' ' A' ' 10' ' ' ARG . 1.2 mp0 -133.01 151.24 52.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.341 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -136.31 127.25 27.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.222 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.83 136.73 26.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.258 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.618 ' CG2' HD13 ' A' ' 92' ' ' LEU . 27.4 mt -121.49 111.22 30.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.58 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.39 117.49 20.67 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.349 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.633 ' N ' HD13 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -147.38 55.75 2.51 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.744 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.97 127.16 9.19 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.466 2.111 . . . . 0.0 112.244 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 4.2 mm? -108.04 69.78 0.74 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.748 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.7 t30 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.981 -179.757 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -74.08 -34.6 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.614 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.72 114.3 6.21 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.774 0.321 . . . . 0.0 111.282 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 t -143.5 155.61 44.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.471 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.49 119.44 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.654 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HG3' ' HG2' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -137.47 117.25 13.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.35 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.517 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 75.8 mtt180 -139.8 138.73 36.06 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.514 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 t -147.46 111.18 5.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.441 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.981 HD11 HD11 ' A' ' 36' ' ' ILE . 1.3 tt -104.77 118.28 51.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.637 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HD3' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -121.36 120.09 34.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.725 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.554 HG22 ' HB ' ' A' ' 36' ' ' ILE . 9.2 pt -118.7 126.3 75.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 111.33 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.491 ' HD2' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -114.26 130.81 56.65 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.845 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.595 HG23 ' CD1' ' A' ' 34' ' ' ILE . 3.0 m -127.88 118.01 22.85 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -129.29 140.63 51.35 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.986 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.481 HE21 ' HB2' ' A' ' 30' ' ' ARG . 2.0 tp60 -139.92 138.76 35.87 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.759 0.314 . . . . 0.0 111.333 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -137.92 119.73 15.25 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.576 HG23 ' HB3' ' A' ' 30' ' ' ARG . 6.7 mt -114.55 100.32 10.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.773 0.32 . . . . 0.0 111.149 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.78 84.52 0.24 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.907 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.6 -54.24 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.512 2.141 . . . . 0.0 112.584 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -176.09 -66.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.716 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -125.15 126.09 25.21 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.644 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.93 111.13 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.59 2.193 . . . . 0.0 112.232 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 152.24 35.22 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.049 2.499 . . . . 0.0 113.233 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 p -84.55 -36.82 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.58 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -145.26 37.42 1.13 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.627 0.251 . . . . 0.0 111.613 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -143.62 154.59 43.7 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.758 0.314 . . . . 0.0 111.245 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -82.46 125.11 77.11 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.735 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.71 162.25 42.67 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.733 2.289 . . . . 0.0 112.691 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG13 ' HA2' ' A' ' 80' ' ' GLY . 21.5 t -87.9 146.4 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.576 ' HB3' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -126.71 165.13 19.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.279 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.48 149.35 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -145.18 143.28 30.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.453 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.493 ' O ' HD13 ' A' ' 34' ' ' ILE . 1.6 m -136.12 121.95 19.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.742 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 105' ' ' LEU . 19.9 mm -130.4 117.42 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.622 0.248 . . . . 0.0 111.479 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 10.9 pt-20 -134.73 149.38 50.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.094 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.981 HD11 HD11 ' A' ' 9' ' ' ILE . 14.0 tt -152.18 130.49 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.207 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.486 HG23 ' HD3' ' A' ' 10' ' ' ARG . 4.3 m -137.24 119.15 18.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.962 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' A' ' 9' ' ' ILE . 52.8 tp -129.7 142.46 50.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.31 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 42' ' ' GLU . 4.3 tt -118.1 152.25 35.95 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.077 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.593 ' N ' HD23 ' A' ' 39' ' ' LEU . 4.7 p-10 -176.87 -30.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.318 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 7.1 p30 -53.91 -27.89 33.4 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.631 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.807 ' HB2' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.02 -33.21 59.66 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.554 0.216 . . . . 0.0 110.589 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.83 -74.33 0.93 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.884 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -129.47 -48.11 1.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 41' ' ' ASP . 17.1 tt0 71.09 7.0 6.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.774 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.718 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.1 pp -126.2 140.4 36.94 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-O 120.733 0.301 . . . . 0.0 111.413 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.63 -171.47 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.985 2.456 . . . . 0.0 112.374 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.7 ' HB3' ' CB ' ' A' ' 93' ' ' LEU . . . -160.81 -64.98 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.391 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.451 ' O ' HD13 ' A' ' 50' ' ' ILE . 17.7 m -96.97 -56.42 2.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.172 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 49' ' ' THR . 48.6 mm -132.84 -85.28 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.839 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 44.3 t80 63.24 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.145 0.498 . . . . 0.0 111.136 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -164.19 102.17 0.86 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.571 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.605 ' CG ' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -97.72 102.96 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.554 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' CD ' ' A' ' 67' ' ' ARG . 8.7 m -103.07 143.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.478 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 ' OG1' ' A' ' 68' ' ' THR . 2.4 mt -125.41 146.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.521 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.03 138.85 28.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.929 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.431 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 14.8 p80 -163.77 124.36 2.21 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.573 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER 67.37 168.38 0.25 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.79 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.447 ' HB2' ' CD2' ' A' ' 84' ' ' PHE . 1.5 t-80 -61.31 130.64 91.85 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.693 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.4 -22.32 20.68 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.916 2.41 . . . . 0.0 113.245 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 35.5 p -67.09 -3.07 6.46 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.76 -73.98 0.45 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.386 0.136 . . . . 0.0 111.056 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.35 -34.08 75.97 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.333 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 1.2 t-20 72.57 146.8 0.12 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.429 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 64' ' ' ASN . 31.7 Cg_exo -58.82 142.19 98.67 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.993 2.462 . . . . 0.0 112.479 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.485 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 1.7 m-80 -115.14 155.28 27.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.093 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.782 ' CD ' HG12 ' A' ' 54' ' ' VAL . 0.8 OUTLIER -143.68 153.85 42.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 -179.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.868 HG23 ' HD2' ' A' ' 72' ' ' PRO . 45.6 m -138.44 117.21 12.3 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.792 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -125.47 -54.63 1.56 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -89.49 -67.58 0.83 Allowed 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.379 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.478 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 0.3 OUTLIER 179.09 61.06 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.468 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.868 ' HD2' HG23 ' A' ' 68' ' ' THR . 94.8 Cg_endo -93.07 103.33 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.92 2.413 . . . . 0.0 113.207 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 71' ' ' ASP . 86.4 Cg_endo -84.43 178.91 4.78 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.652 2.235 . . . . 0.0 112.382 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -167.94 153.03 6.77 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.62 111.5 0.07 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.968 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 76' ' ' ILE . 6.1 tp -159.62 142.01 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.853 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 14.7 pt-20 -132.27 111.6 11.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.479 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -121.39 168.3 11.82 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.338 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -109.94 176.58 5.01 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.773 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.549 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 110.91 -154.94 16.38 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.168 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -93.17 110.11 21.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 0.0 110.403 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.17 91.67 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.433 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -142.91 111.23 0.65 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.473 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 9.7 m-85 -160.94 168.56 11.47 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 120.613 0.244 . . . . 0.0 111.04 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.34 160.53 26.85 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.064 2.509 . . . . 0.0 112.966 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.082 HD22 HD23 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -150.89 123.05 8.28 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.578 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -127.55 145.89 50.71 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.95 0.405 . . . . 0.0 111.71 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 9' ' ' ILE . 8.9 tt -129.59 118.8 46.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.249 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.435 ' OG ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -119.47 119.59 34.33 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 -179.257 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.605 HG13 ' CG ' ' A' ' 53' ' ' LYS . 4.5 t -106.26 142.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.096 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -141.09 157.27 45.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.877 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -151.35 -175.74 5.3 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.733 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.7 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -72.63 -20.4 61.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.15 -169.23 1.66 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.496 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 58.35 1.02 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.842 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.51 4.77 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.778 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.445 ' C ' HD21 ' A' ' 92' ' ' LEU . . . -137.7 44.34 1.14 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.991 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -113.36 90.44 3.34 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.884 0.373 . . . . 0.0 111.025 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -142.66 156.59 45.07 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.532 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 5.9 pttm -112.2 140.59 46.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.479 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.463 HG22 ' CE1' ' A' ' 103' ' ' HIS . 2.1 mp -133.34 109.0 12.39 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.667 0.27 . . . . 0.0 111.506 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -88.21 147.39 6.52 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.221 2.614 . . . . 0.0 113.625 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.471 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . 8.7 m-70 -148.58 172.28 14.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.444 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -134.24 129.73 36.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.942 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.082 HD23 HD22 ' A' ' 86' ' ' LEU . 1.3 pp -113.97 100.95 8.8 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.984 0.421 . . . . 0.0 111.244 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -177.87 44.86 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.34 136.42 31.48 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.776 0.322 . . . . 0.0 111.535 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.439 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -61.73 128.95 38.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.637 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 64.45 65.3 0.66 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.26 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -105.18 131.77 52.23 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.813 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.0 p -132.79 66.71 1.55 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.869 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -104.9 119.64 39.49 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.702 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.491 ' CD ' ' HD2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -148.01 143.48 27.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.292 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.552 ' CG1' HD11 ' A' ' 11' ' ' ILE . 2.8 p -141.11 142.77 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.532 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -127.77 146.02 50.72 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.101 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 130.81 40.78 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.7 m -111.66 140.13 32.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.094 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.676 HG22 ' CD1' ' A' ' 120' ' ' ILE . 10.9 mt -139.99 111.79 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.784 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.409 ' HG2' ' HG3' ' A' ' 6' ' ' LYS . 46.7 mt-30 -129.9 107.55 9.46 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.265 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.676 ' CD1' HG22 ' A' ' 118' ' ' ILE . 3.9 mp -137.2 58.31 17.35 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.26 -46.0 1.15 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.47 2.113 . . . . 0.0 112.62 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.39 40.68 0.47 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.986 0.422 . . . . 0.0 110.552 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.362 -179.9 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.682 0.277 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.81 146.71 8.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.084 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' A' ' 122' ' ' LEU . . . -85.74 59.84 5.88 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.015 0.436 . . . . 0.0 110.753 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t -132.41 151.05 52.03 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.411 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.508 HG13 ' H ' ' A' ' 120' ' ' ILE . 11.5 p -134.81 119.45 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 111.428 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -123.79 105.11 9.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.599 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.415 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 4.1 mtt180 -118.07 169.66 9.48 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.003 0.43 . . . . 0.0 111.365 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -161.56 125.37 3.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.53 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.3 tt -105.06 118.44 52.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.115 0.484 . . . . 0.0 110.947 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.46 117.53 29.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.053 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.613 ' CD1' HD13 ' A' ' 88' ' ' ILE . 8.5 pt -122.83 128.75 75.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.585 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -119.23 141.89 48.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.402 ' OG1' HD12 ' A' ' 34' ' ' ILE . 5.6 m -137.35 111.06 8.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.151 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.5 mp0 -125.09 129.79 50.95 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.734 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -132.64 143.43 49.66 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.141 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -139.02 119.52 13.91 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.15 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 30' ' ' ARG . 8.2 mt -118.55 111.01 32.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.777 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.29 96.26 1.34 Allowed Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.217 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.554 ' O ' HG23 ' A' ' 21' ' ' VAL . 55.9 Cg_endo -72.37 -43.64 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.711 2.274 . . . . 0.0 112.765 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 58.69 22.94 10.49 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.611 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 19' ' ' PRO . 41.2 t -125.4 136.11 27.81 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.99 108.74 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.827 2.352 . . . . 0.0 112.283 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.34 137.53 18.94 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.656 2.237 . . . . 0.0 112.867 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.14 -50.19 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -124.89 -61.05 1.33 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.81 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -167.87 120.33 0.88 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.667 0.27 . . . . 0.0 111.274 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -160.82 54.89 0.61 Allowed Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.193 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.93 133.71 10.27 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.721 2.281 . . . . 0.0 112.945 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.2 t -137.99 124.77 27.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.819 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.54 ' HB3' HG23 ' A' ' 17' ' ' ILE . 5.5 ptp180 -133.16 165.12 25.52 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.346 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.01 157.16 33.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.666 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 10.9 p-90 -155.42 142.24 18.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.449 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 p -147.93 117.93 7.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.331 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.437 HD13 HD21 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -133.88 141.25 44.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.585 -179.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -131.39 134.17 46.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.641 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 55' ' ' ILE . 19.5 mt -124.38 106.38 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.643 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 73' ' ' PRO . 18.1 t -118.04 148.44 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.696 0.284 . . . . 0.0 111.387 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.876 HD13 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -159.33 148.59 18.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.323 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 42' ' ' GLU . 1.4 tp -102.72 160.82 14.25 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.255 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -173.76 -44.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.194 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.93 1.48 20.5 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.943 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.617 ' HG3' HD21 ' A' ' 39' ' ' LEU . 15.5 mm-40 -86.42 -36.73 18.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.578 0.228 . . . . 0.0 110.798 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.38 -72.83 0.63 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.683 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HD3' HD13 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -142.31 116.46 9.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.779 0.323 . . . . 0.0 110.836 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.93 35.48 1.26 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.175 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.407 HD13 ' HD3' ' A' ' 44' ' ' LYS . 4.2 mp -131.28 126.63 21.48 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.279 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.01 -174.34 1.9 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.856 2.371 . . . . 0.0 112.475 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.586 ' HB3' ' HG ' ' A' ' 93' ' ' LEU . . . -154.73 -63.69 0.13 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.622 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.525 HG22 HG13 ' A' ' 50' ' ' ILE . 27.2 m -99.07 -65.97 0.93 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.551 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.525 HG13 HG22 ' A' ' 49' ' ' THR . 56.6 mt -128.58 -92.77 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.399 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.434 ' CE1' ' HE2' ' A' ' 53' ' ' LYS . 35.7 t80 62.35 97.82 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.18 0.514 . . . . 0.0 111.399 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -164.5 112.56 1.09 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.062 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.923 ' HG2' HG13 ' A' ' 90' ' ' VAL . 4.8 mtmt -101.89 123.74 46.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.704 HG12 ' HG3' ' A' ' 67' ' ' ARG . 11.4 m -132.29 116.5 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 111.136 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.594 HG13 HG23 ' A' ' 88' ' ' ILE . 3.7 mp -103.24 149.56 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.192 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 65' ' ' PRO . 20.9 m-85 -138.19 119.12 14.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.294 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.474 ' CE1' ' CG2' ' A' ' 55' ' ' ILE . 5.5 m-70 -123.39 116.44 23.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.076 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.519 HD11 HD22 ' A' ' 105' ' ' LEU . 4.2 mp 64.18 -178.11 0.16 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.918 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.48 109.79 2.1 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.821 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.445 ' HB3' ' HG3' ' A' ' 65' ' ' PRO . 32.3 Cg_exo -59.73 -18.49 48.72 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.805 2.336 . . . . 0.0 113.041 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 m -74.24 5.79 4.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.374 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.36 -51.23 0.58 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-O 120.528 0.204 . . . . 0.0 111.026 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 -13.68 37.59 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 30.1 t30 72.52 140.91 0.08 OUTLIER Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.803 0.335 . . . . 0.0 111.237 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.445 ' HG3' ' HB3' ' A' ' 60' ' ' PRO . 23.5 Cg_exo -63.9 171.15 7.73 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.79 2.327 . . . . 0.0 112.649 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.436 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 5.1 m120 -124.71 137.92 54.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.704 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -129.87 146.27 51.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.258 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.67 136.35 37.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.743 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -161.86 -50.04 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.719 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.3 t -159.03 40.36 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.166 0.508 . . . . 0.0 110.663 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.96 157.79 74.68 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.006 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 44.1 Cg_exo -56.43 170.44 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.114 2.543 . . . . 0.0 112.28 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HB3' HG22 ' A' ' 37' ' ' VAL . 19.0 Cg_endo -58.13 171.46 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.959 2.439 . . . . 0.0 112.903 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.36 85.9 2.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.343 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -110.21 130.57 55.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -135.19 125.83 44.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.033 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -129.83 125.25 35.25 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 8.9 mt-10 -152.76 172.98 15.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.377 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -119.17 -179.6 3.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.213 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.97 -156.06 25.06 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.362 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -69.28 130.52 42.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.66 95.2 0.1 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.71 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.06 109.03 0.39 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.908 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.49 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 30.8 m-85 -153.77 164.8 19.44 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 111.105 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 10.8 Cg_endo -54.57 168.73 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.497 2.798 . . . . 0.0 113.981 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.437 ' HG ' ' HA ' ' A' ' 57' ' ' HIS . 6.7 mp -134.05 155.74 49.48 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.525 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -158.11 120.94 3.82 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.937 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.613 HD13 ' CD1' ' A' ' 11' ' ' ILE . 2.3 mp -125.22 126.36 70.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.475 ' OG ' HG23 ' A' ' 54' ' ' VAL . 57.4 p -127.98 115.43 18.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.997 0.427 . . . . 0.0 110.917 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.923 HG13 ' HG2' ' A' ' 53' ' ' LYS . 26.1 t -104.36 138.85 27.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.998 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.408 ' C ' HD23 ' A' ' 92' ' ' LEU . 21.1 m-85 -131.44 153.71 49.44 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.75 HD21 ' N ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -148.25 -165.78 2.36 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.023 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.586 ' HG ' ' HB3' ' A' ' 48' ' ' ALA . 7.9 mp -56.5 -62.03 2.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 179.05 50.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.013 0.435 . . . . 0.0 110.701 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -112.03 -154.21 0.54 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.516 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.36 -14.35 20.21 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.644 ' C ' HD21 ' A' ' 92' ' ' LEU . . . -61.52 -22.65 61.75 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.811 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.75 ' N ' HD21 ' A' ' 92' ' ' LEU . 4.4 pt-20 -68.08 84.84 0.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.086 0.47 . . . . 0.0 110.377 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.32 156.75 45.27 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.729 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 89' ' ' SER . 1.7 mtmm -103.07 153.22 20.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.654 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.529 ' O ' HD12 ' A' ' 88' ' ' ILE . 25.5 mt -137.58 99.79 9.4 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.012 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.33 130.94 8.33 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.861 2.374 . . . . 0.0 112.22 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.458 ' CD2' HG22 ' A' ' 101' ' ' ILE . 4.9 m-70 -132.71 167.43 20.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.59 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -134.94 135.12 41.27 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.6 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.519 HD22 HD11 ' A' ' 58' ' ' LEU . 5.8 tp -125.75 84.72 2.31 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.675 0.274 . . . . 0.0 111.314 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -168.63 38.2 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.256 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -140.44 133.96 30.07 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.785 0.326 . . . . 0.0 111.548 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.422 ' H ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.11 130.64 47.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.829 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 67.0 61.32 0.5 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 6.3 tp10 -96.58 136.84 36.54 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.699 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.7 t -141.11 70.46 1.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.617 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.23 119.25 37.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.184 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.83 154.28 35.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.46 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 t -142.36 152.18 18.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.585 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -134.53 109.24 8.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.65 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -113.11 147.91 36.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.917 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.66 140.74 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.21 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.672 HG23 HD13 ' A' ' 92' ' ' LEU . 2.9 mt -124.52 117.83 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.13 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.75 116.21 19.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.017 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.508 ' H ' HG13 ' A' ' 5' ' ' VAL . 1.7 mp -128.57 53.43 11.16 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.232 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.76 -167.81 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.755 2.303 . . . . 0.0 112.246 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.402 HD12 ' HB3' ' A' ' 3' ' ' ALA . 17.2 mt -91.48 51.93 1.98 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.987 0.423 . . . . 0.0 110.695 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.381 -0.819 . . . . 0.0 111.105 179.787 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mtt . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.783 0.325 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 2' ' ' VAL . 14.0 m -142.16 75.12 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.926 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.59 -171.3 0.15 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.318 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.668 HG22 ' CB ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER -152.52 152.68 32.19 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.889 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.4 t -127.18 119.63 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.532 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -137.81 112.85 9.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.358 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.57 ' NH1' HD13 ' A' ' 92' ' ' LEU . 35.0 mtp180 -138.84 167.76 21.29 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.078 0.466 . . . . 0.0 111.871 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -167.6 124.97 1.18 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.675 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.803 HD11 HD11 ' A' ' 36' ' ' ILE . 17.5 tt -108.49 118.98 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.937 0.398 . . . . 0.0 110.983 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG2' ' HG2' ' A' ' 115' ' ' GLU . 58.1 mtp85 -122.89 111.86 17.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.801 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.541 ' CD1' HD13 ' A' ' 88' ' ' ILE . 47.8 pt -106.95 137.2 38.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.015 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -125.16 128.59 48.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.132 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.586 HG23 ' CD1' ' A' ' 34' ' ' ILE . 74.3 m -130.89 124.48 31.25 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.85 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -139.32 143.58 37.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.205 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' A' ' 16' ' ' HIS . 1.8 tt0 -137.84 144.46 41.46 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.632 0.253 . . . . 0.0 111.32 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.472 ' N ' ' HG3' ' A' ' 15' ' ' GLN . 15.3 t60 -140.36 119.42 12.75 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.066 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' ' 30' ' ' ARG . 6.8 mt -118.46 109.09 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.741 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.5 tp -173.14 95.66 0.35 Allowed Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.84 -55.21 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.923 2.416 . . . . 0.0 112.737 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 71.13 0.21 3.33 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.463 HG23 ' HD2' ' A' ' 22' ' ' PRO . 9.3 p -125.72 138.31 31.71 Favored Pre-proline 0 CA--C 1.531 0.212 0 O-C-N 122.435 -0.166 . . . . 0.0 110.848 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.463 ' HD2' HG23 ' A' ' 21' ' ' VAL . 15.2 Cg_endo -57.27 142.4 94.73 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.686 2.257 . . . . 0.0 112.389 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.49 113.26 3.08 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.75 2.3 . . . . 0.0 112.823 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.555 HG23 ' HG2' ' A' ' 25' ' ' GLU . 11.9 m -146.93 -47.62 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.629 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.555 ' HG2' HG23 ' A' ' 24' ' ' VAL . 6.9 pt-20 -128.22 -51.29 1.3 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.35 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -83.65 -41.86 17.31 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.307 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 64.65 165.61 0.12 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.337 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.13 134.24 36.52 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.065 2.51 . . . . 0.0 113.091 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.98 176.6 3.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.976 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.496 ' HB3' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -138.03 164.41 29.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.858 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -122.3 149.23 44.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.742 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.452 ' HB2' HD21 ' A' ' 105' ' ' LEU . 14.9 p-90 -148.47 140.2 23.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.039 0.447 . . . . 0.0 111.344 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.2 t -129.94 117.69 20.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.476 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.586 ' CD1' HG23 ' A' ' 13' ' ' THR . 28.7 mm -125.73 127.23 71.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.139 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -147.68 157.47 43.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.809 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.803 HD11 HD11 ' A' ' 9' ' ' ILE . 11.4 tt -155.13 128.42 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.962 0.41 . . . . 0.0 111.518 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 73' ' ' PRO . 22.9 t -119.34 148.49 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.807 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.677 HD12 ' HB ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -160.41 145.47 14.67 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.698 0.285 . . . . 0.0 111.378 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.556 HD21 ' HG3' ' A' ' 42' ' ' GLU . 3.1 tp -103.3 164.16 11.81 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -171.74 -45.67 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.944 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.54 0.48 17.17 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.556 ' HG3' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -82.99 -34.96 26.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.637 0.256 . . . . 0.0 110.651 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.91 -55.86 0.29 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.744 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -162.71 114.05 1.53 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG3' ' HB3' ' A' ' 40' ' ' ASP . 18.1 tt0 -98.66 38.07 1.41 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.987 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.79 134.06 24.51 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.944 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.85 -171.24 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.834 2.356 . . . . 0.0 112.65 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.842 ' HB3' ' CB ' ' A' ' 93' ' ' LEU . . . -165.39 -45.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.444 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.17 -66.03 0.83 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.576 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.3 mm -114.88 -87.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.786 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 49.3 t80 58.79 96.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.897 0.379 . . . . 0.0 111.357 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 6.7 t70 -172.52 110.64 0.23 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.878 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.956 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -102.64 127.07 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.614 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 m -126.2 142.41 42.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.685 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.478 HG12 HD13 ' A' ' 36' ' ' ILE . 2.3 mp -127.4 150.33 33.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.37 144.2 36.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.532 ' HB2' HD12 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -140.39 119.91 13.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.995 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.532 HD12 ' HB2' ' A' ' 57' ' ' HIS . 5.1 mp 67.62 -175.35 0.19 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.309 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.87 157.55 4.03 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.86 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.05 -2.4 8.74 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.13 2.553 . . . . 0.0 113.558 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.32 -9.81 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.93 142.8 57.21 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.568 0.223 . . . . 0.0 110.799 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.59 87.0 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.391 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -154.81 129.5 4.91 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.057 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.94 -171.31 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.526 2.151 . . . . 0.0 112.15 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.406 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 20.6 m-20 -108.77 151.17 26.58 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.887 0.375 . . . . 0.0 111.074 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.17 155.98 40.78 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.041 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.62 122.63 26.34 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.798 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.452 ' HA ' ' HZ2' ' A' ' 53' ' ' LYS . 16.0 t80 -143.9 -57.02 0.38 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.601 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 t -148.61 34.51 0.78 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.721 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.69 160.27 45.06 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.115 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.42 171.67 10.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.934 2.422 . . . . 0.0 112.434 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.602 ' HB3' HG13 ' A' ' 37' ' ' VAL . 18.7 Cg_endo -58.99 162.55 13.27 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.928 2.419 . . . . 0.0 112.822 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -108.59 156.12 19.88 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.336 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.19 121.38 0.75 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.624 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 76' ' ' ILE . 11.3 tp -158.87 119.89 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.959 0.409 . . . . 0.0 111.329 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -126.86 111.52 14.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.646 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.43 161.73 25.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.81 179.74 3.99 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.957 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.91 -170.25 18.73 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.224 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -66.96 120.51 13.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.797 0.332 . . . . 0.0 111.158 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.93 128.1 0.96 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.907 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.39 107.77 0.26 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.717 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.509 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 16.0 m-85 -153.49 164.52 20.24 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.717 0.294 . . . . 0.0 111.016 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.551 ' O ' HD13 ' A' ' 86' ' ' LEU . 32.3 Cg_exo -59.66 163.43 13.25 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.924 2.416 . . . . 0.0 113.572 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -126.65 166.69 16.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.932 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -155.96 128.69 7.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.173 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.541 HD13 ' CD1' ' A' ' 11' ' ' ILE . 3.4 mp -136.1 116.45 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.654 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 6.7 t -122.82 146.22 47.74 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.214 0.531 . . . . 0.0 111.477 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.956 HG13 ' HG2' ' A' ' 53' ' ' LYS . 3.2 t -123.56 144.29 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.867 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.519 ' HA ' ' HG3' ' A' ' 98' ' ' GLU . 50.3 m-85 -137.24 154.43 50.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.188 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.57 HD13 ' NH1' ' A' ' 7' ' ' ARG . 9.2 tp -152.01 178.1 9.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.842 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -74.07 -30.27 62.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.738 0.304 . . . . 0.0 110.331 179.199 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -106.89 -159.19 0.69 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.161 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -128.52 74.29 1.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.922 0.392 . . . . 0.0 110.683 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.542 ' HB3' HG23 ' A' ' 118' ' ' ILE . . . -115.16 -50.61 2.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.484 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.75 36.5 1.93 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.746 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.519 ' HG3' ' HA ' ' A' ' 91' ' ' PHE . 22.8 tt0 -88.5 76.36 8.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.513 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -142.72 156.74 45.06 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.689 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -110.32 149.38 30.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.063 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 100' ' ' LYS . 21.9 mm -135.3 113.21 11.22 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.266 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -85.82 153.11 10.01 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.941 2.427 . . . . 0.0 112.473 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.431 ' HB3' HD23 ' A' ' 86' ' ' LEU . 7.1 m170 -144.4 171.39 14.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.061 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.18 143.18 49.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.034 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.774 ' HB2' HD21 ' A' ' 86' ' ' LEU . 9.1 tp -130.61 82.12 2.04 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.838 0.352 . . . . 0.0 111.417 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -170.73 47.25 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.286 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -141.61 132.16 25.4 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 111.725 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -64.96 115.4 5.35 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.763 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.409 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 0.5 OUTLIER 74.86 73.0 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.433 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 40.3 tt0 -108.84 141.05 41.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.567 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.6 p -139.83 75.37 1.51 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.05 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.75 119.79 39.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.344 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.8 145.08 25.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.506 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.406 HG21 HG21 ' A' ' 101' ' ' ILE . 14.2 t -126.6 150.48 32.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.704 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 10' ' ' ARG . 4.7 mt-10 -134.05 109.05 8.7 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.828 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -113.05 140.28 47.97 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.69 136.41 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.436 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.542 HG23 ' HB3' ' A' ' 96' ' ' ALA . 1.8 mp -126.69 111.04 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.37 132.34 45.74 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.985 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 120' ' ' ILE . 2.5 tp -161.6 61.75 1.37 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 121.329 0.585 . . . . 0.0 111.377 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.668 ' CB ' HG22 ' A' ' 4' ' ' THR . 56.2 Cg_endo -73.66 -46.41 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.739 2.293 . . . . 0.0 112.772 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.2 tp -175.89 88.11 0.04 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.259 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.05 -179.458 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.961 0.41 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 m -106.02 -28.64 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.073 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.55 90.14 0.08 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.756 0.312 . . . . 0.0 111.377 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.48 154.78 50.66 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.875 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.06 119.06 35.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.965 0.412 . . . . 0.0 110.977 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -137.0 116.33 12.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.192 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.541 ' HA ' HD12 ' A' ' 39' ' ' LEU . 31.8 mtt-85 -132.45 159.04 40.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.368 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -160.56 127.1 4.15 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.841 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.839 HG21 HG21 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.77 122.84 66.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.717 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.588 ' N ' HD13 ' A' ' 9' ' ' ILE . 13.3 mtt180 -124.72 129.03 49.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 88' ' ' ILE . 1.1 pt -127.39 127.14 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.969 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.493 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -120.82 130.26 53.9 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.185 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.616 HG23 ' CD1' ' A' ' 34' ' ' ILE . 84.8 m -133.27 108.52 8.8 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -119.5 143.93 47.29 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.143 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.704 ' HB2' HD12 ' A' ' 105' ' ' LEU . 3.1 tp60 -139.25 142.02 37.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.186 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.438 ' N ' ' HG3' ' A' ' 15' ' ' GLN . 63.4 t-80 -144.91 119.29 9.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.925 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.604 HG22 ' HD3' ' A' ' 19' ' ' PRO . 17.7 mt -108.57 136.94 42.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.974 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 mt -120.58 67.67 14.19 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 111.434 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.604 ' HD3' HG22 ' A' ' 17' ' ' ILE . 94.9 Cg_endo -79.53 -23.47 7.15 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.831 2.354 . . . . 0.0 113.007 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -80.59 -63.36 1.43 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.305 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.3 t -104.26 100.05 19.97 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.16 112.92 3.66 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.5 2.133 . . . . 0.0 112.092 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.17 68.47 2.53 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.696 2.264 . . . . 0.0 112.263 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.9 t 54.16 57.72 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.052 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -142.74 164.64 29.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.356 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -108.02 134.21 51.24 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.324 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 70.17 155.36 0.15 Allowed Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.51 118.1 4.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.826 2.351 . . . . 0.0 112.754 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.4 t -112.54 152.81 14.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.369 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.45 163.48 29.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.021 0.438 . . . . 0.0 111.526 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.39 153.37 35.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.831 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.493 ' CZ2' HG21 ' A' ' 61' ' ' THR . 23.1 p-90 -153.91 151.8 29.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.595 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 13' ' ' THR . 11.7 t -148.68 119.34 7.49 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.992 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.858 HD11 HD22 ' A' ' 105' ' ' LEU . 25.2 mm -126.25 137.16 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.683 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 9.3 pt-20 -157.51 119.59 3.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.702 0.287 . . . . 0.0 111.482 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.467 ' CD1' HD12 ' A' ' 55' ' ' ILE . 13.6 tt -124.98 127.71 72.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.45 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.76 HG12 ' CB ' ' A' ' 73' ' ' PRO . 34.6 m -129.74 158.36 42.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.478 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.64 HD13 ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -160.09 155.61 25.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.856 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 7' ' ' ARG . 81.4 mt -88.03 168.01 13.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.764 0.316 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.11 -58.7 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.496 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.6 -23.92 67.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.151 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -90.36 -36.65 14.51 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.538 0.208 . . . . 0.0 110.93 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.92 54.55 0.55 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.39 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt 63.79 116.59 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.09 0.471 . . . . 0.0 111.646 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -88.48 31.74 0.81 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.521 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.2 mt -129.69 134.36 26.11 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.774 -0.193 . . . . 0.0 111.132 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.16 173.09 13.52 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.809 2.34 . . . . 0.0 112.36 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -145.48 -70.97 0.26 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.501 ' OG1' HD13 ' A' ' 93' ' ' LEU . 19.0 p -117.77 -74.69 0.6 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.63 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.9 mt -100.96 -85.74 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.534 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 3.3 t80 51.59 95.85 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.128 0.489 . . . . 0.0 111.133 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -171.3 103.78 0.21 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.717 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.937 ' HG2' HG13 ' A' ' 90' ' ' VAL . 5.4 mttt -99.21 114.28 26.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.037 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.863 HG12 ' HA ' ' A' ' 67' ' ' ARG . 27.5 m -128.07 160.76 37.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.749 HG22 ' HB2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -123.4 167.26 17.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.967 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.511 ' N ' HG23 ' A' ' 55' ' ' ILE . 10.7 t80 -134.16 131.59 38.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.241 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.6 ' HD2' HD23 ' A' ' 86' ' ' LEU . 48.2 m170 -129.41 104.94 7.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' A' ' 85' ' ' PRO . 0.2 OUTLIER -69.79 -34.48 73.78 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.211 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.493 ' CD2' HD23 ' A' ' 105' ' ' LEU . 7.4 p80 -59.09 139.48 87.69 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.127 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 59' ' ' HIS . 43.5 Cg_exo -57.49 -14.68 17.25 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.086 2.524 . . . . 0.0 113.87 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.493 HG21 ' CZ2' ' A' ' 32' ' ' TRP . 0.3 OUTLIER -56.42 -14.72 3.21 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.483 0.182 . . . . 0.0 111.402 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.6 110.57 9.4 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.548 0.213 . . . . 0.0 110.546 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.6 -48.45 79.34 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.398 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.75 142.32 32.8 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.78 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.26 169.69 2.02 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.872 2.381 . . . . 0.0 112.57 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.749 ' HB2' HG22 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -90.98 146.44 23.86 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.262 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.863 ' HA ' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -142.01 136.76 30.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.515 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.605 ' CG2' HD11 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -130.97 98.96 4.74 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 111.002 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -115.38 -49.58 2.76 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.865 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -146.94 35.08 0.91 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.921 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -130.52 159.73 69.45 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.29 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.26 173.08 3.57 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.063 2.509 . . . . 0.0 112.629 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.76 ' CB ' HG12 ' A' ' 37' ' ' VAL . 30.0 Cg_endo -62.36 174.14 2.9 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.989 2.459 . . . . 0.0 112.77 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -136.38 95.08 3.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.392 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.542 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -121.19 110.33 16.04 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.002 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 75' ' ' ARG . 20.6 mm -134.81 117.31 22.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -129.71 130.15 45.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.128 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -155.56 178.37 10.31 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.702 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.71 131.36 56.79 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.786 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.34 -131.07 2.14 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.03 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -120.27 110.31 16.42 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.16 0.505 . . . . 0.0 111.209 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.17 99.02 0.12 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.439 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -148.83 108.45 0.41 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.514 -0.851 . . . . 0.0 113.236 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HB2' ' CA ' ' A' ' 59' ' ' HIS . 10.4 m-85 -155.82 170.03 9.44 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 122.177 0.191 . . . . 0.0 110.645 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.522 ' HB2' HD13 ' A' ' 58' ' ' LEU . 31.6 Cg_exo -59.2 168.43 4.78 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.854 2.37 . . . . 0.0 112.811 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.784 HD11 ' CB ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -144.24 172.49 12.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.703 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 21.0 t70 -159.83 116.79 2.57 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.897 0.379 . . . . 0.0 111.085 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 11' ' ' ILE . 3.7 mp -108.1 131.57 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.4 p -128.33 119.64 25.46 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.983 0.42 . . . . 0.0 110.551 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.937 HG13 ' HG2' ' A' ' 53' ' ' LYS . 40.7 t -106.53 135.55 44.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.729 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -134.83 150.24 50.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.721 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.066 HD22 HG21 ' A' ' 118' ' ' ILE . 12.2 tp -142.96 -69.55 0.34 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.707 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.501 HD13 ' OG1' ' A' ' 49' ' ' THR . 0.2 OUTLIER -129.4 -76.73 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.541 0.21 . . . . 0.0 111.189 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -137.26 -57.48 0.7 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.289 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 27.1 0.85 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -78.52 -37.64 42.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.74 37.56 0.39 Allowed Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.834 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -90.1 92.39 8.94 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 110.532 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.02 144.32 33.58 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.344 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 130.13 38.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.392 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.01 132.82 21.54 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.527 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 94.7 Cg_endo -79.85 143.58 16.57 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.689 2.259 . . . . 0.0 111.932 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.1 171.91 10.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.01 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -122.54 140.26 52.97 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.657 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.858 HD22 HD11 ' A' ' 34' ' ' ILE . 57.6 tp -140.09 70.01 1.36 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.561 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -174.62 42.8 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -141.61 137.36 31.81 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.463 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.597 HD12 HD12 ' A' ' 17' ' ' ILE . 1.6 mp -50.41 119.75 4.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 58.99 80.64 0.18 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.708 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -111.3 135.09 52.35 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.748 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.5 p -132.57 71.41 1.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.049 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -106.14 119.51 39.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.415 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.5 157.01 33.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.983 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.515 HG23 HD11 ' A' ' 11' ' ' ILE . 3.4 t -139.53 152.32 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.613 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -138.1 109.31 6.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.62 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -113.26 123.94 51.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.021 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 m -103.29 147.22 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.401 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 1.066 HG21 HD22 ' A' ' 92' ' ' LEU . 9.8 mt -137.87 120.65 19.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -129.46 113.49 14.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.864 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.2 pt -146.68 68.03 11.68 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.545 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.69 62.33 5.56 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.571 2.181 . . . . 0.0 112.625 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -173.73 -60.98 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.08 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.097 -179.824 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.46 0.172 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 m 36.66 67.39 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.042 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.03 79.85 1.2 Allowed 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.152 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.06 135.03 20.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.452 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 t -130.29 119.01 45.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.779 0.323 . . . . 0.0 111.389 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -137.62 122.61 19.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.465 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.441 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -134.33 167.37 20.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.204 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 2.3 t -172.56 129.15 0.54 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.444 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.014 HG21 HG21 ' A' ' 90' ' ' VAL . 1.2 tt -109.26 118.3 56.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.54 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.31 114.18 16.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.942 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 36' ' ' ILE . 1.1 pt -118.38 126.67 75.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 113.58 26.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.989 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.634 HG23 ' CD1' ' A' ' 34' ' ' ILE . 85.4 m -119.47 96.36 5.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.193 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -125.4 147.89 49.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.09 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -133.61 165.43 24.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.0 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -163.39 119.82 1.77 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.203 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.508 HG12 ' HA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -94.35 128.22 45.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.982 0.42 . . . . 0.0 111.506 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.33 128.63 0.45 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.579 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.604 ' O ' HG23 ' A' ' 21' ' ' VAL . 25.9 Cg_endo -63.38 -51.0 2.91 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.652 2.234 . . . . 0.0 112.708 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.1 29.55 17.99 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.779 0.323 . . . . 0.0 111.059 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.71 HG12 ' HD2' ' A' ' 23' ' ' PRO . 10.5 t -125.41 106.8 27.22 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.21 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.448 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 48.0 Cg_exo -54.7 -47.47 26.57 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.56 2.173 . . . . 0.0 112.787 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.71 ' HD2' HG12 ' A' ' 21' ' ' VAL . 74.8 Cg_exo -49.92 153.3 6.32 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.688 2.259 . . . . 0.0 112.711 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 24' ' ' VAL . 7.2 p -71.88 80.82 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.271 0.558 . . . . 0.0 111.162 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -114.68 158.11 22.23 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.102 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -123.18 -179.36 4.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 64.24 70.98 0.61 Allowed Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.057 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -57.44 145.46 88.13 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.866 2.378 . . . . 0.0 112.771 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.9 t -116.98 147.41 20.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HA ' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -93.53 155.21 17.45 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.736 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 1.6 mt-30 -117.42 107.0 13.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.708 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.431 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 57.5 p-90 -100.93 158.86 15.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.665 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.454 ' O ' HD13 ' A' ' 34' ' ' ILE . 15.3 t -144.77 117.64 8.77 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.634 ' CD1' HG23 ' A' ' 13' ' ' THR . 17.7 mm -122.88 138.79 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.618 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.16 127.84 13.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.658 HG21 ' CD1' ' A' ' 55' ' ' ILE . 8.6 mt -119.5 106.41 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.342 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 73' ' ' PRO . 21.6 t -118.01 150.14 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.83 0.348 . . . . 0.0 111.627 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.821 HD13 ' HD3' ' A' ' 53' ' ' LYS . 1.1 pp -166.95 148.2 5.9 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.276 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 7.1 mt -76.95 162.84 27.25 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.329 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -166.27 -59.5 0.03 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.956 0.408 . . . . 0.0 110.393 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -58.86 -31.0 68.14 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.314 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -92.15 -29.97 16.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.72 47.75 2.29 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.709 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 mttm 57.1 94.76 0.02 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 111.156 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.28 -28.84 60.06 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.29 120.56 77.3 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.051 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HB3' ' CD2' ' A' ' 51' ' ' PHE . 73.2 Cg_endo -75.6 -171.89 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.591 2.194 . . . . 0.0 112.545 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.84 -55.1 0.46 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.342 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -120.73 -60.49 1.66 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.631 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.9 mm -116.93 -84.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.912 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 47' ' ' PRO . 73.8 t80 58.85 95.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.899 0.381 . . . . 0.0 111.391 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -176.68 151.79 0.94 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.71 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.821 ' HD3' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -133.15 111.57 11.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.518 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.482 HG13 ' CG ' ' A' ' 67' ' ' ARG . 21.6 t -112.12 149.29 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.0 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.665 HG23 HG13 ' A' ' 88' ' ' ILE . 4.1 mp -135.0 154.79 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.662 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.1 150.9 38.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 111.408 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.485 ' HB3' ' NE2' ' A' ' 59' ' ' HIS . 12.6 m-70 -135.49 115.33 13.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.502 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 85' ' ' PRO . 0.1 OUTLIER -61.99 -39.1 91.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.297 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.485 ' NE2' ' HB3' ' A' ' 57' ' ' HIS . 20.5 p80 -56.64 134.75 77.93 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 120.764 0.316 . . . . 0.0 111.485 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.16 -15.8 30.36 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.0 2.467 . . . . 0.0 113.265 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.74 -16.47 1.71 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.44 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.63 83.95 2.21 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.858 0.361 . . . . 0.0 110.454 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.82 -36.8 82.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.397 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -99.25 122.12 53.11 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.733 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.23 164.85 3.41 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.776 2.318 . . . . 0.0 112.614 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -106.86 131.03 54.41 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.18 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.482 ' CG ' HG13 ' A' ' 54' ' ' VAL . 3.8 mtt85 -145.1 131.12 19.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.777 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.25 103.05 8.92 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 111.327 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -104.34 -53.87 2.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.322 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -156.25 35.65 0.33 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.82 165.44 13.97 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.85 157.65 27.72 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.77 2.314 . . . . 0.0 112.423 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HB2' HG22 ' A' ' 37' ' ' VAL . 55.3 Cg_endo -70.05 154.37 66.64 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.609 2.206 . . . . 0.0 112.48 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.87 146.31 25.03 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.406 ' H ' HD12 ' A' ' 76' ' ' ILE . 2.4 tpt180 -171.8 80.8 0.06 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.754 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.406 HD12 ' H ' ' A' ' 75' ' ' ARG . 3.9 mp -141.36 143.2 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.108 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -135.41 130.4 34.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 1.3 mt-10 -137.42 166.2 24.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.912 0.386 . . . . 0.0 111.398 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -100.23 126.58 46.54 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.59 -169.0 33.16 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.732 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -115.34 110.18 19.0 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.661 0.267 . . . . 0.0 110.551 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.88 128.51 1.26 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.458 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.4 95.96 0.15 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.211 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 87.6 m-85 -142.08 165.73 25.82 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-O 120.553 0.216 . . . . 0.0 111.072 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 86' ' ' LEU . 76.2 Cg_exo -50.47 165.95 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.992 2.461 . . . . 0.0 113.367 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 85' ' ' PRO . 1.1 mp -146.51 165.75 28.52 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.882 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -157.38 134.94 10.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.277 0.56 . . . . 0.0 111.128 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.665 HG13 HG23 ' A' ' 55' ' ' ILE . 3.8 mp -128.94 127.19 65.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.884 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.7 p -118.05 137.48 52.88 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.005 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 9' ' ' ILE . 3.9 t -123.8 132.72 70.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.333 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.48 158.87 37.18 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.654 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.741 ' CD1' ' HB3' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -145.65 -49.24 0.23 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.106 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.89 -83.54 0.07 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.01 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.32 -79.49 0.59 Allowed 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 120.562 0.22 . . . . 0.0 111.224 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.75 32.71 1.04 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 111.61 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.741 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -77.29 -39.7 47.07 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.89 0.376 . . . . 0.0 110.361 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.674 ' C ' HD21 ' A' ' 92' ' ' LEU . . . -148.18 24.43 1.41 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.619 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 5.0 tt0 -77.63 103.15 7.39 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.713 0.257 . . . . 0.0 110.386 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.49 155.32 45.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.057 0.456 . . . . 0.0 112.032 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.96 138.24 54.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.137 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.975 HG13 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -132.17 110.45 14.07 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.629 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.49 160.76 28.59 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.639 2.226 . . . . 0.0 112.326 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.527 ' CE1' HG13 ' A' ' 114' ' ' VAL . 2.5 m-70 -144.07 170.18 16.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -134.24 95.45 3.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.423 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.686 HD12 ' OE1' ' A' ' 110' ' ' GLU . 15.8 tp -77.99 121.98 24.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.353 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.2 -179.42 5.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.084 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -107.83 166.47 10.68 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.592 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.48 ' HA ' HG22 ' A' ' 17' ' ' ILE . 1.9 tp 77.2 60.32 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.137 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 66.11 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.541 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.686 ' OE1' HD12 ' A' ' 105' ' ' LEU . 45.0 tt0 -130.82 147.15 52.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.086 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -140.74 74.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.572 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -117.64 119.29 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.91 157.37 23.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.53 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.975 HG21 HG13 ' A' ' 101' ' ' ILE . 29.7 m -137.68 158.11 33.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.312 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -142.93 109.02 5.21 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.348 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.37 150.11 33.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.1 p -124.36 134.9 65.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.202 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.727 ' CG2' HD13 ' A' ' 92' ' ' LEU . 3.4 mp -131.98 111.19 17.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.65 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -129.7 139.44 51.35 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.187 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.524 ' O ' HG23 ' A' ' 120' ' ' ILE . 6.5 tp -169.05 72.19 0.74 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 121.369 0.604 . . . . 0.0 111.144 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.37 154.23 65.5 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.12 -43.42 21.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.827 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.868 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.838 HG21 ' HB3' ' A' ' 44' ' ' LYS . 11.9 p -158.8 141.05 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.751 0.31 . . . . 0.0 111.701 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.93 36.61 0.4 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.682 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.52 126.27 8.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.501 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.856 HG22 ' HG2' ' A' ' 44' ' ' LYS . 16.6 t -130.83 119.34 45.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.889 0.376 . . . . 0.0 111.018 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -133.64 110.95 10.22 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.742 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 15.1 mtt85 -126.44 161.65 27.41 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.352 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 2.3 t -170.47 116.92 0.51 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.59 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.865 HD11 HD11 ' A' ' 36' ' ' ILE . 7.8 tt -103.41 118.06 49.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 121.023 0.44 . . . . 0.0 110.93 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -118.09 112.11 19.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.477 HG22 ' CG1' ' A' ' 36' ' ' ILE . 40.1 pt -113.63 133.51 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.31 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -128.77 125.33 37.62 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.954 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -130.89 103.87 6.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -117.64 146.38 43.72 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.169 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.634 ' HG2' ' HA ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -146.04 148.26 32.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.887 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.43 ' HA ' ' H ' ' A' ' 109' ' ' GLN . 0.6 OUTLIER -162.9 120.37 1.97 Allowed 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.655 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 107' ' ' PHE . 24.8 mt -71.91 147.27 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.667 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.576 HD12 HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -121.42 75.43 33.21 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.928 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.62 -23.84 12.44 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.749 2.299 . . . . 0.0 112.823 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.78 -32.68 63.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.38 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.576 HG23 HD12 ' A' ' 18' ' ' LEU . 21.4 t -76.62 132.26 72.5 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.931 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HA ' ' HD2' ' A' ' 23' ' ' PRO . 74.0 Cg_endo -75.38 111.54 3.33 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.493 2.129 . . . . 0.0 112.419 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 22' ' ' PRO . 59.0 Cg_endo -71.18 -179.98 3.98 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.745 2.297 . . . . 0.0 112.517 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 m -59.39 -32.61 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.69 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.12 -67.21 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.473 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -156.13 31.33 0.34 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.032 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -118.75 79.29 16.42 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.814 0.34 . . . . 0.0 110.986 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.04 159.35 52.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.818 2.345 . . . . 0.0 112.636 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 m -122.34 176.49 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.236 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 1.1 ptt-85 -131.3 160.37 35.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.069 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -100.17 160.08 14.61 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.855 0.36 . . . . 0.0 111.079 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.1 p-90 -159.4 151.58 20.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.613 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -148.36 118.11 7.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.696 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tp -124.9 137.04 58.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.926 0.393 . . . . 0.0 111.573 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.413 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -157.67 149.54 22.1 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.786 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.936 HG21 HD13 ' A' ' 55' ' ' ILE . 12.5 tt -156.61 132.51 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.025 0.441 . . . . 0.0 111.331 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.81 HG12 ' CB ' ' A' ' 73' ' ' PRO . 35.3 m -130.39 159.04 42.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.975 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.58 HD12 ' HB ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER -164.49 145.21 7.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 111.475 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.769 HD21 ' HG3' ' A' ' 42' ' ' GLU . 2.7 tp -97.57 155.16 17.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.378 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.06 -46.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.973 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -78.23 2.61 17.73 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.378 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.769 ' HG3' HD21 ' A' ' 39' ' ' LEU . 8.9 mm-40 -82.24 -27.9 32.21 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.495 0.188 . . . . 0.0 110.781 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.26 -59.08 0.13 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.167 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.856 ' HG2' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -153.05 119.56 5.6 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.777 0.322 . . . . 0.0 111.453 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.19 30.41 4.17 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.957 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.43 134.44 21.21 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.177 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 36.4 Cg_endo -65.75 -44.93 7.23 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.664 2.243 . . . . 0.0 112.769 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 66.57 -76.05 0.05 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.52 0.328 . . . . 0.0 111.798 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.405 HG22 ' CD1' ' A' ' 50' ' ' ILE . 91.4 m -104.02 -69.61 0.8 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.565 0.221 . . . . 0.0 110.977 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.405 ' CD1' HG22 ' A' ' 49' ' ' THR . 2.5 mp -122.77 -81.81 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.772 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 47' ' ' PRO . 5.5 t80 62.48 101.62 0.03 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.296 0.57 . . . . 0.0 110.953 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 35.1 t70 -166.75 111.54 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.848 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.74 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -116.28 126.34 53.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.211 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.582 HG23 ' HD3' ' A' ' 67' ' ' ARG . 14.2 p -122.3 152.48 26.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.884 0.373 . . . . 0.0 111.588 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.936 HD13 HG21 ' A' ' 36' ' ' ILE . 2.1 mt -130.98 131.3 64.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.374 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.59 144.07 51.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.696 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' C ' HD12 ' A' ' 58' ' ' LEU . 5.7 p-80 -147.57 119.85 8.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.0 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.603 HD11 HD22 ' A' ' 105' ' ' LEU . 4.9 mp 67.18 -172.09 0.19 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.677 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -60.52 141.14 92.03 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.11 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.13 -15.1 13.27 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.844 2.363 . . . . 0.0 113.062 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.4 p -65.19 -3.54 4.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.558 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.51 161.25 2.76 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.458 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.51 -48.47 48.05 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.538 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -161.15 142.71 8.84 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 111.278 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.34 -175.83 2.41 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.88 2.387 . . . . 0.0 112.247 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.495 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 3.4 m120 -128.24 145.61 50.99 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.836 0.35 . . . . 0.0 111.158 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.582 ' HD3' HG23 ' A' ' 54' ' ' VAL . 3.2 mmm-85 -141.81 153.37 44.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.69 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 4.3 m -130.71 119.07 21.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.849 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.752 ' CD2' HG22 ' A' ' 70' ' ' THR . 3.1 p90 -164.13 -49.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.584 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.752 HG22 ' CD2' ' A' ' 69' ' ' PHE . 14.8 t -152.02 32.12 0.54 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.648 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.27 161.89 24.81 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.16 166.83 28.51 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.765 2.31 . . . . 0.0 112.653 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.81 ' CB ' HG12 ' A' ' 37' ' ' VAL . 55.5 Cg_endo -70.37 138.68 36.43 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.876 2.384 . . . . 0.0 112.639 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -93.37 148.57 21.94 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.146 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -171.69 84.1 0.08 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.72 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 mt -134.91 134.28 53.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.495 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -134.51 137.73 44.1 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.831 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.15 -177.59 6.01 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.82 125.14 48.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.595 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.95 -162.83 16.84 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.588 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -122.82 110.89 16.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.0 0.429 . . . . 0.0 110.942 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.61 124.5 0.76 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.954 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.662 ' HA2' HD23 ' A' ' 105' ' ' LEU . . . -144.93 107.06 0.42 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.274 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.415 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 11.0 m-85 -141.59 167.47 16.9 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.67 0.271 . . . . 0.0 111.367 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.9 171.85 0.94 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.24 2.627 . . . . 0.0 113.733 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 105' ' ' LEU . 5.1 mp -139.37 166.05 25.58 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.563 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -155.0 114.6 3.71 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.728 0.299 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.7 mp -124.19 120.45 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.623 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.05 149.37 42.29 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.853 0.359 . . . . 0.0 111.094 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.74 HG13 ' HG2' ' A' ' 53' ' ' LYS . 3.7 t -131.08 131.38 63.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.222 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 54.2 m-85 -142.54 144.17 32.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.174 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.77 -54.01 1.15 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.396 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -179.64 -44.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.758 0.313 . . . . 0.0 110.895 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.76 -174.61 2.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.917 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.05 71.26 3.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 111.356 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.06 -50.86 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.577 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -145.65 33.14 1.56 Allowed Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.455 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HB2' ' CD1' ' A' ' 91' ' ' PHE . 3.2 pt-20 -102.09 103.0 13.55 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.792 0.329 . . . . 0.0 110.786 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.34 151.18 41.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 2.0 mtmt -104.52 124.92 50.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.337 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.43 114.05 29.0 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.684 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.6 151.94 15.12 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.874 2.382 . . . . 0.0 111.907 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.467 ' HB3' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -136.64 171.35 14.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 111.398 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -133.86 128.96 35.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.54 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.693 ' HB2' HD11 ' A' ' 86' ' ' LEU . 4.4 tp -108.1 106.35 16.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.777 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.99 168.11 14.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.147 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.634 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 9.3 p90 -94.9 165.61 12.37 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.419 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tp 84.45 62.59 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.341 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.43 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 1.3 tm0? 65.4 111.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.648 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.35 128.82 34.45 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.831 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.9 p -127.41 66.1 1.31 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.714 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' A' ' 103' ' ' HIS . 5.0 m-85 -108.48 119.42 39.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.561 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.37 152.87 20.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.372 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.9 t -139.65 149.16 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.651 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -135.16 108.87 8.01 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.484 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.36 146.24 39.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.121 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.56 128.71 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.176 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 3.5 mp -121.5 111.21 30.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -123.03 122.78 39.35 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.1 pp -148.23 68.58 10.37 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 121.082 0.468 . . . . 0.0 111.347 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.53 -41.11 6.73 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.635 2.223 . . . . 0.0 112.41 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.84 -47.46 2.7 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.576 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.943 179.755 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.774 0.321 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t 60.49 91.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.336 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.92 179.27 8.6 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.578 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t -140.63 147.23 39.03 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.698 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.76 119.46 51.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -138.04 117.68 13.06 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.502 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -143.08 169.2 18.03 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.587 HG22 HD23 ' A' ' 39' ' ' LEU . 9.8 t -172.39 133.58 0.65 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.427 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 9' ' ' ILE . 9.5 tp -109.11 118.39 56.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.032 0.444 . . . . 0.0 111.022 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -124.89 108.21 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.79 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.873 HG12 HD13 ' A' ' 88' ' ' ILE . 1.8 pp -118.58 128.95 75.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.066 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 2.6 mptp? -115.49 125.28 52.86 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.651 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.749 HG23 ' CD1' ' A' ' 34' ' ' ILE . 97.5 m -130.06 127.2 39.41 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -138.96 158.82 43.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.912 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' NE2' ' HG ' ' A' ' 105' ' ' LEU . 1.4 tt0 -153.11 144.28 23.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.757 0.313 . . . . 0.0 111.275 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.414 ' HA ' ' H ' ' A' ' 109' ' ' GLN . 14.0 m-70 -142.18 119.23 11.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.864 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 4.8 mt -114.6 101.13 11.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.913 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.638 HD12 ' HD2' ' A' ' 19' ' ' PRO . 17.6 tp 176.95 129.99 0.19 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.068 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.638 ' HD2' HD12 ' A' ' 18' ' ' LEU . 81.5 Cg_endo -81.88 -44.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.715 2.276 . . . . 0.0 112.494 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -179.28 -49.87 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.197 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.456 HG23 ' HD2' ' A' ' 22' ' ' PRO . 9.1 p -121.53 137.35 26.89 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.501 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 21' ' ' VAL . 19.7 Cg_endo -58.22 107.26 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.857 2.371 . . . . 0.0 112.689 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -87.03 -13.19 4.63 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.912 2.408 . . . . 0.0 113.757 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 24' ' ' VAL . 12.1 t 63.45 41.87 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.985 0.421 . . . . 0.0 110.91 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.01 177.05 8.07 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.36 30.22 2.6 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.295 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.492 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -70.09 -57.81 5.77 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.443 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.505 ' HB3' ' HG3' ' A' ' 19' ' ' PRO . 17.9 Cg_endo -59.86 179.22 0.29 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.618 2.212 . . . . 0.0 113.395 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.33 174.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.968 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.439 ' CB ' HG12 ' A' ' 17' ' ' ILE . 1.1 ptt-85 -117.74 161.58 19.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.319 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.06 156.44 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.665 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -154.55 137.55 15.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.155 0.503 . . . . 0.0 111.567 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.7 t -134.83 117.21 15.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.934 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.749 ' CD1' HG23 ' A' ' 13' ' ' THR . 6.9 mm -128.94 142.76 43.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.945 0.402 . . . . 0.0 111.605 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.477 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 11.4 pt-20 -151.63 143.62 23.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.633 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.69 HG12 HG21 ' A' ' 55' ' ' ILE . 3.8 mp -128.66 133.61 66.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.01 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.495 ' C ' HD13 ' A' ' 38' ' ' LEU . 20.2 t -141.52 129.45 22.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.911 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.556 ' CD1' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -156.35 176.93 12.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.668 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.587 HD23 HG22 ' A' ' 8' ' ' THR . 3.8 mm? -104.96 162.52 13.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.216 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 1.1 m-20 -155.26 -59.57 0.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.42 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -77.69 -10.13 59.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.63 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -92.58 -27.8 17.13 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.77 45.6 1.2 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.444 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.98 103.76 0.07 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.006 0.431 . . . . 0.0 111.29 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 41' ' ' ASP . 1.2 tm-20 -96.83 35.57 1.52 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.258 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.608 ' O ' HD11 ' A' ' 93' ' ' LEU . 2.0 mp -119.53 102.35 47.81 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.55 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.55 151.66 58.97 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.842 2.361 . . . . 0.0 112.664 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.31 -69.82 0.3 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.158 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.486 ' HB ' HD12 ' A' ' 50' ' ' ILE . 8.1 p -83.79 -58.12 2.93 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.759 0.314 . . . . 0.0 110.421 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.564 HD13 ' HE3' ' A' ' 95' ' ' LYS . 4.9 mp -130.91 -86.39 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.634 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 46.3 t80 46.43 89.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.007 0.432 . . . . 0.0 111.703 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -175.58 134.22 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.663 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.593 ' HG2' HG13 ' A' ' 90' ' ' VAL . 1.4 mttt -119.86 149.73 41.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 110.675 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.663 HG13 ' HD2' ' A' ' 67' ' ' ARG . 11.3 t -141.51 116.38 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.561 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.88 HG23 HG22 ' A' ' 88' ' ' ILE . 1.8 mp -103.98 138.52 28.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.22 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -132.28 139.4 48.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.842 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.619 ' ND1' HG21 ' A' ' 34' ' ' ILE . 3.0 p-80 -154.66 117.41 4.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.172 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.594 ' HB3' HD22 ' A' ' 105' ' ' LEU . 0.5 OUTLIER 49.32 -163.24 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.504 -179.768 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.516 ' HB3' HG22 ' A' ' 61' ' ' THR . 0.9 OUTLIER -73.36 118.42 68.67 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.503 0.192 . . . . 0.0 110.493 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.33 -6.08 6.23 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.83 2.353 . . . . 0.0 113.812 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 59' ' ' HIS . 12.8 t -56.18 -16.65 5.58 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.41 -65.56 1.12 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.528 0.204 . . . . 0.0 110.957 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.92 -27.28 64.64 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.3 t30 71.92 151.95 0.14 Allowed Pre-proline 0 N--CA 1.465 0.313 0 CA-C-O 120.719 0.295 . . . . 0.0 111.387 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.72 159.25 38.07 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.512 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.512 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -123.91 138.81 54.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.441 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.663 ' HD2' HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -141.76 126.12 17.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.58 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 1.7 m -105.96 104.98 14.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.935 0.398 . . . . 0.0 111.373 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -134.0 -55.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.048 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -146.02 33.76 1.01 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.106 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.01 159.71 63.3 Favored Pre-proline 0 N--CA 1.466 0.365 0 CA-C-O 120.762 0.315 . . . . 0.0 111.61 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -76.57 175.78 10.92 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.227 2.618 . . . . 0.0 112.58 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.444 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . 48.0 Cg_exo -56.09 175.25 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.875 2.383 . . . . 0.0 112.739 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -137.43 160.79 38.11 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.21 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -176.98 104.09 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.483 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.479 HD11 ' CD2' ' A' ' 74' ' ' PHE . 3.7 mp -139.65 132.7 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.045 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.67 122.95 24.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -137.28 167.56 21.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.601 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.1 173.37 6.42 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.778 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.67 -129.1 7.86 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.31 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -117.12 110.44 18.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.792 0.329 . . . . 0.0 110.627 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.2 88.71 0.09 OUTLIER Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.221 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -136.0 103.77 0.46 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.519 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.424 ' CD2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -150.78 168.18 11.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 120.486 0.184 . . . . 0.0 110.766 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.424 ' HD2' ' CD2' ' A' ' 84' ' ' PHE . 53.2 Cg_exo -56.91 173.34 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.973 2.449 . . . . 0.0 113.675 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 105' ' ' LEU . 3.3 mp -140.24 160.58 39.64 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.559 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -158.18 115.52 2.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.169 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.88 HG22 HG23 ' A' ' 55' ' ' ILE . 3.9 pt -113.82 105.21 18.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.242 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.4 p -112.37 136.99 51.17 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.01 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.593 HG13 ' HG2' ' A' ' 53' ' ' LYS . 5.7 t -131.62 119.27 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.344 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.586 ' C ' HD23 ' A' ' 92' ' ' LEU . 16.5 m-85 -125.59 155.96 39.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.947 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.677 HD11 HG21 ' A' ' 118' ' ' ILE . 0.2 OUTLIER -149.67 -171.44 3.9 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.765 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.608 HD11 ' O ' ' A' ' 46' ' ' ILE . 3.7 mt -77.26 136.43 38.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.832 0.348 . . . . 0.0 111.593 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 67.55 10.76 7.98 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.208 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.564 ' HE3' HD13 ' A' ' 50' ' ' ILE . 4.8 mmpt? 51.32 75.06 0.21 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.518 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.836 ' HB1' HG13 ' A' ' 120' ' ' ILE . . . -108.03 -28.14 9.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.965 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.444 ' N ' HD11 ' A' ' 92' ' ' LEU . . . -131.31 34.54 2.59 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.722 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.85 98.96 0.3 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.643 0.258 . . . . 0.0 110.602 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -141.86 125.86 17.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.361 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 2.0 pttp -131.07 132.84 45.16 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.736 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -137.21 119.66 11.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.507 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -87.16 149.87 8.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.925 2.416 . . . . 0.0 112.607 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 58.6 m80 -139.95 172.35 12.89 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.117 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.61 144.97 49.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.818 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.704 ' HB2' HD11 ' A' ' 86' ' ' LEU . 2.5 tp -127.37 88.35 2.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.795 0.331 . . . . 0.0 111.461 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -167.94 39.2 0.04 OUTLIER 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.432 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -141.62 124.88 16.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.391 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -56.74 130.01 43.69 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.69 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.414 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER 71.02 68.98 0.17 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.594 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -102.92 135.64 44.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.545 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.5 p -140.72 67.22 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.82 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -113.42 119.82 38.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.656 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.7 137.14 16.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.398 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.3 t -116.67 146.94 20.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.986 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -132.78 108.64 9.12 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.878 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.69 148.69 37.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.084 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.2 p -124.25 148.94 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.623 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.677 HG21 HD11 ' A' ' 92' ' ' LEU . 11.1 mt -133.94 110.88 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.444 ' O ' HD13 ' A' ' 120' ' ' ILE . 29.5 tt0 -130.3 104.5 7.31 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.401 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.836 HG13 ' HB1' ' A' ' 96' ' ' ALA . 21.2 mm -136.98 56.38 12.56 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 120.998 0.428 . . . . 0.0 111.473 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.21 -36.17 3.46 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.556 2.171 . . . . 0.0 112.468 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.6 mt -137.58 39.0 2.44 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.745 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.426 ' CB ' HG23 ' A' ' 120' ' ' ILE . 2.8 m-20 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.356 -0.831 . . . . 0.0 111.198 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtt . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.47 177.02 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 120.672 0.273 . . . . 0.0 111.159 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.611 ' HB1' ' CE ' ' A' ' 44' ' ' LYS . . . -126.46 126.7 44.22 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.214 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 t -153.87 138.77 17.18 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.753 0.311 . . . . 0.0 110.828 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 7.2 p -140.79 127.81 21.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.275 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.03 110.36 19.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.163 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.557 ' NE ' HD13 ' A' ' 92' ' ' LEU . 39.0 mtp85 -109.24 157.22 19.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.269 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 t -165.94 124.95 1.61 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.469 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.4 tt -108.67 118.2 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 110.769 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' O ' HG22 ' A' ' 37' ' ' VAL . 22.6 mtp180 -125.24 131.08 53.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.607 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.912 HG21 HD13 ' A' ' 88' ' ' ILE . 1.3 pt -127.35 129.84 70.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.142 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.69 112.4 25.46 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.23 113.8 20.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -135.61 154.33 51.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.738 0.304 . . . . 0.0 111.166 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.62 138.17 23.22 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.267 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -135.2 119.43 17.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.967 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 30' ' ' ARG . 8.0 mt -118.64 121.85 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.738 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.708 HD22 ' HB2' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -164.25 117.26 1.0 Allowed Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.432 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HD2' HD23 ' A' ' 18' ' ' LEU . 64.7 Cg_endo -73.73 -10.51 23.44 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.739 2.293 . . . . 0.0 112.926 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.708 ' HB2' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -48.4 -44.86 35.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.261 0.224 . . . . 0.0 111.455 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.2 t -66.82 110.16 4.55 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.284 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.54 106.74 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.671 2.247 . . . . 0.0 112.402 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.19 -162.49 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.111 2.541 . . . . 0.0 111.998 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.7 t -77.63 -29.21 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.494 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -171.85 104.24 0.19 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.646 0.26 . . . . 0.0 110.393 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 11.1 p30 45.63 -161.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.636 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 26' ' ' ASN . 10.3 m-85 68.59 133.3 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-O 120.88 0.371 . . . . 0.0 111.334 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.89 -43.42 3.49 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.369 2.046 . . . . 0.0 112.578 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.1 t 67.48 128.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.223 0 O-C-N 123.442 0.463 . . . . 0.0 111.037 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.526 ' HB3' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -116.83 162.12 18.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' CG ' ' HB3' ' A' ' 79' ' ' GLN . 2.6 mt-30 -124.2 159.83 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -158.47 160.61 36.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.262 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.1 p -146.73 121.91 10.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.523 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.4 tp -126.4 124.21 65.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.962 0.411 . . . . 0.0 110.949 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -127.2 135.81 51.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.632 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.759 HG21 HG13 ' A' ' 55' ' ' ILE . 8.0 mt -123.91 105.89 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.917 HG12 ' HB3' ' A' ' 73' ' ' PRO . 27.1 m -119.72 149.1 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.84 0.352 . . . . 0.0 111.6 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.5 HD21 ' CB ' ' A' ' 68' ' ' THR . 2.6 pp -172.04 151.89 2.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.265 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -108.05 162.51 13.98 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.514 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -174.19 -47.71 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.396 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -86.04 2.72 45.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -24.93 24.63 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 5' ' ' VAL . . . -112.35 -74.82 0.71 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.342 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.611 ' CE ' ' HB1' ' A' ' 3' ' ' ALA . 7.0 mmtp -87.98 -56.55 3.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 64.95 16.77 10.73 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.239 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.542 HD12 ' HD3' ' A' ' 44' ' ' LYS . 5.6 mt -109.86 140.99 22.8 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.033 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.56 174.41 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.94 2.427 . . . . 0.0 112.633 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB1' ' HG ' ' A' ' 93' ' ' LEU . . . -155.29 -164.49 1.78 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.375 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -66.9 -47.8 70.7 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.431 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.43 -86.28 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.623 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 29.3 t80 53.29 92.84 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.102 0.477 . . . . 0.0 111.384 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 2.8 t70 -172.43 116.22 0.33 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.696 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.523 ' CG ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -99.83 125.55 45.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.59 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.747 HG12 ' HG3' ' A' ' 67' ' ' ARG . 36.0 m -122.78 132.26 71.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.959 0.409 . . . . 0.0 111.56 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.759 HG13 HG21 ' A' ' 36' ' ' ILE . 1.3 mm -123.11 140.22 47.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.932 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -143.81 97.88 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.515 ' HB3' HD23 ' A' ' 86' ' ' LEU . 22.2 p80 -111.45 125.99 54.47 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.93 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.698 HD21 HD23 ' A' ' 105' ' ' LEU . 1.1 mt 69.0 161.04 0.2 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.364 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.422 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -76.83 -49.84 2.53 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.609 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 59' ' ' HIS . 85.9 Cg_exo -46.39 -29.44 7.07 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.157 2.572 . . . . 0.0 113.677 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 61' ' ' THR . 28.8 m -69.9 2.64 3.25 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -60.72 -34.09 73.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.507 0.194 . . . . 0.0 110.742 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.99 89.22 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.097 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -132.41 90.68 33.13 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 121.212 0.53 . . . . 0.0 110.994 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.84 152.78 73.71 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.673 2.249 . . . . 0.0 112.179 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.42 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 5.9 m120 -96.79 130.64 44.01 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.747 ' HG3' HG12 ' A' ' 54' ' ' VAL . 1.5 mpp_? -145.61 112.63 6.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.61 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.5 ' CB ' HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -93.86 131.56 39.14 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -140.51 -54.05 0.51 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.603 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.95 36.48 0.4 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.741 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.19 163.35 34.32 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.01 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.85 171.66 2.72 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.865 2.377 . . . . 0.0 112.415 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.917 ' HB3' HG12 ' A' ' 37' ' ' VAL . 36.5 Cg_endo -64.89 169.43 11.77 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.632 2.221 . . . . 0.0 112.621 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.522 ' HB2' HD12 ' A' ' 36' ' ' ILE . 15.0 m-85 -117.06 64.26 0.72 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.713 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.54 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 24.4 tpt180 -82.81 90.74 6.95 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.776 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 74' ' ' PHE . 1.8 mp -126.84 131.82 70.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.388 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -136.65 123.24 20.97 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.536 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -133.79 177.91 7.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.579 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.446 ' HB3' ' CG ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -129.87 -179.22 5.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.066 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.49 -148.74 17.3 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.967 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.85 110.17 16.88 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.811 0.339 . . . . 0.0 110.861 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.07 -117.96 0.55 Allowed Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.118 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.11 114.79 2.32 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.679 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.452 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.0 m-85 -165.42 168.49 8.2 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 120.546 0.212 . . . . 0.0 110.976 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.489 ' C ' HD12 ' A' ' 86' ' ' LEU . 37.1 Cg_endo -65.81 -177.44 0.76 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.981 2.454 . . . . 0.0 113.014 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 105' ' ' LEU . 5.4 mp -146.15 166.08 27.25 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.751 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -158.71 123.63 4.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.783 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.912 HD13 HG21 ' A' ' 11' ' ' ILE . 33.9 mt -129.25 112.49 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.009 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.22 116.02 24.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.685 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.523 HG23 ' CG ' ' A' ' 53' ' ' LYS . 1.2 p -104.7 143.32 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.314 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 27.5 m-85 -133.26 155.78 48.76 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.524 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.623 HD23 ' HB3' ' A' ' 96' ' ' ALA . 4.6 tp -142.2 -63.17 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.731 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.568 ' HG ' ' HB1' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -144.6 -68.7 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.313 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -146.62 -63.49 0.3 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.359 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 51.53 1.2 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 111.185 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.623 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -104.41 -36.98 7.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.416 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . 180.0 46.04 0.08 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.535 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.426 ' CB ' ' HA ' ' A' ' 91' ' ' PHE . 11.4 pt-20 -111.34 111.02 21.77 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.08 0.467 . . . . 0.0 110.745 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.454 ' H ' HG12 ' A' ' 90' ' ' VAL . 5.4 ttt180 -142.29 151.79 42.35 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.303 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 0.2 OUTLIER -117.35 127.79 54.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.381 179.172 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.424 HG23 ' CE1' ' A' ' 103' ' ' HIS . 3.7 tt -139.24 121.42 10.21 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 121.024 0.44 . . . . 0.0 111.921 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.56 160.5 9.4 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.916 2.41 . . . . 0.0 112.393 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 38.1 m80 -144.69 172.21 13.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -124.33 145.04 49.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.115 0.483 . . . . 0.0 111.053 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.698 HD23 HD21 ' A' ' 58' ' ' LEU . 6.2 tp -139.16 78.63 1.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.378 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -161.82 38.94 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.367 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -141.47 130.39 23.12 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.168 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 2.4 pp -59.86 131.51 51.1 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.467 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.32 62.97 0.36 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.658 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -103.33 134.65 46.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.649 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.1 t -134.14 71.79 1.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.16 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.73 119.17 38.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.709 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -143.08 141.93 31.4 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.205 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 31.9 t -127.81 145.02 35.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -140.73 108.35 5.61 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.468 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.49 138.85 49.53 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.106 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.5 m -104.5 140.9 21.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.498 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 10.0 mt -138.05 111.08 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.36 119.1 35.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.649 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.401 HG12 HD21 ' A' ' 92' ' ' LEU . 1.2 mp -125.07 52.13 6.01 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.748 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.97 -44.03 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.488 2.125 . . . . 0.0 112.637 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER 70.07 -67.52 0.23 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.277 0.361 . . . . 0.0 111.642 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.885 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.9 mtt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.511 0.196 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.62 -36.07 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.583 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.34 84.3 0.1 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.734 0.302 . . . . 0.0 111.399 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 t -149.02 155.66 41.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.872 0.367 . . . . 0.0 110.946 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -129.14 119.09 48.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.808 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -137.41 104.96 5.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.586 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -125.4 165.57 18.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.956 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.5 t -172.99 139.56 0.84 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.09 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.553 HG21 HG21 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -109.99 118.2 56.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.47 179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.8 mtt85 -124.78 105.3 9.18 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.621 HG21 ' CD1' ' A' ' 88' ' ' ILE . 2.2 pt -112.51 134.09 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.052 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.623 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -118.41 141.59 48.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.27 -179.554 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -138.55 109.75 6.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.081 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -120.97 136.68 54.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.502 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.516 ' HG3' HD21 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -140.06 150.43 44.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.671 0.272 . . . . 0.0 111.691 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -147.64 119.66 8.22 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.41 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.452 HG13 ' OE1' ' A' ' 15' ' ' GLN . 14.5 mt -105.77 116.15 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.972 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.32 93.2 0.36 Allowed Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.104 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -66.22 -48.43 2.59 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.49 2.127 . . . . 0.0 112.586 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 55.67 36.11 26.59 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.998 0.428 . . . . 0.0 110.881 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.401 HG13 ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -105.99 136.42 19.31 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.614 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' CB ' ' HD2' ' A' ' 23' ' ' PRO . 19.0 Cg_endo -58.29 173.98 0.85 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.797 2.331 . . . . 0.0 112.073 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 22' ' ' PRO . 12.4 Cg_endo -55.8 89.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.009 2.473 . . . . 0.0 112.36 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.8 t -135.81 -55.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.926 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -140.51 172.7 12.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.63 35.36 4.46 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.072 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.48 92.22 32.03 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.634 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.32 155.69 12.02 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.88 2.387 . . . . 0.0 112.689 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.874 HG13 ' HA2' ' A' ' 80' ' ' GLY . 25.5 t -118.95 113.52 41.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.768 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -109.42 163.55 13.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.311 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -134.05 111.02 10.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.571 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.437 ' HB3' ' HG3' ' A' ' 15' ' ' GLN . 23.3 p-90 -116.1 150.21 37.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.307 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -140.1 147.27 40.0 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 12' ' ' LYS . 5.7 tp -146.48 135.32 16.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.487 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 3.7 pm0 -134.97 144.57 47.47 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.822 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.445 HG21 ' CD1' ' A' ' 55' ' ' ILE . 4.2 mp -121.32 107.07 19.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.889 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.72 138.36 34.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.245 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.026 HD21 HG21 ' A' ' 68' ' ' THR . 0.6 OUTLIER -166.18 160.08 15.8 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.527 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -105.02 161.85 13.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -151.64 -63.17 0.18 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.678 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.09 -19.54 65.88 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.514 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -86.65 -32.66 20.43 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.196 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.57 48.08 0.97 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.28 106.31 0.04 OUTLIER 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.983 0.42 . . . . 0.0 111.3 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.24 16.34 6.38 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.932 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.1 mt -125.47 104.58 28.06 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-O 120.515 0.198 . . . . 0.0 111.409 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HA ' HD11 ' A' ' 93' ' ' LEU . 74.2 Cg_endo -75.33 -170.5 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.799 2.333 . . . . 0.0 112.556 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.83 -45.87 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.879 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.433 ' HB ' HD12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -93.65 -67.79 0.84 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.791 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.475 HD13 ' HD3' ' A' ' 95' ' ' LYS . 4.3 mp -133.38 -89.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.032 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 40.3 t80 58.72 100.14 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.2 0.524 . . . . 0.0 110.864 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.8 110.36 1.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.844 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.724 ' HD3' HD13 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -100.98 102.59 13.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.364 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.402 HG23 ' CG ' ' A' ' 67' ' ' ARG . 9.6 p -103.95 139.42 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.342 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 55' ' ' ILE . 3.7 mp -130.69 144.84 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.433 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.08 148.15 42.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.469 ' HB3' HD23 ' A' ' 86' ' ' LEU . 19.7 p80 -161.12 59.35 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.679 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -178.31 175.64 1.16 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.359 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 162.17 19.95 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.011 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.81 2.73 6.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.649 2.232 . . . . 0.0 113.713 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -4.95 8.07 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.47 ' CZ ' ' HG3' ' A' ' 65' ' ' PRO . 1.6 t80 59.94 71.29 0.58 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-O 121.001 0.429 . . . . 0.0 111.414 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.41 -28.9 12.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.872 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.422 ' O ' HD21 ' A' ' 58' ' ' LEU . 37.5 t30 -168.37 85.19 0.71 Allowed Pre-proline 0 C--O 1.233 0.191 0 CA-C-O 120.761 0.315 . . . . 0.0 111.24 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.47 ' HG3' ' CZ ' ' A' ' 62' ' ' PHE . 81.1 Cg_endo -77.14 140.53 19.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.623 2.215 . . . . 0.0 112.618 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -109.96 128.67 55.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.701 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.402 ' CG ' HG23 ' A' ' 54' ' ' VAL . 76.2 mtt180 -144.8 139.51 27.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.997 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 1.026 HG21 HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -124.04 104.65 9.01 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.095 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -102.24 -41.4 6.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.107 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 t -170.53 43.25 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.495 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.19 166.18 20.64 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.236 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.79 172.48 5.79 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.898 2.399 . . . . 0.0 112.445 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.97 -179.03 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.778 2.319 . . . . 0.0 112.61 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -140.89 159.17 42.78 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -173.92 114.18 0.2 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.075 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -142.9 151.18 17.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.245 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -133.63 141.85 47.82 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.917 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 32' ' ' TRP . 13.6 mt-10 -133.79 152.08 51.77 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.959 0.409 . . . . 0.0 111.586 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.95 178.98 5.43 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.367 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.874 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 86.15 -103.72 2.81 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.67 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -121.69 112.12 18.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.085 0.469 . . . . 0.0 111.418 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.13 115.17 0.61 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.177 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.629 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . -166.4 103.85 0.21 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.392 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.445 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -150.55 167.8 12.27 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.648 0.261 . . . . 0.0 111.195 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.78 173.14 2.38 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.245 2.63 . . . . 0.0 113.325 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 105' ' ' LEU . 2.5 mp -142.62 160.11 40.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.32 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -157.6 113.4 2.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.799 0.333 . . . . 0.0 111.568 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.621 ' CD1' HG21 ' A' ' 11' ' ' ILE . 2.0 tt -116.47 121.79 68.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.533 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.6 121.94 26.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.115 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.578 HG13 ' HG2' ' A' ' 53' ' ' LYS . 5.8 t -99.95 154.3 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.643 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.47 ' CD2' ' HG3' ' A' ' 98' ' ' GLU . 51.4 m-85 -148.52 158.23 43.99 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.885 HD13 HG21 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -153.45 -175.13 5.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.134 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 47' ' ' PRO . 8.9 mp -60.93 -67.0 0.44 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.537 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -94.15 19.77 8.86 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.574 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.475 ' HD3' HD13 ' A' ' 50' ' ' ILE . 4.4 mmmm 58.35 55.36 5.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.17 -37.62 37.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 90' ' ' VAL . . . -122.49 26.39 6.32 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.606 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.0 tt0 -67.08 90.9 0.2 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.633 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -142.45 142.37 32.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.503 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -126.62 119.32 26.75 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.393 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.6 mt -128.77 120.72 20.68 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.482 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.2 154.83 8.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.004 2.47 . . . . 0.0 112.692 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 81.7 m-70 -140.12 172.1 13.23 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.396 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -128.54 124.6 36.4 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.114 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.629 HD13 ' HA2' ' A' ' 83' ' ' GLY . 1.3 tm? -113.56 95.03 5.13 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.761 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 13.6 t-20 178.8 41.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.062 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -137.4 125.27 22.61 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.663 0.268 . . . . 0.0 111.138 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.04 123.89 12.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.83 60.88 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.419 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.0 138.97 30.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.46 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.2 p -148.16 63.75 1.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.905 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -115.19 119.36 36.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.389 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -147.32 133.84 19.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.506 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 t -105.59 147.4 11.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.72 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -136.45 108.45 7.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.695 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -116.64 138.51 51.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.8 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.62 140.92 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.986 0.422 . . . . 0.0 111.555 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.885 HG21 HD13 ' A' ' 92' ' ' LEU . 2.0 mp -130.56 111.39 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.585 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -122.5 136.95 55.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.214 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 120' ' ' ILE . 6.9 tt -160.24 55.85 0.75 Allowed Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 121.286 0.565 . . . . 0.0 111.21 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.47 125.36 10.07 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.719 2.28 . . . . 0.0 112.531 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -31.49 52.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.973 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.064 -0.969 . . . . 0.0 111.151 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HG2' ' N ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.428 ' N ' ' HG2' ' A' ' 1' ' ' MET . 14.4 p -82.96 -35.6 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.14 82.31 5.04 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.851 0.358 . . . . 0.0 110.955 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 t -145.91 141.76 28.1 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 44' ' ' LYS . 19.4 t -133.42 119.24 34.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.078 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -137.03 104.89 5.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.159 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.491 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -132.57 172.98 11.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.189 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.9 t -173.22 141.36 0.93 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.702 HG21 HG21 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -109.2 118.14 55.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 110.636 179.673 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.8 mtt-85 -124.75 118.25 25.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.802 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 36' ' ' ILE . 1.6 pt -123.56 129.81 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.661 ' O ' HD12 ' A' ' 34' ' ' ILE . 34.2 mtmt -108.19 133.09 52.93 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -131.33 104.2 6.89 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 25.3 tm0? -115.1 137.98 51.4 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.698 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 31' ' ' GLN . 21.0 tt0 -139.39 151.98 46.75 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.751 0.31 . . . . 0.0 111.705 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.441 ' CD2' ' HB2' ' A' ' 18' ' ' LEU . 3.7 t-160 -150.0 119.18 6.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.722 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 40.8 mt -97.41 101.89 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.75 0.309 . . . . 0.0 110.648 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' HB2' ' CD2' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -134.41 85.16 38.68 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.753 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.21 -57.69 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.013 2.475 . . . . 0.0 112.891 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 54.02 23.46 4.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.647 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.04 138.81 32.88 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.698 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HA ' ' HD2' ' A' ' 23' ' ' PRO . 60.2 Cg_exo -51.97 108.35 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.516 2.144 . . . . 0.0 112.252 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 22' ' ' PRO . 41.8 Cg_endo -68.82 103.01 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.805 2.336 . . . . 0.0 112.842 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 24' ' ' VAL . 14.6 p -167.48 42.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.039 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -155.81 -50.62 0.08 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.582 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -164.13 -174.96 3.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.682 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 3.9 m-85 -61.54 141.61 94.59 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-O 120.553 0.216 . . . . 0.0 110.826 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 27' ' ' PHE . 40.0 Cg_exo -57.36 169.65 2.11 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.086 2.524 . . . . 0.0 112.973 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HB ' ' HA2' ' A' ' 80' ' ' GLY . 7.3 m -98.13 157.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.95 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.408 ' HB3' HG12 ' A' ' 17' ' ' ILE . 2.8 mtt-85 -136.08 163.43 30.34 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.213 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 3.7 mt-30 -118.54 148.94 42.12 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.075 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.464 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 15.0 p-90 -156.11 155.23 32.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.103 0.478 . . . . 0.0 112.145 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.1 t -149.29 117.74 6.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.539 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 12' ' ' LYS . 9.3 tp -122.29 143.05 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.428 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 4.0 pt-20 -144.64 118.73 9.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.833 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.744 ' HA ' HG22 ' A' ' 11' ' ' ILE . 4.6 mp -101.07 110.35 27.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.676 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 73' ' ' PRO . 24.3 t -124.03 147.8 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.721 0.296 . . . . 0.0 111.589 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.619 ' HB3' HD12 ' A' ' 9' ' ' ILE . 2.9 pp -156.89 171.2 20.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.255 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 7' ' ' ARG . 2.5 tp -120.18 159.02 25.72 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.21 -45.62 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.287 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.3 2.58 15.29 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.43 -36.52 26.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.577 0.227 . . . . 0.0 111.007 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.4 -66.96 0.25 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.809 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.829 ' HB2' HG22 ' A' ' 5' ' ' VAL . 4.2 mttt -155.07 108.92 2.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.558 0.218 . . . . 0.0 110.849 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -90.08 49.62 1.74 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.751 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.441 HD13 ' HD3' ' A' ' 44' ' ' LYS . 3.7 mp -127.45 132.93 24.57 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.216 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.85 -177.98 4.01 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.84 2.36 . . . . 0.0 112.565 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.62 -54.53 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.25 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.8 p -125.82 -55.09 1.51 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.347 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 91' ' ' PHE . 0.6 OUTLIER -118.9 -86.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.015 179.078 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 t80 56.23 96.82 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.075 0.464 . . . . 0.0 111.213 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -174.41 127.52 0.34 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.664 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.857 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -114.55 133.09 56.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.806 0.336 . . . . 0.0 110.703 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.49 HG13 ' HG3' ' A' ' 67' ' ' ARG . 6.7 t -132.44 118.82 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.645 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.512 HG21 HG12 ' A' ' 36' ' ' ILE . 3.6 mp -106.99 144.91 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.382 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -138.95 144.87 39.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.068 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.5 ' HB3' HD23 ' A' ' 86' ' ' LEU . 1.7 p80 -167.27 137.31 2.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.691 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 2.6 mt 74.93 147.0 0.09 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.267 0.354 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 -54.89 0.47 Allowed Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -47.64 -30.92 13.28 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.047 2.498 . . . . 0.0 114.415 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.491 HG22 ' HB2' ' A' ' 58' ' ' LEU . 12.8 t -81.27 9.92 6.3 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.557 0.218 . . . . 0.0 111.153 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -51.22 -30.12 16.35 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.916 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.53 6.27 18.06 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -159.09 66.88 3.06 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.641 0.258 . . . . 0.0 111.405 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.61 177.41 3.4 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.873 2.382 . . . . 0.0 112.548 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.427 ' ND2' HD13 ' A' ' 36' ' ' ILE . 58.6 t30 -108.11 139.76 42.29 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.0 0.429 . . . . 0.0 111.164 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG3' HG13 ' A' ' 54' ' ' VAL . 3.6 mpp_? -137.04 147.4 46.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.749 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.44 HG21 ' CD2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -132.77 123.83 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.061 0.458 . . . . 0.0 111.396 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -136.05 -54.46 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.311 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 t -155.65 39.34 0.38 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -123.5 155.75 65.24 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -57.25 172.72 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.08 2.52 . . . . 0.0 112.819 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.847 ' HB3' HG22 ' A' ' 37' ' ' VAL . 32.6 Cg_exo -57.88 166.96 4.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.881 2.387 . . . . 0.0 112.939 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -127.8 84.46 2.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.658 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.2 ttp85 -99.85 113.91 26.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.45 115.7 18.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -122.18 144.08 49.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.3 166.64 32.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.943 0.402 . . . . 0.0 111.449 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -123.65 170.52 10.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' A' ' 29' ' ' VAL . . . 98.35 -81.8 0.62 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.472 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -113.61 116.61 29.77 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' HA3' ' CD1' ' A' ' 32' ' ' TRP . . . -170.99 88.29 0.09 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.763 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -160.26 74.64 0.2 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.666 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.552 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 22.7 m-85 -143.37 165.7 23.95 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 120.632 0.253 . . . . 0.0 111.35 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 37.3 Cg_endo -65.38 171.1 9.78 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.136 2.557 . . . . 0.0 113.729 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 103' ' ' HIS . 5.1 mp -143.29 159.59 42.06 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.964 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -155.37 112.71 3.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.663 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.479 HG23 HG13 ' A' ' 55' ' ' ILE . 3.2 mp -117.52 124.46 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.685 0.279 . . . . 0.0 111.319 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.1 p -126.59 131.89 51.41 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.857 HG13 ' HG2' ' A' ' 53' ' ' LYS . 24.2 t -124.42 137.46 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.022 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.52 ' HB3' HD12 ' A' ' 50' ' ' ILE . 11.5 m-85 -131.61 154.9 48.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.349 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' ' 96' ' ' ALA . 2.5 tm? -141.15 -53.84 0.47 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.112 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' A' ' 92' ' ' LEU . 5.5 tt -152.48 -52.06 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.157 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -170.25 -63.63 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.563 0.22 . . . . 0.0 111.143 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.54 21.95 8.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.407 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.8 ' HB3' HD12 ' A' ' 92' ' ' LEU . . . -87.12 -50.86 6.34 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.802 0.334 . . . . 0.0 110.696 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -149.88 23.54 1.15 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.687 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -76.66 84.76 3.31 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.731 0.301 . . . . 0.0 110.789 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -142.28 146.04 34.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.148 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -124.87 147.75 48.63 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.471 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 114' ' ' VAL . 8.2 tp -148.0 111.77 3.83 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 121.008 0.433 . . . . 0.0 111.879 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -85.99 133.25 4.13 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.033 2.489 . . . . 0.0 112.342 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 1.7 m-70 -113.18 163.34 14.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.303 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.44 138.46 54.01 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.484 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 6.0 tp -123.48 92.12 3.62 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.653 0.263 . . . . 0.0 110.911 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -167.98 33.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -141.91 126.28 17.66 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.808 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 2.9 pp -58.21 131.85 51.8 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.748 0.309 . . . . 0.0 110.679 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 73.09 67.16 0.11 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.63 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 32.5 tt0 -92.45 141.28 28.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 t -144.8 64.86 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.02 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 119.27 38.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.55 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 12' ' ' LYS . 7.5 tt0 -141.67 131.37 24.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.213 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.633 HG21 HG21 ' A' ' 101' ' ' ILE . 43.5 t -116.43 140.4 38.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -133.46 108.54 8.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.62 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.27 119.07 36.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.54 144.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.574 HG21 ' HG ' ' A' ' 92' ' ' LEU . 35.2 mt -134.6 111.15 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.63 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.46 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -128.38 106.13 8.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.174 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 119' ' ' GLN . 16.1 mm -135.4 62.03 47.68 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.192 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.76 -43.11 1.4 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.352 2.035 . . . . 0.0 112.871 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.77 93.16 2.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.027 0.441 . . . . 0.0 110.297 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.52 -179.347 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.16 174.73 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.669 0.271 . . . . 0.0 111.233 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.81 78.71 1.58 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.985 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.56 135.41 24.91 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.4 119.26 48.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.128 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -129.22 106.07 8.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.545 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 46.9 mtt85 -123.46 152.71 41.39 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.996 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.889 HG22 HD23 ' A' ' 39' ' ' LEU . 6.9 t -160.96 143.95 12.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 90' ' ' VAL . 1.0 OUTLIER -117.17 125.04 73.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 111.099 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.568 ' O ' HG22 ' A' ' 37' ' ' VAL . 28.2 mtt85 -132.06 108.83 9.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.552 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.436 HD13 HD13 ' A' ' 88' ' ' ILE . 1.3 pt -117.78 132.15 68.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.069 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.612 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.1 mptm? -118.21 139.17 51.69 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.445 HG22 HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -137.09 102.91 4.97 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.7 tt0 -113.69 118.76 35.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.224 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.56 ' HB2' HD11 ' A' ' 105' ' ' LEU . 13.5 tt0 -119.98 146.34 45.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 111.914 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.435 ' CD2' ' HB3' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -146.72 119.8 8.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.61 ' O ' HD12 ' A' ' 18' ' ' LEU . 26.1 mt -99.46 128.5 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.179 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 17' ' ' ILE . 5.9 mp -135.63 106.9 9.92 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.677 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.94 -56.57 0.56 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.691 2.261 . . . . 0.0 112.871 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 49.6 81.07 0.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.719 0.295 . . . . 0.0 111.443 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 36.2 t -65.12 110.11 3.82 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.301 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.97 161.51 10.31 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.741 2.294 . . . . 0.0 112.28 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.74 45.19 1.92 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.726 2.284 . . . . 0.0 112.794 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.1 t -148.18 -65.77 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.093 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -133.31 -174.52 3.52 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.873 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -132.56 116.88 17.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.601 0.239 . . . . 0.0 111.284 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -163.08 110.85 1.03 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.076 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.86 129.76 13.78 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.733 2.289 . . . . 0.0 112.465 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.08 138.31 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 111.7 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -104.09 160.41 14.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.997 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.435 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 1.0 OUTLIER -135.84 113.57 11.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.673 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.695 ' CG ' HD21 ' A' ' 105' ' ' LEU . 14.1 p-90 -121.8 154.63 36.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.766 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 t -136.71 118.61 15.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.529 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 12' ' ' LYS . 6.3 tp -119.18 136.95 54.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.527 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -135.32 138.88 43.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.346 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.772 HG21 ' CD1' ' A' ' 55' ' ' ILE . 2.9 mp -123.9 105.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.844 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 73' ' ' PRO . 31.2 m -115.59 150.48 17.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.919 0.39 . . . . 0.0 111.499 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.812 HD21 HG21 ' A' ' 68' ' ' THR . 0.5 OUTLIER -172.51 178.95 2.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.243 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.889 HD23 HG22 ' A' ' 8' ' ' THR . 2.9 mm? -103.88 165.84 10.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.293 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -167.28 -50.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.446 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.15 -31.43 65.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.465 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' HB2' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -82.78 -36.63 25.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.045 -179.577 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.19 50.07 1.11 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.824 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.9 mttm 52.85 96.62 0.01 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.89 0.376 . . . . 0.0 111.42 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -24.8 59.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.588 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 46' ' ' ILE . 3.5 mp -82.51 114.75 53.89 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.865 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.85 -175.3 1.14 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.594 2.196 . . . . 0.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -145.49 -51.27 0.25 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.674 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.404 HG22 HD12 ' A' ' 50' ' ' ILE . 14.0 m -104.77 -69.67 0.8 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.835 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 49' ' ' THR . 2.7 mp -132.53 -85.07 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.838 -0.165 . . . . 0.0 111.019 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 39.0 t80 56.15 95.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.044 0.45 . . . . 0.0 111.505 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -159.16 111.86 2.22 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.498 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.926 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -99.21 121.68 41.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.64 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.411 HG12 ' OG ' ' A' ' 89' ' ' SER . 12.2 p -120.81 128.19 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 0.0 111.109 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.772 ' CD1' HG21 ' A' ' 36' ' ' ILE . 3.3 mp -116.63 145.24 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.434 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -142.82 128.2 18.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.41 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 3.6 p80 -127.57 135.65 50.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.771 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER 67.01 -178.93 0.21 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.279 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.549 ' HB3' HG22 ' A' ' 61' ' ' THR . 0.1 OUTLIER -52.11 154.29 4.12 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.754 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 59' ' ' HIS . 9.6 Cg_exo -71.49 2.05 4.93 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.167 2.578 . . . . 0.0 113.312 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 59' ' ' HIS . 15.0 t -82.89 9.8 9.19 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.795 0.331 . . . . 0.0 110.817 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -61.07 162.19 7.54 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.398 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.17 -49.63 14.75 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -139.33 115.56 8.41 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.303 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 62' ' ' PHE . 56.1 Cg_endo -70.41 -179.37 3.15 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.513 2.142 . . . . 0.0 112.068 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.413 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 10.0 m120 -111.74 127.39 55.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.819 0.342 . . . . 0.0 111.052 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.4 ttt-85 -143.37 122.96 13.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.71 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.812 HG21 HD21 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -106.63 139.32 41.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -159.86 -55.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.119 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.33 38.03 1.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.035 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.83 160.19 67.73 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.505 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -62.13 174.74 2.34 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.16 2.573 . . . . 0.0 112.649 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.612 ' HB2' HG12 ' A' ' 37' ' ' VAL . 65.7 Cg_endo -74.21 148.73 39.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.74 2.293 . . . . 0.0 112.712 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -99.13 155.79 17.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.01 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.96 86.91 0.1 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.5 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -136.67 151.94 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.319 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -122.45 157.72 31.33 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.994 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.97 141.14 49.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.182 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.88 136.04 53.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.743 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 30' ' ' ARG . . . 128.19 -156.43 20.8 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.839 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -75.81 131.12 39.55 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.055 0.455 . . . . 0.0 111.312 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.9 -127.86 1.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.939 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.04 104.37 0.13 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.752 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 3.4 m-85 -155.5 170.8 8.14 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 120.707 0.289 . . . . 0.0 111.25 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 87.8 Cg_exo -49.86 170.25 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.477 2.785 . . . . 0.0 114.177 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD23 HD11 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -135.16 159.66 40.83 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.72 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -156.21 120.94 4.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.926 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.583 HG23 HG13 ' A' ' 55' ' ' ILE . 3.1 mp -135.33 124.0 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.275 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.411 ' OG ' HG12 ' A' ' 54' ' ' VAL . 1.4 p -123.61 122.23 37.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.95 0.405 . . . . 0.0 110.302 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.926 HG13 ' HG2' ' A' ' 53' ' ' LYS . 19.2 t -107.4 111.88 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.069 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -102.9 157.54 16.9 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.781 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.628 HD11 ' CB ' ' A' ' 95' ' ' LYS . 1.3 pt? -146.27 -159.81 1.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.612 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 12.4 mt -55.59 -66.85 0.35 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.409 0.147 . . . . 0.0 111.014 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -177.37 42.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.221 0.534 . . . . 0.0 110.42 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.672 ' HD2' HG21 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -110.96 -166.24 1.06 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.026 -179.512 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.65 -13.44 61.36 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.817 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.12 -27.91 57.94 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.097 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -65.26 83.43 0.05 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.107 0.48 . . . . 0.0 110.624 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.46 155.45 45.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.545 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -121.54 145.89 47.5 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.615 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.793 HG21 HG21 ' A' ' 114' ' ' VAL . 3.7 mp -138.59 114.47 8.77 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.468 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -88.63 155.85 6.32 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.082 2.522 . . . . 0.0 112.254 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -140.26 172.02 13.33 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.034 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.66 119.32 21.24 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.2 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.695 HD21 ' CG ' ' A' ' 32' ' ' TRP . 4.3 tp -112.95 86.5 2.38 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -165.36 39.83 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -142.09 139.75 32.32 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.458 HD12 ' H ' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -62.03 127.36 31.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.368 179.374 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 64.9 79.02 0.26 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.245 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 39.3 tt0 -109.63 136.38 49.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.014 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -133.69 70.95 1.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.106 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -110.09 119.1 38.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.059 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -154.57 132.23 11.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.415 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.793 HG21 HG21 ' A' ' 101' ' ' ILE . 25.0 t -109.59 145.72 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.678 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -132.16 108.65 9.41 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.079 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.424 ' HB3' HG22 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -113.29 151.71 30.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.7 149.31 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.957 0.408 . . . . 0.0 111.871 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.3 mt -143.29 110.97 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.507 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -129.79 118.33 21.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.637 0.256 . . . . 0.0 111.28 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.672 HG21 ' HD2' ' A' ' 95' ' ' LYS . 1.6 pp -138.2 48.58 2.03 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.83 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 120' ' ' ILE . 71.1 Cg_endo -76.45 -42.41 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.56 2.173 . . . . 0.0 112.866 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 mp -103.8 -50.07 3.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.647 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.547 179.719 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmm . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.407 0.146 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 m -76.78 -32.41 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.546 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.67 83.99 2.09 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.59 128.02 9.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 44' ' ' LYS . 19.0 t -123.38 119.43 57.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.097 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.72 104.85 5.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.19 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.401 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 47.3 mtt180 -134.59 175.44 9.53 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.038 0.447 . . . . 0.0 111.258 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 4.9 t -160.77 146.05 14.45 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.335 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.812 HD11 HD11 ' A' ' 88' ' ' ILE . 1.6 tt -113.87 118.05 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-O 120.931 0.396 . . . . 0.0 110.784 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -130.29 111.13 12.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.505 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.839 HD11 HG21 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -122.06 142.27 39.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.121 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.564 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -120.59 138.4 53.91 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.755 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.404 HG23 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -142.2 120.12 12.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.161 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -130.33 160.14 34.84 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.77 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -152.86 142.04 21.44 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.279 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -131.96 119.67 21.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.733 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.48 HG22 ' HD3' ' A' ' 19' ' ' PRO . 28.4 mt -117.88 126.99 75.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.608 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -120.4 75.87 24.89 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.161 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD3' HG22 ' A' ' 17' ' ' ILE . 66.2 Cg_endo -75.48 -37.86 1.64 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.541 2.16 . . . . 0.0 112.716 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -80.71 -37.57 30.41 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.1 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 18' ' ' LEU . 12.6 t -65.41 111.41 6.05 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.478 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.47 107.43 0.5 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.647 2.231 . . . . 0.0 112.203 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.556 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 5.8 Cg_exo -79.84 47.37 2.5 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.41 2.74 . . . . 0.0 112.937 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t 67.56 -69.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 122.798 0.439 . . . . 0.0 111.941 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -85.42 3.61 39.3 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.556 ' HA ' ' HD2' ' A' ' 23' ' ' PRO . 5.3 m-80 62.44 53.69 2.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 110.886 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.656 ' O ' HG23 ' A' ' 29' ' ' VAL . 2.5 m-85 -124.17 114.03 27.83 Favored Pre-proline 0 CA--C 1.529 0.135 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.032 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.92 107.97 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.94 2.426 . . . . 0.0 112.655 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 27' ' ' PHE . 40.2 t -120.84 146.05 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.282 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.42 162.37 26.5 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.355 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.413 ' CG ' ' HB3' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -119.53 162.14 19.42 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -158.87 141.47 14.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.195 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -138.38 117.65 12.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.564 HD12 ' O ' ' A' ' 12' ' ' LYS . 8.1 tp -127.55 139.74 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.988 0.423 . . . . 0.0 111.953 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.444 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -143.46 132.98 23.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.673 179.304 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.656 HD12 HG21 ' A' ' 55' ' ' ILE . 5.4 mm -113.62 111.58 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.212 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.68 133.76 64.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.707 0.289 . . . . 0.0 110.966 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.583 HD13 ' HE2' ' A' ' 53' ' ' LYS . 4.0 pp -169.37 174.95 5.76 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.582 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.9 mm? -114.94 160.92 18.98 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.413 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -167.83 -49.36 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.16 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.72 1.91 28.24 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -83.94 -34.78 24.39 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 111.052 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.9 -75.17 0.93 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.868 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.679 ' HB2' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -119.43 112.08 18.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.608 0.242 . . . . 0.0 110.79 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -104.6 30.5 5.36 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.191 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 mt -132.32 124.2 19.11 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.293 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.32 168.57 24.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.877 2.385 . . . . 0.0 112.538 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.764 ' HB3' HD23 ' A' ' 93' ' ' LEU . . . -154.42 -50.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.652 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 p -121.63 -68.1 0.92 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.716 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.711 HD11 ' HE2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -126.19 -89.67 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.168 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 13.2 t80 57.47 95.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.993 0.425 . . . . 0.0 111.522 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -165.95 125.61 1.68 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.623 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.602 ' CG ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -110.84 105.22 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.368 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.0 140.58 24.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.39 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.656 HG21 HD12 ' A' ' 36' ' ' ILE . 3.5 mp -123.86 141.5 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.963 0.411 . . . . 0.0 111.327 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -128.78 154.9 45.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.765 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 19.2 p80 -164.82 137.61 4.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.769 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER 74.56 174.12 0.26 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.607 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.41 159.99 36.82 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.503 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.5 -9.36 10.88 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.112 2.541 . . . . 0.0 113.531 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.4 p -58.48 -13.35 5.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.379 0.133 . . . . 0.0 111.329 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.11 142.26 57.69 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 120.717 0.294 . . . . 0.0 111.092 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.66 81.13 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.212 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 2.1 t-20 -153.62 115.07 2.64 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.355 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 64' ' ' ASN . 34.7 Cg_exo -61.9 -174.16 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.16 2.574 . . . . 0.0 112.517 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.431 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 29.1 m-20 -87.71 150.83 23.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.041 0.448 . . . . 0.0 111.559 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.62 136.67 18.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.577 HG21 HD11 ' A' ' 38' ' ' LEU . 22.9 m -129.41 108.08 10.0 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -141.92 -54.07 0.44 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.257 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 p -140.08 33.9 1.93 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.135 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.42 164.05 42.27 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.277 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.79 168.43 22.94 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.803 2.335 . . . . 0.0 112.696 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.79 161.54 45.54 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.721 2.281 . . . . 0.0 112.845 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.409 ' HB2' HG12 ' A' ' 36' ' ' ILE . 34.0 m-85 -105.22 154.7 19.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.219 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.04 71.83 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.61 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 mt -130.47 141.01 47.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.414 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.57 138.77 47.56 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.526 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -140.23 167.54 21.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.002 0.43 . . . . 0.0 111.453 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.413 ' HB3' ' CG ' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -129.9 141.53 50.79 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.847 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.41 -131.75 2.36 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.604 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.404 ' HE1' HG22 ' A' ' 29' ' ' VAL . 7.9 m0 -120.2 110.33 16.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.882 0.373 . . . . 0.0 110.848 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.46 -126.54 0.86 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.389 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.41 94.04 1.52 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.574 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.514 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.1 m-85 -156.13 169.92 9.68 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.63 0.252 . . . . 0.0 111.088 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 58.6 Cg_endo -72.01 172.35 14.84 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.767 2.311 . . . . 0.0 113.38 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.452 ' CG ' ' HB2' ' A' ' 103' ' ' HIS . 0.4 OUTLIER -146.46 159.69 43.08 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.517 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -149.55 119.0 6.88 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.678 0.275 . . . . 0.0 111.383 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.839 HG21 HD11 ' A' ' 11' ' ' ILE . 5.0 tt -111.11 114.12 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -110.15 135.0 51.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.602 HG23 ' CG ' ' A' ' 53' ' ' LYS . 3.8 p -122.15 138.65 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.966 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -134.69 157.58 46.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.547 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.529 HD11 ' H ' ' A' ' 96' ' ' ALA . 1.4 pt? -146.02 -163.47 1.74 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.764 HD23 ' HB3' ' A' ' 48' ' ' ALA . 2.5 mp -97.02 -16.78 20.4 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.469 ' HB2' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -108.35 1.77 22.06 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.711 ' HE2' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER 48.24 37.42 8.29 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.529 ' H ' HD11 ' A' ' 92' ' ' LEU . . . -95.01 -50.44 5.1 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.613 0.244 . . . . 0.0 111.39 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.03 16.86 56.92 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.893 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 23.4 tt0 -70.78 96.43 1.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.82 0.31 . . . . 0.0 110.559 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.534 ' H ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.57 156.92 45.16 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.849 -179.388 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -118.58 139.42 51.51 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.464 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.586 ' O ' HG22 ' A' ' 88' ' ' ILE . 1.8 mp -128.03 99.7 24.96 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-O 120.941 0.4 . . . . 0.0 111.38 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -87.89 144.32 6.24 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.032 2.488 . . . . 0.0 112.422 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.452 ' CE1' HG22 ' A' ' 101' ' ' ILE . 38.9 m80 -136.92 172.15 13.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -121.42 151.24 40.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.405 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 tp -139.06 85.32 2.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 0.0 110.624 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -161.41 38.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.519 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -141.68 134.04 28.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.396 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 pp -58.74 131.09 49.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.508 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 62.25 75.4 0.4 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.027 0.441 . . . . 0.0 110.599 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -105.33 135.67 46.28 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.018 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t -136.87 74.43 1.49 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.165 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -113.64 119.14 36.41 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.383 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -148.21 136.44 21.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.09 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.505 ' CG1' HD11 ' A' ' 11' ' ' ILE . 6.3 p -116.94 143.2 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.81 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.34 122.03 20.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.078 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.74 159.22 37.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.49 138.09 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.485 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.25 110.75 26.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.175 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -130.03 120.36 24.59 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.469 HD13 ' HB2' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -146.56 55.38 2.54 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.09 -44.27 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.484 2.123 . . . . 0.0 112.86 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.0 tp -106.49 -35.8 6.98 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.106 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttm . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.746 0.308 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 p -108.43 -34.85 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.657 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 58.13 77.04 0.31 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.84 0.353 . . . . 0.0 111.674 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 121' ' ' PRO . 0.7 OUTLIER -151.61 166.23 31.86 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.66 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 43' ' ' GLY . 29.7 t -134.96 118.91 25.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.755 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.77 106.28 5.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.675 ' NH1' HD11 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -124.05 167.55 14.04 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.632 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -178.06 133.0 0.15 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.902 HG21 HG21 ' A' ' 90' ' ' VAL . 3.6 tt -106.14 118.22 53.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.059 0.457 . . . . 0.0 110.834 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -116.56 107.05 14.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.012 HD13 HG21 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -110.38 135.13 50.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -120.14 138.68 53.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.998 -179.543 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 105' ' ' LEU . 1.2 m -141.07 113.99 8.42 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 3.9 mt-30 -127.02 147.71 50.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.677 0.275 . . . . 0.0 111.078 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -138.88 145.08 39.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -143.32 119.3 10.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.827 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 10.2 mt -114.19 141.95 28.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.738 0.304 . . . . 0.0 110.792 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.632 HD23 ' HB2' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -120.76 89.56 45.33 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.11 -1.48 11.64 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.745 2.297 . . . . 0.0 113.165 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.632 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -64.79 -15.26 61.45 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.08 131.23 94.44 Favored Pre-proline 0 C--O 1.234 0.267 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 59.3 Cg_endo -72.74 125.65 10.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.287 1.991 . . . . 0.0 112.855 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 22' ' ' PRO . 35.8 Cg_exo -60.13 177.55 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.994 2.463 . . . . 0.0 112.383 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 24' ' ' VAL . 8.0 t 64.15 36.41 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.236 0.541 . . . . 0.0 110.109 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -162.67 -52.6 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.714 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -148.41 140.65 24.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.925 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.49 162.4 67.07 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.912 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.69 115.33 2.61 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.767 2.311 . . . . 0.0 112.29 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.531 HG13 ' HA2' ' A' ' 80' ' ' GLY . 21.9 t -93.6 128.0 45.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.02 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.35 159.4 23.48 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.107 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -116.59 158.51 23.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -157.6 145.49 18.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.334 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 p -146.04 117.56 8.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.652 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 2.3 tp -130.34 134.74 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.46 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.9 pt-20 -136.47 135.08 38.32 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.471 ' CG2' HG13 ' A' ' 55' ' ' ILE . 4.1 mp -110.06 114.83 48.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.716 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.7 t -125.2 135.69 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.277 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.716 HD11 HG21 ' A' ' 68' ' ' THR . 1.4 pp -157.69 154.23 27.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.424 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 42' ' ' GLU . 2.5 mp -99.58 161.89 13.35 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.598 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -174.72 -46.9 0.01 OUTLIER 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.06 -19.59 65.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.363 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HB2' HD23 ' A' ' 39' ' ' LEU . 1.9 mt-10 -98.69 -36.7 9.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.244 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.662 ' O ' HG13 ' A' ' 5' ' ' VAL . . . -99.9 45.85 1.46 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.875 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt 62.01 100.98 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.08 48.47 1.37 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.198 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.1 mt -128.0 110.92 20.12 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.291 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.77 161.4 10.25 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.153 2.569 . . . . 0.0 113.036 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.64 -54.0 0.82 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.628 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.403 HG22 HG13 ' A' ' 50' ' ' ILE . 32.0 m -117.06 -63.49 1.44 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.93 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.403 HG13 HG22 ' A' ' 49' ' ' THR . 64.2 mt -120.82 -78.12 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.795 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.7 t80 57.75 98.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.284 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 9.9 t70 -172.53 107.45 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.898 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.507 ' CG ' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -91.34 128.92 37.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.488 HG23 ' OG ' ' A' ' 89' ' ' SER . 3.0 m -132.16 116.28 28.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 121.086 0.47 . . . . 0.0 111.654 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.991 HG23 HG22 ' A' ' 88' ' ' ILE . 2.3 mm -106.75 155.67 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -142.24 141.13 32.46 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.429 ' NE2' HG21 ' A' ' 61' ' ' THR . 14.5 p-80 -150.44 119.55 6.74 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.935 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 105' ' ' LEU . 5.7 mp 67.68 162.88 0.19 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.328 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.401 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -81.78 -51.36 0.83 Allowed Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.68 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 58' ' ' LEU . 74.4 Cg_exo -49.98 -26.09 13.66 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.04 2.494 . . . . 0.0 113.872 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.429 HG21 ' NE2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -78.41 9.25 4.07 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.605 0.24 . . . . 0.0 111.145 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -60.72 -31.5 70.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.843 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.7 -34.94 78.18 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.057 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -133.73 75.88 67.15 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 121.018 0.437 . . . . 0.0 111.402 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.26 -176.6 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.112 2.542 . . . . 0.0 112.0 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -110.62 128.1 55.54 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.886 0.374 . . . . 0.0 111.185 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.87 105.8 3.59 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.482 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.716 HG21 HD11 ' A' ' 38' ' ' LEU . 6.2 m -97.46 116.6 29.97 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.254 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -121.66 -51.23 2.05 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.96 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 p -147.33 35.36 0.89 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.77 157.94 58.37 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.302 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.82 172.48 10.59 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.093 2.528 . . . . 0.0 112.607 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.9 177.67 1.3 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.822 2.348 . . . . 0.0 112.383 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -141.74 163.47 32.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.914 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER -174.96 121.55 0.22 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -140.18 131.14 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.195 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.0 113.64 10.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.816 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -139.51 174.16 10.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.535 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.52 168.9 11.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.115 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.531 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 128.3 -121.67 3.77 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.324 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -118.34 110.94 18.1 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.776 0.322 . . . . 0.0 110.481 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.35 112.45 0.41 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.927 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -165.93 109.19 0.35 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.612 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 6.7 m-85 -160.85 170.65 8.13 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 120.397 0.141 . . . . 0.0 110.983 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.74 169.81 3.06 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.125 2.55 . . . . 0.0 113.253 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 105' ' ' LEU . 3.6 mp -143.03 168.28 20.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.219 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 25.9 t0 -158.78 119.33 3.26 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.716 0.293 . . . . 0.0 111.651 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.012 HG21 HD13 ' A' ' 11' ' ' ILE . 1.1 pp -112.68 109.51 28.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 111.151 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.488 ' OG ' HG23 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -122.14 111.41 16.94 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.498 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 9' ' ' ILE . 19.2 t -105.29 145.65 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.607 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 11.8 m-85 -131.66 152.81 50.57 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.72 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.893 HD22 HG21 ' A' ' 118' ' ' ILE . 5.4 tp -141.65 -54.46 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.089 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 92' ' ' LEU . 1.2 mp -143.2 -70.46 0.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.834 0.349 . . . . 0.0 110.596 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' HB3' ' HD3' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -161.92 -49.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.73 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.436 ' HD3' ' HB3' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -140.47 29.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.563 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.689 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -98.03 -45.63 6.19 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.972 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA3' HG12 ' A' ' 118' ' ' ILE . . . -158.75 43.18 0.48 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.304 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 3.8 tt0 -100.35 99.34 9.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.539 0.209 . . . . 0.0 110.947 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -142.52 149.06 38.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.736 0.303 . . . . 0.0 111.52 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -134.33 137.3 44.09 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.145 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.4 mt -144.41 121.83 6.56 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.386 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 98.0 Cg_endo -79.29 147.07 20.21 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.62 2.214 . . . . 0.0 112.363 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.27 172.58 11.67 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.164 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -131.24 138.8 49.49 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.063 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.548 ' HB2' HD11 ' A' ' 86' ' ' LEU . 4.0 tp -131.21 83.12 2.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.838 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -160.94 35.25 0.15 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.308 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -138.85 132.2 30.14 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -58.98 125.24 22.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.512 179.427 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 71.31 70.79 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.19 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 1.2 tp10 -107.33 138.01 44.32 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.481 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p -137.7 73.18 1.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.853 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -109.72 119.35 39.12 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.413 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -152.13 127.62 10.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.788 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -104.04 145.68 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.744 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.85 108.53 9.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.547 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.36 123.75 50.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.77 142.56 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 111.684 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.893 HG21 HD22 ' A' ' 92' ' ' LEU . 3.5 mp -131.34 120.74 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.751 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -127.29 121.35 30.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.448 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.553 HD11 ' NH1' ' A' ' 7' ' ' ARG . 2.7 pt -153.92 65.13 5.07 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.607 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.636 ' HB3' HG22 ' A' ' 4' ' ' THR . 39.1 Cg_endo -66.51 -31.89 40.75 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.54 2.16 . . . . 0.0 112.884 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.45 26.06 10.35 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.224 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.142 179.599 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.465 0.174 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 t -115.91 -61.84 2.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.921 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 67.79 139.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.687 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.07 147.17 26.17 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.997 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.462 HG13 ' CA ' ' A' ' 43' ' ' GLY . 21.9 t -124.64 119.02 55.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.727 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -135.77 105.82 6.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.7 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 25.8 mtt-85 -123.23 159.54 28.48 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.033 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 t -173.34 129.31 0.45 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.752 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 36' ' ' ILE . 2.3 tt -108.38 118.26 55.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.925 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.97 110.11 16.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.663 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.3 pt -115.86 137.06 50.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.533 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.5 mptp? -121.55 137.98 54.5 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.044 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.488 HG22 ' HG ' ' A' ' 105' ' ' LEU . 3.5 m -140.65 104.62 4.77 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -121.5 154.19 36.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.938 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.52 ' HB2' HD21 ' A' ' 105' ' ' LEU . 1.4 tt0 -154.65 143.2 20.64 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.014 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -135.02 119.36 17.84 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.716 0.293 . . . . 0.0 111.097 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 14.9 mt -116.04 100.88 11.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.783 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.3 109.23 2.25 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.591 ' O ' HG23 ' A' ' 21' ' ' VAL . 35.4 Cg_endo -66.83 -48.47 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.535 2.157 . . . . 0.0 112.581 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 56.98 32.68 22.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.024 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 19' ' ' PRO . 22.5 t -125.35 139.81 34.75 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.599 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.66 167.72 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.838 2.359 . . . . 0.0 112.483 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.59 79.1 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.682 2.255 . . . . 0.0 112.488 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.62 -44.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.359 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -141.72 143.16 33.39 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.006 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.93 -172.43 3.98 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.792 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 65.08 82.77 0.2 Allowed Pre-proline 0 N--CA 1.465 0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.032 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.34 160.82 44.13 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.851 2.367 . . . . 0.0 112.906 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.495 HG13 ' HA2' ' A' ' 80' ' ' GLY . 30.2 t -90.79 149.78 3.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.964 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -126.05 152.7 45.45 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.204 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.62 154.43 21.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.187 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -152.81 137.58 17.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.053 0.454 . . . . 0.0 111.559 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.4 t -141.53 117.7 10.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.509 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 12' ' ' LYS . 9.1 tp -128.55 144.57 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.291 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.41 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -158.4 154.83 27.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.973 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.968 HG21 HD13 ' A' ' 55' ' ' ILE . 18.8 tt -148.3 125.46 2.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.965 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.777 HG12 ' HB3' ' A' ' 73' ' ' PRO . 27.7 m -128.89 123.74 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.198 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.588 HD22 ' CG2' ' A' ' 68' ' ' THR . 0.9 OUTLIER -137.83 142.51 40.78 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 3.7 mm? -80.47 165.9 21.73 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.833 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.94 -65.94 0.16 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -64.4 -21.3 66.59 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.638 0.256 . . . . 0.0 111.09 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.92 -31.13 22.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.643 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' CA ' HG13 ' A' ' 5' ' ' VAL . . . -106.48 40.39 2.52 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.49 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 mttt 64.14 97.18 0.04 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 110.978 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -69.59 -12.44 61.64 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.662 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.56 134.96 46.93 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-O 120.525 0.203 . . . . 0.0 111.07 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.42 -172.85 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.687 2.258 . . . . 0.0 112.628 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.688 ' CB ' HD21 ' A' ' 93' ' ' LEU . . . -162.29 -64.1 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.605 ' OG1' HD23 ' A' ' 93' ' ' LEU . 25.6 m -116.31 -51.8 2.6 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.397 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.685 HD12 ' HB3' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -133.79 -83.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.783 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.1 t80 54.4 94.82 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.136 0.493 . . . . 0.0 111.13 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -171.82 143.82 1.7 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.271 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -137.61 134.47 35.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 111.238 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.634 HG13 ' CD ' ' A' ' 67' ' ' ARG . 21.7 t -117.92 145.82 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.531 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.968 HD13 HG21 ' A' ' 36' ' ' ILE . 2.8 mt -123.99 134.08 67.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.775 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 65' ' ' PRO . 49.6 m-85 -135.04 135.02 40.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.91 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -157.47 130.14 7.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.22 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 1.8 mt 73.75 -177.06 0.17 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -55.8 138.37 70.89 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.615 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 59' ' ' HIS . 21.7 Cg_exo -65.82 -6.24 13.71 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.987 2.458 . . . . 0.0 112.857 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -9.12 3.29 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.63 152.06 5.48 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.691 0.281 . . . . 0.0 111.11 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.68 -48.04 40.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.397 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 13.1 p30 -157.82 136.87 8.1 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.04 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 39.1 Cg_exo -57.92 170.23 2.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.943 2.429 . . . . 0.0 112.788 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.5 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.0 m-20 -101.67 151.43 22.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.471 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.634 ' CD ' HG13 ' A' ' 54' ' ' VAL . 7.6 mmm-85 -144.93 156.11 43.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.853 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.709 ' OG1' HD11 ' A' ' 55' ' ' ILE . 87.5 m -134.71 112.82 11.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.859 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.493 ' HD1' HG23 ' A' ' 70' ' ' THR . 1.7 t80 -153.18 -51.03 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.838 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.493 HG23 ' HD1' ' A' ' 69' ' ' PHE . 55.6 p -144.17 30.18 1.29 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.835 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -123.49 150.92 62.29 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.206 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 38.1 Cg_exo -60.85 166.75 9.76 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.086 2.524 . . . . 0.0 112.466 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.777 ' HB3' HG12 ' A' ' 37' ' ' VAL . 27.8 Cg_exo -62.18 -173.22 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.042 2.495 . . . . 0.0 112.693 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.73 161.08 39.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 111.757 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.73 94.77 0.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.661 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.66 111.19 35.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -131.92 124.57 29.72 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.027 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -153.86 168.2 27.15 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.707 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -112.8 149.36 33.15 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.982 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.495 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 137.93 -113.84 1.02 Allowed Glycine 0 C--N 1.334 0.448 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.262 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -126.06 109.97 13.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.574 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.27 76.88 0.16 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.673 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -129.85 106.51 0.73 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.79 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 7.1 m-85 -158.18 167.75 13.84 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.582 0.229 . . . . 0.0 110.836 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 42.0 Cg_endo -67.55 168.29 18.58 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.929 2.419 . . . . 0.0 113.662 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 103' ' ' HIS . 0.5 OUTLIER -150.41 157.74 43.37 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.492 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -150.4 136.28 18.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.027 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.0 pt -125.92 139.14 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.886 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.2 p -130.02 146.82 51.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.858 0.361 . . . . 0.0 110.995 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 38.9 t -138.06 147.0 26.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.12 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.685 ' HB3' HD12 ' A' ' 50' ' ' ILE . 96.6 m-85 -155.54 144.99 21.05 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.9 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.629 HD23 ' HD3' ' A' ' 95' ' ' LYS . 16.4 tp -134.4 -50.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.539 0.209 . . . . 0.0 111.455 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.688 HD21 ' CB ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -161.67 -62.8 0.05 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.834 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -179.55 42.92 0.0 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.312 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.629 ' HD3' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -113.85 -163.73 0.88 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.938 -179.581 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.35 -26.26 38.79 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.662 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.85 -33.35 59.99 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.648 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -71.21 84.27 0.75 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.203 0.525 . . . . 0.0 110.669 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -142.4 151.81 42.2 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.34 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -121.47 143.24 49.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.79 120.72 10.3 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -90.86 150.79 4.0 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.241 2.627 . . . . 0.0 112.676 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.434 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . 59.9 m-70 -143.95 166.82 23.88 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.114 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -125.88 129.84 50.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.799 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -110.28 102.21 10.89 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.785 0.326 . . . . 0.0 111.335 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -177.26 45.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.27 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -141.55 128.61 20.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.644 0.259 . . . . 0.0 111.31 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 109' ' ' GLN . 3.1 pp -60.03 132.81 55.11 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.407 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.482 ' HB2' HD12 ' A' ' 108' ' ' LEU . 0.1 OUTLIER 68.98 44.66 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.171 0.51 . . . . 0.0 110.834 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.76 135.41 37.99 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.604 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -146.54 58.81 1.2 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.728 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -107.03 119.21 38.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.13 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 2.5 pt-20 -145.65 142.55 29.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.188 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.51 147.04 17.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.556 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.69 108.45 8.02 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.692 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -113.82 139.25 49.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.681 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 117' ' ' VAL . 11.9 p -123.73 121.44 62.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.077 0.465 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.414 HG21 HD22 ' A' ' 92' ' ' LEU . 2.9 mp -113.74 111.24 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.377 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -126.06 148.53 49.31 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.29 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 120' ' ' ILE . 3.6 tp -171.56 59.59 0.28 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 121.27 0.557 . . . . 0.0 111.554 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.04 -27.22 10.14 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.582 2.188 . . . . 0.0 112.521 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.1 mt -67.57 -43.22 81.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.003 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.6 m120 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.064 179.882 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.5 m -98.32 30.5 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.677 0.275 . . . . 0.0 111.566 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.24 150.38 21.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.708 0.29 . . . . 0.0 111.186 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.85 151.22 30.16 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 44' ' ' LYS . 34.0 t -137.64 119.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.032 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -129.71 105.25 7.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.606 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.3 mtt180 -123.84 163.19 21.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.092 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.9 t -158.77 143.69 16.06 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.775 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 tp -115.05 122.88 70.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.822 0.344 . . . . 0.0 110.779 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' CD ' ' HG2' ' A' ' 115' ' ' GLU . 9.3 mtt180 -134.0 106.39 7.22 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.024 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.84 HD13 HG13 ' A' ' 88' ' ' ILE . 1.1 pt -113.12 123.44 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.565 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -114.58 124.4 51.77 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.41 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.419 HG22 HD13 ' A' ' 105' ' ' LEU . 5.4 m -125.0 108.75 12.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 3.0 tt0 -116.22 142.33 46.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.783 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -142.14 142.18 32.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 31' ' ' GLN . 82.9 t60 -133.8 119.23 18.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.67 0.271 . . . . 0.0 111.139 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 9.9 mt -118.73 139.23 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.815 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 18' ' ' LEU . 8.8 tp -142.07 78.64 17.0 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 120.813 0.34 . . . . 0.0 111.391 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.12 -27.47 8.23 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.801 2.334 . . . . 0.0 112.941 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -65.86 -63.8 1.01 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.319 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -113.6 134.62 21.98 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.71 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -52.66 106.56 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.785 2.323 . . . . 0.0 112.442 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.77 -47.38 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.582 2.188 . . . . 0.0 112.391 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.96 -31.94 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.707 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -141.62 160.87 39.27 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.393 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -54.65 -43.34 72.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.416 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.686 ' O ' HG23 ' A' ' 29' ' ' VAL . 4.0 m-85 -78.35 150.17 76.57 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.806 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.56 114.05 1.59 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.969 2.446 . . . . 0.0 112.568 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 27' ' ' PHE . 21.8 t -125.26 150.13 30.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.208 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.68 163.99 21.59 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 111.314 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -117.08 158.17 24.64 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.844 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.455 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 67.7 p-90 -154.02 140.18 18.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.0 p -142.77 117.52 9.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.003 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.7 tp -127.61 127.2 68.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 111.422 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.565 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 1.7 pt-20 -130.37 135.35 47.95 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.668 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.77 HG12 HG21 ' A' ' 55' ' ' ILE . 4.3 mp -115.69 106.36 20.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.047 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -104.83 140.85 21.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.986 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.686 ' CD2' HG21 ' A' ' 68' ' ' THR . 1.2 pp -159.26 161.52 36.0 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.187 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 39' ' ' LEU . 1.1 mm? -120.82 159.53 25.27 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.42 -45.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.057 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.12 2.45 15.17 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.209 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -83.41 -36.24 24.42 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.65 0.262 . . . . 0.0 110.959 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.55 -70.72 0.23 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.719 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.658 ' HB2' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -134.01 120.87 20.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.686 0.279 . . . . 0.0 111.32 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.83 30.01 5.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.471 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.3 mt -128.27 131.63 23.89 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.691 -0.232 . . . . 0.0 111.183 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.544 ' HA ' HD12 ' A' ' 93' ' ' LEU . 72.5 Cg_endo -76.07 -172.72 1.43 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.828 2.352 . . . . 0.0 112.625 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.707 ' HB3' ' CB ' ' A' ' 93' ' ' LEU . . . -156.01 -49.68 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.422 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 m -110.73 -63.99 1.33 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.593 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.11 -74.41 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.838 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 47.9 t80 56.86 93.24 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.445 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -158.57 116.0 2.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.372 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.742 ' HG2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -110.81 115.06 28.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.385 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 t -112.73 150.1 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 111.66 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.829 HG23 ' CD1' ' A' ' 88' ' ' ILE . 4.9 mp -131.07 133.47 62.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.639 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -127.46 121.34 30.53 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.831 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.517 ' CE1' HG21 ' A' ' 61' ' ' THR . 0.1 OUTLIER -128.67 108.98 10.93 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.82 HD11 ' CD2' ' A' ' 105' ' ' LEU . 6.2 mp 70.39 156.23 0.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.531 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.41 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 1.7 m-70 -74.88 -50.56 4.05 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.43 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 58' ' ' LEU . 82.4 Cg_exo -47.7 -29.35 10.82 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.975 2.45 . . . . 0.0 113.496 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.517 HG21 ' CE1' ' A' ' 57' ' ' HIS . 3.5 m -73.4 9.06 1.45 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -35.49 69.68 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.702 0.287 . . . . 0.0 110.679 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.98 -31.14 71.5 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.374 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -139.85 68.17 35.82 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.206 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.57 -175.58 1.15 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.779 2.319 . . . . 0.0 111.771 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 1.6 m120 -119.81 139.87 51.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.158 0.504 . . . . 0.0 111.106 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.36 140.29 23.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.679 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.686 HG21 ' CD2' ' A' ' 38' ' ' LEU . 86.9 m -116.47 113.1 22.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.051 0.453 . . . . 0.0 111.467 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -131.95 -56.22 0.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.621 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.2 33.88 1.09 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.35 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -125.8 159.48 61.07 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.58 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.3 Cg_exo -67.07 175.01 6.08 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.346 2.697 . . . . 0.0 112.434 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 38.4 Cg_endo -65.92 -178.08 0.94 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.8 2.333 . . . . 0.0 112.502 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.82 162.43 30.58 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 111.701 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.67 80.34 0.04 OUTLIER 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.403 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.6 mm -116.6 130.76 70.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.385 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.75 128.77 29.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.579 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.455 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 3.3 mt-10 -138.26 167.34 22.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.987 0.422 . . . . 0.0 111.692 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -121.6 128.03 51.51 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.854 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.24 -121.44 1.01 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.559 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -121.21 110.1 15.77 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 110.756 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.8 106.63 0.25 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.508 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.22 101.37 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.834 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 10.0 m-85 -152.94 171.33 6.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.544 0.212 . . . . 0.0 111.186 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.9 Cg_exo -56.03 176.1 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.288 2.658 . . . . 0.0 113.308 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.78 147.14 29.54 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.07 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -145.54 124.15 12.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.854 0.359 . . . . 0.0 111.116 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.84 HG13 HD13 ' A' ' 11' ' ' ILE . 14.6 mm -122.96 125.74 72.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.958 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.4 p -127.81 144.84 51.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.805 0.336 . . . . 0.0 111.55 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.742 HG23 ' HG2' ' A' ' 53' ' ' LYS . 4.0 p -134.23 132.81 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 8.3 m-85 -133.44 155.76 48.94 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.562 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.452 HD23 ' N ' ' A' ' 92' ' ' LEU . 1.4 pt? -144.62 -157.23 0.77 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.397 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.707 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -98.02 38.09 1.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.124 0.487 . . . . 0.0 110.708 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -170.54 -167.12 0.56 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.421 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 42.05 3.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.722 0.296 . . . . 0.0 111.049 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.49 -28.39 8.2 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -114.17 -10.66 13.33 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.187 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -56.16 107.42 0.36 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.971 0.385 . . . . 0.0 110.748 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.466 ' H ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.34 146.51 35.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.812 -179.641 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 123.26 22.04 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.208 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.952 HD13 HG11 ' A' ' 114' ' ' VAL . 19.9 tt -129.79 124.13 21.49 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-O 120.927 0.394 . . . . 0.0 111.894 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.07 160.52 8.65 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.008 2.472 . . . . 0.0 112.312 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -148.61 172.41 14.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.966 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.63 143.75 50.96 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.696 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.82 ' CD2' HD11 ' A' ' 58' ' ' LEU . 7.4 tp -130.65 88.47 2.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.011 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -172.04 42.15 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -141.51 130.03 22.61 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.163 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 3.4 pp -58.16 131.3 50.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.526 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.94 53.74 1.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.905 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 15' ' ' GLN . 1.2 tp10 -85.07 135.23 34.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.28 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.9 t -143.74 62.52 1.36 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.649 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -105.31 119.31 38.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.308 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 1.2 pt-20 -153.41 145.64 23.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.127 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.952 HG11 HD13 ' A' ' 101' ' ' ILE . 27.0 m -125.51 151.46 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.727 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.432 ' HG2' ' CD ' ' A' ' 10' ' ' ARG . 1.3 mt-10 -137.52 109.08 6.97 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.672 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 155.63 27.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.53 143.88 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.352 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.27 111.02 14.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -121.5 121.11 36.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.638 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.65 HD13 HD21 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -145.41 75.09 13.78 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.92 0.37 8.4 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.679 2.253 . . . . 0.0 113.55 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.4 tp 75.9 -62.28 0.44 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.428 0.291 . . . . 0.0 111.06 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.991 179.794 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.671 0.272 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 t -92.05 132.1 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.063 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.65 115.67 1.67 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.294 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.91 121.05 18.93 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.639 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 44' ' ' LYS . 17.5 t -134.0 119.39 31.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.218 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.0 105.86 12.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.285 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.32 162.39 16.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.249 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 4.2 t -175.0 149.28 1.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.374 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.744 HD11 HD11 ' A' ' 36' ' ' ILE . 2.5 tt -128.29 133.89 65.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.482 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 111.56 11.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.297 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.93 HD13 HD13 ' A' ' 88' ' ' ILE . 8.0 pt -114.81 130.15 69.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.37 136.89 52.83 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.8 HG23 ' CD1' ' A' ' 34' ' ' ILE . 5.6 m -133.66 111.51 10.67 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.77 117.27 24.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.942 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 109' ' ' GLN . 3.0 tp60 -109.97 147.12 34.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.952 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -155.03 119.93 4.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.077 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.862 HG22 ' HA ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -112.66 129.96 67.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.02 0.438 . . . . 0.0 111.334 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.434 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -151.55 94.36 3.42 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.52 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD3' HD13 ' A' ' 17' ' ' ILE . 24.0 Cg_exo -64.29 -55.9 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.812 2.341 . . . . 0.0 112.722 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 53.45 34.59 18.57 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.906 0.384 . . . . 0.0 111.173 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 10.6 p -125.86 139.69 34.86 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 52.0 Cg_exo -55.62 167.2 2.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.78 2.32 . . . . 0.0 112.639 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.0 92.77 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.793 2.329 . . . . 0.0 112.322 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.75 -66.46 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.964 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -147.47 159.02 44.19 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.59 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -69.51 85.06 0.43 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.523 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.2 74.7 7.76 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.697 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.76 120.84 6.91 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.804 2.336 . . . . 0.0 112.572 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.61 94.38 2.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.787 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.569 ' HA ' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -99.69 150.51 22.22 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.772 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -105.11 163.1 12.82 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -156.57 146.96 21.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.998 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.5 p -139.9 117.45 11.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.246 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.8 ' CD1' HG23 ' A' ' 13' ' ' THR . 27.2 mm -119.54 121.5 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.1 pm0 -131.18 116.64 17.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.666 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.744 HD11 HD11 ' A' ' 9' ' ' ILE . 7.9 tt -117.66 123.71 72.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.754 HG12 ' HB3' ' A' ' 73' ' ' PRO . 35.5 m -128.08 143.36 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.872 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.609 HD22 ' HE2' ' A' ' 53' ' ' LYS . 3.2 pp -144.32 163.02 34.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.635 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tp -106.16 157.49 17.52 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.2 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.48 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -171.45 -44.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.067 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.68 1.42 19.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.367 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -34.51 27.52 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.641 0.257 . . . . 0.0 110.751 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.8 -71.59 0.34 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.544 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.8 ' HB2' HG22 ' A' ' 5' ' ' VAL . 1.3 mtmt -144.18 107.09 4.47 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.869 0.366 . . . . 0.0 110.799 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.48 ' HG3' ' HB3' ' A' ' 40' ' ' ASP . 2.3 tt0 -96.26 45.55 1.07 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.83 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.5 118.13 21.44 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.799 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.84 161.4 6.28 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.905 2.403 . . . . 0.0 112.648 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB3' ' HG ' ' A' ' 93' ' ' LEU . . . -129.44 -71.43 0.62 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.568 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 p -113.06 -63.36 1.45 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.021 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.61 -80.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.07 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 31.6 t80 54.3 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.283 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.4 t0 -161.08 124.52 3.31 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.805 ' HG2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -117.39 136.77 52.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.445 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.751 HG13 ' HG3' ' A' ' 67' ' ' ARG . 6.6 t -128.96 135.83 61.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.02 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.507 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 4.9 mt -112.89 140.54 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.456 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.71 129.05 18.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.478 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.445 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 23.4 p-80 -140.21 123.36 16.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.977 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.604 HD21 HD23 ' A' ' 105' ' ' LEU . 75.2 mt 68.84 -175.79 0.2 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.86 164.63 59.77 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 120.693 0.282 . . . . 0.0 111.188 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.5 -12.66 17.93 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.006 2.47 . . . . 0.0 113.123 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.94 -13.66 2.87 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.391 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -68.05 167.86 13.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.651 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.36 -48.7 65.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.289 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -175.58 149.0 1.05 Allowed Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.115 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.36 163.43 36.47 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.621 2.214 . . . . 0.0 112.021 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.507 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 3.2 m120 -108.02 157.64 18.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.095 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.751 ' HG3' HG13 ' A' ' 54' ' ' VAL . 4.0 mtt180 -150.77 156.22 40.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.783 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.546 HG21 HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -134.54 126.16 28.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.91 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.749 ' CE2' HG22 ' A' ' 70' ' ' THR . 10.2 p90 -165.59 -45.11 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.887 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.749 HG22 ' CE2' ' A' ' 69' ' ' PHE . 13.6 t -146.04 30.49 1.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -134.2 156.83 78.71 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.203 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 40.1 Cg_endo -66.76 175.61 5.18 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.014 2.476 . . . . 0.0 112.188 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.754 ' HB3' HG12 ' A' ' 37' ' ' VAL . 10.9 Cg_endo -54.04 168.14 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.209 2.606 . . . . 0.0 112.8 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.409 ' CD2' ' ND2' ' A' ' 66' ' ' ASN . 72.2 m-85 -128.7 88.66 2.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.919 0.39 . . . . 0.0 111.965 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 3.3 ttp85 -107.69 90.8 3.41 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.222 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.07 137.28 57.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.532 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.28 142.16 50.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.827 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -159.92 168.27 26.11 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.687 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -107.06 175.02 5.64 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.881 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.76 -141.98 12.8 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.631 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -126.57 110.1 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.122 0.487 . . . . 0.0 110.934 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.4 -129.18 6.35 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.361 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.17 47.98 3.43 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.701 -0.559 . . . . 0.0 111.701 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.497 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 64.1 m-85 -142.13 159.7 57.8 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.82 0.343 . . . . 0.0 111.019 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 39.2 Cg_endo -67.32 162.63 37.82 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.941 2.427 . . . . 0.0 113.622 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -148.88 134.24 18.47 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.795 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -143.96 153.02 41.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 111.415 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.93 HD13 HD13 ' A' ' 11' ' ' ILE . 3.9 mp -136.99 120.5 22.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 p -105.27 145.23 30.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.805 HG23 ' HG2' ' A' ' 53' ' ' LYS . 6.1 p -133.29 143.28 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -145.3 155.18 43.05 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.572 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.928 HD11 ' HB3' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -136.22 -45.53 0.63 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.629 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -143.37 -75.66 0.26 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.59 0.233 . . . . 0.0 111.22 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -140.34 -55.83 0.53 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.117 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.43 61.54 0.39 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 111.261 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.928 ' HB3' HD11 ' A' ' 92' ' ' LEU . . . -111.78 -39.65 4.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.794 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.624 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . -157.99 32.78 0.51 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.629 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.2 pp20? -88.93 116.76 27.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.977 0.418 . . . . 0.0 110.854 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.51 ' H ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -143.61 156.39 44.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.742 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -120.82 129.65 53.65 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.881 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.658 ' CG2' HG21 ' A' ' 114' ' ' VAL . 3.1 mt -111.37 99.84 45.4 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 120.692 0.282 . . . . 0.0 111.596 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -88.85 140.22 4.06 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.129 2.553 . . . . 0.0 112.248 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.71 172.33 17.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.314 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -114.51 150.85 34.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.647 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.776 ' HB2' HD22 ' A' ' 86' ' ' LEU . 13.2 tp -125.38 82.28 2.05 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.886 0.374 . . . . 0.0 111.102 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.7 -175.36 4.38 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.744 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.477 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 2.8 p90 -111.46 166.3 11.25 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.769 0.318 . . . . 0.0 111.856 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.862 ' HA ' HG22 ' A' ' 17' ' ' ILE . 0.5 OUTLIER 81.12 65.18 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.331 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 15' ' ' GLN . 19.3 mt-30 66.38 133.19 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.123 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.419 ' CB ' ' HB3' ' A' ' 15' ' ' GLN . 35.4 tt0 -157.66 134.68 10.1 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.262 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.39 71.89 1.49 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.582 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -115.99 119.17 35.05 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.704 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -153.49 139.37 18.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.29 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.658 HG21 ' CG2' ' A' ' 101' ' ' ILE . 13.0 t -118.81 152.46 21.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.63 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.38 108.89 8.97 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -113.26 151.84 30.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.431 ' C ' HD12 ' A' ' 118' ' ' ILE . 13.9 p -127.9 151.52 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.845 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.624 HG23 ' HA3' ' A' ' 97' ' ' GLY . 4.2 mp -141.32 126.5 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.079 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -127.11 117.18 21.9 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.761 0.315 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -129.94 61.84 60.45 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.337 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -87.96 26.96 0.56 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.704 2.27 . . . . 0.0 113.03 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.91 76.64 0.32 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.937 0.399 . . . . 0.0 111.095 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.169 179.759 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.235 0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 43' ' ' GLY . 25.0 t -129.57 119.26 47.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.153 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.44 ' O ' HD12 ' A' ' 39' ' ' LEU . 5.0 tmtp? -138.29 107.46 6.06 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.507 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.402 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 6.4 ptp180 -130.65 131.87 45.12 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.75 0.31 . . . . 0.0 110.833 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.3 t -126.37 139.86 52.95 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 9' ' ' ILE . 1.5 tt -106.47 121.79 59.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.584 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.413 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 26.2 mtt180 -124.29 118.31 26.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pt -120.28 127.16 75.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.415 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -112.18 130.9 55.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.954 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.593 HG21 HD11 ' A' ' 86' ' ' LEU . 83.7 m -130.71 129.41 42.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.175 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 12.7 mp0 -140.48 155.12 46.77 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.092 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.74 149.1 29.36 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.384 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 31' ' ' GLN . 11.7 t-160 -139.92 119.62 13.29 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.199 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 24.9 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.721 0.296 . . . . 0.0 110.927 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.584 HG22 ' HE1' ' A' ' 81' ' ' TRP . 21.8 t . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -129.05 164.97 22.1 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.744 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 16' ' ' HIS . 1.2 tt0 -115.2 159.29 21.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.709 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -159.73 142.33 13.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.37 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.04 133.84 25.33 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 34' ' ' ILE . 3.9 tp -146.04 122.89 3.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.271 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.415 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -132.35 139.87 48.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.056 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.715 HG21 ' CD1' ' A' ' 55' ' ' ILE . 2.9 mt -125.87 112.13 29.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.798 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 10' ' ' ARG . 27.7 m -122.7 157.39 27.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.574 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.018 HD21 HG21 ' A' ' 68' ' ' THR . 0.2 OUTLIER -171.62 172.45 4.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.558 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 6' ' ' LYS . 52.6 mt -98.76 165.89 11.57 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.036 0.446 . . . . 0.0 111.235 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -166.04 -48.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.547 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -78.3 -10.36 59.64 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.091 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.61 -37.06 8.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.741 ' O ' HG13 ' A' ' 5' ' ' VAL . . . -106.05 49.76 0.86 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.679 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? 62.34 117.81 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.101 0.477 . . . . 0.0 111.447 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.58 32.9 0.93 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.394 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.2 mt -127.12 131.95 24.09 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.23 158.62 48.58 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.782 2.321 . . . . 0.0 112.622 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HB3' HD12 ' A' ' 93' ' ' LEU . . . -120.95 -74.35 0.62 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.331 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.3 m -108.13 -60.25 1.75 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.737 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.4 mt -119.63 -83.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.786 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.1 t80 55.69 96.83 0.02 OUTLIER 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.129 0.49 . . . . 0.0 111.383 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.48 119.76 0.79 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.286 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.697 ' CE ' HD13 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -109.9 120.88 43.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.502 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.801 HG13 ' HD2' ' A' ' 67' ' ' ARG . 5.6 t -120.39 115.67 47.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.715 ' CD1' HG21 ' A' ' 36' ' ' ILE . 2.3 mp -94.24 147.93 5.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.359 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 87' ' ' ASP . 92.4 t80 -139.03 132.68 30.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.596 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -152.41 142.32 22.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.236 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.0 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 CA--C 1.531 0.345 0 CA-C-O 120.747 0.228 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -88.2 143.72 26.88 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.945 0.403 . . . . 0.0 111.287 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.801 ' HD2' HG13 ' A' ' 54' ' ' VAL . 9.2 mmm180 -133.02 146.61 51.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.788 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 1.018 HG21 HD21 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -137.59 116.8 12.62 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.861 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.681 ' CE2' HG22 ' A' ' 70' ' ' THR . 1.9 p90 -162.57 -45.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.893 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.681 HG22 ' CE2' ' A' ' 69' ' ' PHE . 15.1 t -141.07 27.76 1.94 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.893 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.77 157.77 70.33 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.201 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.87 170.51 17.72 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.912 2.408 . . . . 0.0 112.125 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.6 158.23 51.13 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.68 2.253 . . . . 0.0 112.401 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.553 ' HD2' HD11 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -113.83 158.12 21.44 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.425 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -171.53 103.87 0.2 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.746 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.553 HD11 ' HD2' ' A' ' 74' ' ' PHE . 3.8 mp -125.99 123.6 64.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.052 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.34 114.42 10.11 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.92 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.08 178.95 9.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.213 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.426 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.0 mt-30 -105.39 138.99 40.7 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.73 -173.17 42.96 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.887 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.584 ' HE1' HG22 ' A' ' 29' ' ' VAL . 11.7 m0 -112.1 109.75 19.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.607 0.241 . . . . 0.0 110.646 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.6 -117.22 0.6 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.319 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.41 91.79 1.82 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.655 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.593 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 36.4 m-85 -150.93 166.82 14.23 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 120.701 0.286 . . . . 0.0 111.267 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.34 159.52 39.4 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.151 2.568 . . . . 0.0 112.927 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.593 HD11 HG21 ' A' ' 13' ' ' THR . 0.8 OUTLIER -152.7 121.8 6.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.811 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 56' ' ' TYR . 9.2 t70 -128.05 146.33 50.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.573 HD13 ' N ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -129.38 128.47 66.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 111.145 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.573 ' N ' HD13 ' A' ' 88' ' ' ILE . 90.0 p -111.32 131.18 55.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.601 HG23 ' HG2' ' A' ' 53' ' ' LYS . 2.9 p -116.02 142.75 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.706 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -139.09 150.4 45.67 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.088 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.792 HD12 ' HB3' ' A' ' 96' ' ' ALA . 1.1 tm? -137.18 -49.02 0.61 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.26 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.632 ' HB2' HD13 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -151.55 -64.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.322 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.55 -54.19 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.079 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.97 44.24 2.48 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.989 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.792 ' HB3' HD12 ' A' ' 92' ' ' LEU . . . -105.08 -50.76 3.17 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.288 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.13 26.07 0.31 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.006 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 20.2 mt-10 -70.32 100.42 1.72 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.663 0.268 . . . . 0.0 110.772 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.465 ' H ' HG12 ' A' ' 90' ' ' VAL . 1.3 tpt180 -142.7 156.45 45.03 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.525 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 134.69 41.74 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.328 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.525 HG12 HG21 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -126.46 119.69 23.21 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 121.009 0.433 . . . . 0.0 111.909 -179.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.67 151.44 10.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.275 2.65 . . . . 0.0 112.548 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.472 ' CD2' ' HB3' ' A' ' 112' ' ' TYR . 7.3 m80 -147.77 167.0 25.83 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.949 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -129.62 149.92 51.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.626 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 tp -128.68 93.88 3.73 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 111.224 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -174.85 45.39 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.236 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -141.44 127.33 19.32 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -56.58 119.84 6.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.405 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 3.2 mm-40 69.23 66.69 0.27 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.795 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 1.2 tp10 -92.52 137.04 32.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.576 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.5 t -143.35 72.56 1.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.439 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.472 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 6.7 m-85 -121.08 119.27 31.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.335 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -144.82 147.2 32.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.366 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.525 HG21 HG12 ' A' ' 101' ' ' ILE . 24.0 t -122.56 148.84 26.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.913 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.08 109.02 8.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.451 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 137.51 51.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.153 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.72 150.42 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.73 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.4 mt -137.95 126.38 31.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -130.31 130.15 44.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.34 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -152.89 65.2 5.62 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--N 1.346 0.43 0 C-N-CA 122.533 2.155 . . . . 0.0 112.774 179.653 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.72 0.295 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -130.57 119.12 45.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.19 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' HD13 ' A' ' 39' ' ' LEU . 18.8 mttt -134.88 115.95 14.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.169 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.443 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 39.3 mtt180 -137.39 165.96 24.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.08 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 t -178.09 131.13 0.14 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.855 HD12 HD12 ' A' ' 38' ' ' LEU . 14.6 tt -104.23 118.1 50.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 121.125 0.488 . . . . 0.0 110.627 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -115.03 107.4 15.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.657 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.9 pt -114.76 131.89 65.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -124.1 135.46 53.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.113 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.736 HG22 HD13 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -135.54 105.75 6.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.825 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -119.34 147.58 44.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.188 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.594 ' HG2' ' HA ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -143.56 147.04 33.83 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.083 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -156.22 120.37 4.47 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.68 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.466 HG12 ' HB3' ' A' ' 30' ' ' ARG . 25.0 mt . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 120.697 0.285 . . . . 0.0 111.027 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.463 0.205 0 CA-C-O 120.584 0.23 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.466 ' HB3' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -139.33 158.28 44.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.041 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 160.92 14.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.422 ' HB3' ' NE2' ' A' ' 15' ' ' GLN . 32.6 p-90 -158.4 148.16 19.66 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.034 0.445 . . . . 0.0 111.762 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -143.48 124.42 14.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.56 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 12' ' ' LYS . 9.3 tp -130.33 141.47 46.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 111.756 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.48 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.9 OUTLIER -149.44 143.78 25.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.778 HG21 HG12 ' A' ' 55' ' ' ILE . 4.2 mp -136.43 106.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.538 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 73' ' ' PRO . 21.7 t -113.71 135.48 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.73 0.3 . . . . 0.0 111.281 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 9' ' ' ILE . 1.4 tt -155.63 135.37 12.67 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.713 HD22 ' HB2' ' A' ' 42' ' ' GLU . 11.3 mt -70.76 164.39 25.26 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.268 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -161.23 -52.8 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.892 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.35 -13.61 61.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.584 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.713 ' HB2' HD22 ' A' ' 39' ' ' LEU . 2.4 tt0 -103.13 -34.7 8.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.387 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.82 40.36 2.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.816 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 65.37 91.16 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.66 52.16 1.84 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.25 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.29 112.59 11.09 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.91 159.4 53.03 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.635 2.223 . . . . 0.0 112.449 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.723 ' HB3' HD21 ' A' ' 93' ' ' LEU . . . -146.91 -62.5 0.29 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.688 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.567 HG22 HG13 ' A' ' 50' ' ' ILE . 86.2 m -106.74 -68.49 0.88 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 49' ' ' THR . 46.1 mt -113.8 -80.07 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.948 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 52.5 t80 55.39 92.76 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.874 0.368 . . . . 0.0 111.549 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 3.8 t70 -169.26 116.92 0.62 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.23 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.701 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -114.9 120.22 39.21 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.552 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.467 HG22 ' OG ' ' A' ' 89' ' ' SER . 34.6 m -116.87 159.34 16.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.012 0.434 . . . . 0.0 111.524 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.778 HG12 HG21 ' A' ' 36' ' ' ILE . 4.2 mp -137.18 130.43 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.406 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -126.47 143.06 51.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.893 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -167.27 126.0 1.34 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 tp . . . . . 0 N--CA 1.465 0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 CA--C 1.53 0.292 0 CA-C-O 120.71 0.212 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 4.4 m-80 -106.73 136.99 45.59 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.166 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.61 151.22 41.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.173 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 87.5 m -130.45 102.61 6.24 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -130.83 -48.53 1.04 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.406 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 t -140.69 -36.75 0.46 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.791 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.05 159.13 1.53 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.3 169.65 21.1 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.094 2.53 . . . . 0.0 112.851 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HB3' HG13 ' A' ' 37' ' ' VAL . 39.9 Cg_exo -57.38 152.04 49.2 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.944 2.429 . . . . 0.0 113.085 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -100.42 141.39 33.33 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.977 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.29 89.34 0.54 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.462 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.1 143.09 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.733 0.302 . . . . 0.0 111.658 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.03 143.43 46.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.72 -177.27 6.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.205 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -120.11 136.71 54.5 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -175.29 -170.0 37.73 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.92 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -127.29 110.41 12.81 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.853 0.358 . . . . 0.0 110.976 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.56 128.17 1.2 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.63 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.67 117.39 2.48 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.313 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.571 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 12.1 m-85 -157.32 166.22 17.09 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 120.579 0.228 . . . . 0.0 110.905 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.6 Cg_endo -69.49 168.33 21.5 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.029 2.486 . . . . 0.0 113.293 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.648 HD22 ' HB2' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -151.73 118.66 5.82 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.473 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.26 154.37 38.92 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.363 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.748 ' CG2' HG23 ' A' ' 55' ' ' ILE . 2.3 pt -140.91 151.46 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.47 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.467 ' OG ' HG22 ' A' ' 54' ' ' VAL . 79.8 p -137.06 147.66 46.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.043 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.701 HG13 ' HG2' ' A' ' 53' ' ' LYS . 21.6 t -126.97 139.58 51.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.301 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 30.0 m-85 -144.48 150.94 38.43 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.672 HD21 HG21 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -142.13 -47.1 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.528 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -153.0 -71.5 0.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.588 0.232 . . . . 0.0 111.247 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -136.03 -68.6 0.5 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.041 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 35.99 1.32 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.107 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.644 ' HB1' HG12 ' A' ' 120' ' ' ILE . . . -77.74 -38.18 47.61 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.43 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.525 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . -168.27 37.38 0.21 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.213 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 6.9 tt0 -80.15 103.8 10.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -142.18 151.88 42.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.947 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.427 ' HG2' ' CB ' ' A' ' 89' ' ' SER . 8.2 mtpt -131.93 149.79 52.34 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.102 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.584 HG21 HG11 ' A' ' 114' ' ' VAL . 1.4 tp -148.71 123.9 5.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -87.56 155.13 7.73 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.217 2.611 . . . . 0.0 112.451 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.13 169.15 23.67 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.417 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.415 ' C ' HD21 ' A' ' 86' ' ' LEU . 6.5 m-20 -126.77 140.67 52.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.13 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.736 HD13 HG22 ' A' ' 13' ' ' THR . 58.1 tp -121.9 93.32 3.96 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.996 0.426 . . . . 0.0 111.122 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.99 -168.7 1.44 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.305 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.594 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -116.07 164.01 15.09 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.08 0.466 . . . . 0.0 112.091 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 84.67 69.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.523 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 63.65 103.58 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.958 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -126.82 134.2 50.61 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.14 67.4 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.592 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -119.37 119.43 33.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.627 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 1.3 pt-20 -151.47 149.56 29.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.383 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 101' ' ' ILE . 4.5 t -122.41 149.94 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.623 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -137.75 108.65 6.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.403 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -113.8 141.97 46.65 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.16 148.89 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.983 0.421 . . . . 0.0 111.927 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.672 HG21 HD21 ' A' ' 92' ' ' LEU . 4.3 mp -134.65 111.29 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.403 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.427 ' CG ' ' HD3' ' A' ' 121' ' ' PRO . 43.4 tt0 -125.3 114.67 19.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.605 0.24 . . . . 0.0 111.539 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.668 ' CD1' HG22 ' A' ' 118' ' ' ILE . 4.1 mp -139.91 56.21 7.65 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 111.314 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.427 ' HD3' ' CG ' ' A' ' 119' ' ' GLN . 83.4 Cg_endo . . . . . 0 C--N 1.346 0.406 0 C-N-CA 122.67 2.247 . . . . 0.0 112.454 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.662 0.268 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 43' ' ' GLY . 21.5 t -140.04 119.23 12.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.181 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.34 106.81 6.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.383 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -127.61 163.11 24.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.363 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.485 HG22 HD23 ' A' ' 39' ' ' LEU . 5.2 t -170.39 129.17 0.86 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.541 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.5 tt -109.84 118.37 56.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.988 0.423 . . . . 0.0 110.882 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.684 ' O ' HG22 ' A' ' 37' ' ' VAL . 17.8 mtt85 -123.92 117.7 25.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.705 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.547 ' CD1' HD13 ' A' ' 88' ' ' ILE . 19.8 pt -113.05 136.65 48.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.198 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 1.8 mptp? -108.38 134.94 50.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.6 m -128.02 128.27 44.69 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.889 0.376 . . . . 0.0 111.551 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -145.86 127.78 15.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.65 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -140.49 146.15 37.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.755 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -143.49 119.39 10.6 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.509 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.753 HG23 ' HG2' ' A' ' 30' ' ' ARG . 39.6 mt . . . . . 0 CA--C 1.531 0.217 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.102 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.796 HG13 ' HA2' ' A' ' 80' ' ' GLY . 21.7 t . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.717 0.294 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.753 ' HG2' HG23 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -106.93 165.08 11.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.886 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.77 156.55 34.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.381 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -157.65 141.29 15.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.427 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.7 t -147.2 117.74 7.49 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.718 HD11 HD13 ' A' ' 105' ' ' LEU . 39.6 mt -135.68 136.36 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.853 0.359 . . . . 0.0 111.635 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.98 155.28 44.52 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.579 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.627 HG12 HG21 ' A' ' 55' ' ' ILE . 4.0 mp -131.38 109.0 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.26 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 10' ' ' ARG . 34.2 m -111.61 146.26 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.376 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD22 ' CG2' ' A' ' 68' ' ' THR . 1.2 pp -163.7 170.15 17.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.313 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.581 HD12 ' HG3' ' A' ' 42' ' ' GLU . 4.0 mm? -108.42 165.29 11.62 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -168.23 -47.18 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.778 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -3.86 45.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.771 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HG3' HD12 ' A' ' 39' ' ' LEU . 3.9 mm-40 -104.27 -35.38 8.01 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.514 0.197 . . . . 0.0 111.138 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.543 ' O ' HG13 ' A' ' 5' ' ' VAL . . . -113.34 45.92 1.25 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.461 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt 66.7 123.25 0.02 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.046 0.45 . . . . 0.0 111.525 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.66 29.06 2.12 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.429 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.9 mt -129.63 134.5 26.28 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.016 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.63 -174.23 1.94 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.672 2.248 . . . . 0.0 112.473 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.678 ' HB3' ' CD1' ' A' ' 93' ' ' LEU . . . -144.32 -51.89 0.31 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.233 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 p -126.0 -52.36 1.54 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.562 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.47 -89.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.093 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 40.3 t80 57.09 97.74 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.242 0.544 . . . . 0.0 110.861 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.65 109.96 1.27 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.53 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.82 ' HG2' HG13 ' A' ' 90' ' ' VAL . 1.4 mttm -112.55 137.05 51.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.354 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.503 ' C ' HD13 ' A' ' 55' ' ' ILE . 12.5 p -139.36 149.81 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.015 0.436 . . . . 0.0 111.652 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.878 HG23 HG22 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -126.72 140.66 48.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.42 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.86 130.57 38.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.704 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.435 ' O ' HD12 ' A' ' 58' ' ' LEU . 3.8 p80 -132.89 113.94 13.46 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.238 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 57' ' ' HIS . 1.3 mp . . . . . 0 N--CA 1.465 0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--O 1.233 0.262 0 CA-C-O 120.687 0.203 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.475 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 2.7 m120 -98.69 133.78 42.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HG3' HG23 ' A' ' 54' ' ' VAL . 2.6 mtt180 -129.19 153.84 47.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.05 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 35.1 m -132.29 99.16 4.6 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.017 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -124.77 -49.17 1.76 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.64 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.4 t -174.49 50.81 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.155 0.502 . . . . 0.0 110.397 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.45 162.0 57.25 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.152 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.21 162.48 14.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.942 2.428 . . . . 0.0 112.625 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.39 168.68 3.65 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.11 2.54 . . . . 0.0 112.851 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.95 165.8 13.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.49 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.37 94.11 0.22 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.597 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.29 115.37 48.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -137.77 126.51 23.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.915 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -144.87 -179.13 6.4 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.426 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -130.28 177.34 7.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.176 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.796 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 96.09 -162.1 22.76 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.123 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -67.32 128.83 37.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.4 126.88 0.86 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.669 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.77 110.82 0.29 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.75 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.404 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 12.4 m-85 -155.4 166.26 16.59 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 120.662 0.268 . . . . 0.0 111.272 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.416 ' C ' HD12 ' A' ' 86' ' ' LEU . 31.6 Cg_exo -60.34 177.32 0.6 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.157 2.572 . . . . 0.0 113.229 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.653 HD11 ' HB2' ' A' ' 105' ' ' LEU . 5.3 mp -142.84 167.01 23.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.993 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -155.15 122.9 5.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.298 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.878 HG22 HG23 ' A' ' 55' ' ' ILE . 11.8 pt -129.84 123.24 56.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.686 0.279 . . . . 0.0 111.144 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -119.85 142.43 48.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.78 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.82 HG13 ' HG2' ' A' ' 53' ' ' LYS . 4.2 t -126.71 137.41 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.806 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.476 ' CD2' ' CG ' ' A' ' 98' ' ' GLU . 48.0 m-85 -145.47 145.78 31.23 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.736 HD22 ' CG2' ' A' ' 118' ' ' ILE . 3.5 tp -138.49 -68.44 0.45 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.678 ' CD1' ' HB3' ' A' ' 48' ' ' ALA . 6.4 tp -136.64 -66.89 0.52 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.357 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' HB3' ' CE ' ' A' ' 95' ' ' LYS . 2.6 mt-10 -166.07 -54.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.436 ' CE ' ' HB3' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -115.75 45.96 1.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.165 0.507 . . . . 0.0 110.676 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -116.59 -49.53 2.65 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.217 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.4 -81.82 0.03 OUTLIER Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.396 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.6 OUTLIER 47.19 59.91 3.76 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 111.554 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.08 136.95 30.66 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.166 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 2.9 pttt -117.85 149.98 39.94 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.59 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 tt -149.45 123.5 4.63 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.961 0.41 . . . . 0.0 111.562 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.3 158.85 13.01 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.707 2.271 . . . . 0.0 112.138 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.31 172.49 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -125.59 146.52 49.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.569 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.718 HD13 HD11 ' A' ' 34' ' ' ILE . 5.5 tp -139.13 74.05 1.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -164.61 46.65 0.1 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.13 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -140.25 132.58 28.34 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.339 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 3.3 pp -61.2 131.7 51.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.07 61.02 0.77 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.819 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.13 131.7 37.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.69 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.5 t -137.14 69.96 1.4 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.751 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.36 153.35 20.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.012 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 12' ' ' LYS . 3.3 tt0 -164.66 136.61 4.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.252 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.62 143.65 33.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -139.34 108.51 6.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.719 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.408 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 1.6 m-70 -113.05 119.01 36.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.477 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.45 147.67 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.631 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.736 ' CG2' HD22 ' A' ' 92' ' ' LEU . 20.0 mt -142.12 110.85 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.525 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -129.88 125.89 36.67 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.536 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.412 HG12 ' CD2' ' A' ' 92' ' ' LEU . 0.8 OUTLIER -152.78 54.61 1.26 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.669 179.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 C--N 1.349 0.571 0 C-N-CA 122.446 2.097 . . . . 0.0 112.506 179.674 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.566 0.222 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.666 HG22 ' HG3' ' A' ' 44' ' ' LYS . 19.5 t -126.94 119.14 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 111.338 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.25 104.91 7.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.268 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.601 ' HB3' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -118.36 169.83 9.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.409 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -165.89 123.79 1.5 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.713 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 36' ' ' ILE . 8.8 tt -108.86 124.55 65.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.924 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 0.2 OUTLIER -120.11 120.33 35.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.023 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.783 HD13 HG12 ' A' ' 88' ' ' ILE . 7.8 pt -123.4 132.71 70.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.071 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 4.1 mtmt -120.41 146.17 46.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.22 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.449 HG21 HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -136.82 116.85 13.31 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.687 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 3.8 tt0 -123.74 148.83 46.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.987 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -154.87 144.1 21.12 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.979 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -147.88 119.59 8.05 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.343 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.422 HG23 ' HG2' ' A' ' 30' ' ' ARG . 45.0 mt . . . . . 0 C--N 1.332 -0.165 0 CA-C-O 120.77 0.319 . . . . 0.0 110.633 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.765 0.317 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.422 ' HG2' HG23 ' A' ' 17' ' ' ILE . 3.7 mtt180 -138.58 164.23 30.0 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.597 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.39 151.17 22.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.55 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -155.74 132.4 10.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.419 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 14' ' ' GLN . 27.7 t -143.88 125.91 15.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.539 HG21 ' CG ' ' A' ' 57' ' ' HIS . 1.9 tp -135.79 129.7 48.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.5 OUTLIER -135.78 157.06 47.79 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 9' ' ' ILE . 12.5 tt -154.54 130.44 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.736 HG12 ' CB ' ' A' ' 73' ' ' PRO . 25.4 m -134.97 160.73 40.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.657 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.976 HD21 HG21 ' A' ' 68' ' ' THR . 0.2 OUTLIER -159.32 175.1 13.78 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.934 0.397 . . . . 0.0 111.531 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.56 HD22 ' HB2' ' A' ' 42' ' ' GLU . 3.7 mt -106.79 166.13 10.81 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.101 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.85 -56.29 0.06 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.209 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -54.98 -40.33 69.93 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.233 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.56 ' HB2' HD22 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -89.5 -29.44 18.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.1 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.428 ' C ' HG13 ' A' ' 5' ' ' VAL . . . -110.31 59.05 0.37 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.861 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.666 ' HG3' HG22 ' A' ' 5' ' ' VAL . 7.4 mttp 60.21 97.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.912 0.387 . . . . 0.0 111.618 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -24.66 62.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.507 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 1.9 mt -100.91 123.72 44.4 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-O 120.577 0.227 . . . . 0.0 110.837 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 46' ' ' ILE . 42.7 Cg_exo -56.93 169.04 2.08 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.874 2.382 . . . . 0.0 112.506 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.662 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . . . -139.65 -51.48 0.51 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.621 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.461 ' O ' HD13 ' A' ' 50' ' ' ILE . 7.0 m -110.49 -65.62 1.15 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.783 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 49' ' ' THR . 33.5 mm -138.05 -80.68 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 39.4 t80 63.08 100.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.025 0.44 . . . . 0.0 110.885 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 8.7 t70 -160.83 110.69 1.71 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.565 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.802 ' HD3' HD22 ' A' ' 38' ' ' LEU . 8.0 mttp -104.89 107.35 18.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.542 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.44 141.78 17.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.608 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 36' ' ' ILE . 1.7 mp -121.24 148.69 24.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.196 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -143.99 128.4 17.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.298 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.539 ' CG ' HG21 ' A' ' 34' ' ' ILE . 6.9 p80 -144.18 120.48 10.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.539 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 57' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.764 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 CA--C 1.533 0.449 0 CA-C-O 120.631 0.18 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 17.7 m120 -113.46 144.37 42.93 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.235 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.66 150.79 36.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.976 HG21 HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -133.06 115.87 15.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.844 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CE2' HG22 ' A' ' 70' ' ' THR . 3.2 p90 -156.75 -47.62 0.07 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.583 HG22 ' CE2' ' A' ' 69' ' ' PHE . 14.2 t -129.4 29.08 5.14 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.006 0.431 . . . . 0.0 110.766 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -141.41 159.08 62.09 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.404 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 42.8 Cg_endo -67.45 173.81 8.23 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.908 2.405 . . . . 0.0 112.469 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.736 ' CB ' HG12 ' A' ' 37' ' ' VAL . 20.3 Cg_endo -59.9 -179.3 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.797 2.331 . . . . 0.0 112.688 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.47 157.74 44.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.793 0.33 . . . . 0.0 110.794 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.65 81.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.785 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.71 122.71 51.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.168 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.64 115.53 16.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.491 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -139.34 174.27 10.69 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.05 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.21 124.68 31.1 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.971 0.415 . . . . 0.0 110.977 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.02 -157.05 21.77 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.126 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 13.6 p-90 -82.88 116.59 22.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 111.07 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.451 ' HA3' HD21 ' A' ' 58' ' ' LEU . . . -168.75 -121.79 0.59 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.727 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.754 ' HA2' HD23 ' A' ' 105' ' ' LEU . . . 71.67 101.93 0.06 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.959 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.0 m-85 -162.96 171.04 6.77 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.63 0.252 . . . . 0.0 110.96 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 77.3 Cg_exo -52.01 166.53 0.63 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.045 2.496 . . . . 0.0 113.243 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.707 HD11 ' HB2' ' A' ' 105' ' ' LEU . 4.2 mp -142.92 169.74 17.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.414 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -160.43 138.82 10.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.176 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.783 HG12 HD13 ' A' ' 11' ' ' ILE . 6.4 tp -136.54 128.17 43.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.05 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.8 p -127.06 116.2 20.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.732 HG21 HG21 ' A' ' 9' ' ' ILE . 21.6 t -104.22 120.92 55.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.154 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 13.2 m-85 -126.1 156.02 40.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.736 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.618 HD13 ' CG2' ' A' ' 118' ' ' ILE . 0.8 OUTLIER -145.7 -166.57 2.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.56 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.3 pp -92.06 34.47 1.02 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 111.107 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -165.66 159.07 16.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.329 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.47 47.53 1.19 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.071 0.462 . . . . 0.0 110.772 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -116.25 -37.34 3.81 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.614 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.591 ' H ' HD21 ' A' ' 92' ' ' LEU . . . -118.65 30.68 5.85 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.161 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 16.2 mt-10 -92.57 92.77 8.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.825 0.313 . . . . 0.0 110.451 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -142.23 153.26 43.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.885 0.374 . . . . 0.0 111.817 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' C ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -135.75 146.37 47.57 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.786 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 88' ' ' ILE . 3.7 mp -141.78 122.48 8.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.64 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.06 129.26 4.56 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.866 2.377 . . . . 0.0 112.352 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.29 172.46 6.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.287 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -134.59 138.9 44.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.62 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.754 HD23 ' HA2' ' A' ' 83' ' ' GLY . 0.9 OUTLIER -130.33 84.58 2.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.6 37.31 0.32 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.175 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -141.9 132.03 24.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.13 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -59.88 131.8 51.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 71.58 74.22 0.17 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.441 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.73 131.37 55.0 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.59 61.63 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.292 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -105.6 119.31 38.8 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.534 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 3.2 pt-20 -142.16 139.6 32.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.126 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.564 ' CG1' HD11 ' A' ' 11' ' ' ILE . 5.8 p -131.96 148.97 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.69 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.466 ' HG2' ' HG3' ' A' ' 10' ' ' ARG . 1.2 mp0 -133.01 151.24 52.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.341 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -136.31 127.25 27.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.222 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.83 136.73 26.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.258 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.618 ' CG2' HD13 ' A' ' 92' ' ' LEU . 27.4 mt -121.49 111.22 30.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.58 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.39 117.49 20.67 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.349 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.633 ' N ' HD13 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -147.38 55.75 2.51 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.744 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.349 0.573 0 C-N-CA 122.466 2.111 . . . . 0.0 112.244 179.58 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.462 0.132 0 CA-C-O 120.646 0.26 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.49 119.44 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.654 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HG3' ' HG2' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -137.47 117.25 13.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.35 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.517 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 75.8 mtt180 -139.8 138.73 36.06 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.514 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 t -147.46 111.18 5.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.441 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.981 HD11 HD11 ' A' ' 36' ' ' ILE . 1.3 tt -104.77 118.28 51.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.637 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HD3' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -121.36 120.09 34.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.725 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.554 HG22 ' HB ' ' A' ' 36' ' ' ILE . 9.2 pt -118.7 126.3 75.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 111.33 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.491 ' HD2' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -114.26 130.81 56.65 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.845 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.595 HG23 ' CD1' ' A' ' 34' ' ' ILE . 3.0 m -127.88 118.01 22.85 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -129.29 140.63 51.35 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.986 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.487 HE22 HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -139.92 138.76 35.87 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.759 0.314 . . . . 0.0 111.333 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -137.92 119.73 15.25 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.576 HG23 ' HB3' ' A' ' 30' ' ' ARG . 6.7 mt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.773 0.32 . . . . 0.0 111.149 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG13 ' HA2' ' A' ' 80' ' ' GLY . 21.5 t . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 120.671 0.272 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.576 ' HB3' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -126.71 165.13 19.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.279 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.48 149.35 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -145.18 143.28 30.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.453 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.493 ' O ' HD13 ' A' ' 34' ' ' ILE . 1.6 m -136.12 121.95 19.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.742 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 105' ' ' LEU . 19.9 mm -130.4 117.42 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.622 0.248 . . . . 0.0 111.479 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.462 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 10.9 pt-20 -134.73 149.38 50.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.094 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.981 HD11 HD11 ' A' ' 9' ' ' ILE . 14.0 tt -152.18 130.49 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.207 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.486 HG23 ' HD3' ' A' ' 10' ' ' ARG . 4.3 m -137.24 119.15 18.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.962 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' A' ' 9' ' ' ILE . 52.8 tp -129.7 142.46 50.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.31 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 42' ' ' GLU . 4.3 tt -118.1 152.25 35.95 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.077 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.593 ' N ' HD23 ' A' ' 39' ' ' LEU . 4.7 p-10 -176.87 -30.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.318 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 7.1 p30 -53.91 -27.89 33.4 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.631 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.807 ' HB2' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.02 -33.21 59.66 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.554 0.216 . . . . 0.0 110.589 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.83 -74.33 0.93 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.884 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -129.47 -48.11 1.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 41' ' ' ASP . 17.1 tt0 71.09 7.0 6.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.774 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.718 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.1 pp -126.2 140.4 36.94 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-O 120.733 0.301 . . . . 0.0 111.413 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.63 -171.47 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.985 2.456 . . . . 0.0 112.374 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.7 ' HB3' ' CB ' ' A' ' 93' ' ' LEU . . . -160.81 -64.98 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.391 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.451 ' O ' HD13 ' A' ' 50' ' ' ILE . 17.7 m -96.97 -56.42 2.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.172 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 49' ' ' THR . 48.6 mm -132.84 -85.28 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.839 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 44.3 t80 63.24 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.145 0.498 . . . . 0.0 111.136 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -164.19 102.17 0.86 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.571 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.605 ' CG ' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -97.72 102.96 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.554 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' CD ' ' A' ' 67' ' ' ARG . 8.7 m -103.07 143.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.478 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 ' OG1' ' A' ' 68' ' ' THR . 2.4 mt -125.41 146.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.521 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.03 138.85 28.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.929 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.431 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 18.7 p-80 -163.77 124.36 2.21 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.573 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.79 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.763 0.235 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.485 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 1.7 m-80 -115.14 155.28 27.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.093 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.782 ' CD ' HG12 ' A' ' 54' ' ' VAL . 0.8 OUTLIER -143.68 153.85 42.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 -179.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.868 HG23 ' HD2' ' A' ' 72' ' ' PRO . 45.6 m -138.44 117.21 12.3 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.792 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -125.47 -54.63 1.56 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -89.49 -67.58 0.83 Allowed 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.379 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.478 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 0.3 OUTLIER 179.09 61.06 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.468 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.868 ' HD2' HG23 ' A' ' 68' ' ' THR . 94.8 Cg_endo -93.07 103.33 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.92 2.413 . . . . 0.0 113.207 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 71' ' ' ASP . 86.4 Cg_endo -84.43 178.91 4.78 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.652 2.235 . . . . 0.0 112.382 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -167.94 153.03 6.77 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.62 111.5 0.07 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.968 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 76' ' ' ILE . 6.1 tp -159.62 142.01 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.853 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 14.7 pt-20 -132.27 111.6 11.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.479 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -121.39 168.3 11.82 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.338 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -109.94 176.58 5.01 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.773 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.549 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 110.91 -154.94 16.38 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.168 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -93.17 110.11 21.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 0.0 110.403 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.17 91.67 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.433 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -142.91 111.23 0.65 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.473 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 9.7 m-85 -160.94 168.56 11.47 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 120.613 0.244 . . . . 0.0 111.04 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.34 160.53 26.85 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.064 2.509 . . . . 0.0 112.966 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.082 HD22 HD23 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -150.89 123.05 8.28 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.578 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -127.55 145.89 50.71 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.95 0.405 . . . . 0.0 111.71 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 9' ' ' ILE . 8.9 tt -129.59 118.8 46.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.249 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.435 ' OG ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -119.47 119.59 34.33 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 -179.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.605 HG13 ' CG ' ' A' ' 53' ' ' LYS . 4.5 t -106.26 142.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.096 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -141.09 157.27 45.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.877 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -151.35 -175.74 5.3 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.733 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.7 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -72.63 -20.4 61.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.15 -169.23 1.66 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.496 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 58.35 1.02 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.842 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.51 4.77 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.778 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.445 ' C ' HD21 ' A' ' 92' ' ' LEU . . . -137.7 44.34 1.14 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.991 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -113.36 90.44 3.34 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.884 0.373 . . . . 0.0 111.025 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -142.66 156.59 45.07 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.532 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 5.9 pttm -112.2 140.59 46.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.479 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.463 HG22 ' CE1' ' A' ' 103' ' ' HIS . 2.1 mp -133.34 109.0 12.39 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.667 0.27 . . . . 0.0 111.506 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -88.21 147.39 6.52 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.221 2.614 . . . . 0.0 113.625 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.471 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . 8.7 m-70 -148.58 172.28 14.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.444 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -134.24 129.73 36.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.942 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.082 HD23 HD22 ' A' ' 86' ' ' LEU . 1.3 pp -113.97 100.95 8.8 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.984 0.421 . . . . 0.0 111.244 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -177.87 44.86 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.34 136.42 31.48 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.776 0.322 . . . . 0.0 111.535 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.439 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -61.73 128.95 38.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.637 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 64.45 65.3 0.66 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.26 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -105.18 131.77 52.23 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.813 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.0 p -132.79 66.71 1.55 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.869 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -104.9 119.64 39.49 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.702 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.491 ' CD ' ' HD2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -148.01 143.48 27.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.292 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.552 ' CG1' HD11 ' A' ' 11' ' ' ILE . 2.8 p -141.11 142.77 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.532 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -127.77 146.02 50.72 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.101 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 130.81 40.78 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.7 m -111.66 140.13 32.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.094 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.676 HG22 ' CD1' ' A' ' 120' ' ' ILE . 10.9 mt -139.99 111.79 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.784 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.409 ' HG2' ' HG3' ' A' ' 6' ' ' LYS . 46.7 mt-30 -129.9 107.55 9.46 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.265 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.676 ' CD1' HG22 ' A' ' 118' ' ' ILE . 3.9 mp -137.2 58.31 17.35 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 C--N 1.348 0.523 0 C-N-CA 122.47 2.113 . . . . 0.0 112.62 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.617 0.246 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.508 HG13 ' H ' ' A' ' 120' ' ' ILE . 11.5 p -134.81 119.45 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 111.428 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -123.79 105.11 9.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.599 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.415 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 4.1 mtt180 -118.07 169.66 9.48 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.003 0.43 . . . . 0.0 111.365 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -161.56 125.37 3.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.53 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.3 tt -105.06 118.44 52.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.115 0.484 . . . . 0.0 110.947 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.46 117.53 29.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.053 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.613 ' CD1' HD13 ' A' ' 88' ' ' ILE . 8.5 pt -122.83 128.75 75.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.585 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -119.23 141.89 48.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.402 ' OG1' HD12 ' A' ' 34' ' ' ILE . 5.6 m -137.35 111.06 8.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.151 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.5 mp0 -125.09 129.79 50.95 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.734 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -132.64 143.43 49.66 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.141 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -139.02 119.52 13.91 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.15 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 30' ' ' ARG . 8.2 mt . . . . . 0 C--O 1.232 0.171 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.777 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.571 0.224 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.54 ' HB3' HG23 ' A' ' 17' ' ' ILE . 5.5 ptp180 -133.16 165.12 25.52 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.346 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.01 157.16 33.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.666 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 10.9 p-90 -155.42 142.24 18.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.449 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 p -147.93 117.93 7.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.331 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.437 HD13 HD21 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -133.88 141.25 44.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.585 -179.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -131.39 134.17 46.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.641 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 55' ' ' ILE . 19.5 mt -124.38 106.38 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.643 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 73' ' ' PRO . 18.1 t -118.04 148.44 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.696 0.284 . . . . 0.0 111.387 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.876 HD13 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -159.33 148.59 18.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.323 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 42' ' ' GLU . 1.4 tp -102.72 160.82 14.25 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.255 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -173.76 -44.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.194 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.93 1.48 20.5 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.943 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.617 ' HG3' HD21 ' A' ' 39' ' ' LEU . 15.5 mm-40 -86.42 -36.73 18.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.578 0.228 . . . . 0.0 110.798 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.38 -72.83 0.63 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.683 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HD3' HD13 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -142.31 116.46 9.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.779 0.323 . . . . 0.0 110.836 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.93 35.48 1.26 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.175 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.407 HD13 ' HD3' ' A' ' 44' ' ' LYS . 4.2 mp -131.28 126.63 21.48 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.279 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.01 -174.34 1.9 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.856 2.371 . . . . 0.0 112.475 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.586 ' HB3' ' HG ' ' A' ' 93' ' ' LEU . . . -154.73 -63.69 0.13 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.622 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.525 HG22 HG13 ' A' ' 50' ' ' ILE . 27.2 m -99.07 -65.97 0.93 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.551 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.525 HG13 HG22 ' A' ' 49' ' ' THR . 56.6 mt -128.58 -92.77 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.399 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.434 ' CE1' ' HE2' ' A' ' 53' ' ' LYS . 35.7 t80 62.35 97.82 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.18 0.514 . . . . 0.0 111.399 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -164.5 112.56 1.09 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.062 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.923 ' HG2' HG13 ' A' ' 90' ' ' VAL . 4.8 mtmt -101.89 123.74 46.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.704 HG12 ' HG3' ' A' ' 67' ' ' ARG . 11.4 m -132.29 116.5 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 111.136 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.594 HG13 HG23 ' A' ' 88' ' ' ILE . 3.7 mp -103.24 149.56 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.192 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 65' ' ' PRO . 20.9 m-85 -138.19 119.12 14.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.294 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.474 ' CE1' ' CG2' ' A' ' 55' ' ' ILE . 5.5 m-70 -123.39 116.44 23.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.076 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.519 HD11 HD22 ' A' ' 105' ' ' LEU . 4.2 mp . . . . . 0 N--CA 1.465 0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.918 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 23.5 Cg_exo . . . . . 0 CA--C 1.53 0.315 0 CA-C-O 120.902 0.292 . . . . 0.0 112.649 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.436 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 5.1 m120 -124.71 137.92 54.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.704 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -129.87 146.27 51.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.258 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.67 136.35 37.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.743 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -161.86 -50.04 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.719 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.3 t -159.03 40.36 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.166 0.508 . . . . 0.0 110.663 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.96 157.79 74.68 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.006 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 44.1 Cg_exo -56.43 170.44 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.114 2.543 . . . . 0.0 112.28 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HB3' HG22 ' A' ' 37' ' ' VAL . 19.0 Cg_endo -58.13 171.46 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.959 2.439 . . . . 0.0 112.903 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.36 85.9 2.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.343 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -110.21 130.57 55.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -135.19 125.83 44.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.033 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -129.83 125.25 35.25 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 8.9 mt-10 -152.76 172.98 15.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.377 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -119.17 -179.6 3.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.213 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.97 -156.06 25.06 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.362 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -69.28 130.52 42.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.66 95.2 0.1 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.71 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.06 109.03 0.39 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.908 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.49 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 30.8 m-85 -153.77 164.8 19.44 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 111.105 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 10.8 Cg_endo -54.57 168.73 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.497 2.798 . . . . 0.0 113.981 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.437 HD21 HD13 ' A' ' 34' ' ' ILE . 6.7 mp -134.05 155.74 49.48 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.525 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -158.11 120.94 3.82 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.937 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.613 HD13 ' CD1' ' A' ' 11' ' ' ILE . 2.3 mp -125.22 126.36 70.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.475 ' OG ' HG23 ' A' ' 54' ' ' VAL . 57.4 p -127.98 115.43 18.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.997 0.427 . . . . 0.0 110.917 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.923 HG13 ' HG2' ' A' ' 53' ' ' LYS . 26.1 t -104.36 138.85 27.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.998 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.408 ' C ' HD23 ' A' ' 92' ' ' LEU . 21.1 m-85 -131.44 153.71 49.44 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.75 HD21 ' N ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -148.25 -165.78 2.36 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.023 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.586 ' HG ' ' HB3' ' A' ' 48' ' ' ALA . 7.9 mp -56.5 -62.03 2.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 179.05 50.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.013 0.435 . . . . 0.0 110.701 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -112.03 -154.21 0.54 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.516 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.36 -14.35 20.21 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.644 ' C ' HD21 ' A' ' 92' ' ' LEU . . . -61.52 -22.65 61.75 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.811 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.75 ' N ' HD21 ' A' ' 92' ' ' LEU . 4.4 pt-20 -68.08 84.84 0.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.086 0.47 . . . . 0.0 110.377 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.32 156.75 45.27 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.729 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 89' ' ' SER . 1.7 mtmm -103.07 153.22 20.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.654 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.529 ' O ' HD12 ' A' ' 88' ' ' ILE . 25.5 mt -137.58 99.79 9.4 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.012 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.33 130.94 8.33 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.861 2.374 . . . . 0.0 112.22 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.458 ' CD2' HG22 ' A' ' 101' ' ' ILE . 4.9 m-70 -132.71 167.43 20.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.59 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -134.94 135.12 41.27 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.6 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.519 HD22 HD11 ' A' ' 58' ' ' LEU . 5.8 tp -125.75 84.72 2.31 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.675 0.274 . . . . 0.0 111.314 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -168.63 38.2 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.256 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -140.44 133.96 30.07 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.785 0.326 . . . . 0.0 111.548 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.11 130.64 47.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.829 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 67.0 61.32 0.5 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 6.3 tp10 -96.58 136.84 36.54 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.699 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.7 t -141.11 70.46 1.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.617 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.23 119.25 37.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.184 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.83 154.28 35.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.46 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 t -142.36 152.18 18.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.585 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -134.53 109.24 8.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.65 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -113.11 147.91 36.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.917 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.66 140.74 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.21 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.672 HG23 HD13 ' A' ' 92' ' ' LEU . 2.9 mt -124.52 117.83 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.13 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.75 116.21 19.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.017 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.508 ' H ' HG13 ' A' ' 5' ' ' VAL . 1.7 mp -128.57 53.43 11.16 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.232 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 C--N 1.347 0.463 0 C-N-CA 122.755 2.303 . . . . 0.0 112.246 179.891 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.668 HG22 ' CB ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.603 0.239 . . . . 0.0 110.889 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.4 t -127.18 119.63 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.532 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -137.81 112.85 9.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.358 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.57 ' NH1' HD13 ' A' ' 92' ' ' LEU . 35.0 mtp180 -138.84 167.76 21.29 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.078 0.466 . . . . 0.0 111.871 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -167.6 124.97 1.18 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.675 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.803 HD11 HD11 ' A' ' 36' ' ' ILE . 17.5 tt -108.49 118.98 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.937 0.398 . . . . 0.0 110.983 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG2' ' HG2' ' A' ' 115' ' ' GLU . 58.1 mtp85 -122.89 111.86 17.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.801 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.541 ' CD1' HD13 ' A' ' 88' ' ' ILE . 47.8 pt -106.95 137.2 38.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.015 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -125.16 128.59 48.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.132 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.586 HG23 ' CD1' ' A' ' 34' ' ' ILE . 74.3 m -130.89 124.48 31.25 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.85 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -139.32 143.58 37.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.205 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -137.84 144.46 41.46 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.632 0.253 . . . . 0.0 111.32 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.472 ' N ' ' HG3' ' A' ' 15' ' ' GLN . 15.3 t60 -140.36 119.42 12.75 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.066 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' ' 30' ' ' ARG . 6.8 mt . . . . . 0 N--CA 1.463 0.199 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.741 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.233 0.228 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.496 ' HB3' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -138.03 164.41 29.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.858 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -122.3 149.23 44.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.742 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.452 ' HB2' HD21 ' A' ' 105' ' ' LEU . 14.9 p-90 -148.47 140.2 23.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.039 0.447 . . . . 0.0 111.344 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.2 t -129.94 117.69 20.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.476 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.586 ' CD1' HG23 ' A' ' 13' ' ' THR . 28.7 mm -125.73 127.23 71.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.139 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -147.68 157.47 43.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.809 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.803 HD11 HD11 ' A' ' 9' ' ' ILE . 11.4 tt -155.13 128.42 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.962 0.41 . . . . 0.0 111.518 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 73' ' ' PRO . 22.9 t -119.34 148.49 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.807 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.677 HD12 ' HB ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -160.41 145.47 14.67 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.698 0.285 . . . . 0.0 111.378 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.556 HD21 ' HG3' ' A' ' 42' ' ' GLU . 3.1 tp -103.3 164.16 11.81 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -171.74 -45.67 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.944 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.54 0.48 17.17 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.556 ' HG3' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -82.99 -34.96 26.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.637 0.256 . . . . 0.0 110.651 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.91 -55.86 0.29 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.744 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -162.71 114.05 1.53 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG3' ' HB3' ' A' ' 40' ' ' ASP . 18.1 tt0 -98.66 38.07 1.41 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.987 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.79 134.06 24.51 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.944 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.85 -171.24 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.834 2.356 . . . . 0.0 112.65 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.842 ' HB3' ' CB ' ' A' ' 93' ' ' LEU . . . -165.39 -45.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.444 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.17 -66.03 0.83 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.576 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.3 mm -114.88 -87.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.786 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 49.3 t80 58.79 96.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.897 0.379 . . . . 0.0 111.357 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 6.7 t70 -172.52 110.64 0.23 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.878 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.956 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -102.64 127.07 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.614 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 m -126.2 142.41 42.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.685 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.478 HG12 HD13 ' A' ' 36' ' ' ILE . 2.3 mp -127.4 150.33 33.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.37 144.2 36.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.532 ' HB2' HD12 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -140.39 119.91 13.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.995 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.532 HD12 ' HB2' ' A' ' 57' ' ' HIS . 5.1 mp . . . . . 0 CA--C 1.532 0.253 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.309 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 CA--C 1.53 0.297 0 CA-C-O 120.598 0.166 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.406 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 20.6 m-20 -108.77 151.17 26.58 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.887 0.375 . . . . 0.0 111.074 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.17 155.98 40.78 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.041 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.62 122.63 26.34 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.798 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.452 ' HA ' ' HZ2' ' A' ' 53' ' ' LYS . 16.0 t80 -143.9 -57.02 0.38 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.601 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 t -148.61 34.51 0.78 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.721 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.69 160.27 45.06 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.115 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.42 171.67 10.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.934 2.422 . . . . 0.0 112.434 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.602 ' HB3' HG13 ' A' ' 37' ' ' VAL . 18.7 Cg_endo -58.99 162.55 13.27 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.928 2.419 . . . . 0.0 112.822 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -108.59 156.12 19.88 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.336 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.19 121.38 0.75 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.624 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 76' ' ' ILE . 11.3 tp -158.87 119.89 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.959 0.409 . . . . 0.0 111.329 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -126.86 111.52 14.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.646 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.43 161.73 25.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.81 179.74 3.99 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.957 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.91 -170.25 18.73 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.224 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -66.96 120.51 13.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.797 0.332 . . . . 0.0 111.158 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.93 128.1 0.96 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.907 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.39 107.77 0.26 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.717 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.509 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 16.0 m-85 -153.49 164.52 20.24 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.717 0.294 . . . . 0.0 111.016 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.551 ' O ' HD13 ' A' ' 86' ' ' LEU . 32.3 Cg_exo -59.66 163.43 13.25 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.924 2.416 . . . . 0.0 113.572 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -126.65 166.69 16.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.932 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -155.96 128.69 7.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.173 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.541 HD13 ' CD1' ' A' ' 11' ' ' ILE . 3.4 mp -136.1 116.45 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.654 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 6.7 t -122.82 146.22 47.74 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.214 0.531 . . . . 0.0 111.477 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.956 HG13 ' HG2' ' A' ' 53' ' ' LYS . 3.2 t -123.56 144.29 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.867 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.519 ' HA ' ' HG3' ' A' ' 98' ' ' GLU . 50.3 m-85 -137.24 154.43 50.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.188 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.57 HD13 ' NH1' ' A' ' 7' ' ' ARG . 9.2 tp -152.01 178.1 9.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.842 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -74.07 -30.27 62.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.738 0.304 . . . . 0.0 110.331 179.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -106.89 -159.19 0.69 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.161 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -128.52 74.29 1.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.922 0.392 . . . . 0.0 110.683 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.542 ' HB3' HG23 ' A' ' 118' ' ' ILE . . . -115.16 -50.61 2.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.484 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.75 36.5 1.93 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.746 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.519 ' HG3' ' HA ' ' A' ' 91' ' ' PHE . 22.8 tt0 -88.5 76.36 8.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.513 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -142.72 156.74 45.06 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.689 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -110.32 149.38 30.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.063 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 100' ' ' LYS . 21.9 mm -135.3 113.21 11.22 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.266 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -85.82 153.11 10.01 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.941 2.427 . . . . 0.0 112.473 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.431 ' HB3' HD23 ' A' ' 86' ' ' LEU . 7.1 m170 -144.4 171.39 14.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.061 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.18 143.18 49.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.034 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.774 ' HB2' HD21 ' A' ' 86' ' ' LEU . 9.1 tp -130.61 82.12 2.04 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.838 0.352 . . . . 0.0 111.417 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -170.73 47.25 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.286 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -141.61 132.16 25.4 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 111.725 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -64.96 115.4 5.35 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.763 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.409 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 0.5 OUTLIER 74.86 73.0 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.433 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 40.3 tt0 -108.84 141.05 41.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.567 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.6 p -139.83 75.37 1.51 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.05 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.75 119.79 39.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.344 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.8 145.08 25.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.506 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.406 HG21 HG21 ' A' ' 101' ' ' ILE . 14.2 t -126.6 150.48 32.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.704 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 10' ' ' ARG . 4.7 mt-10 -134.05 109.05 8.7 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.828 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -113.05 140.28 47.97 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.69 136.41 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.436 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.542 HG23 ' HB3' ' A' ' 96' ' ' ALA . 1.8 mp -126.69 111.04 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.37 132.34 45.74 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.985 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 120' ' ' ILE . 2.5 tp -161.6 61.75 1.37 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 121.329 0.585 . . . . 0.0 111.377 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.668 ' CB ' HG22 ' A' ' 4' ' ' THR . 56.2 Cg_endo . . . . . 0 C--N 1.349 0.582 0 C-N-CA 122.739 2.293 . . . . 0.0 112.772 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.635 0.255 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.06 119.06 35.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.965 0.412 . . . . 0.0 110.977 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -137.0 116.33 12.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.192 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.541 ' HA ' HD12 ' A' ' 39' ' ' LEU . 31.8 mtt-85 -132.45 159.04 40.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.368 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -160.56 127.1 4.15 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.841 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.839 HG21 HG21 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.77 122.84 66.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.717 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.588 ' N ' HD13 ' A' ' 9' ' ' ILE . 13.3 mtt180 -124.72 129.03 49.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 88' ' ' ILE . 1.1 pt -127.39 127.14 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.969 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.493 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -120.82 130.26 53.9 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.185 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.616 HG23 ' CD1' ' A' ' 34' ' ' ILE . 84.8 m -133.27 108.52 8.8 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -119.5 143.93 47.29 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.143 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.704 ' HB2' HD12 ' A' ' 105' ' ' LEU . 3.1 tp60 -139.25 142.02 37.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.186 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.438 ' N ' ' HG3' ' A' ' 15' ' ' GLN . 63.4 t-80 -144.91 119.29 9.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.925 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 108' ' ' LEU . 17.7 mt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.974 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.721 0.296 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.45 163.48 29.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.021 0.438 . . . . 0.0 111.526 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.39 153.37 35.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.831 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -153.91 151.8 29.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.595 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 13' ' ' THR . 11.7 t -148.68 119.34 7.49 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.992 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.858 HD11 HD22 ' A' ' 105' ' ' LEU . 25.2 mm -126.25 137.16 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.683 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 9.3 pt-20 -157.51 119.59 3.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.702 0.287 . . . . 0.0 111.482 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.467 ' CD1' HD12 ' A' ' 55' ' ' ILE . 13.6 tt -124.98 127.71 72.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.45 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.76 HG12 ' CB ' ' A' ' 73' ' ' PRO . 34.6 m -129.74 158.36 42.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.478 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.64 HD13 ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -160.09 155.61 25.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.856 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 7' ' ' ARG . 81.4 mt -88.03 168.01 13.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.764 0.316 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.11 -58.7 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.496 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.6 -23.92 67.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.151 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -90.36 -36.65 14.51 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.538 0.208 . . . . 0.0 110.93 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.92 54.55 0.55 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.39 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt 63.79 116.59 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.09 0.471 . . . . 0.0 111.646 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -88.48 31.74 0.81 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.521 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.2 mt -129.69 134.36 26.11 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.774 -0.193 . . . . 0.0 111.132 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.16 173.09 13.52 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.809 2.34 . . . . 0.0 112.36 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -145.48 -70.97 0.26 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.501 ' OG1' HD13 ' A' ' 93' ' ' LEU . 19.0 p -117.77 -74.69 0.6 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.63 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.9 mt -100.96 -85.74 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.534 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 3.3 t80 51.59 95.85 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.128 0.489 . . . . 0.0 111.133 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -171.3 103.78 0.21 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.717 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.937 ' HG2' HG13 ' A' ' 90' ' ' VAL . 5.4 mttt -99.21 114.28 26.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.037 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.863 HG12 ' HA ' ' A' ' 67' ' ' ARG . 27.5 m -128.07 160.76 37.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.749 HG22 ' HB2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -123.4 167.26 17.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.967 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.511 ' N ' HG23 ' A' ' 55' ' ' ILE . 10.7 t80 -134.16 131.59 38.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.241 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.6 ' HD2' HD23 ' A' ' 86' ' ' LEU . 48.2 m170 -129.41 104.94 7.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' A' ' 85' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.315 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.211 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo . . . . . 0 CA--C 1.53 0.296 0 CA-C-O 120.743 0.226 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.749 ' HB2' HG22 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -90.98 146.44 23.86 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.262 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.863 ' HA ' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -142.01 136.76 30.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.515 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.605 ' CG2' HD11 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -130.97 98.96 4.74 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 111.002 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -115.38 -49.58 2.76 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.865 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -146.94 35.08 0.91 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.921 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -130.52 159.73 69.45 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.29 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.26 173.08 3.57 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.063 2.509 . . . . 0.0 112.629 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.76 ' CB ' HG12 ' A' ' 37' ' ' VAL . 30.0 Cg_endo -62.36 174.14 2.9 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.989 2.459 . . . . 0.0 112.77 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -136.38 95.08 3.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.392 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.542 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -121.19 110.33 16.04 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.002 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 75' ' ' ARG . 20.6 mm -134.81 117.31 22.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -129.71 130.15 45.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.128 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -155.56 178.37 10.31 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.702 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.71 131.36 56.79 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.786 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.34 -131.07 2.14 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.03 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -120.27 110.31 16.42 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.16 0.505 . . . . 0.0 111.209 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.17 99.02 0.12 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.439 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -148.83 108.45 0.41 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.514 -0.851 . . . . 0.0 113.236 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -155.82 170.03 9.44 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 122.177 0.191 . . . . 0.0 110.645 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.522 ' HB2' HD13 ' A' ' 58' ' ' LEU . 31.6 Cg_exo -59.2 168.43 4.78 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.854 2.37 . . . . 0.0 112.811 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.784 HD11 ' CB ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -144.24 172.49 12.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.703 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 21.0 t70 -159.83 116.79 2.57 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.897 0.379 . . . . 0.0 111.085 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 11' ' ' ILE . 3.7 mp -108.1 131.57 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.4 p -128.33 119.64 25.46 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.983 0.42 . . . . 0.0 110.551 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.937 HG13 ' HG2' ' A' ' 53' ' ' LYS . 40.7 t -106.53 135.55 44.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.729 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -134.83 150.24 50.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.721 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.066 HD22 HG21 ' A' ' 118' ' ' ILE . 12.2 tp -142.96 -69.55 0.34 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.707 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.501 HD13 ' OG1' ' A' ' 49' ' ' THR . 0.2 OUTLIER -129.4 -76.73 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.541 0.21 . . . . 0.0 111.189 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -137.26 -57.48 0.7 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.289 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 27.1 0.85 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -78.52 -37.64 42.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.74 37.56 0.39 Allowed Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.834 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -90.1 92.39 8.94 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 110.532 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.02 144.32 33.58 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.344 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 130.13 38.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.392 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.01 132.82 21.54 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.527 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 94.7 Cg_endo -79.85 143.58 16.57 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.689 2.259 . . . . 0.0 111.932 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.1 171.91 10.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.01 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -122.54 140.26 52.97 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.657 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.858 HD22 HD11 ' A' ' 34' ' ' ILE . 57.6 tp -140.09 70.01 1.36 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.561 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -174.62 42.8 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -141.61 137.36 31.81 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.463 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.597 HD12 HD12 ' A' ' 17' ' ' ILE . 1.6 mp -50.41 119.75 4.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 58.99 80.64 0.18 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.708 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -111.3 135.09 52.35 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.748 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.5 p -132.57 71.41 1.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.049 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -106.14 119.51 39.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.415 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.5 157.01 33.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.983 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.515 HG23 HD11 ' A' ' 11' ' ' ILE . 3.4 t -139.53 152.32 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.613 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -138.1 109.31 6.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.62 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -113.26 123.94 51.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.021 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 m -103.29 147.22 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.401 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 1.066 HG21 HD22 ' A' ' 92' ' ' LEU . 9.8 mt -137.87 120.65 19.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -129.46 113.49 14.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.864 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.2 pt -146.68 68.03 11.68 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.545 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 CA--C 1.532 0.412 0 C-N-CA 122.571 2.181 . . . . 0.0 112.625 179.859 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.577 0.227 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 t -130.29 119.01 45.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.779 0.323 . . . . 0.0 111.389 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -137.62 122.61 19.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.465 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.441 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -134.33 167.37 20.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.204 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 2.3 t -172.56 129.15 0.54 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.444 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.014 HG21 HG21 ' A' ' 90' ' ' VAL . 1.2 tt -109.26 118.3 56.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.54 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.31 114.18 16.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.942 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 36' ' ' ILE . 1.1 pt -118.38 126.67 75.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 113.58 26.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.989 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.634 HG23 ' CD1' ' A' ' 34' ' ' ILE . 85.4 m -119.47 96.36 5.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.193 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -125.4 147.89 49.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.09 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -133.61 165.43 24.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.0 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.433 ' CD2' ' HG3' ' A' ' 109' ' ' GLN . 22.9 t-160 -163.39 119.82 1.77 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.203 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.508 HG12 ' HA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.982 0.42 . . . . 0.0 111.506 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.589 0.233 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HA ' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -93.53 155.21 17.45 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.736 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 1.6 mt-30 -117.42 107.0 13.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.708 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.431 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 57.5 p-90 -100.93 158.86 15.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.665 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.454 ' O ' HD13 ' A' ' 34' ' ' ILE . 15.3 t -144.77 117.64 8.77 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.634 ' CD1' HG23 ' A' ' 13' ' ' THR . 17.7 mm -122.88 138.79 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.618 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.16 127.84 13.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.658 HG21 ' CD1' ' A' ' 55' ' ' ILE . 8.6 mt -119.5 106.41 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.342 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 73' ' ' PRO . 21.6 t -118.01 150.14 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.83 0.348 . . . . 0.0 111.627 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.821 HD13 ' HD3' ' A' ' 53' ' ' LYS . 1.1 pp -166.95 148.2 5.9 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.276 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 7.1 mt -76.95 162.84 27.25 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.329 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -166.27 -59.5 0.03 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.956 0.408 . . . . 0.0 110.393 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -58.86 -31.0 68.14 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.314 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -92.15 -29.97 16.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.72 47.75 2.29 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.709 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 mttm 57.1 94.76 0.02 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 111.156 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.28 -28.84 60.06 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.29 120.56 77.3 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.051 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HB3' ' CD2' ' A' ' 51' ' ' PHE . 73.2 Cg_endo -75.6 -171.89 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.591 2.194 . . . . 0.0 112.545 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.84 -55.1 0.46 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.342 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -120.73 -60.49 1.66 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.631 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.9 mm -116.93 -84.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.912 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 47' ' ' PRO . 73.8 t80 58.85 95.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.899 0.381 . . . . 0.0 111.391 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -176.68 151.79 0.94 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.71 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.821 ' HD3' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -133.15 111.57 11.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.518 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.482 HG13 ' CG ' ' A' ' 67' ' ' ARG . 21.6 t -112.12 149.29 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.0 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.665 HG23 HG13 ' A' ' 88' ' ' ILE . 4.1 mp -135.0 154.79 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.662 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.1 150.9 38.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 111.408 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.404 ' ND1' HD21 ' A' ' 86' ' ' LEU . 12.6 m-70 -135.49 115.33 13.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.502 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 85' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.312 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.297 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 C--O 1.233 0.262 0 CA-C-O 120.695 0.206 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -106.86 131.03 54.41 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.18 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.482 ' CG ' HG13 ' A' ' 54' ' ' VAL . 3.8 mtt85 -145.1 131.12 19.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.777 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.25 103.05 8.92 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 111.327 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -104.34 -53.87 2.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.322 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -156.25 35.65 0.33 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.82 165.44 13.97 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.85 157.65 27.72 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.77 2.314 . . . . 0.0 112.423 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HB2' HG22 ' A' ' 37' ' ' VAL . 55.3 Cg_endo -70.05 154.37 66.64 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.609 2.206 . . . . 0.0 112.48 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.87 146.31 25.03 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.406 ' H ' HD12 ' A' ' 76' ' ' ILE . 2.4 tpt180 -171.8 80.8 0.06 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.754 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.406 HD12 ' H ' ' A' ' 75' ' ' ARG . 3.9 mp -141.36 143.2 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.108 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -135.41 130.4 34.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 1.3 mt-10 -137.42 166.2 24.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.912 0.386 . . . . 0.0 111.398 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -100.23 126.58 46.54 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.59 -169.0 33.16 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.732 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -115.34 110.18 19.0 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.661 0.267 . . . . 0.0 110.551 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.88 128.51 1.26 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.458 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.4 95.96 0.15 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.211 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 87.6 m-85 -142.08 165.73 25.82 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-O 120.553 0.216 . . . . 0.0 111.072 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 86' ' ' LEU . 76.2 Cg_exo -50.47 165.95 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.992 2.461 . . . . 0.0 113.367 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 85' ' ' PRO . 1.1 mp -146.51 165.75 28.52 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.882 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -157.38 134.94 10.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.277 0.56 . . . . 0.0 111.128 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.665 HG13 HG23 ' A' ' 55' ' ' ILE . 3.8 mp -128.94 127.19 65.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.884 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.7 p -118.05 137.48 52.88 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.005 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 9' ' ' ILE . 3.9 t -123.8 132.72 70.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.333 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.48 158.87 37.18 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.654 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.741 ' CD1' ' HB3' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -145.65 -49.24 0.23 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.106 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.89 -83.54 0.07 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.01 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.32 -79.49 0.59 Allowed 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 120.562 0.22 . . . . 0.0 111.224 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.75 32.71 1.04 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 111.61 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.741 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -77.29 -39.7 47.07 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.89 0.376 . . . . 0.0 110.361 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.674 ' C ' HD21 ' A' ' 92' ' ' LEU . . . -148.18 24.43 1.41 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.619 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 5.0 tt0 -77.63 103.15 7.39 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.713 0.257 . . . . 0.0 110.386 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.49 155.32 45.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.057 0.456 . . . . 0.0 112.032 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.96 138.24 54.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.137 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.975 HG13 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -132.17 110.45 14.07 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.629 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.49 160.76 28.59 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.639 2.226 . . . . 0.0 112.326 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.527 ' CE1' HG13 ' A' ' 114' ' ' VAL . 2.5 m-70 -144.07 170.18 16.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -134.24 95.45 3.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.423 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.686 HD12 ' OE1' ' A' ' 110' ' ' GLU . 15.8 tp -77.99 121.98 24.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.353 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.2 -179.42 5.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.084 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -107.83 166.47 10.68 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.592 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.48 ' HA ' HG22 ' A' ' 17' ' ' ILE . 1.9 tp 77.2 60.32 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.137 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.433 ' HG3' ' CD2' ' A' ' 16' ' ' HIS . 8.9 mt-30 66.11 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.541 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.686 ' OE1' HD12 ' A' ' 105' ' ' LEU . 45.0 tt0 -130.82 147.15 52.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.086 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -140.74 74.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.572 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -117.64 119.29 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.91 157.37 23.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.53 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.975 HG21 HG13 ' A' ' 101' ' ' ILE . 29.7 m -137.68 158.11 33.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.312 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -142.93 109.02 5.21 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.348 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.37 150.11 33.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.1 p -124.36 134.9 65.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.202 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.727 ' CG2' HD13 ' A' ' 92' ' ' LEU . 3.4 mp -131.98 111.19 17.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.65 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -129.7 139.44 51.35 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.187 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 120' ' ' ILE . 6.5 tp -169.05 72.19 0.74 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 121.369 0.604 . . . . 0.0 111.144 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 C--N 1.347 0.457 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.818 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.567 0.222 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.856 HG22 ' HG2' ' A' ' 44' ' ' LYS . 16.6 t -130.83 119.34 45.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.889 0.376 . . . . 0.0 111.018 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -133.64 110.95 10.22 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.742 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 15.1 mtt85 -126.44 161.65 27.41 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.352 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 2.3 t -170.47 116.92 0.51 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.59 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.865 HD11 HD11 ' A' ' 36' ' ' ILE . 7.8 tt -103.41 118.06 49.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 121.023 0.44 . . . . 0.0 110.93 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -118.09 112.11 19.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.477 HG22 ' CG1' ' A' ' 36' ' ' ILE . 40.1 pt -113.63 133.51 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.31 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -128.77 125.33 37.62 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.954 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -130.89 103.87 6.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -117.64 146.38 43.72 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.169 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.634 ' HG2' ' HA ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -146.04 148.26 32.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.887 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.43 ' HA ' ' H ' ' A' ' 109' ' ' GLN . 0.6 OUTLIER -162.9 120.37 1.97 Allowed 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.655 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 107' ' ' PHE . 24.8 mt . . . . . 0 N--CA 1.465 0.323 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.667 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 m . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.587 0.232 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 1.1 ptt-85 -131.3 160.37 35.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.069 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -100.17 160.08 14.61 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.855 0.36 . . . . 0.0 111.079 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.1 p-90 -159.4 151.58 20.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.613 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -148.36 118.11 7.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.696 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tp -124.9 137.04 58.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.926 0.393 . . . . 0.0 111.573 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.413 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -157.67 149.54 22.1 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.786 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.936 HG21 HD13 ' A' ' 55' ' ' ILE . 12.5 tt -156.61 132.51 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.025 0.441 . . . . 0.0 111.331 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.81 HG12 ' CB ' ' A' ' 73' ' ' PRO . 35.3 m -130.39 159.04 42.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.975 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.58 HD12 ' HB ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER -164.49 145.21 7.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 111.475 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.769 HD21 ' HG3' ' A' ' 42' ' ' GLU . 2.7 tp -97.57 155.16 17.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.378 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.06 -46.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.973 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -78.23 2.61 17.73 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.378 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.769 ' HG3' HD21 ' A' ' 39' ' ' LEU . 8.9 mm-40 -82.24 -27.9 32.21 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.495 0.188 . . . . 0.0 110.781 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.26 -59.08 0.13 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.167 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.856 ' HG2' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -153.05 119.56 5.6 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.777 0.322 . . . . 0.0 111.453 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.19 30.41 4.17 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.957 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.43 134.44 21.21 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.177 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 36.4 Cg_endo -65.75 -44.93 7.23 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.664 2.243 . . . . 0.0 112.769 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 66.57 -76.05 0.05 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.52 0.328 . . . . 0.0 111.798 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.405 HG22 ' CD1' ' A' ' 50' ' ' ILE . 91.4 m -104.02 -69.61 0.8 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.565 0.221 . . . . 0.0 110.977 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.405 ' CD1' HG22 ' A' ' 49' ' ' THR . 2.5 mp -122.77 -81.81 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.772 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 47' ' ' PRO . 5.5 t80 62.48 101.62 0.03 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.296 0.57 . . . . 0.0 110.953 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 35.1 t70 -166.75 111.54 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.848 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.74 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -116.28 126.34 53.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.211 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.582 HG23 ' HD3' ' A' ' 67' ' ' ARG . 14.2 p -122.3 152.48 26.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.884 0.373 . . . . 0.0 111.588 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.936 HD13 HG21 ' A' ' 36' ' ' ILE . 2.1 mt -130.98 131.3 64.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.374 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.59 144.07 51.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.696 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.6 p80 -147.57 119.85 8.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.0 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.603 HD11 HD22 ' A' ' 105' ' ' LEU . 4.9 mp . . . . . 0 CA--C 1.53 0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.677 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo . . . . . 0 CA--C 1.53 0.295 0 CA-C-O 120.603 0.168 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.495 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 3.4 m120 -128.24 145.61 50.99 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.836 0.35 . . . . 0.0 111.158 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.582 ' HD3' HG23 ' A' ' 54' ' ' VAL . 3.2 mmm-85 -141.81 153.37 44.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.69 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 4.3 m -130.71 119.07 21.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.849 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.752 ' CD2' HG22 ' A' ' 70' ' ' THR . 3.1 p90 -164.13 -49.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.584 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.752 HG22 ' CD2' ' A' ' 69' ' ' PHE . 14.8 t -152.02 32.12 0.54 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.648 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.27 161.89 24.81 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.16 166.83 28.51 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.765 2.31 . . . . 0.0 112.653 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.81 ' CB ' HG12 ' A' ' 37' ' ' VAL . 55.5 Cg_endo -70.37 138.68 36.43 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.876 2.384 . . . . 0.0 112.639 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -93.37 148.57 21.94 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.146 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -171.69 84.1 0.08 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.72 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 mt -134.91 134.28 53.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.495 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -134.51 137.73 44.1 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.831 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.15 -177.59 6.01 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.82 125.14 48.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.595 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.95 -162.83 16.84 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.588 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -122.82 110.89 16.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.0 0.429 . . . . 0.0 110.942 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.61 124.5 0.76 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.954 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.662 ' HA2' HD23 ' A' ' 105' ' ' LEU . . . -144.93 107.06 0.42 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.274 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.415 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 11.0 m-85 -141.59 167.47 16.9 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.67 0.271 . . . . 0.0 111.367 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.9 171.85 0.94 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.24 2.627 . . . . 0.0 113.733 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 105' ' ' LEU . 5.1 mp -139.37 166.05 25.58 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.563 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -155.0 114.6 3.71 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.728 0.299 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.7 mp -124.19 120.45 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.623 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.05 149.37 42.29 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.853 0.359 . . . . 0.0 111.094 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.74 HG13 ' HG2' ' A' ' 53' ' ' LYS . 3.7 t -131.08 131.38 63.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.222 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 54.2 m-85 -142.54 144.17 32.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.174 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.77 -54.01 1.15 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.396 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -179.64 -44.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.758 0.313 . . . . 0.0 110.895 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.76 -174.61 2.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.917 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.05 71.26 3.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 111.356 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.06 -50.86 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.577 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -145.65 33.14 1.56 Allowed Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.455 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HB2' ' CD1' ' A' ' 91' ' ' PHE . 3.2 pt-20 -102.09 103.0 13.55 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.792 0.329 . . . . 0.0 110.786 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.34 151.18 41.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 2.0 mtmt -104.52 124.92 50.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.337 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.43 114.05 29.0 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.684 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.6 151.94 15.12 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.874 2.382 . . . . 0.0 111.907 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.467 ' HB3' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -136.64 171.35 14.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 111.398 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -133.86 128.96 35.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.54 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.693 ' HB2' HD11 ' A' ' 86' ' ' LEU . 4.4 tp -108.1 106.35 16.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.777 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.99 168.11 14.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.147 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.634 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 9.3 p90 -94.9 165.61 12.37 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.419 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tp 84.45 62.59 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.341 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.43 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 1.3 tm0? 65.4 111.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.648 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.35 128.82 34.45 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.831 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.9 p -127.41 66.1 1.31 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.714 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' A' ' 103' ' ' HIS . 5.0 m-85 -108.48 119.42 39.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.561 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.37 152.87 20.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.372 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.9 t -139.65 149.16 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.651 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -135.16 108.87 8.01 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.484 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.36 146.24 39.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.121 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.56 128.71 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.176 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 3.5 mp -121.5 111.21 30.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -123.03 122.78 39.35 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.1 pp -148.23 68.58 10.37 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 121.082 0.468 . . . . 0.0 111.347 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 C--N 1.346 0.436 0 C-N-CA 122.635 2.223 . . . . 0.0 112.41 179.853 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.76 119.46 51.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -138.04 117.68 13.06 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.502 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -143.08 169.2 18.03 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.587 HG22 HD23 ' A' ' 39' ' ' LEU . 9.8 t -172.39 133.58 0.65 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.427 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 9' ' ' ILE . 9.5 tp -109.11 118.39 56.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.032 0.444 . . . . 0.0 111.022 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -124.89 108.21 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.79 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.873 HG12 HD13 ' A' ' 88' ' ' ILE . 1.8 pp -118.58 128.95 75.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.066 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 2.6 mptp? -115.49 125.28 52.86 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.651 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.749 HG23 ' CD1' ' A' ' 34' ' ' ILE . 97.5 m -130.06 127.2 39.41 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -138.96 158.82 43.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.912 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' NE2' ' HG ' ' A' ' 105' ' ' LEU . 1.4 tt0 -153.11 144.28 23.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.757 0.313 . . . . 0.0 111.275 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.414 ' HA ' ' H ' ' A' ' 109' ' ' GLN . 14.0 m-70 -142.18 119.23 11.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.864 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 4.8 mt . . . . . 0 C--O 1.233 0.193 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.913 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 121.014 0.435 . . . . 0.0 111.968 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.439 ' CB ' HG12 ' A' ' 17' ' ' ILE . 1.1 ptt-85 -117.74 161.58 19.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.319 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.06 156.44 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.665 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -154.55 137.55 15.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.155 0.503 . . . . 0.0 111.567 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.7 t -134.83 117.21 15.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.934 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.749 ' CD1' HG23 ' A' ' 13' ' ' THR . 6.9 mm -128.94 142.76 43.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.945 0.402 . . . . 0.0 111.605 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.477 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 11.4 pt-20 -151.63 143.62 23.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.633 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.69 HG12 HG21 ' A' ' 55' ' ' ILE . 3.8 mp -128.66 133.61 66.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.01 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.495 ' C ' HD13 ' A' ' 38' ' ' LEU . 20.2 t -141.52 129.45 22.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.911 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.556 ' CD1' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -156.35 176.93 12.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.668 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.587 HD23 HG22 ' A' ' 8' ' ' THR . 3.8 mm? -104.96 162.52 13.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.216 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 1.1 m-20 -155.26 -59.57 0.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.42 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -77.69 -10.13 59.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.63 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -92.58 -27.8 17.13 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.77 45.6 1.2 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.444 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.98 103.76 0.07 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.006 0.431 . . . . 0.0 111.29 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 41' ' ' ASP . 1.2 tm-20 -96.83 35.57 1.52 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.258 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.608 ' O ' HD11 ' A' ' 93' ' ' LEU . 2.0 mp -119.53 102.35 47.81 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.55 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.55 151.66 58.97 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.842 2.361 . . . . 0.0 112.664 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.31 -69.82 0.3 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.158 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.486 ' HB ' HD12 ' A' ' 50' ' ' ILE . 8.1 p -83.79 -58.12 2.93 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.759 0.314 . . . . 0.0 110.421 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.564 HD13 ' HE3' ' A' ' 95' ' ' LYS . 4.9 mp -130.91 -86.39 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.634 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 46.3 t80 46.43 89.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.007 0.432 . . . . 0.0 111.703 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -175.58 134.22 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.663 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.593 ' HG2' HG13 ' A' ' 90' ' ' VAL . 1.4 mttt -119.86 149.73 41.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 110.675 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.663 HG13 ' HD2' ' A' ' 67' ' ' ARG . 11.3 t -141.51 116.38 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.561 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.88 HG23 HG22 ' A' ' 88' ' ' ILE . 1.8 mp -103.98 138.52 28.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.22 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -132.28 139.4 48.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.842 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.619 ' ND1' HG21 ' A' ' 34' ' ' ILE . 3.0 p-80 -154.66 117.41 4.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.172 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.594 ' HB3' HD22 ' A' ' 105' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.504 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 C--O 1.235 0.357 0 CA-C-O 120.801 0.25 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.512 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -123.91 138.81 54.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.441 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.663 ' HD2' HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -141.76 126.12 17.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.58 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 1.7 m -105.96 104.98 14.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.935 0.398 . . . . 0.0 111.373 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -134.0 -55.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.048 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -146.02 33.76 1.01 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.106 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.01 159.71 63.3 Favored Pre-proline 0 N--CA 1.466 0.365 0 CA-C-O 120.762 0.315 . . . . 0.0 111.61 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -76.57 175.78 10.92 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.227 2.618 . . . . 0.0 112.58 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.444 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . 48.0 Cg_exo -56.09 175.25 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.875 2.383 . . . . 0.0 112.739 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -137.43 160.79 38.11 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.21 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -176.98 104.09 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.483 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.479 HD11 ' CD2' ' A' ' 74' ' ' PHE . 3.7 mp -139.65 132.7 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.045 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.67 122.95 24.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -137.28 167.56 21.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.601 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.1 173.37 6.42 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.778 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.67 -129.1 7.86 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.31 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -117.12 110.44 18.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.792 0.329 . . . . 0.0 110.627 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.2 88.71 0.09 OUTLIER Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.221 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -136.0 103.77 0.46 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.519 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.424 ' CD2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -150.78 168.18 11.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 120.486 0.184 . . . . 0.0 110.766 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.424 ' HD2' ' CD2' ' A' ' 84' ' ' PHE . 53.2 Cg_exo -56.91 173.34 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.973 2.449 . . . . 0.0 113.675 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 105' ' ' LEU . 3.3 mp -140.24 160.58 39.64 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.559 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -158.18 115.52 2.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.169 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.88 HG22 HG23 ' A' ' 55' ' ' ILE . 3.9 pt -113.82 105.21 18.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.242 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.4 p -112.37 136.99 51.17 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.01 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.593 HG13 ' HG2' ' A' ' 53' ' ' LYS . 5.7 t -131.62 119.27 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.344 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.586 ' C ' HD23 ' A' ' 92' ' ' LEU . 16.5 m-85 -125.59 155.96 39.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.947 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.677 HD11 HG21 ' A' ' 118' ' ' ILE . 0.2 OUTLIER -149.67 -171.44 3.9 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.765 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.608 HD11 ' O ' ' A' ' 46' ' ' ILE . 3.7 mt -77.26 136.43 38.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.832 0.348 . . . . 0.0 111.593 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 67.55 10.76 7.98 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.208 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.564 ' HE3' HD13 ' A' ' 50' ' ' ILE . 4.8 mmpt? 51.32 75.06 0.21 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.518 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.836 ' HB1' HG13 ' A' ' 120' ' ' ILE . . . -108.03 -28.14 9.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.965 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.444 ' N ' HD11 ' A' ' 92' ' ' LEU . . . -131.31 34.54 2.59 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.722 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.85 98.96 0.3 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.643 0.258 . . . . 0.0 110.602 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -141.86 125.86 17.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.361 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 2.0 pttp -131.07 132.84 45.16 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.736 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -137.21 119.66 11.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.507 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -87.16 149.87 8.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.925 2.416 . . . . 0.0 112.607 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 58.6 m80 -139.95 172.35 12.89 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.117 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.61 144.97 49.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.818 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.704 ' HB2' HD11 ' A' ' 86' ' ' LEU . 2.5 tp -127.37 88.35 2.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.795 0.331 . . . . 0.0 111.461 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -167.94 39.2 0.04 OUTLIER 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.432 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -141.62 124.88 16.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.391 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -56.74 130.01 43.69 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.69 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.414 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER 71.02 68.98 0.17 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.594 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -102.92 135.64 44.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.545 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.5 p -140.72 67.22 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.82 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -113.42 119.82 38.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.656 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.7 137.14 16.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.398 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.3 t -116.67 146.94 20.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.986 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -132.78 108.64 9.12 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.878 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.69 148.69 37.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.084 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.2 p -124.25 148.94 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.623 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.677 HG21 HD11 ' A' ' 92' ' ' LEU . 11.1 mt -133.94 110.88 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.444 ' O ' HD13 ' A' ' 120' ' ' ILE . 29.5 tt0 -130.3 104.5 7.31 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.401 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.836 HG13 ' HB1' ' A' ' 96' ' ' ALA . 21.2 mm -136.98 56.38 12.56 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 120.998 0.428 . . . . 0.0 111.473 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 C--N 1.348 0.508 0 C-N-CA 122.556 2.171 . . . . 0.0 112.468 179.614 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.753 0.311 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 7.2 p -140.79 127.81 21.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.275 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.03 110.36 19.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.163 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.557 ' NE ' HD13 ' A' ' 92' ' ' LEU . 39.0 mtp85 -109.24 157.22 19.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.269 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 t -165.94 124.95 1.61 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.469 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.4 tt -108.67 118.2 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 110.769 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' O ' HG22 ' A' ' 37' ' ' VAL . 22.6 mtp180 -125.24 131.08 53.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.607 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.912 HG21 HD13 ' A' ' 88' ' ' ILE . 1.3 pt -127.35 129.84 70.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.142 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.69 112.4 25.46 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.23 113.8 20.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -135.61 154.33 51.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.738 0.304 . . . . 0.0 111.166 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.62 138.17 23.22 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.267 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -135.2 119.43 17.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.967 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 30' ' ' ARG . 8.0 mt . . . . . 0 N--CA 1.462 0.137 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.738 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.936 0.398 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.526 ' HB3' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -116.83 162.12 18.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.446 ' CG ' ' HB3' ' A' ' 79' ' ' GLN . 2.6 mt-30 -124.2 159.83 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -158.47 160.61 36.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.262 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.1 p -146.73 121.91 10.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.523 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.4 tp -126.4 124.21 65.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.962 0.411 . . . . 0.0 110.949 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -127.2 135.81 51.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.632 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.759 HG21 HG13 ' A' ' 55' ' ' ILE . 8.0 mt -123.91 105.89 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.917 HG12 ' HB3' ' A' ' 73' ' ' PRO . 27.1 m -119.72 149.1 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.84 0.352 . . . . 0.0 111.6 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.5 HD21 ' CB ' ' A' ' 68' ' ' THR . 2.6 pp -172.04 151.89 2.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.265 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -108.05 162.51 13.98 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.514 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -174.19 -47.71 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.396 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -86.04 2.72 45.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -24.93 24.63 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 5' ' ' VAL . . . -112.35 -74.82 0.71 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.342 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.542 ' HD3' HD12 ' A' ' 46' ' ' ILE . 7.0 mmtp -87.98 -56.55 3.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 64.95 16.77 10.73 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.239 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.542 HD12 ' HD3' ' A' ' 44' ' ' LYS . 5.6 mt -109.86 140.99 22.8 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.033 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.56 174.41 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.94 2.427 . . . . 0.0 112.633 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB1' ' HG ' ' A' ' 93' ' ' LEU . . . -155.29 -164.49 1.78 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.375 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -66.9 -47.8 70.7 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.431 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.43 -86.28 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.623 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 29.3 t80 53.29 92.84 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.102 0.477 . . . . 0.0 111.384 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 2.8 t70 -172.43 116.22 0.33 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.696 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.523 ' CG ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -99.83 125.55 45.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.59 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.747 HG12 ' HG3' ' A' ' 67' ' ' ARG . 36.0 m -122.78 132.26 71.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.959 0.409 . . . . 0.0 111.56 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.759 HG13 HG21 ' A' ' 36' ' ' ILE . 1.3 mm -123.11 140.22 47.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.932 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -143.81 97.88 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.548 ' HD2' HD12 ' A' ' 58' ' ' LEU . 26.5 p-80 -111.45 125.99 54.47 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.93 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.698 HD21 HD23 ' A' ' 105' ' ' LEU . 1.1 mt . . . . . 0 N--CA 1.463 0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.364 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--O 1.233 0.237 0 CA-C-O 120.8 0.25 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.42 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 7.2 m-80 -96.79 130.64 44.01 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.747 ' HG3' HG12 ' A' ' 54' ' ' VAL . 1.5 mpp_? -145.61 112.63 6.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.61 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.5 ' CB ' HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -93.86 131.56 39.14 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -140.51 -54.05 0.51 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.603 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.95 36.48 0.4 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.741 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.19 163.35 34.32 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.01 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.85 171.66 2.72 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.865 2.377 . . . . 0.0 112.415 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.917 ' HB3' HG12 ' A' ' 37' ' ' VAL . 36.5 Cg_endo -64.89 169.43 11.77 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.632 2.221 . . . . 0.0 112.621 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.522 ' HB2' HD12 ' A' ' 36' ' ' ILE . 15.0 m-85 -117.06 64.26 0.72 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.713 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.54 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 24.4 tpt180 -82.81 90.74 6.95 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.776 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 74' ' ' PHE . 1.8 mp -126.84 131.82 70.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.388 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -136.65 123.24 20.97 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.536 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -133.79 177.91 7.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.579 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.446 ' HB3' ' CG ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -129.87 -179.22 5.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.066 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.49 -148.74 17.3 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.967 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.85 110.17 16.88 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.811 0.339 . . . . 0.0 110.861 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.07 -117.96 0.55 Allowed Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.118 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.11 114.79 2.32 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.679 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.452 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.0 m-85 -165.42 168.49 8.2 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 120.546 0.212 . . . . 0.0 110.976 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.489 ' C ' HD12 ' A' ' 86' ' ' LEU . 37.1 Cg_endo -65.81 -177.44 0.76 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.981 2.454 . . . . 0.0 113.014 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 105' ' ' LEU . 5.4 mp -146.15 166.08 27.25 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.751 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -158.71 123.63 4.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.783 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.912 HD13 HG21 ' A' ' 11' ' ' ILE . 33.9 mt -129.25 112.49 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.009 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.22 116.02 24.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.685 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.523 HG23 ' CG ' ' A' ' 53' ' ' LYS . 1.2 p -104.7 143.32 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.314 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 27.5 m-85 -133.26 155.78 48.76 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.524 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.623 HD23 ' HB3' ' A' ' 96' ' ' ALA . 4.6 tp -142.2 -63.17 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.731 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.568 ' HG ' ' HB1' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -144.6 -68.7 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.313 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -146.62 -63.49 0.3 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.359 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 51.53 1.2 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 111.185 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.623 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -104.41 -36.98 7.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.416 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . 180.0 46.04 0.08 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.535 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.426 ' CB ' ' HA ' ' A' ' 91' ' ' PHE . 11.4 pt-20 -111.34 111.02 21.77 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.08 0.467 . . . . 0.0 110.745 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.454 ' H ' HG12 ' A' ' 90' ' ' VAL . 5.4 ttt180 -142.29 151.79 42.35 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.303 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 0.2 OUTLIER -117.35 127.79 54.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.381 179.172 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.424 HG23 ' CE1' ' A' ' 103' ' ' HIS . 3.7 tt -139.24 121.42 10.21 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 121.024 0.44 . . . . 0.0 111.921 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.56 160.5 9.4 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.916 2.41 . . . . 0.0 112.393 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 38.1 m80 -144.69 172.21 13.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -124.33 145.04 49.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.115 0.483 . . . . 0.0 111.053 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.698 HD23 HD21 ' A' ' 58' ' ' LEU . 6.2 tp -139.16 78.63 1.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.378 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -161.82 38.94 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.367 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -141.47 130.39 23.12 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.168 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 2.4 pp -59.86 131.51 51.1 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.467 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.32 62.97 0.36 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.658 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -103.33 134.65 46.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.649 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.1 t -134.14 71.79 1.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.16 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.73 119.17 38.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.709 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -143.08 141.93 31.4 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.205 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 31.9 t -127.81 145.02 35.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -140.73 108.35 5.61 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.468 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.49 138.85 49.53 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.106 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.5 m -104.5 140.9 21.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.498 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 10.0 mt -138.05 111.08 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.36 119.1 35.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.649 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.401 HG12 HD21 ' A' ' 92' ' ' LEU . 1.2 mp -125.07 52.13 6.01 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.748 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 C--N 1.347 0.494 0 C-N-CA 122.488 2.125 . . . . 0.0 112.637 179.764 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.872 0.367 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -129.14 119.09 48.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.808 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -137.41 104.96 5.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.586 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -125.4 165.57 18.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.956 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.5 t -172.99 139.56 0.84 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.09 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.553 HG21 HG21 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -109.99 118.2 56.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.47 179.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.8 mtt85 -124.78 105.3 9.18 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.621 HG21 ' CD1' ' A' ' 88' ' ' ILE . 2.2 pt -112.51 134.09 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.052 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.623 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -118.41 141.59 48.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.27 -179.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -138.55 109.75 6.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.081 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -120.97 136.68 54.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.502 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.516 ' HG3' HD21 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -140.06 150.43 44.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.671 0.272 . . . . 0.0 111.691 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -147.64 119.66 8.22 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.41 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.452 HG13 ' OE1' ' A' ' 15' ' ' GLN . 14.5 mt . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.972 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.874 HG13 ' HA2' ' A' ' 80' ' ' GLY . 25.5 t . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.5 0.191 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -109.42 163.55 13.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.311 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -134.05 111.02 10.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.571 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.437 ' HB3' ' HG3' ' A' ' 15' ' ' GLN . 23.3 p-90 -116.1 150.21 37.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.307 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -140.1 147.27 40.0 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 12' ' ' LYS . 5.7 tp -146.48 135.32 16.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.487 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 3.7 pm0 -134.97 144.57 47.47 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.822 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.445 HG21 ' CD1' ' A' ' 55' ' ' ILE . 4.2 mp -121.32 107.07 19.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.889 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.72 138.36 34.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.245 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.026 HD21 HG21 ' A' ' 68' ' ' THR . 0.6 OUTLIER -166.18 160.08 15.8 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.527 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -105.02 161.85 13.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -151.64 -63.17 0.18 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.678 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.09 -19.54 65.88 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.514 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -86.65 -32.66 20.43 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.196 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.57 48.08 0.97 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.28 106.31 0.04 OUTLIER 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.983 0.42 . . . . 0.0 111.3 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.24 16.34 6.38 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.932 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.1 mt -125.47 104.58 28.06 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-O 120.515 0.198 . . . . 0.0 111.409 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HA ' HD11 ' A' ' 93' ' ' LEU . 74.2 Cg_endo -75.33 -170.5 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.799 2.333 . . . . 0.0 112.556 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.83 -45.87 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.879 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.433 ' HB ' HD12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -93.65 -67.79 0.84 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.791 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.475 HD13 ' HD3' ' A' ' 95' ' ' LYS . 4.3 mp -133.38 -89.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.032 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 40.3 t80 58.72 100.14 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.2 0.524 . . . . 0.0 110.864 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.8 110.36 1.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.844 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.724 ' HD3' HD13 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -100.98 102.59 13.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.364 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.402 HG23 ' CG ' ' A' ' 67' ' ' ARG . 9.6 p -103.95 139.42 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.342 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 55' ' ' ILE . 3.7 mp -130.69 144.84 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.433 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.08 148.15 42.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.504 ' CD2' HG21 ' A' ' 34' ' ' ILE . 26.1 p-80 -161.12 59.35 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.679 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.2 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.359 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo . . . . . 0 CA--C 1.529 0.234 0 CA-C-O 120.714 0.214 . . . . 0.0 112.618 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -109.96 128.67 55.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.701 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.402 ' CG ' HG23 ' A' ' 54' ' ' VAL . 76.2 mtt180 -144.8 139.51 27.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.997 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 1.026 HG21 HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -124.04 104.65 9.01 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.095 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -102.24 -41.4 6.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.107 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 t -170.53 43.25 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.495 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.19 166.18 20.64 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.236 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.79 172.48 5.79 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.898 2.399 . . . . 0.0 112.445 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.97 -179.03 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.778 2.319 . . . . 0.0 112.61 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -140.89 159.17 42.78 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -173.92 114.18 0.2 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.075 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -142.9 151.18 17.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.245 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -133.63 141.85 47.82 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.917 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 32' ' ' TRP . 13.6 mt-10 -133.79 152.08 51.77 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.959 0.409 . . . . 0.0 111.586 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.95 178.98 5.43 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.367 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.874 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 86.15 -103.72 2.81 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.67 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -121.69 112.12 18.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.085 0.469 . . . . 0.0 111.418 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.13 115.17 0.61 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.177 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.629 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . -166.4 103.85 0.21 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.392 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.445 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -150.55 167.8 12.27 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.648 0.261 . . . . 0.0 111.195 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.78 173.14 2.38 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.245 2.63 . . . . 0.0 113.325 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 105' ' ' LEU . 2.5 mp -142.62 160.11 40.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.32 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -157.6 113.4 2.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.799 0.333 . . . . 0.0 111.568 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.621 ' CD1' HG21 ' A' ' 11' ' ' ILE . 2.0 tt -116.47 121.79 68.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.533 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.6 121.94 26.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.115 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.578 HG13 ' HG2' ' A' ' 53' ' ' LYS . 5.8 t -99.95 154.3 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.643 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.47 ' CD2' ' HG3' ' A' ' 98' ' ' GLU . 51.4 m-85 -148.52 158.23 43.99 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.885 HD13 HG21 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -153.45 -175.13 5.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.134 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 47' ' ' PRO . 8.9 mp -60.93 -67.0 0.44 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.537 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -94.15 19.77 8.86 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.574 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.475 ' HD3' HD13 ' A' ' 50' ' ' ILE . 4.4 mmmm 58.35 55.36 5.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.17 -37.62 37.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 90' ' ' VAL . . . -122.49 26.39 6.32 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.606 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.0 tt0 -67.08 90.9 0.2 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.633 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -142.45 142.37 32.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.503 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -126.62 119.32 26.75 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.393 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.6 mt -128.77 120.72 20.68 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.482 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.2 154.83 8.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.004 2.47 . . . . 0.0 112.692 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 81.7 m-70 -140.12 172.1 13.23 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.396 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -128.54 124.6 36.4 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.114 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.629 HD13 ' HA2' ' A' ' 83' ' ' GLY . 1.3 tm? -113.56 95.03 5.13 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.761 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 13.6 t-20 178.8 41.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.062 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -137.4 125.27 22.61 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.663 0.268 . . . . 0.0 111.138 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.04 123.89 12.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.83 60.88 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.419 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.0 138.97 30.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.46 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.2 p -148.16 63.75 1.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.905 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -115.19 119.36 36.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.389 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -147.32 133.84 19.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.506 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 t -105.59 147.4 11.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.72 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -136.45 108.45 7.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.695 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -116.64 138.51 51.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.8 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.62 140.92 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.986 0.422 . . . . 0.0 111.555 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.885 HG21 HD13 ' A' ' 92' ' ' LEU . 2.0 mp -130.56 111.39 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.585 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -122.5 136.95 55.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.214 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 120' ' ' ILE . 6.9 tt -160.24 55.85 0.75 Allowed Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 121.286 0.565 . . . . 0.0 111.21 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 C--N 1.347 0.499 0 C-N-CA 122.719 2.28 . . . . 0.0 112.531 179.904 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.738 0.304 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 44' ' ' LYS . 19.4 t -133.42 119.24 34.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.078 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -137.03 104.89 5.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.159 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.491 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -132.57 172.98 11.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.189 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.9 t -173.22 141.36 0.93 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.702 HG21 HG21 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -109.2 118.14 55.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 110.636 179.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.8 mtt-85 -124.75 118.25 25.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.802 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 36' ' ' ILE . 1.6 pt -123.56 129.81 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.661 ' O ' HD12 ' A' ' 34' ' ' ILE . 34.2 mtmt -108.19 133.09 52.93 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -131.33 104.2 6.89 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 25.3 tm0? -115.1 137.98 51.4 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.698 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.448 ' NE2' ' HG ' ' A' ' 105' ' ' LEU . 4.8 tt0 -139.39 151.98 46.75 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.751 0.31 . . . . 0.0 111.705 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -150.0 119.18 6.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.722 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 40.8 mt . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.75 0.309 . . . . 0.0 110.648 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HB ' ' HA2' ' A' ' 80' ' ' GLY . 7.3 m . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.95 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.408 ' HB3' HG12 ' A' ' 17' ' ' ILE . 2.8 mtt-85 -136.08 163.43 30.34 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.213 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 3.7 mt-30 -118.54 148.94 42.12 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.075 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.464 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 15.0 p-90 -156.11 155.23 32.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.103 0.478 . . . . 0.0 112.145 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.1 t -149.29 117.74 6.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.539 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 12' ' ' LYS . 9.3 tp -122.29 143.05 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.428 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 4.0 pt-20 -144.64 118.73 9.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.833 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.744 ' HA ' HG22 ' A' ' 11' ' ' ILE . 4.6 mp -101.07 110.35 27.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.676 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 73' ' ' PRO . 24.3 t -124.03 147.8 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.721 0.296 . . . . 0.0 111.589 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.619 ' HB3' HD12 ' A' ' 9' ' ' ILE . 2.9 pp -156.89 171.2 20.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.255 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 7' ' ' ARG . 2.5 tp -120.18 159.02 25.72 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.21 -45.62 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.287 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.3 2.58 15.29 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.43 -36.52 26.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.577 0.227 . . . . 0.0 111.007 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.4 -66.96 0.25 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.809 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.829 ' HB2' HG22 ' A' ' 5' ' ' VAL . 4.2 mttt -155.07 108.92 2.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.558 0.218 . . . . 0.0 110.849 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -90.08 49.62 1.74 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.751 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.441 HD13 ' HD3' ' A' ' 44' ' ' LYS . 3.7 mp -127.45 132.93 24.57 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.216 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.85 -177.98 4.01 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.84 2.36 . . . . 0.0 112.565 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.62 -54.53 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.25 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.8 p -125.82 -55.09 1.51 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.347 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 91' ' ' PHE . 0.6 OUTLIER -118.9 -86.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.015 179.078 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 t80 56.23 96.82 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.075 0.464 . . . . 0.0 111.213 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -174.41 127.52 0.34 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.664 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.857 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -114.55 133.09 56.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.806 0.336 . . . . 0.0 110.703 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.49 HG13 ' HG3' ' A' ' 67' ' ' ARG . 6.7 t -132.44 118.82 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.645 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.512 HG21 HG12 ' A' ' 36' ' ' ILE . 3.6 mp -106.99 144.91 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.382 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -138.95 144.87 39.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.068 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.5 ' HB3' HD23 ' A' ' 86' ' ' LEU . 1.7 p80 -167.27 137.31 2.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.691 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 2.6 mt . . . . . 0 N--CA 1.468 0.433 0 O-C-N 123.267 0.354 . . . . 0.0 111.044 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo . . . . . 0 CA--C 1.532 0.383 0 CA-C-O 120.671 0.196 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.427 ' ND2' HD13 ' A' ' 36' ' ' ILE . 58.6 t30 -108.11 139.76 42.29 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.0 0.429 . . . . 0.0 111.164 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG3' HG13 ' A' ' 54' ' ' VAL . 3.6 mpp_? -137.04 147.4 46.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.749 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.44 HG21 ' CD2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -132.77 123.83 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.061 0.458 . . . . 0.0 111.396 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -136.05 -54.46 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.311 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 t -155.65 39.34 0.38 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -123.5 155.75 65.24 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -57.25 172.72 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.08 2.52 . . . . 0.0 112.819 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.847 ' HB3' HG22 ' A' ' 37' ' ' VAL . 32.6 Cg_exo -57.88 166.96 4.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.881 2.387 . . . . 0.0 112.939 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -127.8 84.46 2.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.658 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.2 ttp85 -99.85 113.91 26.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.45 115.7 18.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -122.18 144.08 49.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.3 166.64 32.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.943 0.402 . . . . 0.0 111.449 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -123.65 170.52 10.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' A' ' 29' ' ' VAL . . . 98.35 -81.8 0.62 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.472 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -113.61 116.61 29.77 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' HA3' ' CD1' ' A' ' 32' ' ' TRP . . . -170.99 88.29 0.09 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.763 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -160.26 74.64 0.2 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.666 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.552 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 22.7 m-85 -143.37 165.7 23.95 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 120.632 0.253 . . . . 0.0 111.35 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 37.3 Cg_endo -65.38 171.1 9.78 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.136 2.557 . . . . 0.0 113.729 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 103' ' ' HIS . 5.1 mp -143.29 159.59 42.06 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.964 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -155.37 112.71 3.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.663 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.479 HG23 HG13 ' A' ' 55' ' ' ILE . 3.2 mp -117.52 124.46 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.685 0.279 . . . . 0.0 111.319 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.1 p -126.59 131.89 51.41 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.857 HG13 ' HG2' ' A' ' 53' ' ' LYS . 24.2 t -124.42 137.46 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.022 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.52 ' HB3' HD12 ' A' ' 50' ' ' ILE . 11.5 m-85 -131.61 154.9 48.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.349 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' ' 96' ' ' ALA . 2.5 tm? -141.15 -53.84 0.47 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.112 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' A' ' 92' ' ' LEU . 5.5 tt -152.48 -52.06 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.157 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -170.25 -63.63 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.563 0.22 . . . . 0.0 111.143 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.54 21.95 8.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.407 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.8 ' HB3' HD12 ' A' ' 92' ' ' LEU . . . -87.12 -50.86 6.34 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.802 0.334 . . . . 0.0 110.696 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -149.88 23.54 1.15 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.687 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -76.66 84.76 3.31 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.731 0.301 . . . . 0.0 110.789 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -142.28 146.04 34.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.148 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -124.87 147.75 48.63 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.471 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 114' ' ' VAL . 8.2 tp -148.0 111.77 3.83 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 121.008 0.433 . . . . 0.0 111.879 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -85.99 133.25 4.13 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.033 2.489 . . . . 0.0 112.342 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 1.7 m-70 -113.18 163.34 14.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.303 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.44 138.46 54.01 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.484 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 6.0 tp -123.48 92.12 3.62 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.653 0.263 . . . . 0.0 110.911 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -167.98 33.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -141.91 126.28 17.66 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.808 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 2.9 pp -58.21 131.85 51.8 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.748 0.309 . . . . 0.0 110.679 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 73.09 67.16 0.11 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.63 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 32.5 tt0 -92.45 141.28 28.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 t -144.8 64.86 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.02 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 119.27 38.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.55 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 12' ' ' LYS . 7.5 tt0 -141.67 131.37 24.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.213 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.633 HG21 HG21 ' A' ' 101' ' ' ILE . 43.5 t -116.43 140.4 38.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -133.46 108.54 8.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.62 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.27 119.07 36.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.54 144.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.574 HG21 ' HG ' ' A' ' 92' ' ' LEU . 35.2 mt -134.6 111.15 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.63 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.46 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -128.38 106.13 8.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.174 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 119' ' ' GLN . 16.1 mm -135.4 62.03 47.68 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.192 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--N 1.347 0.464 0 C-N-CA 122.352 2.035 . . . . 0.0 112.871 -179.835 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.184 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.4 119.26 48.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.128 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -129.22 106.07 8.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.545 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 46.9 mtt85 -123.46 152.71 41.39 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.996 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.889 HG22 HD23 ' A' ' 39' ' ' LEU . 6.9 t -160.96 143.95 12.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 90' ' ' VAL . 1.0 OUTLIER -117.17 125.04 73.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 111.099 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.568 ' O ' HG22 ' A' ' 37' ' ' VAL . 28.2 mtt85 -132.06 108.83 9.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.552 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.436 HD13 HD13 ' A' ' 88' ' ' ILE . 1.3 pt -117.78 132.15 68.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.069 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.612 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.1 mptm? -118.21 139.17 51.69 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.445 HG22 HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -137.09 102.91 4.97 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.7 tt0 -113.69 118.76 35.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.224 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.56 ' HB2' HD11 ' A' ' 105' ' ' LEU . 13.5 tt0 -119.98 146.34 45.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 111.914 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.435 ' CD2' ' HB3' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -146.72 119.8 8.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.438 ' O ' HD23 ' A' ' 108' ' ' LEU . 26.1 mt . . . . . 0 CA--C 1.529 0.142 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.179 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -104.09 160.41 14.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.997 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.435 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 1.0 OUTLIER -135.84 113.57 11.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.673 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.695 ' CG ' HD21 ' A' ' 105' ' ' LEU . 14.1 p-90 -121.8 154.63 36.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.766 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 t -136.71 118.61 15.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.529 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 12' ' ' LYS . 6.3 tp -119.18 136.95 54.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.527 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -135.32 138.88 43.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.346 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.772 HG21 ' CD1' ' A' ' 55' ' ' ILE . 2.9 mp -123.9 105.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.844 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 73' ' ' PRO . 31.2 m -115.59 150.48 17.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.919 0.39 . . . . 0.0 111.499 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.812 HD21 HG21 ' A' ' 68' ' ' THR . 0.5 OUTLIER -172.51 178.95 2.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.243 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.889 HD23 HG22 ' A' ' 8' ' ' THR . 2.9 mm? -103.88 165.84 10.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.293 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -167.28 -50.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.446 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.15 -31.43 65.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.465 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' HB2' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -82.78 -36.63 25.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.045 -179.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.19 50.07 1.11 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.824 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.9 mttm 52.85 96.62 0.01 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.89 0.376 . . . . 0.0 111.42 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -24.8 59.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.588 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 46' ' ' ILE . 3.5 mp -82.51 114.75 53.89 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.865 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.85 -175.3 1.14 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.594 2.196 . . . . 0.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -145.49 -51.27 0.25 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.674 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.404 HG22 HD12 ' A' ' 50' ' ' ILE . 14.0 m -104.77 -69.67 0.8 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.835 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 49' ' ' THR . 2.7 mp -132.53 -85.07 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.838 -0.165 . . . . 0.0 111.019 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 39.0 t80 56.15 95.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.044 0.45 . . . . 0.0 111.505 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -159.16 111.86 2.22 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.498 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.926 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -99.21 121.68 41.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.64 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.411 HG12 ' OG ' ' A' ' 89' ' ' SER . 12.2 p -120.81 128.19 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 0.0 111.109 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.772 ' CD1' HG21 ' A' ' 36' ' ' ILE . 3.3 mp -116.63 145.24 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.434 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -142.82 128.2 18.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.41 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 3.6 p80 -127.57 135.65 50.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.771 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.279 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.53 0.296 0 CA-C-O 120.549 0.145 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.413 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 10.0 m120 -111.74 127.39 55.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.819 0.342 . . . . 0.0 111.052 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.4 ttt-85 -143.37 122.96 13.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.71 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.812 HG21 HD21 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -106.63 139.32 41.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -159.86 -55.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.119 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.33 38.03 1.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.035 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.83 160.19 67.73 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.505 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -62.13 174.74 2.34 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.16 2.573 . . . . 0.0 112.649 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.612 ' HB2' HG12 ' A' ' 37' ' ' VAL . 65.7 Cg_endo -74.21 148.73 39.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.74 2.293 . . . . 0.0 112.712 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -99.13 155.79 17.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.01 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.96 86.91 0.1 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.5 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -136.67 151.94 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.319 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -122.45 157.72 31.33 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.994 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.97 141.14 49.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.182 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.88 136.04 53.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.743 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 30' ' ' ARG . . . 128.19 -156.43 20.8 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.839 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -75.81 131.12 39.55 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.055 0.455 . . . . 0.0 111.312 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.9 -127.86 1.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.939 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.04 104.37 0.13 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.752 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 3.4 m-85 -155.5 170.8 8.14 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 120.707 0.289 . . . . 0.0 111.25 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 87.8 Cg_exo -49.86 170.25 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.477 2.785 . . . . 0.0 114.177 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD23 HD11 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -135.16 159.66 40.83 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.72 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -156.21 120.94 4.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.926 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.583 HG23 HG13 ' A' ' 55' ' ' ILE . 3.1 mp -135.33 124.0 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.275 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.411 ' OG ' HG12 ' A' ' 54' ' ' VAL . 1.4 p -123.61 122.23 37.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.95 0.405 . . . . 0.0 110.302 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.926 HG13 ' HG2' ' A' ' 53' ' ' LYS . 19.2 t -107.4 111.88 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.069 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -102.9 157.54 16.9 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.781 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.628 HD11 ' CB ' ' A' ' 95' ' ' LYS . 1.3 pt? -146.27 -159.81 1.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.612 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 12.4 mt -55.59 -66.85 0.35 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.409 0.147 . . . . 0.0 111.014 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -177.37 42.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.221 0.534 . . . . 0.0 110.42 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.672 ' HD2' HG21 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -110.96 -166.24 1.06 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.026 -179.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.65 -13.44 61.36 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.817 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.12 -27.91 57.94 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.097 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -65.26 83.43 0.05 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.107 0.48 . . . . 0.0 110.624 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.46 155.45 45.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.545 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -121.54 145.89 47.5 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.615 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.793 HG21 HG21 ' A' ' 114' ' ' VAL . 3.7 mp -138.59 114.47 8.77 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.468 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -88.63 155.85 6.32 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.082 2.522 . . . . 0.0 112.254 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 112' ' ' TYR . 6.1 m170 -140.26 172.02 13.33 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.034 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.66 119.32 21.24 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.2 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.695 HD21 ' CG ' ' A' ' 32' ' ' TRP . 4.3 tp -112.95 86.5 2.38 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -165.36 39.83 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -142.09 139.75 32.32 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.458 ' H ' HD12 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -62.03 127.36 31.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.368 179.374 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 64.9 79.02 0.26 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.245 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 39.3 tt0 -109.63 136.38 49.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.014 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -133.69 70.95 1.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.106 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 103' ' ' HIS . 5.5 m-85 -110.09 119.1 38.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.059 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -154.57 132.23 11.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.415 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.793 HG21 HG21 ' A' ' 101' ' ' ILE . 25.0 t -109.59 145.72 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.678 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -132.16 108.65 9.41 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.079 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.424 ' HB3' HG22 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -113.29 151.71 30.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.7 149.31 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.957 0.408 . . . . 0.0 111.871 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.3 mt -143.29 110.97 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.507 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -129.79 118.33 21.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.637 0.256 . . . . 0.0 111.28 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.672 HG21 ' HD2' ' A' ' 95' ' ' LYS . 1.6 pp -138.2 48.58 2.03 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.83 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 120' ' ' ILE . 71.1 Cg_endo . . . . . 0 C--N 1.351 0.704 0 C-N-CA 122.56 2.173 . . . . 0.0 112.866 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.582 0.23 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 44' ' ' LYS . 19.0 t -123.38 119.43 57.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.097 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.72 104.85 5.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.19 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.401 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 47.3 mtt180 -134.59 175.44 9.53 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.038 0.447 . . . . 0.0 111.258 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 4.9 t -160.77 146.05 14.45 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.335 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.812 HD11 HD11 ' A' ' 88' ' ' ILE . 1.6 tt -113.87 118.05 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-O 120.931 0.396 . . . . 0.0 110.784 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -130.29 111.13 12.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.505 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.839 HD11 HG21 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -122.06 142.27 39.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.121 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.564 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -120.59 138.4 53.91 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.755 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.404 HG23 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -142.2 120.12 12.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.161 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -130.33 160.14 34.84 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.77 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -152.86 142.04 21.44 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.279 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -131.96 119.67 21.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.733 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.4 mt . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.608 179.67 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.404 HG22 ' HE1' ' A' ' 81' ' ' TRP . 40.2 t . . . . . 0 N--CA 1.464 0.235 0 CA-C-O 120.69 0.281 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.42 162.37 26.5 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.355 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.413 ' CG ' ' HB3' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -119.53 162.14 19.42 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -158.87 141.47 14.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.195 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -138.38 117.65 12.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.564 HD12 ' O ' ' A' ' 12' ' ' LYS . 8.1 tp -127.55 139.74 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.988 0.423 . . . . 0.0 111.953 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.444 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -143.46 132.98 23.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.673 179.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.656 HD12 HG21 ' A' ' 55' ' ' ILE . 5.4 mm -113.62 111.58 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.212 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.68 133.76 64.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.707 0.289 . . . . 0.0 110.966 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.583 HD13 ' HE2' ' A' ' 53' ' ' LYS . 4.0 pp -169.37 174.95 5.76 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.582 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.9 mm? -114.94 160.92 18.98 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.413 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -167.83 -49.36 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.16 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.72 1.91 28.24 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -83.94 -34.78 24.39 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 111.052 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.9 -75.17 0.93 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.868 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.679 ' HB2' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -119.43 112.08 18.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.608 0.242 . . . . 0.0 110.79 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -104.6 30.5 5.36 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.191 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 mt -132.32 124.2 19.11 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.293 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.32 168.57 24.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.877 2.385 . . . . 0.0 112.538 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.764 ' HB3' HD23 ' A' ' 93' ' ' LEU . . . -154.42 -50.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.652 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 p -121.63 -68.1 0.92 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.716 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.711 HD11 ' HE2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -126.19 -89.67 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.168 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 13.2 t80 57.47 95.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.993 0.425 . . . . 0.0 111.522 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -165.95 125.61 1.68 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.623 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.602 ' CG ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -110.84 105.22 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.368 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.0 140.58 24.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.39 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.656 HG21 HD12 ' A' ' 36' ' ' ILE . 3.5 mp -123.86 141.5 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.963 0.411 . . . . 0.0 111.327 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -128.78 154.9 45.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.765 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 19.2 p80 -164.82 137.61 4.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.769 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.607 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo . . . . . 0 CA--C 1.532 0.402 0 CA-C-O 120.809 0.254 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.431 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 29.1 m-20 -87.71 150.83 23.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.041 0.448 . . . . 0.0 111.559 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.62 136.67 18.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.577 HG21 HD11 ' A' ' 38' ' ' LEU . 22.9 m -129.41 108.08 10.0 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -141.92 -54.07 0.44 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.257 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 p -140.08 33.9 1.93 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.135 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.42 164.05 42.27 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.277 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.79 168.43 22.94 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.803 2.335 . . . . 0.0 112.696 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.79 161.54 45.54 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.721 2.281 . . . . 0.0 112.845 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.409 ' HB2' HG12 ' A' ' 36' ' ' ILE . 34.0 m-85 -105.22 154.7 19.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.219 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.04 71.83 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.61 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 mt -130.47 141.01 47.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.414 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.57 138.77 47.56 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.526 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -140.23 167.54 21.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.002 0.43 . . . . 0.0 111.453 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.413 ' HB3' ' CG ' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -129.9 141.53 50.79 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.847 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.41 -131.75 2.36 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.604 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.404 ' HE1' HG22 ' A' ' 29' ' ' VAL . 7.9 m0 -120.2 110.33 16.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.882 0.373 . . . . 0.0 110.848 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.46 -126.54 0.86 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.389 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.41 94.04 1.52 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.574 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.514 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.1 m-85 -156.13 169.92 9.68 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.63 0.252 . . . . 0.0 111.088 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 58.6 Cg_endo -72.01 172.35 14.84 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.767 2.311 . . . . 0.0 113.38 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.452 ' CG ' ' HB2' ' A' ' 103' ' ' HIS . 0.4 OUTLIER -146.46 159.69 43.08 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.517 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -149.55 119.0 6.88 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.678 0.275 . . . . 0.0 111.383 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.839 HG21 HD11 ' A' ' 11' ' ' ILE . 5.0 tt -111.11 114.12 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -110.15 135.0 51.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.602 HG23 ' CG ' ' A' ' 53' ' ' LYS . 3.8 p -122.15 138.65 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.966 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -134.69 157.58 46.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.547 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.529 HD11 ' H ' ' A' ' 96' ' ' ALA . 1.4 pt? -146.02 -163.47 1.74 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.764 HD23 ' HB3' ' A' ' 48' ' ' ALA . 2.5 mp -97.02 -16.78 20.4 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.469 ' HB2' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -108.35 1.77 22.06 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.711 ' HE2' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER 48.24 37.42 8.29 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.529 ' H ' HD11 ' A' ' 92' ' ' LEU . . . -95.01 -50.44 5.1 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.613 0.244 . . . . 0.0 111.39 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.03 16.86 56.92 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.893 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 23.4 tt0 -70.78 96.43 1.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.82 0.31 . . . . 0.0 110.559 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.534 ' H ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.57 156.92 45.16 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.849 -179.388 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -118.58 139.42 51.51 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.464 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.586 ' O ' HG22 ' A' ' 88' ' ' ILE . 1.8 mp -128.03 99.7 24.96 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-O 120.941 0.4 . . . . 0.0 111.38 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -87.89 144.32 6.24 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.032 2.488 . . . . 0.0 112.422 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.452 ' CE1' HG22 ' A' ' 101' ' ' ILE . 38.9 m80 -136.92 172.15 13.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -121.42 151.24 40.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.405 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 tp -139.06 85.32 2.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 0.0 110.624 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -161.41 38.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.519 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -141.68 134.04 28.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.396 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 pp -58.74 131.09 49.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.508 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 62.25 75.4 0.4 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.027 0.441 . . . . 0.0 110.599 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -105.33 135.67 46.28 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.018 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t -136.87 74.43 1.49 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.165 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -113.64 119.14 36.41 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.383 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -148.21 136.44 21.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.09 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.505 ' CG1' HD11 ' A' ' 11' ' ' ILE . 6.3 p -116.94 143.2 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.81 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.34 122.03 20.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.078 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.74 159.22 37.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.49 138.09 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.485 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.25 110.75 26.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.175 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -130.03 120.36 24.59 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.469 HD13 ' HB2' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -146.56 55.38 2.54 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 C--N 1.354 0.823 0 C-N-CA 122.484 2.123 . . . . 0.0 112.86 179.645 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 121' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.733 0.301 . . . . 0.0 110.66 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 43' ' ' GLY . 29.7 t -134.96 118.91 25.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.755 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.77 106.28 5.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.675 ' NH1' HD11 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -124.05 167.55 14.04 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.632 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -178.06 133.0 0.15 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.902 HG21 HG21 ' A' ' 90' ' ' VAL . 3.6 tt -106.14 118.22 53.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.059 0.457 . . . . 0.0 110.834 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -116.56 107.05 14.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.012 HD13 HG21 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -110.38 135.13 50.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -120.14 138.68 53.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.998 -179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 105' ' ' LEU . 1.2 m -141.07 113.99 8.42 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.2 mt-30 -127.02 147.71 50.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.677 0.275 . . . . 0.0 111.078 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -138.88 145.08 39.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -143.32 119.3 10.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.827 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 10.2 mt . . . . . 0 C--N 1.332 -0.168 0 CA-C-O 120.738 0.304 . . . . 0.0 110.792 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.531 HG13 ' HA2' ' A' ' 80' ' ' GLY . 21.9 t . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.888 0.375 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.35 159.4 23.48 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.107 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -116.59 158.51 23.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -157.6 145.49 18.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.334 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 p -146.04 117.56 8.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.652 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 2.3 tp -130.34 134.74 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.46 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.9 pt-20 -136.47 135.08 38.32 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.471 ' CG2' HG13 ' A' ' 55' ' ' ILE . 4.1 mp -110.06 114.83 48.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.716 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.7 t -125.2 135.69 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.277 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.716 HD11 HG21 ' A' ' 68' ' ' THR . 1.4 pp -157.69 154.23 27.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.424 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 42' ' ' GLU . 2.5 mp -99.58 161.89 13.35 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.598 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -174.72 -46.9 0.01 OUTLIER 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.06 -19.59 65.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.363 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HB2' HD23 ' A' ' 39' ' ' LEU . 1.9 mt-10 -98.69 -36.7 9.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.244 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.662 ' O ' HG13 ' A' ' 5' ' ' VAL . . . -99.9 45.85 1.46 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.875 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt 62.01 100.98 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.08 48.47 1.37 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.198 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.1 mt -128.0 110.92 20.12 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.291 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.77 161.4 10.25 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.153 2.569 . . . . 0.0 113.036 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.64 -54.0 0.82 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.628 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.403 HG22 HG13 ' A' ' 50' ' ' ILE . 32.0 m -117.06 -63.49 1.44 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.93 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.403 HG13 HG22 ' A' ' 49' ' ' THR . 64.2 mt -120.82 -78.12 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.795 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.7 t80 57.75 98.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.284 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 9.9 t70 -172.53 107.45 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.898 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.507 ' CG ' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -91.34 128.92 37.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.488 HG23 ' OG ' ' A' ' 89' ' ' SER . 3.0 m -132.16 116.28 28.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 121.086 0.47 . . . . 0.0 111.654 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.991 HG23 HG22 ' A' ' 88' ' ' ILE . 2.3 mm -106.75 155.67 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -142.24 141.13 32.46 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.408 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 14.5 p-80 -150.44 119.55 6.74 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.935 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 105' ' ' LEU . 5.7 mp . . . . . 0 N--CA 1.466 0.351 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.328 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo . . . . . 0 C--O 1.233 0.266 0 CA-C-O 120.606 0.169 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -110.62 128.1 55.54 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.886 0.374 . . . . 0.0 111.185 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.87 105.8 3.59 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.482 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.716 HG21 HD11 ' A' ' 38' ' ' LEU . 6.2 m -97.46 116.6 29.97 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.254 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -121.66 -51.23 2.05 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.96 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 p -147.33 35.36 0.89 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.77 157.94 58.37 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.302 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.82 172.48 10.59 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.093 2.528 . . . . 0.0 112.607 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.9 177.67 1.3 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.822 2.348 . . . . 0.0 112.383 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -141.74 163.47 32.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.914 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER -174.96 121.55 0.22 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -140.18 131.14 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.195 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.0 113.64 10.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.816 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -139.51 174.16 10.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.535 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.52 168.9 11.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.115 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.531 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 128.3 -121.67 3.77 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.324 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -118.34 110.94 18.1 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.776 0.322 . . . . 0.0 110.481 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.35 112.45 0.41 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.927 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -165.93 109.19 0.35 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.612 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 6.7 m-85 -160.85 170.65 8.13 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 120.397 0.141 . . . . 0.0 110.983 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.74 169.81 3.06 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.125 2.55 . . . . 0.0 113.253 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 105' ' ' LEU . 3.6 mp -143.03 168.28 20.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.219 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 25.9 t0 -158.78 119.33 3.26 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.716 0.293 . . . . 0.0 111.651 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.012 HG21 HD13 ' A' ' 11' ' ' ILE . 1.1 pp -112.68 109.51 28.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 111.151 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.488 ' OG ' HG23 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -122.14 111.41 16.94 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.498 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 9' ' ' ILE . 19.2 t -105.29 145.65 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.607 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 11.8 m-85 -131.66 152.81 50.57 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.72 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.893 HD22 HG21 ' A' ' 118' ' ' ILE . 5.4 tp -141.65 -54.46 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.089 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 92' ' ' LEU . 1.2 mp -143.2 -70.46 0.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.834 0.349 . . . . 0.0 110.596 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' HB3' ' HD3' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -161.92 -49.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.73 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.436 ' HD3' ' HB3' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -140.47 29.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.563 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.689 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -98.03 -45.63 6.19 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.972 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA3' HG12 ' A' ' 118' ' ' ILE . . . -158.75 43.18 0.48 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.304 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 3.8 tt0 -100.35 99.34 9.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.539 0.209 . . . . 0.0 110.947 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -142.52 149.06 38.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.736 0.303 . . . . 0.0 111.52 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -134.33 137.3 44.09 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.145 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.4 mt -144.41 121.83 6.56 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.386 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 98.0 Cg_endo -79.29 147.07 20.21 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.62 2.214 . . . . 0.0 112.363 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.27 172.58 11.67 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.164 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -131.24 138.8 49.49 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.063 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.548 ' HB2' HD11 ' A' ' 86' ' ' LEU . 4.0 tp -131.21 83.12 2.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.838 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.94 35.25 0.15 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.308 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -138.85 132.2 30.14 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -58.98 125.24 22.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.512 179.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 71.31 70.79 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.19 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 1.2 tp10 -107.33 138.01 44.32 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.481 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p -137.7 73.18 1.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.853 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -109.72 119.35 39.12 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.413 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -152.13 127.62 10.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.788 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -104.04 145.68 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.744 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.85 108.53 9.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.547 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.36 123.75 50.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.77 142.56 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 111.684 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.893 HG21 HD22 ' A' ' 92' ' ' LEU . 3.5 mp -131.34 120.74 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.751 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -127.29 121.35 30.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.448 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.553 HD11 ' NH1' ' A' ' 7' ' ' ARG . 2.7 pt -153.92 65.13 5.07 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.607 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.636 ' HB3' HG22 ' A' ' 4' ' ' THR . 39.1 Cg_endo . . . . . 0 C--N 1.347 0.451 0 C-N-CA 122.54 2.16 . . . . 0.0 112.884 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.784 0.326 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.462 HG13 ' CA ' ' A' ' 43' ' ' GLY . 21.9 t -124.64 119.02 55.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.727 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -135.77 105.82 6.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.7 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 25.8 mtt-85 -123.23 159.54 28.48 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.033 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 t -173.34 129.31 0.45 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.752 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 36' ' ' ILE . 2.3 tt -108.38 118.26 55.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.925 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.97 110.11 16.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.663 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.3 pt -115.86 137.06 50.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.533 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.5 mptp? -121.55 137.98 54.5 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.044 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.488 HG22 ' HG ' ' A' ' 105' ' ' LEU . 3.5 m -140.65 104.62 4.77 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -121.5 154.19 36.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.938 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.52 ' HB2' HD21 ' A' ' 105' ' ' LEU . 3.3 tt0 -154.65 143.2 20.64 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.014 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -135.02 119.36 17.84 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.716 0.293 . . . . 0.0 111.097 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 14.9 mt . . . . . 0 C--O 1.233 0.226 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.783 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.495 HG13 ' HA2' ' A' ' 80' ' ' GLY . 30.2 t . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.715 0.293 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -126.05 152.7 45.45 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.204 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.62 154.43 21.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.187 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -152.81 137.58 17.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.053 0.454 . . . . 0.0 111.559 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.4 t -141.53 117.7 10.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.509 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 12' ' ' LYS . 9.1 tp -128.55 144.57 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.291 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.41 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -158.4 154.83 27.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.973 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.968 HG21 HD13 ' A' ' 55' ' ' ILE . 18.8 tt -148.3 125.46 2.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.965 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.777 HG12 ' HB3' ' A' ' 73' ' ' PRO . 27.7 m -128.89 123.74 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.198 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.588 HD22 ' CG2' ' A' ' 68' ' ' THR . 0.9 OUTLIER -137.83 142.51 40.78 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 3.7 mm? -80.47 165.9 21.73 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.833 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.94 -65.94 0.16 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -64.4 -21.3 66.59 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.638 0.256 . . . . 0.0 111.09 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.92 -31.13 22.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.643 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.462 ' CA ' HG13 ' A' ' 5' ' ' VAL . . . -106.48 40.39 2.52 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.49 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 mttt 64.14 97.18 0.04 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 110.978 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -69.59 -12.44 61.64 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.662 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.56 134.96 46.93 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-O 120.525 0.203 . . . . 0.0 111.07 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.42 -172.85 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.687 2.258 . . . . 0.0 112.628 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.688 ' CB ' HD21 ' A' ' 93' ' ' LEU . . . -162.29 -64.1 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.605 ' OG1' HD23 ' A' ' 93' ' ' LEU . 25.6 m -116.31 -51.8 2.6 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.397 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.685 HD12 ' HB3' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -133.79 -83.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.783 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.1 t80 54.4 94.82 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.136 0.493 . . . . 0.0 111.13 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -171.82 143.82 1.7 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.271 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -137.61 134.47 35.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 111.238 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.634 HG13 ' CD ' ' A' ' 67' ' ' ARG . 21.7 t -117.92 145.82 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.531 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.968 HD13 HG21 ' A' ' 36' ' ' ILE . 2.8 mt -123.99 134.08 67.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.775 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 65' ' ' PRO . 49.6 m-85 -135.04 135.02 40.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.91 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -157.47 130.14 7.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.22 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 1.8 mt . . . . . 0 C--O 1.234 0.242 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 39.1 Cg_exo . . . . . 0 N--CA 1.474 0.35 0 N-CA-C 112.788 0.265 . . . . 0.0 112.788 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.5 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.0 m-20 -101.67 151.43 22.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.471 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.634 ' CD ' HG13 ' A' ' 54' ' ' VAL . 7.6 mmm-85 -144.93 156.11 43.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.853 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.709 ' OG1' HD11 ' A' ' 55' ' ' ILE . 87.5 m -134.71 112.82 11.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.859 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.493 ' HD1' HG23 ' A' ' 70' ' ' THR . 1.7 t80 -153.18 -51.03 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.838 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.493 HG23 ' HD1' ' A' ' 69' ' ' PHE . 55.6 p -144.17 30.18 1.29 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.835 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -123.49 150.92 62.29 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.206 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 38.1 Cg_exo -60.85 166.75 9.76 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.086 2.524 . . . . 0.0 112.466 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.777 ' HB3' HG12 ' A' ' 37' ' ' VAL . 27.8 Cg_exo -62.18 -173.22 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.042 2.495 . . . . 0.0 112.693 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.73 161.08 39.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 111.757 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.73 94.77 0.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.661 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.66 111.19 35.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -131.92 124.57 29.72 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.027 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -153.86 168.2 27.15 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.707 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -112.8 149.36 33.15 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.982 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.495 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 137.93 -113.84 1.02 Allowed Glycine 0 C--N 1.334 0.448 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.262 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -126.06 109.97 13.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.574 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.27 76.88 0.16 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.673 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -129.85 106.51 0.73 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.79 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 7.1 m-85 -158.18 167.75 13.84 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.582 0.229 . . . . 0.0 110.836 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 42.0 Cg_endo -67.55 168.29 18.58 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.929 2.419 . . . . 0.0 113.662 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 103' ' ' HIS . 0.5 OUTLIER -150.41 157.74 43.37 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.492 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -150.4 136.28 18.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.027 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.0 pt -125.92 139.14 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.886 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.2 p -130.02 146.82 51.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.858 0.361 . . . . 0.0 110.995 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 38.9 t -138.06 147.0 26.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.12 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.685 ' HB3' HD12 ' A' ' 50' ' ' ILE . 96.6 m-85 -155.54 144.99 21.05 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.9 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.629 HD23 ' HD3' ' A' ' 95' ' ' LYS . 16.4 tp -134.4 -50.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.539 0.209 . . . . 0.0 111.455 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.688 HD21 ' CB ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -161.67 -62.8 0.05 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.834 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -179.55 42.92 0.0 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.312 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.629 ' HD3' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -113.85 -163.73 0.88 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.938 -179.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.35 -26.26 38.79 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.662 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.85 -33.35 59.99 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.648 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -71.21 84.27 0.75 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.203 0.525 . . . . 0.0 110.669 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -142.4 151.81 42.2 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.34 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -121.47 143.24 49.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.79 120.72 10.3 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -90.86 150.79 4.0 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.241 2.627 . . . . 0.0 112.676 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.434 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . 59.9 m-70 -143.95 166.82 23.88 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.114 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -125.88 129.84 50.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.799 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -110.28 102.21 10.89 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.785 0.326 . . . . 0.0 111.335 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.431 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 4.0 t-20 -177.26 45.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.27 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -141.55 128.61 20.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.644 0.259 . . . . 0.0 111.31 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 109' ' ' GLN . 3.1 pp -60.03 132.81 55.11 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.407 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.482 ' HB2' HD12 ' A' ' 108' ' ' LEU . 0.1 OUTLIER 68.98 44.66 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.171 0.51 . . . . 0.0 110.834 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.76 135.41 37.99 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.604 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -146.54 58.81 1.2 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.728 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -107.03 119.21 38.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.13 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 2.5 pt-20 -145.65 142.55 29.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.188 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.51 147.04 17.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.556 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.69 108.45 8.02 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.692 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -113.82 139.25 49.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.681 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 117' ' ' VAL . 11.9 p -123.73 121.44 62.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.077 0.465 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.414 HG21 HD22 ' A' ' 92' ' ' LEU . 2.9 mp -113.74 111.24 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.377 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -126.06 148.53 49.31 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.29 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 120' ' ' ILE . 3.6 tp -171.56 59.59 0.28 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 121.27 0.557 . . . . 0.0 111.554 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 C--N 1.349 0.554 0 C-N-CA 122.582 2.188 . . . . 0.0 112.521 179.582 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.716 0.293 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 44' ' ' LYS . 34.0 t -137.64 119.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.032 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -129.71 105.25 7.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.606 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.3 mtt180 -123.84 163.19 21.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.092 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.9 t -158.77 143.69 16.06 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.775 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 tp -115.05 122.88 70.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.822 0.344 . . . . 0.0 110.779 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.432 ' CD ' ' HG2' ' A' ' 115' ' ' GLU . 9.3 mtt180 -134.0 106.39 7.22 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.024 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.84 HD13 HG13 ' A' ' 88' ' ' ILE . 1.1 pt -113.12 123.44 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.565 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -114.58 124.4 51.77 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.41 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.419 HG22 HD13 ' A' ' 105' ' ' LEU . 5.4 m -125.0 108.75 12.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 3.0 tt0 -116.22 142.33 46.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.783 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -142.14 142.18 32.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 31' ' ' GLN . 82.9 t60 -133.8 119.23 18.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.67 0.271 . . . . 0.0 111.139 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 9.9 mt . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.815 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.234 0.279 0 CA-C-O 120.622 0.248 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.68 163.99 21.59 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 111.314 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -117.08 158.17 24.64 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.844 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.455 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 67.7 p-90 -154.02 140.18 18.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.0 p -142.77 117.52 9.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.003 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.7 tp -127.61 127.2 68.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 111.422 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.565 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 1.7 pt-20 -130.37 135.35 47.95 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.668 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.77 HG12 HG21 ' A' ' 55' ' ' ILE . 4.3 mp -115.69 106.36 20.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.047 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -104.83 140.85 21.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.986 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.686 ' CD2' HG21 ' A' ' 68' ' ' THR . 1.2 pp -159.26 161.52 36.0 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.187 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 39' ' ' LEU . 1.1 mm? -120.82 159.53 25.27 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.42 -45.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.057 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.12 2.45 15.17 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.209 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -83.41 -36.24 24.42 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.65 0.262 . . . . 0.0 110.959 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.55 -70.72 0.23 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.719 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.658 ' HB2' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -134.01 120.87 20.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.686 0.279 . . . . 0.0 111.32 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.83 30.01 5.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.471 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.3 mt -128.27 131.63 23.89 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.691 -0.232 . . . . 0.0 111.183 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.544 ' HA ' HD12 ' A' ' 93' ' ' LEU . 72.5 Cg_endo -76.07 -172.72 1.43 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.828 2.352 . . . . 0.0 112.625 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.707 ' HB3' ' CB ' ' A' ' 93' ' ' LEU . . . -156.01 -49.68 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.422 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 m -110.73 -63.99 1.33 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.593 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.11 -74.41 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.838 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 47.9 t80 56.86 93.24 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.445 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -158.57 116.0 2.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.372 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.742 ' HG2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -110.81 115.06 28.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.385 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 t -112.73 150.1 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 111.66 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.829 HG23 ' CD1' ' A' ' 88' ' ' ILE . 4.9 mp -131.07 133.47 62.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.639 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -127.46 121.34 30.53 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.831 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -128.67 108.98 10.93 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.82 HD11 ' CD2' ' A' ' 105' ' ' LEU . 6.2 mp . . . . . 0 N--CA 1.467 0.391 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.531 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo . . . . . 0 C--O 1.234 0.28 0 N-CA-C 111.771 -0.126 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 1.6 m120 -119.81 139.87 51.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.158 0.504 . . . . 0.0 111.106 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.36 140.29 23.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.679 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.686 HG21 ' CD2' ' A' ' 38' ' ' LEU . 86.9 m -116.47 113.1 22.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.051 0.453 . . . . 0.0 111.467 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -131.95 -56.22 0.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.621 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.2 33.88 1.09 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.35 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -125.8 159.48 61.07 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.58 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.3 Cg_exo -67.07 175.01 6.08 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.346 2.697 . . . . 0.0 112.434 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 38.4 Cg_endo -65.92 -178.08 0.94 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.8 2.333 . . . . 0.0 112.502 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.82 162.43 30.58 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 111.701 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.67 80.34 0.04 OUTLIER 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.403 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.6 mm -116.6 130.76 70.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.385 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.75 128.77 29.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.579 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.455 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 3.3 mt-10 -138.26 167.34 22.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.987 0.422 . . . . 0.0 111.692 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -121.6 128.03 51.51 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.854 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.24 -121.44 1.01 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.559 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -121.21 110.1 15.77 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 110.756 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.8 106.63 0.25 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.508 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.22 101.37 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.834 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 10.0 m-85 -152.94 171.33 6.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.544 0.212 . . . . 0.0 111.186 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.9 Cg_exo -56.03 176.1 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.288 2.658 . . . . 0.0 113.308 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.78 147.14 29.54 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.07 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -145.54 124.15 12.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.854 0.359 . . . . 0.0 111.116 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.84 HG13 HD13 ' A' ' 11' ' ' ILE . 14.6 mm -122.96 125.74 72.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.958 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.4 p -127.81 144.84 51.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.805 0.336 . . . . 0.0 111.55 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.742 HG23 ' HG2' ' A' ' 53' ' ' LYS . 4.0 p -134.23 132.81 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 8.3 m-85 -133.44 155.76 48.94 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.562 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.452 HD23 ' N ' ' A' ' 92' ' ' LEU . 1.4 pt? -144.62 -157.23 0.77 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.397 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.707 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -98.02 38.09 1.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.124 0.487 . . . . 0.0 110.708 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -170.54 -167.12 0.56 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.421 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 42.05 3.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.722 0.296 . . . . 0.0 111.049 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.49 -28.39 8.2 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -114.17 -10.66 13.33 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.187 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -56.16 107.42 0.36 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.971 0.385 . . . . 0.0 110.748 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.466 ' H ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.34 146.51 35.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.812 -179.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 123.26 22.04 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.208 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.952 HD13 HG11 ' A' ' 114' ' ' VAL . 19.9 tt -129.79 124.13 21.49 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-O 120.927 0.394 . . . . 0.0 111.894 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.07 160.52 8.65 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.008 2.472 . . . . 0.0 112.312 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -148.61 172.41 14.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.966 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.63 143.75 50.96 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.696 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.82 ' CD2' HD11 ' A' ' 58' ' ' LEU . 7.4 tp -130.65 88.47 2.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.011 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -172.04 42.15 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -141.51 130.03 22.61 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.163 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 3.4 pp -58.16 131.3 50.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.526 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.94 53.74 1.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.905 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 15' ' ' GLN . 1.2 tp10 -85.07 135.23 34.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.28 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.9 t -143.74 62.52 1.36 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.649 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -105.31 119.31 38.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.308 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 1.2 pt-20 -153.41 145.64 23.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.127 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.952 HG11 HD13 ' A' ' 101' ' ' ILE . 27.0 m -125.51 151.46 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.727 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.432 ' HG2' ' CD ' ' A' ' 10' ' ' ARG . 1.3 mt-10 -137.52 109.08 6.97 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.672 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 155.63 27.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.53 143.88 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.352 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.27 111.02 14.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -121.5 121.11 36.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.638 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.65 HD13 HD21 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -145.41 75.09 13.78 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 CA--C 1.535 0.561 0 C-N-CA 122.679 2.253 . . . . 0.0 113.55 -179.712 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.654 0.264 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 44' ' ' LYS . 17.5 t -134.0 119.39 31.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.218 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.0 105.86 12.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.285 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.32 162.39 16.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.249 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 4.2 t -175.0 149.28 1.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.374 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.744 HD11 HD11 ' A' ' 36' ' ' ILE . 2.5 tt -128.29 133.89 65.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.482 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 111.56 11.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.297 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.93 HD13 HD13 ' A' ' 88' ' ' ILE . 8.0 pt -114.81 130.15 69.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.37 136.89 52.83 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.8 HG23 ' CD1' ' A' ' 34' ' ' ILE . 5.6 m -133.66 111.51 10.67 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.77 117.27 24.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.942 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 109' ' ' GLN . 3.0 tp60 -109.97 147.12 34.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.952 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -155.03 119.93 4.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.077 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.862 HG22 ' HA ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.02 0.438 . . . . 0.0 111.334 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.234 0.279 0 CA-C-O 120.948 0.404 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.569 ' HA ' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -99.69 150.51 22.22 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.772 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -105.11 163.1 12.82 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -156.57 146.96 21.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.998 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.5 p -139.9 117.45 11.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.246 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.8 ' CD1' HG23 ' A' ' 13' ' ' THR . 27.2 mm -119.54 121.5 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.1 pm0 -131.18 116.64 17.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.666 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.744 HD11 HD11 ' A' ' 9' ' ' ILE . 7.9 tt -117.66 123.71 72.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.754 HG12 ' HB3' ' A' ' 73' ' ' PRO . 35.5 m -128.08 143.36 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.872 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.609 HD22 ' HE2' ' A' ' 53' ' ' LYS . 3.2 pp -144.32 163.02 34.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.635 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tp -106.16 157.49 17.52 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.2 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.48 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -171.45 -44.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.067 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.68 1.42 19.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.367 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -34.51 27.52 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.641 0.257 . . . . 0.0 110.751 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.8 -71.59 0.34 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.544 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.8 ' HB2' HG22 ' A' ' 5' ' ' VAL . 1.3 mtmt -144.18 107.09 4.47 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.869 0.366 . . . . 0.0 110.799 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.48 ' HG3' ' HB3' ' A' ' 40' ' ' ASP . 2.3 tt0 -96.26 45.55 1.07 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.83 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.5 118.13 21.44 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.799 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.84 161.4 6.28 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.905 2.403 . . . . 0.0 112.648 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB3' ' HG ' ' A' ' 93' ' ' LEU . . . -129.44 -71.43 0.62 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.568 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 p -113.06 -63.36 1.45 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.021 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.61 -80.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.07 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 31.6 t80 54.3 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.283 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.4 t0 -161.08 124.52 3.31 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.805 ' HG2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -117.39 136.77 52.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.445 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.751 HG13 ' HG3' ' A' ' 67' ' ' ARG . 6.6 t -128.96 135.83 61.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.02 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.507 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 4.9 mt -112.89 140.54 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.456 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.71 129.05 18.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.478 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.445 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 6.4 p80 -140.21 123.36 16.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.977 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.604 HD21 HD23 ' A' ' 105' ' ' LEU . 75.2 mt . . . . . 0 CA--C 1.531 0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--O 1.232 0.219 0 CA-C-O 120.755 0.231 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.507 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.9 m-80 -108.02 157.64 18.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.095 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.751 ' HG3' HG13 ' A' ' 54' ' ' VAL . 4.0 mtt180 -150.77 156.22 40.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.783 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.546 HG21 HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -134.54 126.16 28.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.91 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.749 ' CE2' HG22 ' A' ' 70' ' ' THR . 10.2 p90 -165.59 -45.11 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.887 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.749 HG22 ' CE2' ' A' ' 69' ' ' PHE . 13.6 t -146.04 30.49 1.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -134.2 156.83 78.71 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.203 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 40.1 Cg_endo -66.76 175.61 5.18 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.014 2.476 . . . . 0.0 112.188 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.754 ' HB3' HG12 ' A' ' 37' ' ' VAL . 10.9 Cg_endo -54.04 168.14 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.209 2.606 . . . . 0.0 112.8 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -128.7 88.66 2.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.919 0.39 . . . . 0.0 111.965 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 3.3 ttp85 -107.69 90.8 3.41 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.222 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.07 137.28 57.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.532 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.28 142.16 50.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.827 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -159.92 168.27 26.11 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.687 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -107.06 175.02 5.64 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.881 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.76 -141.98 12.8 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.631 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -126.57 110.1 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.122 0.487 . . . . 0.0 110.934 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.4 -129.18 6.35 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.361 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.17 47.98 3.43 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.701 -0.559 . . . . 0.0 111.701 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.497 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 64.1 m-85 -142.13 159.7 57.8 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.82 0.343 . . . . 0.0 111.019 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 39.2 Cg_endo -67.32 162.63 37.82 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.941 2.427 . . . . 0.0 113.622 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -148.88 134.24 18.47 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.795 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -143.96 153.02 41.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 111.415 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.93 HD13 HD13 ' A' ' 11' ' ' ILE . 3.9 mp -136.99 120.5 22.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 p -105.27 145.23 30.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.805 HG23 ' HG2' ' A' ' 53' ' ' LYS . 6.1 p -133.29 143.28 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -145.3 155.18 43.05 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.572 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.928 HD11 ' HB3' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -136.22 -45.53 0.63 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.629 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -143.37 -75.66 0.26 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.59 0.233 . . . . 0.0 111.22 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -140.34 -55.83 0.53 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.117 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.43 61.54 0.39 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 111.261 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.928 ' HB3' HD11 ' A' ' 92' ' ' LEU . . . -111.78 -39.65 4.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.794 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.624 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . -157.99 32.78 0.51 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.629 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.2 pp20? -88.93 116.76 27.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.977 0.418 . . . . 0.0 110.854 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.51 ' H ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -143.61 156.39 44.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.742 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -120.82 129.65 53.65 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.881 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.658 ' CG2' HG21 ' A' ' 114' ' ' VAL . 3.1 mt -111.37 99.84 45.4 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 120.692 0.282 . . . . 0.0 111.596 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -88.85 140.22 4.06 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.129 2.553 . . . . 0.0 112.248 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.71 172.33 17.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.314 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -114.51 150.85 34.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.647 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.776 ' HB2' HD22 ' A' ' 86' ' ' LEU . 13.2 tp -125.38 82.28 2.05 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.886 0.374 . . . . 0.0 111.102 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.7 -175.36 4.38 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.744 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.477 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 2.8 p90 -111.46 166.3 11.25 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.769 0.318 . . . . 0.0 111.856 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.862 ' HA ' HG22 ' A' ' 17' ' ' ILE . 0.5 OUTLIER 81.12 65.18 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.331 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 15' ' ' GLN . 19.3 mt-30 66.38 133.19 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.123 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.419 ' CB ' ' HB3' ' A' ' 15' ' ' GLN . 35.4 tt0 -157.66 134.68 10.1 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.262 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.39 71.89 1.49 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.582 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -115.99 119.17 35.05 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.704 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -153.49 139.37 18.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.29 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.658 HG21 ' CG2' ' A' ' 101' ' ' ILE . 13.0 t -118.81 152.46 21.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.63 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.38 108.89 8.97 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -113.26 151.84 30.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.431 ' C ' HD12 ' A' ' 118' ' ' ILE . 13.9 p -127.9 151.52 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.845 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.624 HG23 ' HA3' ' A' ' 97' ' ' GLY . 4.2 mp -141.32 126.5 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.079 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -127.11 117.18 21.9 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.761 0.315 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -129.94 61.84 60.45 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.337 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 CA--C 1.534 0.518 0 C-N-CA 122.704 2.27 . . . . 0.0 113.03 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.802 0.334 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.1 m -118.62 164.94 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.512 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.57 -178.66 4.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.332 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 t -137.88 146.48 43.42 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 43' ' ' GLY . 25.0 t -129.57 119.26 47.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.153 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.44 ' O ' HD12 ' A' ' 39' ' ' LEU . 5.0 tmtp? -138.29 107.46 6.06 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.507 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.402 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 6.4 ptp180 -130.65 131.87 45.12 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.75 0.31 . . . . 0.0 110.833 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.3 t -126.37 139.86 52.95 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 9' ' ' ILE . 1.5 tt -106.47 121.79 59.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.584 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.413 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 26.2 mtt180 -124.29 118.31 26.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pt -120.28 127.16 75.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.415 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -112.18 130.9 55.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.954 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.593 HG21 HD11 ' A' ' 86' ' ' LEU . 83.7 m -130.71 129.41 42.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.175 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 12.7 mp0 -140.48 155.12 46.77 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.092 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.74 149.1 29.36 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.384 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 31' ' ' GLN . 11.7 t-160 -139.92 119.62 13.29 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.199 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 24.9 mt -108.26 103.65 15.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.721 0.296 . . . . 0.0 110.927 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.7 tp -169.29 131.54 1.11 Allowed Pre-proline 0 N--CA 1.463 0.219 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.94 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.25 -50.65 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.623 2.215 . . . . 0.0 112.65 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 75.64 -56.26 0.6 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.954 0.502 . . . . 0.0 111.414 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.59 124.73 47.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.718 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -55.67 109.21 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.736 2.291 . . . . 0.0 112.371 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.85 169.27 21.62 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.7 2.267 . . . . 0.0 112.767 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 p -83.72 -34.26 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.285 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.99 -50.99 0.09 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.881 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -155.42 108.03 2.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.002 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -147.76 56.98 3.02 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.177 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.9 102.62 1.24 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.703 2.269 . . . . 0.0 112.565 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.584 HG22 ' HE1' ' A' ' 81' ' ' TRP . 21.8 t -102.37 141.68 18.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.276 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -129.05 164.97 22.1 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.744 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 16' ' ' HIS . 1.2 tt0 -115.2 159.29 21.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.709 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -159.73 142.33 13.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.37 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.04 133.84 25.33 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 34' ' ' ILE . 3.9 tp -146.04 122.89 3.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.271 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.415 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -132.35 139.87 48.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.056 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.715 HG21 ' CD1' ' A' ' 55' ' ' ILE . 2.9 mt -125.87 112.13 29.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.798 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 10' ' ' ARG . 27.7 m -122.7 157.39 27.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.574 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.018 HD21 HG21 ' A' ' 68' ' ' THR . 0.2 OUTLIER -171.62 172.45 4.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.558 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 6' ' ' LYS . 52.6 mt -98.76 165.89 11.57 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.036 0.446 . . . . 0.0 111.235 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -166.04 -48.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.547 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -78.3 -10.36 59.64 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.091 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.61 -37.06 8.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.741 ' O ' HG13 ' A' ' 5' ' ' VAL . . . -106.05 49.76 0.86 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.679 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? 62.34 117.81 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.101 0.477 . . . . 0.0 111.447 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.58 32.9 0.93 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.394 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.2 mt -127.12 131.95 24.09 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.23 158.62 48.58 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.782 2.321 . . . . 0.0 112.622 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HB3' HD12 ' A' ' 93' ' ' LEU . . . -120.95 -74.35 0.62 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.331 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.3 m -108.13 -60.25 1.75 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.737 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.4 mt -119.63 -83.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.786 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.1 t80 55.69 96.83 0.02 OUTLIER 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.129 0.49 . . . . 0.0 111.383 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.48 119.76 0.79 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.286 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.697 ' CE ' HD13 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -109.9 120.88 43.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.502 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.801 HG13 ' HD2' ' A' ' 67' ' ' ARG . 5.6 t -120.39 115.67 47.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.715 ' CD1' HG21 ' A' ' 36' ' ' ILE . 2.3 mp -94.24 147.93 5.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.359 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 87' ' ' ASP . 92.4 t80 -139.03 132.68 30.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.596 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -152.41 142.32 22.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER 75.06 173.36 0.26 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.0 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.585 ' CG ' HG22 ' A' ' 61' ' ' THR . 0.3 OUTLIER -52.05 149.48 9.32 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.409 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.62 1.99 7.9 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.8 2.333 . . . . 0.0 113.888 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.585 HG22 ' CG ' ' A' ' 59' ' ' HIS . 8.0 t -74.28 8.09 2.41 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.543 0.211 . . . . 0.0 111.166 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.98 165.69 24.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.753 0.311 . . . . 0.0 110.915 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.65 -35.9 62.85 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.346 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -167.7 131.61 1.45 Allowed Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.17 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.3 -171.25 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.731 2.287 . . . . 0.0 112.479 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -88.2 143.72 26.88 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.945 0.403 . . . . 0.0 111.287 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.801 ' HD2' HG13 ' A' ' 54' ' ' VAL . 9.2 mmm180 -133.02 146.61 51.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.788 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 1.018 HG21 HD21 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -137.59 116.8 12.62 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.861 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.681 ' CE2' HG22 ' A' ' 70' ' ' THR . 1.9 p90 -162.57 -45.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.893 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.681 HG22 ' CE2' ' A' ' 69' ' ' PHE . 15.1 t -141.07 27.76 1.94 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.893 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.77 157.77 70.33 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.201 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.87 170.51 17.72 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.912 2.408 . . . . 0.0 112.125 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.6 158.23 51.13 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.68 2.253 . . . . 0.0 112.401 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.553 ' HD2' HD11 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -113.83 158.12 21.44 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.425 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -171.53 103.87 0.2 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.746 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.553 HD11 ' HD2' ' A' ' 74' ' ' PHE . 3.8 mp -125.99 123.6 64.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.052 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.34 114.42 10.11 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.92 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.08 178.95 9.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.213 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.426 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.0 mt-30 -105.39 138.99 40.7 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.73 -173.17 42.96 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.887 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.584 ' HE1' HG22 ' A' ' 29' ' ' VAL . 11.7 m0 -112.1 109.75 19.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.607 0.241 . . . . 0.0 110.646 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.6 -117.22 0.6 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.319 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.41 91.79 1.82 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.655 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.593 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 36.4 m-85 -150.93 166.82 14.23 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 120.701 0.286 . . . . 0.0 111.267 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.34 159.52 39.4 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.151 2.568 . . . . 0.0 112.927 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.593 HD11 HG21 ' A' ' 13' ' ' THR . 0.8 OUTLIER -152.7 121.8 6.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.811 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 56' ' ' TYR . 9.2 t70 -128.05 146.33 50.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.573 HD13 ' N ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -129.38 128.47 66.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 111.145 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.573 ' N ' HD13 ' A' ' 88' ' ' ILE . 90.0 p -111.32 131.18 55.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.601 HG23 ' HG2' ' A' ' 53' ' ' LYS . 2.9 p -116.02 142.75 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.706 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -139.09 150.4 45.67 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.088 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.792 HD12 ' HB3' ' A' ' 96' ' ' ALA . 1.1 tm? -137.18 -49.02 0.61 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.26 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.632 ' HB2' HD13 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -151.55 -64.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.322 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.55 -54.19 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.079 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.97 44.24 2.48 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.989 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.792 ' HB3' HD12 ' A' ' 92' ' ' LEU . . . -105.08 -50.76 3.17 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.288 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.13 26.07 0.31 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.006 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 20.2 mt-10 -70.32 100.42 1.72 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.663 0.268 . . . . 0.0 110.772 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.465 ' H ' HG12 ' A' ' 90' ' ' VAL . 1.3 tpt180 -142.7 156.45 45.03 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.525 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 134.69 41.74 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.328 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.525 HG12 HG21 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -126.46 119.69 23.21 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 121.009 0.433 . . . . 0.0 111.909 -179.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.67 151.44 10.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.275 2.65 . . . . 0.0 112.548 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.472 ' CD2' ' HB3' ' A' ' 112' ' ' TYR . 7.3 m80 -147.77 167.0 25.83 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.949 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -129.62 149.92 51.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.626 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 tp -128.68 93.88 3.73 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 111.224 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -174.85 45.39 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.236 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -141.44 127.33 19.32 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -56.58 119.84 6.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.405 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 3.2 mm-40 69.23 66.69 0.27 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.795 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 1.2 tp10 -92.52 137.04 32.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.576 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.5 t -143.35 72.56 1.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.439 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.472 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 6.7 m-85 -121.08 119.27 31.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.335 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -144.82 147.2 32.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.366 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.525 HG21 HG12 ' A' ' 101' ' ' ILE . 24.0 t -122.56 148.84 26.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.913 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.08 109.02 8.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.451 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 137.51 51.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.153 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.72 150.42 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.73 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.4 mt -137.95 126.38 31.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -130.31 130.15 44.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.34 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -152.89 65.2 5.62 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.27 -33.22 15.04 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.533 2.155 . . . . 0.0 112.774 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.63 -65.86 1.08 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.83 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.411 -0.804 . . . . 0.0 111.13 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.594 0.235 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 2' ' ' VAL . 11.6 p -84.24 118.26 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.857 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.77 -179.89 6.88 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.462 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -146.44 159.44 43.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.838 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -130.57 119.12 45.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.19 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' HD13 ' A' ' 39' ' ' LEU . 18.8 mttt -134.88 115.95 14.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.169 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.443 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 39.3 mtt180 -137.39 165.96 24.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.08 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 t -178.09 131.13 0.14 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.855 HD12 HD12 ' A' ' 38' ' ' LEU . 14.6 tt -104.23 118.1 50.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 121.125 0.488 . . . . 0.0 110.627 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -115.03 107.4 15.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.657 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.9 pt -114.76 131.89 65.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -124.1 135.46 53.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.113 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.736 HG22 HD13 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -135.54 105.75 6.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.825 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -119.34 147.58 44.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.188 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.594 ' HG2' ' HA ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -143.56 147.04 33.83 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.083 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -156.22 120.37 4.47 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.68 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.466 HG12 ' HB3' ' A' ' 30' ' ' ARG . 25.0 mt -76.91 140.84 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.697 0.285 . . . . 0.0 111.027 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.29 82.94 4.23 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.642 ' O ' HG23 ' A' ' 21' ' ' VAL . 35.7 Cg_endo -67.53 -50.51 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.593 2.195 . . . . 0.0 112.666 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 55.99 30.66 16.53 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.33 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 19' ' ' PRO . 22.1 t -125.49 139.3 33.63 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.797 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.95 167.42 1.13 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.906 2.404 . . . . 0.0 112.544 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.72 -2.53 12.34 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.623 2.215 . . . . 0.0 113.195 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.19 -55.53 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 120.62 0.248 . . . . 0.0 111.37 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -123.21 159.74 28.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.205 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -90.62 165.05 13.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.258 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -168.04 87.25 0.71 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.048 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.62 95.41 0.71 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.747 2.298 . . . . 0.0 112.997 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.6 t -141.0 136.17 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.466 ' HB3' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -139.33 158.28 44.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.041 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 160.92 14.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.422 ' HB3' ' NE2' ' A' ' 15' ' ' GLN . 32.6 p-90 -158.4 148.16 19.66 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.034 0.445 . . . . 0.0 111.762 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -143.48 124.42 14.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.56 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 12' ' ' LYS . 9.3 tp -130.33 141.47 46.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 111.756 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.48 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.9 OUTLIER -149.44 143.78 25.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.778 HG21 HG12 ' A' ' 55' ' ' ILE . 4.2 mp -136.43 106.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.538 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 73' ' ' PRO . 21.7 t -113.71 135.48 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.73 0.3 . . . . 0.0 111.281 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 9' ' ' ILE . 1.4 tt -155.63 135.37 12.67 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.713 HD22 ' HB2' ' A' ' 42' ' ' GLU . 11.3 mt -70.76 164.39 25.26 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.268 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -161.23 -52.8 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.892 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.35 -13.61 61.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.584 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.713 ' HB2' HD22 ' A' ' 39' ' ' LEU . 2.4 tt0 -103.13 -34.7 8.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.387 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.82 40.36 2.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.816 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 65.37 91.16 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.66 52.16 1.84 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.25 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.29 112.59 11.09 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.91 159.4 53.03 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.635 2.223 . . . . 0.0 112.449 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.723 ' HB3' HD21 ' A' ' 93' ' ' LEU . . . -146.91 -62.5 0.29 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.688 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.567 HG22 HG13 ' A' ' 50' ' ' ILE . 86.2 m -106.74 -68.49 0.88 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 49' ' ' THR . 46.1 mt -113.8 -80.07 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.948 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 52.5 t80 55.39 92.76 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.874 0.368 . . . . 0.0 111.549 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 3.8 t70 -169.26 116.92 0.62 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.23 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.701 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -114.9 120.22 39.21 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.552 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.467 HG22 ' OG ' ' A' ' 89' ' ' SER . 34.6 m -116.87 159.34 16.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.012 0.434 . . . . 0.0 111.524 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.778 HG12 HG21 ' A' ' 36' ' ' ILE . 4.2 mp -137.18 130.43 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.406 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -126.47 143.06 51.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.893 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -167.27 126.0 1.34 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 tp 70.71 157.07 0.16 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.503 ' HB2' ' CD2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -89.32 -56.7 0.28 Allowed Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.419 ' HD2' ' HG ' ' A' ' 58' ' ' LEU . 84.1 Cg_exo -46.65 -30.65 9.21 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.009 2.473 . . . . 0.0 113.699 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.7 p -73.13 8.57 1.57 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -26.95 64.6 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.19 -41.29 68.43 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.412 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -140.21 82.72 16.49 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.062 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -61.47 172.73 3.2 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.842 2.361 . . . . 0.0 112.188 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 4.4 m-80 -106.73 136.99 45.59 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.166 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.61 151.22 41.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.173 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 87.5 m -130.45 102.61 6.24 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -130.83 -48.53 1.04 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.406 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 t -140.69 -36.75 0.46 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.791 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.05 159.13 1.53 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.3 169.65 21.1 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.094 2.53 . . . . 0.0 112.851 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HB3' HG13 ' A' ' 37' ' ' VAL . 39.9 Cg_exo -57.38 152.04 49.2 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.944 2.429 . . . . 0.0 113.085 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -100.42 141.39 33.33 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.977 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.29 89.34 0.54 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.462 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.1 143.09 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.733 0.302 . . . . 0.0 111.658 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.03 143.43 46.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.72 -177.27 6.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.205 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -120.11 136.71 54.5 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -175.29 -170.0 37.73 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.92 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -127.29 110.41 12.81 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.853 0.358 . . . . 0.0 110.976 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.56 128.17 1.2 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.63 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.67 117.39 2.48 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.313 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.571 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 12.1 m-85 -157.32 166.22 17.09 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 120.579 0.228 . . . . 0.0 110.905 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.6 Cg_endo -69.49 168.33 21.5 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.029 2.486 . . . . 0.0 113.293 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.648 HD22 ' HB2' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -151.73 118.66 5.82 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.473 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.26 154.37 38.92 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.363 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.748 ' CG2' HG23 ' A' ' 55' ' ' ILE . 2.3 pt -140.91 151.46 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.47 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.467 ' OG ' HG22 ' A' ' 54' ' ' VAL . 79.8 p -137.06 147.66 46.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.043 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.701 HG13 ' HG2' ' A' ' 53' ' ' LYS . 21.6 t -126.97 139.58 51.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.301 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 30.0 m-85 -144.48 150.94 38.43 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.672 HD21 HG21 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -142.13 -47.1 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.528 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -153.0 -71.5 0.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.588 0.232 . . . . 0.0 111.247 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -136.03 -68.6 0.5 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.041 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 35.99 1.32 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.107 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.644 ' HB1' HG12 ' A' ' 120' ' ' ILE . . . -77.74 -38.18 47.61 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.43 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.525 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . -168.27 37.38 0.21 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.213 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 6.9 tt0 -80.15 103.8 10.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -142.18 151.88 42.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.947 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.427 ' HG2' ' CB ' ' A' ' 89' ' ' SER . 8.2 mtpt -131.93 149.79 52.34 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.102 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.584 HG21 HG11 ' A' ' 114' ' ' VAL . 1.4 tp -148.71 123.9 5.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -87.56 155.13 7.73 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.217 2.611 . . . . 0.0 112.451 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.13 169.15 23.67 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.417 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.415 ' C ' HD21 ' A' ' 86' ' ' LEU . 6.5 m-20 -126.77 140.67 52.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.13 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.736 HD13 HG22 ' A' ' 13' ' ' THR . 58.1 tp -121.9 93.32 3.96 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.996 0.426 . . . . 0.0 111.122 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.99 -168.7 1.44 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.305 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.594 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -116.07 164.01 15.09 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.08 0.466 . . . . 0.0 112.091 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 84.67 69.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.523 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 63.65 103.58 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.958 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -126.82 134.2 50.61 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.14 67.4 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.592 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -119.37 119.43 33.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.627 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 1.3 pt-20 -151.47 149.56 29.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.383 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 101' ' ' ILE . 4.5 t -122.41 149.94 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.623 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -137.75 108.65 6.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.403 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -113.8 141.97 46.65 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.16 148.89 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.983 0.421 . . . . 0.0 111.927 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.672 HG21 HD21 ' A' ' 92' ' ' LEU . 4.3 mp -134.65 111.29 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.403 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.427 ' CG ' ' HD3' ' A' ' 121' ' ' PRO . 43.4 tt0 -125.3 114.67 19.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.605 0.24 . . . . 0.0 111.539 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.668 ' CD1' HG22 ' A' ' 118' ' ' ILE . 4.1 mp -139.91 56.21 7.65 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 111.314 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.427 ' HD3' ' CG ' ' A' ' 119' ' ' GLN . 83.4 Cg_endo -77.16 -172.6 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.67 2.247 . . . . 0.0 112.454 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 tp -100.69 89.64 3.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 110.553 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.916 -179.667 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.636 0.255 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.9 -48.9 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.393 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.14 97.75 3.57 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.802 0.334 . . . . 0.0 110.893 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.3 148.72 33.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.038 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 43' ' ' GLY . 21.5 t -140.04 119.23 12.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.181 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.34 106.81 6.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.383 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -127.61 163.11 24.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.363 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.485 HG22 HD23 ' A' ' 39' ' ' LEU . 5.2 t -170.39 129.17 0.86 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.541 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.5 tt -109.84 118.37 56.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.988 0.423 . . . . 0.0 110.882 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.684 ' O ' HG22 ' A' ' 37' ' ' VAL . 17.8 mtt85 -123.92 117.7 25.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.705 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.547 ' CD1' HD13 ' A' ' 88' ' ' ILE . 19.8 pt -113.05 136.65 48.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.198 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 1.8 mptp? -108.38 134.94 50.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.6 m -128.02 128.27 44.69 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.889 0.376 . . . . 0.0 111.551 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -145.86 127.78 15.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.65 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -140.49 146.15 37.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.755 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -143.49 119.39 10.6 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.509 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.753 HG23 ' HG2' ' A' ' 30' ' ' ARG . 39.6 mt -95.28 118.18 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.102 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -173.19 103.44 0.31 Allowed Pre-proline 0 N--CA 1.466 0.375 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.2 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 28' ' ' PRO . 41.1 Cg_endo -68.67 -41.14 6.35 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.564 2.176 . . . . 0.0 112.984 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 57.48 35.86 26.34 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.522 HG12 ' HD2' ' A' ' 23' ' ' PRO . 8.9 t -109.05 105.33 57.06 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.729 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.471 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 53.2 Cg_exo -53.46 -49.16 18.32 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.625 2.217 . . . . 0.0 112.73 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HD2' HG12 ' A' ' 21' ' ' VAL . 93.9 Cg_endo -78.3 -8.62 16.32 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.314 2.009 . . . . 0.0 113.223 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t 63.28 94.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.827 0.346 . . . . 0.0 110.99 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.514 ' OE2' HG21 ' A' ' 21' ' ' VAL . 7.6 pt-20 -65.28 -55.44 18.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.286 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 172.06 -72.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.786 0.327 . . . . 0.0 111.288 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -93.03 148.08 35.07 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.95 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 74.5 Cg_endo -76.29 117.02 4.48 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.754 2.303 . . . . 0.0 112.395 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.796 HG13 ' HA2' ' A' ' 80' ' ' GLY . 21.7 t -72.15 110.63 5.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.718 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.753 ' HG2' HG23 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -106.93 165.08 11.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.886 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.77 156.55 34.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.381 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -157.65 141.29 15.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.427 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.7 t -147.2 117.74 7.49 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.718 HD11 HD13 ' A' ' 105' ' ' LEU . 39.6 mt -135.68 136.36 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.853 0.359 . . . . 0.0 111.635 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.98 155.28 44.52 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.579 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.627 HG12 HG21 ' A' ' 55' ' ' ILE . 4.0 mp -131.38 109.0 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.26 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 10' ' ' ARG . 34.2 m -111.61 146.26 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.376 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD22 ' CG2' ' A' ' 68' ' ' THR . 1.2 pp -163.7 170.15 17.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.313 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.581 HD12 ' HG3' ' A' ' 42' ' ' GLU . 4.0 mm? -108.42 165.29 11.62 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -168.23 -47.18 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.778 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -3.86 45.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.771 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HG3' HD12 ' A' ' 39' ' ' LEU . 3.9 mm-40 -104.27 -35.38 8.01 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.514 0.197 . . . . 0.0 111.138 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.543 ' O ' HG13 ' A' ' 5' ' ' VAL . . . -113.34 45.92 1.25 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.461 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt 66.7 123.25 0.02 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.046 0.45 . . . . 0.0 111.525 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.66 29.06 2.12 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.429 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.9 mt -129.63 134.5 26.28 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.016 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.63 -174.23 1.94 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.672 2.248 . . . . 0.0 112.473 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.678 ' HB3' ' CD1' ' A' ' 93' ' ' LEU . . . -144.32 -51.89 0.31 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.233 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 p -126.0 -52.36 1.54 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.562 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.47 -89.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.093 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 40.3 t80 57.09 97.74 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.242 0.544 . . . . 0.0 110.861 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.65 109.96 1.27 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.53 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.82 ' HG2' HG13 ' A' ' 90' ' ' VAL . 1.4 mttm -112.55 137.05 51.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.354 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.503 ' C ' HD13 ' A' ' 55' ' ' ILE . 12.5 p -139.36 149.81 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.015 0.436 . . . . 0.0 111.652 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.878 HG23 HG22 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -126.72 140.66 48.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.42 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.86 130.57 38.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.704 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.447 ' O ' ' HB ' ' A' ' 61' ' ' THR . 3.8 p80 -132.89 113.94 13.46 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.238 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 57' ' ' HIS . 1.3 mp 72.35 176.5 0.27 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.55 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 59.2 t-80 -86.84 -41.28 0.54 Allowed Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 59' ' ' HIS . 38.2 Cg_endo -72.53 2.19 5.44 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.206 1.937 . . . . 0.0 114.174 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 10.1 t -68.16 0.42 3.72 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 121.239 -0.184 . . . . 0.0 111.432 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -56.36 -33.35 65.61 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.457 0.17 . . . . 0.0 111.161 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.65 -43.9 69.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.282 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -157.25 86.54 2.74 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.958 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.04 169.37 18.15 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.702 2.268 . . . . 0.0 112.472 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.475 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 2.7 m120 -98.69 133.78 42.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HG3' HG23 ' A' ' 54' ' ' VAL . 2.6 mtt180 -129.19 153.84 47.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.05 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 35.1 m -132.29 99.16 4.6 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.017 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -124.77 -49.17 1.76 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.64 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.4 t -174.49 50.81 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.155 0.502 . . . . 0.0 110.397 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.45 162.0 57.25 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.152 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.21 162.48 14.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.942 2.428 . . . . 0.0 112.625 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.39 168.68 3.65 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.11 2.54 . . . . 0.0 112.851 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.95 165.8 13.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.49 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.37 94.11 0.22 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.597 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.29 115.37 48.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -137.77 126.51 23.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.915 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -144.87 -179.13 6.4 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.426 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -130.28 177.34 7.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.176 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.796 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 96.09 -162.1 22.76 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.123 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -67.32 128.83 37.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.4 126.88 0.86 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.669 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.77 110.82 0.29 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.75 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.404 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 12.4 m-85 -155.4 166.26 16.59 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 120.662 0.268 . . . . 0.0 111.272 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.416 ' C ' HD12 ' A' ' 86' ' ' LEU . 31.6 Cg_exo -60.34 177.32 0.6 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.157 2.572 . . . . 0.0 113.229 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.653 HD11 ' HB2' ' A' ' 105' ' ' LEU . 5.3 mp -142.84 167.01 23.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.993 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -155.15 122.9 5.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.298 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.878 HG22 HG23 ' A' ' 55' ' ' ILE . 11.8 pt -129.84 123.24 56.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.686 0.279 . . . . 0.0 111.144 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -119.85 142.43 48.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.78 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.82 HG13 ' HG2' ' A' ' 53' ' ' LYS . 4.2 t -126.71 137.41 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.806 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.476 ' CD2' ' CG ' ' A' ' 98' ' ' GLU . 48.0 m-85 -145.47 145.78 31.23 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.736 HD22 ' CG2' ' A' ' 118' ' ' ILE . 3.5 tp -138.49 -68.44 0.45 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.678 ' CD1' ' HB3' ' A' ' 48' ' ' ALA . 6.4 tp -136.64 -66.89 0.52 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.357 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' HB3' ' CE ' ' A' ' 95' ' ' LYS . 2.6 mt-10 -166.07 -54.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.436 ' CE ' ' HB3' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -115.75 45.96 1.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.165 0.507 . . . . 0.0 110.676 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -116.59 -49.53 2.65 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.217 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.4 -81.82 0.03 OUTLIER Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.396 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.6 OUTLIER 47.19 59.91 3.76 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 111.554 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.08 136.95 30.66 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.166 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 2.9 pttt -117.85 149.98 39.94 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.59 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 tt -149.45 123.5 4.63 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.961 0.41 . . . . 0.0 111.562 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.3 158.85 13.01 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.707 2.271 . . . . 0.0 112.138 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.31 172.49 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -125.59 146.52 49.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.569 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.718 HD13 HD11 ' A' ' 34' ' ' ILE . 5.5 tp -139.13 74.05 1.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -164.61 46.65 0.1 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.13 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -140.25 132.58 28.34 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.339 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 3.3 pp -61.2 131.7 51.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.07 61.02 0.77 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.819 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.13 131.7 37.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.69 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.5 t -137.14 69.96 1.4 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.751 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.36 153.35 20.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.012 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 12' ' ' LYS . 3.3 tt0 -164.66 136.61 4.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.252 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.62 143.65 33.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -139.34 108.51 6.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.719 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.408 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 1.6 m-70 -113.05 119.01 36.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.477 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.45 147.67 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.631 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.736 ' CG2' HD22 ' A' ' 92' ' ' LEU . 20.0 mt -142.12 110.85 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.525 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -129.88 125.89 36.67 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.536 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.412 HG12 ' CD2' ' A' ' 92' ' ' LEU . 0.8 OUTLIER -152.78 54.61 1.26 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.669 179.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.29 -31.38 11.72 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.446 2.097 . . . . 0.0 112.506 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.85 -33.13 27.16 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.283 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.865 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 m -62.2 162.37 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.863 0.363 . . . . 0.0 111.678 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 122' ' ' LEU . . . -85.73 93.49 8.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.316 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.29 121.14 6.55 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.49 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.666 HG22 ' HG3' ' A' ' 44' ' ' LYS . 19.5 t -126.94 119.14 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 111.338 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.25 104.91 7.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.268 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.601 ' HB3' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -118.36 169.83 9.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.409 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -165.89 123.79 1.5 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.713 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 36' ' ' ILE . 8.8 tt -108.86 124.55 65.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.924 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HG3' ' HG2' ' A' ' 115' ' ' GLU . 0.2 OUTLIER -120.11 120.33 35.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.023 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.783 HD13 HG12 ' A' ' 88' ' ' ILE . 7.8 pt -123.4 132.71 70.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.071 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 4.1 mtmt -120.41 146.17 46.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.22 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.449 HG21 HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -136.82 116.85 13.31 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.687 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 3.8 tt0 -123.74 148.83 46.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.987 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -154.87 144.1 21.12 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.979 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -147.88 119.59 8.05 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.343 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.422 HG23 ' HG2' ' A' ' 30' ' ' ARG . 45.0 mt -89.31 100.39 10.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.77 0.319 . . . . 0.0 110.633 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.04 108.22 1.92 Allowed Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.775 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.51 -52.94 0.88 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.662 2.241 . . . . 0.0 112.952 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 55.65 21.69 4.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.739 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.471 HG23 ' HD2' ' A' ' 22' ' ' PRO . 8.4 p -125.77 138.16 31.44 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.032 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.471 ' HD2' HG23 ' A' ' 21' ' ' VAL . 15.6 Cg_endo -57.39 145.88 85.77 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.667 2.245 . . . . 0.0 112.317 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.67 96.49 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.79 2.327 . . . . 0.0 112.568 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.591 HG13 ' HG3' ' A' ' 25' ' ' GLU . 13.2 p -115.55 -38.31 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.433 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.591 ' HG3' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -173.93 -42.75 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.012 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.36 -178.3 3.94 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.409 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -174.73 -53.18 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.285 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.42 87.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.632 2.221 . . . . 0.0 112.594 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.31 118.28 35.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.097 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.422 ' HG2' HG23 ' A' ' 17' ' ' ILE . 3.7 mtt180 -138.58 164.23 30.0 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.597 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.39 151.17 22.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.55 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -155.74 132.4 10.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.419 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 14' ' ' GLN . 27.7 t -143.88 125.91 15.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.539 HG21 ' CG ' ' A' ' 57' ' ' HIS . 1.9 tp -135.79 129.7 48.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.5 OUTLIER -135.78 157.06 47.79 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 9' ' ' ILE . 12.5 tt -154.54 130.44 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.736 HG12 ' CB ' ' A' ' 73' ' ' PRO . 25.4 m -134.97 160.73 40.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.657 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.976 HD21 HG21 ' A' ' 68' ' ' THR . 0.2 OUTLIER -159.32 175.1 13.78 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.934 0.397 . . . . 0.0 111.531 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.56 HD22 ' HB2' ' A' ' 42' ' ' GLU . 3.7 mt -106.79 166.13 10.81 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.101 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.85 -56.29 0.06 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.209 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -54.98 -40.33 69.93 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.233 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.56 ' HB2' HD22 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -89.5 -29.44 18.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.1 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.428 ' C ' HG13 ' A' ' 5' ' ' VAL . . . -110.31 59.05 0.37 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.861 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.666 ' HG3' HG22 ' A' ' 5' ' ' VAL . 7.4 mttp 60.21 97.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.912 0.387 . . . . 0.0 111.618 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -24.66 62.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.507 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 1.9 mt -100.91 123.72 44.4 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-O 120.577 0.227 . . . . 0.0 110.837 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 46' ' ' ILE . 42.7 Cg_exo -56.93 169.04 2.08 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.874 2.382 . . . . 0.0 112.506 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.662 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . . . -139.65 -51.48 0.51 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.621 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.461 ' O ' HD13 ' A' ' 50' ' ' ILE . 7.0 m -110.49 -65.62 1.15 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.783 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 49' ' ' THR . 33.5 mm -138.05 -80.68 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 39.4 t80 63.08 100.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.025 0.44 . . . . 0.0 110.885 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 8.7 t70 -160.83 110.69 1.71 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.565 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.802 ' HD3' HD22 ' A' ' 38' ' ' LEU . 8.0 mttp -104.89 107.35 18.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.542 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.44 141.78 17.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.608 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 36' ' ' ILE . 1.7 mp -121.24 148.69 24.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.196 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -143.99 128.4 17.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.298 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.539 ' CG ' HG21 ' A' ' 34' ' ' ILE . 6.9 p80 -144.18 120.48 10.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.539 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 57' ' ' HIS . 0.8 OUTLIER 72.75 163.12 0.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.764 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.467 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -81.79 -46.99 1.03 Allowed Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 58' ' ' LEU . 81.5 Cg_exo -46.52 -24.78 2.96 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.078 2.519 . . . . 0.0 114.194 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.6 p -77.01 6.73 5.83 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.484 0.183 . . . . 0.0 111.06 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -60.62 -33.65 73.09 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 111.021 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.95 76.56 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.298 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -151.85 94.25 3.36 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.388 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.45 -175.31 1.28 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.892 2.395 . . . . 0.0 112.362 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 17.7 m120 -113.46 144.37 42.93 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.235 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.66 150.79 36.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.976 HG21 HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -133.06 115.87 15.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.844 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CE2' HG22 ' A' ' 70' ' ' THR . 3.2 p90 -156.75 -47.62 0.07 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.583 HG22 ' CE2' ' A' ' 69' ' ' PHE . 14.2 t -129.4 29.08 5.14 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.006 0.431 . . . . 0.0 110.766 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -141.41 159.08 62.09 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.404 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 42.8 Cg_endo -67.45 173.81 8.23 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.908 2.405 . . . . 0.0 112.469 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.736 ' CB ' HG12 ' A' ' 37' ' ' VAL . 20.3 Cg_endo -59.9 -179.3 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.797 2.331 . . . . 0.0 112.688 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.47 157.74 44.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.793 0.33 . . . . 0.0 110.794 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.65 81.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.785 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.71 122.71 51.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.168 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.64 115.53 16.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.491 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -139.34 174.27 10.69 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.05 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.21 124.68 31.1 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.971 0.415 . . . . 0.0 110.977 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.02 -157.05 21.77 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.126 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 13.6 p-90 -82.88 116.59 22.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 111.07 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.451 ' HA3' HD21 ' A' ' 58' ' ' LEU . . . -168.75 -121.79 0.59 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.727 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.754 ' HA2' HD23 ' A' ' 105' ' ' LEU . . . 71.67 101.93 0.06 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.959 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.0 m-85 -162.96 171.04 6.77 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.63 0.252 . . . . 0.0 110.96 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 77.3 Cg_exo -52.01 166.53 0.63 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.045 2.496 . . . . 0.0 113.243 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.707 HD11 ' HB2' ' A' ' 105' ' ' LEU . 4.2 mp -142.92 169.74 17.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.414 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -160.43 138.82 10.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.176 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.783 HG12 HD13 ' A' ' 11' ' ' ILE . 6.4 tp -136.54 128.17 43.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.05 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.8 p -127.06 116.2 20.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.732 HG21 HG21 ' A' ' 9' ' ' ILE . 21.6 t -104.22 120.92 55.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.154 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 13.2 m-85 -126.1 156.02 40.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.736 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.618 HD13 ' CG2' ' A' ' 118' ' ' ILE . 0.8 OUTLIER -145.7 -166.57 2.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.56 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.3 pp -92.06 34.47 1.02 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 111.107 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -165.66 159.07 16.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.329 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.47 47.53 1.19 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.071 0.462 . . . . 0.0 110.772 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -116.25 -37.34 3.81 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.614 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.591 ' H ' HD21 ' A' ' 92' ' ' LEU . . . -118.65 30.68 5.85 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.161 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 16.2 mt-10 -92.57 92.77 8.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.825 0.313 . . . . 0.0 110.451 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -142.23 153.26 43.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.885 0.374 . . . . 0.0 111.817 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' C ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -135.75 146.37 47.57 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.786 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 88' ' ' ILE . 3.7 mp -141.78 122.48 8.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.64 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.06 129.26 4.56 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.866 2.377 . . . . 0.0 112.352 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.29 172.46 6.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.287 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -134.59 138.9 44.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.62 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.754 HD23 ' HA2' ' A' ' 83' ' ' GLY . 0.9 OUTLIER -130.33 84.58 2.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.6 37.31 0.32 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.175 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -141.9 132.03 24.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.13 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -59.88 131.8 51.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.747 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 71.58 74.22 0.17 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.441 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.73 131.37 55.0 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.59 61.63 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.292 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -105.6 119.31 38.8 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.534 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 3.2 pt-20 -142.16 139.6 32.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.126 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.564 ' CG1' HD11 ' A' ' 11' ' ' ILE . 5.8 p -131.96 148.97 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.69 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.466 ' HG2' ' HG3' ' A' ' 10' ' ' ARG . 1.2 mp0 -133.01 151.24 52.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.341 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -136.31 127.25 27.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.222 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.83 136.73 26.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.258 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.618 ' CG2' HD13 ' A' ' 92' ' ' LEU . 27.4 mt -121.49 111.22 30.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.58 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.39 117.49 20.67 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.349 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.633 ' N ' HD13 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -147.38 55.75 2.51 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.744 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.97 127.16 9.19 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.466 2.111 . . . . 0.0 112.244 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 4.2 mm? -108.04 69.78 0.74 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.748 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.7 t30 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.981 -179.757 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -74.08 -34.6 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.614 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.72 114.3 6.21 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.774 0.321 . . . . 0.0 111.282 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 t -143.5 155.61 44.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.471 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.49 119.44 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.654 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HG3' ' HG2' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -137.47 117.25 13.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.35 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.517 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 75.8 mtt180 -139.8 138.73 36.06 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.514 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 t -147.46 111.18 5.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.441 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.981 HD11 HD11 ' A' ' 36' ' ' ILE . 1.3 tt -104.77 118.28 51.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.637 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HD3' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -121.36 120.09 34.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.725 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.554 HG22 ' HB ' ' A' ' 36' ' ' ILE . 9.2 pt -118.7 126.3 75.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 111.33 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.491 ' HD2' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -114.26 130.81 56.65 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.845 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.595 HG23 ' CD1' ' A' ' 34' ' ' ILE . 3.0 m -127.88 118.01 22.85 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -129.29 140.63 51.35 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.986 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.487 HE22 HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -139.92 138.76 35.87 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.759 0.314 . . . . 0.0 111.333 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -137.92 119.73 15.25 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.576 HG23 ' HB3' ' A' ' 30' ' ' ARG . 6.7 mt -114.55 100.32 10.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.773 0.32 . . . . 0.0 111.149 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.78 84.52 0.24 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.907 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.6 -54.24 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.512 2.141 . . . . 0.0 112.584 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -176.09 -66.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.716 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -125.15 126.09 25.21 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.644 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.93 111.13 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.59 2.193 . . . . 0.0 112.232 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 152.24 35.22 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.049 2.499 . . . . 0.0 113.233 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 p -84.55 -36.82 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.58 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -145.26 37.42 1.13 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.627 0.251 . . . . 0.0 111.613 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -143.62 154.59 43.7 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.758 0.314 . . . . 0.0 111.245 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -82.46 125.11 77.11 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.735 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.71 162.25 42.67 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.733 2.289 . . . . 0.0 112.691 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG13 ' HA2' ' A' ' 80' ' ' GLY . 21.5 t -87.9 146.4 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.576 ' HB3' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -126.71 165.13 19.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.279 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.48 149.35 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -145.18 143.28 30.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.453 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.493 ' O ' HD13 ' A' ' 34' ' ' ILE . 1.6 m -136.12 121.95 19.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.742 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 105' ' ' LEU . 19.9 mm -130.4 117.42 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.622 0.248 . . . . 0.0 111.479 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 10.9 pt-20 -134.73 149.38 50.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.094 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.981 HD11 HD11 ' A' ' 9' ' ' ILE . 14.0 tt -152.18 130.49 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.207 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.486 HG23 ' HD3' ' A' ' 10' ' ' ARG . 4.3 m -137.24 119.15 18.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.962 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' A' ' 9' ' ' ILE . 52.8 tp -129.7 142.46 50.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.31 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 42' ' ' GLU . 4.3 tt -118.1 152.25 35.95 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.077 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.593 ' N ' HD23 ' A' ' 39' ' ' LEU . 4.7 p-10 -176.87 -30.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.318 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 7.1 p30 -53.91 -27.89 33.4 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.631 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.807 ' HB2' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.02 -33.21 59.66 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.554 0.216 . . . . 0.0 110.589 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.83 -74.33 0.93 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.884 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -129.47 -48.11 1.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 41' ' ' ASP . 17.1 tt0 71.09 7.0 6.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.774 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.718 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.1 pp -126.2 140.4 36.94 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-O 120.733 0.301 . . . . 0.0 111.413 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.63 -171.47 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.985 2.456 . . . . 0.0 112.374 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.7 ' HB3' ' CB ' ' A' ' 93' ' ' LEU . . . -160.81 -64.98 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.391 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.451 ' O ' HD13 ' A' ' 50' ' ' ILE . 17.7 m -96.97 -56.42 2.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.172 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 49' ' ' THR . 48.6 mm -132.84 -85.28 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.839 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 44.3 t80 63.24 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.145 0.498 . . . . 0.0 111.136 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -164.19 102.17 0.86 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.571 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.605 ' CG ' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -97.72 102.96 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.554 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' CD ' ' A' ' 67' ' ' ARG . 8.7 m -103.07 143.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.478 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 ' OG1' ' A' ' 68' ' ' THR . 2.4 mt -125.41 146.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.521 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.03 138.85 28.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.929 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.431 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 18.7 p-80 -163.77 124.36 2.21 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.573 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER 67.37 168.38 0.25 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.79 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.447 ' HB2' ' CD2' ' A' ' 84' ' ' PHE . 1.9 t60 -61.31 130.64 91.85 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.693 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.4 -22.32 20.68 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.916 2.41 . . . . 0.0 113.245 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 35.5 p -67.09 -3.07 6.46 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.76 -73.98 0.45 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.386 0.136 . . . . 0.0 111.056 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.35 -34.08 75.97 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.333 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 1.2 t-20 72.57 146.8 0.12 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.429 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 64' ' ' ASN . 31.7 Cg_exo -58.82 142.19 98.67 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.993 2.462 . . . . 0.0 112.479 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.485 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 1.7 m-80 -115.14 155.28 27.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.093 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.782 ' CD ' HG12 ' A' ' 54' ' ' VAL . 0.8 OUTLIER -143.68 153.85 42.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 -179.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.868 HG23 ' HD2' ' A' ' 72' ' ' PRO . 45.6 m -138.44 117.21 12.3 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.792 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -125.47 -54.63 1.56 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -89.49 -67.58 0.83 Allowed 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.379 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.478 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 0.3 OUTLIER 179.09 61.06 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.468 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.868 ' HD2' HG23 ' A' ' 68' ' ' THR . 94.8 Cg_endo -93.07 103.33 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.92 2.413 . . . . 0.0 113.207 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 71' ' ' ASP . 86.4 Cg_endo -84.43 178.91 4.78 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.652 2.235 . . . . 0.0 112.382 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -167.94 153.03 6.77 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.62 111.5 0.07 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.968 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 76' ' ' ILE . 6.1 tp -159.62 142.01 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.853 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 14.7 pt-20 -132.27 111.6 11.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.479 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -121.39 168.3 11.82 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.338 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -109.94 176.58 5.01 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.773 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.549 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 110.91 -154.94 16.38 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.168 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -93.17 110.11 21.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 0.0 110.403 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.17 91.67 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.433 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -142.91 111.23 0.65 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.473 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 9.7 m-85 -160.94 168.56 11.47 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 120.613 0.244 . . . . 0.0 111.04 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.34 160.53 26.85 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.064 2.509 . . . . 0.0 112.966 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.082 HD22 HD23 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -150.89 123.05 8.28 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.578 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -127.55 145.89 50.71 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.95 0.405 . . . . 0.0 111.71 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 9' ' ' ILE . 8.9 tt -129.59 118.8 46.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.249 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.435 ' OG ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -119.47 119.59 34.33 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 -179.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.605 HG13 ' CG ' ' A' ' 53' ' ' LYS . 4.5 t -106.26 142.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.096 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -141.09 157.27 45.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.877 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -151.35 -175.74 5.3 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.733 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.7 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -72.63 -20.4 61.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.15 -169.23 1.66 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.496 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 58.35 1.02 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.842 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.51 4.77 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.778 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.445 ' C ' HD21 ' A' ' 92' ' ' LEU . . . -137.7 44.34 1.14 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.991 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -113.36 90.44 3.34 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.884 0.373 . . . . 0.0 111.025 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -142.66 156.59 45.07 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.532 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 5.9 pttm -112.2 140.59 46.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.479 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.463 HG22 ' CE1' ' A' ' 103' ' ' HIS . 2.1 mp -133.34 109.0 12.39 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.667 0.27 . . . . 0.0 111.506 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -88.21 147.39 6.52 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.221 2.614 . . . . 0.0 113.625 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.471 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . 8.7 m-70 -148.58 172.28 14.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.444 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -134.24 129.73 36.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.942 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.082 HD23 HD22 ' A' ' 86' ' ' LEU . 1.3 pp -113.97 100.95 8.8 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.984 0.421 . . . . 0.0 111.244 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -177.87 44.86 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.34 136.42 31.48 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.776 0.322 . . . . 0.0 111.535 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.439 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -61.73 128.95 38.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.637 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 64.45 65.3 0.66 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.26 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -105.18 131.77 52.23 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.813 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.0 p -132.79 66.71 1.55 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.869 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -104.9 119.64 39.49 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.702 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.491 ' CD ' ' HD2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -148.01 143.48 27.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.292 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.552 ' CG1' HD11 ' A' ' 11' ' ' ILE . 2.8 p -141.11 142.77 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.532 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -127.77 146.02 50.72 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.101 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 130.81 40.78 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.7 m -111.66 140.13 32.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.094 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.676 HG22 ' CD1' ' A' ' 120' ' ' ILE . 10.9 mt -139.99 111.79 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.784 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.409 ' HG2' ' HG3' ' A' ' 6' ' ' LYS . 46.7 mt-30 -129.9 107.55 9.46 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.265 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.676 ' CD1' HG22 ' A' ' 118' ' ' ILE . 3.9 mp -137.2 58.31 17.35 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.26 -46.0 1.15 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.47 2.113 . . . . 0.0 112.62 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.39 40.68 0.47 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.986 0.422 . . . . 0.0 110.552 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.362 -179.9 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.682 0.277 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.81 146.71 8.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.084 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' A' ' 122' ' ' LEU . . . -85.74 59.84 5.88 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.015 0.436 . . . . 0.0 110.753 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t -132.41 151.05 52.03 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.411 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.508 HG13 ' H ' ' A' ' 120' ' ' ILE . 11.5 p -134.81 119.45 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 111.428 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -123.79 105.11 9.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.599 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.415 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 4.1 mtt180 -118.07 169.66 9.48 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.003 0.43 . . . . 0.0 111.365 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -161.56 125.37 3.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.53 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.3 tt -105.06 118.44 52.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.115 0.484 . . . . 0.0 110.947 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.46 117.53 29.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.053 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.613 ' CD1' HD13 ' A' ' 88' ' ' ILE . 8.5 pt -122.83 128.75 75.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.585 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -119.23 141.89 48.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.402 ' OG1' HD12 ' A' ' 34' ' ' ILE . 5.6 m -137.35 111.06 8.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.151 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.5 mp0 -125.09 129.79 50.95 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.734 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -132.64 143.43 49.66 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.141 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -139.02 119.52 13.91 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.15 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 30' ' ' ARG . 8.2 mt -118.55 111.01 32.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.777 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.29 96.26 1.34 Allowed Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.217 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.554 ' O ' HG23 ' A' ' 21' ' ' VAL . 55.9 Cg_endo -72.37 -43.64 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.711 2.274 . . . . 0.0 112.765 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 58.69 22.94 10.49 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.611 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 19' ' ' PRO . 41.2 t -125.4 136.11 27.81 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.99 108.74 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.827 2.352 . . . . 0.0 112.283 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.34 137.53 18.94 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.656 2.237 . . . . 0.0 112.867 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.14 -50.19 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -124.89 -61.05 1.33 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.81 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -167.87 120.33 0.88 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.667 0.27 . . . . 0.0 111.274 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -160.82 54.89 0.61 Allowed Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.193 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.93 133.71 10.27 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.721 2.281 . . . . 0.0 112.945 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.2 t -137.99 124.77 27.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.819 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.54 ' HB3' HG23 ' A' ' 17' ' ' ILE . 5.5 ptp180 -133.16 165.12 25.52 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.346 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.01 157.16 33.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.666 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 10.9 p-90 -155.42 142.24 18.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.449 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 p -147.93 117.93 7.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.331 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.437 HD13 HD21 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -133.88 141.25 44.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.585 -179.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -131.39 134.17 46.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.641 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 55' ' ' ILE . 19.5 mt -124.38 106.38 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.643 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 73' ' ' PRO . 18.1 t -118.04 148.44 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.696 0.284 . . . . 0.0 111.387 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.876 HD13 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -159.33 148.59 18.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.323 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 42' ' ' GLU . 1.4 tp -102.72 160.82 14.25 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.255 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -173.76 -44.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.194 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.93 1.48 20.5 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.943 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.617 ' HG3' HD21 ' A' ' 39' ' ' LEU . 15.5 mm-40 -86.42 -36.73 18.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.578 0.228 . . . . 0.0 110.798 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.38 -72.83 0.63 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.683 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HD3' HD13 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -142.31 116.46 9.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.779 0.323 . . . . 0.0 110.836 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.93 35.48 1.26 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.175 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.407 HD13 ' HD3' ' A' ' 44' ' ' LYS . 4.2 mp -131.28 126.63 21.48 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.279 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.01 -174.34 1.9 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.856 2.371 . . . . 0.0 112.475 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.586 ' HB3' ' HG ' ' A' ' 93' ' ' LEU . . . -154.73 -63.69 0.13 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.622 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.525 HG22 HG13 ' A' ' 50' ' ' ILE . 27.2 m -99.07 -65.97 0.93 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.551 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.525 HG13 HG22 ' A' ' 49' ' ' THR . 56.6 mt -128.58 -92.77 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.399 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.434 ' CE1' ' HE2' ' A' ' 53' ' ' LYS . 35.7 t80 62.35 97.82 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.18 0.514 . . . . 0.0 111.399 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -164.5 112.56 1.09 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.062 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.923 ' HG2' HG13 ' A' ' 90' ' ' VAL . 4.8 mtmt -101.89 123.74 46.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.704 HG12 ' HG3' ' A' ' 67' ' ' ARG . 11.4 m -132.29 116.5 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 111.136 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.594 HG13 HG23 ' A' ' 88' ' ' ILE . 3.7 mp -103.24 149.56 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.192 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 65' ' ' PRO . 20.9 m-85 -138.19 119.12 14.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.294 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.474 ' CE1' ' CG2' ' A' ' 55' ' ' ILE . 5.5 m-70 -123.39 116.44 23.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.076 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.519 HD11 HD22 ' A' ' 105' ' ' LEU . 4.2 mp 64.18 -178.11 0.16 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.918 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.48 109.79 2.1 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.821 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.445 ' HB3' ' HG3' ' A' ' 65' ' ' PRO . 32.3 Cg_exo -59.73 -18.49 48.72 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.805 2.336 . . . . 0.0 113.041 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 m -74.24 5.79 4.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.374 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.36 -51.23 0.58 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-O 120.528 0.204 . . . . 0.0 111.026 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 -13.68 37.59 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 30.1 t30 72.52 140.91 0.08 OUTLIER Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.803 0.335 . . . . 0.0 111.237 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.445 ' HG3' ' HB3' ' A' ' 60' ' ' PRO . 23.5 Cg_exo -63.9 171.15 7.73 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.79 2.327 . . . . 0.0 112.649 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.436 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 5.1 m120 -124.71 137.92 54.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.704 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -129.87 146.27 51.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.258 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.67 136.35 37.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.743 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -161.86 -50.04 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.719 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.3 t -159.03 40.36 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.166 0.508 . . . . 0.0 110.663 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.96 157.79 74.68 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.006 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 44.1 Cg_exo -56.43 170.44 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.114 2.543 . . . . 0.0 112.28 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HB3' HG22 ' A' ' 37' ' ' VAL . 19.0 Cg_endo -58.13 171.46 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.959 2.439 . . . . 0.0 112.903 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.36 85.9 2.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.343 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -110.21 130.57 55.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -135.19 125.83 44.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.033 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -129.83 125.25 35.25 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 8.9 mt-10 -152.76 172.98 15.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.377 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -119.17 -179.6 3.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.213 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.97 -156.06 25.06 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.362 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -69.28 130.52 42.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.66 95.2 0.1 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.71 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.06 109.03 0.39 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.908 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.49 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 30.8 m-85 -153.77 164.8 19.44 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 111.105 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 10.8 Cg_endo -54.57 168.73 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.497 2.798 . . . . 0.0 113.981 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.437 HD21 HD13 ' A' ' 34' ' ' ILE . 6.7 mp -134.05 155.74 49.48 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.525 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -158.11 120.94 3.82 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.937 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.613 HD13 ' CD1' ' A' ' 11' ' ' ILE . 2.3 mp -125.22 126.36 70.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.475 ' OG ' HG23 ' A' ' 54' ' ' VAL . 57.4 p -127.98 115.43 18.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.997 0.427 . . . . 0.0 110.917 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.923 HG13 ' HG2' ' A' ' 53' ' ' LYS . 26.1 t -104.36 138.85 27.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.998 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.408 ' C ' HD23 ' A' ' 92' ' ' LEU . 21.1 m-85 -131.44 153.71 49.44 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.75 HD21 ' N ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -148.25 -165.78 2.36 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.023 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.586 ' HG ' ' HB3' ' A' ' 48' ' ' ALA . 7.9 mp -56.5 -62.03 2.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 179.05 50.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.013 0.435 . . . . 0.0 110.701 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -112.03 -154.21 0.54 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.516 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.36 -14.35 20.21 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.644 ' C ' HD21 ' A' ' 92' ' ' LEU . . . -61.52 -22.65 61.75 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.811 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.75 ' N ' HD21 ' A' ' 92' ' ' LEU . 4.4 pt-20 -68.08 84.84 0.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.086 0.47 . . . . 0.0 110.377 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.32 156.75 45.27 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.729 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 89' ' ' SER . 1.7 mtmm -103.07 153.22 20.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.654 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.529 ' O ' HD12 ' A' ' 88' ' ' ILE . 25.5 mt -137.58 99.79 9.4 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.012 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.33 130.94 8.33 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.861 2.374 . . . . 0.0 112.22 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.458 ' CD2' HG22 ' A' ' 101' ' ' ILE . 4.9 m-70 -132.71 167.43 20.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.59 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -134.94 135.12 41.27 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.6 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.519 HD22 HD11 ' A' ' 58' ' ' LEU . 5.8 tp -125.75 84.72 2.31 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.675 0.274 . . . . 0.0 111.314 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -168.63 38.2 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.256 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -140.44 133.96 30.07 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.785 0.326 . . . . 0.0 111.548 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -61.11 130.64 47.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.829 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 67.0 61.32 0.5 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 6.3 tp10 -96.58 136.84 36.54 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.699 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.7 t -141.11 70.46 1.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.617 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.23 119.25 37.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.184 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.83 154.28 35.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.46 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 t -142.36 152.18 18.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.585 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -134.53 109.24 8.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.65 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -113.11 147.91 36.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.917 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.66 140.74 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.21 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.672 HG23 HD13 ' A' ' 92' ' ' LEU . 2.9 mt -124.52 117.83 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.13 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.75 116.21 19.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.017 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.508 ' H ' HG13 ' A' ' 5' ' ' VAL . 1.7 mp -128.57 53.43 11.16 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.232 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.76 -167.81 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.755 2.303 . . . . 0.0 112.246 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.402 HD12 ' HB3' ' A' ' 3' ' ' ALA . 17.2 mt -91.48 51.93 1.98 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.987 0.423 . . . . 0.0 110.695 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.381 -0.819 . . . . 0.0 111.105 179.787 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mtt . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.783 0.325 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 2' ' ' VAL . 14.0 m -142.16 75.12 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.926 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.59 -171.3 0.15 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.318 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.668 HG22 ' CB ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER -152.52 152.68 32.19 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.889 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.4 t -127.18 119.63 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.532 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -137.81 112.85 9.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.358 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.57 ' NH1' HD13 ' A' ' 92' ' ' LEU . 35.0 mtp180 -138.84 167.76 21.29 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.078 0.466 . . . . 0.0 111.871 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -167.6 124.97 1.18 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.675 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.803 HD11 HD11 ' A' ' 36' ' ' ILE . 17.5 tt -108.49 118.98 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.937 0.398 . . . . 0.0 110.983 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG2' ' HG2' ' A' ' 115' ' ' GLU . 58.1 mtp85 -122.89 111.86 17.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.801 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.541 ' CD1' HD13 ' A' ' 88' ' ' ILE . 47.8 pt -106.95 137.2 38.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.015 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -125.16 128.59 48.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.132 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.586 HG23 ' CD1' ' A' ' 34' ' ' ILE . 74.3 m -130.89 124.48 31.25 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.85 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -139.32 143.58 37.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.205 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -137.84 144.46 41.46 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.632 0.253 . . . . 0.0 111.32 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.472 ' N ' ' HG3' ' A' ' 15' ' ' GLN . 15.3 t60 -140.36 119.42 12.75 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.066 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' ' 30' ' ' ARG . 6.8 mt -118.46 109.09 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.741 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.5 tp -173.14 95.66 0.35 Allowed Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.84 -55.21 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.923 2.416 . . . . 0.0 112.737 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 71.13 0.21 3.33 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.463 HG23 ' HD2' ' A' ' 22' ' ' PRO . 9.3 p -125.72 138.31 31.71 Favored Pre-proline 0 CA--C 1.531 0.212 0 O-C-N 122.435 -0.166 . . . . 0.0 110.848 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.463 ' HD2' HG23 ' A' ' 21' ' ' VAL . 15.2 Cg_endo -57.27 142.4 94.73 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.686 2.257 . . . . 0.0 112.389 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.49 113.26 3.08 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.75 2.3 . . . . 0.0 112.823 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.555 HG23 ' HG2' ' A' ' 25' ' ' GLU . 11.9 m -146.93 -47.62 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.629 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.555 ' HG2' HG23 ' A' ' 24' ' ' VAL . 6.9 pt-20 -128.22 -51.29 1.3 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.35 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -83.65 -41.86 17.31 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.307 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 64.65 165.61 0.12 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.337 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.13 134.24 36.52 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.065 2.51 . . . . 0.0 113.091 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.98 176.6 3.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.976 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.496 ' HB3' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -138.03 164.41 29.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.858 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -122.3 149.23 44.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.742 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.452 ' HB2' HD21 ' A' ' 105' ' ' LEU . 14.9 p-90 -148.47 140.2 23.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.039 0.447 . . . . 0.0 111.344 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.2 t -129.94 117.69 20.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.476 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.586 ' CD1' HG23 ' A' ' 13' ' ' THR . 28.7 mm -125.73 127.23 71.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.139 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -147.68 157.47 43.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.809 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.803 HD11 HD11 ' A' ' 9' ' ' ILE . 11.4 tt -155.13 128.42 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.962 0.41 . . . . 0.0 111.518 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 73' ' ' PRO . 22.9 t -119.34 148.49 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.807 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.677 HD12 ' HB ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -160.41 145.47 14.67 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.698 0.285 . . . . 0.0 111.378 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.556 HD21 ' HG3' ' A' ' 42' ' ' GLU . 3.1 tp -103.3 164.16 11.81 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -171.74 -45.67 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.944 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.54 0.48 17.17 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.556 ' HG3' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -82.99 -34.96 26.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.637 0.256 . . . . 0.0 110.651 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.91 -55.86 0.29 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.744 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -162.71 114.05 1.53 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG3' ' HB3' ' A' ' 40' ' ' ASP . 18.1 tt0 -98.66 38.07 1.41 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.987 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.79 134.06 24.51 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.944 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.85 -171.24 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.834 2.356 . . . . 0.0 112.65 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.842 ' HB3' ' CB ' ' A' ' 93' ' ' LEU . . . -165.39 -45.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.444 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.17 -66.03 0.83 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.576 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.3 mm -114.88 -87.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.786 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 49.3 t80 58.79 96.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.897 0.379 . . . . 0.0 111.357 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 6.7 t70 -172.52 110.64 0.23 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.878 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.956 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -102.64 127.07 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.614 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 m -126.2 142.41 42.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.685 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.478 HG12 HD13 ' A' ' 36' ' ' ILE . 2.3 mp -127.4 150.33 33.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.37 144.2 36.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.532 ' HB2' HD12 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -140.39 119.91 13.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.995 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.532 HD12 ' HB2' ' A' ' 57' ' ' HIS . 5.1 mp 67.62 -175.35 0.19 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.309 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.87 157.55 4.03 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.86 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.05 -2.4 8.74 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.13 2.553 . . . . 0.0 113.558 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.32 -9.81 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.93 142.8 57.21 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.568 0.223 . . . . 0.0 110.799 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.59 87.0 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.391 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -154.81 129.5 4.91 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.057 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.94 -171.31 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.526 2.151 . . . . 0.0 112.15 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.406 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 20.6 m-20 -108.77 151.17 26.58 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.887 0.375 . . . . 0.0 111.074 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.17 155.98 40.78 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.041 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.62 122.63 26.34 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.798 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.452 ' HA ' ' HZ2' ' A' ' 53' ' ' LYS . 16.0 t80 -143.9 -57.02 0.38 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.601 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 t -148.61 34.51 0.78 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.721 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.69 160.27 45.06 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.115 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.42 171.67 10.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.934 2.422 . . . . 0.0 112.434 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.602 ' HB3' HG13 ' A' ' 37' ' ' VAL . 18.7 Cg_endo -58.99 162.55 13.27 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.928 2.419 . . . . 0.0 112.822 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -108.59 156.12 19.88 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.336 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.19 121.38 0.75 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.624 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 76' ' ' ILE . 11.3 tp -158.87 119.89 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.959 0.409 . . . . 0.0 111.329 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -126.86 111.52 14.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.646 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.43 161.73 25.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.81 179.74 3.99 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.957 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.91 -170.25 18.73 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.224 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -66.96 120.51 13.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.797 0.332 . . . . 0.0 111.158 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.93 128.1 0.96 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.907 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.39 107.77 0.26 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.717 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.509 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 16.0 m-85 -153.49 164.52 20.24 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.717 0.294 . . . . 0.0 111.016 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.551 ' O ' HD13 ' A' ' 86' ' ' LEU . 32.3 Cg_exo -59.66 163.43 13.25 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.924 2.416 . . . . 0.0 113.572 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -126.65 166.69 16.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.932 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -155.96 128.69 7.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.173 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.541 HD13 ' CD1' ' A' ' 11' ' ' ILE . 3.4 mp -136.1 116.45 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.654 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 6.7 t -122.82 146.22 47.74 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.214 0.531 . . . . 0.0 111.477 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.956 HG13 ' HG2' ' A' ' 53' ' ' LYS . 3.2 t -123.56 144.29 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.867 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.519 ' HA ' ' HG3' ' A' ' 98' ' ' GLU . 50.3 m-85 -137.24 154.43 50.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.188 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.57 HD13 ' NH1' ' A' ' 7' ' ' ARG . 9.2 tp -152.01 178.1 9.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.842 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -74.07 -30.27 62.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.738 0.304 . . . . 0.0 110.331 179.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -106.89 -159.19 0.69 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.161 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -128.52 74.29 1.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.922 0.392 . . . . 0.0 110.683 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.542 ' HB3' HG23 ' A' ' 118' ' ' ILE . . . -115.16 -50.61 2.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.484 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.75 36.5 1.93 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.746 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.519 ' HG3' ' HA ' ' A' ' 91' ' ' PHE . 22.8 tt0 -88.5 76.36 8.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.513 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -142.72 156.74 45.06 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.689 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -110.32 149.38 30.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.063 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 100' ' ' LYS . 21.9 mm -135.3 113.21 11.22 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.266 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -85.82 153.11 10.01 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.941 2.427 . . . . 0.0 112.473 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.431 ' HB3' HD23 ' A' ' 86' ' ' LEU . 7.1 m170 -144.4 171.39 14.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.061 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.18 143.18 49.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.034 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.774 ' HB2' HD21 ' A' ' 86' ' ' LEU . 9.1 tp -130.61 82.12 2.04 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.838 0.352 . . . . 0.0 111.417 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -170.73 47.25 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.286 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -141.61 132.16 25.4 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 111.725 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -64.96 115.4 5.35 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.763 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.409 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 0.5 OUTLIER 74.86 73.0 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.433 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 40.3 tt0 -108.84 141.05 41.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.567 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.6 p -139.83 75.37 1.51 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.05 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.75 119.79 39.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.344 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.8 145.08 25.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.506 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.406 HG21 HG21 ' A' ' 101' ' ' ILE . 14.2 t -126.6 150.48 32.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.704 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 10' ' ' ARG . 4.7 mt-10 -134.05 109.05 8.7 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.828 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -113.05 140.28 47.97 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.69 136.41 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.436 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.542 HG23 ' HB3' ' A' ' 96' ' ' ALA . 1.8 mp -126.69 111.04 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.37 132.34 45.74 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.985 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 120' ' ' ILE . 2.5 tp -161.6 61.75 1.37 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 121.329 0.585 . . . . 0.0 111.377 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.668 ' CB ' HG22 ' A' ' 4' ' ' THR . 56.2 Cg_endo -73.66 -46.41 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.739 2.293 . . . . 0.0 112.772 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.2 tp -175.89 88.11 0.04 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.259 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.05 -179.458 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.961 0.41 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 m -106.02 -28.64 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.073 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.55 90.14 0.08 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.756 0.312 . . . . 0.0 111.377 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.48 154.78 50.66 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.875 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.06 119.06 35.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.965 0.412 . . . . 0.0 110.977 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -137.0 116.33 12.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.192 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.541 ' HA ' HD12 ' A' ' 39' ' ' LEU . 31.8 mtt-85 -132.45 159.04 40.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.368 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -160.56 127.1 4.15 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.841 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.839 HG21 HG21 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.77 122.84 66.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.717 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.588 ' N ' HD13 ' A' ' 9' ' ' ILE . 13.3 mtt180 -124.72 129.03 49.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 88' ' ' ILE . 1.1 pt -127.39 127.14 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.969 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.493 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -120.82 130.26 53.9 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.185 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.616 HG23 ' CD1' ' A' ' 34' ' ' ILE . 84.8 m -133.27 108.52 8.8 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -119.5 143.93 47.29 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.143 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.704 ' HB2' HD12 ' A' ' 105' ' ' LEU . 3.1 tp60 -139.25 142.02 37.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.186 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.438 ' N ' ' HG3' ' A' ' 15' ' ' GLN . 63.4 t-80 -144.91 119.29 9.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.925 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.604 HG22 ' HD3' ' A' ' 19' ' ' PRO . 17.7 mt -108.57 136.94 42.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.974 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 mt -120.58 67.67 14.19 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 111.434 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.604 ' HD3' HG22 ' A' ' 17' ' ' ILE . 94.9 Cg_endo -79.53 -23.47 7.15 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.831 2.354 . . . . 0.0 113.007 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -80.59 -63.36 1.43 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.305 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.3 t -104.26 100.05 19.97 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.16 112.92 3.66 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.5 2.133 . . . . 0.0 112.092 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.17 68.47 2.53 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.696 2.264 . . . . 0.0 112.263 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.9 t 54.16 57.72 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.052 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -142.74 164.64 29.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.356 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -108.02 134.21 51.24 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.324 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 70.17 155.36 0.15 Allowed Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.51 118.1 4.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.826 2.351 . . . . 0.0 112.754 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.4 t -112.54 152.81 14.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.369 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.45 163.48 29.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.021 0.438 . . . . 0.0 111.526 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.39 153.37 35.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.831 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.493 ' CZ2' HG21 ' A' ' 61' ' ' THR . 23.1 p-90 -153.91 151.8 29.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.595 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 13' ' ' THR . 11.7 t -148.68 119.34 7.49 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.992 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.858 HD11 HD22 ' A' ' 105' ' ' LEU . 25.2 mm -126.25 137.16 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.683 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 9.3 pt-20 -157.51 119.59 3.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.702 0.287 . . . . 0.0 111.482 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.467 ' CD1' HD12 ' A' ' 55' ' ' ILE . 13.6 tt -124.98 127.71 72.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.45 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.76 HG12 ' CB ' ' A' ' 73' ' ' PRO . 34.6 m -129.74 158.36 42.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.478 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.64 HD13 ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -160.09 155.61 25.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.856 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 7' ' ' ARG . 81.4 mt -88.03 168.01 13.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.764 0.316 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.11 -58.7 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.496 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.6 -23.92 67.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.151 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -90.36 -36.65 14.51 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.538 0.208 . . . . 0.0 110.93 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.92 54.55 0.55 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.39 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt 63.79 116.59 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.09 0.471 . . . . 0.0 111.646 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -88.48 31.74 0.81 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.521 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.2 mt -129.69 134.36 26.11 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.774 -0.193 . . . . 0.0 111.132 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.16 173.09 13.52 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.809 2.34 . . . . 0.0 112.36 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -145.48 -70.97 0.26 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.501 ' OG1' HD13 ' A' ' 93' ' ' LEU . 19.0 p -117.77 -74.69 0.6 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.63 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.9 mt -100.96 -85.74 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.534 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 3.3 t80 51.59 95.85 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.128 0.489 . . . . 0.0 111.133 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -171.3 103.78 0.21 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.717 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.937 ' HG2' HG13 ' A' ' 90' ' ' VAL . 5.4 mttt -99.21 114.28 26.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.037 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.863 HG12 ' HA ' ' A' ' 67' ' ' ARG . 27.5 m -128.07 160.76 37.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.749 HG22 ' HB2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -123.4 167.26 17.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.967 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.511 ' N ' HG23 ' A' ' 55' ' ' ILE . 10.7 t80 -134.16 131.59 38.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.241 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.6 ' HD2' HD23 ' A' ' 86' ' ' LEU . 48.2 m170 -129.41 104.94 7.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' A' ' 85' ' ' PRO . 0.2 OUTLIER -69.79 -34.48 73.78 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.211 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.493 ' CD2' HD23 ' A' ' 105' ' ' LEU . 7.4 p80 -59.09 139.48 87.69 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.127 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 59' ' ' HIS . 43.5 Cg_exo -57.49 -14.68 17.25 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.086 2.524 . . . . 0.0 113.87 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.493 HG21 ' CZ2' ' A' ' 32' ' ' TRP . 0.3 OUTLIER -56.42 -14.72 3.21 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.483 0.182 . . . . 0.0 111.402 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.6 110.57 9.4 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.548 0.213 . . . . 0.0 110.546 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.6 -48.45 79.34 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.398 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.75 142.32 32.8 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.78 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.26 169.69 2.02 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.872 2.381 . . . . 0.0 112.57 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.749 ' HB2' HG22 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -90.98 146.44 23.86 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.262 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.863 ' HA ' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -142.01 136.76 30.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.515 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.605 ' CG2' HD11 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -130.97 98.96 4.74 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 111.002 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -115.38 -49.58 2.76 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.865 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -146.94 35.08 0.91 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.921 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -130.52 159.73 69.45 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.29 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.26 173.08 3.57 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.063 2.509 . . . . 0.0 112.629 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.76 ' CB ' HG12 ' A' ' 37' ' ' VAL . 30.0 Cg_endo -62.36 174.14 2.9 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.989 2.459 . . . . 0.0 112.77 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -136.38 95.08 3.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.392 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.542 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -121.19 110.33 16.04 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.002 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 75' ' ' ARG . 20.6 mm -134.81 117.31 22.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -129.71 130.15 45.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.128 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -155.56 178.37 10.31 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.702 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.71 131.36 56.79 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.786 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.34 -131.07 2.14 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.03 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -120.27 110.31 16.42 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.16 0.505 . . . . 0.0 111.209 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.17 99.02 0.12 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.439 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -148.83 108.45 0.41 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.514 -0.851 . . . . 0.0 113.236 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HB2' ' CA ' ' A' ' 59' ' ' HIS . 10.4 m-85 -155.82 170.03 9.44 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 122.177 0.191 . . . . 0.0 110.645 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.522 ' HB2' HD13 ' A' ' 58' ' ' LEU . 31.6 Cg_exo -59.2 168.43 4.78 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.854 2.37 . . . . 0.0 112.811 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.784 HD11 ' CB ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -144.24 172.49 12.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.703 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 21.0 t70 -159.83 116.79 2.57 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.897 0.379 . . . . 0.0 111.085 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 11' ' ' ILE . 3.7 mp -108.1 131.57 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.4 p -128.33 119.64 25.46 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.983 0.42 . . . . 0.0 110.551 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.937 HG13 ' HG2' ' A' ' 53' ' ' LYS . 40.7 t -106.53 135.55 44.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.729 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -134.83 150.24 50.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.721 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.066 HD22 HG21 ' A' ' 118' ' ' ILE . 12.2 tp -142.96 -69.55 0.34 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.707 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.501 HD13 ' OG1' ' A' ' 49' ' ' THR . 0.2 OUTLIER -129.4 -76.73 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.541 0.21 . . . . 0.0 111.189 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -137.26 -57.48 0.7 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.289 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 27.1 0.85 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -78.52 -37.64 42.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.74 37.56 0.39 Allowed Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.834 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -90.1 92.39 8.94 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 110.532 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.02 144.32 33.58 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.344 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 130.13 38.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.392 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.01 132.82 21.54 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.527 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 94.7 Cg_endo -79.85 143.58 16.57 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.689 2.259 . . . . 0.0 111.932 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.1 171.91 10.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.01 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -122.54 140.26 52.97 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.657 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.858 HD22 HD11 ' A' ' 34' ' ' ILE . 57.6 tp -140.09 70.01 1.36 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.561 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -174.62 42.8 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -141.61 137.36 31.81 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.463 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.597 HD12 HD12 ' A' ' 17' ' ' ILE . 1.6 mp -50.41 119.75 4.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 58.99 80.64 0.18 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.708 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -111.3 135.09 52.35 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.748 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.5 p -132.57 71.41 1.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.049 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -106.14 119.51 39.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.415 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.5 157.01 33.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.983 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.515 HG23 HD11 ' A' ' 11' ' ' ILE . 3.4 t -139.53 152.32 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.613 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -138.1 109.31 6.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.62 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -113.26 123.94 51.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.021 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 m -103.29 147.22 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.401 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 1.066 HG21 HD22 ' A' ' 92' ' ' LEU . 9.8 mt -137.87 120.65 19.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -129.46 113.49 14.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.864 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.2 pt -146.68 68.03 11.68 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.545 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.69 62.33 5.56 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.571 2.181 . . . . 0.0 112.625 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -173.73 -60.98 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.08 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.097 -179.824 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.46 0.172 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 m 36.66 67.39 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.042 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.03 79.85 1.2 Allowed 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.152 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.06 135.03 20.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.452 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 t -130.29 119.01 45.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.779 0.323 . . . . 0.0 111.389 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -137.62 122.61 19.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.465 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.441 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -134.33 167.37 20.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.204 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 2.3 t -172.56 129.15 0.54 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.444 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.014 HG21 HG21 ' A' ' 90' ' ' VAL . 1.2 tt -109.26 118.3 56.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.54 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.31 114.18 16.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.942 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 36' ' ' ILE . 1.1 pt -118.38 126.67 75.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 113.58 26.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.989 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.634 HG23 ' CD1' ' A' ' 34' ' ' ILE . 85.4 m -119.47 96.36 5.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.193 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -125.4 147.89 49.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.09 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -133.61 165.43 24.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.0 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.433 ' CD2' ' HG3' ' A' ' 109' ' ' GLN . 22.9 t-160 -163.39 119.82 1.77 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.203 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.508 HG12 ' HA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -94.35 128.22 45.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.982 0.42 . . . . 0.0 111.506 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.33 128.63 0.45 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.579 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.604 ' O ' HG23 ' A' ' 21' ' ' VAL . 25.9 Cg_endo -63.38 -51.0 2.91 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.652 2.234 . . . . 0.0 112.708 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.1 29.55 17.99 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.779 0.323 . . . . 0.0 111.059 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.71 HG12 ' HD2' ' A' ' 23' ' ' PRO . 10.5 t -125.41 106.8 27.22 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.21 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.448 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 48.0 Cg_exo -54.7 -47.47 26.57 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.56 2.173 . . . . 0.0 112.787 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.71 ' HD2' HG12 ' A' ' 21' ' ' VAL . 74.8 Cg_exo -49.92 153.3 6.32 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.688 2.259 . . . . 0.0 112.711 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 24' ' ' VAL . 7.2 p -71.88 80.82 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.271 0.558 . . . . 0.0 111.162 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -114.68 158.11 22.23 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.102 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -123.18 -179.36 4.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 64.24 70.98 0.61 Allowed Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.057 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -57.44 145.46 88.13 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.866 2.378 . . . . 0.0 112.771 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.9 t -116.98 147.41 20.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HA ' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -93.53 155.21 17.45 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.736 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 1.6 mt-30 -117.42 107.0 13.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.708 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.431 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 57.5 p-90 -100.93 158.86 15.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.665 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.454 ' O ' HD13 ' A' ' 34' ' ' ILE . 15.3 t -144.77 117.64 8.77 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.634 ' CD1' HG23 ' A' ' 13' ' ' THR . 17.7 mm -122.88 138.79 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.618 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.16 127.84 13.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.658 HG21 ' CD1' ' A' ' 55' ' ' ILE . 8.6 mt -119.5 106.41 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.342 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 73' ' ' PRO . 21.6 t -118.01 150.14 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.83 0.348 . . . . 0.0 111.627 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.821 HD13 ' HD3' ' A' ' 53' ' ' LYS . 1.1 pp -166.95 148.2 5.9 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.276 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 7.1 mt -76.95 162.84 27.25 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.329 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -166.27 -59.5 0.03 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.956 0.408 . . . . 0.0 110.393 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -58.86 -31.0 68.14 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.314 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -92.15 -29.97 16.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.72 47.75 2.29 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.709 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 mttm 57.1 94.76 0.02 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 111.156 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.28 -28.84 60.06 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.29 120.56 77.3 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.051 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HB3' ' CD2' ' A' ' 51' ' ' PHE . 73.2 Cg_endo -75.6 -171.89 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.591 2.194 . . . . 0.0 112.545 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.84 -55.1 0.46 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.342 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -120.73 -60.49 1.66 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.631 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.9 mm -116.93 -84.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.912 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 47' ' ' PRO . 73.8 t80 58.85 95.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.899 0.381 . . . . 0.0 111.391 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -176.68 151.79 0.94 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.71 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.821 ' HD3' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -133.15 111.57 11.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.518 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.482 HG13 ' CG ' ' A' ' 67' ' ' ARG . 21.6 t -112.12 149.29 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.0 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.665 HG23 HG13 ' A' ' 88' ' ' ILE . 4.1 mp -135.0 154.79 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.662 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.1 150.9 38.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 111.408 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.485 ' HB3' ' NE2' ' A' ' 59' ' ' HIS . 12.6 m-70 -135.49 115.33 13.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.502 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 85' ' ' PRO . 0.1 OUTLIER -61.99 -39.1 91.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.297 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.485 ' NE2' ' HB3' ' A' ' 57' ' ' HIS . 20.5 p80 -56.64 134.75 77.93 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 120.764 0.316 . . . . 0.0 111.485 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.16 -15.8 30.36 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.0 2.467 . . . . 0.0 113.265 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.74 -16.47 1.71 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.44 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.63 83.95 2.21 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.858 0.361 . . . . 0.0 110.454 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.82 -36.8 82.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.397 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -99.25 122.12 53.11 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.733 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.23 164.85 3.41 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.776 2.318 . . . . 0.0 112.614 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -106.86 131.03 54.41 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.18 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.482 ' CG ' HG13 ' A' ' 54' ' ' VAL . 3.8 mtt85 -145.1 131.12 19.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.777 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.25 103.05 8.92 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 111.327 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -104.34 -53.87 2.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.322 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -156.25 35.65 0.33 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.82 165.44 13.97 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.85 157.65 27.72 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.77 2.314 . . . . 0.0 112.423 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HB2' HG22 ' A' ' 37' ' ' VAL . 55.3 Cg_endo -70.05 154.37 66.64 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.609 2.206 . . . . 0.0 112.48 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.87 146.31 25.03 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.406 ' H ' HD12 ' A' ' 76' ' ' ILE . 2.4 tpt180 -171.8 80.8 0.06 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.754 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.406 HD12 ' H ' ' A' ' 75' ' ' ARG . 3.9 mp -141.36 143.2 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.108 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -135.41 130.4 34.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 1.3 mt-10 -137.42 166.2 24.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.912 0.386 . . . . 0.0 111.398 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -100.23 126.58 46.54 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.59 -169.0 33.16 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.732 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -115.34 110.18 19.0 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.661 0.267 . . . . 0.0 110.551 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.88 128.51 1.26 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.458 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.4 95.96 0.15 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.211 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 87.6 m-85 -142.08 165.73 25.82 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-O 120.553 0.216 . . . . 0.0 111.072 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 86' ' ' LEU . 76.2 Cg_exo -50.47 165.95 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.992 2.461 . . . . 0.0 113.367 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 85' ' ' PRO . 1.1 mp -146.51 165.75 28.52 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.882 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -157.38 134.94 10.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.277 0.56 . . . . 0.0 111.128 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.665 HG13 HG23 ' A' ' 55' ' ' ILE . 3.8 mp -128.94 127.19 65.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.884 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.7 p -118.05 137.48 52.88 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.005 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 9' ' ' ILE . 3.9 t -123.8 132.72 70.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.333 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.48 158.87 37.18 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.654 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.741 ' CD1' ' HB3' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -145.65 -49.24 0.23 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.106 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.89 -83.54 0.07 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.01 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.32 -79.49 0.59 Allowed 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 120.562 0.22 . . . . 0.0 111.224 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.75 32.71 1.04 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 111.61 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.741 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -77.29 -39.7 47.07 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.89 0.376 . . . . 0.0 110.361 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.674 ' C ' HD21 ' A' ' 92' ' ' LEU . . . -148.18 24.43 1.41 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.619 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 5.0 tt0 -77.63 103.15 7.39 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.713 0.257 . . . . 0.0 110.386 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.49 155.32 45.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.057 0.456 . . . . 0.0 112.032 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.96 138.24 54.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.137 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.975 HG13 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -132.17 110.45 14.07 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.629 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.49 160.76 28.59 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.639 2.226 . . . . 0.0 112.326 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.527 ' CE1' HG13 ' A' ' 114' ' ' VAL . 2.5 m-70 -144.07 170.18 16.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -134.24 95.45 3.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.423 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.686 HD12 ' OE1' ' A' ' 110' ' ' GLU . 15.8 tp -77.99 121.98 24.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.353 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.2 -179.42 5.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.084 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -107.83 166.47 10.68 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.592 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.48 ' HA ' HG22 ' A' ' 17' ' ' ILE . 1.9 tp 77.2 60.32 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.137 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.433 ' HG3' ' CD2' ' A' ' 16' ' ' HIS . 8.9 mt-30 66.11 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.541 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.686 ' OE1' HD12 ' A' ' 105' ' ' LEU . 45.0 tt0 -130.82 147.15 52.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.086 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -140.74 74.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.572 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -117.64 119.29 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.91 157.37 23.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.53 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.975 HG21 HG13 ' A' ' 101' ' ' ILE . 29.7 m -137.68 158.11 33.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.312 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -142.93 109.02 5.21 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.348 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.37 150.11 33.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.1 p -124.36 134.9 65.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.202 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.727 ' CG2' HD13 ' A' ' 92' ' ' LEU . 3.4 mp -131.98 111.19 17.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.65 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -129.7 139.44 51.35 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.187 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 120' ' ' ILE . 6.5 tp -169.05 72.19 0.74 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 121.369 0.604 . . . . 0.0 111.144 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.37 154.23 65.5 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.12 -43.42 21.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.827 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.868 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.838 HG21 ' HB3' ' A' ' 44' ' ' LYS . 11.9 p -158.8 141.05 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.751 0.31 . . . . 0.0 111.701 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.93 36.61 0.4 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.682 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.52 126.27 8.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.501 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.856 HG22 ' HG2' ' A' ' 44' ' ' LYS . 16.6 t -130.83 119.34 45.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.889 0.376 . . . . 0.0 111.018 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -133.64 110.95 10.22 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.742 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 15.1 mtt85 -126.44 161.65 27.41 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.352 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 2.3 t -170.47 116.92 0.51 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.59 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.865 HD11 HD11 ' A' ' 36' ' ' ILE . 7.8 tt -103.41 118.06 49.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 121.023 0.44 . . . . 0.0 110.93 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -118.09 112.11 19.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.477 HG22 ' CG1' ' A' ' 36' ' ' ILE . 40.1 pt -113.63 133.51 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.31 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -128.77 125.33 37.62 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.954 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -130.89 103.87 6.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -117.64 146.38 43.72 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.169 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.634 ' HG2' ' HA ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -146.04 148.26 32.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.887 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.43 ' HA ' ' H ' ' A' ' 109' ' ' GLN . 0.6 OUTLIER -162.9 120.37 1.97 Allowed 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.655 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 107' ' ' PHE . 24.8 mt -71.91 147.27 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.667 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.576 HD12 HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -121.42 75.43 33.21 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.928 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.62 -23.84 12.44 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.749 2.299 . . . . 0.0 112.823 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.78 -32.68 63.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.38 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.576 HG23 HD12 ' A' ' 18' ' ' LEU . 21.4 t -76.62 132.26 72.5 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.931 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HA ' ' HD2' ' A' ' 23' ' ' PRO . 74.0 Cg_endo -75.38 111.54 3.33 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.493 2.129 . . . . 0.0 112.419 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 22' ' ' PRO . 59.0 Cg_endo -71.18 -179.98 3.98 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.745 2.297 . . . . 0.0 112.517 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 m -59.39 -32.61 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.69 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.12 -67.21 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.473 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -156.13 31.33 0.34 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.032 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -118.75 79.29 16.42 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.814 0.34 . . . . 0.0 110.986 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.04 159.35 52.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.818 2.345 . . . . 0.0 112.636 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 m -122.34 176.49 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.236 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 1.1 ptt-85 -131.3 160.37 35.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.069 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -100.17 160.08 14.61 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.855 0.36 . . . . 0.0 111.079 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.1 p-90 -159.4 151.58 20.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.613 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -148.36 118.11 7.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.696 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tp -124.9 137.04 58.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.926 0.393 . . . . 0.0 111.573 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.413 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -157.67 149.54 22.1 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.786 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.936 HG21 HD13 ' A' ' 55' ' ' ILE . 12.5 tt -156.61 132.51 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.025 0.441 . . . . 0.0 111.331 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.81 HG12 ' CB ' ' A' ' 73' ' ' PRO . 35.3 m -130.39 159.04 42.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.975 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.58 HD12 ' HB ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER -164.49 145.21 7.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 111.475 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.769 HD21 ' HG3' ' A' ' 42' ' ' GLU . 2.7 tp -97.57 155.16 17.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.378 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.06 -46.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.973 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -78.23 2.61 17.73 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.378 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.769 ' HG3' HD21 ' A' ' 39' ' ' LEU . 8.9 mm-40 -82.24 -27.9 32.21 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.495 0.188 . . . . 0.0 110.781 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.26 -59.08 0.13 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.167 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.856 ' HG2' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -153.05 119.56 5.6 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.777 0.322 . . . . 0.0 111.453 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.19 30.41 4.17 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.957 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.43 134.44 21.21 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.177 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 36.4 Cg_endo -65.75 -44.93 7.23 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.664 2.243 . . . . 0.0 112.769 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 66.57 -76.05 0.05 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.52 0.328 . . . . 0.0 111.798 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.405 HG22 ' CD1' ' A' ' 50' ' ' ILE . 91.4 m -104.02 -69.61 0.8 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.565 0.221 . . . . 0.0 110.977 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.405 ' CD1' HG22 ' A' ' 49' ' ' THR . 2.5 mp -122.77 -81.81 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.772 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 47' ' ' PRO . 5.5 t80 62.48 101.62 0.03 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.296 0.57 . . . . 0.0 110.953 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 35.1 t70 -166.75 111.54 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.848 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.74 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -116.28 126.34 53.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.211 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.582 HG23 ' HD3' ' A' ' 67' ' ' ARG . 14.2 p -122.3 152.48 26.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.884 0.373 . . . . 0.0 111.588 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.936 HD13 HG21 ' A' ' 36' ' ' ILE . 2.1 mt -130.98 131.3 64.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.374 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.59 144.07 51.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.696 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.6 p80 -147.57 119.85 8.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.0 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.603 HD11 HD22 ' A' ' 105' ' ' LEU . 4.9 mp 67.18 -172.09 0.19 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.677 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.516 ' HD2' HG23 ' A' ' 61' ' ' THR . 2.2 t60 -60.52 141.14 92.03 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.11 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.13 -15.1 13.27 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.844 2.363 . . . . 0.0 113.062 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.516 HG23 ' HD2' ' A' ' 59' ' ' HIS . 26.4 p -65.19 -3.54 4.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.558 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.51 161.25 2.76 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.458 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.51 -48.47 48.05 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.538 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -161.15 142.71 8.84 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 111.278 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.34 -175.83 2.41 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.88 2.387 . . . . 0.0 112.247 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.495 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 3.4 m120 -128.24 145.61 50.99 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.836 0.35 . . . . 0.0 111.158 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.582 ' HD3' HG23 ' A' ' 54' ' ' VAL . 3.2 mmm-85 -141.81 153.37 44.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.69 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 4.3 m -130.71 119.07 21.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.849 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.752 ' CD2' HG22 ' A' ' 70' ' ' THR . 3.1 p90 -164.13 -49.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.584 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.752 HG22 ' CD2' ' A' ' 69' ' ' PHE . 14.8 t -152.02 32.12 0.54 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.648 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.27 161.89 24.81 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.16 166.83 28.51 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.765 2.31 . . . . 0.0 112.653 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.81 ' CB ' HG12 ' A' ' 37' ' ' VAL . 55.5 Cg_endo -70.37 138.68 36.43 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.876 2.384 . . . . 0.0 112.639 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -93.37 148.57 21.94 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.146 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -171.69 84.1 0.08 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.72 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 mt -134.91 134.28 53.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.495 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -134.51 137.73 44.1 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.831 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.15 -177.59 6.01 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.82 125.14 48.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.595 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.95 -162.83 16.84 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.588 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -122.82 110.89 16.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.0 0.429 . . . . 0.0 110.942 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.61 124.5 0.76 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.954 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.662 ' HA2' HD23 ' A' ' 105' ' ' LEU . . . -144.93 107.06 0.42 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.274 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.415 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 11.0 m-85 -141.59 167.47 16.9 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.67 0.271 . . . . 0.0 111.367 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.9 171.85 0.94 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.24 2.627 . . . . 0.0 113.733 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 105' ' ' LEU . 5.1 mp -139.37 166.05 25.58 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.563 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -155.0 114.6 3.71 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.728 0.299 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.7 mp -124.19 120.45 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.623 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.05 149.37 42.29 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.853 0.359 . . . . 0.0 111.094 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.74 HG13 ' HG2' ' A' ' 53' ' ' LYS . 3.7 t -131.08 131.38 63.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.222 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 54.2 m-85 -142.54 144.17 32.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.174 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.77 -54.01 1.15 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.396 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -179.64 -44.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.758 0.313 . . . . 0.0 110.895 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.76 -174.61 2.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.917 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.05 71.26 3.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 111.356 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.06 -50.86 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.577 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -145.65 33.14 1.56 Allowed Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.455 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HB2' ' CD1' ' A' ' 91' ' ' PHE . 3.2 pt-20 -102.09 103.0 13.55 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.792 0.329 . . . . 0.0 110.786 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.34 151.18 41.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 2.0 mtmt -104.52 124.92 50.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.337 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.43 114.05 29.0 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.684 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.6 151.94 15.12 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.874 2.382 . . . . 0.0 111.907 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.467 ' HB3' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -136.64 171.35 14.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 111.398 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -133.86 128.96 35.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.54 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.693 ' HB2' HD11 ' A' ' 86' ' ' LEU . 4.4 tp -108.1 106.35 16.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.777 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.99 168.11 14.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.147 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.634 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 9.3 p90 -94.9 165.61 12.37 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.419 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tp 84.45 62.59 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.341 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.43 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 1.3 tm0? 65.4 111.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.648 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.35 128.82 34.45 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.831 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.9 p -127.41 66.1 1.31 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.714 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' A' ' 103' ' ' HIS . 5.0 m-85 -108.48 119.42 39.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.561 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.37 152.87 20.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.372 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.9 t -139.65 149.16 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.651 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -135.16 108.87 8.01 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.484 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.36 146.24 39.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.121 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.56 128.71 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.176 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 3.5 mp -121.5 111.21 30.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -123.03 122.78 39.35 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.1 pp -148.23 68.58 10.37 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 121.082 0.468 . . . . 0.0 111.347 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.53 -41.11 6.73 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.635 2.223 . . . . 0.0 112.41 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.84 -47.46 2.7 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.576 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.943 179.755 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.774 0.321 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t 60.49 91.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.336 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.92 179.27 8.6 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.578 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t -140.63 147.23 39.03 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.698 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.76 119.46 51.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -138.04 117.68 13.06 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.502 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -143.08 169.2 18.03 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.587 HG22 HD23 ' A' ' 39' ' ' LEU . 9.8 t -172.39 133.58 0.65 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.427 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 9' ' ' ILE . 9.5 tp -109.11 118.39 56.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.032 0.444 . . . . 0.0 111.022 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -124.89 108.21 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.79 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.873 HG12 HD13 ' A' ' 88' ' ' ILE . 1.8 pp -118.58 128.95 75.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.066 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 2.6 mptp? -115.49 125.28 52.86 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.651 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.749 HG23 ' CD1' ' A' ' 34' ' ' ILE . 97.5 m -130.06 127.2 39.41 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -138.96 158.82 43.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.912 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' NE2' ' HG ' ' A' ' 105' ' ' LEU . 1.4 tt0 -153.11 144.28 23.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.757 0.313 . . . . 0.0 111.275 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.414 ' HA ' ' H ' ' A' ' 109' ' ' GLN . 14.0 m-70 -142.18 119.23 11.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.864 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 4.8 mt -114.6 101.13 11.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.913 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.638 HD12 ' HD2' ' A' ' 19' ' ' PRO . 17.6 tp 176.95 129.99 0.19 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.068 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.638 ' HD2' HD12 ' A' ' 18' ' ' LEU . 81.5 Cg_endo -81.88 -44.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.715 2.276 . . . . 0.0 112.494 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -179.28 -49.87 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.197 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.456 HG23 ' HD2' ' A' ' 22' ' ' PRO . 9.1 p -121.53 137.35 26.89 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.501 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 21' ' ' VAL . 19.7 Cg_endo -58.22 107.26 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.857 2.371 . . . . 0.0 112.689 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -87.03 -13.19 4.63 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.912 2.408 . . . . 0.0 113.757 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 24' ' ' VAL . 12.1 t 63.45 41.87 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.985 0.421 . . . . 0.0 110.91 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.01 177.05 8.07 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.36 30.22 2.6 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.295 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.492 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -70.09 -57.81 5.77 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.443 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.505 ' HB3' ' HG3' ' A' ' 19' ' ' PRO . 17.9 Cg_endo -59.86 179.22 0.29 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.618 2.212 . . . . 0.0 113.395 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.33 174.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.968 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.439 ' CB ' HG12 ' A' ' 17' ' ' ILE . 1.1 ptt-85 -117.74 161.58 19.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.319 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.06 156.44 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.665 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -154.55 137.55 15.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.155 0.503 . . . . 0.0 111.567 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.7 t -134.83 117.21 15.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.934 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.749 ' CD1' HG23 ' A' ' 13' ' ' THR . 6.9 mm -128.94 142.76 43.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.945 0.402 . . . . 0.0 111.605 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.477 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 11.4 pt-20 -151.63 143.62 23.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.633 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.69 HG12 HG21 ' A' ' 55' ' ' ILE . 3.8 mp -128.66 133.61 66.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.01 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.495 ' C ' HD13 ' A' ' 38' ' ' LEU . 20.2 t -141.52 129.45 22.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.911 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.556 ' CD1' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -156.35 176.93 12.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.668 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.587 HD23 HG22 ' A' ' 8' ' ' THR . 3.8 mm? -104.96 162.52 13.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.216 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 1.1 m-20 -155.26 -59.57 0.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.42 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -77.69 -10.13 59.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.63 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -92.58 -27.8 17.13 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.77 45.6 1.2 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.444 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.98 103.76 0.07 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.006 0.431 . . . . 0.0 111.29 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 41' ' ' ASP . 1.2 tm-20 -96.83 35.57 1.52 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.258 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.608 ' O ' HD11 ' A' ' 93' ' ' LEU . 2.0 mp -119.53 102.35 47.81 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.55 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.55 151.66 58.97 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.842 2.361 . . . . 0.0 112.664 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.31 -69.82 0.3 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.158 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.486 ' HB ' HD12 ' A' ' 50' ' ' ILE . 8.1 p -83.79 -58.12 2.93 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.759 0.314 . . . . 0.0 110.421 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.564 HD13 ' HE3' ' A' ' 95' ' ' LYS . 4.9 mp -130.91 -86.39 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.634 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 46.3 t80 46.43 89.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.007 0.432 . . . . 0.0 111.703 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -175.58 134.22 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.663 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.593 ' HG2' HG13 ' A' ' 90' ' ' VAL . 1.4 mttt -119.86 149.73 41.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 110.675 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.663 HG13 ' HD2' ' A' ' 67' ' ' ARG . 11.3 t -141.51 116.38 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.561 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.88 HG23 HG22 ' A' ' 88' ' ' ILE . 1.8 mp -103.98 138.52 28.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.22 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -132.28 139.4 48.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.842 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.619 ' ND1' HG21 ' A' ' 34' ' ' ILE . 3.0 p-80 -154.66 117.41 4.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.172 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.594 ' HB3' HD22 ' A' ' 105' ' ' LEU . 0.5 OUTLIER 49.32 -163.24 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.504 -179.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.516 ' HB3' HG22 ' A' ' 61' ' ' THR . 0.9 OUTLIER -73.36 118.42 68.67 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.503 0.192 . . . . 0.0 110.493 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.33 -6.08 6.23 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.83 2.353 . . . . 0.0 113.812 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 59' ' ' HIS . 12.8 t -56.18 -16.65 5.58 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.41 -65.56 1.12 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.528 0.204 . . . . 0.0 110.957 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.92 -27.28 64.64 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.3 t30 71.92 151.95 0.14 Allowed Pre-proline 0 N--CA 1.465 0.313 0 CA-C-O 120.719 0.295 . . . . 0.0 111.387 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.72 159.25 38.07 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.512 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.512 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -123.91 138.81 54.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.441 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.663 ' HD2' HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -141.76 126.12 17.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.58 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 53' ' ' LYS . 1.7 m -105.96 104.98 14.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.935 0.398 . . . . 0.0 111.373 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -134.0 -55.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.048 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -146.02 33.76 1.01 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.106 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.01 159.71 63.3 Favored Pre-proline 0 N--CA 1.466 0.365 0 CA-C-O 120.762 0.315 . . . . 0.0 111.61 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -76.57 175.78 10.92 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.227 2.618 . . . . 0.0 112.58 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.444 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . 48.0 Cg_exo -56.09 175.25 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.875 2.383 . . . . 0.0 112.739 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -137.43 160.79 38.11 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.21 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -176.98 104.09 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.483 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.479 HD11 ' CD2' ' A' ' 74' ' ' PHE . 3.7 mp -139.65 132.7 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.045 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.67 122.95 24.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -137.28 167.56 21.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.601 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.1 173.37 6.42 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.778 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.67 -129.1 7.86 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.31 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -117.12 110.44 18.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.792 0.329 . . . . 0.0 110.627 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.2 88.71 0.09 OUTLIER Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.221 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -136.0 103.77 0.46 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.519 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.424 ' CD2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -150.78 168.18 11.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 120.486 0.184 . . . . 0.0 110.766 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.424 ' HD2' ' CD2' ' A' ' 84' ' ' PHE . 53.2 Cg_exo -56.91 173.34 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.973 2.449 . . . . 0.0 113.675 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 105' ' ' LEU . 3.3 mp -140.24 160.58 39.64 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.559 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -158.18 115.52 2.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.169 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.88 HG22 HG23 ' A' ' 55' ' ' ILE . 3.9 pt -113.82 105.21 18.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.242 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.4 p -112.37 136.99 51.17 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.01 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.593 HG13 ' HG2' ' A' ' 53' ' ' LYS . 5.7 t -131.62 119.27 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.344 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.586 ' C ' HD23 ' A' ' 92' ' ' LEU . 16.5 m-85 -125.59 155.96 39.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.947 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.677 HD11 HG21 ' A' ' 118' ' ' ILE . 0.2 OUTLIER -149.67 -171.44 3.9 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.765 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.608 HD11 ' O ' ' A' ' 46' ' ' ILE . 3.7 mt -77.26 136.43 38.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.832 0.348 . . . . 0.0 111.593 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 67.55 10.76 7.98 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.208 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.564 ' HE3' HD13 ' A' ' 50' ' ' ILE . 4.8 mmpt? 51.32 75.06 0.21 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.518 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.836 ' HB1' HG13 ' A' ' 120' ' ' ILE . . . -108.03 -28.14 9.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.965 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.444 ' N ' HD11 ' A' ' 92' ' ' LEU . . . -131.31 34.54 2.59 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.722 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.85 98.96 0.3 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.643 0.258 . . . . 0.0 110.602 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -141.86 125.86 17.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.361 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 2.0 pttp -131.07 132.84 45.16 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.736 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -137.21 119.66 11.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.507 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -87.16 149.87 8.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.925 2.416 . . . . 0.0 112.607 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 58.6 m80 -139.95 172.35 12.89 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.117 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.61 144.97 49.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.818 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.704 ' HB2' HD11 ' A' ' 86' ' ' LEU . 2.5 tp -127.37 88.35 2.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.795 0.331 . . . . 0.0 111.461 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -167.94 39.2 0.04 OUTLIER 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.432 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -141.62 124.88 16.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.391 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -56.74 130.01 43.69 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.69 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.414 ' H ' ' HA ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER 71.02 68.98 0.17 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.594 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -102.92 135.64 44.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.545 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.5 p -140.72 67.22 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.82 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -113.42 119.82 38.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.656 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.7 137.14 16.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.398 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.3 t -116.67 146.94 20.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.986 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -132.78 108.64 9.12 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.878 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.69 148.69 37.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.084 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.2 p -124.25 148.94 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.623 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.677 HG21 HD11 ' A' ' 92' ' ' LEU . 11.1 mt -133.94 110.88 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.444 ' O ' HD13 ' A' ' 120' ' ' ILE . 29.5 tt0 -130.3 104.5 7.31 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.401 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.836 HG13 ' HB1' ' A' ' 96' ' ' ALA . 21.2 mm -136.98 56.38 12.56 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 120.998 0.428 . . . . 0.0 111.473 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.21 -36.17 3.46 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.556 2.171 . . . . 0.0 112.468 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.6 mt -137.58 39.0 2.44 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.745 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.426 ' CB ' HG23 ' A' ' 120' ' ' ILE . 2.8 m-20 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.356 -0.831 . . . . 0.0 111.198 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtt . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.47 177.02 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 120.672 0.273 . . . . 0.0 111.159 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.611 ' HB1' ' CE ' ' A' ' 44' ' ' LYS . . . -126.46 126.7 44.22 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.214 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 t -153.87 138.77 17.18 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.753 0.311 . . . . 0.0 110.828 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 7.2 p -140.79 127.81 21.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.275 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.03 110.36 19.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.163 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.557 ' NE ' HD13 ' A' ' 92' ' ' LEU . 39.0 mtp85 -109.24 157.22 19.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.269 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 t -165.94 124.95 1.61 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.469 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.4 tt -108.67 118.2 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 110.769 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' O ' HG22 ' A' ' 37' ' ' VAL . 22.6 mtp180 -125.24 131.08 53.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.607 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.912 HG21 HD13 ' A' ' 88' ' ' ILE . 1.3 pt -127.35 129.84 70.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.142 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.69 112.4 25.46 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.23 113.8 20.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -135.61 154.33 51.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.738 0.304 . . . . 0.0 111.166 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.62 138.17 23.22 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.267 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.503 ' CE1' HD12 ' A' ' 18' ' ' LEU . 66.6 t-80 -135.2 119.43 17.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.967 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 30' ' ' ARG . 8.0 mt -118.64 121.85 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.738 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.708 HD22 ' HB2' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -164.25 117.26 1.0 Allowed Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.432 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HD2' HD23 ' A' ' 18' ' ' LEU . 64.7 Cg_endo -73.73 -10.51 23.44 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.739 2.293 . . . . 0.0 112.926 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.708 ' HB2' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -48.4 -44.86 35.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.261 0.224 . . . . 0.0 111.455 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.2 t -66.82 110.16 4.55 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.284 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.54 106.74 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.671 2.247 . . . . 0.0 112.402 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.19 -162.49 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.111 2.541 . . . . 0.0 111.998 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.7 t -77.63 -29.21 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.494 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -171.85 104.24 0.19 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.646 0.26 . . . . 0.0 110.393 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 11.1 p30 45.63 -161.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.636 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 26' ' ' ASN . 10.3 m-85 68.59 133.3 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-O 120.88 0.371 . . . . 0.0 111.334 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.89 -43.42 3.49 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.369 2.046 . . . . 0.0 112.578 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.1 t 67.48 128.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.223 0 O-C-N 123.442 0.463 . . . . 0.0 111.037 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.526 ' HB3' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -116.83 162.12 18.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' CG ' ' HB3' ' A' ' 79' ' ' GLN . 2.6 mt-30 -124.2 159.83 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -158.47 160.61 36.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.262 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.1 p -146.73 121.91 10.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.523 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.4 tp -126.4 124.21 65.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.962 0.411 . . . . 0.0 110.949 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -127.2 135.81 51.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.632 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.759 HG21 HG13 ' A' ' 55' ' ' ILE . 8.0 mt -123.91 105.89 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.917 HG12 ' HB3' ' A' ' 73' ' ' PRO . 27.1 m -119.72 149.1 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.84 0.352 . . . . 0.0 111.6 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.5 HD21 ' CB ' ' A' ' 68' ' ' THR . 2.6 pp -172.04 151.89 2.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.265 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -108.05 162.51 13.98 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.514 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -174.19 -47.71 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.396 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -86.04 2.72 45.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -24.93 24.63 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 5' ' ' VAL . . . -112.35 -74.82 0.71 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.342 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.611 ' CE ' ' HB1' ' A' ' 3' ' ' ALA . 7.0 mmtp -87.98 -56.55 3.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 64.95 16.77 10.73 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.239 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.542 HD12 ' HD3' ' A' ' 44' ' ' LYS . 5.6 mt -109.86 140.99 22.8 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.033 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.56 174.41 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.94 2.427 . . . . 0.0 112.633 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB1' ' HG ' ' A' ' 93' ' ' LEU . . . -155.29 -164.49 1.78 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.375 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -66.9 -47.8 70.7 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.431 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.43 -86.28 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.623 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 29.3 t80 53.29 92.84 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.102 0.477 . . . . 0.0 111.384 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 2.8 t70 -172.43 116.22 0.33 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.696 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.523 ' CG ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -99.83 125.55 45.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.59 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.747 HG12 ' HG3' ' A' ' 67' ' ' ARG . 36.0 m -122.78 132.26 71.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.959 0.409 . . . . 0.0 111.56 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.759 HG13 HG21 ' A' ' 36' ' ' ILE . 1.3 mm -123.11 140.22 47.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.932 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -143.81 97.88 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.548 ' HD2' HD12 ' A' ' 58' ' ' LEU . 26.5 p-80 -111.45 125.99 54.47 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.93 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.698 HD21 HD23 ' A' ' 105' ' ' LEU . 1.1 mt 69.0 161.04 0.2 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.364 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.422 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -76.83 -49.84 2.53 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.609 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 59' ' ' HIS . 85.9 Cg_exo -46.39 -29.44 7.07 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.157 2.572 . . . . 0.0 113.677 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 61' ' ' THR . 28.8 m -69.9 2.64 3.25 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -60.72 -34.09 73.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.507 0.194 . . . . 0.0 110.742 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.99 89.22 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.097 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -132.41 90.68 33.13 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 121.212 0.53 . . . . 0.0 110.994 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.84 152.78 73.71 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.673 2.249 . . . . 0.0 112.179 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.42 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 7.2 m-80 -96.79 130.64 44.01 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.747 ' HG3' HG12 ' A' ' 54' ' ' VAL . 1.5 mpp_? -145.61 112.63 6.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.61 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.5 ' CB ' HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -93.86 131.56 39.14 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -140.51 -54.05 0.51 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.603 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.95 36.48 0.4 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.741 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.19 163.35 34.32 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.01 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.85 171.66 2.72 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.865 2.377 . . . . 0.0 112.415 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.917 ' HB3' HG12 ' A' ' 37' ' ' VAL . 36.5 Cg_endo -64.89 169.43 11.77 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.632 2.221 . . . . 0.0 112.621 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.522 ' HB2' HD12 ' A' ' 36' ' ' ILE . 15.0 m-85 -117.06 64.26 0.72 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.713 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.54 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 24.4 tpt180 -82.81 90.74 6.95 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.776 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 74' ' ' PHE . 1.8 mp -126.84 131.82 70.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.388 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -136.65 123.24 20.97 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.536 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -133.79 177.91 7.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.579 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.446 ' HB3' ' CG ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -129.87 -179.22 5.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.066 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.49 -148.74 17.3 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.967 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.85 110.17 16.88 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.811 0.339 . . . . 0.0 110.861 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.07 -117.96 0.55 Allowed Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.118 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.11 114.79 2.32 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.679 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.452 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.0 m-85 -165.42 168.49 8.2 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 120.546 0.212 . . . . 0.0 110.976 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.489 ' C ' HD12 ' A' ' 86' ' ' LEU . 37.1 Cg_endo -65.81 -177.44 0.76 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.981 2.454 . . . . 0.0 113.014 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 105' ' ' LEU . 5.4 mp -146.15 166.08 27.25 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.751 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -158.71 123.63 4.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.783 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.912 HD13 HG21 ' A' ' 11' ' ' ILE . 33.9 mt -129.25 112.49 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.009 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.22 116.02 24.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.685 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.523 HG23 ' CG ' ' A' ' 53' ' ' LYS . 1.2 p -104.7 143.32 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.314 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 27.5 m-85 -133.26 155.78 48.76 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.524 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.623 HD23 ' HB3' ' A' ' 96' ' ' ALA . 4.6 tp -142.2 -63.17 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.731 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.568 ' HG ' ' HB1' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -144.6 -68.7 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.313 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -146.62 -63.49 0.3 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.359 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 51.53 1.2 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 111.185 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.623 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -104.41 -36.98 7.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.416 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . 180.0 46.04 0.08 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.535 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.426 ' CB ' ' HA ' ' A' ' 91' ' ' PHE . 11.4 pt-20 -111.34 111.02 21.77 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.08 0.467 . . . . 0.0 110.745 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.454 ' H ' HG12 ' A' ' 90' ' ' VAL . 5.4 ttt180 -142.29 151.79 42.35 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.303 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 0.2 OUTLIER -117.35 127.79 54.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.381 179.172 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.424 HG23 ' CE1' ' A' ' 103' ' ' HIS . 3.7 tt -139.24 121.42 10.21 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 121.024 0.44 . . . . 0.0 111.921 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.56 160.5 9.4 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.916 2.41 . . . . 0.0 112.393 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 38.1 m80 -144.69 172.21 13.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -124.33 145.04 49.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.115 0.483 . . . . 0.0 111.053 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.698 HD23 HD21 ' A' ' 58' ' ' LEU . 6.2 tp -139.16 78.63 1.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.378 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -161.82 38.94 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.367 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -141.47 130.39 23.12 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.168 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 2.4 pp -59.86 131.51 51.1 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.467 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.32 62.97 0.36 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.658 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -103.33 134.65 46.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.649 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.1 t -134.14 71.79 1.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.16 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.73 119.17 38.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.709 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -143.08 141.93 31.4 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.205 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 31.9 t -127.81 145.02 35.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -140.73 108.35 5.61 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.468 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.49 138.85 49.53 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.106 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.5 m -104.5 140.9 21.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.498 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 7' ' ' ARG . 10.0 mt -138.05 111.08 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.36 119.1 35.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.649 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.401 HG12 HD21 ' A' ' 92' ' ' LEU . 1.2 mp -125.07 52.13 6.01 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.748 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.97 -44.03 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.488 2.125 . . . . 0.0 112.637 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER 70.07 -67.52 0.23 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.277 0.361 . . . . 0.0 111.642 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.885 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.9 mtt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.511 0.196 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.62 -36.07 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.583 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.34 84.3 0.1 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.734 0.302 . . . . 0.0 111.399 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 t -149.02 155.66 41.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.872 0.367 . . . . 0.0 110.946 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -129.14 119.09 48.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.808 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -137.41 104.96 5.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.586 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -125.4 165.57 18.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.956 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.5 t -172.99 139.56 0.84 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.09 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.553 HG21 HG21 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -109.99 118.2 56.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.47 179.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.8 mtt85 -124.78 105.3 9.18 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.621 HG21 ' CD1' ' A' ' 88' ' ' ILE . 2.2 pt -112.51 134.09 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.052 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.623 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -118.41 141.59 48.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.27 -179.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -138.55 109.75 6.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.081 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -120.97 136.68 54.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.502 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.516 ' HG3' HD21 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -140.06 150.43 44.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.671 0.272 . . . . 0.0 111.691 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -147.64 119.66 8.22 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.41 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.452 HG13 ' OE1' ' A' ' 15' ' ' GLN . 14.5 mt -105.77 116.15 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.972 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.32 93.2 0.36 Allowed Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.104 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -66.22 -48.43 2.59 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.49 2.127 . . . . 0.0 112.586 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 55.67 36.11 26.59 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.998 0.428 . . . . 0.0 110.881 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.401 HG13 ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -105.99 136.42 19.31 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.614 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' CB ' ' HD2' ' A' ' 23' ' ' PRO . 19.0 Cg_endo -58.29 173.98 0.85 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.797 2.331 . . . . 0.0 112.073 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 22' ' ' PRO . 12.4 Cg_endo -55.8 89.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.009 2.473 . . . . 0.0 112.36 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.8 t -135.81 -55.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.926 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -140.51 172.7 12.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.63 35.36 4.46 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.072 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.48 92.22 32.03 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.634 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.32 155.69 12.02 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.88 2.387 . . . . 0.0 112.689 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.874 HG13 ' HA2' ' A' ' 80' ' ' GLY . 25.5 t -118.95 113.52 41.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.768 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -109.42 163.55 13.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.311 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -134.05 111.02 10.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.571 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.437 ' HB3' ' HG3' ' A' ' 15' ' ' GLN . 23.3 p-90 -116.1 150.21 37.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.307 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -140.1 147.27 40.0 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 12' ' ' LYS . 5.7 tp -146.48 135.32 16.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.487 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 3.7 pm0 -134.97 144.57 47.47 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.822 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.445 HG21 ' CD1' ' A' ' 55' ' ' ILE . 4.2 mp -121.32 107.07 19.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.889 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.72 138.36 34.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.245 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.026 HD21 HG21 ' A' ' 68' ' ' THR . 0.6 OUTLIER -166.18 160.08 15.8 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.527 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -105.02 161.85 13.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -151.64 -63.17 0.18 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.678 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.09 -19.54 65.88 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.514 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -86.65 -32.66 20.43 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.196 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.57 48.08 0.97 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.28 106.31 0.04 OUTLIER 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.983 0.42 . . . . 0.0 111.3 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.24 16.34 6.38 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.932 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.1 mt -125.47 104.58 28.06 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-O 120.515 0.198 . . . . 0.0 111.409 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HA ' HD11 ' A' ' 93' ' ' LEU . 74.2 Cg_endo -75.33 -170.5 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.799 2.333 . . . . 0.0 112.556 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.83 -45.87 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.879 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.433 ' HB ' HD12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -93.65 -67.79 0.84 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.791 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.475 HD13 ' HD3' ' A' ' 95' ' ' LYS . 4.3 mp -133.38 -89.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.032 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 40.3 t80 58.72 100.14 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.2 0.524 . . . . 0.0 110.864 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.8 110.36 1.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.844 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.724 ' HD3' HD13 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -100.98 102.59 13.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.364 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.402 HG23 ' CG ' ' A' ' 67' ' ' ARG . 9.6 p -103.95 139.42 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.342 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 55' ' ' ILE . 3.7 mp -130.69 144.84 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.433 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.08 148.15 42.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.504 ' CD2' HG21 ' A' ' 34' ' ' ILE . 26.1 p-80 -161.12 59.35 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.679 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -178.31 175.64 1.16 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.359 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 162.17 19.95 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.011 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.81 2.73 6.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.649 2.232 . . . . 0.0 113.713 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -4.95 8.07 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.47 ' CZ ' ' HG3' ' A' ' 65' ' ' PRO . 1.6 t80 59.94 71.29 0.58 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-O 121.001 0.429 . . . . 0.0 111.414 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.41 -28.9 12.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.872 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.422 ' O ' HD21 ' A' ' 58' ' ' LEU . 37.5 t30 -168.37 85.19 0.71 Allowed Pre-proline 0 C--O 1.233 0.191 0 CA-C-O 120.761 0.315 . . . . 0.0 111.24 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.47 ' HG3' ' CZ ' ' A' ' 62' ' ' PHE . 81.1 Cg_endo -77.14 140.53 19.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.623 2.215 . . . . 0.0 112.618 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -109.96 128.67 55.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.701 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.402 ' CG ' HG23 ' A' ' 54' ' ' VAL . 76.2 mtt180 -144.8 139.51 27.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.997 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 1.026 HG21 HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -124.04 104.65 9.01 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.095 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -102.24 -41.4 6.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.107 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 t -170.53 43.25 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.495 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.19 166.18 20.64 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.236 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.79 172.48 5.79 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.898 2.399 . . . . 0.0 112.445 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.97 -179.03 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.778 2.319 . . . . 0.0 112.61 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -140.89 159.17 42.78 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -173.92 114.18 0.2 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.075 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -142.9 151.18 17.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.245 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -133.63 141.85 47.82 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.917 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 32' ' ' TRP . 13.6 mt-10 -133.79 152.08 51.77 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.959 0.409 . . . . 0.0 111.586 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.95 178.98 5.43 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.367 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.874 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 86.15 -103.72 2.81 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.67 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -121.69 112.12 18.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.085 0.469 . . . . 0.0 111.418 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.13 115.17 0.61 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.177 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.629 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . -166.4 103.85 0.21 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.392 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.445 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -150.55 167.8 12.27 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.648 0.261 . . . . 0.0 111.195 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.78 173.14 2.38 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.245 2.63 . . . . 0.0 113.325 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 105' ' ' LEU . 2.5 mp -142.62 160.11 40.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.32 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -157.6 113.4 2.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.799 0.333 . . . . 0.0 111.568 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.621 ' CD1' HG21 ' A' ' 11' ' ' ILE . 2.0 tt -116.47 121.79 68.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.533 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.6 121.94 26.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.115 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.578 HG13 ' HG2' ' A' ' 53' ' ' LYS . 5.8 t -99.95 154.3 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.643 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.47 ' CD2' ' HG3' ' A' ' 98' ' ' GLU . 51.4 m-85 -148.52 158.23 43.99 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.885 HD13 HG21 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -153.45 -175.13 5.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.134 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 47' ' ' PRO . 8.9 mp -60.93 -67.0 0.44 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.537 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -94.15 19.77 8.86 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.574 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.475 ' HD3' HD13 ' A' ' 50' ' ' ILE . 4.4 mmmm 58.35 55.36 5.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.17 -37.62 37.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 90' ' ' VAL . . . -122.49 26.39 6.32 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.606 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.0 tt0 -67.08 90.9 0.2 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.633 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -142.45 142.37 32.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.503 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -126.62 119.32 26.75 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.393 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.6 mt -128.77 120.72 20.68 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.482 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.2 154.83 8.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.004 2.47 . . . . 0.0 112.692 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 81.7 m-70 -140.12 172.1 13.23 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.396 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -128.54 124.6 36.4 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.114 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.629 HD13 ' HA2' ' A' ' 83' ' ' GLY . 1.3 tm? -113.56 95.03 5.13 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.761 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 13.6 t-20 178.8 41.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.062 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -137.4 125.27 22.61 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.663 0.268 . . . . 0.0 111.138 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.04 123.89 12.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.83 60.88 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.419 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.0 138.97 30.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.46 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.2 p -148.16 63.75 1.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.905 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -115.19 119.36 36.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.389 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -147.32 133.84 19.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.506 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 t -105.59 147.4 11.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.72 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -136.45 108.45 7.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.695 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -116.64 138.51 51.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.8 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.62 140.92 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.986 0.422 . . . . 0.0 111.555 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.885 HG21 HD13 ' A' ' 92' ' ' LEU . 2.0 mp -130.56 111.39 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.585 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -122.5 136.95 55.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.214 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 120' ' ' ILE . 6.9 tt -160.24 55.85 0.75 Allowed Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 121.286 0.565 . . . . 0.0 111.21 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.47 125.36 10.07 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.719 2.28 . . . . 0.0 112.531 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -31.49 52.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.973 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.064 -0.969 . . . . 0.0 111.151 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HG2' ' N ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.428 ' N ' ' HG2' ' A' ' 1' ' ' MET . 14.4 p -82.96 -35.6 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.14 82.31 5.04 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.851 0.358 . . . . 0.0 110.955 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 t -145.91 141.76 28.1 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 44' ' ' LYS . 19.4 t -133.42 119.24 34.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.078 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -137.03 104.89 5.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.159 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.491 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -132.57 172.98 11.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.189 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.9 t -173.22 141.36 0.93 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.702 HG21 HG21 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -109.2 118.14 55.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 110.636 179.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.8 mtt-85 -124.75 118.25 25.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.802 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 36' ' ' ILE . 1.6 pt -123.56 129.81 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.661 ' O ' HD12 ' A' ' 34' ' ' ILE . 34.2 mtmt -108.19 133.09 52.93 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -131.33 104.2 6.89 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 25.3 tm0? -115.1 137.98 51.4 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.698 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.448 ' NE2' ' HG ' ' A' ' 105' ' ' LEU . 4.8 tt0 -139.39 151.98 46.75 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.751 0.31 . . . . 0.0 111.705 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.441 ' CD2' ' HB2' ' A' ' 18' ' ' LEU . 3.7 t-160 -150.0 119.18 6.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.722 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 40.8 mt -97.41 101.89 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.75 0.309 . . . . 0.0 110.648 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' HB2' ' CD2' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -134.41 85.16 38.68 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.753 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.21 -57.69 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.013 2.475 . . . . 0.0 112.891 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 54.02 23.46 4.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.647 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.04 138.81 32.88 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.698 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HA ' ' HD2' ' A' ' 23' ' ' PRO . 60.2 Cg_exo -51.97 108.35 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.516 2.144 . . . . 0.0 112.252 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 22' ' ' PRO . 41.8 Cg_endo -68.82 103.01 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.805 2.336 . . . . 0.0 112.842 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.49 ' O ' HG22 ' A' ' 24' ' ' VAL . 14.6 p -167.48 42.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.039 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -155.81 -50.62 0.08 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.582 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -164.13 -174.96 3.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.682 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 3.9 m-85 -61.54 141.61 94.59 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-O 120.553 0.216 . . . . 0.0 110.826 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 27' ' ' PHE . 40.0 Cg_exo -57.36 169.65 2.11 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.086 2.524 . . . . 0.0 112.973 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HB ' ' HA2' ' A' ' 80' ' ' GLY . 7.3 m -98.13 157.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.95 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.408 ' HB3' HG12 ' A' ' 17' ' ' ILE . 2.8 mtt-85 -136.08 163.43 30.34 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.213 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 3.7 mt-30 -118.54 148.94 42.12 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.075 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.464 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 15.0 p-90 -156.11 155.23 32.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.103 0.478 . . . . 0.0 112.145 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.1 t -149.29 117.74 6.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.539 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 12' ' ' LYS . 9.3 tp -122.29 143.05 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.428 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 4.0 pt-20 -144.64 118.73 9.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.833 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.744 ' HA ' HG22 ' A' ' 11' ' ' ILE . 4.6 mp -101.07 110.35 27.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.676 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 73' ' ' PRO . 24.3 t -124.03 147.8 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.721 0.296 . . . . 0.0 111.589 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.619 ' HB3' HD12 ' A' ' 9' ' ' ILE . 2.9 pp -156.89 171.2 20.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.255 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 7' ' ' ARG . 2.5 tp -120.18 159.02 25.72 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.21 -45.62 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.287 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.3 2.58 15.29 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.43 -36.52 26.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.577 0.227 . . . . 0.0 111.007 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.4 -66.96 0.25 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.809 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.829 ' HB2' HG22 ' A' ' 5' ' ' VAL . 4.2 mttt -155.07 108.92 2.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.558 0.218 . . . . 0.0 110.849 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -90.08 49.62 1.74 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.751 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.441 HD13 ' HD3' ' A' ' 44' ' ' LYS . 3.7 mp -127.45 132.93 24.57 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.216 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.85 -177.98 4.01 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.84 2.36 . . . . 0.0 112.565 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.62 -54.53 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.25 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.8 p -125.82 -55.09 1.51 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.347 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 91' ' ' PHE . 0.6 OUTLIER -118.9 -86.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.015 179.078 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 t80 56.23 96.82 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.075 0.464 . . . . 0.0 111.213 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -174.41 127.52 0.34 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.664 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.857 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -114.55 133.09 56.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.806 0.336 . . . . 0.0 110.703 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.49 HG13 ' HG3' ' A' ' 67' ' ' ARG . 6.7 t -132.44 118.82 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.645 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.512 HG21 HG12 ' A' ' 36' ' ' ILE . 3.6 mp -106.99 144.91 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.382 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -138.95 144.87 39.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.068 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.5 ' HB3' HD23 ' A' ' 86' ' ' LEU . 1.7 p80 -167.27 137.31 2.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.691 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 2.6 mt 74.93 147.0 0.09 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.267 0.354 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 -54.89 0.47 Allowed Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -47.64 -30.92 13.28 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.047 2.498 . . . . 0.0 114.415 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.491 HG22 ' HB2' ' A' ' 58' ' ' LEU . 12.8 t -81.27 9.92 6.3 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.557 0.218 . . . . 0.0 111.153 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -51.22 -30.12 16.35 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.916 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.53 6.27 18.06 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -159.09 66.88 3.06 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.641 0.258 . . . . 0.0 111.405 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.61 177.41 3.4 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.873 2.382 . . . . 0.0 112.548 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.427 ' ND2' HD13 ' A' ' 36' ' ' ILE . 58.6 t30 -108.11 139.76 42.29 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.0 0.429 . . . . 0.0 111.164 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG3' HG13 ' A' ' 54' ' ' VAL . 3.6 mpp_? -137.04 147.4 46.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.749 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.44 HG21 ' CD2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -132.77 123.83 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.061 0.458 . . . . 0.0 111.396 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -136.05 -54.46 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.311 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 t -155.65 39.34 0.38 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -123.5 155.75 65.24 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -57.25 172.72 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.08 2.52 . . . . 0.0 112.819 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.847 ' HB3' HG22 ' A' ' 37' ' ' VAL . 32.6 Cg_exo -57.88 166.96 4.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.881 2.387 . . . . 0.0 112.939 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -127.8 84.46 2.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.658 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.2 ttp85 -99.85 113.91 26.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.45 115.7 18.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -122.18 144.08 49.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.3 166.64 32.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.943 0.402 . . . . 0.0 111.449 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -123.65 170.52 10.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' A' ' 29' ' ' VAL . . . 98.35 -81.8 0.62 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.472 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -113.61 116.61 29.77 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' HA3' ' CD1' ' A' ' 32' ' ' TRP . . . -170.99 88.29 0.09 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.763 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 105' ' ' LEU . . . -160.26 74.64 0.2 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.666 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.552 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 22.7 m-85 -143.37 165.7 23.95 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 120.632 0.253 . . . . 0.0 111.35 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 37.3 Cg_endo -65.38 171.1 9.78 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.136 2.557 . . . . 0.0 113.729 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 103' ' ' HIS . 5.1 mp -143.29 159.59 42.06 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.964 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -155.37 112.71 3.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.663 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.479 HG23 HG13 ' A' ' 55' ' ' ILE . 3.2 mp -117.52 124.46 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.685 0.279 . . . . 0.0 111.319 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.1 p -126.59 131.89 51.41 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.857 HG13 ' HG2' ' A' ' 53' ' ' LYS . 24.2 t -124.42 137.46 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.022 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.52 ' HB3' HD12 ' A' ' 50' ' ' ILE . 11.5 m-85 -131.61 154.9 48.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.349 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' ' 96' ' ' ALA . 2.5 tm? -141.15 -53.84 0.47 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.112 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' A' ' 92' ' ' LEU . 5.5 tt -152.48 -52.06 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.157 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -170.25 -63.63 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.563 0.22 . . . . 0.0 111.143 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.54 21.95 8.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.407 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.8 ' HB3' HD12 ' A' ' 92' ' ' LEU . . . -87.12 -50.86 6.34 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.802 0.334 . . . . 0.0 110.696 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -149.88 23.54 1.15 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.687 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -76.66 84.76 3.31 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.731 0.301 . . . . 0.0 110.789 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -142.28 146.04 34.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.148 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -124.87 147.75 48.63 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.471 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 114' ' ' VAL . 8.2 tp -148.0 111.77 3.83 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 121.008 0.433 . . . . 0.0 111.879 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -85.99 133.25 4.13 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.033 2.489 . . . . 0.0 112.342 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 1.7 m-70 -113.18 163.34 14.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.303 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.44 138.46 54.01 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.484 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 6.0 tp -123.48 92.12 3.62 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.653 0.263 . . . . 0.0 110.911 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -167.98 33.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -141.91 126.28 17.66 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.808 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 2.9 pp -58.21 131.85 51.8 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.748 0.309 . . . . 0.0 110.679 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 73.09 67.16 0.11 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.63 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 32.5 tt0 -92.45 141.28 28.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 t -144.8 64.86 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.02 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 119.27 38.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.55 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 12' ' ' LYS . 7.5 tt0 -141.67 131.37 24.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.213 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.633 HG21 HG21 ' A' ' 101' ' ' ILE . 43.5 t -116.43 140.4 38.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -133.46 108.54 8.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.62 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.27 119.07 36.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.54 144.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.574 HG21 ' HG ' ' A' ' 92' ' ' LEU . 35.2 mt -134.6 111.15 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.63 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.46 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -128.38 106.13 8.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.174 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 119' ' ' GLN . 16.1 mm -135.4 62.03 47.68 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.192 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.76 -43.11 1.4 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.352 2.035 . . . . 0.0 112.871 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.77 93.16 2.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.027 0.441 . . . . 0.0 110.297 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.52 -179.347 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.16 174.73 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.669 0.271 . . . . 0.0 111.233 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.81 78.71 1.58 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.985 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.56 135.41 24.91 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.4 119.26 48.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.128 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -129.22 106.07 8.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.545 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 46.9 mtt85 -123.46 152.71 41.39 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.996 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.889 HG22 HD23 ' A' ' 39' ' ' LEU . 6.9 t -160.96 143.95 12.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 90' ' ' VAL . 1.0 OUTLIER -117.17 125.04 73.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 111.099 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.568 ' O ' HG22 ' A' ' 37' ' ' VAL . 28.2 mtt85 -132.06 108.83 9.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.552 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.436 HD13 HD13 ' A' ' 88' ' ' ILE . 1.3 pt -117.78 132.15 68.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.069 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.612 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.1 mptm? -118.21 139.17 51.69 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.445 HG22 HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -137.09 102.91 4.97 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.7 tt0 -113.69 118.76 35.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.224 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.56 ' HB2' HD11 ' A' ' 105' ' ' LEU . 13.5 tt0 -119.98 146.34 45.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 111.914 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.435 ' CD2' ' HB3' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -146.72 119.8 8.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.61 ' O ' HD12 ' A' ' 18' ' ' LEU . 26.1 mt -99.46 128.5 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.179 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 17' ' ' ILE . 5.9 mp -135.63 106.9 9.92 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.677 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.94 -56.57 0.56 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.691 2.261 . . . . 0.0 112.871 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 49.6 81.07 0.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.719 0.295 . . . . 0.0 111.443 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.515 HG13 ' ND2' ' A' ' 26' ' ' ASN . 36.2 t -65.12 110.11 3.82 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.301 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.97 161.51 10.31 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.741 2.294 . . . . 0.0 112.28 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.74 45.19 1.92 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.726 2.284 . . . . 0.0 112.794 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.1 t -148.18 -65.77 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.093 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -133.31 -174.52 3.52 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.873 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.515 ' ND2' HG13 ' A' ' 21' ' ' VAL . 29.6 m120 -132.56 116.88 17.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.601 0.239 . . . . 0.0 111.284 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -163.08 110.85 1.03 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.076 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.86 129.76 13.78 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.733 2.289 . . . . 0.0 112.465 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.08 138.31 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 111.7 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -104.09 160.41 14.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.997 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.435 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 1.0 OUTLIER -135.84 113.57 11.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.673 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.695 ' CG ' HD21 ' A' ' 105' ' ' LEU . 14.1 p-90 -121.8 154.63 36.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.766 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 t -136.71 118.61 15.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.529 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 12' ' ' LYS . 6.3 tp -119.18 136.95 54.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.527 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -135.32 138.88 43.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.346 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.772 HG21 ' CD1' ' A' ' 55' ' ' ILE . 2.9 mp -123.9 105.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.844 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 73' ' ' PRO . 31.2 m -115.59 150.48 17.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.919 0.39 . . . . 0.0 111.499 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.812 HD21 HG21 ' A' ' 68' ' ' THR . 0.5 OUTLIER -172.51 178.95 2.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.243 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.889 HD23 HG22 ' A' ' 8' ' ' THR . 2.9 mm? -103.88 165.84 10.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.293 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -167.28 -50.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.446 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.15 -31.43 65.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.465 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' HB2' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -82.78 -36.63 25.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.045 -179.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.19 50.07 1.11 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.824 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.9 mttm 52.85 96.62 0.01 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.89 0.376 . . . . 0.0 111.42 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -24.8 59.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.588 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 46' ' ' ILE . 3.5 mp -82.51 114.75 53.89 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.865 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.85 -175.3 1.14 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.594 2.196 . . . . 0.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -145.49 -51.27 0.25 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.674 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.404 HG22 HD12 ' A' ' 50' ' ' ILE . 14.0 m -104.77 -69.67 0.8 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.835 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 49' ' ' THR . 2.7 mp -132.53 -85.07 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.838 -0.165 . . . . 0.0 111.019 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 39.0 t80 56.15 95.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.044 0.45 . . . . 0.0 111.505 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -159.16 111.86 2.22 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.498 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.926 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -99.21 121.68 41.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.64 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.411 HG12 ' OG ' ' A' ' 89' ' ' SER . 12.2 p -120.81 128.19 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 0.0 111.109 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.772 ' CD1' HG21 ' A' ' 36' ' ' ILE . 3.3 mp -116.63 145.24 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.434 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -142.82 128.2 18.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.41 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 3.6 p80 -127.57 135.65 50.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.771 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER 67.01 -178.93 0.21 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.279 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.549 ' HB3' HG22 ' A' ' 61' ' ' THR . 0.1 OUTLIER -52.11 154.29 4.12 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.754 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 59' ' ' HIS . 9.6 Cg_exo -71.49 2.05 4.93 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.167 2.578 . . . . 0.0 113.312 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 59' ' ' HIS . 15.0 t -82.89 9.8 9.19 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.795 0.331 . . . . 0.0 110.817 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -61.07 162.19 7.54 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.398 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.17 -49.63 14.75 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -139.33 115.56 8.41 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.303 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 62' ' ' PHE . 56.1 Cg_endo -70.41 -179.37 3.15 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.513 2.142 . . . . 0.0 112.068 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.413 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 10.0 m120 -111.74 127.39 55.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.819 0.342 . . . . 0.0 111.052 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.4 ttt-85 -143.37 122.96 13.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.71 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.812 HG21 HD21 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -106.63 139.32 41.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -159.86 -55.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.119 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.33 38.03 1.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.035 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.83 160.19 67.73 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.505 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -62.13 174.74 2.34 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.16 2.573 . . . . 0.0 112.649 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.612 ' HB2' HG12 ' A' ' 37' ' ' VAL . 65.7 Cg_endo -74.21 148.73 39.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.74 2.293 . . . . 0.0 112.712 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -99.13 155.79 17.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.01 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.96 86.91 0.1 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.5 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -136.67 151.94 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.319 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -122.45 157.72 31.33 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.994 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.97 141.14 49.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.182 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.88 136.04 53.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.743 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 30' ' ' ARG . . . 128.19 -156.43 20.8 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.839 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -75.81 131.12 39.55 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.055 0.455 . . . . 0.0 111.312 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.9 -127.86 1.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.939 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.04 104.37 0.13 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.752 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 3.4 m-85 -155.5 170.8 8.14 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 120.707 0.289 . . . . 0.0 111.25 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 87.8 Cg_exo -49.86 170.25 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.477 2.785 . . . . 0.0 114.177 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD23 HD11 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -135.16 159.66 40.83 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.72 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -156.21 120.94 4.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.926 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.583 HG23 HG13 ' A' ' 55' ' ' ILE . 3.1 mp -135.33 124.0 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.275 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.411 ' OG ' HG12 ' A' ' 54' ' ' VAL . 1.4 p -123.61 122.23 37.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.95 0.405 . . . . 0.0 110.302 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.926 HG13 ' HG2' ' A' ' 53' ' ' LYS . 19.2 t -107.4 111.88 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.069 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -102.9 157.54 16.9 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.781 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.628 HD11 ' CB ' ' A' ' 95' ' ' LYS . 1.3 pt? -146.27 -159.81 1.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.612 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 12.4 mt -55.59 -66.85 0.35 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.409 0.147 . . . . 0.0 111.014 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -177.37 42.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.221 0.534 . . . . 0.0 110.42 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.672 ' HD2' HG21 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -110.96 -166.24 1.06 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.026 -179.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.65 -13.44 61.36 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.817 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.12 -27.91 57.94 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.097 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -65.26 83.43 0.05 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.107 0.48 . . . . 0.0 110.624 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.46 155.45 45.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.545 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -121.54 145.89 47.5 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.615 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.793 HG21 HG21 ' A' ' 114' ' ' VAL . 3.7 mp -138.59 114.47 8.77 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.468 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -88.63 155.85 6.32 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.082 2.522 . . . . 0.0 112.254 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 112' ' ' TYR . 6.1 m170 -140.26 172.02 13.33 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.034 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.66 119.32 21.24 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.2 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.695 HD21 ' CG ' ' A' ' 32' ' ' TRP . 4.3 tp -112.95 86.5 2.38 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -165.36 39.83 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -142.09 139.75 32.32 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.458 ' H ' HD12 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -62.03 127.36 31.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.368 179.374 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 64.9 79.02 0.26 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.245 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 39.3 tt0 -109.63 136.38 49.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.014 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -133.69 70.95 1.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.106 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 103' ' ' HIS . 5.5 m-85 -110.09 119.1 38.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.059 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -154.57 132.23 11.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.415 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.793 HG21 HG21 ' A' ' 101' ' ' ILE . 25.0 t -109.59 145.72 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.678 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -132.16 108.65 9.41 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.079 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.424 ' HB3' HG22 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -113.29 151.71 30.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.7 149.31 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.957 0.408 . . . . 0.0 111.871 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.3 mt -143.29 110.97 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.507 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -129.79 118.33 21.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.637 0.256 . . . . 0.0 111.28 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.672 HG21 ' HD2' ' A' ' 95' ' ' LYS . 1.6 pp -138.2 48.58 2.03 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.83 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 120' ' ' ILE . 71.1 Cg_endo -76.45 -42.41 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.56 2.173 . . . . 0.0 112.866 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 mp -103.8 -50.07 3.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.647 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.547 179.719 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmm . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.407 0.146 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 m -76.78 -32.41 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.546 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.67 83.99 2.09 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.59 128.02 9.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 44' ' ' LYS . 19.0 t -123.38 119.43 57.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.097 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.72 104.85 5.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.19 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.401 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 47.3 mtt180 -134.59 175.44 9.53 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.038 0.447 . . . . 0.0 111.258 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 4.9 t -160.77 146.05 14.45 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.335 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.812 HD11 HD11 ' A' ' 88' ' ' ILE . 1.6 tt -113.87 118.05 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-O 120.931 0.396 . . . . 0.0 110.784 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -130.29 111.13 12.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.505 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.839 HD11 HG21 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -122.06 142.27 39.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.121 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.564 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -120.59 138.4 53.91 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.755 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.404 HG23 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -142.2 120.12 12.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.161 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -130.33 160.14 34.84 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.77 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -152.86 142.04 21.44 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.279 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.405 ' CD2' ' HG ' ' A' ' 18' ' ' LEU . 3.3 t-160 -131.96 119.67 21.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.733 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.48 HG22 ' HD3' ' A' ' 19' ' ' PRO . 28.4 mt -117.88 126.99 75.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.608 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -120.4 75.87 24.89 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.161 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD3' HG22 ' A' ' 17' ' ' ILE . 66.2 Cg_endo -75.48 -37.86 1.64 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.541 2.16 . . . . 0.0 112.716 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -80.71 -37.57 30.41 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.1 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 18' ' ' LEU . 12.6 t -65.41 111.41 6.05 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.478 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.47 107.43 0.5 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.647 2.231 . . . . 0.0 112.203 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.556 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 5.8 Cg_exo -79.84 47.37 2.5 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.41 2.74 . . . . 0.0 112.937 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t 67.56 -69.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 122.798 0.439 . . . . 0.0 111.941 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -85.42 3.61 39.3 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.556 ' HA ' ' HD2' ' A' ' 23' ' ' PRO . 5.3 m-80 62.44 53.69 2.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 110.886 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.656 ' O ' HG23 ' A' ' 29' ' ' VAL . 2.5 m-85 -124.17 114.03 27.83 Favored Pre-proline 0 CA--C 1.529 0.135 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.032 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.92 107.97 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.94 2.426 . . . . 0.0 112.655 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 27' ' ' PHE . 40.2 t -120.84 146.05 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.282 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.42 162.37 26.5 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.355 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.413 ' CG ' ' HB3' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -119.53 162.14 19.42 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -158.87 141.47 14.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.195 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -138.38 117.65 12.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.564 HD12 ' O ' ' A' ' 12' ' ' LYS . 8.1 tp -127.55 139.74 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.988 0.423 . . . . 0.0 111.953 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.444 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -143.46 132.98 23.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.673 179.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.656 HD12 HG21 ' A' ' 55' ' ' ILE . 5.4 mm -113.62 111.58 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.212 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.68 133.76 64.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.707 0.289 . . . . 0.0 110.966 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.583 HD13 ' HE2' ' A' ' 53' ' ' LYS . 4.0 pp -169.37 174.95 5.76 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.582 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.9 mm? -114.94 160.92 18.98 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.413 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -167.83 -49.36 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.16 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.72 1.91 28.24 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -83.94 -34.78 24.39 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 111.052 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.9 -75.17 0.93 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.868 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.679 ' HB2' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -119.43 112.08 18.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.608 0.242 . . . . 0.0 110.79 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -104.6 30.5 5.36 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.191 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 mt -132.32 124.2 19.11 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.293 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.32 168.57 24.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.877 2.385 . . . . 0.0 112.538 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.764 ' HB3' HD23 ' A' ' 93' ' ' LEU . . . -154.42 -50.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.652 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 p -121.63 -68.1 0.92 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.716 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.711 HD11 ' HE2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -126.19 -89.67 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.168 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 13.2 t80 57.47 95.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.993 0.425 . . . . 0.0 111.522 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -165.95 125.61 1.68 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.623 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.602 ' CG ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -110.84 105.22 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.368 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.0 140.58 24.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.39 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.656 HG21 HD12 ' A' ' 36' ' ' ILE . 3.5 mp -123.86 141.5 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.963 0.411 . . . . 0.0 111.327 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -128.78 154.9 45.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.765 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 19.2 p80 -164.82 137.61 4.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.769 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER 74.56 174.12 0.26 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.607 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.41 159.99 36.82 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.503 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.5 -9.36 10.88 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.112 2.541 . . . . 0.0 113.531 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.4 p -58.48 -13.35 5.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.379 0.133 . . . . 0.0 111.329 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.11 142.26 57.69 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 120.717 0.294 . . . . 0.0 111.092 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.66 81.13 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.212 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 2.1 t-20 -153.62 115.07 2.64 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.355 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 64' ' ' ASN . 34.7 Cg_exo -61.9 -174.16 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.16 2.574 . . . . 0.0 112.517 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.431 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 29.1 m-20 -87.71 150.83 23.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.041 0.448 . . . . 0.0 111.559 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.62 136.67 18.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.577 HG21 HD11 ' A' ' 38' ' ' LEU . 22.9 m -129.41 108.08 10.0 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -141.92 -54.07 0.44 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.257 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 p -140.08 33.9 1.93 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.135 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.42 164.05 42.27 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.277 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.79 168.43 22.94 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.803 2.335 . . . . 0.0 112.696 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.79 161.54 45.54 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.721 2.281 . . . . 0.0 112.845 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.409 ' HB2' HG12 ' A' ' 36' ' ' ILE . 34.0 m-85 -105.22 154.7 19.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.219 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.04 71.83 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.61 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 mt -130.47 141.01 47.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.414 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.57 138.77 47.56 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.526 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -140.23 167.54 21.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.002 0.43 . . . . 0.0 111.453 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.413 ' HB3' ' CG ' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -129.9 141.53 50.79 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.847 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.41 -131.75 2.36 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.604 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.404 ' HE1' HG22 ' A' ' 29' ' ' VAL . 7.9 m0 -120.2 110.33 16.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.882 0.373 . . . . 0.0 110.848 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.46 -126.54 0.86 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.389 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.41 94.04 1.52 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.574 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.514 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.1 m-85 -156.13 169.92 9.68 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.63 0.252 . . . . 0.0 111.088 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 58.6 Cg_endo -72.01 172.35 14.84 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.767 2.311 . . . . 0.0 113.38 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.452 ' CG ' ' HB2' ' A' ' 103' ' ' HIS . 0.4 OUTLIER -146.46 159.69 43.08 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.517 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -149.55 119.0 6.88 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.678 0.275 . . . . 0.0 111.383 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.839 HG21 HD11 ' A' ' 11' ' ' ILE . 5.0 tt -111.11 114.12 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -110.15 135.0 51.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.602 HG23 ' CG ' ' A' ' 53' ' ' LYS . 3.8 p -122.15 138.65 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.966 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -134.69 157.58 46.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.547 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.529 HD11 ' H ' ' A' ' 96' ' ' ALA . 1.4 pt? -146.02 -163.47 1.74 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.764 HD23 ' HB3' ' A' ' 48' ' ' ALA . 2.5 mp -97.02 -16.78 20.4 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.469 ' HB2' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -108.35 1.77 22.06 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.711 ' HE2' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER 48.24 37.42 8.29 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.529 ' H ' HD11 ' A' ' 92' ' ' LEU . . . -95.01 -50.44 5.1 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.613 0.244 . . . . 0.0 111.39 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.03 16.86 56.92 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.893 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 23.4 tt0 -70.78 96.43 1.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.82 0.31 . . . . 0.0 110.559 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.534 ' H ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.57 156.92 45.16 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.849 -179.388 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -118.58 139.42 51.51 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.464 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.586 ' O ' HG22 ' A' ' 88' ' ' ILE . 1.8 mp -128.03 99.7 24.96 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-O 120.941 0.4 . . . . 0.0 111.38 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -87.89 144.32 6.24 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.032 2.488 . . . . 0.0 112.422 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.452 ' CE1' HG22 ' A' ' 101' ' ' ILE . 38.9 m80 -136.92 172.15 13.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -121.42 151.24 40.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.405 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 tp -139.06 85.32 2.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 0.0 110.624 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -161.41 38.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.519 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -141.68 134.04 28.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.396 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 pp -58.74 131.09 49.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.508 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 62.25 75.4 0.4 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.027 0.441 . . . . 0.0 110.599 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -105.33 135.67 46.28 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.018 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t -136.87 74.43 1.49 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.165 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -113.64 119.14 36.41 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.383 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -148.21 136.44 21.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.09 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.505 ' CG1' HD11 ' A' ' 11' ' ' ILE . 6.3 p -116.94 143.2 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.81 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.34 122.03 20.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.078 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.74 159.22 37.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.49 138.09 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.485 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.25 110.75 26.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.175 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -130.03 120.36 24.59 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.469 HD13 ' HB2' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -146.56 55.38 2.54 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.09 -44.27 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.484 2.123 . . . . 0.0 112.86 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.0 tp -106.49 -35.8 6.98 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.106 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttm . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.746 0.308 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 p -108.43 -34.85 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.657 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 58.13 77.04 0.31 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.84 0.353 . . . . 0.0 111.674 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 121' ' ' PRO . 0.7 OUTLIER -151.61 166.23 31.86 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.66 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 43' ' ' GLY . 29.7 t -134.96 118.91 25.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.755 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.77 106.28 5.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.675 ' NH1' HD11 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -124.05 167.55 14.04 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.632 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -178.06 133.0 0.15 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.902 HG21 HG21 ' A' ' 90' ' ' VAL . 3.6 tt -106.14 118.22 53.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.059 0.457 . . . . 0.0 110.834 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -116.56 107.05 14.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.012 HD13 HG21 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -110.38 135.13 50.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -120.14 138.68 53.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.998 -179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 105' ' ' LEU . 1.2 m -141.07 113.99 8.42 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 1.2 mt-30 -127.02 147.71 50.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.677 0.275 . . . . 0.0 111.078 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -138.88 145.08 39.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -143.32 119.3 10.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.827 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 10.2 mt -114.19 141.95 28.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.738 0.304 . . . . 0.0 110.792 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.632 HD23 ' HB2' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -120.76 89.56 45.33 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.11 -1.48 11.64 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.745 2.297 . . . . 0.0 113.165 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.632 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -64.79 -15.26 61.45 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.08 131.23 94.44 Favored Pre-proline 0 C--O 1.234 0.267 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 59.3 Cg_endo -72.74 125.65 10.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.287 1.991 . . . . 0.0 112.855 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 22' ' ' PRO . 35.8 Cg_exo -60.13 177.55 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.994 2.463 . . . . 0.0 112.383 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 24' ' ' VAL . 8.0 t 64.15 36.41 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.236 0.541 . . . . 0.0 110.109 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -162.67 -52.6 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.714 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -148.41 140.65 24.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.925 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.49 162.4 67.07 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.912 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.69 115.33 2.61 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.767 2.311 . . . . 0.0 112.29 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.531 HG13 ' HA2' ' A' ' 80' ' ' GLY . 21.9 t -93.6 128.0 45.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.02 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.35 159.4 23.48 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.107 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -116.59 158.51 23.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -157.6 145.49 18.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.334 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 p -146.04 117.56 8.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.652 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 2.3 tp -130.34 134.74 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.46 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.9 pt-20 -136.47 135.08 38.32 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.471 ' CG2' HG13 ' A' ' 55' ' ' ILE . 4.1 mp -110.06 114.83 48.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.716 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.7 t -125.2 135.69 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.277 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.716 HD11 HG21 ' A' ' 68' ' ' THR . 1.4 pp -157.69 154.23 27.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.424 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 42' ' ' GLU . 2.5 mp -99.58 161.89 13.35 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.598 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -174.72 -46.9 0.01 OUTLIER 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.06 -19.59 65.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.363 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HB2' HD23 ' A' ' 39' ' ' LEU . 1.9 mt-10 -98.69 -36.7 9.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.244 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.662 ' O ' HG13 ' A' ' 5' ' ' VAL . . . -99.9 45.85 1.46 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.875 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt 62.01 100.98 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.08 48.47 1.37 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.198 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.1 mt -128.0 110.92 20.12 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.291 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.77 161.4 10.25 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.153 2.569 . . . . 0.0 113.036 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.64 -54.0 0.82 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.628 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.403 HG22 HG13 ' A' ' 50' ' ' ILE . 32.0 m -117.06 -63.49 1.44 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.93 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.403 HG13 HG22 ' A' ' 49' ' ' THR . 64.2 mt -120.82 -78.12 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.795 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.7 t80 57.75 98.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.284 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 9.9 t70 -172.53 107.45 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.898 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.507 ' CG ' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -91.34 128.92 37.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.488 HG23 ' OG ' ' A' ' 89' ' ' SER . 3.0 m -132.16 116.28 28.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 121.086 0.47 . . . . 0.0 111.654 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.991 HG23 HG22 ' A' ' 88' ' ' ILE . 2.3 mm -106.75 155.67 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -142.24 141.13 32.46 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.429 ' NE2' HG21 ' A' ' 61' ' ' THR . 14.5 p-80 -150.44 119.55 6.74 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.935 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 105' ' ' LEU . 5.7 mp 67.68 162.88 0.19 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.328 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.401 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -81.78 -51.36 0.83 Allowed Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.68 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 58' ' ' LEU . 74.4 Cg_exo -49.98 -26.09 13.66 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.04 2.494 . . . . 0.0 113.872 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.429 HG21 ' NE2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -78.41 9.25 4.07 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.605 0.24 . . . . 0.0 111.145 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -60.72 -31.5 70.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.843 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.7 -34.94 78.18 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.057 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -133.73 75.88 67.15 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 121.018 0.437 . . . . 0.0 111.402 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.26 -176.6 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.112 2.542 . . . . 0.0 112.0 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -110.62 128.1 55.54 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.886 0.374 . . . . 0.0 111.185 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.87 105.8 3.59 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.482 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.716 HG21 HD11 ' A' ' 38' ' ' LEU . 6.2 m -97.46 116.6 29.97 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.254 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -121.66 -51.23 2.05 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.96 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 p -147.33 35.36 0.89 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.77 157.94 58.37 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.302 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.82 172.48 10.59 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.093 2.528 . . . . 0.0 112.607 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.9 177.67 1.3 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.822 2.348 . . . . 0.0 112.383 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -141.74 163.47 32.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.914 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER -174.96 121.55 0.22 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -140.18 131.14 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.195 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.0 113.64 10.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.816 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -139.51 174.16 10.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.535 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.52 168.9 11.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.115 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.531 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 128.3 -121.67 3.77 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.324 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -118.34 110.94 18.1 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.776 0.322 . . . . 0.0 110.481 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.35 112.45 0.41 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.927 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -165.93 109.19 0.35 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.612 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 6.7 m-85 -160.85 170.65 8.13 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 120.397 0.141 . . . . 0.0 110.983 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.74 169.81 3.06 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.125 2.55 . . . . 0.0 113.253 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 105' ' ' LEU . 3.6 mp -143.03 168.28 20.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.219 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 25.9 t0 -158.78 119.33 3.26 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.716 0.293 . . . . 0.0 111.651 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.012 HG21 HD13 ' A' ' 11' ' ' ILE . 1.1 pp -112.68 109.51 28.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 111.151 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.488 ' OG ' HG23 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -122.14 111.41 16.94 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.498 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 9' ' ' ILE . 19.2 t -105.29 145.65 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.607 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 11.8 m-85 -131.66 152.81 50.57 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.72 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.893 HD22 HG21 ' A' ' 118' ' ' ILE . 5.4 tp -141.65 -54.46 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.089 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 92' ' ' LEU . 1.2 mp -143.2 -70.46 0.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.834 0.349 . . . . 0.0 110.596 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' HB3' ' HD3' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -161.92 -49.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.73 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.436 ' HD3' ' HB3' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -140.47 29.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.563 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.689 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -98.03 -45.63 6.19 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.972 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA3' HG12 ' A' ' 118' ' ' ILE . . . -158.75 43.18 0.48 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.304 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 3.8 tt0 -100.35 99.34 9.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.539 0.209 . . . . 0.0 110.947 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -142.52 149.06 38.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.736 0.303 . . . . 0.0 111.52 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -134.33 137.3 44.09 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.145 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.4 mt -144.41 121.83 6.56 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.386 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 98.0 Cg_endo -79.29 147.07 20.21 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.62 2.214 . . . . 0.0 112.363 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.27 172.58 11.67 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.164 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -131.24 138.8 49.49 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.063 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.548 ' HB2' HD11 ' A' ' 86' ' ' LEU . 4.0 tp -131.21 83.12 2.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.838 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.94 35.25 0.15 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.308 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -138.85 132.2 30.14 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -58.98 125.24 22.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.512 179.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 71.31 70.79 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.19 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 1.2 tp10 -107.33 138.01 44.32 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.481 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p -137.7 73.18 1.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.853 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -109.72 119.35 39.12 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.413 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -152.13 127.62 10.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.788 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -104.04 145.68 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.744 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.85 108.53 9.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.547 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.36 123.75 50.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.77 142.56 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 111.684 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.893 HG21 HD22 ' A' ' 92' ' ' LEU . 3.5 mp -131.34 120.74 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.751 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -127.29 121.35 30.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.448 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.553 HD11 ' NH1' ' A' ' 7' ' ' ARG . 2.7 pt -153.92 65.13 5.07 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.607 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.636 ' HB3' HG22 ' A' ' 4' ' ' THR . 39.1 Cg_endo -66.51 -31.89 40.75 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.54 2.16 . . . . 0.0 112.884 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.45 26.06 10.35 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.224 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.142 179.599 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.465 0.174 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 t -115.91 -61.84 2.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.921 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 67.79 139.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.687 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.07 147.17 26.17 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.997 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.462 HG13 ' CA ' ' A' ' 43' ' ' GLY . 21.9 t -124.64 119.02 55.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.727 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -135.77 105.82 6.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.7 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 25.8 mtt-85 -123.23 159.54 28.48 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.033 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 t -173.34 129.31 0.45 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.752 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 36' ' ' ILE . 2.3 tt -108.38 118.26 55.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.925 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.97 110.11 16.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.663 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.3 pt -115.86 137.06 50.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.533 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.5 mptp? -121.55 137.98 54.5 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.044 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.488 HG22 ' HG ' ' A' ' 105' ' ' LEU . 3.5 m -140.65 104.62 4.77 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -121.5 154.19 36.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.938 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.52 ' HB2' HD21 ' A' ' 105' ' ' LEU . 3.3 tt0 -154.65 143.2 20.64 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.014 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -135.02 119.36 17.84 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.716 0.293 . . . . 0.0 111.097 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 14.9 mt -116.04 100.88 11.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.783 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.3 109.23 2.25 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.591 ' O ' HG23 ' A' ' 21' ' ' VAL . 35.4 Cg_endo -66.83 -48.47 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.535 2.157 . . . . 0.0 112.581 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 56.98 32.68 22.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.024 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 19' ' ' PRO . 22.5 t -125.35 139.81 34.75 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.599 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.66 167.72 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.838 2.359 . . . . 0.0 112.483 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.59 79.1 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.682 2.255 . . . . 0.0 112.488 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.62 -44.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.359 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -141.72 143.16 33.39 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.006 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.93 -172.43 3.98 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.792 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 65.08 82.77 0.2 Allowed Pre-proline 0 N--CA 1.465 0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.032 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.34 160.82 44.13 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.851 2.367 . . . . 0.0 112.906 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.495 HG13 ' HA2' ' A' ' 80' ' ' GLY . 30.2 t -90.79 149.78 3.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.964 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -126.05 152.7 45.45 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.204 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.62 154.43 21.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.187 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -152.81 137.58 17.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.053 0.454 . . . . 0.0 111.559 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.4 t -141.53 117.7 10.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.509 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 12' ' ' LYS . 9.1 tp -128.55 144.57 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.291 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.41 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -158.4 154.83 27.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.973 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.968 HG21 HD13 ' A' ' 55' ' ' ILE . 18.8 tt -148.3 125.46 2.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.965 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.777 HG12 ' HB3' ' A' ' 73' ' ' PRO . 27.7 m -128.89 123.74 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.198 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.588 HD22 ' CG2' ' A' ' 68' ' ' THR . 0.9 OUTLIER -137.83 142.51 40.78 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 7' ' ' ARG . 3.7 mm? -80.47 165.9 21.73 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.833 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.94 -65.94 0.16 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -64.4 -21.3 66.59 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.638 0.256 . . . . 0.0 111.09 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.92 -31.13 22.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.643 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' CA ' HG13 ' A' ' 5' ' ' VAL . . . -106.48 40.39 2.52 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.49 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 mttt 64.14 97.18 0.04 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 110.978 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -69.59 -12.44 61.64 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.662 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.56 134.96 46.93 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-O 120.525 0.203 . . . . 0.0 111.07 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.42 -172.85 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.687 2.258 . . . . 0.0 112.628 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.688 ' CB ' HD21 ' A' ' 93' ' ' LEU . . . -162.29 -64.1 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.605 ' OG1' HD23 ' A' ' 93' ' ' LEU . 25.6 m -116.31 -51.8 2.6 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.397 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.685 HD12 ' HB3' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -133.79 -83.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.783 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.1 t80 54.4 94.82 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.136 0.493 . . . . 0.0 111.13 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -171.82 143.82 1.7 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.271 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -137.61 134.47 35.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 111.238 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.634 HG13 ' CD ' ' A' ' 67' ' ' ARG . 21.7 t -117.92 145.82 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.531 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.968 HD13 HG21 ' A' ' 36' ' ' ILE . 2.8 mt -123.99 134.08 67.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.775 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 65' ' ' PRO . 49.6 m-85 -135.04 135.02 40.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.91 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -157.47 130.14 7.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.22 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 1.8 mt 73.75 -177.06 0.17 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -55.8 138.37 70.89 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.615 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 59' ' ' HIS . 21.7 Cg_exo -65.82 -6.24 13.71 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.987 2.458 . . . . 0.0 112.857 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -9.12 3.29 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.63 152.06 5.48 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.691 0.281 . . . . 0.0 111.11 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.68 -48.04 40.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.397 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 13.1 p30 -157.82 136.87 8.1 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.04 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 39.1 Cg_exo -57.92 170.23 2.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.943 2.429 . . . . 0.0 112.788 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.5 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.0 m-20 -101.67 151.43 22.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.471 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.634 ' CD ' HG13 ' A' ' 54' ' ' VAL . 7.6 mmm-85 -144.93 156.11 43.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.853 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.709 ' OG1' HD11 ' A' ' 55' ' ' ILE . 87.5 m -134.71 112.82 11.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.859 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.493 ' HD1' HG23 ' A' ' 70' ' ' THR . 1.7 t80 -153.18 -51.03 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.838 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.493 HG23 ' HD1' ' A' ' 69' ' ' PHE . 55.6 p -144.17 30.18 1.29 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.835 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -123.49 150.92 62.29 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.206 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 38.1 Cg_exo -60.85 166.75 9.76 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.086 2.524 . . . . 0.0 112.466 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.777 ' HB3' HG12 ' A' ' 37' ' ' VAL . 27.8 Cg_exo -62.18 -173.22 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.042 2.495 . . . . 0.0 112.693 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.73 161.08 39.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 111.757 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.73 94.77 0.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.661 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.66 111.19 35.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -131.92 124.57 29.72 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.027 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -153.86 168.2 27.15 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.707 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -112.8 149.36 33.15 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.982 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.495 ' HA2' HG13 ' A' ' 29' ' ' VAL . . . 137.93 -113.84 1.02 Allowed Glycine 0 C--N 1.334 0.448 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.262 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -126.06 109.97 13.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.574 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.27 76.88 0.16 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.673 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -129.85 106.51 0.73 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.79 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 7.1 m-85 -158.18 167.75 13.84 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.582 0.229 . . . . 0.0 110.836 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 42.0 Cg_endo -67.55 168.29 18.58 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.929 2.419 . . . . 0.0 113.662 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 103' ' ' HIS . 0.5 OUTLIER -150.41 157.74 43.37 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.492 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -150.4 136.28 18.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.027 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.0 pt -125.92 139.14 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.886 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.2 p -130.02 146.82 51.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.858 0.361 . . . . 0.0 110.995 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 38.9 t -138.06 147.0 26.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.12 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.685 ' HB3' HD12 ' A' ' 50' ' ' ILE . 96.6 m-85 -155.54 144.99 21.05 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.9 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.629 HD23 ' HD3' ' A' ' 95' ' ' LYS . 16.4 tp -134.4 -50.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.539 0.209 . . . . 0.0 111.455 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.688 HD21 ' CB ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -161.67 -62.8 0.05 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.834 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -179.55 42.92 0.0 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.312 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.629 ' HD3' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -113.85 -163.73 0.88 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.938 -179.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.35 -26.26 38.79 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.662 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.85 -33.35 59.99 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.648 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -71.21 84.27 0.75 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.203 0.525 . . . . 0.0 110.669 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -142.4 151.81 42.2 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.34 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -121.47 143.24 49.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.79 120.72 10.3 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -90.86 150.79 4.0 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.241 2.627 . . . . 0.0 112.676 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.434 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . 59.9 m-70 -143.95 166.82 23.88 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.114 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -125.88 129.84 50.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.799 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -110.28 102.21 10.89 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.785 0.326 . . . . 0.0 111.335 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.431 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 4.0 t-20 -177.26 45.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.27 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -141.55 128.61 20.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.644 0.259 . . . . 0.0 111.31 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 109' ' ' GLN . 3.1 pp -60.03 132.81 55.11 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.407 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.482 ' HB2' HD12 ' A' ' 108' ' ' LEU . 0.1 OUTLIER 68.98 44.66 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.171 0.51 . . . . 0.0 110.834 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.76 135.41 37.99 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.604 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -146.54 58.81 1.2 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.728 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -107.03 119.21 38.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.13 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 2.5 pt-20 -145.65 142.55 29.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.188 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.51 147.04 17.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.556 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.69 108.45 8.02 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.692 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -113.82 139.25 49.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.681 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 117' ' ' VAL . 11.9 p -123.73 121.44 62.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.077 0.465 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.414 HG21 HD22 ' A' ' 92' ' ' LEU . 2.9 mp -113.74 111.24 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.377 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -126.06 148.53 49.31 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.29 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 120' ' ' ILE . 3.6 tp -171.56 59.59 0.28 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 121.27 0.557 . . . . 0.0 111.554 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.04 -27.22 10.14 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.582 2.188 . . . . 0.0 112.521 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.1 mt -67.57 -43.22 81.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.003 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.6 m120 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.064 179.882 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.5 m -98.32 30.5 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.677 0.275 . . . . 0.0 111.566 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.24 150.38 21.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.708 0.29 . . . . 0.0 111.186 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.85 151.22 30.16 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 44' ' ' LYS . 34.0 t -137.64 119.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.032 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -129.71 105.25 7.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.606 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.3 mtt180 -123.84 163.19 21.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.092 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 1.9 t -158.77 143.69 16.06 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.775 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 tp -115.05 122.88 70.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.822 0.344 . . . . 0.0 110.779 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' CD ' ' HG2' ' A' ' 115' ' ' GLU . 9.3 mtt180 -134.0 106.39 7.22 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.024 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.84 HD13 HG13 ' A' ' 88' ' ' ILE . 1.1 pt -113.12 123.44 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.565 ' HB2' ' CG ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -114.58 124.4 51.77 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.41 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.419 HG22 HD13 ' A' ' 105' ' ' LEU . 5.4 m -125.0 108.75 12.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 3.0 tt0 -116.22 142.33 46.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.783 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -142.14 142.18 32.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 31' ' ' GLN . 82.9 t60 -133.8 119.23 18.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.67 0.271 . . . . 0.0 111.139 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 108' ' ' LEU . 9.9 mt -118.73 139.23 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.815 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 18' ' ' LEU . 8.8 tp -142.07 78.64 17.0 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 120.813 0.34 . . . . 0.0 111.391 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.12 -27.47 8.23 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.801 2.334 . . . . 0.0 112.941 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -65.86 -63.8 1.01 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.319 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -113.6 134.62 21.98 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.71 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -52.66 106.56 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.785 2.323 . . . . 0.0 112.442 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.77 -47.38 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.582 2.188 . . . . 0.0 112.391 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.96 -31.94 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.707 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -141.62 160.87 39.27 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.393 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -54.65 -43.34 72.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.416 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.686 ' O ' HG23 ' A' ' 29' ' ' VAL . 4.0 m-85 -78.35 150.17 76.57 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.806 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.56 114.05 1.59 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.969 2.446 . . . . 0.0 112.568 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 27' ' ' PHE . 21.8 t -125.26 150.13 30.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.208 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.68 163.99 21.59 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 111.314 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -117.08 158.17 24.64 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.844 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.455 ' CZ2' ' HB2' ' A' ' 78' ' ' GLU . 67.7 p-90 -154.02 140.18 18.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.0 p -142.77 117.52 9.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.003 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.7 tp -127.61 127.2 68.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 111.422 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.565 ' CG ' ' HB2' ' A' ' 12' ' ' LYS . 1.7 pt-20 -130.37 135.35 47.95 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.668 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.77 HG12 HG21 ' A' ' 55' ' ' ILE . 4.3 mp -115.69 106.36 20.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.047 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -104.83 140.85 21.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.986 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.686 ' CD2' HG21 ' A' ' 68' ' ' THR . 1.2 pp -159.26 161.52 36.0 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.187 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 39' ' ' LEU . 1.1 mm? -120.82 159.53 25.27 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.42 -45.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.057 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.12 2.45 15.17 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.209 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -83.41 -36.24 24.42 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.65 0.262 . . . . 0.0 110.959 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.55 -70.72 0.23 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.719 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.658 ' HB2' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -134.01 120.87 20.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.686 0.279 . . . . 0.0 111.32 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.83 30.01 5.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.471 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.3 mt -128.27 131.63 23.89 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.691 -0.232 . . . . 0.0 111.183 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.544 ' HA ' HD12 ' A' ' 93' ' ' LEU . 72.5 Cg_endo -76.07 -172.72 1.43 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.828 2.352 . . . . 0.0 112.625 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.707 ' HB3' ' CB ' ' A' ' 93' ' ' LEU . . . -156.01 -49.68 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.422 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 m -110.73 -63.99 1.33 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.593 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.11 -74.41 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.838 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 47.9 t80 56.86 93.24 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.445 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -158.57 116.0 2.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.372 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.742 ' HG2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -110.81 115.06 28.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.385 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 t -112.73 150.1 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 111.66 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.829 HG23 ' CD1' ' A' ' 88' ' ' ILE . 4.9 mp -131.07 133.47 62.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.639 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -127.46 121.34 30.53 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.831 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.659 ' CD2' HG21 ' A' ' 61' ' ' THR . 0.2 OUTLIER -128.67 108.98 10.93 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.82 HD11 ' CD2' ' A' ' 105' ' ' LEU . 6.2 mp 70.39 156.23 0.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.531 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.41 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 1.7 m-70 -74.88 -50.56 4.05 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.43 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 58' ' ' LEU . 82.4 Cg_exo -47.7 -29.35 10.82 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.975 2.45 . . . . 0.0 113.496 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.659 HG21 ' CD2' ' A' ' 57' ' ' HIS . 3.5 m -73.4 9.06 1.45 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -35.49 69.68 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.702 0.287 . . . . 0.0 110.679 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.98 -31.14 71.5 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.374 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -139.85 68.17 35.82 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.206 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.57 -175.58 1.15 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.779 2.319 . . . . 0.0 111.771 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 1.6 m120 -119.81 139.87 51.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.158 0.504 . . . . 0.0 111.106 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.36 140.29 23.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.679 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.686 HG21 ' CD2' ' A' ' 38' ' ' LEU . 86.9 m -116.47 113.1 22.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.051 0.453 . . . . 0.0 111.467 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -131.95 -56.22 0.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.621 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.2 33.88 1.09 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.35 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -125.8 159.48 61.07 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.58 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.3 Cg_exo -67.07 175.01 6.08 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.346 2.697 . . . . 0.0 112.434 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 38.4 Cg_endo -65.92 -178.08 0.94 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.8 2.333 . . . . 0.0 112.502 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.82 162.43 30.58 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 111.701 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.67 80.34 0.04 OUTLIER 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.403 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.6 mm -116.6 130.76 70.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.385 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.75 128.77 29.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.579 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.455 ' HB2' ' CZ2' ' A' ' 32' ' ' TRP . 3.3 mt-10 -138.26 167.34 22.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.987 0.422 . . . . 0.0 111.692 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -121.6 128.03 51.51 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.854 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.24 -121.44 1.01 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.559 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -121.21 110.1 15.77 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 110.756 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.8 106.63 0.25 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.508 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.22 101.37 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.834 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 10.0 m-85 -152.94 171.33 6.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.544 0.212 . . . . 0.0 111.186 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.9 Cg_exo -56.03 176.1 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.288 2.658 . . . . 0.0 113.308 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.78 147.14 29.54 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.07 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -145.54 124.15 12.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.854 0.359 . . . . 0.0 111.116 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.84 HG13 HD13 ' A' ' 11' ' ' ILE . 14.6 mm -122.96 125.74 72.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.958 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.4 p -127.81 144.84 51.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.805 0.336 . . . . 0.0 111.55 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.742 HG23 ' HG2' ' A' ' 53' ' ' LYS . 4.0 p -134.23 132.81 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 8.3 m-85 -133.44 155.76 48.94 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.562 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.452 HD23 ' N ' ' A' ' 92' ' ' LEU . 1.4 pt? -144.62 -157.23 0.77 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.397 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.707 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -98.02 38.09 1.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.124 0.487 . . . . 0.0 110.708 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -170.54 -167.12 0.56 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.421 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 42.05 3.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.722 0.296 . . . . 0.0 111.049 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.49 -28.39 8.2 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -114.17 -10.66 13.33 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.187 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -56.16 107.42 0.36 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.971 0.385 . . . . 0.0 110.748 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.466 ' H ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.34 146.51 35.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.812 -179.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 123.26 22.04 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.208 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.952 HD13 HG11 ' A' ' 114' ' ' VAL . 19.9 tt -129.79 124.13 21.49 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-O 120.927 0.394 . . . . 0.0 111.894 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.07 160.52 8.65 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.008 2.472 . . . . 0.0 112.312 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -148.61 172.41 14.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.966 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.63 143.75 50.96 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.696 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.82 ' CD2' HD11 ' A' ' 58' ' ' LEU . 7.4 tp -130.65 88.47 2.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.011 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -172.04 42.15 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -141.51 130.03 22.61 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.163 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 3.4 pp -58.16 131.3 50.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.526 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.94 53.74 1.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.905 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 15' ' ' GLN . 1.2 tp10 -85.07 135.23 34.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.28 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.9 t -143.74 62.52 1.36 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.649 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -105.31 119.31 38.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.308 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 12' ' ' LYS . 1.2 pt-20 -153.41 145.64 23.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.127 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.952 HG11 HD13 ' A' ' 101' ' ' ILE . 27.0 m -125.51 151.46 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.727 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.432 ' HG2' ' CD ' ' A' ' 10' ' ' ARG . 1.3 mt-10 -137.52 109.08 6.97 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.672 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 155.63 27.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.53 143.88 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.352 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.27 111.02 14.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -121.5 121.11 36.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.638 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.65 HD13 HD21 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -145.41 75.09 13.78 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.92 0.37 8.4 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.679 2.253 . . . . 0.0 113.55 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.4 tp 75.9 -62.28 0.44 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.428 0.291 . . . . 0.0 111.06 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.991 179.794 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.671 0.272 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 t -92.05 132.1 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.063 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.65 115.67 1.67 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.294 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.91 121.05 18.93 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.639 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 44' ' ' LYS . 17.5 t -134.0 119.39 31.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.218 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.0 105.86 12.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.285 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.32 162.39 16.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.249 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 4.2 t -175.0 149.28 1.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.374 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.744 HD11 HD11 ' A' ' 36' ' ' ILE . 2.5 tt -128.29 133.89 65.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.482 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 111.56 11.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.297 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.93 HD13 HD13 ' A' ' 88' ' ' ILE . 8.0 pt -114.81 130.15 69.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.37 136.89 52.83 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.8 HG23 ' CD1' ' A' ' 34' ' ' ILE . 5.6 m -133.66 111.51 10.67 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.77 117.27 24.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.942 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 109' ' ' GLN . 3.0 tp60 -109.97 147.12 34.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.952 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -155.03 119.93 4.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.077 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.862 HG22 ' HA ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -112.66 129.96 67.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.02 0.438 . . . . 0.0 111.334 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.434 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -151.55 94.36 3.42 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.52 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD3' HD13 ' A' ' 17' ' ' ILE . 24.0 Cg_exo -64.29 -55.9 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.812 2.341 . . . . 0.0 112.722 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 53.45 34.59 18.57 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.906 0.384 . . . . 0.0 111.173 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 10.6 p -125.86 139.69 34.86 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 52.0 Cg_exo -55.62 167.2 2.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.78 2.32 . . . . 0.0 112.639 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.0 92.77 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.793 2.329 . . . . 0.0 112.322 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.75 -66.46 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.964 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -147.47 159.02 44.19 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.59 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -69.51 85.06 0.43 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.523 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.2 74.7 7.76 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.697 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.76 120.84 6.91 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.804 2.336 . . . . 0.0 112.572 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.61 94.38 2.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.787 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.569 ' HA ' HG12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -99.69 150.51 22.22 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.772 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -105.11 163.1 12.82 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -156.57 146.96 21.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.998 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.5 p -139.9 117.45 11.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.246 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.8 ' CD1' HG23 ' A' ' 13' ' ' THR . 27.2 mm -119.54 121.5 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.1 pm0 -131.18 116.64 17.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.666 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.744 HD11 HD11 ' A' ' 9' ' ' ILE . 7.9 tt -117.66 123.71 72.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.754 HG12 ' HB3' ' A' ' 73' ' ' PRO . 35.5 m -128.08 143.36 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.872 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.609 HD22 ' HE2' ' A' ' 53' ' ' LYS . 3.2 pp -144.32 163.02 34.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.635 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tp -106.16 157.49 17.52 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.2 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.48 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -171.45 -44.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.067 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.68 1.42 19.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.367 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -34.51 27.52 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.641 0.257 . . . . 0.0 110.751 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.8 -71.59 0.34 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.544 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.8 ' HB2' HG22 ' A' ' 5' ' ' VAL . 1.3 mtmt -144.18 107.09 4.47 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.869 0.366 . . . . 0.0 110.799 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.48 ' HG3' ' HB3' ' A' ' 40' ' ' ASP . 2.3 tt0 -96.26 45.55 1.07 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.83 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.5 118.13 21.44 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.799 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.84 161.4 6.28 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.905 2.403 . . . . 0.0 112.648 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB3' ' HG ' ' A' ' 93' ' ' LEU . . . -129.44 -71.43 0.62 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.568 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 p -113.06 -63.36 1.45 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.021 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.61 -80.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.07 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 31.6 t80 54.3 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.283 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.4 t0 -161.08 124.52 3.31 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.805 ' HG2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -117.39 136.77 52.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.445 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.751 HG13 ' HG3' ' A' ' 67' ' ' ARG . 6.6 t -128.96 135.83 61.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.02 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.507 ' HB ' ' CB ' ' A' ' 66' ' ' ASN . 4.9 mt -112.89 140.54 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.456 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.71 129.05 18.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.478 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.445 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 6.4 p80 -140.21 123.36 16.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.977 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.604 HD21 HD23 ' A' ' 105' ' ' LEU . 75.2 mt 68.84 -175.79 0.2 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.86 164.63 59.77 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 120.693 0.282 . . . . 0.0 111.188 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.5 -12.66 17.93 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.006 2.47 . . . . 0.0 113.123 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.94 -13.66 2.87 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.391 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -68.05 167.86 13.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.651 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.36 -48.7 65.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.289 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -175.58 149.0 1.05 Allowed Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.115 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.36 163.43 36.47 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.621 2.214 . . . . 0.0 112.021 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.507 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.9 m-80 -108.02 157.64 18.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.095 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.751 ' HG3' HG13 ' A' ' 54' ' ' VAL . 4.0 mtt180 -150.77 156.22 40.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.783 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.546 HG21 HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -134.54 126.16 28.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.91 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.749 ' CE2' HG22 ' A' ' 70' ' ' THR . 10.2 p90 -165.59 -45.11 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.887 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.749 HG22 ' CE2' ' A' ' 69' ' ' PHE . 13.6 t -146.04 30.49 1.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -134.2 156.83 78.71 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.203 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 40.1 Cg_endo -66.76 175.61 5.18 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.014 2.476 . . . . 0.0 112.188 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.754 ' HB3' HG12 ' A' ' 37' ' ' VAL . 10.9 Cg_endo -54.04 168.14 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.209 2.606 . . . . 0.0 112.8 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -128.7 88.66 2.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.919 0.39 . . . . 0.0 111.965 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 3.3 ttp85 -107.69 90.8 3.41 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.222 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.07 137.28 57.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.532 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.28 142.16 50.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.827 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -159.92 168.27 26.11 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.687 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -107.06 175.02 5.64 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.881 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.76 -141.98 12.8 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.631 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -126.57 110.1 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.122 0.487 . . . . 0.0 110.934 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.4 -129.18 6.35 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.361 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.17 47.98 3.43 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.701 -0.559 . . . . 0.0 111.701 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.497 ' HB2' ' HA ' ' A' ' 58' ' ' LEU . 64.1 m-85 -142.13 159.7 57.8 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.82 0.343 . . . . 0.0 111.019 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 39.2 Cg_endo -67.32 162.63 37.82 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.941 2.427 . . . . 0.0 113.622 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -148.88 134.24 18.47 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.795 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -143.96 153.02 41.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 111.415 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.93 HD13 HD13 ' A' ' 11' ' ' ILE . 3.9 mp -136.99 120.5 22.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 p -105.27 145.23 30.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.805 HG23 ' HG2' ' A' ' 53' ' ' LYS . 6.1 p -133.29 143.28 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -145.3 155.18 43.05 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.572 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.928 HD11 ' HB3' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -136.22 -45.53 0.63 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.629 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -143.37 -75.66 0.26 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.59 0.233 . . . . 0.0 111.22 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -140.34 -55.83 0.53 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.117 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.43 61.54 0.39 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 111.261 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.928 ' HB3' HD11 ' A' ' 92' ' ' LEU . . . -111.78 -39.65 4.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.794 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.624 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . -157.99 32.78 0.51 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.629 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.2 pp20? -88.93 116.76 27.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.977 0.418 . . . . 0.0 110.854 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.51 ' H ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -143.61 156.39 44.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.742 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -120.82 129.65 53.65 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.881 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.658 ' CG2' HG21 ' A' ' 114' ' ' VAL . 3.1 mt -111.37 99.84 45.4 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 120.692 0.282 . . . . 0.0 111.596 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -88.85 140.22 4.06 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.129 2.553 . . . . 0.0 112.248 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.71 172.33 17.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.314 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -114.51 150.85 34.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.647 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.776 ' HB2' HD22 ' A' ' 86' ' ' LEU . 13.2 tp -125.38 82.28 2.05 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.886 0.374 . . . . 0.0 111.102 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.7 -175.36 4.38 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.744 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.477 ' HA ' ' HG2' ' A' ' 15' ' ' GLN . 2.8 p90 -111.46 166.3 11.25 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.769 0.318 . . . . 0.0 111.856 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.862 ' HA ' HG22 ' A' ' 17' ' ' ILE . 0.5 OUTLIER 81.12 65.18 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.331 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 15' ' ' GLN . 19.3 mt-30 66.38 133.19 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.123 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.419 ' CB ' ' HB3' ' A' ' 15' ' ' GLN . 35.4 tt0 -157.66 134.68 10.1 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.262 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.39 71.89 1.49 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.582 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -115.99 119.17 35.05 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.704 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -153.49 139.37 18.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.29 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.658 HG21 ' CG2' ' A' ' 101' ' ' ILE . 13.0 t -118.81 152.46 21.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.63 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.38 108.89 8.97 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -113.26 151.84 30.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.431 ' C ' HD12 ' A' ' 118' ' ' ILE . 13.9 p -127.9 151.52 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.845 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.624 HG23 ' HA3' ' A' ' 97' ' ' GLY . 4.2 mp -141.32 126.5 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.079 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -127.11 117.18 21.9 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.761 0.315 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -129.94 61.84 60.45 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.337 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -87.96 26.96 0.56 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.704 2.27 . . . . 0.0 113.03 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.91 76.64 0.32 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.937 0.399 . . . . 0.0 111.095 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.169 179.759 . . . . . . . . 0 0 . 1 stop_ save_